|
Recent advances in the detection of respiratory virus infection in humans.
|
NA
|
3
|
|
[Jungle yellow fever with positive serology for leptospira in a young peruvian male].
|
NA
|
NA
|
|
Coronavirus infections and immune responses.
|
NA
|
NA
|
|
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
|
NA
|
3
|
|
Drug treatment options for the 2019-new coronavirus (2019-nCoV).
|
NA
|
3
|
|
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.
|
NA
|
3
|
|
The Novel Coronavirus: A Bird’s Eye View.
|
NA
|
NA
|
|
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
|
NA
|
3
|
|
[Diagnosis and clinical management of 2019 novel coronavirus infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)].
|
NA
|
3
|
|
[2019-nCoV: new challenges from coronavirus].
|
NA
|
NA
|
|
[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
|
NA
|
3
|
|
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.
|
NA
|
3
|
|
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.
|
NA
|
3
|
|
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).
|
NA
|
3
|
|
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
|
NA
|
3
|
|
[Interpretation of “Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)”].
|
NA
|
NA
|
|
Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement.
|
NA
|
3
|
|
[Suggestions for disinfection of ophthalmic examination equipment and protection of ophthalmologist against 2019 novel coronavirus infection].
|
NA
|
NA
|
|
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
|
NA
|
3
|
|
Critical care management of adults with community-acquired severe respiratory viral infection.
|
NA
|
3
|
|
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.
|
NA
|
3
|
|
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
|
NA
|
3
|
|
Overview of The 2019 Novel Coronavirus (2019-nCoV): The Pathogen of Severe Specific Contagious Pneumonia (SSCP).
|
NA
|
3
|
|
[Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection (1st Edition)].
|
NA
|
NA
|
|
[Emergency response plan for the neonatal intensive care unit during epidemic of 2019 novel coronavirus].
|
NA
|
NA
|
|
[Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)].
|
NA
|
3
|
|
Potential interventions for novel coronavirus in China: A systematic review.
|
NA
|
3
|
|
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
|
NA
|
3
|
|
[Pharmacotherapeutics for the New Coronavirus Pneumonia].
|
NA
|
3
|
|
The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome Coronavirus.
|
NA
|
NA
|
|
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
|
NA
|
3
|
|
[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
|
NA
|
NA
|
|
[Analysis of CT features of 15 Children with 2019 novel coronavirus infection].
|
NA
|
3
|
|
[The network investigation on knowledge, attitude and practice about Novel coronavirus pneumonia of the residents in Anhui Province].
|
NA
|
3
|
|
[Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].
|
NA
|
NA
|
|
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
|
NA
|
NA
|
|
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.
|
NA
|
NA
|
|
[Health protection guideline of mobile cabin hospitals during Novel Coronavirus Pneumonia (NPC) outbreak].
|
NA
|
NA
|
|
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
|
NA
|
NA
|
|
[Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China].
|
NA
|
NA
|
|
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
|
NA
|
3
|
|
[Preliminary Recommendations for Lung Surgery during 2019 Novel Coronavirus Disease (COVID-19) Epidemic Period].
|
NA
|
NA
|
|
[Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)].
|
NA
|
NA
|
|
[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
|
NA
|
3
|
|
[Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
|
NA
|
NA
|
|
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies.
|
NA
|
NA
|
|
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.
|
NA
|
NA
|
|
[Emergency management of prevention and control of novel coronavirus pneumonia in departments of stomatology].
|
NA
|
NA
|
|
[Thinking of treatment strategies for colorectal cancer patients in tumor hospitals under the background of coronavirus pneumonia].
|
NA
|
NA
|
|
[Standardized diagnosis and treatment of colorectal cancer during the outbreak of novel coronavirus pneumonia in Renji hospital].
|
NA
|
NA
|
|
[Psychological intervention in oral patients in novel coronavirus pneumonia outbreak period].
|
NA
|
NA
|
|
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
|
NA
|
3
|
|
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
|
NA
|
NA
|
|
[The keypoints in treatment of the critical novel coronavirus pneumonia patient].
|
NA
|
3
|
|
[Pay attention to the exposure risk of patients with chronic wounds on the way to hospital during coronavirus disease 2019 epidemic prevention and control].
|
NA
|
NA
|
|
Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases.
|
NA
|
NA
|
|
COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.
|
NA
|
NA
|
|
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.
|
NA
|
NA
|
|
[Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)].
|
NA
|
NA
|
|
[Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
|
NA
|
3
|
|
[The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease].
|
NA
|
3
|
|
[Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia].
|
NA
|
NA
|
|
Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.
|
NA
|
NA
|
|
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.
|
NA
|
3
|
|
[What are the highlights of “Diagnosis and treatment of Disease 2019 novel coronavirus infection suitable for Military support Hubei medical team”].
|
NA
|
3
|
|
2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings.
|
NA
|
3
|
|
[Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel coronavirus disease].
|
NA
|
NA
|
|
[Chemotherapy strategy for colorectal cancer under the outbreak of novel coronavirus pneumonia].
|
NA
|
NA
|
|
The 2019 novel coronavirus resource.
|
NA
|
3
|
|
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.
|
NA
|
NA
|
|
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
|
NA
|
3
|
|
[Surgical treatment for esophageal cancer during the outbreak of COVID-19].
|
NA
|
NA
|
|
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
|
NA
|
3
|
|
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.
|
NA
|
3
|
|
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.
|
NA
|
3
|
|
[Treatment of pancreatic diseases and prevention of infection during outbreak of 2019 coronavirus disease].
|
NA
|
NA
|
|
Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.
|
NA
|
3
|
|
Clinical trial analysis of 2019-nCoV therapy registered in China.
|
NA
|
3
|
|
[Treatment strategies of Budd-Chiari syndrome during the epidemic period of 2019 coronavirus disease].
|
NA
|
NA
|
|
[Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia].
|
NA
|
NA
|
|
Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2.
|
NA
|
3
|
|
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.
|
NA
|
3
|
|
[The keypoints in treatment of the critical coronavirus disease 2019 patient].
|
NA
|
3
|
|
[Recommendations for the regulation of medical practices of burn treatment during the outbreak of the coronavirus disease 2019].
|
NA
|
NA
|
|
[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of novel coronavirus pneumonia].
|
NA
|
NA
|
|
Characteristics of COVID-19 infection in Beijing.
|
NA
|
3
|
|
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.
|
NA
|
3
|
|
First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan.
|
NA
|
NA
|
|
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.
|
NA
|
NA
|
|
[Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases].
|
NA
|
3
|
|
[Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies].
|
NA
|
3
|
|
Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.
|
NA
|
NA
|
|
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
|
NA
|
3
|
|
[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].
|
NA
|
3
|
|
[Cause analysis and treatment strategies of “recurrence” with novel coronavirus pneumonia (covid-19) patients after discharge from hospital].
|
NA
|
3
|
|
[Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].
|
NA
|
NA
|
|
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
|
NA
|
3
|
|
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.
|
NA
|
3
|
|
[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].
|
NA
|
3
|
|
Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63.
|
NA
|
3
|
|
[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease epidemic].
|
NA
|
NA
|
|
[Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].
|
NA
|
NA
|
|
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
|
NA
|
NA
|
|
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
|
NA
|
3
|
|
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools.
|
NA
|
3
|
|
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.
|
NA
|
3
|
|
[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].
|
NA
|
3
|
|
Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.
|
NA
|
3
|
|
[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].
|
NA
|
NA
|
|
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
[Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin].
|
NA
|
3
|
|
[The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease].
|
NA
|
NA
|
|
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
|
NA
|
3
|
|
Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes.
|
NA
|
3
|
|
The outbreak of COVID-19: An overview.
|
NA
|
3
|
|
Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.
|
NA
|
NA
|
|
The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
|
NA
|
3
|
|
Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
|
NA
|
NA
|
|
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
|
NA
|
3
|
|
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
|
NA
|
NA
|
|
Middle East respiratory syndrome.
|
NA
|
3
|
|
[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province].
|
NA
|
NA
|
|
[The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease].
|
NA
|
NA
|
|
[Healing the schism between public health and medicine, promoting the integration of prevention and treatment].
|
NA
|
NA
|
|
Of chloroquine and COVID-19.
|
NA
|
NA
|
|
Discovering drugs to treat coronavirus disease 2019 (COVID-19).
|
NA
|
3
|
|
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model.
|
NA
|
3
|
|
Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial.
|
NA
|
3
|
|
Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
|
NA
|
3
|
|
Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks.
|
NA
|
NA
|
|
[The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals].
|
NA
|
3
|
|
[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].
|
NA
|
NA
|
|
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China.
|
NA
|
NA
|
|
Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.
|
NA
|
3
|
|
[Treatment of early relapsed plasma cells leukemia after unrelated bone marrow transplant with KRD (carfilzomib, lenalidomide and dexamethasone): a case report.]
|
NA
|
NA
|
|
Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs.
|
NA
|
NA
|
|
CT Manifestations of Novel Coronavirus Pneumonia: A Case Report
|
NA
|
3
|
|
Dysregulation of immune response in patients with COVID-19 in Wuhan, China.
|
NA
|
3
|
|
Chest computed tomography in children with COVID-19 respiratory infection.
|
NA
|
3
|
|
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.
|
NA
|
NA
|
|
A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019.
|
NA
|
3
|
|
[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].
|
NA
|
NA
|
|
[Pharmacotherapeutics for the new coronavirus pneumonia].
|
NA
|
NA
|
|
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
|
NA
|
NA
|
|
[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
|
NA
|
NA
|
|
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
|
NA
|
NA
|
|
COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.
|
NA
|
3
|
|
A Review of Coronavirus Disease-2019 (COVID-19).
|
NA
|
3
|
|
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
|
NA
|
3
|
|
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
|
NA
|
3
|
|
A Diabetic Patient With 2019-nCoV (COVID-19) Infection Who Recovered and Was Discharged From Hospital.
|
NA
|
3
|
|
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
|
NA
|
3
|
|
COVID-19 spike-host cell receptor GRP78 binding site prediction.
|
NA
|
NA
|
|
Coronavirus disease 2019: What we know?
|
NA
|
3
|
|
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
|
NA
|
NA
|
|
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
|
NA
|
3
|
|
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.
|
NA
|
3
|
|
Clinical progression of patients with COVID-19 in Shanghai, China.
|
NA
|
3
|
|
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.
|
NA
|
3
|
|
The SARS-CoV-2 outbreak: what we know.
|
NA
|
3
|
|
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19).
|
NA
|
3
|
|
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0).
|
NA
|
3
|
|
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
|
NA
|
3
|
|
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
|
NA
|
3
|
|
Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
|
NA
|
3
|
|
Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.
|
NA
|
3
|
|
[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].
|
NA
|
NA
|
|
Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.
|
NA
|
3
|
|
Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.
|
NA
|
NA
|
|
COVID-19 and Italy: what next?
|
NA
|
NA
|
|
Teicoplanin: an alternative drug for the treatment of COVID-19?
|
NA
|
3
|
|
Ginkgolic acid inhibits fusion of enveloped viruses.
|
NA
|
3
|
|
A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage.
|
NA
|
3
|
|
Clinical features of pediatric patients with COVID-19: a report of two family cluster cases.
|
NA
|
3
|
|
Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients.
|
NA
|
NA
|
|
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
|
NA
|
3
|
|
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
|
NA
|
3
|
|
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.
|
NA
|
3
|
|
[Challenges and countermeasures on Chinese malaria elimination programme during the coronavirus disease 2019 (COVID-19) outbreak].
|
NA
|
NA
|
|
[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
|
NA
|
3
|
|
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020.
|
NA
|
NA
|
|
Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.
|
NA
|
3
|
|
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.
|
NA
|
3
|
|
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
|
NA
|
3
|
|
Insight into COVID-2019 for pediatricians.
|
NA
|
3
|
|
[2019-nCoV: new challenges from coronavirus].
|
NA
|
NA
|
|
AI-Driven Tools for Coronavirus Outbreak: Need of Active Learning and Cross-Population Train/Test Models on Multitudinal/Multimodal Data.
|
NA
|
NA
|
|
CT image of novel coronavirus pneumonia: a case report.
|
NA
|
NA
|
|
SARS-CoV-2 and COVID-19: The most important research questions.
|
NA
|
NA
|
|
Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
|
NA
|
3
|
|
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.
|
NA
|
NA
|
|
COVID-19 - what should anaethesiologists and intensivists know about it?
|
NA
|
3
|
|
WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.
|
NA
|
NA
|
|
[Treatment strategies for colorectal cancer patients in tumor hospitals under the background of corona virus disease 2019].
|
NA
|
NA
|
|
[Standardized diagnosis and treatment of colorectal cancer during the outbreak of corona virus disease 2019 in Renji hospital].
|
NA
|
NA
|
|
[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].
|
NA
|
3
|
|
CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity.
|
NA
|
3
|
|
Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study.
|
NA
|
NA
|
|
First Pediatric Case of Coronavirus Disease 2019 in Korea.
|
NA
|
NA
|
|
How Should the Rehabilitation Community Prepare for 2019-nCoV?
|
NA
|
NA
|
|
Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates.
|
NA
|
3
|
|
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines.
|
NA
|
NA
|
|
COVID-19 Infection: Implications for Perioperative and Critical Care Physicians.
|
NA
|
3
|
|
Response of Chinese Anesthesiologists to the COVID-19 Outbreak.
|
NA
|
NA
|
|
Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan’s Experience.
|
NA
|
NA
|
|
PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology.
|
NA
|
NA
|
|
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
|
NA
|
NA
|
|
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
|
NA
|
3
|
|
The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.
|
NA
|
3
|
|
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.
|
NA
|
NA
|
|
Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV.
|
NA
|
3
|
|
Clinical features and treatment of COVID-19 patients in northeast Chongqing.
|
NA
|
3
|
|
A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence.
|
NA
|
3
|
|
Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
|
NA
|
3
|
|
Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.
|
NA
|
3
|
|
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
|
NA
|
NA
|
|
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
|
NA
|
NA
|
|
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.
|
NA
|
NA
|
|
The Impact of COVID-19 Epidemic Declaration on Psychological Consequences: A Study on Active Weibo Users.
|
NA
|
NA
|
|
[Standardized management guideline for pediatric wards of hematology and oncology during the epidemic of coronavirus disease 2019].
|
NA
|
NA
|
|
Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children.
|
NA
|
3
|
|
[SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation in a neonate].
|
NA
|
3
|
|
[Twin girls infected with SARS-CoV-2].
|
NA
|
3
|
|
[Emergency plan for inter-hospital transfer of newborns with SARS-CoV-2 infection].
|
NA
|
NA
|
|
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
|
NA
|
3
|
|
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
|
NA
|
3
|
|
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
|
NA
|
3
|
|
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
|
NA
|
3
|
|
Updated approaches against SARS-CoV-2.
|
NA
|
3
|
|
Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China.
|
NA
|
3
|
|
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
|
NA
|
3
|
|
[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)].
|
NA
|
3
|
|
COVID-19: decision making and palliative care.
|
NA
|
NA
|
|
Clinical observation and management of COVID-19 patients.
|
NA
|
3
|
|
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
|
NA
|
3
|
|
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study.
|
NA
|
3
|
|
Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target.
|
NA
|
3
|
|
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
|
NA
|
3
|
|
Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan.
|
NA
|
3
|
|
Coronavirus disease 2019: initial chest CT findings.
|
NA
|
3
|
|
Optimizing COVID-19 candidate therapeutics: Thinking Without Borders.
|
NA
|
NA
|
|
Cancer Care Delivery Challenges Amidst Coronavirus Disease - 19 (COVID-19) Outbreak: Specific Precautions for Cancer Patients and Cancer Care Providers to Prevent Spread.
|
NA
|
NA
|
|
Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.
|
NA
|
3
|
|
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.
|
NA
|
NA
|
|
Italy in a Time of Emergency and Scarce Resources: The Need for Embedding Ethical Reflection in Social and Clinical Settings.
|
NA
|
NA
|
|
Facts and reflections on COVID-19 and anti-hypertensives drugs.
|
NA
|
NA
|
|
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
|
NA
|
3
|
|
Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility.
|
NA
|
3
|
|
Structural and biochemical characterization of SADS-CoV papain-like protease 2.
|
NA
|
NA
|
|
[Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units].
|
NA
|
NA
|
|
Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy.
|
NA
|
NA
|
|
SARS-CoV-2: a storm is raging.
|
NA
|
NA
|
|
Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.
|
NA
|
3
|
|
Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
|
NA
|
3
|
|
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
|
NA
|
3
|
|
Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection.
|
NA
|
NA
|
|
Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China.
|
NA
|
NA
|
|
Development Path and Urgency of further Strengthening Construction of Public Hospitals Based on Novel Coronavirus Pneumonia Treatment.
|
NA
|
NA
|
|
[Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic].
|
NA
|
NA
|
|
Controversial treatments: An updated understanding of the coronavirus disease 2019.
|
NA
|
3
|
|
Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
|
NA
|
3
|
|
Safe Delivery for COVID-19 Infected Pregnancies.
|
NA
|
NA
|
|
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).
|
NA
|
3
|
|
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
|
NA
|
3
|
|
[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].
|
NA
|
3
|
|
[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
|
NA
|
3
|
|
[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
|
NA
|
3
|
|
[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
|
NA
|
3
|
|
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.
|
NA
|
3
|
|
Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.
|
NA
|
3
|
|
The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice.
|
NA
|
NA
|
|
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
|
NA
|
3
|
|
Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.
|
NA
|
3
|
|
[Management of a colon cancer patient infected with corona virus disease 2019].
|
NA
|
NA
|
|
[Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period - FRANCOGYN group for the CNGOF].
|
NA
|
NA
|
|
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
|
NA
|
NA
|
|
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
|
NA
|
3
|
|
COVID-19 Infection in a Patient with End-Stage Kidney Disease.
|
NA
|
3
|
|
Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
|
NA
|
3
|
|
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis.
|
NA
|
NA
|
|
Sixty-eight consecutive patients assessed for COVID-19 infection: Experience from a UK Regional infectious diseases Unit.
|
NA
|
NA
|
|
Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT.
|
NA
|
3
|
|
[Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV].
|
NA
|
NA
|
|
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.
|
NA
|
3
|
|
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China.
|
NA
|
3
|
|
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
|
NA
|
NA
|
|
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
COVID-19: The outbreak caused by a new coronavirus.
|
NA
|
NA
|
|
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
|
NA
|
3
|
|
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.
|
NA
|
3
|
|
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
|
NA
|
3
|
|
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
|
NA
|
NA
|
|
COVID-19: what has been learned and to be learned about the novel coronavirus disease.
|
NA
|
3
|
|
Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
|
NA
|
NA
|
|
Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.
|
NA
|
3
|
|
A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
|
NA
|
NA
|
|
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients.
|
NA
|
3
|
|
COVID-19 treatment by repurposing drugs until the vaccine is in sight.
|
NA
|
3
|
|
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.
|
NA
|
3
|
|
Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.
|
NA
|
NA
|
|
The possible impact of COVID-19 on colorectal surgery in Italy.
|
NA
|
NA
|
|
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.
|
NA
|
3
|
|
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.
|
NA
|
3
|
|
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
|
NA
|
NA
|
|
COVID-19, ACE2, and the cardiovascular consequences.
|
NA
|
3
|
|
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China.
|
NA
|
NA
|
|
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
|
NA
|
3
|
|
[Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].
|
NA
|
3
|
|
Risk-adapted Treatment Strategy For COVID-19 Patients.
|
NA
|
3
|
|
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.
|
NA
|
NA
|
|
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
|
NA
|
3
|
|
Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.
|
NA
|
3
|
|
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
|
NA
|
NA
|
|
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
|
NA
|
3
|
|
Emerging prophylaxis strategies against COVID-19.
|
NA
|
NA
|
|
Potential Treatments for COVID-19; a Narrative Literature Review.
|
NA
|
NA
|
|
Experience of Diagnosing and Managing Patients in Oral Maxillofacial Surgery during the Prevention and Control Period of the New Coronavirus Pneumonia.
|
NA
|
NA
|
|
Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Balancing Health Privacy, Health Information Exchange and Research in the Context of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
|
NA
|
3
|
|
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China.
|
NA
|
3
|
|
Diabetes is a risk factor for the progression and prognosis of COVID-19.
|
NA
|
NA
|
|
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.
|
NA
|
NA
|
|
Coronavirus pandemic and Colorectal surgery: practical advice based on the Italian experience.
|
NA
|
NA
|
|
Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak.
|
NA
|
NA
|
|
Effect of delay in diagnosis on transmission of COVID-19.
|
NA
|
3
|
|
Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.
|
NA
|
3
|
|
Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.
|
NA
|
NA
|
|
Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report.
|
NA
|
3
|
|
Implications for Online Management: Two Cases with COVID-19.
|
NA
|
NA
|
|
[An epidemiologic thinking on the diagnosis criteria of COVID-19].
|
NA
|
NA
|
|
[Analysis of CT features of 15 children with 2019 novel coronavirus infection].
|
NA
|
3
|
|
Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment.
|
NA
|
3
|
|
Coronavirus disease 2019 (COVID-19): current status and future perspectives.
|
NA
|
NA
|
|
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.
|
NA
|
3
|
|
The epidemiology, diagnosis and treatment of COVID-19.
|
NA
|
3
|
|
EMA advice on the use of NSAIDs for Covid-19.
|
NA
|
NA
|
|
COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.
|
NA
|
3
|
|
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis.
|
NA
|
3
|
|
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.
|
NA
|
3
|
|
Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR).
|
NA
|
NA
|
|
A new threat from an old enemy: Re‑emergence of coronavirus (Review).
|
NA
|
3
|
|
Why the immune system fails to mount an adaptive immune response to a Covid -19 infection.
|
NA
|
NA
|
|
Epidemiological analysis of COVID-19 and practical experience from China.
|
NA
|
3
|
|
Obesity and its Implications for COVID-19 Mortality.
|
NA
|
NA
|
|
An assessment of United States dermatology practices during the COVID-19 outbreak.
|
NA
|
NA
|
|
[From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].
|
NA
|
3
|
|
[Coinfection between dengue and covid-19: need for approach in endemic zones.]
|
NA
|
NA
|
|
Neurologists and Covid-19: A note on courage in a time of uncertainty.
|
NA
|
NA
|
|
Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.
|
NA
|
3
|
|
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China.
|
NA
|
3
|
|
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus.
|
NA
|
3
|
|
The versatile heparin in COVID-19.
|
NA
|
NA
|
|
Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): a clinical update.
|
NA
|
3
|
|
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how.
|
NA
|
NA
|
|
How young patients with cancer perceive the Covid-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears?
|
NA
|
3
|
|
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.
|
NA
|
3
|
|
Applying Palliative Care Principles to Communicate with Children about COVID-19.
|
NA
|
NA
|
|
Goals of Care in a Pandemic: Our Experience and Recommendations.
|
NA
|
NA
|
|
Creating a Palliative Care Inpatient Response Plan for COVID19 - The UW Medicine Experience.
|
NA
|
NA
|
|
Telemedicine in the Time of Coronavirus.
|
NA
|
NA
|
|
Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study.
|
NA
|
NA
|
|
[Suggestions for thoracic surgery clinical practice in non-epidemic area of 2019 coronavirus disease].
|
NA
|
NA
|
|
Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019.
|
NA
|
3
|
|
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.
|
NA
|
NA
|
|
A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
|
NA
|
NA
|
|
Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center.
|
NA
|
NA
|
|
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.
|
NA
|
3
|
|
Primary care management of the coronavirus (COVID-19).
|
NA
|
3
|
|
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study.
|
NA
|
3
|
|
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis.
|
NA
|
3
|
|
Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.
|
NA
|
3
|
|
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
|
NA
|
NA
|
|
A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
|
NA
|
NA
|
|
COVID-19 in post-transplantation patients- report of two cases.
|
NA
|
NA
|
|
C-reactive protein levels in the early stage of COVID-19.
|
NA
|
NA
|
|
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.
|
NA
|
3
|
|
SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.
|
NA
|
3
|
|
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.
|
NA
|
NA
|
|
Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses.
|
NA
|
3
|
|
Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal.
|
NA
|
NA
|
|
Updating the diagnostic criteria of COVID-19 “suspected case” and “confirmed case” is necessary.
|
NA
|
NA
|
|
Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP).
|
NA
|
3
|
|
Projecting hospital utilization during the COVID-19 outbreaks in the United States.
|
NA
|
NA
|
|
How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.
|
NA
|
NA
|
|
Health services provision of 48 public tertiary dental hospitals during the COVID-19 epidemic in China.
|
NA
|
NA
|
|
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
|
NA
|
3
|
|
Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy.
|
NA
|
NA
|
|
Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection.
|
NA
|
3
|
|
The COVID-19 Pandemic: New Global Challenges for the Hemophilia Community.
|
NA
|
NA
|
|
Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.
|
NA
|
3
|
|
Palliative Care Pandemic Pack: a Specialist Palliative Care Service response to planning the COVID-19 pandemic.
|
NA
|
NA
|
|
Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.
|
NA
|
3
|
|
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
|
NA
|
3
|
|
Unknown unknowns - COVID-19 and potential global mortality.
|
NA
|
NA
|
|
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
|
NA
|
3
|
|
Incidence of novel coronavirus (2019-nCoV) infection among people under home quarantine in Shenzhen, China.
|
NA
|
NA
|
|
Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution.
|
NA
|
3
|
|
Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals.
|
NA
|
NA
|
|
Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study
|
NA
|
3
|
|
The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease.
|
NA
|
3
|
|
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
|
NA
|
NA
|
|
Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.
|
NA
|
3
|
|
Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.
|
NA
|
NA
|
|
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
|
NA
|
NA
|
|
Macrolide treatment for COVID-19: Will this be the way forward?
|
NA
|
3
|
|
Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.
|
NA
|
NA
|
|
A comparative-descriptive analysis of clinical characteristics in 2019-Coronavirus-infected children and adults.
|
NA
|
3
|
|
COVID-19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings.
|
NA
|
NA
|
|
Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
|
NA
|
NA
|
|
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.
|
NA
|
3
|
|
[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)].
|
NA
|
NA
|
|
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
|
NA
|
NA
|
|
COVID-19 Related Misinformation on Social Media: A Qualitative Study from Iran.
|
NA
|
NA
|
|
Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.
|
NA
|
3
|
|
Current Drugs with Potential for Treatment of COVID-19: A Literature Review.
|
NA
|
3
|
|
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
|
NA
|
3
|
|
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
|
NA
|
NA
|
|
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
|
NA
|
3
|
|
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
|
NA
|
3
|
|
Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.
|
NA
|
3
|
|
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?
|
NA
|
3
|
|
The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?
|
NA
|
3
|
|
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.
|
NA
|
3
|
|
Surgical Management of Patients With COVID-19 Infection. Recommendations of the Spanish Association of Surgeons.
|
NA
|
NA
|
|
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
|
NA
|
3
|
|
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
|
NA
|
3
|
|
Flavonoids isolated from loquat (Eriobotrya japonica) leaves inhibit oxidative stress and inflammation induced by cigarette smoke in COPD mice: the role of TRPV1 signaling pathways.
|
NA
|
NA
|
|
Tocilizumab treatment in COVID-19: A single center experience.
|
NA
|
3
|
|
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
|
NA
|
3
|
|
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
|
NA
|
3
|
|
[Thoughts on the reform of preventive medicine education in the context of new medicine].
|
NA
|
NA
|
|
[Consideration of surgeons participating in COVID-19 emergency medical rescue].
|
NA
|
NA
|
|
Deployment of convalescent plasma for the prevention and treatment of COVID-19.
|
NA
|
3
|
|
Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China.
|
NA
|
3
|
|
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
|
NA
|
3
|
|
COVID-19 And Older Adults: What We Know.
|
NA
|
NA
|
|
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement.
|
NA
|
NA
|
|
Clinical trials on drug repositioning for COVID-19 treatment.
|
NA
|
3
|
|
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.
|
NA
|
3
|
|
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.
|
NA
|
3
|
|
Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.
|
NA
|
3
|
|
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.
|
NA
|
3
|
|
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses.
|
NA
|
3
|
|
Daily Situation Report on Coronavirus disease (COVID-19) in Iran; March 17, 2020.
|
NA
|
NA
|
|
Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen.
|
NA
|
3
|
|
Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises.
|
NA
|
NA
|
|
Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel.
|
NA
|
NA
|
|
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
|
NA
|
3
|
|
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.
|
NA
|
NA
|
|
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.
|
NA
|
3
|
|
Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
|
NA
|
3
|
|
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments.
|
NA
|
NA
|
|
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review.
|
NA
|
NA
|
|
Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19.
|
NA
|
3
|
|
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.
|
NA
|
3
|
|
PCR Assays Turned Positive in 25 Discharged COVID-19 Patients.
|
NA
|
NA
|
|
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.
|
NA
|
3
|
|
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
|
NA
|
3
|
|
Comment on “Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19”.
|
NA
|
NA
|
|
Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.
|
NA
|
NA
|
|
[Coronavirus and COVID-19 : focus on a galopping pandemic].
|
NA
|
3
|
|
Hsa-miR-217 Inhibits the Proliferation, Migration and Invasion in Non-small-cell Lung Cancer Cells Via Targeting SIRT1 and p53/KAI1 Signaling
|
NA
|
NA
|
|
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.
|
NA
|
NA
|
|
Considerations for statin therapy in patients with COVID-19.
|
NA
|
3
|
|
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.
|
NA
|
3
|
|
The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Study: Rationale and Design.
|
NA
|
NA
|
|
Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
|
NA
|
NA
|
|
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series.
|
NA
|
3
|
|
Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.
|
NA
|
3
|
|
[Analysis of medication characteristics of traditional Chinese medicine in treating coronavirus disease-19 based on data mining].
|
NA
|
3
|
|
[Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients].
|
NA
|
3
|
|
[Treatment experience of burn patients combined with inhalation injury during epidemic period of Corona Virus Disease 2019].
|
NA
|
NA
|
|
In Silico Discovery of Candidate Drugs against Covid-19.
|
NA
|
3
|
|
[Health protection guideline of mobile cabin hospitals during COVID-19 outbreak].
|
NA
|
NA
|
|
Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?
|
NA
|
3
|
|
Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.
|
NA
|
3
|
|
Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic.
|
NA
|
NA
|
|
Novel Coronavirus Infection in Newborn Babies Under 28 Days in China.
|
NA
|
3
|
|
Upheaval in cancer care during the COVID-19 outbreak.
|
NA
|
NA
|
|
Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
|
NA
|
NA
|
|
In silico identification of vaccine targets for 2019-nCoV.
|
NA
|
NA
|
|
A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
Acute stroke management pathway during Coronavirus-19 pandemic.
|
NA
|
NA
|
|
Coronavirus: Update Related to the Current Outbreak of COVID-19.
|
NA
|
NA
|
|
Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
|
NA
|
3
|
|
Clinical characteristics of a case series of children with coronavirus disease 2019.
|
NA
|
3
|
|
Factors associated with prolonged viral RNA shedding in patients with COVID-19.
|
NA
|
NA
|
|
Utilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.
|
NA
|
3
|
|
Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report.
|
NA
|
3
|
|
Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019.
|
NA
|
3
|
|
A classifier prediction model to predict the status of Coronavirus COVID-19 patients in South Korea.
|
NA
|
NA
|
|
Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha.
|
NA
|
3
|
|
A primer on viral-associated olfactory loss in the era of COVID-19.
|
NA
|
3
|
|
COVID19 Prevention & Care; A Cancer Specific Guideline.
|
NA
|
NA
|
|
Epidemiology and Clinical Characteristics of COVID-19.
|
NA
|
3
|
|
Coronavirus membrane fusion mechanism offers as a potential target for antiviral development.
|
NA
|
3
|
|
The possible of immunotherapy for COVID-19: A systematic review.
|
NA
|
3
|
|
Structure of Mpro from COVID-19 virus and discovery of its inhibitors.
|
NA
|
3
|
|
Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report.
|
NA
|
NA
|
|
Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.
|
NA
|
3
|
|
Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience.
|
NA
|
NA
|
|
Serial Computed Tomography Manifestations in a Child with Coronavirus Disease (COVID-19) Pneumonia.
|
NA
|
NA
|
|
Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?
|
NA
|
3
|
|
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.
|
NA
|
3
|
|
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.
|
NA
|
3
|
|
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness.
|
NA
|
NA
|
|
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.
|
NA
|
NA
|
|
Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic.
|
NA
|
NA
|
|
[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
|
NA
|
3
|
|
[Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees].
|
NA
|
NA
|
|
[Roles of multidisciplinary team (MDT) in diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19)].
|
NA
|
3
|
|
Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020.
|
NA
|
3
|
|
Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.
|
NA
|
3
|
|
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
|
NA
|
3
|
|
COVID-19 with Different Severity: A Multi-center Study of Clinical Features.
|
NA
|
3
|
|
Attitudes of Anesthesiology Specialists and Residents Toward Patients Infected with the Novel Coronavirus (COVID-19): A National Survey Study.
|
NA
|
NA
|
|
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020.
|
NA
|
NA
|
|
ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19.
|
NA
|
3
|
|
Management of ovarian cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?
|
NA
|
NA
|
|
Clinical and ethical challenges for emergency departments during communicable disease outbreaks: can lessons from Ebola Virus Disease be applied to the COVID-19 pandemic?
|
NA
|
NA
|
|
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
|
NA
|
3
|
|
Type 1 interferons as a potential treatment against COVID-19.
|
NA
|
NA
|
|
Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery.
|
NA
|
NA
|
|
Rapid De-Escalation and Triaging Patients in Community-Based Palliative Care.
|
NA
|
NA
|
|
Crisis Symptom Management and Patient Communication Protocols Are Important Tools for All Clinicians Responding to COVID-19.
|
NA
|
3
|
|
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
|
NA
|
3
|
|
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
|
NA
|
NA
|
|
Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats.
|
NA
|
NA
|
|
Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.
|
NA
|
3
|
|
TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?
|
NA
|
NA
|
|
Cancer Care Goes Virtual in Response to COVID-19.
|
NA
|
NA
|
|
Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
|
NA
|
NA
|
|
Halting coronavirus polymerase.
|
NA
|
NA
|
|
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.
|
NA
|
3
|
|
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
|
NA
|
NA
|
|
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.
|
NA
|
NA
|
|
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.
|
NA
|
3
|
|
Feto-placental surgeries during the covid-19 pandemic: starting the discussion.
|
NA
|
NA
|
|
Novel Coronavirus (SARS-CoV-2) Infection in A Renal Transplant Recipient: Case Report.
|
NA
|
3
|
|
Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
|
NA
|
NA
|
|
SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management.
|
NA
|
3
|
|
The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19: A promising cure for the global panic.
|
NA
|
3
|
|
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.
|
NA
|
3
|
|
The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic.
|
NA
|
NA
|
|
Medically-Necessary, Time-Sensitive Procedures: A Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 and diabetes: Knowledge in progress.
|
NA
|
3
|
|
Fighting against COVID-19: Innovative strategies for clinical pharmacists.
|
NA
|
NA
|
|
Drug repositioning an alternative for the treatment of coronavirus COVID-19.
|
NA
|
NA
|
|
Health-Related-Quality of Life in Common Variable Immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19: Initial experience of an international group of hand surgeons.
|
NA
|
NA
|
|
Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.
|
NA
|
NA
|
|
Morphological anomalies of circulating blood cells in COVID-19.
|
NA
|
NA
|
|
Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.
|
NA
|
NA
|
|
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model.
|
NA
|
3
|
|
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
|
NA
|
3
|
|
Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.
|
NA
|
3
|
|
Performance of Electrophysiology Procedures at an Academic Medical Center Amidst the 2020 Coronavirus (COVID-19) Pandemic.
|
NA
|
3
|
|
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
|
NA
|
3
|
|
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
|
NA
|
3
|
|
[Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
|
NA
|
3
|
|
[Study on treatment of “cytokine storm” by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].
|
NA
|
3
|
|
[Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
|
NA
|
NA
|
|
[Analysis on pattern of prescriptions and syndromes of traditional Chinese medicine for prevention and treatment of COVID-19].
|
NA
|
3
|
|
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining].
|
NA
|
3
|
|
[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].
|
NA
|
3
|
|
[Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)].
|
NA
|
3
|
|
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
|
NA
|
NA
|
|
Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
|
NA
|
3
|
|
Coronavirus disease 2019: new things to know!
|
NA
|
3
|
|
COVID-19 indirect contact transmission through the oral mucosa must not be ignored.
|
NA
|
NA
|
|
Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases.
|
NA
|
3
|
|
[Covid-19 in patients on dialysis: infection prevention and control strategies].
|
NA
|
3
|
|
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
|
NA
|
3
|
|
Rehabilitation following critical illness in people with COVID-19 infection.
|
NA
|
NA
|
|
Innovation in Response to the COVID-19 Pandemic Crisis.
|
NA
|
NA
|
|
Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19).
|
NA
|
3
|
|
Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC)_Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), and European Society of Minimally Invasive Neurological Therapy (ESMINT).
|
NA
|
NA
|
|
Molecular immune pathogenesis and diagnosis of COVID-19.
|
NA
|
NA
|
|
Latin American healthcare systems in times of pandemic.
|
NA
|
NA
|
|
Clinical characteristics and immunosuppressants management of coronavirus disease 2019 in solid organ transplant recipients.
|
NA
|
3
|
|
Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report.
|
NA
|
3
|
|
DOACs and ‘newer’ haemophilia therapies in COVID-19.
|
NA
|
NA
|
|
Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
|
NA
|
3
|
|
Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19.
|
NA
|
3
|
|
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
|
NA
|
3
|
|
Cytokine Storm in COVID-19 and Treatment.
|
NA
|
3
|
|
Graft cryopreservation does not impact overall survival allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide for GVHD prophylaxis.
|
NA
|
NA
|
|
Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.
|
NA
|
3
|
|
Rapid Implementation of Inpatient Telepalliative Medicine Consultations during COVID-19 Pandemic.
|
NA
|
NA
|
|
The Family Caregiving Crisis Meets an Actual Pandemic.
|
NA
|
NA
|
|
COVID-19 - Considerations for the paediatric rheumatologist.
|
NA
|
NA
|
|
Clinical Features of COVID-19-Related Liver Damage.
|
NA
|
3
|
|
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.
|
NA
|
3
|
|
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
|
NA
|
NA
|
|
Novel ionophores active against La Crosse virus identified through rapid antiviral screening.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.
|
NA
|
3
|
|
Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
|
NA
|
3
|
|
What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate?
|
NA
|
NA
|
|
A framework for open tracheostomy in COVID-19 patients.
|
NA
|
NA
|
|
Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing.
|
NA
|
3
|
|
Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).
|
NA
|
3
|
|
COVID-19 challenge for modern medicine.
|
NA
|
3
|
|
Novel 2019 coronavirus SARS-CoV-2 (COVID-19): an overview for emergency clinicians.
|
NA
|
NA
|
|
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.
|
NA
|
3
|
|
COVID-19 Pandemic: Experiences in China and implications for its prevention and treatment worldwide.
|
NA
|
3
|
|
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.
|
NA
|
3
|
|
Pediatric Airway Management in COVID-19 patients - Consensus Guidelines from the Society for Pediatric Anesthesia’s Pediatric Difficult Intubation Collaborative and the Canadian Pediatric Anesthesia Society.
|
NA
|
NA
|
|
Demand Analysis and Management Suggestion: Sharing Epidemiological Data Among Medical Institutions in Megacities for Epidemic Prevention and Control.
|
NA
|
NA
|
|
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.
|
NA
|
3
|
|
Collaborative Multi-Disciplinary Incident Command at Seattle Children’s Hospital for Rapid Preparatory Pediatric Surgery Countermeasures to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Evidence Based Management Guideline for the COVID-19 Pandemic - Review article.
|
NA
|
3
|
|
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
|
NA
|
3
|
|
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.
|
NA
|
3
|
|
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.
|
NA
|
NA
|
|
A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
|
NA
|
3
|
|
COVID-19: A Brief Overview of the Discovery Clinical Trial.
|
NA
|
NA
|
|
Experience summary of a COVID-19 designated community hospital and its operation model.
|
NA
|
NA
|
|
Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?
|
NA
|
NA
|
|
Why tocilizumab could be an effective treatment for severe COVID-19?
|
NA
|
3
|
|
EZH2-mediated H3K27me3 inhibits ACE2 expression.
|
NA
|
3
|
|
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.
|
NA
|
3
|
|
German recommendations for critically ill patients with COVID‑19.
|
NA
|
3
|
|
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
|
NA
|
3
|
|
The epidemiology and clinical information about COVID-19.
|
NA
|
3
|
|
SARS-CoV-2: at the crossroad between aging and neurodegeneration.
|
NA
|
NA
|
|
Reply to the comment.
|
NA
|
NA
|
|
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.
|
NA
|
NA
|
|
[Application of tracheotomy in the treatment of severe cases of COVID-19].
|
NA
|
3
|
|
Stem cell-based therapy for coronavirus disease 2019.
|
NA
|
3
|
|
[Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China].
|
NA
|
3
|
|
Guidelines for dental care provision during the COVID-19 pandemic.
|
NA
|
NA
|
|
CT Scans of Patients with 2019 Novel Coronavirus (COVID-19) Pneumonia.
|
NA
|
3
|
|
Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19.
|
NA
|
NA
|
|
Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.
|
NA
|
NA
|
|
Recent advances and perspectives of nucleic acid detection for coronavirus.
|
NA
|
3
|
|
Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment.
|
NA
|
3
|
|
Emergency management of nursing human resources and supplies to respond to coronavirus disease 2019 epidemic.
|
NA
|
NA
|
|
Holistic care for patients with severe coronavirus disease 2019: An expert consensus.
|
NA
|
NA
|
|
Contingency management strategies of the Nursing Department in centralized rescue of patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Coronavirus: Update Related to the Current Outbreak of COVID-19.
|
NA
|
3
|
|
Determining the spatial effects of COVID-19 using the spatial panel data model.
|
NA
|
NA
|
|
Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper.
|
NA
|
NA
|
|
Chinese herbal Huo-Gu Formula for treatment of steroid-associated osteonecrosis of femoral head: a 14-years follow-up of convalescent SARS patients.
|
NA
|
NA
|
|
Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020.
|
NA
|
3
|
|
Data on the stability of darunavir/cobicistat suspension after tablet manipulation.
|
NA
|
NA
|
|
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19.
|
NA
|
NA
|
|
A living systematic review protocol for COVID-19 clinical trial registrations.
|
NA
|
NA
|
|
Running a Radiation Oncology Department at the time of coronavirus: an Italian experience.
|
NA
|
NA
|
|
Prostate Cancer Radiotherapy Recommendations in Response to COVID-19.
|
NA
|
NA
|
|
Breast radiotherapy under COVID-19 pandemic resource constraints – approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States.
|
NA
|
NA
|
|
The Heart in COVID19: Primary Target or Secondary Bystander?
|
NA
|
NA
|
|
COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies.
|
NA
|
3
|
|
Management Of Patients On Dialysis And With Kidney Transplant During SARS-COV-2 (COVID-19) Pandemic In Brescia, Italy.
|
NA
|
3
|
|
Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient.
|
NA
|
NA
|
|
Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.
|
NA
|
3
|
|
Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient: Impella CP Mechanical Support During ULMCA Bifurcation Stenting.
|
NA
|
NA
|
|
Hypertension, the renin-angiotensin system, and` the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
|
NA
|
NA
|
|
[Palliation in patients with severe COVID-19].
|
NA
|
3
|
|
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.
|
NA
|
3
|
|
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
|
NA
|
3
|
|
Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
|
NA
|
3
|
|
Global guidance for surgical care during the COVID-19 pandemic.
|
NA
|
NA
|
|
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment.
|
NA
|
3
|
|
Critically-ill COVID-19 patient.
|
NA
|
NA
|
|
ANTIVIRAL TREATMENT OF COVID-19.
|
NA
|
3
|
|
COVID-19: Prevention and control measures in community.
|
NA
|
NA
|
|
The Science Underlying COVID-19: Implications for the Cardiovascular System.
|
NA
|
NA
|
|
Mental Health Care Providers Dealing With Coronavirus Disease 2019 (COVID-19): What Is the Definition of a Case, How Is That Changing, and What Kinds of Tests Are Available?
|
NA
|
NA
|
|
Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications.
|
NA
|
3
|
|
Venous thromboembolism in COVID-19 patients.
|
NA
|
3
|
|
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
|
NA
|
NA
|
|
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.
|
NA
|
3
|
|
[Responsibilities of Weaning Centers during the COVID-19 Pandemic Outbreak - Recommendations for the Assignment of ICU Capacities in COVID-19 Patients as shown by the Berlin-Brandenburg POST-SAVE-Model].
|
NA
|
NA
|
|
Hydroxychloroquine use during the COVID-19 pandemic 2020.
|
NA
|
NA
|
|
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.
|
NA
|
NA
|
|
[The keypoints in treatment of the critical coronavirus disease 2019 patient(2)].
|
NA
|
NA
|
|
[Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia].
|
NA
|
NA
|
|
[Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].
|
NA
|
NA
|
|
[What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
|
NA
|
NA
|
|
Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.
|
NA
|
NA
|
|
[Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].
|
NA
|
NA
|
|
[Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].
|
NA
|
NA
|
|
Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019.
|
NA
|
NA
|
|
EMA advice on renin-angiotensin system medicines during covid-19 pandemic.
|
NA
|
NA
|
|
Convalescent plasma: A possible treatment of COVID-19 in India.
|
NA
|
NA
|
|
Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus.
|
NA
|
NA
|
|
Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials.
|
NA
|
NA
|
|
A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China.
|
NA
|
NA
|
|
[Urology in the corona-virus pandemic-a guideline 4/20].
|
NA
|
NA
|
|
Mechanism of thrombocytopenia in COVID-19 patients.
|
NA
|
NA
|
|
Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients.
|
NA
|
NA
|
|
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the NewCoronavirus
|
NA
|
NA
|
|
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
|
NA
|
NA
|
|
COVID-2019: update on epidemiology, disease spread and management.
|
NA
|
NA
|
|
Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm.
|
NA
|
NA
|
|
Oligonucleotides and the COVID-19 Pandemic: A Perspective.
|
NA
|
NA
|
|
Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China.
|
NA
|
NA
|
|
Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
|
NA
|
NA
|
|
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian Experience.
|
NA
|
NA
|
|
Framework for prioritizing head and neck surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus.
|
NA
|
NA
|
|
The Application of Mobile Telehealth System to Facilitate Patient Information Presentation and Case Discussion.
|
NA
|
NA
|
|
Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.
|
NA
|
NA
|
|
Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient - Solano County, California, February 2020.
|
NA
|
NA
|
|
Management of infantile hemangiomas during the COVID pandemic.
|
NA
|
NA
|
|
Noncutaneous considerations of COVID-19 for dermatology practices.
|
NA
|
NA
|
|
Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection.
|
NA
|
NA
|
|
Grief During the COVID-19 Pandemic: Considerations for Palliative Care Providers.
|
NA
|
NA
|
|
COVID-19: Abnormal liver function tests.
|
NA
|
NA
|
|
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
|
NA
|
NA
|
|
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
|
NA
|
NA
|
|
Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020).
|
NA
|
NA
|
|
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
|
NA
|
NA
|
|
Understanding dynamics of pandemics
|
NA
|
NA
|
|
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society.
|
NA
|
NA
|
|
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
|
NA
|
NA
|
|
Genomic characterization of a novel SARS-CoV-2.
|
NA
|
NA
|
|
A geroscience perspective on COVID-19 mortality.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China.
|
NA
|
NA
|
|
COVID-19 in solid organ transplant recipients: A single-center case series from Spain.
|
NA
|
NA
|
|
Case report: A kidney transplant patient with mild COVID-19.
|
NA
|
NA
|
|
Smell dysfunction: a biomarker for COVID-19.
|
NA
|
NA
|
|
Walk-Through Screening Center for COVID-19: an Accessible and Efficient Screening System in a Pandemic Situation.
|
NA
|
NA
|
|
A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.
|
NA
|
NA
|
|
Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations from Society for Neuroscience in Anesthesiology & Critical Care (SNACC).
|
NA
|
NA
|
|
Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2.
|
NA
|
NA
|
|
Recommendations for the Care of Pediatric Orthopaedic Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures.
|
NA
|
NA
|
|
COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy.
|
NA
|
NA
|
|
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19.
|
NA
|
NA
|
|
Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department.
|
NA
|
NA
|
|
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.
|
NA
|
NA
|
|
Phototherapeutic approach to dermatological patients during the 2019 Coronavirus pandemic: Real-life Data from the Italian Red Zone.
|
NA
|
NA
|
|
Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis.
|
NA
|
NA
|
|
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
|
NA
|
NA
|
|
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment.
|
NA
|
NA
|
|
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.
|
NA
|
NA
|
|
When health professionals look death in the eye: the mental health of professionals who deal daily with the 2019 coronavirus outbreak.
|
NA
|
NA
|
|
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
|
NA
|
NA
|
|
Health Communication Through News Media During the Early Stage of the COVID-19 Outbreak in China: Digital Topic Modeling Approach.
|
NA
|
NA
|
|
Considerations for Obstetric Care during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.
|
NA
|
NA
|
|
Approaches to the management of patients in oral and maxillofacial surgery during COVID-19 pandemic.
|
NA
|
NA
|
|
French consensus on management of head and neck cancer surgery during COVID-19 pandemic.
|
NA
|
NA
|
|
Chloroquine and COVID-19 - a potential game changer?
|
NA
|
NA
|
|
Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.
|
NA
|
NA
|
|
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
|
NA
|
NA
|
|
Covid-19 and immunomodulation in IBD.
|
NA
|
NA
|
|
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy.
|
NA
|
NA
|
|
[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
|
NA
|
NA
|
|
Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series.
|
NA
|
NA
|
|
The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.
|
NA
|
NA
|
|
Novel coronavirus disease (COVID-19) in children
|
NA
|
NA
|
|
COVID-19 outbreak control, example of ministry of health of Turkey
|
NA
|
NA
|
|
The impact of coronavirus infectious disease 19 (COVID-19) on oral health.
|
NA
|
NA
|
|
Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.
|
NA
|
NA
|
|
First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO - a case report.
|
NA
|
NA
|
|
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support.
|
NA
|
NA
|
|
The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic on Cancer Patients.
|
NA
|
NA
|
|
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
|
NA
|
NA
|
|
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
|
NA
|
NA
|
|
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus Outbreak: Is Radiology Ready? Mass Casualty Incident Planning.
|
NA
|
NA
|
|
Angiotensin receptor blockers and COVID-19.
|
NA
|
NA
|
|
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.
|
NA
|
NA
|
|
COVID-19: Four Paediatric Cases in Malaysia.
|
NA
|
NA
|
|
Risk Communication During COVID-19.
|
NA
|
NA
|
|
Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland.
|
NA
|
NA
|
|
Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19.
|
NA
|
NA
|
|
ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.
|
NA
|
NA
|
|
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.
|
NA
|
NA
|
|
Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System.
|
NA
|
NA
|
|
Renin-angiotensin system at the heart of COVID-19 pandemic.
|
NA
|
NA
|
|
Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic.
|
NA
|
NA
|
|
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?
|
NA
|
NA
|
|
Combating Devastating COVID -19 by Drug Repurposing.
|
NA
|
NA
|
|
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment.
|
NA
|
NA
|
|
Multiple Myeloma in the Time of COVID-19.
|
NA
|
NA
|
|
[Analysis of special ehealth service for corona virus disease 2019 (COVID-19) pneumonia].
|
NA
|
NA
|
|
COVID-19 in otolaryngologist practice: a review of current knowledge.
|
NA
|
NA
|
|
Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia.
|
NA
|
NA
|
|
Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.
|
NA
|
NA
|
|
Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak.
|
NA
|
NA
|
|
Successful guselkumab treatment in a psoriatic patient affected with Cornelia de Lange syndrome, and prosecution during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Analysis of selective endoscopy results during the epidemic of coronavirus disease 2019 (COVID-19)].
|
NA
|
NA
|
|
[Strengthening basic and clinical research on ocular infection caused by coronavirus].
|
NA
|
NA
|
|
[Clinical features and outcome of treatment for novel coronavirus pneumonia: a meta-analysis].
|
NA
|
NA
|
|
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.
|
NA
|
NA
|
|
Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres.
|
NA
|
NA
|
|
Treatment options for COVID-19: The reality and challenges.
|
NA
|
NA
|
|
Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.
|
NA
|
NA
|
|
[Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].
|
NA
|
NA
|
|
Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.
|
NA
|
NA
|
|
Psychological support in times of COVID-19: the Essen community-based CoPE concept.
|
NA
|
NA
|
|
Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients.
|
NA
|
NA
|
|
Therapeutic strategies for critically ill patients with COVID-19.
|
NA
|
NA
|
|
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
|
NA
|
NA
|
|
Coronaviruses and people with intellectual disability: an exploratory data analysis.
|
NA
|
NA
|
|
COVID-19 and spinal cord injuries: The viewpoint from an emergency department resident with quadriplegia.
|
NA
|
NA
|
|
[COVID-19, THE KIDNEY AND HYPERTENSION].
|
NA
|
NA
|
|
CoViD-19 Immunopathology and Immunotherapy.
|
NA
|
NA
|
|
Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China.
|
NA
|
NA
|
|
Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China.
|
NA
|
NA
|
|
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
|
NA
|
NA
|
|
Antiviral therapy in management of COVID-19: a systematic review on current evidence.
|
NA
|
NA
|
|
Prone Position in Management of COVID-19 Patients; a Commentary.
|
NA
|
NA
|
|
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
|
NA
|
NA
|
|
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
|
NA
|
NA
|
|
[The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis].
|
NA
|
NA
|
|
[Being a cardiologist at the time of SARS-COVID-19: is it time to reconsider our way of working?]
|
NA
|
NA
|
|
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic.
|
NA
|
NA
|
|
Description of COVID-19 cases along with the measures taken on prevention and control in Zhejiang, China.
|
NA
|
NA
|
|
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up.
|
NA
|
NA
|
|
Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey.
|
NA
|
NA
|
|
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment.
|
NA
|
NA
|
|
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
|
NA
|
NA
|
|
COVID-19 and the clinical hematology laboratory.
|
NA
|
NA
|
|
Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
|
NA
|
NA
|
|
Variable computed tomography appearances of COVID-19.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): two case reports from a family cluster.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on the Management of Head and Neck Malignancies.
|
NA
|
NA
|
|
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
|
NA
|
NA
|
|
[Clinical features of children with SARS-CoV-2 infection: an analysis of 115 cases].
|
NA
|
NA
|
|
[Research advances in cardiovascular system damage caused by SARS-CoV-2 in children].
|
NA
|
NA
|
|
Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].
|
NA
|
NA
|
|
Experience and suggestion of medical practices for burns during the outbreak of COVID-19.
|
NA
|
NA
|
|
Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations.
|
NA
|
NA
|
|
Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Guidelines for the management of surgical departments in non-uniform hospitals during the COVID-19 pandemic.
|
NA
|
NA
|
|
2019 novel coronavirus: an emerging global threat.
|
NA
|
NA
|
|
A short review on antibody therapy for COVID-19.
|
NA
|
NA
|
|
Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan.
|
NA
|
NA
|
|
Optimization of the intravenous infusion workflow in the isolation ward for patients with coronavirus disease 2019.
|
NA
|
NA
|
|
One month of the novel coronavirus 2019 outbreak: Is it still a threat?
|
NA
|
NA
|
|
Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives.
|
NA
|
NA
|
|
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
|
NA
|
NA
|
|
PAK1-blockers: Potential Therapeutics against COVID-19.
|
NA
|
NA
|
|
Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review).
|
NA
|
NA
|
|
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
|
NA
|
NA
|
|
Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.
|
NA
|
NA
|
|
Sustainable practice of ophthalmology during COVID-19: challenges and solutions.
|
NA
|
NA
|
|
Pharmacologic Therapy for COVID-19 Infection.
|
NA
|
NA
|
|
Challenges of COVID-19 pandemic for dermatology.
|
NA
|
NA
|
|
COVID-19 and psoriasis: Should we fear for patients treated with biologics?
|
NA
|
NA
|
|
Obesity and SARS-CoV-2: a population to safeguard.
|
NA
|
NA
|
|
Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with Novel Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
|
NA
|
NA
|
|
Melatonin: Roles in influenza, Covid-19, and other viral infections.
|
NA
|
NA
|
|
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
|
NA
|
NA
|
|
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
|
NA
|
NA
|
|
Atypical presentation of COVID-19 in a frail older person.
|
NA
|
NA
|
|
Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19.
|
NA
|
NA
|
|
Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients.
|
NA
|
NA
|
|
Current epidemiological and clinical features of COVID-19; a global perspective from China.
|
NA
|
NA
|
|
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
|
NA
|
NA
|
|
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.
|
NA
|
NA
|
|
Lessons learned from 9/11: Mental health perspectives on the COVID-19 pandemic.
|
NA
|
NA
|
|
What do we know about the SARS-CoV-2 coronavirus in the environment?
|
NA
|
NA
|
|
Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?
|
NA
|
NA
|
|
Epidemic of COVID-19 in China and associated Psychological Problems.
|
NA
|
NA
|
|
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
|
NA
|
NA
|
|
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
|
NA
|
NA
|
|
Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic.
|
NA
|
NA
|
|
Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana.
|
NA
|
NA
|
|
Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options.
|
NA
|
NA
|
|
[Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia].
|
NA
|
NA
|
|
Systematic rapid “living” review on rehabilitation needs due to covid-19: update to march 31st 2020.
|
NA
|
NA
|
|
Coronavirus disease 2019: reassembly attack of coronavirus.
|
NA
|
NA
|
|
COVID-19: Facts, Cultural Considerations, and Risk of Stigmatization.
|
NA
|
NA
|
|
Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
|
NA
|
NA
|
|
Areas of academic research with the impact of COVID-19.
|
NA
|
NA
|
|
Cardiovascular complications in COVID-19.
|
NA
|
NA
|
|
Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases.
|
NA
|
NA
|
|
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
|
NA
|
NA
|
|
A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report.
|
NA
|
NA
|
|
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
|
NA
|
NA
|
|
Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.
|
NA
|
NA
|
|
Perspectives for repurposing drugs for the coronavirus disease 2019.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients.
|
NA
|
NA
|
|
The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment.
|
NA
|
NA
|
|
[COVID-19 in hospitalized children and adolescents].
|
NA
|
NA
|
|
Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human.
|
NA
|
NA
|
|
Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival.
|
NA
|
NA
|
|
The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study.
|
NA
|
NA
|
|
Rewriting the rules for care of MDS and AML patients in the time of COVID-19.
|
NA
|
NA
|
|
Age-related rhesus macaque models of COVID-19.
|
NA
|
NA
|
|
Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2.
|
NA
|
NA
|
|
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response.
|
NA
|
NA
|
|
Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic.
|
NA
|
NA
|
|
A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant.
|
NA
|
NA
|
|
Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings.
|
NA
|
NA
|
|
[The cure: a question of merit?]
|
NA
|
NA
|
|
[The choices in CoViD-19’s time.]
|
NA
|
NA
|
|
[Ethical, deontologic and legal considerations about SIAARTI Document “Clinical ethics recommendations for the allocation of intensive care treatments, in exceptional, resource-limited circumstances”.]
|
NA
|
NA
|
|
[Between intensive care and palliative care at the time of CoViD-19.]
|
NA
|
NA
|
|
[Vitamin D and coronavirus: a new field of use?]
|
NA
|
NA
|
|
Anosmia as a prominent symptom of COVID-19 infection.
|
NA
|
NA
|
|
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
|
NA
|
NA
|
|
The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
|
NA
|
NA
|
|
The Prevalence, Characteristics, and Prevention Status of Skin Injury Caused by Personal Protective Equipment Among Medical Staff in Fighting COVID-19: A Multicenter, Cross-Sectional Study.
|
NA
|
NA
|
|
Logic in the time of coronavirus.
|
NA
|
NA
|
|
Knowledge and Perceptions of COVID-19 Among Health Care Workers: Cross-Sectional Study.
|
NA
|
NA
|
|
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
|
NA
|
NA
|
|
Chloroquine Dosing Recommendations for Pediatric COVID-19 Supported by Modeling and Simulation.
|
NA
|
NA
|
|
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence.
|
NA
|
NA
|
|
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic.
|
NA
|
NA
|
|
Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED’s Experience During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
|
NA
|
NA
|
|
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
|
NA
|
NA
|
|
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
|
NA
|
NA
|
|
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
|
NA
|
NA
|
|
Déjà vu: Stimulating open drug discovery for SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 Diagnostic and Management Protocol for Pediatric Patients.
|
NA
|
NA
|
|
Challenges and Priorities in Responding to COVID-19 in Inpatient Psychiatry.
|
NA
|
NA
|
|
Hispidin and Lepidine E: two Natural Compounds and Folic acid as Potential Inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study.
|
NA
|
NA
|
|
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
|
NA
|
NA
|
|
The unsynchronized changes of CT image and nucleic acid detection in COVID-19: reports the two cases from Gansu, China.
|
NA
|
NA
|
|
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.
|
NA
|
NA
|
|
Is GSK3β a molecular target of chloroquine treatment against COVID-19?
|
NA
|
NA
|
|
Neuropsychiatric adverse events of chloroquine: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
|
NA
|
NA
|
|
Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Aerosolization of COVID-19 and Contamination Risks During Respiratory Treatments.
|
NA
|
NA
|
|
Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view.
|
NA
|
NA
|
|
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).
|
NA
|
NA
|
|
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.
|
NA
|
NA
|
|
Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases.
|
NA
|
NA
|
|
Intravenous Vitamin C for reduction of cytokines storm in Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center.
|
NA
|
NA
|
|
[Handling of COVID-19 in the emergency department : Field report of the emergency ward of the University Hospital Münster].
|
NA
|
NA
|
|
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
|
NA
|
NA
|
|
[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].
|
NA
|
NA
|
|
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach.
|
NA
|
NA
|
|
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of Novel Coronavirus Disease (COVID-19) in Africa: Caution for Inappropriate Off-Label Use in Healthcare Settings.
|
NA
|
NA
|
|
Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay.
|
NA
|
NA
|
|
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.
|
NA
|
NA
|
|
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.
|
NA
|
NA
|
|
[Medication and comedication in COVID-19 patients].
|
NA
|
NA
|
|
Challenges of intensive care and anesthesiology related to COVID-19 pandemic. Practical considerations
|
NA
|
NA
|
|
Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients
|
NA
|
NA
|
|
Pharmacological options in treating SASR-CoV-2 infection/COVID-19
|
NA
|
NA
|
|
Practical aspects of anesthetic and perioperative care for COVID-19 patients
|
NA
|
NA
|
|
Airway management of coronavirus-infected patients
|
NA
|
NA
|
|
Organ replacement therapy and life-supporting treatment modalities in critically ill COVID-19 patients
|
NA
|
NA
|
|
Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients.
|
NA
|
NA
|
|
Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 - National Poison Data System, United States, January 1, 2020-March 31, 2020.
|
NA
|
NA
|
|
Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.
|
NA
|
NA
|
|
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.
|
NA
|
NA
|
|
Role of duties related to COVID-19 suspected, probable and confirmed fatality cases
|
NA
|
NA
|
|
COVID-19 in cardiac arrest and infection risk to rescuers: A systematic review.
|
NA
|
NA
|
|
Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.
|
NA
|
NA
|
|
Characteristics, Symptom Management, and Outcomes of 101 Patients With COVID-19 Referred for Hospital Palliative Care.
|
NA
|
NA
|
|
COVID-19 pathophysiology: A review.
|
NA
|
NA
|
|
Changes to management of a non-pandemic illness during the COVID-19 pandemic: case study of invasive management of acute coronary syndrome.
|
NA
|
NA
|
|
The post-lockdown period should be used to acquire effective therapies for future resurgence in SARS-Cov-2 infections.
|
NA
|
NA
|
|
Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight.
|
NA
|
NA
|
|
COVID-19 Drug Discovery Using Intensive Approaches.
|
NA
|
NA
|
|
Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak.
|
NA
|
NA
|
|
Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
|
NA
|
NA
|
|
COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression.
|
NA
|
NA
|
|
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.
|
NA
|
NA
|
|
Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19.
|
NA
|
NA
|
|
Management of Traumatic Spinal Fracture in the Coronavirus Disease 2019 Situation.
|
NA
|
NA
|
|
Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study.
|
NA
|
NA
|
|
Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19.
|
NA
|
NA
|
|
Point of care and intensive care lung ultrasound: A reference guide for practitioners during COVID-19.
|
NA
|
NA
|
|
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
|
NA
|
NA
|
|
Keeping people with epilepsy safe during the Covid-19 pandemic.
|
NA
|
NA
|
|
Translating IL-6 biology into effective treatments.
|
NA
|
NA
|
|
[Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].
|
NA
|
NA
|
|
SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant.
|
NA
|
NA
|
|
[Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic Proposals for prioritization from the RENAPE and BIG-RENAPE groups].
|
NA
|
NA
|
|
Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.
|
NA
|
NA
|
|
A Bibliometric Analysis of COVID-19 Research Activity: A Call for Increased Output.
|
NA
|
NA
|
|
Dental care during the coronavirus disease 2019 (COVID-19) outbreak: operatory considerations and clinical aspects.
|
NA
|
NA
|
|
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.
|
NA
|
NA
|
|
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
|
NA
|
NA
|
|
[EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].
|
NA
|
NA
|
|
Direct oral anticoagulant plasma levels’ striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience.
|
NA
|
NA
|
|
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.
|
NA
|
NA
|
|
[An analysis of global research on SARS-CoV-2].
|
NA
|
NA
|
|
[Spike protein in the detection and treatment of novel coronavirus].
|
NA
|
NA
|
|
Pharmacy’s Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging.
|
NA
|
NA
|
|
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach.
|
NA
|
NA
|
|
Current pharmacological treatments for COVID-19: What’s next?
|
NA
|
NA
|
|
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.
|
NA
|
NA
|
|
Role of Telehealth in the Management of COVID-19: Lessons Learned from Previous SARS, MERS, and Ebola Outbreaks.
|
NA
|
NA
|
|
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
|
NA
|
NA
|
|
An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.
|
NA
|
NA
|
|
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
|
NA
|
NA
|
|
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic.
|
NA
|
NA
|
|
Spinal muscular atrophy care in the COVID-19 pandemic era.
|
NA
|
NA
|
|
Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors.
|
NA
|
NA
|
|
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
|
NA
|
NA
|
|
Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
|
NA
|
NA
|
|
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.
|
NA
|
NA
|
|
COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications.
|
NA
|
NA
|
|
Leveraging open hardware to alleviate the burden of COVID-19 on global health systems.
|
NA
|
NA
|
|
Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study.
|
NA
|
NA
|
|
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.
|
NA
|
NA
|
|
Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test.
|
NA
|
NA
|
|
Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.
|
NA
|
NA
|
|
SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.
|
NA
|
NA
|
|
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine.
|
NA
|
NA
|
|
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy.
|
NA
|
NA
|
|
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.
|
NA
|
NA
|
|
Successful Treatment of Preterm Labor in Association with Acute COVID-19 Infection.
|
NA
|
NA
|
|
Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal.
|
NA
|
NA
|
|
Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.
|
NA
|
NA
|
|
18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient With Dynamic Clinical Characteristics in Different Period.
|
NA
|
NA
|
|
Managing Close Contacts of COVID-19 Confirmed Cases in Metropolitan Areas in China.
|
NA
|
NA
|
|
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
|
NA
|
NA
|
|
Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic.
|
NA
|
NA
|
|
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak.
|
NA
|
NA
|
|
Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition).
|
NA
|
NA
|
|
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
|
NA
|
NA
|
|
Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?
|
NA
|
NA
|
|
Recommendations for Deep Brain Stimulation Device Management During a Pandemic.
|
NA
|
NA
|
|
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.
|
NA
|
NA
|
|
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
|
NA
|
NA
|
|
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Current status of potential therapeutic candidates for the COVID-19 crisis.
|
NA
|
NA
|
|
Impact of weather on COVID-19 pandemic in Turkey.
|
NA
|
NA
|
|
Overview of Covid-19; its prevention and management in the light of Unani medicine.
|
NA
|
NA
|
|
How to improve adherence with quarantine: rapid review of the evidence.
|
NA
|
NA
|
|
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
|
NA
|
NA
|
|
Headache medication and the COVID-19 pandemic.
|
NA
|
NA
|
|
Surgery during the COVID-19 pandemic: A comprehensive overview and perioperative care.
|
NA
|
NA
|
|
[Management of a radiotherapy center during the COVID-19 outbreak: The experience of the Mulhouse hospital centre (France)].
|
NA
|
NA
|
|
SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
|
NA
|
NA
|
|
Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
|
NA
|
NA
|
|
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
|
NA
|
NA
|
|
Imaging of coronavirus disease 2019: A Chinese expert consensus statement.
|
NA
|
NA
|
|
Update on treatment of COVID-19: ongoing studies between promising and disappointing results.
|
NA
|
NA
|
|
The Coronavirus Pandemic: What Does the Evidence Show?
|
NA
|
NA
|
|
The impact of respiratory protective equipment on difficult airway management: a randomised, crossover, simulation study.
|
NA
|
NA
|
|
What should a cardiologist know about coronavirus disease 2019?
|
NA
|
NA
|
|
Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience.
|
NA
|
NA
|
|
Urologic Surgery and COVID-19: How the Pandemic Is Changing the Way We Operate.
|
NA
|
NA
|
|
COVID-19: an update on diagnostic and therapeutic approaches.
|
NA
|
NA
|
|
Management of neurological care during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.
|
NA
|
NA
|
|
SEPAR-AEER Consensus Recommendations on the Usefulness of the Thoracic Ultrasound in the Management of the Patient with Suspected or Confirmed Infection with COVID-19.
|
NA
|
NA
|
|
Redesigning emergency department operations amidst a viral pandemic.
|
NA
|
NA
|
|
Pharmacotherapy in COVID-19; A narrative review for emergency providers.
|
NA
|
NA
|
|
COVID-19 outbreak: An elusive enemy.
|
NA
|
NA
|
|
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic.
|
NA
|
NA
|
|
Treatment of SARS-CoV-2: How far have we reached?
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, History, Basic and Clinical Aspects.
|
NA
|
NA
|
|
SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill.
|
NA
|
NA
|
|
Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.
|
NA
|
NA
|
|
Searching an Effective Therapy for the Coronavirus Pandemic: Do We See Light at the End of the Tunnel?
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update.
|
NA
|
NA
|
|
Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.
|
NA
|
NA
|
|
COVID-19 Tragic Pandemic: Concerns over Unintentional “Directed Accelerated Evolution” of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS.
|
NA
|
NA
|
|
Atypical presentation of SARS-CoV-2 infection: A case report.
|
NA
|
NA
|
|
Coronaviruses: A patent dataset report for research and development (R&D) analysis.
|
NA
|
NA
|
|
Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.
|
NA
|
NA
|
|
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.
|
NA
|
NA
|
|
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2.
|
NA
|
NA
|
|
Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.
|
NA
|
NA
|
|
Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective.
|
NA
|
NA
|
|
Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective.
|
NA
|
NA
|
|
The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic.
|
NA
|
NA
|
|
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
|
NA
|
NA
|
|
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
|
NA
|
NA
|
|
Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach.
|
NA
|
NA
|
|
Navigating the impact of COVID-19 on palliative care for head and neck cancer.
|
NA
|
NA
|
|
Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend.
|
NA
|
NA
|
|
A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly.
|
NA
|
NA
|
|
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
|
NA
|
NA
|
|
A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.
|
NA
|
NA
|
|
Patient blood management during the COVID-19 pandemic: a narrative review.
|
NA
|
NA
|
|
Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression.
|
NA
|
NA
|
|
Changes in emergency service access after spread of COVID19 across Italy.
|
NA
|
NA
|
|
Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis.
|
NA
|
NA
|
|
Measuring weight with e-scales in clinical and research settings during the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus Disease 2019 in a Hemodialysis Patient.
|
NA
|
NA
|
|
Early Leukapheresis Depletion in an Ex-Premature with Severe Acute Respiratory Distress Syndrome Due to Bordetella Pertussis and Coronavirus Infection.
|
NA
|
NA
|
|
[The SARS-CoV-2 Pandemic and an Attempted Suicide of a Patient with Delusional Disorder].
|
NA
|
NA
|
|
[Discussion on early warning, prevention and control of emerging infectious diseases from a macroscopic perspective based on big data and effective distance model: enlightenment of COVID-19 epidemic data in China].
|
NA
|
NA
|
|
[Epidemic characteristics and trend analysis of the COVID-19 in Hubei province].
|
NA
|
NA
|
|
[Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China].
|
NA
|
NA
|
|
[Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province].
|
NA
|
NA
|
|
[Preliminary clinical study of direct renin inhibitor aliskiren in the treatment of severe COVID-19 patients with hypertension].
|
NA
|
NA
|
|
[Comparison of epidemiological and clinical characteristics of SARS, pandemic (H1N1) 2009 and COVID-19, and consideration on prevention and control strategies of COVID-19].
|
NA
|
NA
|
|
Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
|
NA
|
NA
|
|
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
|
NA
|
NA
|
|
Increasing the Signal-to-Noise Ratio: COVID-19 Clinical Synopsis for Outpatient Providers.
|
NA
|
NA
|
|
Laryngeal Evaluation during the COVID-19 Pandemic: Transcervical Laryngeal Ultrasonography.
|
NA
|
NA
|
|
Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Best Practice Recommendations for Pediatric Otolaryngology during the COVID-19 Pandemic.
|
NA
|
NA
|
|
On the Pharmacy Radar: COViD-19 and Older People.
|
NA
|
NA
|
|
Can You Catch It? Lessons Learned and Modification of ED Triage Symptom- and Travel-Screening Strategy.
|
NA
|
NA
|
|
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units.
|
NA
|
NA
|
|
Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): A literature review.
|
NA
|
NA
|
|
Nutritional status and COVID-19: an opportunity for lasting change?
|
NA
|
NA
|
|
Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review.
|
NA
|
NA
|
|
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection.
|
NA
|
NA
|
|
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
|
NA
|
NA
|
|
Tackling Corona Virus Disease 2019 (COVID 19) in Workplaces.
|
NA
|
NA
|
|
Prediction of numbers of the accumulative confirmed patients (NACP) and the plateau phase of 2019-nCoV in China.
|
NA
|
NA
|
|
[Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery].
|
NA
|
NA
|
|
SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis.
|
NA
|
NA
|
|
A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.
|
NA
|
NA
|
|
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
|
NA
|
NA
|
|
FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients.
|
NA
|
NA
|
|
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China.
|
NA
|
NA
|
|
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience.
|
NA
|
NA
|
|
Interim Guidelines on Antiviral Therapy for COVID-19.
|
NA
|
NA
|
|
Severe Thrombocytopenia in a Patient with COVID-19.
|
NA
|
NA
|
|
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
|
NA
|
NA
|
|
Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China.
|
NA
|
NA
|
|
A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises.
|
NA
|
NA
|
|
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore.
|
NA
|
NA
|
|
Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19.
|
NA
|
NA
|
|
Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
|
NA
|
NA
|
|
Pandemic Uncertainty: Considerations for Nephrology Nurses.
|
NA
|
NA
|
|
Guidance for management of cancer surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
The impact of the novel coronavirus on trauma and orthopaedics in the UK.
|
NA
|
NA
|
|
COVID-19 in Tuberculosis patients: a report of three cases.
|
NA
|
NA
|
|
The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China.
|
NA
|
NA
|
|
A Novel Plan to Deal with SARS-CoV-2 and COVID-19 Disease.
|
NA
|
NA
|
|
Three Taiwan’s domestic family cluster infections of coronavirus disease 2019.
|
NA
|
NA
|
|
Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Salivary gland disease in the era of COVID-19 pandemic.
|
NA
|
NA
|
|
Medication for COVID-19-an Overview of Approaches Currently Under Study.
|
NA
|
NA
|
|
Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients.
|
NA
|
NA
|
|
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
|
NA
|
NA
|
|
Mild versus severe COVID-19: Laboratory markers.
|
NA
|
NA
|
|
Eosinophil responses during COVID-19 infections and coronavirus vaccination.
|
NA
|
NA
|
|
COVID-19 pandemic-a focused review for clinicians.
|
NA
|
NA
|
|
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development.
|
NA
|
NA
|
|
COVID-19: Disease, management, treatment, and social impact.
|
NA
|
NA
|
|
May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
|
NA
|
NA
|
|
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.
|
NA
|
NA
|
|
Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?
|
NA
|
NA
|
|
The clinical course and its correlated immune status in COVID-19 pneumonia.
|
NA
|
NA
|
|
The Doctor’s Dilemma: lessons from GB Shaw in a modern pandemic COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020.
|
NA
|
NA
|
|
[COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg].
|
NA
|
NA
|
|
General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic.
|
NA
|
NA
|
|
[The COVID-19 Pandemia and its consequences for plastic surgery and hand surgery].
|
NA
|
NA
|
|
Finding the dose for hydroxychloroquine prophylaxis for COVID-19; the desperate search for effectiveness.
|
NA
|
NA
|
|
Neuraxial anaesthesia and peripheral nerve blocks during the COVID-19 pandemic: a literature review and practice recommendations.
|
NA
|
NA
|
|
DIC in COVID-19: Implications for Prognosis and Treatment?
|
NA
|
NA
|
|
COVID-19 and RAS: Unravelling an Unclear Relationship.
|
NA
|
NA
|
|
A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis.
|
NA
|
NA
|
|
Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study.
|
NA
|
NA
|
|
COVID-19: Key Concepts for the Surgeon.
|
NA
|
NA
|
|
Treatment for emerging viruses: Convalescent plasma and COVID-19.
|
NA
|
NA
|
|
Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak.
|
NA
|
NA
|
|
Treatment of Proximal Femoral Fragility Fractures in Patients with COVID-19 During the SARS-CoV-2 Outbreak in Northern Italy.
|
NA
|
NA
|
|
Cancer care in the time of COVID-19-a perspective from Pakistan.
|
NA
|
NA
|
|
Additional challenges faced by cancer patients in Gaza due to COVID-19.
|
NA
|
NA
|
|
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
|
NA
|
NA
|
|
Expert recommendations on blood purification treatment protocol for patients with severe COVID-19: Recommendation and consensus.
|
NA
|
NA
|
|
Clinical and imaging features of COVID-19.
|
NA
|
NA
|
|
Implementation of a Novel Remote Physician SBRT Coverage Process during the Coronavirus Pandemic.
|
NA
|
NA
|
|
Neurological Implications of COVID-19 Infections.
|
NA
|
NA
|
|
Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
|
NA
|
NA
|
|
The ethical challenges of the SARS-CoV-2 pandemic in the global south and the global north - same and different.
|
NA
|
NA
|
|
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
|
NA
|
NA
|
|
The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy.
|
NA
|
NA
|
|
Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors.
|
NA
|
NA
|
|
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020.
|
NA
|
NA
|
|
Redesigning a Department of Surgery during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds.
|
NA
|
NA
|
|
The danger of neglecting melanoma during the COVID-19 pandemic.
|
NA
|
NA
|
|
National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries.
|
NA
|
NA
|
|
The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.
|
NA
|
NA
|
|
Skull base surgery during the Covid-19 pandemic: The Italian skull base society recommendations.
|
NA
|
NA
|
|
[SARS-CoV-2 infection and solid organ transplantation].
|
NA
|
NA
|
|
[Oncology: navigating the COVID-19 Pandemic and Steer the Course].
|
NA
|
NA
|
|
[Hematology in the time of COVID-19].
|
NA
|
NA
|
|
[Rheumatology and COVID-19].
|
NA
|
NA
|
|
[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].
|
NA
|
NA
|
|
[Drugs that aggravate the course of COVID-19 : really ?]
|
NA
|
NA
|
|
[COVID-19 : Intensive care management].
|
NA
|
NA
|
|
[Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department].
|
NA
|
NA
|
|
Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study.
|
NA
|
NA
|
|
A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.
|
NA
|
NA
|
|
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
|
NA
|
NA
|
|
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients.
|
NA
|
NA
|
|
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
|
NA
|
NA
|
|
Ultrasound on the Frontlines of COVID-19: Report from an International Webinar.
|
NA
|
NA
|
|
COVID-19 diagnosis and management: a comprehensive review.
|
NA
|
NA
|
|
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.
|
NA
|
NA
|
|
COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids.
|
NA
|
NA
|
|
Response and role of palliative care during the COVID-19 pandemic: A national telephone survey of hospices in Italy.
|
NA
|
NA
|
|
Use of Radiographic Features in COVID-19 Diagnosis: Challenges and Perspectives.
|
NA
|
NA
|
|
Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.
|
NA
|
NA
|
|
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.
|
NA
|
NA
|
|
Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Toward a consensus view in the management of acute facial injuries during the Covid-19 pandemic.
|
NA
|
NA
|
|
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
|
NA
|
NA
|
|
Effective treatment of severe COVID-19 patients with tocilizumab.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists - Systematic Literature Review and Additional Analysis.
|
NA
|
NA
|
|
[COVID-19 pandemic: structured expansion of ventilation capacities using home respirators].
|
NA
|
NA
|
|
Epidemiologic characteristics of traumatic fractures in elderly patients during the outbreak of coronavirus disease 2019 in China.
|
NA
|
NA
|
|
Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.
|
NA
|
NA
|
|
Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020.
|
NA
|
NA
|
|
Use of CT and artificial intelligence in suspected or COVID-19 positive patients: statement of the Italian Society of Medical and Interventional Radiology.
|
NA
|
NA
|
|
It’s not over until it’s over: the chameleonic behavior of COVID-19 over a six-day period.
|
NA
|
NA
|
|
Chloroquine-induced QTc prolongation in COVID-19 patients.
|
NA
|
NA
|
|
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services.
|
NA
|
NA
|
|
COVID-19: a defining moment for clinical pharmacology?
|
NA
|
NA
|
|
Rethinking the role of hydroxychloroquine in the treatment of COVID-19.
|
NA
|
NA
|
|
Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder.
|
NA
|
NA
|
|
Initial experiences from patients with COVID-19 on ventilatory support in Denmark.
|
NA
|
NA
|
|
A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.
|
NA
|
NA
|
|
Will the antimalarial drug take over to combat COVID-19?
|
NA
|
NA
|
|
Infection Control for CT Equipment and Radiographers’ Personal Protection During the Coronavirus Disease (COVID-19) Outbreak in China.
|
NA
|
NA
|
|
Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.
|
NA
|
NA
|
|
Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.
|
NA
|
NA
|
|
Association of Obesity with Disease Severity among Patients with COVID-19.
|
NA
|
NA
|
|
[Options for controlling new Corona virus infection - 2019-nCoV].
|
NA
|
NA
|
|
MANAGEMENT OF PERSISTENT PNEUMOTHORAX WITH THORACOSCOPY AND BLEBS RESECTION IN COVID-19 PATIENTS.
|
NA
|
NA
|
|
COVID-19 and Nigeria: putting the realities in context.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Patients With Lung Cancer: The Potential Role of Interleukin-17 Target Therapy.
|
NA
|
NA
|
|
COVID-19: Immunology and treatment options.
|
NA
|
NA
|
|
Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2.
|
NA
|
NA
|
|
Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol.
|
NA
|
NA
|
|
The many faces of the anti-COVID immune response.
|
NA
|
NA
|
|
Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work.
|
NA
|
NA
|
|
Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis.
|
NA
|
NA
|
|
The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report.
|
NA
|
NA
|
|
Abdominal Wall Surgery After SARS-CoV-2: Time to Reestablish Postponed Non-essential Procedures?
|
NA
|
NA
|
|
A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
|
NA
|
NA
|
|
COVID-19 infection in kidney transplant recipients.
|
NA
|
NA
|
|
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
|
NA
|
NA
|
|
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine.
|
NA
|
NA
|
|
Palliative care in the context of a pandemic: similar but different.
|
NA
|
NA
|
|
Acute myocardial injury is common in patients with covid-19 and impairs their prognosis.
|
NA
|
NA
|
|
Cardiovascular manifestations and treatment considerations in covid-19.
|
NA
|
NA
|
|
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.
|
NA
|
NA
|
|
Considerations for STI Clinics during the COVID-19 pandemic.
|
NA
|
NA
|
|
A quasi-experiment on using guided mobile learning interventions in ESL classrooms: Time use and academic performance.
|
NA
|
NA
|
|
[Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: changes in treatment modalities related to the COVID-19 health crisis].
|
NA
|
NA
|
|
Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome.
|
NA
|
NA
|
|
What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
|
NA
|
NA
|
|
Comprehensive update on current outbreak of novel coronavirus infection (2019-nCoV).
|
NA
|
NA
|
|
COVID-19: Therapeutics and Their Toxicities.
|
NA
|
NA
|
|
[Public Mental Health as One of the Key Factors in Dealing with COVID-19].
|
NA
|
NA
|
|
Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
|
NA
|
NA
|
|
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.
|
NA
|
NA
|
|
The role of imaging in the detection and management of COVID-19: a review.
|
NA
|
NA
|
|
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.
|
NA
|
NA
|
|
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
|
NA
|
NA
|
|
Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction.
|
NA
|
NA
|
|
CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.
|
NA
|
NA
|
|
Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-a Living Working Document.
|
NA
|
NA
|
|
Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian scenario.
|
NA
|
NA
|
|
SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.
|
NA
|
NA
|
|
Changes in Head and Neck Oncologic Practice During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!
|
NA
|
NA
|
|
Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment.
|
NA
|
NA
|
|
Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
|
NA
|
NA
|
|
COVID-19: A Geriatric Emergency.
|
NA
|
NA
|
|
Early intervention likely improves mortality in COVID-19 infection.
|
NA
|
NA
|
|
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.
|
NA
|
NA
|
|
PLASTIC SURGERY AND THE COVID-19 PANDEMIC: A REVIEW OF CLINICAL GUIDELINES.
|
NA
|
NA
|
|
Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A “Living Working Document”.
|
NA
|
NA
|
|
The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 with cystic features on computed tomography: A case report.
|
NA
|
NA
|
|
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases.
|
NA
|
NA
|
|
COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression.
|
NA
|
NA
|
|
Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients.
|
NA
|
NA
|
|
SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.
|
NA
|
NA
|
|
A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development. IUPHAR Review 29.
|
NA
|
NA
|
|
Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Cutaneous sıde-effects of the potential COVID-19 drugs.
|
NA
|
NA
|
|
Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing.
|
NA
|
NA
|
|
Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19.
|
NA
|
NA
|
|
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
|
NA
|
NA
|
|
Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.
|
NA
|
NA
|
|
The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures.
|
NA
|
NA
|
|
A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19.
|
NA
|
NA
|
|
2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases.
|
NA
|
NA
|
|
COVID-19: impact on colorectal surgery.
|
NA
|
NA
|
|
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).
|
NA
|
NA
|
|
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore.
|
NA
|
NA
|
|
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation.
|
NA
|
NA
|
|
Characteristics of Endodontic Emergencies during Coronavirus Disease 2019 Outbreak in Wuhan.
|
NA
|
NA
|
|
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak.
|
NA
|
NA
|
|
Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles.
|
NA
|
NA
|
|
Antiviral activities of type I interferons to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.
|
NA
|
NA
|
|
The Impact of Sociocultural Influences on the COVID-19 Measures-Reflections From Singapore.
|
NA
|
NA
|
|
Cytokine storm intervention in the early stages of COVID-19 pneumonia.
|
NA
|
NA
|
|
Acute Thrombosis of an Aortic Prosthetic Graft in a Patient with Severe COVID-19-Related Pneumonia.
|
NA
|
NA
|
|
COVID-19 presenting as stroke.
|
NA
|
NA
|
|
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).
|
NA
|
NA
|
|
2019 Novel coronavirus disease (COVID-19) in hemodialysis patients: A report of two cases.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.
|
NA
|
NA
|
|
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
|
NA
|
NA
|
|
Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: A review.
|
NA
|
NA
|
|
Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic.
|
NA
|
NA
|
|
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
|
NA
|
NA
|
|
Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Current targeted therapeutics against COVID-19: Based on first-line experience in China.
|
NA
|
NA
|
|
Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering.
|
NA
|
NA
|
|
Acute limb ischemia in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
|
NA
|
NA
|
|
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.
|
NA
|
NA
|
|
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system.
|
NA
|
NA
|
|
COVID-19 in Vietnam: A lesson of pre-preparation.
|
NA
|
NA
|
|
Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.
|
NA
|
NA
|
|
A cross-sectional study on mental health among health care workers during the outbreak of Corona Virus Disease 2019.
|
NA
|
NA
|
|
Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission.
|
NA
|
NA
|
|
COVID-19 Rapid Guideline in Kidney Transplant Recipients.
|
NA
|
NA
|
|
Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report.
|
NA
|
NA
|
|
Clinical trials and the COVID-19 pandemic.
|
NA
|
NA
|
|
Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China.
|
NA
|
NA
|
|
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.
|
NA
|
NA
|
|
COVID-19, superinfections and antimicrobial development: What can we expect?
|
NA
|
NA
|
|
Disruption of joint arthroplasty services in Europe during the COVID-19 pandemic: an online survey within the European Hip Society (EHS) and the European Knee Associates (EKA).
|
NA
|
NA
|
|
Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic.
|
NA
|
NA
|
|
Dupilumab and COVID-19: What should we expect?
|
NA
|
NA
|
|
A PATH TO RESUME AESTHETIC CARE EXECUTIVE SUMMARY OF PROJECT AesCert™ GUIDANCE SUPPLEMENT: PRACTICAL CONSIDERATIONS FOR AESTHETIC MEDICINE PROFESSIONALS SUPPORTING CLINIC PREPAREDNESS IN RESPONSE TO THE SARS-CoV-2 OUTBREAK.
|
NA
|
NA
|
|
Quadruple therapy for asymptomatic COVID-19 infection patients.
|
NA
|
NA
|
|
Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures.
|
NA
|
NA
|
|
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.
|
NA
|
NA
|
|
The role of triage in the prevention and control of COVID-19.
|
NA
|
NA
|
|
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
|
NA
|
NA
|
|
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19.
|
NA
|
NA
|
|
Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis.
|
NA
|
NA
|
|
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.
|
NA
|
NA
|
|
Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases.
|
NA
|
NA
|
|
[Real-life data and Covid-19: The third avenue of reseach].
|
NA
|
NA
|
|
Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward.
|
NA
|
NA
|
|
Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.
|
NA
|
NA
|
|
Insights into the inhibitory potential of selective phytochemicals against Mpro of 2019-nCoV: a computer-aided study.
|
NA
|
NA
|
|
COVID-19, Modern Pandemic: A Systematic Review From Front-Line Health Care Providers’ Perspective.
|
NA
|
NA
|
|
Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients.
|
NA
|
NA
|
|
The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19.
|
NA
|
NA
|
|
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.
|
NA
|
NA
|
|
Chloroquine: Can it be a Novel Drug for COVID-19.
|
NA
|
NA
|
|
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).
|
NA
|
NA
|
|
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock.
|
NA
|
NA
|
|
An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications.
|
NA
|
NA
|
|
The clinical and immunological features of pediatric COVID-19 patients in China.
|
NA
|
NA
|
|
Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO).
|
NA
|
NA
|
|
Medical treatment options for COVID-19.
|
NA
|
NA
|
|
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
|
NA
|
NA
|
|
FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication.
|
NA
|
NA
|
|
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano.
|
NA
|
NA
|
|
Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.
|
NA
|
NA
|
|
The BMA COVID-19 ethical guidance: a legal analysis.
|
NA
|
NA
|
|
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
|
NA
|
NA
|
|
Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 pneumonia in kidney transplant recipients-Where we are?
|
NA
|
NA
|
|
[Potential harms associated with 4-aminoquinoline treatment].
|
NA
|
NA
|
|
Caution regarding potential changes in AVR practices during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms.
|
NA
|
NA
|
|
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.
|
NA
|
NA
|
|
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental Settings.
|
NA
|
NA
|
|
Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.
|
NA
|
NA
|
|
COVID-19: Present and Future Challenges for Dental Practice.
|
NA
|
NA
|
|
Clinical Recommendations for Epistaxis Management During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Defining Essential Services for Deaf and Hard of Hearing Children during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Mesenchymal stem cells as a potential therapy for COVID-19.
|
NA
|
NA
|
|
Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases.
|
NA
|
NA
|
|
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
|
NA
|
NA
|
|
Guidance for the management of adult patients with coronavirus disease 2019.
|
NA
|
NA
|
|
A human monoclonal antibody blocking SARS-CoV-2 infection.
|
NA
|
NA
|
|
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
|
NA
|
NA
|
|
SARS-CoV-2 can induce brain and spine demyelinating lesions.
|
NA
|
NA
|
|
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
|
NA
|
NA
|
|
Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China.
|
NA
|
NA
|
|
ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective.
|
NA
|
NA
|
|
[First case of COVID-19 treated with tocilizumab in Iceland].
|
NA
|
NA
|
|
Nasopharyngeal wash in preventing and treating upper respiratory tract infections: Could it prevent COVID-19?
|
NA
|
NA
|
|
Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic.
|
NA
|
NA
|
|
COVID-19 Dynamic Computed Tomography (CT) Performance and Observation of Some Laboratory Indicators.
|
NA
|
NA
|
|
Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic.
|
NA
|
NA
|
|
Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City.
|
NA
|
NA
|
|
Pulmonary contusion mimicking COVID-19: A case report.
|
NA
|
NA
|
|
The Indian perspective of COVID-19 outbreak.
|
NA
|
NA
|
|
Are Clinicians Contributing to Excess African American COVID-19 Deaths? Unbeknownst to Them, They May Be.
|
NA
|
NA
|
|
Guide for Nuclear Medicine Applications During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain.
|
NA
|
NA
|
|
Can N95 Respirators Be Reused after Disinfection? How Many Times?
|
NA
|
NA
|
|
Considerations for Postacute Rehabilitation for Survivors of COVID-19.
|
NA
|
NA
|
|
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Tocilizumab for the treatment of severe coronavirus disease 2019.
|
NA
|
NA
|
|
Experiencing Community in a Covid Surge.
|
NA
|
NA
|
|
Individualized prediction nomograms for disease progression in mild COVID-19.
|
NA
|
NA
|
|
Clinical Features of Patients with Coronavirus Disease 2019 (COVID-19) from a Designated Hospital in Beijing, China.
|
NA
|
NA
|
|
The management of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
Otolaryngologists’ Role in Redeployment During the COVID-19 Pandemic: A Commentary.
|
NA
|
NA
|
|
“We’re Not Ready, But I Don’t Think You’re Ever Ready.” Clinician Perspectives on Implementation of Crisis Standards of Care.
|
NA
|
NA
|
|
Antibody-based therapies for COVID-19: Can Europe move faster?
|
NA
|
NA
|
|
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.
|
NA
|
NA
|
|
COVID-19 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
|
NA
|
NA
|
|
Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 RNA polymerase as target for antiviral therapy.
|
NA
|
NA
|
|
Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines.
|
NA
|
NA
|
|
[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].
|
NA
|
NA
|
|
Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.
|
NA
|
NA
|
|
[Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]
|
NA
|
NA
|
|
Renin-angiotensin-aldosterone system and COVID-19 infection.
|
NA
|
NA
|
|
International Liaison Committee on Resuscitation: COVID-19 consensus on science, treatment recommendations and task force insights.
|
NA
|
NA
|
|
Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency.
|
NA
|
NA
|
|
Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
Cytokine Storm Drugs Move from CAR T to COVID-19.
|
NA
|
NA
|
|
Utility of extracorporeal membrane oxygenation in COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 and myocardial injury: Few answers, many questions.
|
NA
|
NA
|
|
Hydroxychloroquine use in the COVID-19 patient.
|
NA
|
NA
|
|
PAP therapy increases the risk of transmission of COVID-19.
|
NA
|
NA
|
|
Pulmonary function testing precautions in a time of COVID-19.
|
NA
|
NA
|
|
Keep cystic fibrosis patients out of the hospital.
|
NA
|
NA
|
|
Asthma increases risk of severity of COVID-19.
|
NA
|
NA
|
|
The War on COVID-19 Pandemic: Role of Rehabilitation Professionals and Hospitals.
|
NA
|
NA
|
|
Encountering COVID-19 as Endocrinologists.
|
NA
|
NA
|
|
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
|
NA
|
NA
|
|
Taking down covid-19.
|
NA
|
NA
|
|
Crisis hits end-of-life care.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the context of COVID-19.
|
NA
|
NA
|
|
An Environmental and Health Perspective for COVID-19 Outbreak: Meteorology and Air Quality Influence, Sewage Epidemiology Indicator, Hospitals Disinfection, Drug Therapies and Recommendations.
|
NA
|
NA
|
|
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment.
|
NA
|
NA
|
|
MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
|
NA
|
NA
|
|
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
|
NA
|
NA
|
|
Outbreak of COVID-19 infection in children: fear and serenity.
|
NA
|
NA
|
|
The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.
|
NA
|
NA
|
|
Coronavirus disease 2019: a clinical review.
|
NA
|
NA
|
|
An update on the status of COVID-19: a comprehensive review.
|
NA
|
NA
|
|
Clinical display, diagnostics and genetic implication of novel Coronavirus (COVID-19) epidemic.
|
NA
|
NA
|
|
Current practice and potential strategy in diagnosing COVID-19.
|
NA
|
NA
|
|
Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic.
|
NA
|
NA
|
|
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease.
|
NA
|
NA
|
|
Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
|
NA
|
NA
|
|
AGS Position Statement: Resource Allocation Strategies and Age-Related Considerations in the COVID-19 Era and Beyond.
|
NA
|
NA
|
|
Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
|
NA
|
NA
|
|
[SARS-CoV-2, a point in the storm].
|
NA
|
NA
|
|
[Emergency department : COVID-19 crisis and organizational aspects].
|
NA
|
NA
|
|
[Asthma and COPD management during the COVID-19 pandemic].
|
NA
|
NA
|
|
[Diabetes and COVID-19 infection].
|
NA
|
NA
|
|
Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain.
|
NA
|
NA
|
|
COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak.
|
NA
|
NA
|
|
Exergames as Coping Strategies for Anxiety Disorders During the COVID-19 Quarantine Period.
|
NA
|
NA
|
|
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
|
NA
|
NA
|
|
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.
|
NA
|
NA
|
|
Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society.
|
NA
|
NA
|
|
Pneumomediastinum following intubation in COVID-19 patients: a case series.
|
NA
|
NA
|
|
Coronavirus Pandemic-Therapy and Vaccines.
|
NA
|
NA
|
|
[Individualized treatment recommendations for lung cancer patients at different stages of treatment during the outbreak of 2019 novel coronavirus disease].
|
NA
|
NA
|
|
Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes.
|
NA
|
NA
|
|
Respiratory management in severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
Human needs in COVID-19 isolation.
|
NA
|
NA
|
|
Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus.
|
NA
|
NA
|
|
Acute respiratory failure in COVID-19: is it “typical” ARDS?
|
NA
|
NA
|
|
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
|
NA
|
NA
|
|
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019.
|
NA
|
NA
|
|
Resource Reallocation during the COVID-19 Pandemic in a Suburban Hospital System: Implications for Outpatient Hip and Knee Arthroplasty.
|
NA
|
NA
|
|
Palliative Care in the Time of COVID-19.
|
NA
|
NA
|
|
An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions.
|
NA
|
NA
|
|
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
|
NA
|
NA
|
|
SARS-CoV-2 infection among patients with systemic autoimmune diseases.
|
NA
|
NA
|
|
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view.
|
NA
|
NA
|
|
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
|
NA
|
NA
|
|
[Management and prevention of common skin problems during epidemic prevention and control of COVID-19].
|
NA
|
NA
|
|
[Consensus of Chinese experts on diagnosis and treatment processes of acute myocardial infarction in the context of prevention and control of COVID-19 (first edition)].
|
NA
|
NA
|
|
[Laboratory testing techniques for SARS-CoV-2].
|
NA
|
NA
|
|
[Correlation between clinical classification of COVID-19 and imaging characteristics of MSCT volume scanning of the lungs].
|
NA
|
NA
|
|
[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].
|
NA
|
NA
|
|
[Conducting clinical studies during the epidemics of communicable diseases: perspectives of methodology and health economics].
|
NA
|
NA
|
|
[Supporting the battle against COVID-19 in E’zhou, Hubei Province: the experience of Guizhou medical team].
|
NA
|
NA
|
|
[Tracheal intubation in patients with severe and critical COVID-19: analysis of 18 cases].
|
NA
|
NA
|
|
Rapid development of an inactivated vaccine candidate for SARS-CoV-2.
|
NA
|
NA
|
|
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
|
NA
|
NA
|
|
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.
|
NA
|
NA
|
|
Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?
|
NA
|
NA
|
|
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
|
NA
|
NA
|
|
First Case of an Infant with COVID-19 in the Middle East.
|
NA
|
NA
|
|
How Essential Is to Focus on Physician’s Health and Burnout in Coronavirus (COVID-19) Pandemic?
|
NA
|
NA
|
|
COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus.
|
NA
|
NA
|
|
Experiencing the Surge: Report from a Large New York Radiation Oncology Department During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis.
|
NA
|
NA
|
|
COVID-19 in Older People: A Rapid Clinical Review.
|
NA
|
NA
|
|
Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options.
|
NA
|
NA
|
|
Application of nanomaterials in treatment, anti-infection and detection of coronaviruses.
|
NA
|
NA
|
|
Animal models for emerging coronavirus: progress and new insights.
|
NA
|
NA
|
|
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
|
NA
|
NA
|
|
COVID-19 - Toward a comprehensive understanding of the disease.
|
NA
|
NA
|
|
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.
|
NA
|
NA
|
|
Comprehensive overview of COVID-19 based on current evidence.
|
NA
|
NA
|
|
COVID-19 and toxicity from potential treatments: Panacea or poison.
|
NA
|
NA
|
|
COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital.
|
NA
|
NA
|
|
Loss of smell or taste as the only symptom of COVID-19.
|
NA
|
NA
|
|
Modified management mode for colorectal cancer during COVID-19 outbreak - a single-center experience.
|
NA
|
NA
|
|
Preventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan’s experience.
|
NA
|
NA
|
|
Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.
|
NA
|
NA
|
|
A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
|
NA
|
NA
|
|
ACE2 Activators for the Treatment of Covid 19 Patients.
|
NA
|
NA
|
|
Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines.
|
NA
|
NA
|
|
Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19.
|
NA
|
NA
|
|
Traditional Chinese Medicine treatment of COVID-19.
|
NA
|
NA
|
|
Rapid Implementation of an Adult Coronavirus Disease 2019 Unit in a Children’s Hospital.
|
NA
|
NA
|
|
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.
|
NA
|
NA
|
|
In Silico Design of Antiviral Peptides Targeting the Spike Protein of SARS-CoV-2.
|
NA
|
NA
|
|
The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19.
|
NA
|
NA
|
|
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.
|
NA
|
NA
|
|
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region.
|
NA
|
NA
|
|
What dentists need to know about COVID-19.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of Cushing’s syndrome.
|
NA
|
NA
|
|
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg.
|
NA
|
NA
|
|
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
|
NA
|
NA
|
|
Spine Surgical Procedures during Coronavirus Disease 2019 Pandemic: Is It Still Possible to Take Care of Patients? Results of an Observational Study in the First Month of Confinement.
|
NA
|
NA
|
|
Effects of the COVID-19 Outbreak on Elder Mistreatment and Response in New York City: Initial Lessons.
|
NA
|
NA
|
|
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.
|
NA
|
NA
|
|
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.
|
NA
|
NA
|
|
A child with household transmitted COVID-19.
|
NA
|
NA
|
|
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
|
NA
|
NA
|
|
Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery.
|
NA
|
NA
|
|
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
|
NA
|
NA
|
|
The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.
|
NA
|
NA
|
|
Covid-19 and drug therapy, what we learned.
|
NA
|
NA
|
|
COVID-19: a novel coronavirus and a novel challenge for oral healthcare.
|
NA
|
NA
|
|
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
|
NA
|
NA
|
|
A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
|
NA
|
NA
|
|
Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.
|
NA
|
NA
|
|
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
|
NA
|
NA
|
|
Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19 infection.
|
NA
|
NA
|
|
Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with Novel Coronavirus Disease (COVID-19) Treated with Hydroxychloroquine.
|
NA
|
NA
|
|
Cognitive-behavioral therapy in the time of coronavirus: Clinician tips for working with eating disorders via telehealth when face-to-face meetings are not possible.
|
NA
|
NA
|
|
Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
|
NA
|
NA
|
|
Systems Barriers to Assessment and Treatment of COVID-19 Positive Patients at the End of Life.
|
NA
|
NA
|
|
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
|
NA
|
NA
|
|
In-hospital management of persons with haemophilia and COVID-19: practical guidance.
|
NA
|
NA
|
|
COVID-19 ventilatory phenotypes and obesity: is there a relationship?
|
NA
|
NA
|
|
Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
|
NA
|
NA
|
|
Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.
|
NA
|
NA
|
|
COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.
|
NA
|
NA
|
|
Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists.
|
NA
|
NA
|
|
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
|
NA
|
NA
|
|
Training in neurology: Flexibility and adaptability of a neurology training program at the epicenter of COVID-19.
|
NA
|
NA
|
|
Current State of Knowledge About SARS-CoV-2 and COVID-19 Disease in Pregnant Women.
|
NA
|
NA
|
|
What will be the new normal for the dental industry?
|
NA
|
NA
|
|
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
|
NA
|
NA
|
|
COVID-19 and Cancer: a Comprehensive Review.
|
NA
|
NA
|
|
Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
|
NA
|
NA
|
|
COVID-19 and off label use of drugs: an ethical viewpoint.
|
NA
|
NA
|
|
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.
|
NA
|
NA
|
|
Systemic Immunobiological, Immunosuppressant and Oncologic Agents for the Treatment of Dermatologic Diseases during the SARS-Cov-2 (COVID19) Pandemic Emergency: a Quick Review for a Quick Consultation.
|
NA
|
NA
|
|
[Materialism and dialectics of epidemic prevention and control: only by respecting science can we do more with less].
|
NA
|
NA
|
|
[Chinese experts’ consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].
|
NA
|
NA
|
|
[Visualization analysis on treatment of coronavirus based on knowledge graph].
|
NA
|
NA
|
|
Imaging examination, diagnosis, and control and prevention of nosocomial infection for coronavirus disease 2019: Expert consensus of Hunan radiologist.
|
NA
|
NA
|
|
Chest CT findings and clinical features of coronavirus disease 2019 in children.
|
NA
|
NA
|
|
Multistage CT features of coronavirus disease 2019.
|
NA
|
NA
|
|
Value of CT application in the screening,diagnosis,and treatment of COVID-19.
|
NA
|
NA
|
|
Unprecedented action has been taken to contain the epidemic of coronavirus disease 2019 in China.
|
NA
|
NA
|
|
Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.
|
NA
|
NA
|
|
SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.
|
NA
|
NA
|
|
Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden.
|
NA
|
NA
|
|
Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.
|
NA
|
NA
|
|
Chilblains in children in the setting of COVID-19 pandemic.
|
NA
|
NA
|
|
Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project).
|
NA
|
NA
|
|
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery.
|
NA
|
NA
|
|
Surgeons, plague, and leadership: A historical mantle to carry forward.
|
NA
|
NA
|
|
Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience.
|
NA
|
NA
|
|
Managing Cancer Care during the COVID-19 Pandemic and Beyond.
|
NA
|
NA
|
|
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis.
|
NA
|
NA
|
|
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
|
NA
|
NA
|
|
Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
|
NA
|
NA
|
|
COVID-19 and Moral Imperialism in Multinational Clinical Research.
|
NA
|
NA
|
|
Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
|
NA
|
NA
|
|
COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).
|
NA
|
NA
|
|
A Dual-Center Observational Review of Hospital-Based Palliative Care in Patients Dying With COVID-19.
|
NA
|
NA
|
|
When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19.
|
NA
|
NA
|
|
Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management.
|
NA
|
NA
|
|
ENHANCED ECG MONITORING OF COVID-19 PATIENTS.
|
NA
|
NA
|
|
The CoV-2 outbreak: how hematologists could help to fight Covid-19.
|
NA
|
NA
|
|
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
|
NA
|
NA
|
|
Current development of COVID-19 diagnostics, vaccines and therapeutics.
|
NA
|
NA
|
|
Could nasal nitric oxide help to mitigate the severity of COVID-19?
|
NA
|
NA
|
|
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19).
|
NA
|
NA
|
|
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
|
NA
|
NA
|
|
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532).
|
NA
|
NA
|
|
Caring for Bereaved Family Members During the COVID-19 Pandemic: Before and After the Death of a Patient.
|
NA
|
NA
|
|
Availability of Internationally Controlled Essential Medicines in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
|
NA
|
NA
|
|
SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
|
NA
|
NA
|
|
First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community.
|
NA
|
NA
|
|
Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.
|
NA
|
NA
|
|
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics.
|
NA
|
NA
|
|
Internet of things (IoT) applications to fight against COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach.
|
NA
|
NA
|
|
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
|
NA
|
NA
|
|
Light as a potential treatment for pandemic coronavirus infections: A perspective.
|
NA
|
NA
|
|
Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?
|
NA
|
NA
|
|
Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
|
NA
|
NA
|
|
[Real-world efficacy and safety of lopinavir/ritonavir and arbidol in treating with COVID-19 : an observational cohort study].
|
NA
|
NA
|
|
[Analysis of the first cluster of cases in a family of COVID-19 in Gansu Province].
|
NA
|
NA
|
|
COVID-19: Living through Another Pandemic.
|
NA
|
NA
|
|
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
|
NA
|
NA
|
|
Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid Review.
|
NA
|
NA
|
|
[Recommendations of the Urolithiasis Committee of the French Urology Association for the management and the treatment of the stone formers patients during the COVID-19 pandemic crisis].
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).
|
NA
|
NA
|
|
Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned.
|
NA
|
NA
|
|
The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research.
|
NA
|
NA
|
|
An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report.
|
NA
|
NA
|
|
Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals’ roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
|
NA
|
NA
|
|
JAACAP’s Role in Advancing the Science of Pediatric Mental Health and Promoting the Care of Youth and Families During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series.
|
NA
|
NA
|
|
Advocacy to provide good quality oncology services during the COVID-19 pandemic - Actions at 3-levels.
|
NA
|
NA
|
|
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.
|
NA
|
NA
|
|
Making Waves: Coronavirus detection, presence and persistence in the water environment: State of the art and knowledge needs for public health.
|
NA
|
NA
|
|
An international comparison analysis of reserve and supply system for emergency medical supplies between China, the United States, Australia, and Canada.
|
NA
|
NA
|
|
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
|
NA
|
NA
|
|
A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.
|
NA
|
NA
|
|
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.
|
NA
|
NA
|
|
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
|
NA
|
NA
|
|
A Hemodialysis Patient with Severe COVID-19 Pneumonia.
|
NA
|
NA
|
|
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.
|
NA
|
NA
|
|
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
|
NA
|
NA
|
|
COVID-19 Trend Estimation in the Elderly Italian Region of Sardinia.
|
NA
|
NA
|
|
Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature.
|
NA
|
NA
|
|
Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.
|
NA
|
NA
|
|
[Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)].
|
NA
|
NA
|
|
[Management of COVID-19: the Zhejiang experience].
|
NA
|
NA
|
|
[Pharmaceutical care for severe and critically ill patients with COVID-19].
|
NA
|
NA
|
|
[Study on the epidemic development of COVID-19 in Hubei province by a modified SEIR model].
|
NA
|
NA
|
|
[Dynamic changes of chest CT imaging in patients with COVID-19].
|
NA
|
NA
|
|
[CT imaging features of patients with different clinical types of COVID-19].
|
NA
|
NA
|
|
[Clinical analysis of suspected COVID-19 patients with anxiety and depression].
|
NA
|
NA
|
|
[Roles of multidisciplinary team in diagnosis and treatment of suspected cases of COVID-19].
|
NA
|
NA
|
|
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
|
NA
|
NA
|
|
[Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].
|
NA
|
NA
|
|
[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].
|
NA
|
NA
|
|
[Clinical experience of high-flow nasal cannula oxygen therapy in severe COVID-19 patients].
|
NA
|
NA
|
|
[Pregnant women complicated with COVID-19: a clinical analysis of 3 cases].
|
NA
|
NA
|
|
[Management of a colon cancer patient complicated with COVID-19].
|
NA
|
NA
|
|
[Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining].
|
NA
|
NA
|
|
CT Scans Obtained for Nonpulmonary Indications: Associated Respiratory Findings of COVID-19.
|
NA
|
NA
|
|
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019.
|
NA
|
NA
|
|
[Chloroquine as a possible treatment for COVID-19].
|
NA
|
NA
|
|
[Respiratory complaints in the time of COVID-19].
|
NA
|
NA
|
|
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
|
NA
|
NA
|
|
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.
|
NA
|
NA
|
|
The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis?
|
NA
|
NA
|
|
The Challenges of COVID-19 for People Living With Diabetes: Considerations for Digital Health.
|
NA
|
NA
|
|
Treating Leukemia in the Time of COVID-19.
|
NA
|
NA
|
|
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
|
NA
|
NA
|
|
Israel Ad Hoc COVID-19 Committee: Guidelines for Care of Older Persons During a Pandemic.
|
NA
|
NA
|
|
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
|
NA
|
NA
|
|
SARS-CoV-2 Infection with Different Radiological Insights.
|
NA
|
NA
|
|
Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies.
|
NA
|
NA
|
|
Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.
|
NA
|
NA
|
|
‘Scientific Strabismus’ or Two Related Pandemics: COVID-19 & Vitamin D Deficiency.
|
NA
|
NA
|
|
Intelligent classification of platelet aggregates by agonist type.
|
NA
|
NA
|
|
Non-communicable disease management in vulnerable patients during Covid-19.
|
NA
|
NA
|
|
The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: Need to interpret with caution.
|
NA
|
NA
|
|
Management of patients with COPD during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and pulmonary hypertension.
|
NA
|
NA
|
|
Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.
|
NA
|
NA
|
|
Therapeutic targets and signaling mechanisms of vitamin C activity against sepsis: a bioinformatics study.
|
NA
|
NA
|
|
A cloth mask for under-resourced healthcare settings in the COVID19 pandemic.
|
NA
|
NA
|
|
Sudden death due to acute pulmonary embolism in a young woman with COVID-19.
|
NA
|
NA
|
|
End-of-life care in patients with a highly transmissible respiratory virus: implications for COVID-19.
|
NA
|
NA
|
|
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
|
NA
|
NA
|
|
Recommendations for Trauma and Emergency General Surgery Practice During COVID-19 Pandemic.
|
NA
|
NA
|
|
A global treatments for coronaviruses including COVID-19.
|
NA
|
NA
|
|
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
|
NA
|
NA
|
|
To Do or Not to Do?-A Review of Cancer Surgery Triage Guidelines in COVID-19 Pandemic.
|
NA
|
NA
|
|
Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report.
|
NA
|
NA
|
|
COVID-19: a look into the modern age pandemic.
|
NA
|
NA
|
|
An Update on Current Therapeutic Drugs Treating COVID-19.
|
NA
|
NA
|
|
Hot Topic Commentary on COVID-19.
|
NA
|
NA
|
|
The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.
|
NA
|
NA
|
|
The challenges in colorectal cancer management during COVID-19 epidemic.
|
NA
|
NA
|
|
2019 novel coronavirus pneumonia with onset of dizziness: a case report.
|
NA
|
NA
|
|
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.
|
NA
|
NA
|
|
Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report from a Multicenter New York Area Institution.
|
NA
|
NA
|
|
Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies.
|
NA
|
NA
|
|
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations.
|
NA
|
NA
|
|
Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis.
|
NA
|
NA
|
|
Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.
|
NA
|
NA
|
|
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.
|
NA
|
NA
|
|
Myth Busters: Dietary Supplements and COVID-19.
|
NA
|
NA
|
|
Managing Diabetes in Pregnancy Before, During, and After COVID-19.
|
NA
|
NA
|
|
Approaching Otolaryngology Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Otologic and Audiologic Considerations for COVID-19.
|
NA
|
NA
|
|
Elective Tracheostomy During Mechanical Ventilation in Patients Affected by COVID-19: Preliminary Case Series From Lombardy, Italy.
|
NA
|
NA
|
|
Clinical orthodontic management during the COVID-19 pandemic.
|
NA
|
NA
|
|
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.
|
NA
|
NA
|
|
Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary.
|
NA
|
NA
|
|
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
|
NA
|
NA
|
|
Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
|
NA
|
NA
|
|
Risk of COVID-19 in young kidney transplant recipients. Results from a single-center observational study.
|
NA
|
NA
|
|
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
|
NA
|
NA
|
|
The role of telemedicine in the delivery of healthcare in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
|
NA
|
NA
|
|
Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE).
|
NA
|
NA
|
|
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
|
NA
|
NA
|
|
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.
|
NA
|
NA
|
|
Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors.
|
NA
|
NA
|
|
Drug repurposing against COVID-19: focus on anticancer agents.
|
NA
|
NA
|
|
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.
|
NA
|
NA
|
|
Lung ultrasound in the monitoring of COVID-19 infection.
|
NA
|
NA
|
|
Should azithromycin be used to treat COVID-19? A rapid review.
|
NA
|
NA
|
|
Recommendations of the Main Board of the Polish Society of Otorhinolaryngologists, Head and Neck Surgeons for providing services during the COVID-19 pandemic for outpatient and hospital practices.
|
NA
|
NA
|
|
COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.
|
NA
|
NA
|
|
Reorganizing the treatment of cardiovascular disease in response to coronavirus disease 2019; time for the polypill?
|
NA
|
NA
|
|
A serological assay to detect SARS-CoV-2 seroconversion in humans.
|
NA
|
NA
|
|
In the midst of the perfect storm: swift public health actions needed in order to increase societal safety during the COVID-19 pandemic.
|
NA
|
NA
|
|
Characterize health and economic vulnerabilities of workers to control the emergence of COVID-19 in an industrial zone in Vietnam.
|
NA
|
NA
|
|
Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China.
|
NA
|
NA
|
|
Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?
|
NA
|
NA
|
|
Co-infection with Influenza A and COVID-19.
|
NA
|
NA
|
|
Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome.
|
NA
|
NA
|
|
Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.
|
NA
|
NA
|
|
Computed tomography findings in a case of coronavirus disease 2019.
|
NA
|
NA
|
|
Novel coronavirus disease 2019 (COVID-19): relationship between chest CT scores and laboratory parameters.
|
NA
|
NA
|
|
Involvement of the Nervous System in SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Is COVID-19 a New Hematologic Disease?
|
NA
|
NA
|
|
Ethical considerations for allocation of scarce resources and alterations in surgical care during a pandemic.
|
NA
|
NA
|
|
Impact of the Covid-19 outbreak on acute stroke pathways - Insights from the Alsace region in France.
|
NA
|
NA
|
|
COVID-19 and islet transplantation: different twins.
|
NA
|
NA
|
|
Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.
|
NA
|
NA
|
|
COVID-19 pneumonia in lung transplant recipients: report of two cases.
|
NA
|
NA
|
|
SARS-CoV-2 infection in two patients following recent lung transplantation.
|
NA
|
NA
|
|
Novel Corona Virus 2019 pneumonia in a kidney transplant recipient.
|
NA
|
NA
|
|
In vitro data of current therapies for SARS-CoV-2.
|
NA
|
NA
|
|
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.
|
NA
|
NA
|
|
[Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection].
|
NA
|
NA
|
|
Cognitive Processing Therapy for Posttraumatic Stress Disorder via Telehealth: Practical Considerations During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.
|
NA
|
NA
|
|
Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
|
NA
|
NA
|
|
CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia.
|
NA
|
NA
|
|
Recovery from COVID-19 in two patients with coexisted HIV infection.
|
NA
|
NA
|
|
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
|
NA
|
NA
|
|
Clinical Characteristics of Re-hospitalized Patients with COVID-19 in China.
|
NA
|
NA
|
|
Protecting dental manpower from COVID 19 infection.
|
NA
|
NA
|
|
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID-19 pandemic.
|
NA
|
NA
|
|
[Renin-angiotensin-aldosterone blockers and Covic-19 infection : friends or enemies ?]
|
NA
|
NA
|
|
The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
|
NA
|
NA
|
|
Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
|
NA
|
NA
|
|
Biological and social aspects of Coronavirus Disease 2019 (COVID-19) related to oral health.
|
NA
|
NA
|
|
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Commentary: COVID in Care Homes-Challenges and Dilemmas in Healthcare Delivery.
|
NA
|
NA
|
|
“Review article: COVID-19 and liver disease - what we know on 1st May 2020”.
|
NA
|
NA
|
|
What do we know about remdesivir drug interactions?
|
NA
|
NA
|
|
Ethical recommendations for a difficult decision-making in intensive care units due to the exceptional situation of crisis by the COVID-19 pandemia: A rapid review & consensus of experts.
|
NA
|
NA
|
|
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
|
NA
|
NA
|
|
Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?
|
NA
|
NA
|
|
[COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs].
|
NA
|
NA
|
|
The Power of ‘Pause’-A Time for Medical Students to Reflect and Mobilize.
|
NA
|
NA
|
|
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.
|
NA
|
NA
|
|
COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.
|
NA
|
NA
|
|
Creating Backup Management Resources for Spine Care during the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Clinical implications and economic effects of the corona virus pandemic on gynaecology, obstetrics and reproductive medicine in Germany-learning from Italy.
|
NA
|
NA
|
|
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
|
NA
|
NA
|
|
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity.
|
NA
|
NA
|
|
An online solution focused brief therapy for adolescent anxiety during the novel coronavirus disease (COVID-19) pandemic: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management.
|
NA
|
NA
|
|
The role of passive immunization in the age of SARS-CoV-2: an update.
|
NA
|
NA
|
|
Chiropractic students call for action against unsubstantiated claims.
|
NA
|
NA
|
|
Covid-19 and its impact on child and adolescent psychiatry - a German and personal perspective.
|
NA
|
NA
|
|
COVID-19 and People with Intellectual Disability: impacts of a pandemic.
|
NA
|
NA
|
|
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic.
|
NA
|
NA
|
|
Towards effective diagnostic assays for COVID-19: a review.
|
NA
|
NA
|
|
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
|
NA
|
NA
|
|
COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions.
|
NA
|
NA
|
|
Opioid Use Disorder and COVID-19: Crashing of the Crises.
|
NA
|
NA
|
|
Innovation During COVID-19: Improving Addiction Treatment Access.
|
NA
|
NA
|
|
FIRST CASE OF CORONAVIRUS DISEASE 2019 IN CHILDHOOD LEUKEMIA IN CHINA.
|
NA
|
NA
|
|
Clinical Analysis of 25 Novel Coronavirus Infections in Children.
|
NA
|
NA
|
|
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.
|
NA
|
NA
|
|
Caring for patients with cancer in the COVID-19 era.
|
NA
|
NA
|
|
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Dynamic changes in routine blood parameters of a severe COVID-19 case.
|
NA
|
NA
|
|
Decreased T cell populations contribute to the increased severity of COVID-19.
|
NA
|
NA
|
|
Cardiological society of India position statement on COVID-19 and heart failure.
|
NA
|
NA
|
|
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.
|
NA
|
NA
|
|
The COVID-19 Pandemic and its Impact on Substance Use: Implications for Prevention and Treatment.
|
NA
|
NA
|
|
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
|
NA
|
NA
|
|
Precautions and recommendations for orthodontic settings during the COVID-19 outbreak: A review.
|
NA
|
NA
|
|
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
|
NA
|
NA
|
|
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
|
NA
|
NA
|
|
2019-nCoV - Towards a 4th generation vaccine.
|
NA
|
NA
|
|
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.
|
NA
|
NA
|
|
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
|
NA
|
NA
|
|
Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.
|
NA
|
NA
|
|
Report of 5 nurses infecting COVID-19 during patient care: case Series.
|
NA
|
NA
|
|
A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?
|
NA
|
NA
|
|
Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19.
|
NA
|
NA
|
|
Minimum costs to manufacture new treatments for COVID-19.
|
NA
|
NA
|
|
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
|
NA
|
NA
|
|
Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.
|
NA
|
NA
|
|
The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis.
|
NA
|
NA
|
|
Managing Patients with Multiple Myeloma during the COVID-19 Pandemic: Recommendations from an Expert Panel - ABHH Monoclonal Gammopathies Committe.
|
NA
|
NA
|
|
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
|
NA
|
NA
|
|
COVID-19 and Cancer Patients.
|
NA
|
NA
|
|
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
|
NA
|
NA
|
|
Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.
|
NA
|
NA
|
|
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.
|
NA
|
NA
|
|
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
|
NA
|
NA
|
|
Diagnosing herpes simplex-1 encephalitis at the time of COVID-19 pandemic.
|
NA
|
NA
|
|
Correction to: Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response.
|
NA
|
NA
|
|
Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.
|
NA
|
NA
|
|
Organ function support in patients with coronavirus disease 2019: Tongji experience.
|
NA
|
NA
|
|
Visualizing the invisible: class excursions to ignite children’s enthusiasm for microbes.
|
NA
|
NA
|
|
What every orthopaedic surgeon should know about COVID-19: A review of the current literature.
|
NA
|
NA
|
|
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.
|
NA
|
NA
|
|
The benefits of Meditation and Mindfulness practices during times of crisis such as Covid-19.
|
NA
|
NA
|
|
SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs.
|
NA
|
NA
|
|
COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.
|
NA
|
NA
|
|
A model based study on the dynamics of COVID-19: Prediction and control.
|
NA
|
NA
|
|
Angiotension-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection.
|
NA
|
NA
|
|
In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2’s Main Protease.
|
NA
|
NA
|
|
COVID-19 and laparoscopic surgery, a scoping review of current literature and local expertise.
|
NA
|
NA
|
|
[Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020)].
|
NA
|
NA
|
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
|
NA
|
NA
|
|
Interleukin-6 Receptor Antagonist Therapy to Treat SARS-CoV-2 Driven Inflammatory Syndrome in a Renal Transplant Recipient.
|
NA
|
NA
|
|
Hyper-immune/convalescent plasma: an old option and a valid strategy for treatment of COVID-19?
|
NA
|
NA
|
|
Producing Independent, Systematic Review Evidence: Cochrane’s Response to COVID-19.
|
NA
|
NA
|
|
Hematology/Oncology Fellowship Emergency Restructuring in Response to the COVID-19 Pandemic-Henry Ford Hospital, Michigan.
|
NA
|
NA
|
|
COVID-19 crisis in Jordan: Response, scenarios, strategies, and recommendations.
|
NA
|
NA
|
|
Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.
|
NA
|
NA
|
|
Clinical trials for Covid-19: can we better use the short window of opportunity?
|
NA
|
NA
|
|
Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID -19 infected patients.
|
NA
|
NA
|
|
Interrogation of safety and efficacy of home-use light-based devices.
|
NA
|
NA
|
|
De Novo Status Epilepticus in patients with COVID-19.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.
|
NA
|
NA
|
|
Allocating Scarce Resources and Triaging Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.
|
NA
|
NA
|
|
QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin.
|
NA
|
NA
|
|
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
|
NA
|
NA
|
|
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today’s battle against COVID-19?
|
NA
|
NA
|
|
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
|
NA
|
NA
|
|
Co-infection with respiratory pathogens among COVID-2019 cases.
|
NA
|
NA
|
|
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
|
NA
|
NA
|
|
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
|
NA
|
NA
|
|
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients.
|
NA
|
NA
|
|
Spatio-Temporal Resource Mapping for Intensive Care Units at Regional Level for COVID-19 Emergency in Italy.
|
NA
|
NA
|
|
Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities.
|
NA
|
NA
|
|
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.
|
NA
|
NA
|
|
An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic.
|
NA
|
NA
|
|
How we treat patients with brain tumour during the COVID-19 pandemic.
|
NA
|
NA
|
|
Transmission and risk factors of OF COVID-19.
|
NA
|
NA
|
|
Antivirals for COVID-19.
|
NA
|
NA
|
|
Renin-angiotensin system inhibitors in COVID-19.
|
NA
|
NA
|
|
Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.
|
NA
|
NA
|
|
Treating acute anxiety in patients with COVID-19.
|
NA
|
NA
|
|
Practical aspects of targeting IL-6 in COVID-19 disease.
|
NA
|
NA
|
|
The role of cardiac imaging in hospitalized COVID-19-positive patients.
|
NA
|
NA
|
|
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.
|
NA
|
NA
|
|
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
|
NA
|
NA
|
|
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.
|
NA
|
NA
|
|
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
|
NA
|
NA
|
|
COVID-19 and the role of chronic inflammation in patients with obesity.
|
NA
|
NA
|
|
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir.
|
NA
|
NA
|
|
Pathophysiology of COVID-19: Why Children Fare Better than Adults?
|
NA
|
NA
|
|
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
|
NA
|
NA
|
|
Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.
|
NA
|
NA
|
|
Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.
|
NA
|
NA
|
|
Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.
|
NA
|
NA
|
|
Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study.
|
NA
|
NA
|
|
The end of cordon sanitaire in Wuhan: the role of non-pharmaceutical interventions.
|
NA
|
NA
|
|
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
|
NA
|
NA
|
|
Emerging pharmacotherapies for COVID-19.
|
NA
|
NA
|
|
Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular Diseases.
|
NA
|
NA
|
|
Brachytherapy during the coronavirus disease 2019 - Lessons from Iran.
|
NA
|
NA
|
|
Neonatal Intensive Care Unit Preparedness for the Novel Coronavirus Disease-2019 Pandemic: A New York City Hospital Perspective.
|
NA
|
NA
|
|
FAVORABLE ANAKINRA RESPONSES IN SEVERE COVID-19 PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS.
|
NA
|
NA
|
|
Acute asthma management during SARS-CoV2-pandemic 2020.
|
NA
|
NA
|
|
Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19.
|
NA
|
NA
|
|
Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives.
|
NA
|
NA
|
|
Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.
|
NA
|
NA
|
|
When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
|
NA
|
NA
|
|
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
|
NA
|
NA
|
|
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
|
NA
|
NA
|
|
The management of patients with metastatic prostate cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 Comes 40 Years After AIDS - Any Lesson?
|
NA
|
NA
|
|
Recommendations for the management of critically ill adult patients with COVID-19.
|
NA
|
NA
|
|
Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil.
|
NA
|
NA
|
|
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
|
NA
|
NA
|
|
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients’ Queries, Needs, Fears, and Actions Taken.
|
NA
|
NA
|
|
Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series.
|
NA
|
NA
|
|
Managing Children with Renal Diseases during COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
|
NA
|
NA
|
|
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
|
NA
|
NA
|
|
Identification of Human Single-Domain Antibodies against SARS-CoV-2.
|
NA
|
NA
|
|
SnapShot: COVID-19.
|
NA
|
NA
|
|
COVID-19 in diabetic patients: Related risks and specifics of management.
|
NA
|
NA
|
|
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
|
NA
|
NA
|
|
Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic.
|
NA
|
NA
|
|
HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?
|
NA
|
NA
|
|
β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects - Implications for coronavirus disease (COVID-19) immunotherapies.
|
NA
|
NA
|
|
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.
|
NA
|
NA
|
|
“Pairing assistance”: the effective way to solve the breakdown of health services system caused by COVID-19 pandemic.
|
NA
|
NA
|
|
Emergency trauma care during the outbreak of corona virus disease 2019 (COVID-19) in China.
|
NA
|
NA
|
|
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Airway management considerations in patients with COVID-19.
|
NA
|
NA
|
|
The renin-angiotensin system - a therapeutic target in COVID-19?
|
NA
|
NA
|
|
Ethical considerations for epidemic vaccine trials.
|
NA
|
NA
|
|
Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from India.
|
NA
|
NA
|
|
When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.
|
NA
|
NA
|
|
Oncology services in corona times: a flash interview among German cancer patients and their physicians.
|
NA
|
NA
|
|
Proposal of a timing strategy for cholesteatoma surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
|
NA
|
NA
|
|
COVID-19 Anxiety.
|
NA
|
NA
|
|
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice.
|
NA
|
NA
|
|
Radiotherapy during COVID-19 pandemic. How to create a No fly zone: a Northern Italy experience.
|
NA
|
NA
|
|
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments.
|
NA
|
NA
|
|
Caring for Patients with Rectal Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.
|
NA
|
NA
|
|
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
|
NA
|
NA
|
|
Management of valvular and structural heart diseases during the coronavirus disease 2019 pandemic: an expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.
|
NA
|
NA
|
|
Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus disease 2019 in renal transplant recipients: report of two cases.
|
NA
|
NA
|
|
Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.
|
NA
|
NA
|
|
Acute kidney injury in patients hospitalized with COVID-19.
|
NA
|
NA
|
|
Is DPP4 inhibition a comrade or adversary in COVID-19 infection.
|
NA
|
NA
|
|
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.
|
NA
|
NA
|
|
On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
|
NA
|
NA
|
|
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.
|
NA
|
NA
|
|
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19.
|
NA
|
NA
|
|
Has COVID-19 played an unexpected “stroke” on the chain of survival?
|
NA
|
NA
|
|
Etoposide-based therapy for severe forms of COVID-19.
|
NA
|
NA
|
|
Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.
|
NA
|
NA
|
|
Coping with diabetes during the COVID - 19 lockdown in India: Results of an online pilot survey.
|
NA
|
NA
|
|
Spillover of SARS-CoV-2 into novel wild hosts in North America: A conceptual model for perpetuation of the pathogen.
|
NA
|
NA
|
|
Management of acute kidney injury in patients with COVID-19.
|
NA
|
NA
|
|
Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
|
NA
|
NA
|
|
Pandemic preparedness of community pharmacies for COVID-19.
|
NA
|
NA
|
|
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.
|
NA
|
NA
|
|
COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab.
|
NA
|
NA
|
|
Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic.
|
NA
|
NA
|
|
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
|
NA
|
NA
|
|
Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series.
|
NA
|
NA
|
|
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times.
|
NA
|
NA
|
|
Early SARS-CoV-2 outbreak detection by sewage-based epidemiology.
|
NA
|
NA
|
|
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
|
NA
|
NA
|
|
Mechanism of inflammatory response in associated comorbidities in COVID-19.
|
NA
|
NA
|
|
The changing landscape of SARS-CoV-2: Implications for the maternal-infant dyad.
|
NA
|
NA
|
|
Combating COVID-19 Pandemic in Nepal: Ethical Challenges in an Outbreak.
|
NA
|
NA
|
|
From natural disaster to pandemic: A health-system pharmacy rises to the challenge.
|
NA
|
NA
|
|
Hazardous Postoperative Outcomes of Unexpected COVID-19 Infected Patients: A Call for Global Consideration of Sampling all Asymptomatic Patients Before Surgical Treatment.
|
NA
|
NA
|
|
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
|
NA
|
NA
|
|
Rapid response in the COVID-19 pandemic: a Delphi study from the European Pediatric Dialysis Working Group.
|
NA
|
NA
|
|
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence.
|
NA
|
NA
|
|
Early experience with remdesivir in SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Reproductive health paradigms in times of COVID-19.
|
NA
|
NA
|
|
Steroid-responsive encephalitis in Covid-19 disease.
|
NA
|
NA
|
|
Ligand-centered assessment of SARS-CoV-2 drug target models in the Protein Data Bank.
|
NA
|
NA
|
|
[Clinical analysis of kidney injury in patients with COVID-19].
|
NA
|
NA
|
|
Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Cardiac Surgery during the COVID-19 Pandemic: Perioperative Considerations and Triage Recommendations.
|
NA
|
NA
|
|
Cardiovascular Disease Prevention and Implications of COVID-19: An Evolving Case Study in the Crescent City.
|
NA
|
NA
|
|
Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
|
NA
|
NA
|
|
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.
|
NA
|
NA
|
|
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
|
NA
|
NA
|
|
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
|
NA
|
NA
|
|
Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
|
NA
|
NA
|
|
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
|
NA
|
NA
|
|
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
|
NA
|
NA
|
|
Molecular Targets for the Testing of COVID-19.
|
NA
|
NA
|
|
Revised Triage and Surveillance Protocols for Temporary Emergency Department Closures in Tertiary Hospitals as a Response to COVID-19 Crisis in Daegu Metropolitan City.
|
NA
|
NA
|
|
Old and re-purposed drugs for the treatment of COVID-19.
|
NA
|
NA
|
|
COVID 19 in neonates.
|
NA
|
NA
|
|
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
[COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)].
|
NA
|
NA
|
|
Evidenced-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19.
|
NA
|
NA
|
|
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology.
|
NA
|
NA
|
|
Consensus Statement - Suggested Recommendations for Acute Stroke Management during the COVID-19 Pandemic: Expert Group on Behalf of the Indian Stroke Association.
|
NA
|
NA
|
|
The Challenge of Managing Parkinson’s Disease Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Managing Migraine in the Times of COVID-19 Pandemic.
|
NA
|
NA
|
|
Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China.
|
NA
|
NA
|
|
Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment.
|
NA
|
NA
|
|
Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality.
|
NA
|
NA
|
|
Best practice recommendations: ENT consultations during the COVID-19 pandemic.
|
NA
|
NA
|
|
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
|
NA
|
NA
|
|
Clinical Considerations in Neurosurgical Radiosurgery in the Time of COVID-19.
|
NA
|
NA
|
|
Combating COVID-19 with Mesenchymal Stem Cell therapy.
|
NA
|
NA
|
|
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.
|
NA
|
NA
|
|
COVID-19 managed with early non-invasive ventilation and a bundle pharmacotherapy: A case report.
|
NA
|
NA
|
|
Clinical characteristics of hospitalised patients with schizophrenia who were suspected to have coronavirus disease (COVID-19) in Hubei Province, China.
|
NA
|
NA
|
|
The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants.
|
NA
|
NA
|
|
Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients.
|
NA
|
NA
|
|
Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
|
NA
|
NA
|
|
Repurposing current therapeutics for treating COVID-19: A vital role of prescription records data mining.
|
NA
|
NA
|
|
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against Covid-19.
|
NA
|
NA
|
|
[COVID-19: care at home or in hospital? Considerations in primary care].
|
NA
|
NA
|
|
Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.
|
NA
|
NA
|
|
Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study.
|
NA
|
NA
|
|
Positive RT-PCR in urine from an asymptomatic patient with novel coronavirus 2019 infection: a case report.
|
NA
|
NA
|
|
Management Strategies of Autoimmune bullous diseases during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
A contribution for the forensic odontologist’s safety in the autopsy room.
|
NA
|
NA
|
|
AOU Policlinico di Bari - West China Hospital of Sichuan University. Global experience of medical profession, battle, health, friendship against COVID -19.
|
NA
|
NA
|
|
Treatments for COVID-19: emerging drugs against the coronavirus.
|
NA
|
NA
|
|
Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.
|
NA
|
NA
|
|
The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.
|
NA
|
NA
|
|
Sofosbuvir as a potential option for the treatment of COVID-19.
|
NA
|
NA
|
|
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
|
NA
|
NA
|
|
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
|
NA
|
NA
|
|
Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.
|
NA
|
NA
|
|
Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography.
|
NA
|
NA
|
|
Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19.
|
NA
|
NA
|
|
The impact of biosensing in a pandemic outbreak: COVID-19.
|
NA
|
NA
|
|
Insights into COVID-19: Mining Physicians’ Opinions on Social Media.
|
NA
|
NA
|
|
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
|
NA
|
NA
|
|
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series.
|
NA
|
NA
|
|
Type 2 Inflammation Modulates ACE2 and TMPRSS2 in Airway Epithelial Cells.
|
NA
|
NA
|
|
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
|
NA
|
NA
|
|
Ruptured Popliteal Artery Aneurysm Complicated with Acute Respiratory Distress Syndrome Secondary to SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Endovascular treatment of a ruptured pararenal abdominal aortic aneurysm in a COVID-19 patient: suggestions and case report.
|
NA
|
NA
|
|
Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.
|
NA
|
NA
|
|
COVID-19 and the Role of Neurosurgeons in Nepal.
|
NA
|
NA
|
|
Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection.
|
NA
|
NA
|
|
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
|
NA
|
NA
|
|
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.
|
NA
|
NA
|
|
Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings.
|
NA
|
NA
|
|
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.
|
NA
|
NA
|
|
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
|
NA
|
NA
|
|
[COVID-19 Triage: Who is an inpatient? The Essen triage model].
|
NA
|
NA
|
|
No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science.
|
NA
|
NA
|
|
The Rationale for Potential Pharmacotherapy of COVID-19.
|
NA
|
NA
|
|
COVID-19: An Update About the Discovery Clinical Trial.
|
NA
|
NA
|
|
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
|
NA
|
NA
|
|
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
|
NA
|
NA
|
|
Artificial Intelligence-Empowered Mobilization of Assessments in COVID-19-like Pandemics: A Case Study for Early Flattening of the Curve.
|
NA
|
NA
|
|
Effect of coronavirus infection on the human heart: A scoping review.
|
NA
|
NA
|
|
Whatever Happened to Evidence-Based Practice During COVID-19?
|
NA
|
NA
|
|
Effects of COVID-19 Pandemic on Otolaryngology Surgery in Italy: The Experience of Our University Hospital.
|
NA
|
NA
|
|
Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
|
NA
|
NA
|
|
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
|
NA
|
NA
|
|
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.
|
NA
|
NA
|
|
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
|
NA
|
NA
|
|
A close-up on COVID-19 and cardiovascular diseases.
|
NA
|
NA
|
|
False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings.
|
NA
|
NA
|
|
ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer.
|
NA
|
NA
|
|
Thrombotic risk in COVID-19: a case series and case-control study.
|
NA
|
NA
|
|
COVID-19 as an Acute Inflammatory Disease.
|
NA
|
NA
|
|
More advice on the use of ibuprofen for COVID-19.
|
NA
|
NA
|
|
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
|
NA
|
NA
|
|
Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 in persons with chronic myeloid leukaemia.
|
NA
|
NA
|
|
Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
|
NA
|
NA
|
|
Data Analysis of Infection Rates Among Exposed Healthcare Workers Could Reveal Effective Prophylactics Against SARS-CoV-2.
|
NA
|
NA
|
|
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
|
NA
|
NA
|
|
Artemisia annua: Trials are needed for COVID-19.
|
NA
|
NA
|
|
Feasibility and High Quality Measured in the Rapid Expansion of Telemedicine During COVID-19 for Sports and Musculoskeletal Medicine Practice.
|
NA
|
NA
|
|
Martini-Klinik experience on prostate cancer surgery during the early phase of COVID-19.
|
NA
|
NA
|
|
Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China.
|
NA
|
NA
|
|
Analysis of an improved workflow of endoscope reprocessing for bedside endoscopic diagnosis and treatment on COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
|
NA
|
NA
|
|
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS): Protocol for a Pragmatic, Open Label, Active Comparator Trial.
|
NA
|
NA
|
|
Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
|
NA
|
NA
|
|
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
|
NA
|
NA
|
|
[Repurposing chlorpromazine to treat COVID-19: the reCoVery study].
|
NA
|
NA
|
|
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry.
|
NA
|
NA
|
|
COVID-19: Current Knowledge and Best Practices for Orthopaedic Surgeons.
|
NA
|
NA
|
|
Nurses reports of actual work hours and preferred work hours per shift among frontline nurses during coronavirus disease 2019 (COVID-19) epidemic: A cross-sectional survey.
|
NA
|
NA
|
|
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability.
|
NA
|
NA
|
|
Psychopharmacology of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area.
|
NA
|
NA
|
|
Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China.
|
NA
|
NA
|
|
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
|
NA
|
NA
|
|
Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic.
|
NA
|
NA
|
|
Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19.
|
NA
|
NA
|
|
Unravelling potential severe psychiatric repercussions on healthcare professionals during the COVID-19 crisis.
|
NA
|
NA
|
|
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
|
NA
|
NA
|
|
Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19 ?
|
NA
|
NA
|
|
Are we equal in adversity? Does Covid-19 affect women and men differently?
|
NA
|
NA
|
|
The impact of preoperative screening system on head and neck cancer surgery during the COVID-19 pandemic: Recommendations from the nationwide survey in Japan.
|
NA
|
NA
|
|
Neurologic complications of COVID-19.
|
NA
|
NA
|
|
Cardiovascular Disease Novel Coronavirus and the Search for Investigational Therapies.
|
NA
|
NA
|
|
Cardiovascular implications of the COVID-19 pandemic: a global perspective.
|
NA
|
NA
|
|
Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
|
NA
|
NA
|
|
Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb, in Patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.
|
NA
|
NA
|
|
Internet of Medical Things (IoMT) for orthopaedic in COVID-19 pandemic: Roles, challenges, and applications.
|
NA
|
NA
|
|
Revisiting conservative orthopaedic management of fractures during COVID-19 pandemic.
|
NA
|
NA
|
|
Qigong for the Prevention, Treatment, and Rehabilitation of COVID-19 Infection in Older Adults.
|
NA
|
NA
|
|
[ELDERLY PEOPLE, DEPENDENCY AND VULNERABILITY IN THE CORONAVIRUS PANDEMIC: AN EMERGENCY FOR A SOCIAL AND HEALTH INTEGRATION.]
|
NA
|
NA
|
|
[Nursing care for controlling coronavirus infections in positive cases: a narrative review.]
|
NA
|
NA
|
|
[Prevention and treatment of Covid-19 in the pediatric population from the family and community perspective].
|
NA
|
NA
|
|
[RECOMMENDATIONS AND PRACTICAL MANAGEMENT OF PREGNANT WOMEN WITH COVID-19: A SCOPING REVIEW].
|
NA
|
NA
|
|
[Pandemic COVID-19, the new health emergency of international concern: a review].
|
NA
|
NA
|
|
A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions.
|
NA
|
NA
|
|
Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study.
|
NA
|
NA
|
|
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.
|
NA
|
NA
|
|
Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study.
|
NA
|
NA
|
|
Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response.
|
NA
|
NA
|
|
What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?
|
NA
|
NA
|
|
Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience.
|
NA
|
NA
|
|
Modeling the effects of intervention strategies on COVID-19 transmission dynamics.
|
NA
|
NA
|
|
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.
|
NA
|
NA
|
|
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care.
|
NA
|
NA
|
|
Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract.
|
NA
|
NA
|
|
COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.
|
NA
|
NA
|
|
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine: COVID-19 and CeD.
|
NA
|
NA
|
|
Urgent Measures for the Containment of the Coronavirus (Covid-19) Epidemic in the Neurorehabilitation/Rehabilitation Departments in the Phase of Maximum Expansion of the Epidemic.
|
NA
|
NA
|
|
The liver in times of COVID-19: What hepatologists should know.
|
NA
|
NA
|
|
A Systematic Review of Asymptomatic Infections with COVID-19.
|
NA
|
NA
|
|
[Colchicine: a potential therapeutic tool against COVID-19. Experience of 5 patients].
|
NA
|
NA
|
|
[Therapeutic options for the management of severe Covid-19: A rheumatology perspective].
|
NA
|
NA
|
|
A surgeon’s role in fighting a medical pandemic: Experiences from the unit at the epicentre of COVID-19 in Singapore - A cohort perspective.
|
NA
|
NA
|
|
Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement.
|
NA
|
NA
|
|
COVID-19, asthma, and biologic therapies: What we need to know.
|
NA
|
NA
|
|
Maintaining Treatment Integrity in the Face of Crisis: A Treatment Selection Model for Transitioning Direct ABA Services to Telehealth.
|
NA
|
NA
|
|
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic.
|
NA
|
NA
|
|
Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).
|
NA
|
NA
|
|
Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
|
NA
|
NA
|
|
Triage of Patients with Venous and Lymphatic Diseases during the COVID-19 pandemic- the Venous and Lymphatic Triage and Acuity Scale (VELTAS).
|
NA
|
NA
|
|
An asplenic with life-threatening Capnocytophaga canimorsus sepsis.
|
NA
|
NA
|
|
The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
|
NA
|
NA
|
|
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Oral Chemotherapy for Treatment of Lung Cancer.
|
NA
|
NA
|
|
Covid-19: A Dynamic Analysis of Fatality Risk in Italy.
|
NA
|
NA
|
|
Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.
|
NA
|
NA
|
|
Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor.
|
NA
|
NA
|
|
Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources.
|
NA
|
NA
|
|
Follow-up and management of head and neck cancer patients during the 2019 novel coronavirus (SARS-CoV-2) disease pandemic.
|
NA
|
NA
|
|
Neurologic Manifestations of Severe Respiratory Viral Contagions.
|
NA
|
NA
|
|
The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.
|
NA
|
NA
|
|
Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.
|
NA
|
NA
|
|
Practice recommendations for the neurovascular ultrasound investigations of acute stroke patients in the setting of COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics.
|
NA
|
NA
|
|
Heparin - an old drug with multiple potential targets in Covid-19 therapy.
|
NA
|
NA
|
|
Should coronavirus disease 2019 concern rheumatologists?
|
NA
|
NA
|
|
Implications of the lack of a unified research project framework: an investigation into the registration of clinical trials of COVID-19.
|
NA
|
NA
|
|
HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
|
NA
|
NA
|
|
Natural experiment concept to accelerate the Re-purposing of existing therapeutics for Covid-19.
|
NA
|
NA
|
|
Respiratory support for adult patients with COVID-19.
|
NA
|
NA
|
|
Novel coronavirus 2019 (COVID-19): Emergence and implications for emergency care.
|
NA
|
NA
|
|
[Statement of the Austrian Society of Pneumology (ASP)].
|
NA
|
NA
|
|
Rare and extreme events: the case of COVID-19 pandemic.
|
NA
|
NA
|
|
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.
|
NA
|
NA
|
|
Telomeres and COVID-19.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.
|
NA
|
NA
|
|
Where do urologists stand in the era of novel coronavirus-2019 disease.
|
NA
|
NA
|
|
Rescue Therapy for Severe COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with Tissue Plasminogen Activator (tPA): A Case Series.
|
NA
|
NA
|
|
Early Outcomes with Utilization of Tissue Plasminogen Activator in COVID-19 Associated Respiratory Distress: A series of five cases.
|
NA
|
NA
|
|
COVID-19: intensive care units, mechanical ventilators, and latent mortality profiles associated with case-fatality in Brazil.
|
NA
|
NA
|
|
Coronavirus: a clinical update of Covid-19.
|
NA
|
NA
|
|
Covid-19 and Myeloma: what are the implications for now and in the future?
|
NA
|
NA
|
|
Kicking on while it’s still kicking off - getting surgery and anaesthesia restarted after COVID-19.
|
NA
|
NA
|
|
Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.
|
NA
|
NA
|
|
Overview of transnational recommendations for COVID-19 transmission control in dental care settings.
|
NA
|
NA
|
|
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
|
NA
|
NA
|
|
Advances in the relationship between coronavirus infection and cardiovascular diseases.
|
NA
|
NA
|
|
Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
|
NA
|
NA
|
|
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
|
NA
|
NA
|
|
Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper.
|
NA
|
NA
|
|
[Coronavirus (SARS-CoV-2) - Outbreak in North Rhine-Westphalia (District of Heinsberg) - First diagnosis of a COVID-19 manifestation in a couple].
|
NA
|
NA
|
|
Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.
|
NA
|
NA
|
|
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management.
|
NA
|
NA
|
|
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
|
NA
|
NA
|
|
Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
|
NA
|
NA
|
|
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
|
NA
|
NA
|
|
Anti-Coagulant and Anti-Platelet Therapy in the COVID-19 Patient: A Best Practices Quality Initiative Across a Large Health System.
|
NA
|
NA
|
|
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
|
NA
|
NA
|
|
Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset.
|
NA
|
NA
|
|
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
|
NA
|
NA
|
|
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).
|
NA
|
NA
|
|
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
|
NA
|
NA
|
|
Potential effects of curcumin in the treatment of COVID-19 infection.
|
NA
|
NA
|
|
[THE PSYCHOLOGICAL IMPACT OF COVID-19 ON MENTAL HEALTH - LITERATURE REVIEW].
|
NA
|
NA
|
|
How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: an experience from Northern Italy.
|
NA
|
NA
|
|
Critical Care Management of Patients with COVID-19: Early Experience in Thailand.
|
NA
|
NA
|
|
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis.
|
NA
|
NA
|
|
Introducing the “Corona Curtain”: an innovative technique to prevent airborne COVID-19 exposure during emergent intubations.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation as Treatment of Severe COVID-19 Infection: A Case Report.
|
NA
|
NA
|
|
High Resolution CT Imaging Dynamic Follow-Up Study of Novel Coronavirus Pneumonia.
|
NA
|
NA
|
|
COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2.
|
NA
|
NA
|
|
Mitigating disruptions, and scalability of radiation oncology physics work during the COVID-19 pandemic.
|
NA
|
NA
|
|
The kidney in COVID-19: protagonist or figurant?
|
NA
|
NA
|
|
Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence.
|
NA
|
NA
|
|
Improving Stroke Care in Times of the COVID-19 Pandemic Through Simulation: Practice Your Protocols!
|
NA
|
NA
|
|
Delays in Stroke Onset to Hospital Arrival Time During COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2: The Path of Prevention and Control.
|
NA
|
NA
|
|
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps and Opportunities.
|
NA
|
NA
|
|
Technologies to optimize the care of severe COVID-19 patients for healthcare providers challenged by limited resources.
|
NA
|
NA
|
|
Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on the Management of End-Stage Renal Disease Patients.
|
NA
|
NA
|
|
The pharmacological development of direct acting agents for emerging needed therapy against SARS-CoV-2.
|
NA
|
NA
|
|
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond.
|
NA
|
NA
|
|
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.
|
NA
|
NA
|
|
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!
|
NA
|
NA
|
|
Viral and host factors related to the clinical outcome of COVID-19.
|
NA
|
NA
|
|
COVID-19Clinical trials: quality matters more than quantity.
|
NA
|
NA
|
|
COVID-19 pandemic. What should PRM specialists do? A clinician’s perspective.
|
NA
|
NA
|
|
A novel coronavirus (SARS-CoV-2) and COVID-19.
|
NA
|
NA
|
|
COVID-19 from the perspective of an immunologist.
|
NA
|
NA
|
|
Psychological health during the coronavirus disease 2019 pandemic outbreak.
|
NA
|
NA
|
|
The Use of Telepsychiatry During COVID-19 and Beyond.
|
NA
|
NA
|
|
ADHD and Covid-19: Current roadblocks and future opportunities.
|
NA
|
NA
|
|
The need for Early Intervention for Psychosis to persist throughout the covid-19 pandemic and beyond.
|
NA
|
NA
|
|
Lockdown in a Specialised Rehabilitation Unit: the Best of Times.
|
NA
|
NA
|
|
[Roles of the public-facility-turned temporary hospital in prevention and control of coronavirus disease 2019 in Wuhan, China and clinical experience in the hospital].
|
NA
|
NA
|
|
[Clinical features of coronavirus disease 2019 in children aged <18 years in Jiangxi, China: an analysis of 23 cases].
|
NA
|
NA
|
|
[Coronavirus disease 2019 and hypertension in 2 children].
|
NA
|
NA
|
|
A Stroke Care Model at an Academic, Comprehensive Stroke Center During the 2020 COVID-19 Pandemic.
|
NA
|
NA
|
|
Predictive molecular pathology in the time of COVID-19.
|
NA
|
NA
|
|
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
|
NA
|
NA
|
|
Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.
|
NA
|
NA
|
|
COVID-19 and immune checkpoint inhibitors: initial considerations.
|
NA
|
NA
|
|
Minimizing SARS-CoV-2 exposure when performing surgical interventions during the covid-19 pandemic.
|
NA
|
NA
|
|
Perioperative anesthesia care for patients with confirmed or suspected COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2/COVID-19: Evidence-Based Recommendations on Diagnosis and Therapy.
|
NA
|
NA
|
|
Facing the COVID-19 outbreak in children with cancer.
|
NA
|
NA
|
|
Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management.
|
NA
|
NA
|
|
Diabetes and COVID-19 : Disease-Management-People.
|
NA
|
NA
|
|
COVID-19: a primer for healthcare providers.
|
NA
|
NA
|
|
SARS-CoV-2 infection in Spanish children with chronic kidney pathologies.
|
NA
|
NA
|
|
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.
|
NA
|
NA
|
|
Lithium’s antiviral effects: a potential drug for CoViD-19 disease?
|
NA
|
NA
|
|
SAGES primer for taking care of yourself during and after the COVID-19 crisis.
|
NA
|
NA
|
|
Colorectal surgery in Italy during the Covid19 outbreak: a survey from the iCral study group.
|
NA
|
NA
|
|
Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome.
|
NA
|
NA
|
|
Potential specific therapies in COVID-19.
|
NA
|
NA
|
|
Buying Time: Using OMM to Potentially Reduce the Demand for Mechanical Ventilation in Patients With COVID-19.
|
NA
|
NA
|
|
Clinical Outcomes in COVID-19 Patients Treated with Tocilizumab: An Individual Patient Data Systematic Review.
|
NA
|
NA
|
|
HIV and SARS-CoV-2 co-infection: A case report from Uganda.
|
NA
|
NA
|
|
Hepatic complications of COVID-19 and its treatment.
|
NA
|
NA
|
|
A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.
|
NA
|
NA
|
|
Baricitinib: a chance to treat COVID-19?
|
NA
|
NA
|
|
Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19.
|
NA
|
NA
|
|
Care in the time of coronavirus: Ethical considerations in head and neck oncology.
|
NA
|
NA
|
|
Increase in Covid-19 Cases and Case Fatality and Case Recovery Rates in Europe: A Cross Temporal Meta-Analysis.
|
NA
|
NA
|
|
Influence of the pandemic dissemination of COVID-19 on radiotherapy practice: A flash survey in Germany, Austria and Switzerland.
|
NA
|
NA
|
|
Acute Type A Aortic Dissection Complicated by COVID-19 Infection.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of 421 Patients with COVID-19 Treated in a Mobile Cabin Hospital.
|
NA
|
NA
|
|
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.
|
NA
|
NA
|
|
COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain.
|
NA
|
NA
|
|
The current understanding and potential therapeutic options to combat COVID-19.
|
NA
|
NA
|
|
Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS).
|
NA
|
NA
|
|
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19.
|
NA
|
NA
|
|
Use of anakinra in severe COVID-19: a case report.
|
NA
|
NA
|
|
International COVID-19 palliative care guidance for nursing homes leaves key themes unaddressed.
|
NA
|
NA
|
|
LGBTQ+ Inclusive Palliative Care in the Context of COVID-19: Pragmatic Recommendations for Clinicians.
|
NA
|
NA
|
|
QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review.
|
NA
|
NA
|
|
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
|
NA
|
NA
|
|
The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test.
|
NA
|
NA
|
|
Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.
|
NA
|
NA
|
|
Significant applications of virtual reality for COVID-19 pandemic.
|
NA
|
NA
|
|
Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases.
|
NA
|
NA
|
|
COVID-19 and diabetes mellitus: A need for prudence in elderly patients from a pooled analysis.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer.
|
NA
|
NA
|
|
Structure of replicating SARS-CoV-2 polymerase.
|
NA
|
NA
|
|
Challenges of virtual talking therapies for substance misuse in New Zealand during the COVID-19 pandemic: an opinion piece.
|
NA
|
NA
|
|
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
|
NA
|
NA
|
|
Prioritisation of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
|
NA
|
NA
|
|
Management of osteoarthritis during COVID-19 pandemic.
|
NA
|
NA
|
|
Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: a call for evidence.
|
NA
|
NA
|
|
COVID-19 and Liver Transplantation: lessons learned from three reported cases.
|
NA
|
NA
|
|
A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19.
|
NA
|
NA
|
|
Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group.
|
NA
|
NA
|
|
Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.
|
NA
|
NA
|
|
Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
|
NA
|
NA
|
|
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
|
NA
|
NA
|
|
Liver transplantation in the era of COVID-19.
|
NA
|
NA
|
|
[Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications].
|
NA
|
NA
|
|
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
|
NA
|
NA
|
|
COVID-19 Lessons: The Alignment of Palliative Medicine and Trauma-Informed Care.
|
NA
|
NA
|
|
Preserving Access: A Review of Stroke Thrombectomy during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Generalized myoclonus in COVID-19.
|
NA
|
NA
|
|
Management of newborns exposed to mothers with confirmed or suspected COVID-19.
|
NA
|
NA
|
|
Disease Site-Specific Guidelines for Curative Radiation Treatment During ‘Limited Surgery’ and ‘Hospital Avoidance’: A Radiation Oncology Perspective From the Epicenter of COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.
|
NA
|
NA
|
|
Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.
|
NA
|
NA
|
|
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.
|
NA
|
NA
|
|
Assessing disability and relapses in multiple sclerosis on tele-neurology.
|
NA
|
NA
|
|
Covid-19 and infection in health-care workers: An emerging problem.
|
NA
|
NA
|
|
Development and Implementation of Coronavirus (COVID-19) Disease Response Protocol at a Large Academic Medical Center.
|
NA
|
NA
|
|
Clinical course of Coronavirus Disease-2019 (COVID-19) in pregnancy.
|
NA
|
NA
|
|
Time to step up: A call to action for the clinical and quantitative pharmacology community to accelerate therapeutics for COVID-19.
|
NA
|
NA
|
|
Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS?
|
NA
|
NA
|
|
COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
|
NA
|
NA
|
|
COVID-19 in a patient with HIV infection.
|
NA
|
NA
|
|
A rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid-19).
|
NA
|
NA
|
|
Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.
|
NA
|
NA
|
|
A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.
|
NA
|
NA
|
|
Pandemic Palliative Care Consultations Spanning State and Institutional Borders.
|
NA
|
NA
|
|
Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin.
|
NA
|
NA
|
|
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
|
NA
|
NA
|
|
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.
|
NA
|
NA
|
|
The hallmarks of COVID-19 disease.
|
NA
|
NA
|
|
Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.
|
NA
|
NA
|
|
Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.
|
NA
|
NA
|
|
Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells.
|
NA
|
NA
|
|
Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs.
|
NA
|
NA
|
|
The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).
|
NA
|
NA
|
|
The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill?
|
NA
|
NA
|
|
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
|
NA
|
NA
|
|
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
|
NA
|
NA
|
|
Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment.
|
NA
|
NA
|
|
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).
|
NA
|
NA
|
|
Pandemics and psychiatry: Repositioning research in context of COVID-19.
|
NA
|
NA
|
|
[Cardiovascular disease in times of COVID-19].
|
NA
|
NA
|
|
[Hydroxychloroquine. Cardiology’s viewpoint in times of coronavirus pandemic].
|
NA
|
NA
|
|
Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
|
NA
|
NA
|
|
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta.
|
NA
|
NA
|
|
Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China.
|
NA
|
NA
|
|
SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.
|
NA
|
NA
|
|
Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort.
|
NA
|
NA
|
|
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2.
|
NA
|
NA
|
|
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
|
NA
|
NA
|
|
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
|
NA
|
NA
|
|
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
|
NA
|
NA
|
|
Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
|
NA
|
NA
|
|
Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic.
|
NA
|
NA
|
|
Why re-invent the wheel if you’ve run out of road?
|
NA
|
NA
|
|
BBMRI-ERIC’s contributions to research and knowledge exchange on COVID-19.
|
NA
|
NA
|
|
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).
|
NA
|
NA
|
|
Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective.
|
NA
|
NA
|
|
Impact of the COVID-19 Outbreak on the Management of Patients with Cancer.
|
NA
|
NA
|
|
Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
|
NA
|
NA
|
|
Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities.
|
NA
|
NA
|
|
Crisis Standard of Care: Management of Infantile Spasms during COVID-19.
|
NA
|
NA
|
|
Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.
|
NA
|
NA
|
|
Time, distance, shielding and ALARA; drawing similarities between measures for radiation protection and Coronavirus disease pandemic response.
|
NA
|
NA
|
|
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
|
NA
|
NA
|
|
A Real-World Evidence Framework for Optimising Dosing in All Patients with COVID-19.
|
NA
|
NA
|
|
Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study.
|
NA
|
NA
|
|
Hyperactive Delirium Requires More Aggressive Management in Patients with COVID-19: Temporarily Rethinking “Low and Slow”.
|
NA
|
NA
|
|
Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.
|
NA
|
NA
|
|
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy.
|
NA
|
NA
|
|
Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
COVID-19 identification in chest X-ray images on flat and hierarchical classification scenarios.
|
NA
|
NA
|
|
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes.
|
NA
|
NA
|
|
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
|
NA
|
NA
|
|
Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic.
|
NA
|
NA
|
|
Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
SARS-CoV-2 and Diabetes: New Challenges for the Disease.
|
NA
|
NA
|
|
Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine.
|
NA
|
NA
|
|
The eye as the discrete but defensible portal of coronavirus infection.
|
NA
|
NA
|
|
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study.
|
NA
|
NA
|
|
The Use of Decision Modelling to Inform Timely Policy Decisions on Cardiac Resource Capacity during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.
|
NA
|
NA
|
|
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.
|
NA
|
NA
|
|
Daring discourse: are we ready to recommend neuraxial anesthesia and peripheral nerve blocks during the COVID-19 pandemic? A pro-con.
|
NA
|
NA
|
|
Trials and tribulations: so many potential treatments, so few answers.
|
NA
|
NA
|
|
YouTube as a source of information on COVID-19 and rheumatic disease link.
|
NA
|
NA
|
|
Clinical Insights into the Gastrointestinal Manifestations of COVID-19.
|
NA
|
NA
|
|
Modifications of emergency dental clinic protocols to combat COVID-19 transmission.
|
NA
|
NA
|
|
Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.
|
NA
|
NA
|
|
[Feasibility analysis on acupuncture therapy for the treatment of Corona Virus Disease 2019 and the exploration on the application scheme].
|
NA
|
NA
|
|
[Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
|
NA
|
NA
|
|
In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2.
|
NA
|
NA
|
|
Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life.
|
NA
|
NA
|
|
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
|
NA
|
NA
|
|
Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.
|
NA
|
NA
|
|
Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV.
|
NA
|
NA
|
|
[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]
|
NA
|
NA
|
|
Radiotherapy in Southern Italy at the time of COVID-19: options for radiation oncology units.
|
NA
|
NA
|
|
Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
|
NA
|
NA
|
|
Acetic acid disinfection as a potential adjunctive therapy for non-severe COVID-19.
|
NA
|
NA
|
|
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.
|
NA
|
NA
|
|
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid.
|
NA
|
NA
|
|
How did we rapidly implement a convalescent plasma program?
|
NA
|
NA
|
|
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Successful recovery from severe COVID-19 pneumonia after kidney transplantation: the interplay between immunosuppression and novel therapy including tocilizumab.
|
NA
|
NA
|
|
Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
|
NA
|
NA
|
|
Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.
|
NA
|
NA
|
|
Digital technology can revolutionize mental health services delivery: The COVID-19 crisis as a catalyst for change.
|
NA
|
NA
|
|
Effects of COVID-19 on Parkinson’s disease clinical features: a community-based case-control study.
|
NA
|
NA
|
|
Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond.
|
NA
|
NA
|
|
Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
|
NA
|
NA
|
|
Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
|
NA
|
NA
|
|
Impact of coronavirus pandemic in appointments and anxiety/concerns of patients regarding orthodontic treatment.
|
NA
|
NA
|
|
ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
|
NA
|
NA
|
|
A review on possible modes of actions of Chloroquine/ Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic.
|
NA
|
NA
|
|
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
|
NA
|
NA
|
|
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
|
NA
|
NA
|
|
[Application of convalescent plasma therapy on novel coronavirus infection].
|
NA
|
NA
|
|
[Application of convalescent plasma therapy on novel coronavirus infection].
|
NA
|
NA
|
|
[Application of convalescent plasma therapy on novel coronavirus infection].
|
NA
|
NA
|
|
[Application of convalescent plasma therapy on novel coronavirus infection].
|
NA
|
NA
|
|
[Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan (Trial Version 2)].
|
NA
|
NA
|
|
[The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].
|
NA
|
NA
|
|
Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?
|
NA
|
NA
|
|
An Otolaryngologist Redeployed to a COVID-19 Intensive Care Unit: Lessons Learned.
|
NA
|
NA
|
|
Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19.
|
NA
|
NA
|
|
Liver injury in COVID-19: The current evidence.
|
NA
|
NA
|
|
Impact of sex and gender on COVID-19 outcomes in Europe.
|
NA
|
NA
|
|
Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed.
|
NA
|
NA
|
|
Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications.
|
NA
|
NA
|
|
Is withdrawing treatment really more problematic than withholding treatment?
|
NA
|
NA
|
|
Dr. Balevic, et al, reply.
|
NA
|
NA
|
|
Treating Covid-19 at the Inflection Point.
|
NA
|
NA
|
|
Staying home during “COVID-19” decreased fractures, but trauma did not quarantine in one hundred and twelve adults and twenty eight children and the “tsunami of recommendations” could not lockdown twelve elective operations.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours.
|
NA
|
NA
|
|
Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19.
|
NA
|
NA
|
|
COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease.
|
NA
|
NA
|
|
COVID-19: Safe Guidelines for Breast Imaging During the Pandemic.
|
NA
|
NA
|
|
Implementation of Preoperative Screening Protocols in Otolaryngology During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Vulnerable Immigrant Populations in the New York Metropolitan Area and COVID-19: Lessons Learned in the Epicenter of the Crisis.
|
NA
|
NA
|
|
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Emergence from the COVID-19 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist.
|
NA
|
NA
|
|
Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America.
|
NA
|
NA
|
|
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives.
|
NA
|
NA
|
|
Pediatric Crohn’s Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab.
|
NA
|
NA
|
|
Management of Lung Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
|
NA
|
NA
|
|
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
|
NA
|
NA
|
|
Procoagulation, hypercoagulation and fibrinolytic “shut down” detected with ClotPro® viscoelastic tests in COVID-19 patients.
|
NA
|
NA
|
|
The preventive strategy for pandemics in the elderly is to collect in advance samples & data to counteract chronic inflammation (inflammaging).
|
NA
|
NA
|
|
Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19.
|
NA
|
NA
|
|
Development of a Palliative Care Toolkit for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Palliative Care Utilization among Patients with COVID-19 in an Underserved Population: A Single-Center Retrospective Study.
|
NA
|
NA
|
|
Review of trials currently testing treatment and prevention of COVID-19.
|
NA
|
NA
|
|
International Guidelines And Recommendations For Surgery During Covid-19 Pandemic: A Systematic Review.
|
NA
|
NA
|
|
Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation.
|
NA
|
NA
|
|
A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
|
NA
|
NA
|
|
Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review.
|
NA
|
NA
|
|
Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety.
|
NA
|
NA
|
|
Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage.
|
NA
|
NA
|
|
Battling COVID-19: using old weapons for a new enemy.
|
NA
|
NA
|
|
Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).
|
NA
|
NA
|
|
When predictions are used to allocate scarce health care resources: three considerations for models in the era of Covid-19.
|
NA
|
NA
|
|
COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.
|
NA
|
NA
|
|
A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue.
|
NA
|
NA
|
|
[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].
|
NA
|
NA
|
|
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
|
NA
|
NA
|
|
Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
|
NA
|
NA
|
|
Dental Public Health Landscape: Challenges, Technological Innovation and Opportunities in the 21st Century and COVID-19 Pandemic.
|
NA
|
NA
|
|
Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach.
|
NA
|
NA
|
|
Potential Application of Whole Body Vibration Exercise For Improving The Clinical Conditions of COVID-19 Infected Individuals: A Narrative Review From the World Association of Vibration Exercise Experts (WAVex) Panel.
|
NA
|
NA
|
|
Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis.
|
NA
|
NA
|
|
Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
|
NA
|
NA
|
|
Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
|
NA
|
NA
|
|
[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
|
NA
|
NA
|
|
COViD-19: Face Mask Effectiveness, Hand Sanitizer Shortages, and Rapid Medication Therapy Trials.
|
NA
|
NA
|
|
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
|
NA
|
NA
|
|
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.
|
NA
|
NA
|
|
Potential COVID-19 therapeutics from a rare disease: Weaponizing lipid dysregulation to combat viral infectivity.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’.
|
NA
|
NA
|
|
Can video consultations replace face-to-face interviews? Palliative medicine and the Covid-19 pandemic: rapid review.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on renal transplantation in the UK.
|
NA
|
NA
|
|
COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.
|
NA
|
NA
|
|
Chloroquine, hydroxychloroquine and COVID-19.
|
NA
|
NA
|
|
The Decreasing Incidence of Acute Appendicitis During COVID-19: A Retrospective Multi-centre Study.
|
NA
|
NA
|
|
Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital.
|
NA
|
NA
|
|
Indications and timing for tracheostomy in patients with SARS CoV2-related.
|
NA
|
NA
|
|
Can Zn Be a Critical Element in COVID-19 Treatment?
|
NA
|
NA
|
|
The role of the orthopaedic surgeon in the COVID-19 era: cautions and perspectives.
|
NA
|
NA
|
|
Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
|
NA
|
NA
|
|
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
|
NA
|
NA
|
|
The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
|
NA
|
NA
|
|
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide.
|
NA
|
NA
|
|
Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.
|
NA
|
NA
|
|
Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non-hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days.
|
NA
|
NA
|
|
Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID-19 pandemic.
|
NA
|
NA
|
|
Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy.
|
NA
|
NA
|
|
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.
|
NA
|
NA
|
|
Gynecologic oncology at the time of COVID-19 outbreak.
|
NA
|
NA
|
|
[Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].
|
NA
|
NA
|
|
Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension:A Meta-Analysis.
|
NA
|
NA
|
|
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.
|
NA
|
NA
|
|
Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.
|
NA
|
NA
|
|
Mechanistic inferences from clinical reports of SARS-CoV-2.
|
NA
|
NA
|
|
Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking.
|
NA
|
NA
|
|
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.
|
NA
|
NA
|
|
COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
|
NA
|
NA
|
|
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
|
NA
|
NA
|
|
Use of systemic therapies for psoriasis in the COVID-19 era.
|
NA
|
NA
|
|
Unmet healthcare needs among migrants without medical insurance in Montreal, Canada.
|
NA
|
NA
|
|
The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19.
|
NA
|
NA
|
|
Evaluation of World Health Organization-Recommended Hand Hygiene Formulations.
|
NA
|
NA
|
|
Improvements in Patient Monitoring for the Intensive Care Unit: Survey Study.
|
NA
|
NA
|
|
Prevalence of COVID-19-like symptoms in Italy and Lombardy, March-April 2020, and their implications on cancer prevention, diagnosis and management.
|
NA
|
NA
|
|
Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital.
|
NA
|
NA
|
|
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
|
NA
|
NA
|
|
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
|
NA
|
NA
|
|
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.
|
NA
|
NA
|
|
Projected increases in suicide in Canada as a consequence of COVID-19.
|
NA
|
NA
|
|
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19.
|
NA
|
NA
|
|
Delayed Diagnosis of Pediatric Appendicitis during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Non-steroidal anti-inflammatory drugs in management of COVID-19; a systematic review on current evidence.
|
NA
|
NA
|
|
Covid-19 in solid organ transplant recipients: A single center experience.
|
NA
|
NA
|
|
COVID-19 - neurologists stay aware!
|
NA
|
NA
|
|
Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post COVID-19 era: Time to reconsider its role for most patients.
|
NA
|
NA
|
|
Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea.
|
NA
|
NA
|
|
In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses.
|
NA
|
NA
|
|
The amount of cytokine-release defines different shades of Sars-Cov2 infection.
|
NA
|
NA
|
|
Viral Infections in Burns.
|
NA
|
NA
|
|
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
|
NA
|
NA
|
|
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Developing a guidance resource for managing delirium in patients with Covid-19.
|
NA
|
NA
|
|
The case of Complement activation in COVID-19 multiorgan impact.
|
NA
|
NA
|
|
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
|
NA
|
NA
|
|
Pediatric Palliative Care in a Pandemic: Role Obligations, Moral Distress, and the Care You Can Give.
|
NA
|
NA
|
|
Tele-consultations and electronic medical records driven remote patient care: Responding to the COVID-19 lockdown in India.
|
NA
|
NA
|
|
COVID-19 Waves: Importance of Accumulative Mortality per Million Inhabitants.
|
NA
|
NA
|
|
Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach.
|
NA
|
NA
|
|
Analysis of the Transmissibility Change of 2019-Novel Coronavirus Pneumonia and Its Potential Factors in China from 2019 to 2020.
|
NA
|
NA
|
|
COVID-19 pandemic, socioeconomic crisis and human stress in resource-limited settings: A case from Bangladesh.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation.
|
NA
|
NA
|
|
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population.
|
NA
|
NA
|
|
Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: Is There an Association?
|
NA
|
NA
|
|
Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity.
|
NA
|
NA
|
|
Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: “a position statement of the Egyptian Society of Cardiology”.
|
NA
|
NA
|
|
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.
|
NA
|
NA
|
|
Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.
|
NA
|
NA
|
|
COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
|
NA
|
NA
|
|
Nutrition Therapy in Critically Ill Patients with Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
How should colorectal surgeons practice during the COVID-19 epidemic? A retrospective single-center analysis based on real-world data from China.
|
NA
|
NA
|
|
[Obesity and risk of severe COVID-19].
|
NA
|
NA
|
|
Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.
|
NA
|
NA
|
|
Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?
|
NA
|
NA
|
|
Identification of Potential Inhibitors of SARS-COV-2 Endoribonuclease (EndoU) from FDA Approved Drugs: A Drug Repurposing Approach to find Therapeutics for COID19.
|
NA
|
NA
|
|
Elective lung cancer surgery in the COVID-19 era: how do we do it?
|
NA
|
NA
|
|
A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem).
|
NA
|
NA
|
|
The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics amidst a Pandemic.
|
NA
|
NA
|
|
Patient visits to an emergency department in anticipation of the COVID-19 pandemic.
|
NA
|
NA
|
|
Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients.
|
NA
|
NA
|
|
When chaos is the norm: How some veterans with PTSD are continuing to engage in trauma-focused treatments during the COVID-19 pandemic.
|
NA
|
NA
|
|
Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?
|
NA
|
NA
|
|
Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring.
|
NA
|
NA
|
|
Telehealth in the Context of COVID-19: Changing Perspectives in Australia, the United Kingdom and the United States.
|
NA
|
NA
|
|
Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process.
|
NA
|
NA
|
|
Obesity and COVID-19: an Italian snapshot.
|
NA
|
NA
|
|
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
|
NA
|
NA
|
|
COVID in NYC: What We Could Do Better.
|
NA
|
NA
|
|
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19.
|
NA
|
NA
|
|
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
|
NA
|
NA
|
|
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?
|
NA
|
NA
|
|
First detection of SARS-CoV-2 in untreated wastewaters in Italy.
|
NA
|
NA
|
|
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
|
NA
|
NA
|
|
Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.
|
NA
|
NA
|
|
Cytokine Blood Filtration Responses in COVID-19.
|
NA
|
NA
|
|
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
|
NA
|
NA
|
|
Answering the Call: Impact of Tele-ICU Nurses During the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Implementation of an operational concept in an ENT clinic in the context of the SARS-CoV-2 pandemic].
|
NA
|
NA
|
|
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.
|
NA
|
NA
|
|
Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies-Acting Now before It Is Too Late-A Joint Call for Action.
|
NA
|
NA
|
|
Model for Taking Care of Patients with Early Childhood Caries during the SARS-Cov-2 Pandemic.
|
NA
|
NA
|
|
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
Graphene-Based Strategies in Liquid Biopsy and in Viral Diseases Diagnosis.
|
NA
|
NA
|
|
Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris.
|
NA
|
NA
|
|
Break in the Stroke Chain of Survival Due to COVID-19.
|
NA
|
NA
|
|
Potential risks of SARS-CoV-2 infection on reproductive health.
|
NA
|
NA
|
|
COVID-19 and fertility: a virtual reality.
|
NA
|
NA
|
|
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma.
|
NA
|
NA
|
|
Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.
|
NA
|
NA
|
|
Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.
|
NA
|
NA
|
|
Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.
|
NA
|
NA
|
|
Coagulopathy of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
|
NA
|
NA
|
|
The effects of the COVID-19 pandemic on oncological surgery.
|
NA
|
NA
|
|
Successful Conservative Management of Acute Appendicitis in a Coronavirus Disease 2019 (COVID-19) Patient.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) in Cancer Patients.
|
NA
|
NA
|
|
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).
|
NA
|
NA
|
|
The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
|
NA
|
NA
|
|
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
|
NA
|
NA
|
|
Challenges and response in the medical management of the orthopaedic department during the coronavirus disease 2019 pandemic: strategies in Wuhan, China.
|
NA
|
NA
|
|
Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
COVID-19 and Asthma: Reflection During the Pandemic.
|
NA
|
NA
|
|
The COVID-19 pandemic: is our medicine still evidence-based?
|
NA
|
NA
|
|
An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19).
|
NA
|
NA
|
|
Facing SARS-CoV-2 outbreak in immunotherapy era.
|
NA
|
NA
|
|
Surviving the surge: Evaluation of early impact of COVID-19 on inpatient pharmacy services at a community teaching hospital.
|
NA
|
NA
|
|
Paying Participants in COVID-19 Trials.
|
NA
|
NA
|
|
Clinical recommendations on lung cancer management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Early results from telephone follow-up of patients with cardiovascular implantable electronic devices during the coronavirus pandemic.
|
NA
|
NA
|
|
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?
|
NA
|
NA
|
|
Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs.
|
NA
|
NA
|
|
Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2.
|
NA
|
NA
|
|
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
|
NA
|
NA
|
|
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
|
NA
|
NA
|
|
Possibilities of telemedicine regarding the COVID-19 pandemic in light of the international and Hungarian experiences and recommendations
|
NA
|
NA
|
|
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.
|
NA
|
NA
|
|
The perplexing question of trained immunity versus adaptive memory in COVID-19.
|
NA
|
NA
|
|
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
|
NA
|
NA
|
|
Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?
|
NA
|
NA
|
|
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.
|
NA
|
NA
|
|
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.
|
NA
|
NA
|
|
Ramipril in High Risk Patients with COVID-19.
|
NA
|
NA
|
|
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.
|
NA
|
NA
|
|
Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
|
NA
|
NA
|
|
Emerging pharmacotherapies for COVID-19.
|
NA
|
NA
|
|
Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists.
|
NA
|
NA
|
|
Role of oxidized LDL-induced “trained macrophages” in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.
|
NA
|
NA
|
|
Modeling the effects of intervention strategies on COVID-19 transmission dynamics.
|
NA
|
NA
|
|
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.
|
NA
|
NA
|
|
Why does COVID-19 disproportionately affect older people?
|
NA
|
NA
|
|
COVID-19 in elderly kidney transplant recipients.
|
NA
|
NA
|
|
Practical recommendations for gynecologic surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Network of Angiotensin Receptors in Breast Cancer.
|
NA
|
NA
|
|
Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells.
|
NA
|
NA
|
|
Proactive COVID-19 Infection Prevention Measures in a Hyperbaric Oxygen Therapy Center.
|
NA
|
NA
|
|
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition.
|
NA
|
NA
|
|
Challenges in Tuberculosis Clinical Trials in the Face of the COVID-19 Pandemic: A Sponsor’s Perspective.
|
NA
|
NA
|
|
Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.
|
NA
|
NA
|
|
Changes in Provision of Psychotherapy in the Early Weeks of the COVID-19 Lockdown in Austria.
|
NA
|
NA
|
|
The role of palliative care in COVID-19.
|
NA
|
NA
|
|
Registries Offer Insights on COVID-19-Cancer Connection.
|
NA
|
NA
|
|
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
|
NA
|
NA
|
|
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
|
NA
|
NA
|
|
Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.
|
NA
|
NA
|
|
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
|
NA
|
NA
|
|
Cancer treatment during COVID-19 pandemic.
|
NA
|
NA
|
|
Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
|
NA
|
NA
|
|
Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
|
NA
|
NA
|
|
Treatment algorithm for COVID-19: a multidisciplinary point of view.
|
NA
|
NA
|
|
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.
|
NA
|
NA
|
|
A manual reduction of hernia under analgesia/sedation (Taxis) in the acute inguinal hernia: a useful technique in COVID-19 times to reduce the need for emergency surgery-a literature review.
|
NA
|
NA
|
|
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
|
NA
|
NA
|
|
Cytokine storm in COVID-19 and parthenolide: preclinical evidence.
|
NA
|
NA
|
|
First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.
|
NA
|
NA
|
|
We Know About COVID-19: Oral and Maxillofacial Surgeons Survey.
|
NA
|
NA
|
|
Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?
|
NA
|
NA
|
|
2019 novel coronavirus: what is currently known, cardiovascular implications and management.
|
NA
|
NA
|
|
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
|
NA
|
NA
|
|
Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
|
NA
|
NA
|
|
Treatment of COVID-19 Patients with Convalescent Plasma.
|
NA
|
NA
|
|
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
|
NA
|
NA
|
|
On the benefits of flattening the curve: A perspective.
|
NA
|
NA
|
|
Evidence for decontamination of single-use filtering facepiece respirators.
|
NA
|
NA
|
|
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
|
NA
|
NA
|
|
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
|
NA
|
NA
|
|
A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19?
|
NA
|
NA
|
|
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
|
NA
|
NA
|
|
Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections.
|
NA
|
NA
|
|
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
|
NA
|
NA
|
|
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.
|
NA
|
NA
|
|
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.
|
NA
|
NA
|
|
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
|
NA
|
NA
|
|
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
|
NA
|
NA
|
|
Neuroleptic malignant syndrome in patients with COVID-19.
|
NA
|
NA
|
|
Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ).
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
|
NA
|
NA
|
|
Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report.
|
NA
|
NA
|
|
COVID-19: Transmission, prevention, and potential therapeutic opportunities.
|
NA
|
NA
|
|
Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
|
NA
|
NA
|
|
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
|
NA
|
NA
|
|
Neurosurgery Practice During Coronavirus Disease 2019 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Evolution of clinical radiotherapy physics practice under COVID-19 constraints.
|
NA
|
NA
|
|
Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19.
|
NA
|
NA
|
|
Wastewater surveillance for population-wide Covid-19: The present and future.
|
NA
|
NA
|
|
Risk of using hydroxychloroquine as a treatment of COVID-19.
|
NA
|
NA
|
|
Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
|
NA
|
NA
|
|
CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic.
|
NA
|
NA
|
|
Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.
|
NA
|
NA
|
|
Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients.
|
NA
|
NA
|
|
Relationship between clinical types and radiological subgroups defined by latent class analysis in 2019 novel coronavirus pneumonia caused by SARS-CoV-2.
|
NA
|
NA
|
|
Critical adjustments in a department of orthopaedics through the COVID-19 pandemic.
|
NA
|
NA
|
|
Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China.
|
NA
|
NA
|
|
Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study.
|
NA
|
NA
|
|
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India.
|
NA
|
NA
|
|
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
|
NA
|
NA
|
|
COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia.
|
NA
|
NA
|
|
Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19.
|
NA
|
NA
|
|
Contributions of dermatologists to COVID-19 research: a brief systematic review.
|
NA
|
NA
|
|
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic.
|
NA
|
NA
|
|
Does lopinavir measure up in the treatment of COVID-19?
|
NA
|
NA
|
|
Antiviral effects of probiotic metabolites on COVID-19.
|
NA
|
NA
|
|
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
|
NA
|
NA
|
|
Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices.
|
NA
|
NA
|
|
Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.
|
NA
|
NA
|
|
The potential transmission of SARS-CoV-2 from patients with negative RT-PCR swab tests to others: two related clusters of COVID-19 outbreak.
|
NA
|
NA
|
|
Prediction of the severity of Corona Virus Disease 2019 and its adverse clinical outcomes.
|
NA
|
NA
|
|
The Greek Response to COVID-19: A True Success Story from an IBD Perspective.
|
NA
|
NA
|
|
The association between treatment with heparin and survival in patients with Covid-19.
|
NA
|
NA
|
|
Management of patients with ovarian cancer in the COVID-19 era.
|
NA
|
NA
|
|
Telemedicine for head and neck ambulatory visits during COVID-19: Evaluating usability and patient satisfaction.
|
NA
|
NA
|
|
Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.
|
NA
|
NA
|
|
Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
|
NA
|
NA
|
|
Empirical Treatment and Prevention of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
|
NA
|
NA
|
|
Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.
|
NA
|
NA
|
|
Meeting the Transitional Care Needs of Older Adults with COVID-19.
|
NA
|
NA
|
|
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
|
NA
|
NA
|
|
Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Liver diseases in COVID-19: Etiology, treatment and prognosis.
|
NA
|
NA
|
|
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
|
NA
|
NA
|
|
Psoriasis, biologic therapy, and the pandemic of the 21st century.
|
NA
|
NA
|
|
Analysis and suggestions for the preview and triage screening of children with suspected COVID-19 outside the epidemic area of Hubei Province.
|
NA
|
NA
|
|
Pediatric coronavirus disease 2019 (COVID-19): An insight from west of Iran.
|
NA
|
NA
|
|
Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19.
|
NA
|
NA
|
|
First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19.
|
NA
|
NA
|
|
Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology.
|
NA
|
NA
|
|
Art therapy in the time of COVID-19.
|
NA
|
NA
|
|
Understanding the mental health burden of COVID-19 in the United Kingdom.
|
NA
|
NA
|
|
COVID-19 and refugee and immigrant youth: A community-based mental health perspective.
|
NA
|
NA
|
|
Emotional impact of the COVID-19 pandemic on U.S. health care workers: A gathering storm.
|
NA
|
NA
|
|
Moral and mental health challenges faced by maternity staff during the COVID-19 pandemic.
|
NA
|
NA
|
|
Psychotherapists’ vicarious traumatization during the COVID-19 pandemic.
|
NA
|
NA
|
|
Stemming COVID-19 in Cuba: Strengths, Strategies, ChallengesFrancisco Durán MD.
|
NA
|
NA
|
|
Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.
|
NA
|
NA
|
|
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
|
NA
|
NA
|
|
Topical rh-aFGF: An effective therapeutic agent for facemask wearing-induced pressure sores.
|
NA
|
NA
|
|
Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment?
|
NA
|
NA
|
|
Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential.
|
NA
|
NA
|
|
Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy.
|
NA
|
NA
|
|
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study.
|
NA
|
NA
|
|
Spanish risk management framework across 17 radiation oncology centers during COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
|
NA
|
NA
|
|
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.
|
NA
|
NA
|
|
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.
|
NA
|
NA
|
|
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
|
NA
|
NA
|
|
National Outreach of Telepalliative Medicine Volunteers for a New York City Safety Net System COVID-19 Pandemic Response.
|
NA
|
NA
|
|
Lack of antiviral activity of darunavir against SARS-CoV-2.
|
NA
|
NA
|
|
Ivermectin: repurposing a multipurpose drug for Venezuela’s humanitarian crisis.
|
NA
|
NA
|
|
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19.
|
NA
|
NA
|
|
COVID-19-Associated Encephalitis Mimicking Glial Tumor.
|
NA
|
NA
|
|
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
|
NA
|
NA
|
|
Development and Clinical Evaluation of a Web-Based Upper Limb Home Rehabilitation System Using a Smartwatch and Machine Learning Model for Chronic Stroke Survivors: Prospective Comparative Study.
|
NA
|
NA
|
|
Conquest of COVID-19. Publish it to Death?
|
NA
|
NA
|
|
Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.
|
NA
|
NA
|
|
Psychological intervention on COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
CT manifestations of the coronavirus disease 2019 of imported infection versus second-generation infection in patients outside the original district (Wuhan, China) of this disease: An observational study.
|
NA
|
NA
|
|
Therapeutic effect of high-flow nasal cannula on severe COVID-19 patients in a makeshift intensive-care unit: A case report.
|
NA
|
NA
|
|
Efficacy and safety of Chinese herbal medicine for Coronavirus disease 2019: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
A case report with COVID-19 during perioperative period of lobectomy.
|
NA
|
NA
|
|
Efficacy and safety of acupuncture therapy for COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases.
|
NA
|
NA
|
|
The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
|
NA
|
NA
|
|
Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.
|
NA
|
NA
|
|
Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.
|
NA
|
NA
|
|
NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19.
|
NA
|
NA
|
|
Adjusting to the new reality: Evaluation of early practice pattern adaptations to the COVID-19 pandemic.
|
NA
|
NA
|
|
Provision of Emergency Maxillofacial Service During the COVID-19 Pandemic : A Collaborative Five Centre UK Study.
|
NA
|
NA
|
|
Lung ultrasound monitoring in patients with COVID-19 on home isolation.
|
NA
|
NA
|
|
Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis.
|
NA
|
NA
|
|
Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic.
|
NA
|
NA
|
|
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
|
NA
|
NA
|
|
SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence.
|
NA
|
NA
|
|
Disproportionate Case Reduction After Ban of Elective Surgeries During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results from New York.
|
NA
|
NA
|
|
Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
|
NA
|
NA
|
|
General Anesthesia Recommendations for Electroconvulsive Therapy During the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.
|
NA
|
NA
|
|
The potential insights of Traditional Chinese Medicine on treatment of COVID-19.
|
NA
|
NA
|
|
Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.
|
NA
|
NA
|
|
Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review.
|
NA
|
NA
|
|
Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a.
|
NA
|
NA
|
|
Managing Severe Aortic Stenosis in the COVID-19 Era.
|
NA
|
NA
|
|
Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.
|
NA
|
NA
|
|
Preventing prejudice by preserving the spirit of mental health legislation during the COVID-19 national emergency.
|
NA
|
NA
|
|
‘’Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients’’.
|
NA
|
NA
|
|
Using the prone position could help to combat the development of fast hypoxia in some patients with COVID-19.
|
NA
|
NA
|
|
First case of focal epilepsy associated with SARS-coronavirus-2.
|
NA
|
NA
|
|
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.
|
NA
|
NA
|
|
Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
|
NA
|
NA
|
|
A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
|
NA
|
NA
|
|
The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.
|
NA
|
NA
|
|
A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence.
|
NA
|
NA
|
|
Thrombosis risk associated with COVID-19 infection. A scoping review.
|
NA
|
NA
|
|
Schizophrenia and COVID-19 delirium.
|
NA
|
NA
|
|
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks.
|
NA
|
NA
|
|
Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.
|
NA
|
NA
|
|
Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells.
|
NA
|
NA
|
|
Coping with COVID-19: Exposure to COVID-19 and Negative Impact on Livelihood Predict Elevated Mental Health Problems in Chinese Adults.
|
NA
|
NA
|
|
Analysis of Outbreak and Global Impacts of the COVID-19.
|
NA
|
NA
|
|
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
|
NA
|
NA
|
|
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions.
|
NA
|
NA
|
|
Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson’s Disease in Germany.
|
NA
|
NA
|
|
Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses.
|
NA
|
NA
|
|
Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses.
|
NA
|
NA
|
|
COVID-19 Related Coagulopathy: A Distinct Entity?
|
NA
|
NA
|
|
Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.
|
NA
|
NA
|
|
[Guide for the prevention and treatment of coronavirus disease 2019].
|
NA
|
NA
|
|
[Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].
|
NA
|
NA
|
|
COVID-19 Emergency Reforms in Massachusetts to Support Behavioral Health Care and Reduce Mortality of People With Serious Mental Illness.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review.
|
NA
|
NA
|
|
Epidemiological characteristics of COVID-19 patients in convalescence period.
|
NA
|
NA
|
|
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.
|
NA
|
NA
|
|
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.
|
NA
|
NA
|
|
Nutrition in times of Covid-19, how to trust the deluge of scientific information.
|
NA
|
NA
|
|
A Patient with Acute Cervical Cord Injury and COVID-19: A First Case Report.
|
NA
|
NA
|
|
Modeling mitigation of influenza epidemics by baloxavir.
|
NA
|
NA
|
|
[Surgery during the SARS-CoV-2 pandemic : Recommendations on operative procedures].
|
NA
|
NA
|
|
[Psychopharmacotherapy during the COVID-19 pandemic].
|
NA
|
NA
|
|
[Recommendations for the support of suffering, severely ill, dying or grieving persons in the corona pandemic from a palliative care perspective : Recommendations of the German Society for Palliative Medicine (DGP), the German Interdisciplinary Association for Intensive and Emergency Medicine (DIVI), the Federal Association for Grief Counseling (BVT), the Working Group for Psycho-oncology in the German Cancer Society, the German Association for Social Work in the Healthcare System (DVSG) and the German Association for Systemic Therapy, Counseling and Family Therapy (DGSF)].
|
NA
|
NA
|
|
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.
|
NA
|
NA
|
|
Impact of the COronaVIrus Disease 2019 lockdown on hand and upper limb emergencies: experience of a referred university trauma hand centre in Paris, France.
|
NA
|
NA
|
|
Applied Clinical Pharmacology in a Crisis - Interleukin-6 Axis Blockade and COVID-19.
|
NA
|
NA
|
|
Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
|
NA
|
NA
|
|
Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.
|
NA
|
NA
|
|
[Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
|
NA
|
NA
|
|
[Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].
|
NA
|
NA
|
|
[Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors].
|
NA
|
NA
|
|
[Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0].
|
NA
|
NA
|
|
[Recent advances in treatment of viral pneumonia using Chinese patent medicine].
|
NA
|
NA
|
|
[Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis].
|
NA
|
NA
|
|
[Treatment of COVID-19 guided by holistic view of traditional Chinese medicine–therapy aimed at both viral and host].
|
NA
|
NA
|
|
[Thoughts and suggestions on arrangement, analysis and summary of medical data during COVID-19 epidemic].
|
NA
|
NA
|
|
COVID-19 quarantine: Post-traumatic stress symptomatology among Lebanese citizens.
|
NA
|
NA
|
|
Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report.
|
NA
|
NA
|
|
COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy.
|
NA
|
NA
|
|
A 55-year-old COVID-19-positive man managed with self-regulation of high-flow oxygen by high-velocity nasal insufflation therapy.
|
NA
|
NA
|
|
Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
|
NA
|
NA
|
|
Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes?
|
NA
|
NA
|
|
Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group.
|
NA
|
NA
|
|
COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.
|
NA
|
NA
|
|
Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?
|
NA
|
NA
|
|
Chinese Society of Interventional Radiology Expert Consensus on the prevention and control of COVID-19 in interventional radiology procedures (first edition).
|
NA
|
NA
|
|
A systematic review of chest imaging findings in COVID-19.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
|
NA
|
NA
|
|
HyPE study: hydroxychloroquine prophylaxis-related adverse events’ analysis among healthcare workers during COVID-19 pandemic: a rising public health concern.
|
NA
|
NA
|
|
Telemedicine during Covid-19 pandemic: Advantage or critical issue?
|
NA
|
NA
|
|
Thromboinflammatory response in SARS-CoV-2 sepsis.
|
NA
|
NA
|
|
Information Technology-Based Management of Clinically Healthy COVID-19 Patients: Lessons From a Living and Treatment Support Center Operated by Seoul National University Hospital.
|
NA
|
NA
|
|
Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach.
|
NA
|
NA
|
|
Challenges and opportunities for telehealth during the COVID-19 pandemic: ideas on spaces and initiatives in the Brazilian context.
|
NA
|
NA
|
|
17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection.
|
NA
|
NA
|
|
The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
|
NA
|
NA
|
|
Cardiovascular Implications in Patients Infected with Covid-19 and the Importance of Social Isolation to Reduce Dissemination of the Disease.
|
NA
|
NA
|
|
Clinical characteristics and therapeutic procedure for a critical case of novel coronavirus pneumonia treated with glucocorticoids and non-invasive ventilator treatment.
|
NA
|
NA
|
|
Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China.
|
NA
|
NA
|
|
Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice.
|
NA
|
NA
|
|
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
|
NA
|
NA
|
|
Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
|
NA
|
NA
|
|
COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study.
|
NA
|
NA
|
|
‘’Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?’’.
|
NA
|
NA
|
|
Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.
|
NA
|
NA
|
|
Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
|
NA
|
NA
|
|
Rationale and Design of ORCHID: A Randomized Placebo-Controlled Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.
|
NA
|
NA
|
|
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
|
NA
|
NA
|
|
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
|
NA
|
NA
|
|
Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?
|
NA
|
NA
|
|
[SARS-CoV-2 infection (COVID-19): what can we expect?]
|
NA
|
NA
|
|
Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
|
NA
|
NA
|
|
The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report.
|
NA
|
NA
|
|
Inequalities in access to water and soap matter for the COVID-19 response in sub-Saharan Africa.
|
NA
|
NA
|
|
Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups.
|
NA
|
NA
|
|
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial.
|
NA
|
NA
|
|
A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
|
NA
|
NA
|
|
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
|
NA
|
NA
|
|
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
[Influence of the coronavirus 2 (SARS-Cov-2) pandemic on acute appendicitis].
|
NA
|
NA
|
|
S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19.
|
NA
|
NA
|
|
New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.
|
NA
|
NA
|
|
Quality improvement during the COVID-19 pandemic.
|
NA
|
NA
|
|
Ethical considerations during the COVID-19 pandemic.
|
NA
|
NA
|
|
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
|
NA
|
NA
|
|
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
|
NA
|
NA
|
|
A new framework to identify dental emergencies in the COVID-19 era.
|
NA
|
NA
|
|
Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials.
|
NA
|
NA
|
|
COVID-19 Outbreak in Malaysia.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
|
NA
|
NA
|
|
COVID-19 in teriflunomide-treated patients with multiple sclerosis.
|
NA
|
NA
|
|
COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
|
NA
|
NA
|
|
31 days of COVID-19-cardiac events during restriction of public life-a comparative study.
|
NA
|
NA
|
|
Novel therapeutic approaches for treatment of COVID-19.
|
NA
|
NA
|
|
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective.
|
NA
|
NA
|
|
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
|
NA
|
NA
|
|
Resuming elective surgery in the time of COVID-19: a safe and comprehensive strategy.
|
NA
|
NA
|
|
COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
|
NA
|
NA
|
|
[Intensive Care During a Global Epidemic].
|
NA
|
NA
|
|
[The Key Role of Taiwanese Nurses in Combating COVID-19 Pandemic].
|
NA
|
NA
|
|
[Infection Control: The Roles and Functions of Nurses Working at the International Medical Center].
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): strengthening our resolve to achieve universal palliative care.
|
NA
|
NA
|
|
Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?
|
NA
|
NA
|
|
[Clinical efficacy of Matrine and Sodium Chloride Injection in treatment of 40 cases of COVID-19].
|
NA
|
NA
|
|
[Analysis of 131 cases of COVID-19 treated with Ganlu Xiaodu Decoction].
|
NA
|
NA
|
|
[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].
|
NA
|
NA
|
|
[TCMATCOV–a bioinformatics platform to predict efficacy of TCM against COVID-19].
|
NA
|
NA
|
|
[Usage of ethnomedicine on COVID-19 in China].
|
NA
|
NA
|
|
[Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19].
|
NA
|
NA
|
|
[Ethical review of clinical study on intervention with traditional Chinese medicine in new public health emergencies].
|
NA
|
NA
|
|
[Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
|
NA
|
NA
|
|
Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
|
NA
|
NA
|
|
Severe acute dried gangrene in COVID-19 infection: a case report.
|
NA
|
NA
|
|
Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic.
|
NA
|
NA
|
|
Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients.
|
NA
|
NA
|
|
An update on novel COVID-19 pandemic: a battle between humans and virus.
|
NA
|
NA
|
|
Probiotics and COVID-19: is there any link?
|
NA
|
NA
|
|
Recommendations for treatment of nail psoriasis during the COVID-19 pandemic.
|
NA
|
NA
|
|
Emergence of novel coronavirus and progress toward treatment and vaccine.
|
NA
|
NA
|
|
Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
|
NA
|
NA
|
|
The effect of Adacolumn® on ulcerative colitis with COVID-19.
|
NA
|
NA
|
|
Author´s answer to: “Effect of adacolumn® in ulcerative colitis with COVID-19”.
|
NA
|
NA
|
|
Development of an openEHR Template for COVID-19 Based on Clinical Guidelines.
|
NA
|
NA
|
|
Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19.
|
NA
|
NA
|
|
Potential pharmacological agents for COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
|
NA
|
NA
|
|
Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India.
|
NA
|
NA
|
|
Effectiveness of preventive measures against COVID-19: A systematic review of In Silico modeling studies in indian context.
|
NA
|
NA
|
|
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
|
NA
|
NA
|
|
“Slowing the Spread and Minimizing the Impact of COVID-19: Lessons from the Past and Recommendations for the Plastic Surgeon”.
|
NA
|
NA
|
|
Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis.
|
NA
|
NA
|
|
Swapping drills for dressings: redeployment of dentists to community nursing.
|
NA
|
NA
|
|
SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty.
|
NA
|
NA
|
|
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
|
NA
|
NA
|
|
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
|
NA
|
NA
|
|
Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.
|
NA
|
NA
|
|
Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
|
NA
|
NA
|
|
COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.
|
NA
|
NA
|
|
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
|
NA
|
NA
|
|
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.
|
NA
|
NA
|
|
The Unexpected Risks of COVID-19 on Asthma Control in Children.
|
NA
|
NA
|
|
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway.
|
NA
|
NA
|
|
Strategy for treating vascular emergencies during the COVID-19 pandemic in China.
|
NA
|
NA
|
|
Special Communication: Evaluation and Treatment of Thoracic Outlet Syndrome During the Global Pandemic Due to SARS-CoV-2 and COVID-19.
|
NA
|
NA
|
|
Perspectives on how to navigate cancer surgery in the breast, head and neck, skin, and soft tissue tumor in limited-resource countries during COVID-19 pandemic.
|
NA
|
NA
|
|
Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
|
NA
|
NA
|
|
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
|
NA
|
NA
|
|
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts, hay fever and flu-like incidence 2016-2019.
|
NA
|
NA
|
|
Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.
|
NA
|
NA
|
|
Anti-Infectious Plants of The Thai Karen: A Meta-Analysis.
|
NA
|
NA
|
|
[Consideration on improving public health emergency management ability of current medical health system].
|
NA
|
NA
|
|
Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes.
|
NA
|
NA
|
|
Letter to the Editor: Robot-Assisted and Minimally Invasive Pediatric Surgery and Urology During the COVID-19 Pandemic: A Short Literature Review.
|
NA
|
NA
|
|
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
|
NA
|
NA
|
|
Coronavirus Disease 2019: Clinical Review.
|
NA
|
NA
|
|
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia.
|
NA
|
NA
|
|
The public health response to the COVID-19 pandemic for people with disabilities.
|
NA
|
NA
|
|
Covid-19 Pandemic and Current Medical Interventions.
|
NA
|
NA
|
|
Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
|
NA
|
NA
|
|
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series.
|
NA
|
NA
|
|
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.
|
NA
|
NA
|
|
Pharmacologicaltreatment of COVID-19: lights and shadows.
|
NA
|
NA
|
|
A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2.
|
NA
|
NA
|
|
The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons.
|
NA
|
NA
|
|
Implications of COVID-19 in pediatric rheumatology.
|
NA
|
NA
|
|
Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center.
|
NA
|
NA
|
|
Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists.
|
NA
|
NA
|
|
Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path.
|
NA
|
NA
|
|
Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?
|
NA
|
NA
|
|
Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement.
|
NA
|
NA
|
|
Clinical update on COVID-19 in pregnancy: A review article.
|
NA
|
NA
|
|
Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19.
|
NA
|
NA
|
|
Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
|
NA
|
NA
|
|
Novel coronavirus and regular physical activity involvement: Opinion.
|
NA
|
NA
|
|
Home delivery of medication during Coronavirus disease 2019, Cape Town, South Africa: Short report.
|
NA
|
NA
|
|
Coronavirus disease-2019 epidemic response in Uganda: The need to strengthen and engage primary healthcare.
|
NA
|
NA
|
|
Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.
|
NA
|
NA
|
|
Factors preventing materno-fetal transmission of SARS-CoV-2.
|
NA
|
NA
|
|
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease.
|
NA
|
NA
|
|
Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations.
|
NA
|
NA
|
|
Statistical analysis of forecasting COVID-19 for upcoming month in Pakistan.
|
NA
|
NA
|
|
COVID-19 created chaos across the globe: Three novel quarantine epidemic models.
|
NA
|
NA
|
|
The role of ecosystems in mitigation and management of Covid-19 and other zoonoses.
|
NA
|
NA
|
|
Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine.
|
NA
|
NA
|
|
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
|
NA
|
NA
|
|
Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.
|
NA
|
NA
|
|
Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots.
|
NA
|
NA
|
|
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
|
NA
|
NA
|
|
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
A comparative study on the time to achieve negative nucleic acid testing and hospital stays between danoprevir and lopinavir/ritonavir in the treatment of patients with COVID-19.
|
NA
|
NA
|
|
Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward.
|
NA
|
NA
|
|
How COVID-19 public interest in the United States fluctuated: A Google Trends Analysis.
|
NA
|
NA
|
|
Virtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire Study.
|
NA
|
NA
|
|
Nature and Diffusion of COVID-19-related Oral Health Information on Chinese Social Media: Analysis of Tweets on Weibo.
|
NA
|
NA
|
|
Evaluating the Effects of COVID-19 on Plastic Surgery Emergencies: Protocols and Analysis from a Level I Trauma Center.
|
NA
|
NA
|
|
The effect of massage on the quality of life in patients recovering from COVID-19: A systematic review protocol.
|
NA
|
NA
|
|
The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.
|
NA
|
NA
|
|
A 3-month-old child with COVID-19: A case report.
|
NA
|
NA
|
|
Zooming-Out COVID: Virtual Clinical Experiences in an Emergency Medicine Clerkship.
|
NA
|
NA
|
|
Melanoma defies ‘lockdown’: ongoing detection during Covid-19 in central London.
|
NA
|
NA
|
|
Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence.
|
NA
|
NA
|
|
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.
|
NA
|
NA
|
|
Prevention, Diagnosis, and Treatment of VTE in Patients With COVID-19: CHEST Guideline and Expert Panel Report.
|
NA
|
NA
|
|
Potential role of statins in COVID-19.
|
NA
|
NA
|
|
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
|
NA
|
NA
|
|
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–The BRACE CORONA Trial.
|
NA
|
NA
|
|
Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment.
|
NA
|
NA
|
|
Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings.
|
NA
|
NA
|
|
Homeopathic Clinical Features of 18 Patients in COVID-19 Outbreaks in Hong Kong.
|
NA
|
NA
|
|
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders.
|
NA
|
NA
|
|
Lassa Fever: Viral Replication, Disease Pathogenesis, and Host Immune Modulations.
|
NA
|
NA
|
|
Biomarkers associated with COVID-19 disease progression.
|
NA
|
NA
|
|
Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
|
NA
|
NA
|
|
The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic.
|
NA
|
NA
|
|
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
|
NA
|
NA
|
|
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
|
NA
|
NA
|
|
Oral Methioninase for Covid-19 Methionine-restriction Therapy.
|
NA
|
NA
|
|
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
|
NA
|
NA
|
|
Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review.
|
NA
|
NA
|
|
Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.
|
NA
|
NA
|
|
SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.
|
NA
|
NA
|
|
Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.
|
NA
|
NA
|
|
Breast Cancer and COVID-19: The Effect of Fear on Patients’ Decision-making Process.
|
NA
|
NA
|
|
Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients.
|
NA
|
NA
|
|
Radiation Therapy During the COVID-19 Pandemic: Experience from Beijing, China.
|
NA
|
NA
|
|
Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
|
NA
|
NA
|
|
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.
|
NA
|
NA
|
|
Are we all in this together? Longitudinal assessment of cumulative adversities by socioeconomic position in the first 3 weeks of lockdown in the UK.
|
NA
|
NA
|
|
[Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data].
|
NA
|
NA
|
|
SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China.
|
NA
|
NA
|
|
Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator.
|
NA
|
NA
|
|
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.
|
NA
|
NA
|
|
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19: Loss of bridging between innate and adaptive immunity?
|
NA
|
NA
|
|
Nebulized Lidocaine in COVID-19, An Hypothesis.
|
NA
|
NA
|
|
COVID-19 and picotechnology: Potential opportunities.
|
NA
|
NA
|
|
Covid-19 and lung cancer: A greater fatality rate?
|
NA
|
NA
|
|
Quality of primary health care in China: challenges and recommendations.
|
NA
|
NA
|
|
A SARS-CoV-2 familial cluster infection reveals asymptomatic transmission to children.
|
NA
|
NA
|
|
Feasibility and Acceptability of Inpatient Palliative Care E-Family Meetings During COVID-19 Pandemic.
|
NA
|
NA
|
|
An Exit Strategy for Resuming Nonemergency Neurosurgery after Severe Acute Respiratory Syndrome Coronavirus 2: A United Kingdom Perspective.
|
NA
|
NA
|
|
A snapshot of the Covid-19 pandemic among pregnant women in France.
|
NA
|
NA
|
|
Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.
|
NA
|
NA
|
|
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
|
NA
|
NA
|
|
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
|
NA
|
NA
|
|
Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
|
NA
|
NA
|
|
National Clinical Guidance for the Management of Cardiovascular Intervention in the COVID-19 Pandemic: From Bangladesh Society of Cardiovascular Interventions (BSCI).
|
NA
|
NA
|
|
Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.
|
NA
|
NA
|
|
Thoracic computerised tomography scans in one hundred eighteen orthopaedic patients during the COVID-19 pandemic: identification of chest lesions; added values; help in managing patients; burden on the computerised tomography scan department.
|
NA
|
NA
|
|
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China.
|
NA
|
NA
|
|
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
|
NA
|
NA
|
|
Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection.
|
NA
|
NA
|
|
Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male: A retrospective study of 18 cases.
|
NA
|
NA
|
|
Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients.
|
NA
|
NA
|
|
Interpretation of the Traditional Chinese Medicine portion of the diagnosis and treatment protocol for corona virus disease 2019 (Trial Version 7).
|
NA
|
NA
|
|
Not Only Virus Spread: The Diffusion of Ageism during the Outbreak of COVID-19.
|
NA
|
NA
|
|
Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.
|
NA
|
NA
|
|
[COVID-19: Pathogenesis of a multi-faceted disease].
|
NA
|
NA
|
|
Covid-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic.
|
NA
|
NA
|
|
Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.
|
NA
|
NA
|
|
[Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic].
|
NA
|
NA
|
|
[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].
|
NA
|
NA
|
|
Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.
|
NA
|
NA
|
|
A Global Survey on the Impact of COVID-19 on Urological Services.
|
NA
|
NA
|
|
Clinical Trials and Tribulations in the COVID-19 Era.
|
NA
|
NA
|
|
Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability.
|
NA
|
NA
|
|
Acute lung injury in patients with COVID-19 infection.
|
NA
|
NA
|
|
Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.
|
NA
|
NA
|
|
COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.
|
NA
|
NA
|
|
The Role of Palliative Care in Caring for the Families of Patients With COVID-19.
|
NA
|
NA
|
|
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review.
|
NA
|
NA
|
|
Patients with cancer in the COVID-19 era: the clinical trial issue.
|
NA
|
NA
|
|
COVID-19 and androgen targeted therapy for prostate cancer patients.
|
NA
|
NA
|
|
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
|
NA
|
NA
|
|
COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment (Review).
|
NA
|
NA
|
|
Clinical interventions for severe and critical COVID-19: what are the options.
|
NA
|
NA
|
|
Global COVID-19: Warnings and suggestions based on experience of China.
|
NA
|
NA
|
|
Should patients stop their radiotherapy or chemotherapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
Suggestions for Radiation Oncologists during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Self-management strategies to consider to combat endometriosis symptoms during the COVID-19 pandemic.
|
NA
|
NA
|
|
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.
|
NA
|
NA
|
|
Valve-in-valve transcatheter aortic valve replacement in a young patient with a suspected COVID-19 infection: a surgical dilemma in the era of the COVID-19 pandemic.
|
NA
|
NA
|
|
A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.
|
NA
|
NA
|
|
Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions.
|
NA
|
NA
|
|
A Global lmmunological Observatory to meet a time of pandemics.
|
NA
|
NA
|
|
Diagnostic methods and potential portable biosensors for coronavirus disease 2019.
|
NA
|
NA
|
|
Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Azithromycin and COVID-19Prompt Early Use at First Signs of this Infection in Adults and Children An Approach Worthy of Consideration.
|
NA
|
NA
|
|
COVID-19: test, trace and isolate-new epidemiological data.
|
NA
|
NA
|
|
COVID-19 in lung transplant recipients: A case series from Milan, Italy.
|
NA
|
NA
|
|
The Application Of Plasmapheresis For Covid-19 Patients.
|
NA
|
NA
|
|
Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?
|
NA
|
NA
|
|
COVID-19 and Inequities in Oral Health Care for Older People: An Opportunity for Emerging Paradigms.
|
NA
|
NA
|
|
Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force.
|
NA
|
NA
|
|
Distribution of Patients at Risk for Complications Related to COVID-19 in the United States: Model Development Study.
|
NA
|
NA
|
|
COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.
|
NA
|
NA
|
|
Recommendations to Leverage the Palliative Nursing Role During COVID-19 and Future Public Health Crises.
|
NA
|
NA
|
|
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.
|
NA
|
NA
|
|
COVID-19: from epidemiology to treatment.
|
NA
|
NA
|
|
Approaching COVID-19 - bedside strategies for intensive care.
|
NA
|
NA
|
|
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19.
|
NA
|
NA
|
|
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
|
NA
|
NA
|
|
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
|
NA
|
NA
|
|
Ensuring safety and sustainability of radiotherapy services during the COVID-19 pandemic in resources constrain country: An Indonesian experience.
|
NA
|
NA
|
|
Corona virus versus existence of human on the earth: A computational and biophysical approach.
|
NA
|
NA
|
|
Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.
|
NA
|
NA
|
|
Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review.
|
NA
|
NA
|
|
Neutralizing antibodies mediate virus-immune pathology of COVID-19.
|
NA
|
NA
|
|
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.
|
NA
|
NA
|
|
Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy.
|
NA
|
NA
|
|
Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations.
|
NA
|
NA
|
|
Potential role of zinc supplementation in prophylaxis and treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
|
NA
|
NA
|
|
High flow nasal cannula oxygen therapy in adults with COVID-19 respiratory failure. A case report.
|
NA
|
NA
|
|
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement.
|
NA
|
NA
|
|
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
|
NA
|
NA
|
|
A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
|
NA
|
NA
|
|
Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model.
|
NA
|
NA
|
|
Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.
|
NA
|
NA
|
|
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.
|
NA
|
NA
|
|
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
|
NA
|
NA
|
|
Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey.
|
NA
|
NA
|
|
‘Do not resuscitate me in Barbados’.
|
NA
|
NA
|
|
Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together.
|
NA
|
NA
|
|
What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?
|
NA
|
NA
|
|
Early Insights into Immune Responses during COVID-19.
|
NA
|
NA
|
|
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
|
NA
|
NA
|
|
COVID-19 infection: the China and Italy perspectives.
|
NA
|
NA
|
|
Brain oxytocin: how puzzle stones from animal studies translate into psychiatry.
|
NA
|
NA
|
|
An overview on COVID-19: reality and expectation.
|
NA
|
NA
|
|
The COVID-19 response must integrate people living with HIV needs in Sub-Saharan Africa: the case of Mali.
|
NA
|
NA
|
|
Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
|
NA
|
NA
|
|
COVID-US: A simplified approach to cardiopulmonary ultrasound in suspected and confirmed COVID-19 patients in surge crisis.
|
NA
|
NA
|
|
High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series.
|
NA
|
NA
|
|
A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.
|
NA
|
NA
|
|
Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Meeting the challenges imposed by COVID-19: Guidance document by the ESTRO Radiation TherapisT Committee (RTTC).
|
NA
|
NA
|
|
Oncocardiology: new challenges, new opportunities.
|
NA
|
NA
|
|
Managing ICU surge during the COVID-19 crisis: rapid guidelines.
|
NA
|
NA
|
|
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience.
|
NA
|
NA
|
|
Need for ensuring care for neuro-emergencies-lessons learned from the COVID-19 pandemic.
|
NA
|
NA
|
|
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress.
|
NA
|
NA
|
|
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases.
|
NA
|
NA
|
|
[Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
|
NA
|
NA
|
|
Renin-angiotensin system inhibition in COVID-19 patients.
|
NA
|
NA
|
|
Severity and risk of COVID-19 in cancer patients: An evidence based learning.
|
NA
|
NA
|
|
COVID-19 related collapse of transplantation systems: a heterogeneous recovery?
|
NA
|
NA
|
|
Caring for the carers: Advice for dealing with sleep problems of hospital staff during the COVID-19 outbreak.
|
NA
|
NA
|
|
Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clonal haematopoiesis and COVID-19: A possible deadly liaison.
|
NA
|
NA
|
|
Guidance on Acute Management of Atrial Fibrillation in COVID-19.
|
NA
|
NA
|
|
[COVID-19 associated severe psychotic relapse].
|
NA
|
NA
|
|
Personal prophylaxis against COVID-19: A compilation of evidence based recommendations.
|
NA
|
NA
|
|
Resource husbandry in challenging times.
|
NA
|
NA
|
|
Endocrine vigilance in COVID-19.
|
NA
|
NA
|
|
Cardiovigilance in COVID 19.
|
NA
|
NA
|
|
Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus.
|
NA
|
NA
|
|
Glucovigilance in COVID-19.
|
NA
|
NA
|
|
COVID-19 in children: Epidemiology, presentation, diagnosis and management.
|
NA
|
NA
|
|
Challenges in providing oral and dental health services in COVID-19 pandemic.
|
NA
|
NA
|
|
Nutritional management and support in COVID-19: Emerging nutrivigilance.
|
NA
|
NA
|
|
Clinical nursing care guidance for management of patient with COVID-19.
|
NA
|
NA
|
|
Comprehensive overview of COVID-19 clinical trials.
|
NA
|
NA
|
|
Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.
|
NA
|
NA
|
|
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
|
NA
|
NA
|
|
Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.
|
NA
|
NA
|
|
[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].
|
NA
|
NA
|
|
[The Agreed Experts’ Position of the Eurasian Association of Therapists on Some new Mechanisms of COVID-19 Pathways: Focus on Hemostasis, Hemotransfusion Issues and Blood gas Exchange].
|
NA
|
NA
|
|
H2S as a potential defence against COVID-19?
|
NA
|
NA
|
|
Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.
|
NA
|
NA
|
|
The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései)
|
NA
|
NA
|
|
Colon cancer during the coronavirus pandemic – recovery from COVID-19 pneumonia of an elderly woman with multiple co-morbidities
|
NA
|
NA
|
|
COVID-19 epidemic in the Seine-Saint-Denis Department of Greater Paris: one month and three waves for a tsunami.
|
NA
|
NA
|
|
COVID-19 rehabilitation units are twice as expensive as regular rehabilitation units.
|
NA
|
NA
|
|
Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19.
|
NA
|
NA
|
|
COVID-19 and telemedicine in hemophilia in a patient with severe hemophilia A and orthopedic surgery.
|
NA
|
NA
|
|
Additive treatment considerations in COVID-19 - the clinician´s perspective on extracorporeal adjunctive purification techniques.
|
NA
|
NA
|
|
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
|
NA
|
NA
|
|
Emergent procedures for oropharyngeal bleeding during the COVID-19 pandemic: Protection of medical staff.
|
NA
|
NA
|
|
Cancer and COVID-19: Unmasking their ties.
|
NA
|
NA
|
|
The Crucial Role of Nurses and Social Workers in Initiating End-of-Life Communication to Reduce Overtreatment in the Midst of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.
|
NA
|
NA
|
|
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
|
NA
|
NA
|
|
Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.
|
NA
|
NA
|
|
Publication of COVID-19 case reports: are we hurrying?
|
NA
|
NA
|
|
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.
|
NA
|
NA
|
|
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
|
NA
|
NA
|
|
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
|
NA
|
NA
|
|
Misinformation about spinal manipulation and boosting immunity: an analysis of Twitter activity during the COVID-19 crisis.
|
NA
|
NA
|
|
Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
|
NA
|
NA
|
|
[Coronavirus: Predictive brain and terror management].
|
NA
|
NA
|
|
Severe and fatal forms of COVID-19 in children.
|
NA
|
NA
|
|
Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
|
NA
|
NA
|
|
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
|
NA
|
NA
|
|
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic.
|
NA
|
NA
|
|
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.
|
NA
|
NA
|
|
Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection.
|
NA
|
NA
|
|
A snapshot of the ongoing clinical research on COVID-19.
|
NA
|
NA
|
|
[The role of ophthalmology in the COVID-19 pandemic].
|
NA
|
NA
|
|
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
|
NA
|
NA
|
|
Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
|
NA
|
NA
|
|
The medico-legal implications in medical malpractice claims during Covid-19 pandemic: Increase or trend reversal?
|
NA
|
NA
|
|
Recommendations on trichological treatments during COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.
|
NA
|
NA
|
|
Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.
|
NA
|
NA
|
|
Hyperpyrexia in COVID-19 patients.
|
NA
|
NA
|
|
Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.
|
NA
|
NA
|
|
Covid-19: a survey on knowledge, awareness and hygiene practices among dental health professionals in an Indian scenario.
|
NA
|
NA
|
|
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
|
NA
|
NA
|
|
Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities.
|
NA
|
NA
|
|
COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.
|
NA
|
NA
|
|
Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system.
|
NA
|
NA
|
|
In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients.
|
NA
|
NA
|
|
Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
|
NA
|
NA
|
|
Knowledge of and attitudes toward COVID-19 among parents of child dental patients during the outbreak.
|
NA
|
NA
|
|
Oncology practice during COVID-19 pandemic: a fast response is the best response.
|
NA
|
NA
|
|
Epidemiology, diagnosis, treatment, and future perspectives concerning SARS-COV-2: a review article.
|
NA
|
NA
|
|
COVID-19 and pediatric inflammatory bowel disease: How to manage it?
|
NA
|
NA
|
|
Impact of COVID-19 on mental health in a Low and Middle-Income Country.
|
NA
|
NA
|
|
Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic.
|
NA
|
NA
|
|
Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma.
|
NA
|
NA
|
|
COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab.
|
NA
|
NA
|
|
Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19.
|
NA
|
NA
|
|
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care Policy.
|
NA
|
NA
|
|
Digital technology for management of severe mental disorders in low-income and middle-income countries.
|
NA
|
NA
|
|
Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances.
|
NA
|
NA
|
|
Clinical Analysis of 25 COVID-19 Infections in Children.
|
NA
|
NA
|
|
COVID-19 and Headache: A Primer for Trainees.
|
NA
|
NA
|
|
Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
|
NA
|
NA
|
|
Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?
|
NA
|
NA
|
|
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.
|
NA
|
NA
|
|
Managing common endocrine disorders amid COVID-19 pandemic.
|
NA
|
NA
|
|
[Expert consensus on Corona Virus Disease 2019 with special blood purification technology].
|
NA
|
NA
|
|
Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP).
|
NA
|
NA
|
|
[Experts consensus for the diagnosis, treatment, and prevention of Coronavirus disease 2019 in the elderly].
|
NA
|
NA
|
|
A Case Series of Patients Coinfected With Influenza and COVID-19.
|
NA
|
NA
|
|
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
|
NA
|
NA
|
|
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Risk management-based security evaluation model for telemedicine systems.
|
NA
|
NA
|
|
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
|
NA
|
NA
|
|
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
First reported case of unrepaired tetralogy of Fallot complicated with coronavirus disease-19 (COVID-19).
|
NA
|
NA
|
|
Safeguarding Non-COVID-19 Research: Looking Up from Ground Zero.
|
NA
|
NA
|
|
Special Ambulatory Gynecologic Considerations in the Era of COVID-19 and Implications for Future Practice.
|
NA
|
NA
|
|
Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
|
NA
|
NA
|
|
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
|
NA
|
NA
|
|
Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.
|
NA
|
NA
|
|
Widely available lysosome targeting agents should be considered as potential therapy for COVID-19.
|
NA
|
NA
|
|
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.
|
NA
|
NA
|
|
Pneumatosis intestinalis in COVID-19.
|
NA
|
NA
|
|
Consent in the time of COVID-19.
|
NA
|
NA
|
|
Relational ethical approaches to the COVID-19 pandemic.
|
NA
|
NA
|
|
ACE2 and COVID-19 and the resulting ARDS.
|
NA
|
NA
|
|
Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak.
|
NA
|
NA
|
|
Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
|
NA
|
NA
|
|
The SARS-CoV-2 (COVID-19) coronavirus pandemic: current situation and implications for Mexico.
|
NA
|
NA
|
|
Excerpts from the documents of Mexican positions and recommendations in cardiovascular diseases and COVID-19.
|
NA
|
NA
|
|
Coronavirus infection in patients with diabetes.
|
NA
|
NA
|
|
Lung ultrasound for the identification of COVID-19 pneumonia.
|
NA
|
NA
|
|
COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship.
|
NA
|
NA
|
|
Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
|
NA
|
NA
|
|
Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
|
NA
|
NA
|
|
Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic.
|
NA
|
NA
|
|
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic.
|
NA
|
NA
|
|
Misinformation about spinal manipulation and boosting immunity: an analysis of Twitter activity during the COVID-19 crisis.
|
NA
|
NA
|
|
Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China.
|
NA
|
NA
|
|
Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report.
|
NA
|
NA
|
|
COVID-19 and Pulmonary Embolism: Not a Coincidence.
|
NA
|
NA
|
|
Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.
|
NA
|
NA
|
|
Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?
|
NA
|
NA
|
|
Diaphragmatic Rupture and Gastric Perforation in a Patient with COVID-19 Pneumonia.
|
NA
|
NA
|
|
What patients “see” doctors in online fever clinics during COVID-19 in Wuhan?
|
NA
|
NA
|
|
Recommendations of protective measures for orthopedic surgeons during COVID-19 pandemic.
|
NA
|
NA
|
|
Assessing the spreading potential of an undetected case of COVID-19 in orthopaedic surgery.
|
NA
|
NA
|
|
Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID 19: a clue from innate immunity.
|
NA
|
NA
|
|
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
|
NA
|
NA
|
|
A complication of coronavirus disease 2019: delirium.
|
NA
|
NA
|
|
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
|
NA
|
NA
|
|
Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring.
|
NA
|
NA
|
|
Lithium as a candidate treatment for COVID-19: Promises and pitfalls.
|
NA
|
NA
|
|
Reactivation of COVID-19 - 14 days from the onset of symptoms may not be enough to allow dental treatment.
|
NA
|
NA
|
|
Registry of patients with congenital bleeding and COVID-19 in madrid.
|
NA
|
NA
|
|
CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
|
NA
|
NA
|
|
Focus on a 2019-novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Structural barriers to adhering to health behaviours in the context of the COVID-19 crisis: Considerations for low- and middle-income countries.
|
NA
|
NA
|
|
Could Water and Sanitation Shortfalls Exacerbate SARS-CoV-2 Transmission Risks?
|
NA
|
NA
|
|
Effective block by pirfenidone, an antifibrotic pyridone compound (5-methyl-1-phenylpyridin-2[H-1]-one), on hyperpolarization-activated cation current: An additional but distinctive target.
|
NA
|
NA
|
|
European Resuscitation Council COVID-19 guidelines executive summary.
|
NA
|
NA
|
|
Development of a Device to Reduce Oropharyngeal Aerosol Transmission.
|
NA
|
NA
|
|
Human Touch via Touchscreen: Rural nurses’ experiential perspectives on telehealth use in pediatric hospice care.
|
NA
|
NA
|
|
Prolonged grief related to COVID-19 deaths: Do we have to fear a steep rise in traumatic and disenfranchised griefs?
|
NA
|
NA
|
|
Mental health ramifications of the COVID-19 pandemic for Black Americans: Clinical and research recommendations.
|
NA
|
NA
|
|
Social and psychological consequences of the COVID-19 pandemic in African-American communities: Lessons from Michigan.
|
NA
|
NA
|
|
Psychological sequelae of social isolation and loneliness might be a larger problem in young adults than older adults.
|
NA
|
NA
|
|
Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient.
|
NA
|
NA
|
|
Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China.
|
NA
|
NA
|
|
COVID-19: A perspective on Africa’s capacity and response.
|
NA
|
NA
|
|
Staying Connected In The COVID-19 Pandemic: Telehealth At The Largest Safety-Net System In The United States.
|
NA
|
NA
|
|
Webside Manner during the COVID-19 Pandemic: Maintaining Human Connection during Virtual Visits.
|
NA
|
NA
|
|
A Report of the Telepsychiatric Evaluation of SARS-CoV-2 Patients.
|
NA
|
NA
|
|
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
|
NA
|
NA
|
|
Short epidemiological overview of the current situation on COVID-19 pandemic in Southeast European (SEE) countries.
|
NA
|
NA
|
|
Different outcome of COVID-19 in members of a family.
|
NA
|
NA
|
|
Early safety indicators of COVID-19 convalescent plasma in 5,000 patients.
|
NA
|
NA
|
|
Approach to the Patient with Thyrotoxicosis Using Telemedicine.
|
NA
|
NA
|
|
Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
|
NA
|
NA
|
|
Harmless Effects of Sterilizing 222-nm far-UV Radiation on Mouse Skin and Eye Tissues.
|
NA
|
NA
|
|
Secondary HLH is uncommon in severe COVID-19.
|
NA
|
NA
|
|
Perspectives of patients with rheumatic diseases in the early phase of COVID-19.
|
NA
|
NA
|
|
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
|
NA
|
NA
|
|
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
|
NA
|
NA
|
|
Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
|
NA
|
NA
|
|
Cardiac injuries in coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Computational modelling of flavivirus dynamics: The ins and outs.
|
NA
|
NA
|
|
Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report of 3 cases.
|
NA
|
NA
|
|
Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
|
NA
|
NA
|
|
A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis.
|
NA
|
NA
|
|
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic.
|
NA
|
NA
|
|
Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
|
NA
|
NA
|
|
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
|
NA
|
NA
|
|
Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets.
|
NA
|
NA
|
|
Preparedness and Preventive Behaviors for a Pandemic Disaster Caused by COVID-19 in Serbia.
|
NA
|
NA
|
|
Large pulmonary cavity in COVID-19 cured patient case report.
|
NA
|
NA
|
|
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.
|
NA
|
NA
|
|
[Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].
|
NA
|
NA
|
|
[Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
|
NA
|
NA
|
|
[Analysis of gastrointestinal symptoms in 80 patients with coronavirus disease 2019].
|
NA
|
NA
|
|
[Clinical study of artesunate in the treatment of coronavirus disease 2019].
|
NA
|
NA
|
|
[Clinical analysis of 23 patients with coronavirus disease 2019 in Xinyang City of Henan Province].
|
NA
|
NA
|
|
[Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019].
|
NA
|
NA
|
|
[Effect of convalescent plasma and immunoglobulin on patients with severe acute respiratory syndrome: a systematic review].
|
NA
|
NA
|
|
Addressing Health Inequities Exacerbated by COVID-19 Among Youth With HIV: Expanding Our Toolkit.
|
NA
|
NA
|
|
Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of Literature on a Neglected Issue Revived in the COVID-19 Pandemic Era.
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
|
NA
|
NA
|
|
[The RAAS and SARS-CoV-2: A riddle to solve].
|
NA
|
NA
|
|
In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein.
|
NA
|
NA
|
|
Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy.
|
NA
|
NA
|
|
Integration of palliative care into COVID-19 pandemic planning.
|
NA
|
NA
|
|
Digital crowdsourcing: unleashing its power in rheumatology.
|
NA
|
NA
|
|
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
|
NA
|
NA
|
|
Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19.
|
NA
|
NA
|
|
SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.
|
NA
|
NA
|
|
Thromboembolic risks in patients with COVID-19: major concern to consider in our management.
|
NA
|
NA
|
|
COVID-19 pandemic: do we need systematic screening of patients with cardiovascular risk factors in Low and Middle-Income Countries (LMICs) for preventing death?
|
NA
|
NA
|
|
Early Trend of Imported COVID-19 Cases in South Korea.
|
NA
|
NA
|
|
Chemistry and Biology of SARS-CoV-2.
|
NA
|
NA
|
|
Breast cancer care during a pandemic: an opportune time for cryoablation?
|
NA
|
NA
|
|
Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
|
NA
|
NA
|
|
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
|
NA
|
NA
|
|
Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
|
NA
|
NA
|
|
Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
|
NA
|
NA
|
|
Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
|
NA
|
NA
|
|
Covid-19: A Comprehensive Review of a Formidable Foe and the Road Ahead.
|
NA
|
NA
|
|
Prevention and control strategies in the diagnosis and treatment of solid tumors in children during the COVID-19 pandemic.
|
NA
|
NA
|
|
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection.
|
NA
|
NA
|
|
Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy.
|
NA
|
NA
|
|
Prevention of pressure ulcers among individuals cared for in the prone position: lessons for the COVID-19 emergency.
|
NA
|
NA
|
|
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
|
NA
|
NA
|
|
Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia.
|
NA
|
NA
|
|
Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.
|
NA
|
NA
|
|
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA.
|
NA
|
NA
|
|
Association between renin-angiotensin system inhibitors and COVID-19 complications.
|
NA
|
NA
|
|
Remote Methods for Conducting Tobacco-Focused Clinical Trials.
|
NA
|
NA
|
|
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper.
|
NA
|
NA
|
|
A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19.
|
NA
|
NA
|
|
Bedside veno-venous ECMO cannulation: A pertinent strategy during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study.
|
NA
|
NA
|
|
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
|
NA
|
NA
|
|
Cytokine Storm Induced by SARS-CoV-2.
|
NA
|
NA
|
|
Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
|
NA
|
NA
|
|
Intra-abdominal hypertension as a trigger of “gut failure” in SARS-CoV-2 infection: Effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function.
|
NA
|
NA
|
|
Pediatric COVID-19: Systematic review of the literature.
|
NA
|
NA
|
|
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
|
NA
|
NA
|
|
Impact of disease on plasma and lung exposure of chloroquine, hydroxy-chloroquine and azithromycin: application of PBPK modelling.
|
NA
|
NA
|
|
A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients.
|
NA
|
NA
|
|
Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?
|
NA
|
NA
|
|
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
|
NA
|
NA
|
|
Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19.
|
NA
|
NA
|
|
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection.
|
NA
|
NA
|
|
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
|
NA
|
NA
|
|
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
|
NA
|
NA
|
|
A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities.
|
NA
|
NA
|
|
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.
|
NA
|
NA
|
|
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
|
NA
|
NA
|
|
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
|
NA
|
NA
|
|
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
|
NA
|
NA
|
|
Overview of lethal human coronaviruses.
|
NA
|
NA
|
|
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.
|
NA
|
NA
|
|
Scientific Collaboration During the COVID-19 Pandemic: N95DECON.org.
|
NA
|
NA
|
|
Acute kidney injury in critically ill patients with COVID-19.
|
NA
|
NA
|
|
Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.
|
NA
|
NA
|
|
Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP).
|
NA
|
NA
|
|
COVID-19 and the heart: An update for clinicians.
|
NA
|
NA
|
|
Pharmacy Department management and organization.
|
NA
|
NA
|
|
Pharmaceutical management of the COVID-19 pandemic in a mid-size hospital.
|
NA
|
NA
|
|
Hospital Pharmacy Service: Facing the logistics of medicines procurement.
|
NA
|
NA
|
|
Hospital pharmacist challenges in evaluation of scientific evidence and its incorporation to pharmacotherapeutic protocols through therapeutic committees in COVID-19 times.
|
NA
|
NA
|
|
Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services).
|
NA
|
NA
|
|
Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.
|
NA
|
NA
|
|
Hospital pharmacist experience in a multidisciplinary team in special care settings.
|
NA
|
NA
|
|
Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.
|
NA
|
NA
|
|
Specialized pharmaceutical care in social health centers in the times of COVID-19.
|
NA
|
NA
|
|
Hospital Pharmacy Compounding against COVID-19 pandemic.
|
NA
|
NA
|
|
The pharmacist facing the logistics of safely dispensing, storing and preserving drugs in healthcare units.
|
NA
|
NA
|
|
Ifema hospital model. Implementation and start-up of the Pharmacy Department.
|
NA
|
NA
|
|
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
|
NA
|
NA
|
|
Clinical research in hospital pharmacy during the fight against COVID-19.
|
NA
|
NA
|
|
Family-based treatment via videoconference: Clinical recommendations for treatment providers during COVID-19 and beyond.
|
NA
|
NA
|
|
Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.
|
NA
|
NA
|
|
The role of hysteroscopy during COVID-19 outbreak: Safeguarding lives and saving resources.
|
NA
|
NA
|
|
Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries.
|
NA
|
NA
|
|
SARS-CoV-2 in the semen: where does it come from?
|
NA
|
NA
|
|
One-step multiplex TaqMan probe-based method for real-time PCR detection of four canine diarrhea viruses.
|
NA
|
NA
|
|
Antiviral activity of the high-molecular-weight plant polysaccharides (Panavir®).
|
NA
|
NA
|
|
Urgent Peritoneal Dialysis in Patients With COVID-19 and Acute Kidney Injury: A Single-Center Experience in a Time of Crisis in the United States.
|
NA
|
NA
|
|
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
|
NA
|
NA
|
|
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A global pandemic and treatments strategies.
|
NA
|
NA
|
|
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
|
NA
|
NA
|
|
Monoclonal antibody as a potential anti-COVID-19.
|
NA
|
NA
|
|
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Diacerein: A potential multi-target therapeutic drug for COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma.
|
NA
|
NA
|
|
Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
|
NA
|
NA
|
|
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
|
NA
|
NA
|
|
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack.
|
NA
|
NA
|
|
Cancer patients affected by COVID-19: Experience from Milan, Lombardy.
|
NA
|
NA
|
|
Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding.
|
NA
|
NA
|
|
Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.
|
NA
|
NA
|
|
Laboratory diagnosis of SARS-CoV-2 - A review of current methods.
|
NA
|
NA
|
|
Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
|
NA
|
NA
|
|
Vitamin D Receptor stimulation to reduce Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
|
NA
|
NA
|
|
Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.
|
NA
|
NA
|
|
Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
|
NA
|
NA
|
|
Linking key intervention timings to rapid decline of the COVID-19 effective reproductive number to quantify lessons from mainland China.
|
NA
|
NA
|
|
Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.
|
NA
|
NA
|
|
COVID-19, interferons, and depression: A commentary.
|
NA
|
NA
|
|
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.
|
NA
|
NA
|
|
COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS.
|
NA
|
NA
|
|
Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?
|
NA
|
NA
|
|
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
|
NA
|
NA
|
|
Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection.
|
NA
|
NA
|
|
Incorporating Video Visits into Ophthalmology Practice: A Retrospective Analysis and Patient Survey to Assess Initial Experiences and Patient Acceptability at an Academic Eye Center.
|
NA
|
NA
|
|
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change.
|
NA
|
NA
|
|
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).
|
NA
|
NA
|
|
Bloodstream infections in critically ill patients with COVID-19.
|
NA
|
NA
|
|
Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom.
|
NA
|
NA
|
|
A compendium answering 150 questions on COVID-19 and SARS-CoV-2.
|
NA
|
NA
|
|
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
|
NA
|
NA
|
|
Ten challenging questions about SARS-CoV-2 and COVID-19.
|
NA
|
NA
|
|
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
|
NA
|
NA
|
|
Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations.
|
NA
|
NA
|
|
COVID-19 in a young man with hypertension: A case study of missed opportunities in intensive progression.
|
NA
|
NA
|
|
IL-15 immunotherapy is a viable strategy for COVID-19.
|
NA
|
NA
|
|
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19.
|
NA
|
NA
|
|
Uric Acid Elevation by Favipiravir, an Antiviral Drug.
|
NA
|
NA
|
|
Interventions as experiments: Connecting the dots in forecasting and overcoming pandemics, global warming, corruption, civil rights violations, misogyny, income inequality, and guns.
|
NA
|
NA
|
|
Application of deep learning for fast detection of COVID-19 in X-Rays using nCOVnet.
|
NA
|
NA
|
|
Coronavirus pandemic: A predictive analysis of the peak outbreak epidemic in South Africa, Turkey, and Brazil.
|
NA
|
NA
|
|
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking.
|
NA
|
NA
|
|
[Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik’s Cube solver.
|
NA
|
NA
|
|
Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al.
|
NA
|
NA
|
|
Ethics for surgeons during the COVID-19 pandemic, review article.
|
NA
|
NA
|
|
SARS-COV-2 Presenting as New Onset Atrial Fibrillation: A Case Report.
|
NA
|
NA
|
|
EML webinar overview: Simulation-assisted discovery of membrane targeting nanomedicine.
|
NA
|
NA
|
|
Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach.
|
NA
|
NA
|
|
A home hospitalization system based on the Internet of things, Fog computing and cloud computing.
|
NA
|
NA
|
|
EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report.
|
NA
|
NA
|
|
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.
|
NA
|
NA
|
|
Genitourinary cancer management during a severe pandemic: Utility of rapid communication tools and evidence-based guidelines.
|
NA
|
NA
|
|
Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection.
|
NA
|
NA
|
|
Impact of COVID-19 on thyroid cancer surgery and adjunct therapy.
|
NA
|
NA
|
|
PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19.
|
NA
|
NA
|
|
YouTube as a source of patient information for Coronavirus Disease (COVID-19): A content-quality and audience engagement analysis.
|
NA
|
NA
|
|
Social Distancing and Transmission-reducing Practices during the 2019 Coronavirus Disease and 2015 Middle East Respiratory Syndrome Coronavirus Outbreaks in Korea.
|
NA
|
NA
|
|
Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea.
|
NA
|
NA
|
|
A Pathophysiological Perspective on COVID-19’s Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.
|
NA
|
NA
|
|
Age Related Morbidity and Mortality among Patients with COVID-19.
|
NA
|
NA
|
|
[Analysis on the theory and clinical ideas of acupuncture and moxibustion for the prevention and treatment of coronavirus disease 2019].
|
NA
|
NA
|
|
[Clinical observation of heat-sensitive moxibustion treatment for coronavirus disease 2019].
|
NA
|
NA
|
|
COVID-19 in Turkey: Lessons Learned.
|
NA
|
NA
|
|
Possible therapeutic agents for COVID-19: a comprehensive review.
|
NA
|
NA
|
|
Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies.
|
NA
|
NA
|
|
Acute Respiratory Distress Syndrome: Diagnosis and Management.
|
NA
|
NA
|
|
Management of Fever in Infants and Young Children.
|
NA
|
NA
|
|
Leveraging parent-child interaction therapy and telehealth capacities to address the unique needs of young children during the COVID-19 public health crisis.
|
NA
|
NA
|
|
Moral medical decision-making: Colliding sacred values in response to COVID-19 pandemic.
|
NA
|
NA
|
|
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations.
|
NA
|
NA
|
|
[Implementation of Remote Clinics in urology practice during the COVID-19 era: What have we learned?]
|
NA
|
NA
|
|
[Emergency surgery during COVID-19 pandemia.]
|
NA
|
NA
|
|
Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice.
|
NA
|
NA
|
|
[Prostate cancer and COVID-19 pandemia: Current recommendations.]
|
NA
|
NA
|
|
[Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.]
|
NA
|
NA
|
|
[Current status for urpper tract transitional cell carcinoma during COVID-19 pandemia.]
|
NA
|
NA
|
|
[De-escalation: Testicular cancer.]
|
NA
|
NA
|
|
[Benign prostatic hyperplasia management during COVID-19 pandemia.]
|
NA
|
NA
|
|
[Reconstructive surgery protocol recommendations during COVID-19 pandemia.]
|
NA
|
NA
|
|
[Functional urology during COVID-19: Recommendations during de-escalation.]
|
NA
|
NA
|
|
[Management of neurourological patients during the COVID-19 pandemic.]
|
NA
|
NA
|
|
[Strategies and recommendations for urolithiasis treatment and follow-up in COVID-19 pandemia.]
|
NA
|
NA
|
|
[Scholia about the pandemia urbi et orbi et orbe generate by de COVID-19 disease.]
|
NA
|
NA
|
|
Herd immunity or suppression strategy to combat COVID-19.
|
NA
|
NA
|
|
Care, Convenience, Comfort, Confidentiality, and Contagion: The 5 C’s that Will Shape the Future of Telemedicine.
|
NA
|
NA
|
|
Recommendations for the management of critically ill adult patients with COVID-19.
|
NA
|
NA
|
|
[Recommendations for treatment of severe coronavirus disease 2019 based on critical care ultrasound].
|
NA
|
NA
|
|
Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.
|
NA
|
NA
|
|
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
|
NA
|
NA
|
|
Widespread severe acute respiratory coronavirus virus 2 (SARS-CoV-2) laboratory surveillance program to minimize asymptomatic transmission in high-risk inpatient and congregate living settings.
|
NA
|
NA
|
|
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
|
NA
|
NA
|
|
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
|
NA
|
NA
|
|
Recommendations on diagnosis and treatment in hepatobiliary surgery under 2019-nCoV epidemic.
|
NA
|
NA
|
|
Perioperative management strategy of severe traumatic brain injury during the outbreak of COVID-19.
|
NA
|
NA
|
|
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
|
NA
|
NA
|
|
Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing, China.
|
NA
|
NA
|
|
Management of Female and Functional Urology Patients During the COVID Pandemic.
|
NA
|
NA
|
|
COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
|
NA
|
NA
|
|
Anti-SARS-CoV-2 hyperimmune plasma workflow.
|
NA
|
NA
|
|
A review of potential treatments to date in COVID-19 patients according to the stage of the disease.
|
NA
|
NA
|
|
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
|
NA
|
NA
|
|
Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein.
|
NA
|
NA
|
|
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
|
NA
|
NA
|
|
Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with 18F-Fluorocholine PET/CT?
|
NA
|
NA
|
|
Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies.
|
NA
|
NA
|
|
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
|
NA
|
NA
|
|
The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
|
NA
|
NA
|
|
Emergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
At the epicenter of the American Coronavirus outbreak - New York inner city hospital COVID-19 experience and current data: a retrospective analysis.
|
NA
|
NA
|
|
Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.
|
NA
|
NA
|
|
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication.
|
NA
|
NA
|
|
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
|
NA
|
NA
|
|
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
|
NA
|
NA
|
|
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.
|
NA
|
NA
|
|
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.
|
NA
|
NA
|
|
Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology
|
NA
|
NA
|
|
PM&R and Pulmonary Rehabilitation for COVID-19.
|
NA
|
NA
|
|
Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report.
|
NA
|
NA
|
|
The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and meta-analysis.
|
NA
|
NA
|
|
Assessment of Chinese medicine for coronavirus-related pneumonia: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
International comparison of guidelines for managing neonates at the early phase of the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
|
NA
|
NA
|
|
[Infection prevention and control of bedside blood purification treatment in patients with COVID-19].
|
NA
|
NA
|
|
Management of clozapine treatment during the COVID-19 pandemic.
|
NA
|
NA
|
|
A Rare Presentation of Coronavirus Disease 2019 (COVID-19) Induced Viral Myositis With Subsequent Rhabdomyolysis.
|
NA
|
NA
|
|
Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials.
|
NA
|
NA
|
|
Extrapulmonary Gastrointestinal Presentation of Coronavirus (COVID-19): A Case Report and Review of Literature.
|
NA
|
NA
|
|
Challenges faced by mental health providers and patients during the coronavirus 2019 pandemic due to technological barriers.
|
NA
|
NA
|
|
The application of DNA nucleotide footprint plotting in coronavirus.
|
NA
|
NA
|
|
The contact activation system as a potential therapeutic target in patients with COVID-19.
|
NA
|
NA
|
|
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
|
NA
|
NA
|
|
Addressing inequities in COVID-19 morbidity and mortality: research and policy recommendations.
|
NA
|
NA
|
|
Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.
|
NA
|
NA
|
|
Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.
|
NA
|
NA
|
|
High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission.
|
NA
|
NA
|
|
Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic.
|
NA
|
NA
|
|
[COVID-19 Concerns and Worries in Patients with Mental Illness].
|
NA
|
NA
|
|
Epidemiological features and viral shedding in children with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID-19.
|
NA
|
NA
|
|
COVID-19 heath crisis: less colorectal resections and yet no more peritonitis or bowel obstruction as a collateral effect?
|
NA
|
NA
|
|
Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities.
|
NA
|
NA
|
|
Varying presentations of COVID-19 in young heart transplant recipients: A case series.
|
NA
|
NA
|
|
Treatment of Covid19 - Repurposing drugs commonly used in dermatology.
|
NA
|
NA
|
|
The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study.
|
NA
|
NA
|
|
Infection Risk Assessment of COVID-19 through Aerosol Transmission: a Case Study of South China Seafood Market.
|
NA
|
NA
|
|
Repositioning of 8565 Existing Drugs for COVID-19.
|
NA
|
NA
|
|
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
|
NA
|
NA
|
|
COVID-19 in the Cancer Patient.
|
NA
|
NA
|
|
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study.
|
NA
|
NA
|
|
Ethical allocation of scarce health care resources in the context of the COVID-19 crisis.
|
NA
|
NA
|
|
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
|
NA
|
NA
|
|
COVID-19 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
|
NA
|
NA
|
|
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
|
NA
|
NA
|
|
Antiretroviral HIV drugs in COVID-19 research: promises and risks. An opinion piece.
|
NA
|
NA
|
|
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold.
|
NA
|
NA
|
|
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities.
|
NA
|
NA
|
|
The role of extracellular vesicles in COVID-19 virus infection.
|
NA
|
NA
|
|
Proactive Identification of Palliative Care Needs Among Patients with COVID-19 in the ICU.
|
NA
|
NA
|
|
The Creation of a Psychiatry-Palliative Care Liaison Team: Utilizing Psychiatrists to Extend Palliative Care Delivery and Access during the COVID-19 Crisis.
|
NA
|
NA
|
|
Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?
|
NA
|
NA
|
|
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
|
NA
|
NA
|
|
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial.
|
NA
|
NA
|
|
COVID-19: impact on and recommendations for breast cancer care: the Singapore experience.
|
NA
|
NA
|
|
Proper Management of People with Obesity during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Antimicrobial Photodynamic Therapy in the Control of COVID-19.
|
NA
|
NA
|
|
Group Testing-Based Robust Algorithm for Diagnosis of COVID-19.
|
NA
|
NA
|
|
Fear of COVID-19 Scale-Associations of Its Scores with Health Literacy and Health-Related Behaviors among Medical Students.
|
NA
|
NA
|
|
Potential of Flavonoid-Inspired Phytomedicines against COVID-19.
|
NA
|
NA
|
|
The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020.
|
NA
|
NA
|
|
Recommendations for Dental Care during COVID-19 Pandemic.
|
NA
|
NA
|
|
Nutritional Support in Coronavirus 2019 Disease.
|
NA
|
NA
|
|
Examining Social Determinants of Health, Stigma, and COVID-19 Disparities.
|
NA
|
NA
|
|
Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.
|
NA
|
NA
|
|
Potential Antiviral Options against SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic.
|
NA
|
NA
|
|
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
|
NA
|
NA
|
|
The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
|
NA
|
NA
|
|
Healthcare delivery in India amid the Covid-19 pandemic: Challenges and opportunities.
|
NA
|
NA
|
|
AYUSH, modern medicine and the Covid-19 pandemic.
|
NA
|
NA
|
|
COVID-19 presenting as severe, persistent abdominal pain and causing late respiratory compromise in a 33-year-old man.
|
NA
|
NA
|
|
Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
|
NA
|
NA
|
|
Large-scale public venues as medical emergency sites in disasters: lessons from COVID-19 and the use of Fangcang shelter hospitals in Wuhan, China.
|
NA
|
NA
|
|
Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study.
|
NA
|
NA
|
|
COVID-19 and neurointerventional service worldwide: a survey of the European Society of Minimally Invasive Neurological Therapy (ESMINT), the Society of NeuroInterventional Surgery (SNIS), the Sociedad Iberolatinoamericana de Neuroradiologia Diagnostica y Terapeutica (SILAN), the Society of Vascular and Interventional Neurology (SVIN), and the World Federation of Interventional and Therapeutic Neuroradiology (WFITN).
|
NA
|
NA
|
|
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
|
NA
|
NA
|
|
Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR.
|
NA
|
NA
|
|
International Public Health Responses to COVID-19 Outbreak: A Rapid Review.
|
NA
|
NA
|
|
Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism.
|
NA
|
NA
|
|
Effect of COVID-19 Epidemic on Delay of Diagnosis and Treatment Path for Patients with Nasopharyngeal Carcinoma.
|
NA
|
NA
|
|
The journey of remdesivir: from Ebola to COVID-19.
|
NA
|
NA
|
|
COVID-19 and community pharmacy services in Pakistan: challenges, barriers and solution for progress.
|
NA
|
NA
|
|
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Clinical characteristics, diagnosis, and treatment of COVID-19: A case report.
|
NA
|
NA
|
|
Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents.
|
NA
|
NA
|
|
Guidelines on the Prevention and Control of Disease in Dental Practice during the Coronavirus Outbreak.
|
NA
|
NA
|
|
Expert Recommendations for Prevention, Treatment and Care of Oral Ulcers and Other Mucosal Diseases during the Coronavirus Outbreak.
|
NA
|
NA
|
|
Preventive and Control Measures for the Coronavirus Pandemic in Clinical Dentistry.
|
NA
|
NA
|
|
Negative nasopharyngeal swabs early in the course of COVID-19.
|
NA
|
NA
|
|
Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols.
|
NA
|
NA
|
|
Bladder Cancer at the time of COVID-19 Outbreak.
|
NA
|
NA
|
|
Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Laparoscopic and Robotic Urology Surgery during Global Pandemic COVID19.
|
NA
|
NA
|
|
Summary and considerations in genitourinary cancer patient care during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
|
NA
|
NA
|
|
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation.
|
NA
|
NA
|
|
Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges.
|
NA
|
NA
|
|
Reorganization Tips from a Sarcoma Unit at Time of the COVID-19 Pandemic in Italy: Early Experience from a Regional Referral Oncologic Center.
|
NA
|
NA
|
|
The thromboembolism in COVID-19: the unsolved problem.
|
NA
|
NA
|
|
Early outcomes after hip fracture surgery in COVID-19 patients in New York City.
|
NA
|
NA
|
|
Save the ICU and save lives during the COVID-19 pandemic.
|
NA
|
NA
|
|
A Case Report of Suicide Attempt Caused by Acute and Transient Psychotic Disorder during the COVID-19 Outbreak.
|
NA
|
NA
|
|
Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
|
NA
|
NA
|
|
Effectiveness of Computed Tomography in the Diagnosis of Novel Coronavirus-2019.
|
NA
|
NA
|
|
Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic.
|
NA
|
NA
|
|
Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy.
|
NA
|
NA
|
|
Heated Air Delivery by Micro-Sauna: An Experimental Treatment Prototype Concept for Coronavirus Disease 2019.
|
NA
|
NA
|
|
Bradycardia in Patients With COVID-19: A Calm Before the Storm?
|
NA
|
NA
|
|
Management of the first severe case of COVID-19 in the small islands of Maldives.
|
NA
|
NA
|
|
CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 pandemic: Emerging perspectives and future trends.
|
NA
|
NA
|
|
Innovative use of artificial intelligence and digital communication in acute stroke pathway in response to COVID-19.
|
NA
|
NA
|
|
Management of COVID-19-Positive Pediatric Patients Undergoing Minimally Invasive Surgical Procedures: Systematic Review and Recommendations of the Board of European Society of Pediatric Endoscopic Surgeons.
|
NA
|
NA
|
|
Endourology and Benign Prostatic Hyperplasia in COVID-19 Pandemic.
|
NA
|
NA
|
|
Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
|
NA
|
NA
|
|
Social media influence in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Subtotal laparoscopic cholecystectomy for gangrenous gallbladder during recovery from COVID-19 pneumonia.
|
NA
|
NA
|
|
Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?
|
NA
|
NA
|
|
Discovery of Aptamers Targeting Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.
|
NA
|
NA
|
|
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.
|
NA
|
NA
|
|
COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine.
|
NA
|
NA
|
|
Commentary on the coronavirus pandemic: Nigeria.
|
NA
|
NA
|
|
Living with PTSD amid a global pandemic.
|
NA
|
NA
|
|
A model for treating COVID-19-related guilt, shame, and moral injury.
|
NA
|
NA
|
|
I may never see the ocean again: Loss and grief among older adults during the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.
|
NA
|
NA
|
|
Coagulation dysfunction: A hallmark in COVID-19.
|
NA
|
NA
|
|
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
|
NA
|
NA
|
|
From “Infodemics” to Health Promotion: A Novel Framework for the Role of Social Media in Public Health.
|
NA
|
NA
|
|
Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.
|
NA
|
NA
|
|
Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients.
|
NA
|
NA
|
|
Cardiac Rehabilitation During COVID-19 Pandemic: Highlighting the Value of Home-Based Programs.
|
NA
|
NA
|
|
Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study.
|
NA
|
NA
|
|
Fostering Existential Maturity to Manage Terror in a Pandemic.
|
NA
|
NA
|
|
Identification of a novel dual-target scaffold for 3CLpro and RdRp proteins of SARS-CoV-2 using 3D-similarity search, molecular docking, molecular dynamics and ADMET evaluation.
|
NA
|
NA
|
|
Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing.
|
NA
|
NA
|
|
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
|
NA
|
NA
|
|
COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.
|
NA
|
NA
|
|
Development of pediatric surgical decision-making guidelines for COVID-19 in a New York City children’s hospital.
|
NA
|
NA
|
|
Transplant Patients’ Isolation and Social Distancing Because of COVID-19: Analysis of the Resilient Capacities of the Transplant in the Management of the Coronavirus Emergency.
|
NA
|
NA
|
|
COVID-19: how to transform a noninvasive ventilation device in a critical care ventilator.
|
NA
|
NA
|
|
Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes.
|
NA
|
NA
|
|
The diagnostic value of detecting sudden smell loss among asymptomatic COVID-19 patients in early stage: The possible early sign of COVID-19.
|
NA
|
NA
|
|
COVID-19 and Liver.
|
NA
|
NA
|
|
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine.
|
NA
|
NA
|
|
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection: A Multi-institutional Study from New York City.
|
NA
|
NA
|
|
Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection.
|
NA
|
NA
|
|
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug.
|
NA
|
NA
|
|
Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections.
|
NA
|
NA
|
|
Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19.
|
NA
|
NA
|
|
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab.
|
NA
|
NA
|
|
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak.
|
NA
|
NA
|
|
Effectiveness of an Eight-Week Web-Based Mindfulness Virtual Community Intervention for University Students on Symptoms of Stress, Anxiety, and Depression: A Randomized Controlled Trial.
|
NA
|
NA
|
|
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management.
|
NA
|
NA
|
|
Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
|
NA
|
NA
|
|
Gastrointestinal manifestations of COVID-19.
|
NA
|
NA
|
|
Endocrinology in the time of COVID-19: Management of neuroendocrine neoplasms (NENs).
|
NA
|
NA
|
|
Treatment strategies of hospitalized patients with coronavirus disease-19.
|
NA
|
NA
|
|
Low dose lung radiation therapy for pneumonia: an examination of historical dose distributions.
|
NA
|
NA
|
|
Can mesenchymal stem cell therapy be the interim management of COVID-19?
|
NA
|
NA
|
|
Modified Anesthesia Protocol for Electroconvulsive Therapy Permits Reduction in Aerosol-Generating Bag-Mask Ventilation during the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Novel Machine Learning-derived Radiomic Signature of the Whole Lung Differentiates Stable From Progressive COVID-19 Infection: A Retrospective Cohort Study.
|
NA
|
NA
|
|
A preliminary experience with a new intramedullary nail for trochanteric fractures.
|
NA
|
NA
|
|
Overview of therapeutic drug research for COVID-19 in China.
|
NA
|
NA
|
|
Pandemic Paradox.
|
NA
|
NA
|
|
[Antithrombotic treatments in patients with SARS-CoV-2 infection: from current evidence to reasonable recommendations - A position paper from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology].
|
NA
|
NA
|
|
[Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience].
|
NA
|
NA
|
|
Involuntary ambulatory triage during the COVID-19 pandemic - A neurosurgical perspective.
|
NA
|
NA
|
|
Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Fighting COVID-19.
|
NA
|
NA
|
|
COVID-19: therapeutic approaches description and discussion.
|
NA
|
NA
|
|
Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital.
|
NA
|
NA
|
|
Diabetic Ketoacidosis in COVID-19: unique concerns and considerations.
|
NA
|
NA
|
|
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19.
|
NA
|
NA
|
|
Identification and validation of a novel clinical signature to predict the prognosis in confirmed COVID-19 patients.
|
NA
|
NA
|
|
Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19.
|
NA
|
NA
|
|
Can the Elastic of Surgical Face Masks Stimulate Ear Protrusion in Children?
|
NA
|
NA
|
|
Clinical course of a critically ill patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.
|
NA
|
NA
|
|
Antithrombotic Therapies in COVID-19 Disease: a Systematic Review.
|
NA
|
NA
|
|
Severe COVID-19 and aging: are monocytes the key?
|
NA
|
NA
|
|
A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.
|
NA
|
NA
|
|
Assessment of paediatric dental guidelines and caries management alternatives in the post COVID-19 period. A critical review and clinical recommendations.
|
NA
|
NA
|
|
The first case of COVID-19 pneumonia in a hemodialysis patient in Japan.
|
NA
|
NA
|
|
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.
|
NA
|
NA
|
|
Possible role of vitamin D in Covid-19 infection in pediatric population.
|
NA
|
NA
|
|
COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.
|
NA
|
NA
|
|
Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report.
|
NA
|
NA
|
|
Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences.
|
NA
|
NA
|
|
Caring for Frail Older Adults During COVID-19: integrating public health ethics into clinical practice.
|
NA
|
NA
|
|
A Comprehensive Review on Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Harnessing resolving-based therapeutics to treat pulmonary viral infections: What can the future offer to COVID-19?
|
NA
|
NA
|
|
Education and scientific dissemination during the COVID-19 pandemic.
|
NA
|
NA
|
|
Increased vulnerability of clinical research units during the COVID-19 crisis and their protection.
|
NA
|
NA
|
|
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature.
|
NA
|
NA
|
|
Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances.
|
NA
|
NA
|
|
Novel Coronavirus Infection (COVID-19) in Children Younger Than One Year: A Systematic Review of Symptoms, Management and Outcomes.
|
NA
|
NA
|
|
An adaptive model of health system organization and responses helped Vietnam to successfully halt the Covid-19 pandemic: What lessons can be learned from a resource-constrained country.
|
NA
|
NA
|
|
Impact of COVID-19 on cardiac surgical training: Our experience in the United Kingdom.
|
NA
|
NA
|
|
Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
|
NA
|
NA
|
|
‘’Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece’’.
|
NA
|
NA
|
|
A simple tool to a complex reality - WhatsApp use in a developing country during COVID-19 pandemic.
|
NA
|
NA
|
|
Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.
|
NA
|
NA
|
|
Patients with specific skin disorders who are affected by COVID-19: what do experiences say about management strategies? : A systematic review.
|
NA
|
NA
|
|
Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbind® Affinity blood filter - approved for the treatment of COVID-19 patients.
|
NA
|
NA
|
|
Dissecting the Interaction between Coronavirus Disease 2019 and Diabetes Mellitus.
|
NA
|
NA
|
|
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.
|
NA
|
NA
|
|
Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond.
|
NA
|
NA
|
|
COVID-19 and the liver: overview.
|
NA
|
NA
|
|
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
|
NA
|
NA
|
|
Personalized recovery of severe COVID19: Rehabilitation from the perspective of patient needs.
|
NA
|
NA
|
|
A case series of COVID-19 patients with chronic hepatitis B virus infection.
|
NA
|
NA
|
|
Developing a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein Model in a Viral Membrane.
|
NA
|
NA
|
|
The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States.
|
NA
|
NA
|
|
Haematological Cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.
|
NA
|
NA
|
|
A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation.
|
NA
|
NA
|
|
Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy.
|
NA
|
NA
|
|
The Battle against COVID 19 Pandemic: What we Need to Know Before we “Test Fire” Ivermectin.
|
NA
|
NA
|
|
Model informed dosing of Hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and Gaps.
|
NA
|
NA
|
|
Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.
|
NA
|
NA
|
|
Available Technologies, Applications and Benefits of Teleorthodontics. A Literature Review and Possible Applications during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Vaccines against Coronaviruses: The State of the Art.
|
NA
|
NA
|
|
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
|
NA
|
NA
|
|
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.
|
NA
|
NA
|
|
“War to the knife” against thromboinflammation to protect endothelial function of COVID-19 patients.
|
NA
|
NA
|
|
Positive results for patients with COVID-19 discharged form hospital in Chongqing, China.
|
NA
|
NA
|
|
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial.
|
NA
|
NA
|
|
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Safety netting; best practice in the face of uncertainty.
|
NA
|
NA
|
|
Telehealth for musculoskeletal physiotherapy.
|
NA
|
NA
|
|
Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies.
|
NA
|
NA
|
|
Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof).
|
NA
|
NA
|
|
In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
|
NA
|
NA
|
|
Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality.
|
NA
|
NA
|
|
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued.
|
NA
|
NA
|
|
Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions.
|
NA
|
NA
|
|
COVID-19 in patients with lung cancer.
|
NA
|
NA
|
|
COVID-19 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign.
|
NA
|
NA
|
|
Coagulopathy, thromboembolic complications and the use of heparin in COVID-19 Pneumonia.
|
NA
|
NA
|
|
Dying individuals and suffering populations: applying a population-level bioethics lens to palliative care in humanitarian contexts: before, during and after the COVID-19 pandemic.
|
NA
|
NA
|
|
Epidemiology of COVID-19 in an Urban Dialysis Center.
|
NA
|
NA
|
|
COVID-19 revisiting inflammatory pathways of arthritis.
|
NA
|
NA
|
|
Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.
|
NA
|
NA
|
|
Neurological involvement of coronavirus disease 2019: a systematic review.
|
NA
|
NA
|
|
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
|
NA
|
NA
|
|
High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis.
|
NA
|
NA
|
|
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
|
NA
|
NA
|
|
Statins: Could an old friend help the fight against COVID-19?
|
NA
|
NA
|
|
A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.
|
NA
|
NA
|
|
COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.
|
NA
|
NA
|
|
Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.
|
NA
|
NA
|
|
Cardiovascular manifestations in severe and critical patients with COVID-19.
|
NA
|
NA
|
|
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020.
|
NA
|
NA
|
|
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.
|
NA
|
NA
|
|
Approaching COVID-19 - bedside strategies for intensive care.
|
NA
|
NA
|
|
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain.
|
NA
|
NA
|
|
Pregnant Women in Trials of COVID-19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials.
|
NA
|
NA
|
|
ACUTE AORTIC DISSECTION SURGERY IN PATIENT WITH COVID-19.
|
NA
|
NA
|
|
Apelin-potential therapy for COVID-19?
|
NA
|
NA
|
|
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
|
NA
|
NA
|
|
Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
|
NA
|
NA
|
|
Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis.
|
NA
|
NA
|
|
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
|
NA
|
NA
|
|
Impact of Covid-19 lockdown on characteristics of autopsy cases in Greece. Comparison between 2019 and 2020.
|
NA
|
NA
|
|
Telemedicine and the 2019 Coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
|
NA
|
NA
|
|
Case Report: A COVID-19 Patient Presenting with Mild Rhabdomyolysis.
|
NA
|
NA
|
|
The neurological insights of the emerging coronaviruses.
|
NA
|
NA
|
|
Epidemiologic characteristics of traumatic fractures during the outbreak of coronavirus disease 2019 (COVID-19) in China: A retrospective & comparative multi-center study.
|
NA
|
NA
|
|
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
|
NA
|
NA
|
|
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report.
|
NA
|
NA
|
|
Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.
|
NA
|
NA
|
|
Contemporary and Future Concepts on Hypertension in African Americans: COVID-19 and Beyond.
|
NA
|
NA
|
|
Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan.
|
NA
|
NA
|
|
Tolerability and effectiveness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis.
|
NA
|
NA
|
|
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
|
NA
|
NA
|
|
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
|
NA
|
NA
|
|
Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method.
|
NA
|
NA
|
|
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
|
NA
|
NA
|
|
Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases
|
NA
|
NA
|
|
Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19.
|
NA
|
NA
|
|
Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
|
NA
|
NA
|
|
Inflammatory Bowel Disease in the COVID-19 Pandemic - the Patients’ Perspective.
|
NA
|
NA
|
|
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.
|
NA
|
NA
|
|
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.
|
NA
|
NA
|
|
Fatal SARS-CoV-2 infection in a renal transplant recipient.
|
NA
|
NA
|
|
Is 0.5% Hydrogen Peroxide Effective against SARS-CoV-2?
|
NA
|
NA
|
|
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
|
NA
|
NA
|
|
Tackling SARS-CoV-2: proposed targets and repurposed drugs.
|
NA
|
NA
|
|
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.
|
NA
|
NA
|
|
Teleconsultation in primary ophthalmic emergencies during the COVID-19 lockdown in Paris: Experience with 500 patients in March and April 2020.
|
NA
|
NA
|
|
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians].
|
NA
|
NA
|
|
COVID-19: Overview of Rheumatology Fellows.
|
NA
|
NA
|
|
Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey.
|
NA
|
NA
|
|
Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies.
|
NA
|
NA
|
|
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
|
NA
|
NA
|
|
Chloroquine cardiac effects and toxicity.A short update.
|
NA
|
NA
|
|
Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy.
|
NA
|
NA
|
|
Facial pressure ulcers in COVID-19 patients undergoing prone positioning: How to prevent an underestimated epidemic?
|
NA
|
NA
|
|
Responding to the Challenges of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership.
|
NA
|
NA
|
|
Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.
|
NA
|
NA
|
|
Comparative analysis of SARS-CoV-2 receptor ACE2 expression in multiple solid tumors and matched non-diseased tissues.
|
NA
|
NA
|
|
All Hands on Deck: A Synchronized Whole-of-World Approach for COVID-19 Mitigation.
|
NA
|
NA
|
|
Effects of Micronutrients or Conditional Amino Acids on COVID-19-Related Outcomes: An Evidence Analysis Center Scoping Review.
|
NA
|
NA
|
|
COVID-19 pandemic: A review based on current evidence.
|
NA
|
NA
|
|
A nonlinear epidemiological model considering asymptotic and quarantine classes for SARS CoV-2 virus.
|
NA
|
NA
|
|
Can Users Search Trends Predict People Scares or Disease Breakout? An Examination of Infectious Skin Diseases in the United States.
|
NA
|
NA
|
|
Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?
|
NA
|
NA
|
|
Multidisciplinary approach to COVID-19 and cancer: consensus from scientific societies in Argentina.
|
NA
|
NA
|
|
Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group.
|
NA
|
NA
|
|
COVID-19: hypofractionation in the Radiation Oncology Department during the ‘state of alarm’: first 100 patients in a private hospital in Spain.
|
NA
|
NA
|
|
Oncofertility and COVID-19-cancer does not wait.
|
NA
|
NA
|
|
Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients.
|
NA
|
NA
|
|
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model.
|
NA
|
NA
|
|
Protracted course of coronavirus disease with severe acute respiratory distress syndrome: a case report.
|
NA
|
NA
|
|
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.
|
NA
|
NA
|
|
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach.
|
NA
|
NA
|
|
A Systematic Review of Cases of Acute Respiratory Distress Syndrome in the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Doxycycline as a potential partner of COVID-19 therapies.
|
NA
|
NA
|
|
Efficacy and safety of antibiotic agents in children with COVID-19: a rapid review.
|
NA
|
NA
|
|
Supportive care for patient with respiratory diseases: an umbrella review.
|
NA
|
NA
|
|
Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review.
|
NA
|
NA
|
|
Application of telemedicine during the coronavirus disease epidemics: a rapid review and meta-analysis.
|
NA
|
NA
|
|
Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis.
|
NA
|
NA
|
|
Appealing for efficient, well organized clinical trials on COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of 16 patients with COVID-19 infection outside of Wuhan, China: a retrospective, single-center study.
|
NA
|
NA
|
|
Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Quantitative analysis of chest CT imaging findings with the risk of ARDS in COVID-19 patients: a preliminary study.
|
NA
|
NA
|
|
Perspectives on the development of neutralizing antibodies against SARS-CoV-2.
|
NA
|
NA
|
|
Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic.
|
NA
|
NA
|
|
Advantages of Using Lotteries to Select Participants for High-Demand Covid-19 Treatment Trials.
|
NA
|
NA
|
|
Financial Burden of Hospitalization of Children with Coronavirus Disease 2019 under the National Health Insurance Service in Korea.
|
NA
|
NA
|
|
nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine.
|
NA
|
NA
|
|
Constituents of buriti oil (Mauritia flexuosa L.) like inhibitors of the SARS-Coronavirus main peptidase: an investigation by docking and molecular dynamics.
|
NA
|
NA
|
|
Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer.
|
NA
|
NA
|
|
Sentinel Case of COVID-19 at Fort Stewart, GA in a National Guard Soldier Participating in Annual Training: A Case Report.
|
NA
|
NA
|
|
Planning for a pandemic: Mitigating risk to radiation therapy service delivery in the COVID-19 era.
|
NA
|
NA
|
|
COVID-related family separation and trauma in the intensive care unit.
|
NA
|
NA
|
|
COVID-19 and Paediatric Dentistry after the lockdown.
|
NA
|
NA
|
|
Perspectives of tele-orthodontics in the COVID-19 emergency and as a future tool in daily practice.
|
NA
|
NA
|
|
Autophagy and SARS-CoV-2 infection: Apossible smart targeting of the autophagy pathway.
|
NA
|
NA
|
|
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
|
NA
|
NA
|
|
In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2.
|
NA
|
NA
|
|
Clinical management of psoriasis patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach.
|
NA
|
NA
|
|
Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2.
|
NA
|
NA
|
|
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
|
NA
|
NA
|
|
Lessons from a lumbar burst fracture patient infected with SARS-CoV-2.
|
NA
|
NA
|
|
The compelling arguments for the need for microvascular investigation in COVID-19 critical patients.
|
NA
|
NA
|
|
Emerging pharmacotherapy for COVID-19.
|
NA
|
NA
|
|
Assessment of Coronavirus Disease 2019 Community Containment Strategies in Shenzhen, China.
|
NA
|
NA
|
|
Tocilizumab’s efficacy in COVID-19 patients is determined by the presence of cytokine storm.
|
NA
|
NA
|
|
Protecting children from iatrogenic harm during COVID19 pandemic.
|
NA
|
NA
|
|
Priorities in testis cancer care during Covid-19 Pandemic.
|
NA
|
NA
|
|
Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era.
|
NA
|
NA
|
|
Impact of COVID-19 in Female Urology.
|
NA
|
NA
|
|
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an in silico docking and molecular dynamics simulation study.
|
NA
|
NA
|
|
Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea.
|
NA
|
NA
|
|
Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea.
|
NA
|
NA
|
|
Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea.
|
NA
|
NA
|
|
Application of remote diagnosis and treatment during the COVID-19 outbreak and their preliminary outcomes：retrospective cohort study.
|
NA
|
NA
|
|
Monitoring and management of home-quarantined COVID-19 infected individuals using a WeChat-based telemedicine system: a cohort study.
|
NA
|
NA
|
|
Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series.
|
NA
|
NA
|
|
Case series and review of liver dysfunction in COVID-19 patients.
|
NA
|
NA
|
|
Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019.
|
NA
|
NA
|
|
Chinese medicine for COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study.
|
NA
|
NA
|
|
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?
|
NA
|
NA
|
|
Organization of biologic therapy during the COVID-19 pandemic based on example of Dermatology Clinic Centre of Postgraduate Medical Education in Warsaw.
|
NA
|
NA
|
|
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
|
NA
|
NA
|
|
Navigating Immunosuppression in a Pandemic: A Guide for the Dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists.
|
NA
|
NA
|
|
Exportin 1 inhibition as antiviral therapy.
|
NA
|
NA
|
|
Application of cognitive Internet of Medical Things for COVID-19 pandemic.
|
NA
|
NA
|
|
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
|
NA
|
NA
|
|
SARS-CoV-2 infection and stem cells: Interaction and intervention.
|
NA
|
NA
|
|
Extensions and adaptations of existing medical information system in order to reduce social contacts during COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.
|
NA
|
NA
|
|
Cholesterol in Relation to COVID-19: Should We Care about It?
|
NA
|
NA
|
|
Short-Term Dexamethasone in Sars-CoV-2 Patients.
|
NA
|
NA
|
|
Nanotechnology for COVID-19: Therapeutics and Vaccine Research.
|
NA
|
NA
|
|
Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice.
|
NA
|
NA
|
|
Molecular Targets in the Chemotherapy of Coronavirus Infection.
|
NA
|
NA
|
|
COVID-19 with acute cholecystitis: a case report.
|
NA
|
NA
|
|
[Clinical features of asymptomatic or subclinical COVID-19 in children].
|
NA
|
NA
|
|
Surgical treatment of thoracolumbar fracture with incomplete lower limb paralysis in a patient with COVID-19.
|
NA
|
NA
|
|
Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review.
|
NA
|
NA
|
|
Amantadine Treatment for People with COVID-19.
|
NA
|
NA
|
|
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.
|
NA
|
NA
|
|
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
|
NA
|
NA
|
|
IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY.
|
NA
|
NA
|
|
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
|
NA
|
NA
|
|
Revisiting the equity debate in COVID-19: ICU is no panacea.
|
NA
|
NA
|
|
COVID-19 in an international European liver transplant recipient cohort.
|
NA
|
NA
|
|
Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19.
|
NA
|
NA
|
|
A multidisciplinary approach for managing the infraglottic difficult airway in the setting of the Coronavirus pandemic.
|
NA
|
NA
|
|
Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.
|
NA
|
NA
|
|
Development of a highly effective low-cost vaporized hydrogen peroxide-based method for disinfection of personal protective equipment for their selective reuse during pandemics.
|
NA
|
NA
|
|
Pharmacists and COVID-19.
|
NA
|
NA
|
|
Literature-based review of the drugs used for the treatment of COVID-19.
|
NA
|
NA
|
|
The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey.
|
NA
|
NA
|
|
Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
|
NA
|
NA
|
|
Congenital heart disease in the era of COVID-19 pandemic.
|
NA
|
NA
|
|
Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 and comorbidities: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Epidemiology and clinical course of COVID-19 in Shanghai, China.
|
NA
|
NA
|
|
Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study.
|
NA
|
NA
|
|
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.
|
NA
|
NA
|
|
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.
|
NA
|
NA
|
|
[Drug treatment of coronavirus disease COVID-19: evidence exists?]
|
NA
|
NA
|
|
[How to communicate with families of patients in complete isolation during SARS-CoV-2 pandemic multidisciplinary working group “ComuniCoViD”.]
|
NA
|
NA
|
|
Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion.
|
NA
|
NA
|
|
The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre.
|
NA
|
NA
|
|
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
|
NA
|
NA
|
|
COVID-19 Pneumonia in Kidney Transplant Recipients: Focus on Immunosuppression Management.
|
NA
|
NA
|
|
SARS-CoV-2 infection in kidney transplant recipients: experience of the italian marche region.
|
NA
|
NA
|
|
Ultravıolet and COVID-19 pandemıc.
|
NA
|
NA
|
|
Virtual empathy and liver cancer.
|
NA
|
NA
|
|
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities.
|
NA
|
NA
|
|
ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies.
|
NA
|
NA
|
|
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
|
NA
|
NA
|
|
Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation.
|
NA
|
NA
|
|
Complicated Grief: What to Expect After the Coronavirus Pandemic.
|
NA
|
NA
|
|
Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force.
|
NA
|
NA
|
|
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients.
|
NA
|
NA
|
|
Obstetric Management of COVID-19 in Pregnant Women.
|
NA
|
NA
|
|
Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
|
NA
|
NA
|
|
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
|
NA
|
NA
|
|
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.
|
NA
|
NA
|
|
Interferon-α2b Treatment for COVID-19.
|
NA
|
NA
|
|
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
|
NA
|
NA
|
|
Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation.
|
NA
|
NA
|
|
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health.
|
NA
|
NA
|
|
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
|
NA
|
NA
|
|
Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report.
|
NA
|
NA
|
|
Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.
|
NA
|
NA
|
|
Clinical Characteristics of 5 COVID-19 Cases With Non-respiratory Symptoms as the First Manifestation in Children.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) in Neonates and Children From China: A Review.
|
NA
|
NA
|
|
SARS-CoV-2 Infection and the Newborn.
|
NA
|
NA
|
|
The Battle Against COVID-19 in Jordan: An Early Overview of the Jordanian Experience.
|
NA
|
NA
|
|
Severe COVID-19: A Review of Recent Progress With a Look Toward the Future.
|
NA
|
NA
|
|
COVID-19: Emergence, Spread, Possible Treatments, and Global Burden.
|
NA
|
NA
|
|
Clinical and Epidemiological Characteristics of COVID-19 Patients in Chongqing China.
|
NA
|
NA
|
|
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
|
NA
|
NA
|
|
Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.
|
NA
|
NA
|
|
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention.
|
NA
|
NA
|
|
Clinical Characteristics and Reasons for Differences in Duration From Symptom Onset to Release From Quarantine Among Patients With COVID-19 in Liaocheng, China.
|
NA
|
NA
|
|
Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19.
|
NA
|
NA
|
|
Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series.
|
NA
|
NA
|
|
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials.
|
NA
|
NA
|
|
Case Report: Clinical Treatment of the First Critical Patient With Coronavirus Disease (COVID-19) in Liaocheng, Shandong Province.
|
NA
|
NA
|
|
The Rise and Impact of COVID-19 in India.
|
NA
|
NA
|
|
Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China.
|
NA
|
NA
|
|
Beliefs towards the COVID-19 pandemic among patients with emotional disorders in China.
|
NA
|
NA
|
|
Effect of COVID-19 on liver transplantation in KOREA.
|
NA
|
NA
|
|
Hyperbaric oxygen as a treatment for COVID-19 infection?
|
NA
|
NA
|
|
Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
|
NA
|
NA
|
|
UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients.
|
NA
|
NA
|
|
Discovering small-molecule therapeutics against SARS-CoV-2.
|
NA
|
NA
|
|
Super-factors associated with transmission of occupational COVID-2019 infection among healthcare staff in Wuhan , China.
|
NA
|
NA
|
|
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
|
NA
|
NA
|
|
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
|
NA
|
NA
|
|
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India.
|
NA
|
NA
|
|
Pirfenidone: A novel hypothetical treatment for COVID-19.
|
NA
|
NA
|
|
Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
|
NA
|
NA
|
|
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.
|
NA
|
NA
|
|
Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients.
|
NA
|
NA
|
|
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations.
|
NA
|
NA
|
|
Management of Infantile Spasms During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Telepsychiatry in the Age of COVID: Some Ethical Considerations.
|
NA
|
NA
|
|
Preparing a young palliative care unit for the COVID-19 pandemic in a teaching hospital in Ghana.
|
NA
|
NA
|
|
Prediction of the rehabilitation duration and risk management for mild-moderate COVID-19.
|
NA
|
NA
|
|
[Study on traditional Chinese medicine common syndrome characteristic of coronavirus disease 2019 based on latent structure combined with system clustering analysis].
|
NA
|
NA
|
|
[Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].
|
NA
|
NA
|
|
[2019 Novel coronavirus, renin-angiotension system imbalance and coronavirus disease 2019].
|
NA
|
NA
|
|
[Application of continuous renal replacement therapy in coronavirus disease 2019].
|
NA
|
NA
|
|
[Understanding and prevention of D-dimer elevation in coronavirus disease 2019 in traditional Chinese medicine].
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Urologists in Germany.
|
NA
|
NA
|
|
Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19).
|
NA
|
NA
|
|
COVID-19 and gynecological cancer: a review of the published guidelines.
|
NA
|
NA
|
|
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
|
NA
|
NA
|
|
ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19.
|
NA
|
NA
|
|
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.
|
NA
|
NA
|
|
The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role?
|
NA
|
NA
|
|
Preventing SARS-CoV-2 infection by blocking a tissue serine protease.
|
NA
|
NA
|
|
COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies.
|
NA
|
NA
|
|
A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention.
|
NA
|
NA
|
|
COVID-19: Pulse oximeters in the spotlight.
|
NA
|
NA
|
|
Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment.
|
NA
|
NA
|
|
Inpatient Dermatology Consultations during Covid 19 Pandemic in a Tertiary Referral Center.
|
NA
|
NA
|
|
Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis.
|
NA
|
NA
|
|
The COVID-19 pandemic and the implementation of telehealth in speech-language and hearing therapy for patients at home: an experience report.
|
NA
|
NA
|
|
Standardization of elective tracheostomies at the Central Institute of the Hospital das Clínicas in São Paulo during the COVID-19 pandemic.
|
NA
|
NA
|
|
Physiotherapy services in the face of a pandemic.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in Brasil: information to physical therapists.
|
NA
|
NA
|
|
Beyond ventilatory support: challenges in general practice and in the treatment of critically Ill children and adolescents with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Sars-CoV-2: A clinical update - II.
|
NA
|
NA
|
|
Alternatives for establishing a surgical airway during the COVID-19 pandemic.
|
NA
|
NA
|
|
Physiotherapy Care of Patients with Coronavirus Disease 2019 (COVID-19) - A Brazilian Experience.
|
NA
|
NA
|
|
Imaging findings in COVID-19 pneumonia.
|
NA
|
NA
|
|
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group.
|
NA
|
NA
|
|
Pharmacist-driven education for solid organ transplant recipients in the COVID-19 era.
|
NA
|
NA
|
|
Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia?
|
NA
|
NA
|
|
Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets.
|
NA
|
NA
|
|
In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19.
|
NA
|
NA
|
|
In Vivo Expressed Biologics for Infectious Disease Prophylaxis: Rapid Delivery of DNA-Based Antiviral Antibodies.
|
NA
|
NA
|
|
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
|
NA
|
NA
|
|
SARS-CoV-2 and SARS-CoV: Virtual Screening of Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
|
NA
|
NA
|
|
Clinical Characteristics of Acute Respiratory Syndrome with SARS-CoV-2 Infection in Children in South China.
|
NA
|
NA
|
|
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.
|
NA
|
NA
|
|
Clinical pharmacology considerations for developing small molecule treatments for COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical Management.
|
NA
|
NA
|
|
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.
|
NA
|
NA
|
|
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries.
|
NA
|
NA
|
|
Organisational challenges, volumes of oncological activity and patients’ perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
|
NA
|
NA
|
|
Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period.
|
NA
|
NA
|
|
A Case of Pediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 in South Dakota.
|
NA
|
NA
|
|
COVID-19: Catastrophic Cause of Acute Lung Injury.
|
NA
|
NA
|
|
2019 Novel Coronavirus Pandemic: What Do We Know?
|
NA
|
NA
|
|
Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.
|
NA
|
NA
|
|
Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial.
|
NA
|
NA
|
|
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
|
NA
|
NA
|
|
Olfactory and taste disorders in COVID-19: a systematic review.
|
NA
|
NA
|
|
Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
|
NA
|
NA
|
|
Clinical Characteristics and Blood Test Results in COVID-19 Patients.
|
NA
|
NA
|
|
Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.
|
NA
|
NA
|
|
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
|
NA
|
NA
|
|
Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?
|
NA
|
NA
|
|
Determinants of COVID-19 disease severity in patients with cancer.
|
NA
|
NA
|
|
Characteristics of COVID-19 Clinical Trials in China Based on the Registration Data on ChiCTR and ClinicalTrials.gov.
|
NA
|
NA
|
|
Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19.
|
NA
|
NA
|
|
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.
|
NA
|
NA
|
|
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.
|
NA
|
NA
|
|
Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.
|
NA
|
NA
|
|
Biosurfactants: A Covid-19 Perspective.
|
NA
|
NA
|
|
Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Adult Mental Health.
|
NA
|
NA
|
|
Tobacco Smoking a Potential Risk Factor in Transmission of COVID-19 Infection.
|
NA
|
NA
|
|
How Nutrition can help to fight against COVID-19 Pandemic.
|
NA
|
NA
|
|
What gastroenterologists should know during COVID-19 Pandemic!
|
NA
|
NA
|
|
Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries.
|
NA
|
NA
|
|
Management of common elective paediatric orthopaedic conditions during the COVID-19 pandemic: the Montreal experience.
|
NA
|
NA
|
|
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
|
NA
|
NA
|
|
A Case Report of Rapidly Lethal Acute Respiratory Distress Syndrome Secondary to Coronavirus Disease 2019 Viral Pneumonia.
|
NA
|
NA
|
|
ACE2, Much More Than Just a Receptor for SARS-COV-2.
|
NA
|
NA
|
|
A Novel Scoring System for Prediction of Disease Severity in COVID-19.
|
NA
|
NA
|
|
Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
|
NA
|
NA
|
|
A Retrospective Analysis of the Clinical and Epidemiological Characteristics of COVID-19 Patients in Henan Provincial People’s Hospital, Zhengzhou, China.
|
NA
|
NA
|
|
Management of Hemoglobin Disorders During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Transmission of SARS-CoV-2, Required Developments in Research and Associated Public Health Concerns.
|
NA
|
NA
|
|
Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton Center.
|
NA
|
NA
|
|
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure.
|
NA
|
NA
|
|
An Evaluation of Florida’s Zika Response Using the WHO Health Systems Framework: Can We Apply These Lessons to COVID-19?
|
NA
|
NA
|
|
I-ACTSS-COVID-19-the Italian acute care and trauma surgery survey for COVID-19 pandemic outbreak.
|
NA
|
NA
|
|
Statistical Evaluation of Clinical Trials Under COVID-19 Pandemic.
|
NA
|
NA
|
|
What about COVID-19 and arachidonic acid pathway?
|
NA
|
NA
|
|
Inequalities and identity processes in crises: Recommendations for facilitating safe response to the COVID-19 pandemic.
|
NA
|
NA
|
|
How the COVID-19 Pandemic Changed Cellular Therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.
|
NA
|
NA
|
|
Treatment of Hepatocellular Carcinoma (HCC) during the COVID-19 Outbreak: The Working Group Report of JAMTT-HCC.
|
NA
|
NA
|
|
Is 2020 the year when primatologists should cancel fieldwork?
|
NA
|
NA
|
|
COVID-19 in Recent Heart Transplant Recipients: Clinicopathologic Features and Early Outcomes.
|
NA
|
NA
|
|
[COVID-19 - A RECENT REVIEW].
|
NA
|
NA
|
|
COVID-19 and Total Laryngectomy-A Report of Two Cases.
|
NA
|
NA
|
|
Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists.
|
NA
|
NA
|
|
Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine.
|
NA
|
NA
|
|
Protecting and Improving the Lives of Older Adults in the COVID-19 Era.
|
NA
|
NA
|
|
Health service psychology education and training in the time of COVID-19: Challenges and opportunities.
|
NA
|
NA
|
|
Addressing trauma and stress in the COVID-19 pandemic: Challenges and the promise of integrated primary care.
|
NA
|
NA
|
|
COVID-19: Understanding and mitigating trauma in ICU survivors.
|
NA
|
NA
|
|
Human and novel coronavirus infections in children: a review.
|
NA
|
NA
|
|
What We Learned about COVID-19 So Far? Notes from Underground.
|
NA
|
NA
|
|
INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.
|
NA
|
NA
|
|
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY.
|
NA
|
NA
|
|
Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome.
|
NA
|
NA
|
|
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
|
NA
|
NA
|
|
Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer.
|
NA
|
NA
|
|
Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI).
|
NA
|
NA
|
|
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
|
NA
|
NA
|
|
Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2.
|
NA
|
NA
|
|
[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia].
|
NA
|
NA
|
|
Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff.
|
NA
|
NA
|
|
Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities.
|
NA
|
NA
|
|
A call to action becomes practice: cardiac and vascular surgery during the COVID-19 pandemic based on the Lombardy emergency guidelines.
|
NA
|
NA
|
|
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
|
NA
|
NA
|
|
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
|
NA
|
NA
|
|
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.
|
NA
|
NA
|
|
Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection.
|
NA
|
NA
|
|
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.
|
NA
|
NA
|
|
Diabetes, Infection Risk And Covid-19.
|
NA
|
NA
|
|
A COVID-19 testing and triage algorithm for psychiatric units: One hospital’s response to the New York region’s pandemic.
|
NA
|
NA
|
|
Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.
|
NA
|
NA
|
|
A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient.
|
NA
|
NA
|
|
Emerging Prevention and Treatment Strategies to Control COVID-19.
|
NA
|
NA
|
|
Montelukast’s ability to fight COVID-19 infection.
|
NA
|
NA
|
|
COVID-19 effect on phototherapy treatment utilization in dermatology.
|
NA
|
NA
|
|
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
|
NA
|
NA
|
|
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19).
|
NA
|
NA
|
|
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
|
NA
|
NA
|
|
A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
|
NA
|
NA
|
|
CytoResc - “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
[Obesity as a risk factor in COVID-19: Possible mechanisms and implications].
|
NA
|
NA
|
|
Organization of a radiotherapy service during the COVID-19 epidemic: Experience of Regional Center of Oncology of Agadir, Morocco.
|
NA
|
NA
|
|
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
|
NA
|
NA
|
|
Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury.
|
NA
|
NA
|
|
Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for Mycobacterial Infections (ESGMYC).
|
NA
|
NA
|
|
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
|
NA
|
NA
|
|
Microwave-Generated Steam Decontamination of N95 Respirators Utilizing Universally Accessible Materials.
|
NA
|
NA
|
|
Ocular oncology practice guidelines during COVID-19 pandemic-An expert consensus.
|
NA
|
NA
|
|
Tele-consultations in the wake of COVID-19 - Suggested guidelines for clinical ophthalmology.
|
NA
|
NA
|
|
Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals.
|
NA
|
NA
|
|
Teleconsultation at a tertiary care government medical university during COVID-19 Lockdown in India - A pilot study.
|
NA
|
NA
|
|
Medical Management of COVID-19: Evidence and Experience.
|
NA
|
NA
|
|
COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients With Chronic Kidney Disease and Renal Transplantation.
|
NA
|
NA
|
|
A potential role for Galectin-3 inhibitors in the treatment of COVID-19.
|
NA
|
NA
|
|
Management of ST-Elevation Myocardial Infarction in the COVID-19 Era: The Role of Thrombosis and Anticoagulation Strategy.
|
NA
|
NA
|
|
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).
|
NA
|
NA
|
|
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.
|
NA
|
NA
|
|
[SARS-CoV-2/COVID-19: systematic review of requirements for personal protective equipment in primary patient contact and organization of the operating area].
|
NA
|
NA
|
|
Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.
|
NA
|
NA
|
|
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
|
NA
|
NA
|
|
Best practice for infection prevention in pediatric respiratory clinics during the COVID-19 epidemic.
|
NA
|
NA
|
|
QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection.
|
NA
|
NA
|
|
COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.
|
NA
|
NA
|
|
Physical activity in a pandemic: A new treatment target for psychological therapy.
|
NA
|
NA
|
|
RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses.
|
NA
|
NA
|
|
Coronaviruses fusion with the membrane and entry to the host cell.
|
NA
|
NA
|
|
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.
|
NA
|
NA
|
|
Primary Symptoms, Comorbidities, and Outcomes of 431 Hospitalized Patients with Confirmative RT-PCR Results for COVID-19.
|
NA
|
NA
|
|
Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Stretching the Analytic Frame: Analytic Therapists’ Experiences with Remote Therapy During COVID-19.
|
NA
|
NA
|
|
Teleanalytic Therapy in the Era of Covid-19: Dissociation in the Countertransference.
|
NA
|
NA
|
|
Statistical Issues and Lessons Learned from COVID-19 Clinical Trials with Lopinavir-Ritonavir and Remdesivir.
|
NA
|
NA
|
|
Global changes and factors of increase in caloric/salty food, screen, and substance use, during the early COVID-19 containment phase in France: a general population online survey.
|
NA
|
NA
|
|
SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection.
|
NA
|
NA
|
|
Reaching Up, Down, In, and Around: Couple and Family Coping During the Corona Virus Pandemic.
|
NA
|
NA
|
|
COVID-19 Interconnectedness: Health Inequity, the Climate Crisis, and Collective Trauma.
|
NA
|
NA
|
|
Current State of Research About Chinese Herbal Medicines (CHM) for the Treatment of Coronavirus Disease 2019 (COVID-19): A Scoping Review.
|
NA
|
NA
|
|
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study.
|
NA
|
NA
|
|
Pulmonary embolism in acute medicine: a case-based review incorporating latest guidelines in the COVID-19 era.
|
NA
|
NA
|
|
Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
Translating COVID-19 Evidence to Maximize Physical Therapists’ Impact and Public Health Response.
|
NA
|
NA
|
|
Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID-19, in Healthy Subjects.
|
NA
|
NA
|
|
Zero COVID-19 infection in inflammatory bowel disease patients: Findings from National IBD Registries in Hong Kong and Taiwan.
|
NA
|
NA
|
|
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
|
NA
|
NA
|
|
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.
|
NA
|
NA
|
|
Nitric Oxide dosed in short bursts at high concentrations may protect against Covid 19.
|
NA
|
NA
|
|
Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey.
|
NA
|
NA
|
|
Targeting adenosinergic pathway and adenosine A2A receptor signaling for the treatment of COVID-19: A hypothesis.
|
NA
|
NA
|
|
Successful blood glucose management of a severe COVID-19 patient with diabetes: A case report.
|
NA
|
NA
|
|
Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study.
|
NA
|
NA
|
|
Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.
|
NA
|
NA
|
|
The Rapid Transformation of Cardiac Surgery Practice in the Coronavirus Disease 2019 (COVID-19) Pandemic: Insights and Clinical Strategies From a Center at the Epicenter.
|
NA
|
NA
|
|
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
|
NA
|
NA
|
|
Pneumococcal superinfection in COVID-19 patients: A series of 5 cases.
|
NA
|
NA
|
|
SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
|
NA
|
NA
|
|
[COVID-19 and its relationship with hypertension and cardiovascular disease].
|
NA
|
NA
|
|
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
|
NA
|
NA
|
|
How can dentistry get back to work safely?
|
NA
|
NA
|
|
What is the impact of COVID-19 on head and neck squamous cell carcinoma patients?
|
NA
|
NA
|
|
Provision of dental hospital services during the COVID-19 epidemic.
|
NA
|
NA
|
|
Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?
|
NA
|
NA
|
|
A COVID-19 pandemic guideline in evidence-based medicine.
|
NA
|
NA
|
|
COVID-19 pandemic: the first wave - an audit and guidance for paediatric dentistry.
|
NA
|
NA
|
|
COVID-19: establishing an oral surgery-led urgent dental care hub.
|
NA
|
NA
|
|
The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics.
|
NA
|
NA
|
|
Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation.
|
NA
|
NA
|
|
Cohort study of chest CT and clinical changes in 29 patients with coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Reflections from London’s Level-1 Major Trauma Centres during the COVID crisis.
|
NA
|
NA
|
|
The orthopaedic and traumatology scenario during Covid-19 outbreak in Italy: chronicles of a silent war.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
|
NA
|
NA
|
|
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.
|
NA
|
NA
|
|
‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients.
|
NA
|
NA
|
|
“Masking” our Emotions: Botulinum Toxin, Facial Expression and Well-Being in the Age of COVID-19.
|
NA
|
NA
|
|
COVID-19 in Immunocompromised Hosts: What We Know So Far.
|
NA
|
NA
|
|
COVID-19 Pandemic: A Time for Collaboration and A Unified Global Health Front.
|
NA
|
NA
|
|
The cytokine storm and COVID-19.
|
NA
|
NA
|
|
Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019.
|
NA
|
NA
|
|
[Medical rehabilitation of patients with pneumonia associated with the new COVID-19 coronavirus infection].
|
NA
|
NA
|
|
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.
|
NA
|
NA
|
|
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
|
NA
|
NA
|
|
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
|
NA
|
NA
|
|
Diabetes and COVID-19: IDF perspective in the Western Pacific Region.
|
NA
|
NA
|
|
Does PDT have potential in the treatment of COVID 19 patients?
|
NA
|
NA
|
|
Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods.
|
NA
|
NA
|
|
Teledentistry during COVID-19 pandemic.
|
NA
|
NA
|
|
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
|
NA
|
NA
|
|
The Another Side of COVID-19 in Alzheimer’s Disease Patients: Drug-Drug Interactions.
|
NA
|
NA
|
|
Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis.
|
NA
|
NA
|
|
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
|
NA
|
NA
|
|
Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma.
|
NA
|
NA
|
|
The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status.
|
NA
|
NA
|
|
Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture.
|
NA
|
NA
|
|
The problem of medical-psychiatric illness in the homeless and its occurrence in the midst of a viral pandemic: A commentary.
|
NA
|
NA
|
|
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
|
NA
|
NA
|
|
Epilepsy self-management during a pandemic: Experiences of people with epilepsy.
|
NA
|
NA
|
|
Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review.
|
NA
|
NA
|
|
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report.
|
NA
|
NA
|
|
Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
|
NA
|
NA
|
|
Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors.
|
NA
|
NA
|
|
COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies.
|
NA
|
NA
|
|
Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City.
|
NA
|
NA
|
|
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
|
NA
|
NA
|
|
Management of COVID-19 in people with epilepsy: drug considerations.
|
NA
|
NA
|
|
Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic.
|
NA
|
NA
|
|
[Almost two-thirds of the elderly with covid-19 surviving in nursing homes].
|
NA
|
NA
|
|
Behind the (Virtual) Mirror: Online Live Supervision in Couple and Family Therapy.
|
NA
|
NA
|
|
Clinical trials for the prevention and treatment of COVID-19: current state of play.
|
NA
|
NA
|
|
Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.
|
NA
|
NA
|
|
Business as usual? Psychological support at a distance.
|
NA
|
NA
|
|
The cytokine storm of COVID-19: a spotlight on prevention and protection.
|
NA
|
NA
|
|
Treatment of psoriasis - unburdened by fear during SARS-CoV2 menace.
|
NA
|
NA
|
|
Prevention in COVID-19 time: from failure to future.
|
NA
|
NA
|
|
Covid-19: current knowledge, disease potential, prevention and clinical advances.
|
NA
|
NA
|
|
Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review.
|
NA
|
NA
|
|
An updated analysis of variations in SARS-CoV-2 genome.
|
NA
|
NA
|
|
SARS-CoV-2 neutralizing antibody development strategies.
|
NA
|
NA
|
|
Potentials of plant-based substance to inhabit and probable cure for the COVID-19.
|
NA
|
NA
|
|
Mesenchymal stem cell derived extracellular vesicles: promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection.
|
NA
|
NA
|
|
Prevalence and Demographic Correlates of Poor Sleep Quality Among Frontline Health Professionals in Liaoning Province, China During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition.
|
NA
|
NA
|
|
Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm.
|
NA
|
NA
|
|
The COVID-19 pandemic: catching up with the cataclysm.
|
NA
|
NA
|
|
The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure.
|
NA
|
NA
|
|
Strategies for Rational Use of Personal Protective Equipment (PPE) Among Healthcare Providers During the COVID-19 Crisis.
|
NA
|
NA
|
|
Emerging Pharmaceutical Treatments of Novel COVID-19: A Review.
|
NA
|
NA
|
|
Acute Respiratory Failure Secondary to COVID-19 Viral Pneumonia Managed With Hydroxychloroquine/Azithromycin Treatment.
|
NA
|
NA
|
|
Recommendations for surgical management of recurrent nasopharyngeal carcinoma during COVID-19 pandemic.
|
NA
|
NA
|
|
Walls.
|
NA
|
NA
|
|
Duties toward Patients with Psychiatric Illness.
|
NA
|
NA
|
|
Avoiding Ineffective End-of-Life Care: A Lesson from Triage?
|
NA
|
NA
|
|
Global Disparity and Solidarity in a Pandemic.
|
NA
|
NA
|
|
Dying during Covid-19.
|
NA
|
NA
|
|
Employment-Based, For-Profit Health Care in a Pandemic.
|
NA
|
NA
|
|
The patient’s pathway for breast cancer in the COVID-19 era: An Italian single-center experience.
|
NA
|
NA
|
|
Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
|
NA
|
NA
|
|
Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients.
|
NA
|
NA
|
|
The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study.
|
NA
|
NA
|
|
[Machine learning-based method for interpreting the guidelines of the diagnosis and treatment of COVID-19].
|
NA
|
NA
|
|
Hospital care in Departments defined as COVID-free: A proposal for a safe hospitalization protecting healthcare professionals and patients not affected by COVID-19.
|
NA
|
NA
|
|
Facility-Level Approaches for COVID-19 When Caseload Surpasses Surge Capacity.
|
NA
|
NA
|
|
Use of Baricitinib in Patients with Moderate and Severe COVID-19.
|
NA
|
NA
|
|
Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system.
|
NA
|
NA
|
|
[Assessment of the psychological status of urologists during the COVID-19 pandemic].
|
NA
|
NA
|
|
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.
|
NA
|
NA
|
|
AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives.
|
NA
|
NA
|
|
Optimizing Medication Management During the COVID-19 Pandemic: It Takes a Village.
|
NA
|
NA
|
|
COVID-19 and psoriasis: biologic treatment and challenges.
|
NA
|
NA
|
|
COVID-19: New adaptation for IVF laboratory protocols.
|
NA
|
NA
|
|
Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis.
|
NA
|
NA
|
|
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.
|
NA
|
NA
|
|
Drug treatment of coronavirus disease 2019 (COVID-19) in China.
|
NA
|
NA
|
|
Autoclave sterilization and ethanol treatment of re-used surgical masks and N95 respirators during COVID-19: impact on their performance and integrity.
|
NA
|
NA
|
|
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.
|
NA
|
NA
|
|
Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
|
NA
|
NA
|
|
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports.
|
NA
|
NA
|
|
Nocturnal oxygen therapy as an option for early COVID-19.
|
NA
|
NA
|
|
Anthropogenic gadolinium in freshwater and drinking water systems.
|
NA
|
NA
|
|
Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis.
|
NA
|
NA
|
|
Weathering the Cytokine Storm in COVID-19: Therapeutic Implications.
|
NA
|
NA
|
|
[COVID-19: Variable symptoms in mild course: olfactory loss and increased resting heart rate].
|
NA
|
NA
|
|
The Impact of COVID-19 on HIV Treatment and Research: A Call to Action.
|
NA
|
NA
|
|
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.
|
NA
|
NA
|
|
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.
|
NA
|
NA
|
|
COVID-19 and dermatology.
|
NA
|
NA
|
|
Symptom management for patients awaiting joint replacement surgery.
|
NA
|
NA
|
|
Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.
|
NA
|
NA
|
|
Psychiatric Training During a Global Pandemic: How COVID-19 Has Affected Clinical Care, Teaching, and Trainee Well-Being.
|
NA
|
NA
|
|
The impact of COVID-19 on ischemic stroke.
|
NA
|
NA
|
|
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
The Role of Pharmacists in the Fight Against COVID-19.
|
NA
|
NA
|
|
CMS Responds to COVID-19 Crisis by Revising Regulations.
|
NA
|
NA
|
|
SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic.
|
NA
|
NA
|
|
Infertility remains a top stressor despite the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry.
|
NA
|
NA
|
|
Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients.
|
NA
|
NA
|
|
“The Most Dangerous Strain”.
|
NA
|
NA
|
|
Reorganization of the endoscopic activity of Cancer Institutes during phase II of the Covid-19 emergency.
|
NA
|
NA
|
|
Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis.
|
NA
|
NA
|
|
Consequences of the COVID-19 Pandemic on Cancer Clinical Trials.
|
NA
|
NA
|
|
Enhancing global health communication during a crisis: lessons from the COVID-19 pandemic.
|
NA
|
NA
|
|
Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
|
NA
|
NA
|
|
Emergency reconstruction of large general hospital under the perspective of new COVID-19 prevention and control.
|
NA
|
NA
|
|
Management of patients with magnetically controlled growth rods amidst the global COVID-19 pandemic.
|
NA
|
NA
|
|
Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada.
|
NA
|
NA
|
|
A contemporary review on pathogenesis and immunity of COVID-19 infection.
|
NA
|
NA
|
|
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.
|
NA
|
NA
|
|
Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study.
|
NA
|
NA
|
|
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.
|
NA
|
NA
|
|
The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study.
|
NA
|
NA
|
|
New York Transplant Teams Versus COVID-19.
|
NA
|
NA
|
|
Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.
|
NA
|
NA
|
|
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
|
NA
|
NA
|
|
Clinico-radiological Presentation of COVID-19 Patients at a Tertiary Care Center at Bhilwara Rajasthan, India.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Oncology Practices During Nationwide Lockdown Period: A Single Centre Experience and the Way Forward.
|
NA
|
NA
|
|
Dermatological consultations in the COVID-19 era: is teledermatology the key to social distancing? An Egyptian experience.
|
NA
|
NA
|
|
[Nutritional management of the critically ill inpatient with COVID-19. A narrative review].
|
NA
|
NA
|
|
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach.
|
NA
|
NA
|
|
Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019.
|
NA
|
NA
|
|
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
|
NA
|
NA
|
|
Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review.
|
NA
|
NA
|
|
Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.
|
NA
|
NA
|
|
The Presentation and Diagnosis of the First Known Community-Transmitted Case of SARS-CoV-2 in the Republic of Ireland.
|
NA
|
NA
|
|
Calcineurin inhibitors revisited: A new paradigm for COVID-19?
|
NA
|
NA
|
|
Current pharmacological treatments for SARS-COV-2: A narrative review.
|
NA
|
NA
|
|
Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
|
NA
|
NA
|
|
When science goes viral: The research response during three months of the COVID-19 outbreak.
|
NA
|
NA
|
|
Psychotic symptoms in COVID-19 patients. A retrospective descriptive study.
|
NA
|
NA
|
|
COVID-19 and immunomodulation treatment for women with reproductive failures.
|
NA
|
NA
|
|
Dose-optimised chest computed tomography for diagnosis of Coronavirus Disease 2019 (COVID-19) - Evaluation of image quality and diagnostic impact.
|
NA
|
NA
|
|
COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform.
|
NA
|
NA
|
|
Therapeutic Potential of B-1a Cells in COVID-19.
|
NA
|
NA
|
|
Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention.
|
NA
|
NA
|
|
Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model.
|
NA
|
NA
|
|
Dying still matters in the age of COVID-19.
|
NA
|
NA
|
|
Remote Monitoring of Patients in Quarantine in the Era of SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
|
NA
|
NA
|
|
A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era.
|
NA
|
NA
|
|
Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives.
|
NA
|
NA
|
|
Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak.
|
NA
|
NA
|
|
Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics.
|
NA
|
NA
|
|
Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review.
|
NA
|
NA
|
|
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.
|
NA
|
NA
|
|
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
|
NA
|
NA
|
|
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).
|
NA
|
NA
|
|
Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples.
|
NA
|
NA
|
|
Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas.
|
NA
|
NA
|
|
Successful treatment of coronavirus disease 2019 in a patient with asthma.
|
NA
|
NA
|
|
COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach.
|
NA
|
NA
|
|
Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities.
|
NA
|
NA
|
|
Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.
|
NA
|
NA
|
|
COVID-19 meets Cystic Fibrosis: for better or worse?
|
NA
|
NA
|
|
Coronaviruses’ sugar shields as vaccine candidates.
|
NA
|
NA
|
|
Hypercytokinemia and Pathogen-Host Interaction in COVID-19.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China.
|
NA
|
NA
|
|
Low-grade fever during COVID-19 convalescence: A report of 3 cases.
|
NA
|
NA
|
|
SARS-CoV-2: minireview and review of first case in Foshan, China.
|
NA
|
NA
|
|
Molecular Aspects of Co-morbidities in COVID-19 Infection.
|
NA
|
NA
|
|
Lockdown of an Orthopedic Department during COVID-19 Epidemics, Our Experience in a General Hospital.
|
NA
|
NA
|
|
The Application of a Reduced Dye Used in Orthopedics as a Novel Treatment against Coronavirus (COVID-19): A Suggested Therapeutic Protocol.
|
NA
|
NA
|
|
Association of New Coronavirus Disease with Fragility Hip and Lower Limb Fractures in Elderly Patients.
|
NA
|
NA
|
|
Pathological Role of Angiotensin II in Severe COVID-19.
|
NA
|
NA
|
|
Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community.
|
NA
|
NA
|
|
COVID-19 Clinical Research.
|
NA
|
NA
|
|
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
|
NA
|
NA
|
|
Longitudinal study of interventional radiology activity in a large metropolitan Italian tertiary care hospital: how the COVID-19 pandemic emergency has changed our activity.
|
NA
|
NA
|
|
An international survey in Latin America on the practice of interventional cardiology during the COVID-19 pandemic, with a particular focus on myocardial infarction.
|
NA
|
NA
|
|
A detailed report on the measures taken in the Department of Conservative Dentistry and Periodontology in Munich at the beginning of the COVID-19 outbreak.
|
NA
|
NA
|
|
Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to Surgery.
|
NA
|
NA
|
|
COVID-19: A collision of complement, coagulation and inflammatory pathways.
|
NA
|
NA
|
|
Social Distancing as a Health Behavior: County-Level Movement in the United States During the COVID-19 Pandemic Is Associated with Conventional Health Behaviors.
|
NA
|
NA
|
|
[In-hospital treatment of COVID-19 patients].
|
NA
|
NA
|
|
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.
|
NA
|
NA
|
|
[Infection prevention in dental care during the outbreak of SARS-CoV-2].
|
NA
|
NA
|
|
Suspected COVID-19 case definition: a narrative review of the most frequent signs and symptoms among confirmed cases.
|
NA
|
NA
|
|
How does the quarantine resulting from COVID-19 impact dental appointments and patient anxiety levels?
|
NA
|
NA
|
|
Caring in the age of COVID-19: lessons from science and society.
|
NA
|
NA
|
|
Strategies to deal with the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review.
|
NA
|
NA
|
|
Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach.
|
NA
|
NA
|
|
Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children.
|
NA
|
NA
|
|
Thoracic cancer surgery during the COVID-19 pandemic: a consensus statement from the Thoracic Domain of the Asian Society for Cardiovascular and Thoracic Surgery.
|
NA
|
NA
|
|
Smoking Prevalence and COVID-19 in Europe.
|
NA
|
NA
|
|
COVID-19 trials in Italy: A call for simplicity, top standards and global pooling.
|
NA
|
NA
|
|
Effects of hydroxychloroquine treatment on QT interval.
|
NA
|
NA
|
|
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective.
|
NA
|
NA
|
|
[Application of tracheotomy in the treatment of severe cases of COVID-19].
|
NA
|
NA
|
|
Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro).
|
NA
|
NA
|
|
Magneto-Optical Nanostructures for Viral Sensing.
|
NA
|
NA
|
|
COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
|
NA
|
NA
|
|
Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
|
NA
|
NA
|
|
COVID-19: A Window of Opportunity for Positive Healthcare Reforms.
|
NA
|
NA
|
|
Clinical Profile of Covid-19 Infected Patients Admitted in a Tertiary Care Hospital in North India.
|
NA
|
NA
|
|
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
|
NA
|
NA
|
|
Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?
|
NA
|
NA
|
|
Topological analysis of SARS CoV-2 main protease.
|
NA
|
NA
|
|
Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
|
NA
|
NA
|
|
Youth mental health in the time of COVID-19.
|
NA
|
NA
|
|
Coping with the COVID-19 crisis: an overview of service adaptation and challenges encountered by a rural Psychiatry of Later Life (POLL) team.
|
NA
|
NA
|
|
Outcomes of a Rapid Adolescent Telehealth Scale-Up During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis.
|
NA
|
NA
|
|
Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.
|
NA
|
NA
|
|
Clinical management of COVID-19.
|
NA
|
NA
|
|
COVID-19 pandemic from an ophthalmology point of view.
|
NA
|
NA
|
|
Knowledge, Attitude and Practice Towards COVID-19 Among Chronic Disease Patients at Addis Zemen Hospital, Northwest Ethiopia.
|
NA
|
NA
|
|
Unclear Issues Regarding COVID-19.
|
NA
|
NA
|
|
Lessons Learned so Far from the Pandemic: A Review on Pregnants and Neonates with COVID-19.
|
NA
|
NA
|
|
Multiple Fatalities in a Family Cluster of COVID-19 With Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
|
NA
|
NA
|
|
Impact of COVID-19 on orthopaedic care: a call for nonoperative management.
|
NA
|
NA
|
|
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents.
|
NA
|
NA
|
|
Clinical Features of 33 Cases in Children Infected With SARS-CoV-2 in Anhui Province, China-A Multi-Center Retrospective Cohort Study.
|
NA
|
NA
|
|
Strategy for Disease Diagnosis, Progression Prediction, Risk Group Stratification and Treatment-Case of COVID-19.
|
NA
|
NA
|
|
Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium.
|
NA
|
NA
|
|
Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial.
|
NA
|
NA
|
|
[Crisis management strategies of hospitals during the pandemic].
|
NA
|
NA
|
|
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.
|
NA
|
NA
|
|
Evaluation of Nutrition Risk and Its Association With Mortality Risk in Severely and Critically Ill COVID-19 Patients.
|
NA
|
NA
|
|
How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients.
|
NA
|
NA
|
|
Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
|
NA
|
NA
|
|
Dealing with Community Mental Health post the Fukushima disaster: lessons learnt for the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 in two infants in China.
|
NA
|
NA
|
|
The chronicle of COVID-19: possible strategies to curb the pandemic.
|
NA
|
NA
|
|
Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis.
|
NA
|
NA
|
|
Similarities and Differences in COVID-19 Awareness, Concern, and Symptoms by Race and Ethnicity in the United States: Cross-Sectional Survey.
|
NA
|
NA
|
|
CT characteristics and diagnostic value of COVID-19 in pregnancy.
|
NA
|
NA
|
|
Expert opinion on the management and follow-up of uveitis patients during SARS-CoV-2 outbreak.
|
NA
|
NA
|
|
Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
|
NA
|
NA
|
|
Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
|
NA
|
NA
|
|
Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study.
|
NA
|
NA
|
|
Heparin 2.0: A New Approach to the Infection Crisis.
|
NA
|
NA
|
|
Sudden cardiac death in COVID-19 patients, a report of three cases.
|
NA
|
NA
|
|
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.
|
NA
|
NA
|
|
Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
|
NA
|
NA
|
|
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
|
NA
|
NA
|
|
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.
|
NA
|
NA
|
|
[Comparison of Recovery Phase CT Features between Mild/moderate and Severe/critical Coronavirus Disease 2019 Patients].
|
NA
|
NA
|
|
A critical evaluation of glucocorticoids in the management of severe COVID-19.
|
NA
|
NA
|
|
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
|
NA
|
NA
|
|
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
|
NA
|
NA
|
|
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.
|
NA
|
NA
|
|
Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon λ In Vitro And In Mice.
|
NA
|
NA
|
|
Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
|
NA
|
NA
|
|
Intervention Protocol of the Orthopedics and Traumatology Department of a High-Complexity University Hospital to Cope with the COVID-19 Pandemic.
|
NA
|
NA
|
|
Endocrine Surgery during the COVID-19 Pandemic: Recommendations from the Turkish Association of Endocrine Surgery.
|
NA
|
NA
|
|
Management of Breast Cancer during the COVID-19 Pandemic.
|
NA
|
NA
|
|
How should be the Surgical Treatment Approach during the COVID-19 Pandemic in Patients with Gastrointestinal Cancer?
|
NA
|
NA
|
|
Rich at risk: socio-economic drivers of COVID-19 pandemic spread.
|
NA
|
NA
|
|
Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19): Forecast of an Emerging Urgency in Pakistan.
|
NA
|
NA
|
|
COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center.
|
NA
|
NA
|
|
Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV).
|
NA
|
NA
|
|
[Nursing Division on the current intensive care situation in Germany : Working group of the Nursing Division of the German Society of Medical Intensive Care and Emergency Medicine (DGIIN)].
|
NA
|
NA
|
|
[Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].
|
NA
|
NA
|
|
Early neurological manifestations of hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study.
|
NA
|
NA
|
|
Impact of COVID-19 on oral emergency services.
|
NA
|
NA
|
|
Management of orthopedic oncology patients during coronavirus pandemic.
|
NA
|
NA
|
|
Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: A single tertiary center cohort.
|
NA
|
NA
|
|
Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review.
|
NA
|
NA
|
|
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.
|
NA
|
NA
|
|
Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.
|
NA
|
NA
|
|
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.
|
NA
|
NA
|
|
The Covid-19 pandemic seen from the frontline.
|
NA
|
NA
|
|
Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
|
NA
|
NA
|
|
Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
|
NA
|
NA
|
|
The accuracy of haemoglobin A1c as a screening and diagnostic test for gestational diabetes: a systematic review and meta-analysis of test accuracy studies.
|
NA
|
NA
|
|
Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
COVID-19 Orthopaedic Safe Care Toolset: Guidelines for the Diagnosis and Management of Patients with Fracture and COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of hematological patients concomitant with COVID-19.
|
NA
|
NA
|
|
Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations.
|
NA
|
NA
|
|
Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review.
|
NA
|
NA
|
|
COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates.
|
NA
|
NA
|
|
Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant.
|
NA
|
NA
|
|
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease.
|
NA
|
NA
|
|
An overview of the situation of hand surgery in Spain during the peak of COVID-19 pandemic.
|
NA
|
NA
|
|
CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2.
|
NA
|
NA
|
|
Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19.
|
NA
|
NA
|
|
Case report study of the first five COVID-19 patients treated with remdesivir in France.
|
NA
|
NA
|
|
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
|
NA
|
NA
|
|
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
|
NA
|
NA
|
|
The curative effects of shortwave diathermy on treating Novel coronavirus (COVID-19) pneumonia: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial.
|
NA
|
NA
|
|
Limiting hospital resources for acute appendicitis in children: Lessons learned from the U.S. epicenter of the COVID-19 pandemic.
|
NA
|
NA
|
|
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic.
|
NA
|
NA
|
|
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
|
NA
|
NA
|
|
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia.
|
NA
|
NA
|
|
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges.
|
NA
|
NA
|
|
Cardiopulmonary Resuscitation in Intensive Care Unit Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.
|
NA
|
NA
|
|
Should chest compressions be considered an aerosol-generating procedure? A literature review in response to recent guidelines on personal protective equipment for patients with suspected COVID-19.
|
NA
|
NA
|
|
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
|
NA
|
NA
|
|
Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.
|
NA
|
NA
|
|
Against the odds: unlikely COVID-19 recovery.
|
NA
|
NA
|
|
Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients : Consensus paper of the Medical University of Vienna.
|
NA
|
NA
|
|
Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology.
|
NA
|
NA
|
|
Thalassemia in the emergency department: special considerations for a rare disease.
|
NA
|
NA
|
|
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.
|
NA
|
NA
|
|
A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic.
|
NA
|
NA
|
|
Chest CT practice and protocols for COVID-19 from radiation dose management perspective.
|
NA
|
NA
|
|
Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
|
NA
|
NA
|
|
The Musings of a Family Therapist in Asia When COVID-19 Struck.
|
NA
|
NA
|
|
Infidelity in the Time of COVID-19.
|
NA
|
NA
|
|
[Problems of mental health in the situation of COVID-19 pandemic].
|
NA
|
NA
|
|
[Pandemic and mental adjustment disorders. Therapy options].
|
NA
|
NA
|
|
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19.
|
NA
|
NA
|
|
Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era.
|
NA
|
NA
|
|
Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation
|
NA
|
NA
|
|
The optimal diagnostic methods for COVID-19.
|
NA
|
NA
|
|
Laboratory diagnosis of coronavirus disease-2019 (COVID-19).
|
NA
|
NA
|
|
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
|
NA
|
NA
|
|
Current Status of COVID-19 Therapies and Drug Repositioning Applications.
|
NA
|
NA
|
|
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab.
|
NA
|
NA
|
|
A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting.
|
NA
|
NA
|
|
Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
|
NA
|
NA
|
|
Use of Lung Ultrasound to Differentiate Coronavirus Disease 2019 (COVID-19) Pneumonia From Community-Acquired Pneumonia.
|
NA
|
NA
|
|
(Vi)-rushed Into Online Group Schema Therapy Based Day-Treatment for Older Adults by the COVID-19 Outbreak in the Netherlands.
|
NA
|
NA
|
|
Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?
|
NA
|
NA
|
|
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk.
|
NA
|
NA
|
|
COVID-19 impact on people with diabetes in South and Central America (SACA region).
|
NA
|
NA
|
|
Diabetes and COVID-19: Global and regional perspectives.
|
NA
|
NA
|
|
Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic.
|
NA
|
NA
|
|
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
|
NA
|
NA
|
|
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review.
|
NA
|
NA
|
|
COVID-19 and frequent use of hand sanitizers; human health and environmental hazards by exposure pathways.
|
NA
|
NA
|
|
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines).
|
NA
|
NA
|
|
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
|
NA
|
NA
|
|
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
|
NA
|
NA
|
|
Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic.
|
NA
|
NA
|
|
Advances in detection of infectious agents by aptamer-based technologies.
|
NA
|
NA
|
|
Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective.
|
NA
|
NA
|
|
The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: Insights and clinical strategies from a center at the epicenter.
|
NA
|
NA
|
|
Ayurvedic clinical profile of COVID-19 - A preliminary report.
|
NA
|
NA
|
|
Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital.
|
NA
|
NA
|
|
Cardiovascular disease management during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Pausing the Fight Against Malaria to Combat the COVID-19 Pandemic in Africa: Is the Future of Malaria Bleak?
|
NA
|
NA
|
|
Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.
|
NA
|
NA
|
|
[Instructions for clinical research of oral diseases under the first level response to public health emergencies].
|
NA
|
NA
|
|
[Experts recommendation on the diagnosis and treatment of oral mucosal diseases during prevention and control stage of the novel coronavirus infection].
|
NA
|
NA
|
|
[Management and prevention of dental emergency during corona virus disease 2019 (COVID-19) epidemic].
|
NA
|
NA
|
|
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
Blood donor recruitment in Guangzhou, China, during the 2019 novel coronavirus (COVID-19) epidemic.
|
NA
|
NA
|
|
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
|
NA
|
NA
|
|
COVID-19 and arterial hypertension: Hypothesis or evidence?
|
NA
|
NA
|
|
Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles.
|
NA
|
NA
|
|
Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.
|
NA
|
NA
|
|
Detecting the Coronavirus (COVID-19).
|
NA
|
NA
|
|
Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state.
|
NA
|
NA
|
|
Surgical care of thoracic malignancies during the COVID-19 pandemic in México: An expert consensus guideline from the Sociedad Mexicana de Oncología (SMeO) and the Sociedad Mexicana de Cirujanos Torácicos Generales (SMCTG).
|
NA
|
NA
|
|
Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
|
NA
|
NA
|
|
Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
|
NA
|
NA
|
|
Practical considerations in prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
Nonoperating room anesthesia in different parts of the world.
|
NA
|
NA
|
|
Considerations for the otolaryngologist in the era of COVID-19: a review of the literature.
|
NA
|
NA
|
|
Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation.
|
NA
|
NA
|
|
The Urgency of Spiritual Care: COVID-19 and the Critical Need for Whole-Person Palliation.
|
NA
|
NA
|
|
The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
|
NA
|
NA
|
|
Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.
|
NA
|
NA
|
|
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
|
NA
|
NA
|
|
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits.
|
NA
|
NA
|
|
Snowballing transmission of COVID-19 (SARS-CoV-2) through wastewater: Any sustainable preventive measures to curtail the scourge in low-income countries?
|
NA
|
NA
|
|
MSCOVID19: Using social media to achieve rapid dissemination of health information.
|
NA
|
NA
|
|
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.
|
NA
|
NA
|
|
Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?
|
NA
|
NA
|
|
Acupuncture for breathlessness in COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Failure of early extubation among cases of coronavirus disease-19 respiratory failure: Case report and clinical experience.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.
|
NA
|
NA
|
|
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives.
|
NA
|
NA
|
|
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy.
|
NA
|
NA
|
|
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
|
NA
|
NA
|
|
Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.
|
NA
|
NA
|
|
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
|
NA
|
NA
|
|
Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU.
|
NA
|
NA
|
|
Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
|
NA
|
NA
|
|
Virtual Reality Exercise as a Coping Strategy for Health and Wellness Promotion in Older Adults during the COVID-19 Pandemic.
|
NA
|
NA
|
|
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening.
|
NA
|
NA
|
|
Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
|
NA
|
NA
|
|
Augmenting Evidence-Based Care With a Texting Mobile Interventionist: A Pilot Randomized Controlled Trial.
|
NA
|
NA
|
|
Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.
|
NA
|
NA
|
|
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China.
|
NA
|
NA
|
|
Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Goals of care and COVID-19: A GOOD framework for dealing with uncertainty.
|
NA
|
NA
|
|
Dying patients with COVID-19: What should Hospital Palliative Care Teams (HPCTs) be prepared for?
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of a familial cluster of COVID-19.
|
NA
|
NA
|
|
Endemic and emerging coronavirus pulmonary infections.
|
NA
|
NA
|
|
The Cutting Edge of Thoracic Anesthesia During the Coronavirus Disease 2019 (COVID-19) Outbreak.
|
NA
|
NA
|
|
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide.
|
NA
|
NA
|
|
COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
|
NA
|
NA
|
|
Fan therapy for cough: case report and literature review.
|
NA
|
NA
|
|
Artificial intelligence and COVID-19: A multidisciplinary approach.
|
NA
|
NA
|
|
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention.
|
NA
|
NA
|
|
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain.
|
NA
|
NA
|
|
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
|
NA
|
NA
|
|
First, do no harm: bilateral radial artery occlusion in a COVID-19 patient.
|
NA
|
NA
|
|
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
|
NA
|
NA
|
|
Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?
|
NA
|
NA
|
|
Richard Allen Williams, M.D.: a Career Fighting Disparities and Fostering Equity.
|
NA
|
NA
|
|
Impacts of the COVID-19 pandemic on Iranian patients with epilepsy.
|
NA
|
NA
|
|
The treatment and follow-up of ‘recurrence’ with discharged COVID-19 patients: data from Guizhou, China.
|
NA
|
NA
|
|
Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
|
NA
|
NA
|
|
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis.
|
NA
|
NA
|
|
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
|
NA
|
NA
|
|
Proning in Non-Intubated (PINI) in Times of COVID-19: Case Series and a Review.
|
NA
|
NA
|
|
Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 - more than respiratory disease: a gastroenterologist’s perspective.
|
NA
|
NA
|
|
COVID-19 with bronchogram - a potential indication of prolonged treatment.
|
NA
|
NA
|
|
Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID-19.
|
NA
|
NA
|
|
Risk, resilience, psychological distress, and anxiety at the beginning of the COVID-19 pandemic in Germany.
|
NA
|
NA
|
|
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.
|
NA
|
NA
|
|
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France.
|
NA
|
NA
|
|
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
|
NA
|
NA
|
|
Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations.
|
NA
|
NA
|
|
Safety of Plasma Infusions in Parkinson’s Disease.
|
NA
|
NA
|
|
Novel coronavirus pandemic: A clinical overview.
|
NA
|
NA
|
|
The role of the family physician in the fight against Coronavirus disease 2019 in Nigeria.
|
NA
|
NA
|
|
Why communities must be at the centre of the Coronavirus disease 2019 response: Lessons from Ebola and human immunodeficiency virus in Africa.
|
NA
|
NA
|
|
The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures.
|
NA
|
NA
|
|
How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.
|
NA
|
NA
|
|
The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
|
NA
|
NA
|
|
Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Management and Treatment of Concussions via Tele-Concussion in a Pediatric Setting: Methodological Approach and Descriptive Analysis.
|
NA
|
NA
|
|
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.
|
NA
|
NA
|
|
Kinetics of viral load and antibody response in relation to COVID-19 severity.
|
NA
|
NA
|
|
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
|
NA
|
NA
|
|
A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review.
|
NA
|
NA
|
|
Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19.
|
NA
|
NA
|
|
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease.
|
NA
|
NA
|
|
Corticosteroid therapy for patients with COVID-19 pneumonia: a before-after study.
|
NA
|
NA
|
|
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Application of Artificial Intelligence in COVID-19 drug repurposing.
|
NA
|
NA
|
|
Hypoxemia in COVID-19 patients: An hypothesis.
|
NA
|
NA
|
|
Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China.
|
NA
|
NA
|
|
Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design.
|
NA
|
NA
|
|
Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications.
|
NA
|
NA
|
|
Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
|
NA
|
NA
|
|
Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
|
NA
|
NA
|
|
Provision of Psychotherapy during the COVID-19 Pandemic among Czech, German and Slovak Psychotherapists.
|
NA
|
NA
|
|
COVID-19 Serological Tests: How Well Do They Actually Perform?
|
NA
|
NA
|
|
Frailty and COVID-19: A Systematic Scoping Review.
|
NA
|
NA
|
|
Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
|
NA
|
NA
|
|
Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.
|
NA
|
NA
|
|
Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.
|
NA
|
NA
|
|
Extensively Drug-Resistant Tuberculosis in the Time of COVID-19-How has the Landscape Changed for Pakistan?
|
NA
|
NA
|
|
Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.
|
NA
|
NA
|
|
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.
|
NA
|
NA
|
|
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
|
NA
|
NA
|
|
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.
|
NA
|
NA
|
|
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
|
NA
|
NA
|
|
Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse.
|
NA
|
NA
|
|
COVID-19 in Children: An Ample Review.
|
NA
|
NA
|
|
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
|
NA
|
NA
|
|
Can vitamins and/or supplements provide hope against coronavirus?
|
NA
|
NA
|
|
A severe refractory COVID-19 patient responding to convalescent plasma; A case series.
|
NA
|
NA
|
|
Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients.
|
NA
|
NA
|
|
Packed Red Blood Cell Transfusion as a Potential Treatment Option in COVID-19 Patients With Hypoxemic Respiratory Failure: A Case Report.
|
NA
|
NA
|
|
An Essential Service Decision Model for ABA Providers During Crisis.
|
NA
|
NA
|
|
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
|
NA
|
NA
|
|
Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
|
NA
|
NA
|
|
The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.
|
NA
|
NA
|
|
The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.
|
NA
|
NA
|
|
Management of Allergic Patients During the COVID-19 Pandemic in Asia.
|
NA
|
NA
|
|
Palliative Care Team Involvement in Patients With COVID-19 in New York City.
|
NA
|
NA
|
|
Alternative management of Covid-19 infection.
|
NA
|
NA
|
|
Recommendations for head and neck surgical procedures during the COVID-19 pandemic.
|
NA
|
NA
|
|
Management of non traumatic surgical emergencies during the COVID-19 pandemia.
|
NA
|
NA
|
|
Surgical cancer care in the COVID-19 era: front line views and consensus.
|
NA
|
NA
|
|
Evaluation of patients undergoing emergency surgery in a COVID-19 pandemic hospital: a cross-sectional study.
|
NA
|
NA
|
|
Evaluation of knowledge and attitudes among intensive care physicians during the COVID-19 pandemic: a cross-sectional survey.
|
NA
|
NA
|
|
Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?
|
NA
|
NA
|
|
Increasing handwashing in young children: A brief review.
|
NA
|
NA
|
|
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19.
|
NA
|
NA
|
|
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.
|
NA
|
NA
|
|
The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
|
NA
|
NA
|
|
Concentration-dependent mortality of chloroquine in overdose.
|
NA
|
NA
|
|
The 3 B’s of cancer care amid the COVID-19 pandemic crisis: “Be safe, be smart, be kind”-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.
|
NA
|
NA
|
|
COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients.
|
NA
|
NA
|
|
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
|
NA
|
NA
|
|
The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.
|
NA
|
NA
|
|
The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19.
|
NA
|
NA
|
|
Effect of COVID-19 on Emergent Stroke Care: A Regional Experience.
|
NA
|
NA
|
|
Triage of patients with venous and lymphatic diseases during the COVID-19 pandemic - The Venous and Lymphatic Triage and Acuity Scale (VELTAS) : A consensus document of the International Union of Phlebology (UIP), Australasian College of Phlebology (ACP), American Vein and Lymphatic Society (AVLS), American Venous Forum (AVF), European College of Phlebology (ECoP), European Venous Forum (EVF), Interventional Radiology Society of Australasia (IRSA), Latin American Venous Forum, Pan-American Society of Phlebology and Lymphology and the Venous Association of India (VAI) This consensus document has been co-published in Phlebology [DOI: 10.1177/0268355520930884] and Journal of Vascular Surgery: Venous and Lymphatic Disorders [DOI: 10.1016/j.jvsv.2020.05.002]. The publications are identical except for minor stylistic and spelling differences in keeping with each journal’s style. The contribution has been published under a Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0), (https://creativecommons.org/licenses/by-nc-nd/4.0/).
|
NA
|
NA
|
|
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.
|
NA
|
NA
|
|
Potential impact of SARS-CoV-2 infection on the thymus.
|
NA
|
NA
|
|
Poly(ADP-ribose) Polymerase Inhibition in Acute Lung Injury: A Re-emerging Concept.
|
NA
|
NA
|
|
Current therapies under investigation for COVID-19: potential COVID-19 treatments.
|
NA
|
NA
|
|
The World Goes Bats: Living Longer and Tolerating Viruses.
|
NA
|
NA
|
|
Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease.
|
NA
|
NA
|
|
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
|
NA
|
NA
|
|
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
|
NA
|
NA
|
|
The Outcome and Implications of Public Precautionary Measures in Taiwan-Declining Respiratory Disease Cases in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Global Storm of Stress-Related Psychopathological Symptoms: A Brief Overview on the Usefulness of Virtual Reality in Facing the Mental Health Impact of COVID-19.
|
NA
|
NA
|
|
Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
|
NA
|
NA
|
|
The newly emerged COVID-19 disease: a systemic review.
|
NA
|
NA
|
|
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study.
|
NA
|
NA
|
|
Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.
|
NA
|
NA
|
|
The experience of women infected by the COVID-19 during pregnancy in Brazil: a qualitative study protocol.
|
NA
|
NA
|
|
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
|
NA
|
NA
|
|
Relapsing viral keratoconjunctivitis in COVID-19: a case report.
|
NA
|
NA
|
|
SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
|
NA
|
NA
|
|
COVID-19 stressors on migrant workers in Kuwait: cumulative risk considerations.
|
NA
|
NA
|
|
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
|
NA
|
NA
|
|
Radical change in osteosarcoma surgical plan due to COVID-19 pandemic.
|
NA
|
NA
|
|
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
|
NA
|
NA
|
|
COVID-19: gynecologic cancer surgery at a single center in Madrid.
|
NA
|
NA
|
|
Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition).
|
NA
|
NA
|
|
LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
|
NA
|
NA
|
|
Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection.
|
NA
|
NA
|
|
COVID-19 Pandemic: Can Maintaining Optimal Zinc Balance Enhance Host Resistance?
|
NA
|
NA
|
|
Immunological and inflammatory profiles in mild and severe cases of COVID-19.
|
NA
|
NA
|
|
Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature.
|
NA
|
NA
|
|
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position.
|
NA
|
NA
|
|
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
|
NA
|
NA
|
|
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update.
|
NA
|
NA
|
|
COVID-19: Current Trends in Invitro Diagnostics.
|
NA
|
NA
|
|
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example.
|
NA
|
NA
|
|
Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study.
|
NA
|
NA
|
|
Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far.
|
NA
|
NA
|
|
Rhabdomyolysis in a Patient With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
|
NA
|
NA
|
|
Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
|
NA
|
NA
|
|
Endocrine and metabolic aspects of the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and ethical preparedness?
|
NA
|
NA
|
|
Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
|
NA
|
NA
|
|
Convalescent plasma therapy in patients with COVID-19.
|
NA
|
NA
|
|
Renal complications in COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.
|
NA
|
NA
|
|
Hematological manifestations of COVID-19.
|
NA
|
NA
|
|
Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis.
|
NA
|
NA
|
|
Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.
|
NA
|
NA
|
|
Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.
|
NA
|
NA
|
|
A review on histotechnology practices in COVID-19 pathology investigations.
|
NA
|
NA
|
|
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
|
NA
|
NA
|
|
Functional assessment and function-based treatment delivered via telehealth: A brief summary.
|
NA
|
NA
|
|
Exploring the ways in which COVID-19 and lockdown has affected the lives of adult patients with anorexia nervosa and their carers.
|
NA
|
NA
|
|
COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.
|
NA
|
NA
|
|
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.
|
NA
|
NA
|
|
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
|
NA
|
NA
|
|
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
|
NA
|
NA
|
|
Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
|
NA
|
NA
|
|
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
|
NA
|
NA
|
|
Health-related concerns and precautions during the COVID-19 pandemic: A comparison of Canadians with and without underlying health conditions.
|
NA
|
NA
|
|
Eating disorders during the COVID-19 pandemic and quarantine: an overview of risks and recommendations for treatment and early intervention.
|
NA
|
NA
|
|
Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus.
|
NA
|
NA
|
|
Advances in Telemedicine in Ophthalmology.
|
NA
|
NA
|
|
Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description.
|
NA
|
NA
|
|
SARS-CoV-2 Infection in Febrile Neonates.
|
NA
|
NA
|
|
Introduction: Psychotherapy through the lens of cinema.
|
NA
|
NA
|
|
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
|
NA
|
NA
|
|
Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
|
NA
|
NA
|
|
Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study.
|
NA
|
NA
|
|
SmartPDT®: Smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy.
|
NA
|
NA
|
|
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
|
NA
|
NA
|
|
Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.
|
NA
|
NA
|
|
Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis.
|
NA
|
NA
|
|
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
|
NA
|
NA
|
|
An update on antiviral antibody-based biopharmaceuticals.
|
NA
|
NA
|
|
The impact of COVID-19 on patients with neuromyelitis optica spectrum disorder; a pilot study.
|
NA
|
NA
|
|
A Proposal for Multidisciplinary Tele-Rehabilitation in the Assessment and Rehabilitation of COVID-19 Survivors.
|
NA
|
NA
|
|
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
|
NA
|
NA
|
|
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
|
NA
|
NA
|
|
Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
|
NA
|
NA
|
|
COVID-19 Epidemic: Clinical Characteristics of Patients in Pediatric Isolation Ward.
|
NA
|
NA
|
|
Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic.
|
NA
|
NA
|
|
Radiotherapy after the easing of public restrictions during COVID-19 epidemic.
|
NA
|
NA
|
|
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
|
NA
|
NA
|
|
SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine.
|
NA
|
NA
|
|
Will the COVID-19 Pandemic Change National Security and Healthcare in the Spectrum of Cardiovascular Disease?
|
NA
|
NA
|
|
Liver transplant immunosuppression during the covid-19 pandemic.
|
NA
|
NA
|
|
Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients.
|
NA
|
NA
|
|
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.
|
NA
|
NA
|
|
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
|
NA
|
NA
|
|
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
|
NA
|
NA
|
|
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
|
NA
|
NA
|
|
Deploying Biomolecules as Anti-COVID-19 Agents.
|
NA
|
NA
|
|
A retrospective analysis of the epidemiology, clinical manifestations, and imaging characteristics of familial cluster-onset COVID-19.
|
NA
|
NA
|
|
Establishing a standardized FUO emergency department: design and practice in dealing with COVID-19.
|
NA
|
NA
|
|
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19.
|
NA
|
NA
|
|
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
|
NA
|
NA
|
|
The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine.
|
NA
|
NA
|
|
COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
|
NA
|
NA
|
|
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
[Exploration of fire needling therapy on coronavirus disease 2019].
|
NA
|
NA
|
|
COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
|
NA
|
NA
|
|
COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective.
|
NA
|
NA
|
|
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
|
NA
|
NA
|
|
Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia Region: A report from the Pediatric Oncology East and Mediterranean (POEM) Group.
|
NA
|
NA
|
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
|
NA
|
NA
|
|
A comprehensive appraisal of laboratory biochemistry tests as major predictors of COVID-19 severity.
|
NA
|
NA
|
|
Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!
|
NA
|
NA
|
|
Rapid Scaling Up of Telehealth Treatment for Tobacco-Dependent Cancer Patients During the COVID-19 Outbreak in New York City.
|
NA
|
NA
|
|
Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition?
|
NA
|
NA
|
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Guidelines and Recommendations for Patient Management, Surgical Activities, and Safety in the Maxillofacial Unit and Head and Neck Department During COVID-19 Pandemic.
|
NA
|
NA
|
|
Studying the trend of the novel coronavirus series in Mauritius and its implications.
|
NA
|
NA
|
|
Personalized therapy approach for hospitalized patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and Kidney Transplantation: Results from the TANGO International Transplant Consortium.
|
NA
|
NA
|
|
Liver injury in severe COVID-19 infection: current insights and challenges.
|
NA
|
NA
|
|
SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review.
|
NA
|
NA
|
|
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy.
|
NA
|
NA
|
|
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
|
NA
|
NA
|
|
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
|
NA
|
NA
|
|
Conducting exposure and response prevention treatment for contamination fears during COVID-19: The behavioral immune system impact on clinician approaches to treatment.
|
NA
|
NA
|
|
Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
|
NA
|
NA
|
|
Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept.
|
NA
|
NA
|
|
Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
|
NA
|
NA
|
|
Conspiracy Beliefs Are Associated with Lower Knowledge and Higher Anxiety Levels Regarding COVID-19 among Students at the University of Jordan.
|
NA
|
NA
|
|
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
|
NA
|
NA
|
|
Clinical trials in the time of a pandemic.
|
NA
|
NA
|
|
COVID-19 pandemic and psychological fatigue in Turkey.
|
NA
|
NA
|
|
Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task force.
|
NA
|
NA
|
|
Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19.
|
NA
|
NA
|
|
Evaluation of teleconsultation system in the urological patient during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 in people living with diabetes: An international consensus.
|
NA
|
NA
|
|
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors.
|
NA
|
NA
|
|
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays.
|
NA
|
NA
|
|
Evidence-based medicine and COVID-19: what to believe and when to change.
|
NA
|
NA
|
|
A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
|
NA
|
NA
|
|
When patients refuse COVID-19 testing, quarantine, and social distancing in inpatient psychiatry: clinical and ethical challenges.
|
NA
|
NA
|
|
COVID-19 and medical emergencies in the dental practice.
|
NA
|
NA
|
|
The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
|
NA
|
NA
|
|
Correction to: The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population.
|
NA
|
NA
|
|
COVID-19: clinical issues from the Japan Surgical Society.
|
NA
|
NA
|
|
Pituitary surgery during Covid-19: a first hand experience and evaluation.
|
NA
|
NA
|
|
The role played by traditional Chinese medicine in preventing and treating COVID-19 in China.
|
NA
|
NA
|
|
That Escalated Quickly: Remdesivir’s Place in Therapy for COVID-19.
|
NA
|
NA
|
|
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
|
NA
|
NA
|
|
Tocilizumab for treatment of mechanically ventilated patients with COVID-19.
|
NA
|
NA
|
|
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
|
NA
|
NA
|
|
Factors affecting stability and infectivity of SARS-CoV-2.
|
NA
|
NA
|
|
Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Transmission of SARS-CoV-2 via fecal-oral and aerosols-borne routes: Environmental dynamics and implications for wastewater management in underprivileged societies.
|
NA
|
NA
|
|
Drinking to cope with the pandemic: The unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women.
|
NA
|
NA
|
|
Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea.
|
NA
|
NA
|
|
Chest CT imaging features and clinical outcome of coronavirus disease 2019 (COVID-19): A single-center case study in Ningbo, China.
|
NA
|
NA
|
|
Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP.
|
NA
|
NA
|
|
Cardiac manifestations in COVID-19 patients-A systematic review.
|
NA
|
NA
|
|
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain.
|
NA
|
NA
|
|
Development and execution of a pandemic preparedness plan: Therapeutic medical physics and radiation dosimetry during the COVID-19 crisis.
|
NA
|
NA
|
|
Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment.
|
NA
|
NA
|
|
In Silico Investigation of the SARS CoV2 Protease with Thymoquinone Major Constituent of Nigella Sativa.
|
NA
|
NA
|
|
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
|
NA
|
NA
|
|
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
|
NA
|
NA
|
|
Electroencephalogram (EEG) in COVID-19: A systematic retrospective study.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of 74 Patients With Severe or Critical COVID-19.
|
NA
|
NA
|
|
BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
|
NA
|
NA
|
|
The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China.
|
NA
|
NA
|
|
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
|
NA
|
NA
|
|
Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations.
|
NA
|
NA
|
|
The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions.
|
NA
|
NA
|
|
Adaptation of a Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses - A reply to Fear versus Data.
|
NA
|
NA
|
|
Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019-Infected Patients With Lung Cancer.
|
NA
|
NA
|
|
Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
|
NA
|
NA
|
|
Minimization of spreading of SARS-CoV-2 via household waste produced by subjects affected by COVID-19 or in quarantine.
|
NA
|
NA
|
|
Surfactant-based prophylaxis and therapy against COVID-19: A possibility.
|
NA
|
NA
|
|
COVID-19, palliative care and public health.
|
NA
|
NA
|
|
Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources.
|
NA
|
NA
|
|
The Role of Imaging Techniques in Management of COVID-19 in China: From Diagnosis to Monitoring and Follow-Up.
|
NA
|
NA
|
|
Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.
|
NA
|
NA
|
|
Emerging pharmacological therapies for ARDS: COVID-19 and beyond.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic on Bariatric Surgery: Results from a Worldwide Survey.
|
NA
|
NA
|
|
Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men.
|
NA
|
NA
|
|
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic.
|
NA
|
NA
|
|
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad.
|
NA
|
NA
|
|
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
|
NA
|
NA
|
|
Is wearing a face mask safe for people with epilepsy?
|
NA
|
NA
|
|
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients.
|
NA
|
NA
|
|
Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
|
NA
|
NA
|
|
The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: A case-control study.
|
NA
|
NA
|
|
Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?
|
NA
|
NA
|
|
SARS-CoV-2: An immunogenetics call to arms.
|
NA
|
NA
|
|
First expert elicitation of knowledge on drivers of emergence of the COVID-19 in pets.
|
NA
|
NA
|
|
[Research progress of the impact of COVID-19 outbreak on people living with HIV].
|
NA
|
NA
|
|
Exploring the Impact of COVID-19 on the Sustainability of Health Critical Care Systems in South America.
|
NA
|
NA
|
|
Does “Flattening the Curve” Affect Critical Care Services Delivery for COVID-19? A Global Health Perspective.
|
NA
|
NA
|
|
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
|
NA
|
NA
|
|
Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression.
|
NA
|
NA
|
|
Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients.
|
NA
|
NA
|
|
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea.
|
NA
|
NA
|
|
COVID-19 Pandemic and Africa: From the Situation in Zimbabwe to a Case for Precision Herbal Medicine.
|
NA
|
NA
|
|
Abuse, self-harm and suicidal ideation in the UK during the COVID-19 pandemic.
|
NA
|
NA
|
|
Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
|
NA
|
NA
|
|
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19.
|
NA
|
NA
|
|
Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19.
|
NA
|
NA
|
|
Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic.
|
NA
|
NA
|
|
Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis.
|
NA
|
NA
|
|
Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review.
|
NA
|
NA
|
|
A Contemporary Review of Neurological Sequelae of COVID-19.
|
NA
|
NA
|
|
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
|
NA
|
NA
|
|
Targeting the NLRP3 Inflammasome in Severe COVID-19.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
|
NA
|
NA
|
|
Coronavirus Disease 2019: A Gastroenterologist’s Perspective in May 2020.
|
NA
|
NA
|
|
Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19.
|
NA
|
NA
|
|
First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA.
|
NA
|
NA
|
|
Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report.
|
NA
|
NA
|
|
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.
|
NA
|
NA
|
|
In the eye of the storm: the right ventricle in COVID-19.
|
NA
|
NA
|
|
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic.
|
NA
|
NA
|
|
Clinical Perspective on 2019 Novel Coronavirus Pneumonia: A Systematic Review of Published Case Reports.
|
NA
|
NA
|
|
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases.
|
NA
|
NA
|
|
Acute Effusive Pericarditis: A Late Complication of COVID-19.
|
NA
|
NA
|
|
Fertility Preservation in Cancer Patients During the Coronavirus (COVID-19) Pandemic.
|
NA
|
NA
|
|
Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms: An Analysis of Seven Patients in China.
|
NA
|
NA
|
|
Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study.
|
NA
|
NA
|
|
Re-positive Cases of Nucleic Acid Tests in Discharged Patients With COVID-19: A Follow-Up Study.
|
NA
|
NA
|
|
COVID-19 diagnostic approaches: different roads to the same destination.
|
NA
|
NA
|
|
Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era.
|
NA
|
NA
|
|
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
|
NA
|
NA
|
|
Clinical trials in the pandemic age: What is fit for purpose?
|
NA
|
NA
|
|
COVID-19 screening during fertility treatment: how do guidelines compare against each other?
|
NA
|
NA
|
|
Changes of hematological and immunological parameters in COVID-19 patients.
|
NA
|
NA
|
|
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT.
|
NA
|
NA
|
|
Roadmap to Resuming Care for Liver Diseases after COVID-19.
|
NA
|
NA
|
|
Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
|
NA
|
NA
|
|
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
|
NA
|
NA
|
|
An exploration of how fake news is taking over social media and putting public health at risk.
|
NA
|
NA
|
|
A Case of COVID-19 with Acute Myocardial Infarction and Cardiogenic Shock.
|
NA
|
NA
|
|
Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic.
|
NA
|
NA
|
|
Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
|
NA
|
NA
|
|
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation?
|
NA
|
NA
|
|
Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin.
|
NA
|
NA
|
|
SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
|
NA
|
NA
|
|
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
|
NA
|
NA
|
|
Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.
|
NA
|
NA
|
|
SARS-CoV-2; What We Know so far.
|
NA
|
NA
|
|
Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
|
NA
|
NA
|
|
Tobacco smoking cessation in mental health services during the COVID-19 pandemic.
|
NA
|
NA
|
|
Are Virtual Fracture Clinics During the COVID-19 Pandemic a Potential Alternative for Delivering Fracture Care? A Systematic Review.
|
NA
|
NA
|
|
The Down Side of Prone Positioning: The Case of a Coronavirus 2019 Survivor.
|
NA
|
NA
|
|
Aspergillus fumigatus and pan-azole resistance: who should be concerned?
|
NA
|
NA
|
|
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
|
NA
|
NA
|
|
Modification of a Validated Risk Stratification Tool to Characterize Geriatric Hip Fracture Outcomes and Optimize Care in a Post COVID-19 World.
|
NA
|
NA
|
|
[COVID-19 and kidney disease].
|
NA
|
NA
|
|
Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment.
|
NA
|
NA
|
|
Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
|
NA
|
NA
|
|
Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19.
|
NA
|
NA
|
|
Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.
|
NA
|
NA
|
|
Forecasting the effect of social distancing on COVID-19 autumn-winter outbreak in the metropolitan area of Buenos Aires.
|
NA
|
NA
|
|
[Collateral damage of COVID-19 pandemic in private healthcare centres of Argentina].
|
NA
|
NA
|
|
[Ethical guides, criteria for admission in intensive care, palliative care. Multi-society recommendations for allocation of resources during the COVID-19 pandemic].
|
NA
|
NA
|
|
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
|
NA
|
NA
|
|
COVID-19 and Telepsychiatry: Development of Evidence-Based Guidance for Clinicians.
|
NA
|
NA
|
|
[The naked king in the pandemic: about the production and communication of scientific knowledge at the time of SARS-CoV-2.]
|
NA
|
NA
|
|
[Remote patient monitoring in dialysis patients: the “change of pace” for home dialysis.]
|
NA
|
NA
|
|
[The televideoconsultation in support of home management of the patient with CoViD-19 by general practitioner: the results in some municipalities of the Marche Region.]
|
NA
|
NA
|
|
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Pros and cons of corticosteroid therapy for COVID-19 patients.
|
NA
|
NA
|
|
Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro.
|
NA
|
NA
|
|
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.
|
NA
|
NA
|
|
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
|
NA
|
NA
|
|
Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review.
|
NA
|
NA
|
|
Lung ultrasound in the diagnosis of COVID-19 infection - A case series and review of the literature.
|
NA
|
NA
|
|
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy.
|
NA
|
NA
|
|
A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
|
NA
|
NA
|
|
[Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury].
|
NA
|
NA
|
|
RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
|
NA
|
NA
|
|
Interventions to Reduce Aerosolized Microbes in Dental Practice: A Systematic Review with Network Meta-analysis of Randomized Controlled Trials.
|
NA
|
NA
|
|
Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review.
|
NA
|
NA
|
|
COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
|
NA
|
NA
|
|
NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.
|
NA
|
NA
|
|
Neurological manifestations of COVID-19: a systematic review.
|
NA
|
NA
|
|
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Clinical and Ethical Considerations in Allocation of Ventilators in an Influenza Pandemic or Other Public Health Disaster: A Comparison of the 2007 and 2015 New York State Ventilator Allocation Guidelines.
|
NA
|
NA
|
|
Biosafety for Dental Patients During Dentistry Care After COVID-19: A Review of the Literature.
|
NA
|
NA
|
|
Assisted reproduction and thromboembolic risk in the COVID-19 pandemic.
|
NA
|
NA
|
|
Are sex discordant outcomes in COVID-19 related to sex hormones?
|
NA
|
NA
|
|
Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study.
|
NA
|
NA
|
|
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.
|
NA
|
NA
|
|
Reorganisation of primary care for older adults during COVID-19: a cross-sectional database study in the UK.
|
NA
|
NA
|
|
Redesigning Primary Care to Address the COVID-19 Pandemic in the Midst of the Pandemic.
|
NA
|
NA
|
|
Informing critical care drug requirements in response to the COVID-19 pandemic.
|
NA
|
NA
|
|
The molecular virology of coronaviruses.
|
NA
|
NA
|
|
Immune-mediated approaches against COVID-19.
|
NA
|
NA
|
|
Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia.
|
NA
|
NA
|
|
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease.
|
NA
|
NA
|
|
An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2.
|
NA
|
NA
|
|
Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study.
|
NA
|
NA
|
|
Recommendations for the prevention and treatment of the novel coronavirus pneumonia in the elderly in China.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore.
|
NA
|
NA
|
|
Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM.
|
NA
|
NA
|
|
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool.
|
NA
|
NA
|
|
Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?
|
NA
|
NA
|
|
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
|
NA
|
NA
|
|
Diabetes and Novel Coronavirus Infection: Implications for Treatment.
|
NA
|
NA
|
|
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
|
NA
|
NA
|
|
Harnessing the Power of Hospitalists in Operational Disaster Planning: COVID-19.
|
NA
|
NA
|
|
Addressing male sexual and reproductive health in the wake of COVID-19 outbreak.
|
NA
|
NA
|
|
Ongoing transcatheter aortic valve implantation (TAVI) practice amidst a global COVID-19 crisis: nurse-led analgesia for transfemoral TAVI.
|
NA
|
NA
|
|
The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection.
|
NA
|
NA
|
|
Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.
|
NA
|
NA
|
|
Opportunities for biomaterials to address the challenges of COVID-19.
|
NA
|
NA
|
|
The use of IV vitamin C for patients with COVID-19: a case series.
|
NA
|
NA
|
|
COVID-19 in multiple sclerosis: The Dutch experience.
|
NA
|
NA
|
|
Patient Perceptions of Head and Neck Ambulatory Telemedicine Visits: A Qualitative Study.
|
NA
|
NA
|
|
Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses.
|
NA
|
NA
|
|
Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: A case series.
|
NA
|
NA
|
|
Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
|
NA
|
NA
|
|
Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer’s Dementia Patients with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
|
NA
|
NA
|
|
Awareness and concerns about novel coronavirus disease 2019 (COVID-19) among parents of pediatric liver transplant recipients.
|
NA
|
NA
|
|
COVID-19 Considerations in Pediatric Dentistry.
|
NA
|
NA
|
|
A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.
|
NA
|
NA
|
|
Tackling the cytokine storm in COVID-19, challenges and hopes.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on the Utilization of Hospice Care Services: A Cohort Study in Taiwan.
|
NA
|
NA
|
|
Repercussions of COVID-19 pandemic on municipal solid waste management: Challenges and opportunities.
|
NA
|
NA
|
|
COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection.
|
NA
|
NA
|
|
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
|
NA
|
NA
|
|
COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry.
|
NA
|
NA
|
|
Efficacy of acupuncture and moxibustion in adjuvant treatment of patients with novel coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
The efficacy of acupuncture for improving the side effects of COVID-19 western medicine treatments: A protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
An uncommon manifestation of COVID-19 pneumonia on CT scan with small cavities in the lungs: A case report.
|
NA
|
NA
|
|
Tuina (massage) therapy for diarrhea in COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
|
NA
|
NA
|
|
Immunopathogenesis of COVID-19 and early immunomodulators.
|
NA
|
NA
|
|
Considerations on COVID-19 pregnancy: a cases series during outbreak in Bergamo Province, North Italy.
|
NA
|
NA
|
|
Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
|
NA
|
NA
|
|
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
|
NA
|
NA
|
|
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
|
NA
|
NA
|
|
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
|
NA
|
NA
|
|
SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
|
NA
|
NA
|
|
Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
|
NA
|
NA
|
|
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial.
|
NA
|
NA
|
|
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
|
NA
|
NA
|
|
COVID-19 Outbreak and Management Approach for Families with Children on Long-Term Kidney Replacement Therapy.
|
NA
|
NA
|
|
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol.
|
NA
|
NA
|
|
COVID-19 pandemic: changes in cancer admissions.
|
NA
|
NA
|
|
Effects of respiratory rehabilitation on patients with novel coronavirus (COVID-19) pneumonia in the rehabilitation phase: protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer.
|
NA
|
NA
|
|
Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
|
NA
|
NA
|
|
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
|
NA
|
NA
|
|
CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatment.
|
NA
|
NA
|
|
Management of hip fractures during the COVID-19 pandemic at a high-volume hip fracture unit in the United Kingdom.
|
NA
|
NA
|
|
Current strategies against COVID-19.
|
NA
|
NA
|
|
Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
|
NA
|
NA
|
|
Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment.
|
NA
|
NA
|
|
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment.
|
NA
|
NA
|
|
Immune Thrombocytopenic Purpura in Patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia.
|
NA
|
NA
|
|
Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection.
|
NA
|
NA
|
|
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment.
|
NA
|
NA
|
|
Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
|
NA
|
NA
|
|
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19.
|
NA
|
NA
|
|
Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options.
|
NA
|
NA
|
|
Machine learning to assist clinical decision-making during the COVID-19 pandemic.
|
NA
|
NA
|
|
Experts consensus on epidemic prevention and control in radiotherapy centers during the COVID-19 outbreak: Experiences from Sichuan Province.
|
NA
|
NA
|
|
Rapid Critical Care Training of Nurses in the Surge Response to the Coronavirus Pandemic.
|
NA
|
NA
|
|
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.
|
NA
|
NA
|
|
Germany’s first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Covid-19 and diabesity: when a pandemia cross another pandemia.
|
NA
|
NA
|
|
The use of mechanistic reasoning in assessing coronavirus interventions.
|
NA
|
NA
|
|
Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine.
|
NA
|
NA
|
|
Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.
|
NA
|
NA
|
|
Perioperative management of COVID-19 patients undergoing cardiac surgery with cardiopulmonary bypass.
|
NA
|
NA
|
|
Care Delivery for Children With Epilepsy During the COVID-19 Pandemic: An International Survey of Clinicians.
|
NA
|
NA
|
|
COVID 19 and manual therapy: international lessons and perspectives on current and future clinical practice and education.
|
NA
|
NA
|
|
Neurological manifestations of SARS-CoV-2 - a systemic review.
|
NA
|
NA
|
|
Cardiac surgery in the time of the novel coronavirus: Why we should think to a new normal.
|
NA
|
NA
|
|
Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol. A cross-sectional study.
|
NA
|
NA
|
|
Severe coronavirus infection in pregnancy: challenging cases report.
|
NA
|
NA
|
|
Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.
|
NA
|
NA
|
|
The medical decision-making process in the time of the coronavirus pandemic.
|
NA
|
NA
|
|
Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology.
|
NA
|
NA
|
|
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.
|
NA
|
NA
|
|
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
|
NA
|
NA
|
|
Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
|
NA
|
NA
|
|
Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.
|
NA
|
NA
|
|
Mortality of high-risk orthopaedic oncology patients during the COVID-19 pandemic: A prospective cohort study.
|
NA
|
NA
|
|
Discordance of COVID-19 guidelines for patients with cancer: A systematic review.
|
NA
|
NA
|
|
Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices.
|
NA
|
NA
|
|
COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation.
|
NA
|
NA
|
|
The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.
|
NA
|
NA
|
|
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis.
|
NA
|
NA
|
|
Let food be the medicine, but not for coronavirus: Nutrition and food science, telling myths from facts.
|
NA
|
NA
|
|
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.
|
NA
|
NA
|
|
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection.
|
NA
|
NA
|
|
COVID-19-Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.
|
NA
|
NA
|
|
Potently neutralizing and protective human antibodies against SARS-CoV-2.
|
NA
|
NA
|
|
Current laboratory diagnosis of coronavirus disease 2019.
|
NA
|
NA
|
|
Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
|
NA
|
NA
|
|
Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.
|
NA
|
NA
|
|
Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on “The Diagnosis and Treatment Program for Coronavirus Disease-2019” from Chinese Authority.
|
NA
|
NA
|
|
Axillary vein thrombosis in COVID positive patient with midline and continuous positive airway pressure Helmet.
|
NA
|
NA
|
|
Peri and postmenopausal women in times of coronavirus pandemic.
|
NA
|
NA
|
|
Learning from COVID-19 to improve access to physiotherapy.
|
NA
|
NA
|
|
Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.
|
NA
|
NA
|
|
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.
|
NA
|
NA
|
|
COVID-19: minimising contaminated aerosol spreading during CPAP treatment.
|
NA
|
NA
|
|
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
|
NA
|
NA
|
|
Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research.
|
NA
|
NA
|
|
COVID-19 vaccine development and a potential nanomaterial path forward.
|
NA
|
NA
|
|
Addressing the Problem of Severe Underinvestment in Mental Health and Well-Being from a Human Rights Perspective.
|
NA
|
NA
|
|
Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.
|
NA
|
NA
|
|
Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19).
|
NA
|
NA
|
|
Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic.
|
NA
|
NA
|
|
Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
|
NA
|
NA
|
|
Pharmacotherapics Advice in Guidelines for COVID-19.
|
NA
|
NA
|
|
Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy.
|
NA
|
NA
|
|
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
|
NA
|
NA
|
|
Severe COVID-19: NLRP3 Inflammasome Dysregulated.
|
NA
|
NA
|
|
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts.
|
NA
|
NA
|
|
Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.
|
NA
|
NA
|
|
Saudi Arabia, pharmacists and COVID-19 pandemic.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Cardiovascular Syndrome: Etiology, Outcomes, and Management.
|
NA
|
NA
|
|
SARS-CoV-2 (COVID 19) Infection in Hypertensive Patients and in Patients With Cardiac Disease.
|
NA
|
NA
|
|
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.
|
NA
|
NA
|
|
False-Negative Nasopharyngeal Swab RT-PCR Assays in Typical COVID-19: Role of Ultra-low-dose Chest CT and Bronchoscopy in Diagnosis.
|
NA
|
NA
|
|
Epidemiologic Characteristics, Transmission Chain, and Risk Factors of Severe Infection of COVID-19 in Tianjin, a Representative Municipality City of China.
|
NA
|
NA
|
|
The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.
|
NA
|
NA
|
|
Mapping population mental health concerns related to COVID-19 and the consequences of physical distancing: a Google trends analysis.
|
NA
|
NA
|
|
Personalized Ventilation to Multiple Patients Using a Single Ventilator: Description and Proof of Concept.
|
NA
|
NA
|
|
Critical Care Clinician Reports on Coronavirus Disease 2019: Results From a National Survey of 4,875 ICU Providers.
|
NA
|
NA
|
|
Proposal for Coronavirus Disease 2019 Management.
|
NA
|
NA
|
|
Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
COVID-19 pandemic: management of patients affected by SARS-CoV-2 in Rome COVID Hospital 2 Trauma Centre and safety of our surgical team.
|
NA
|
NA
|
|
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.
|
NA
|
NA
|
|
Outcomes of elective head and neck confirmed or suspected cancer surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.
|
NA
|
NA
|
|
Targeting zinc metalloenzymes in coronavirus disease 2019.
|
NA
|
NA
|
|
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
|
NA
|
NA
|
|
Rehabilitation needs of the first cohort of post-acute COVID-19 patients in Hubei, China.
|
NA
|
NA
|
|
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.
|
NA
|
NA
|
|
Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Epidemiology, prognosis, and clinical manifestation of cardiovascular disease in COVID-19.
|
NA
|
NA
|
|
Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches.
|
NA
|
NA
|
|
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
|
NA
|
NA
|
|
An integrated electronic health record facilitates a safer and more efficient rural outreach haematology service.
|
NA
|
NA
|
|
COVID-19 and ageism: How positive and negative responses impact older adults and society.
|
NA
|
NA
|
|
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
|
NA
|
NA
|
|
Coping With Trauma, Celebrating Life: Reinventing Patient And Staff Support During The COVID-19 Pandemic.
|
NA
|
NA
|
|
Ultraviolet A light effectively reduces bacteria and viruses including coronavirus.
|
NA
|
NA
|
|
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
|
NA
|
NA
|
|
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child.
|
NA
|
NA
|
|
The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany.
|
NA
|
NA
|
|
Indian Publications on SARS-CoV-2: A bibliometric study of WHO COVID-19 database.
|
NA
|
NA
|
|
COVID-19 pandemic and its recovery time of patients in India: A pilot study.
|
NA
|
NA
|
|
Cytokine prediction of mortality in COVID19 patients.
|
NA
|
NA
|
|
Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
|
NA
|
NA
|
|
Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
|
NA
|
NA
|
|
Pediatric COVID-19 Disease: A Review of the Recent Literature.
|
NA
|
NA
|
|
[ECMO Therapy in a Case of Severe ARDS Related to COVID-19].
|
NA
|
NA
|
|
Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis.
|
NA
|
NA
|
|
Oncology Clinical Trials During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Telemedicine Use in Oncology Practices.
|
NA
|
NA
|
|
Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris.
|
NA
|
NA
|
|
Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
|
NA
|
NA
|
|
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
|
NA
|
NA
|
|
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
|
NA
|
NA
|
|
Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics.
|
NA
|
NA
|
|
A Mixed-Methods Pilot Study of Perinatal Risk and Resilience During COVID-19.
|
NA
|
NA
|
|
Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV).
|
NA
|
NA
|
|
Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study.
|
NA
|
NA
|
|
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients.
|
NA
|
NA
|
|
How a Barcelona Post-Acute Facility became a Referral Center for Comprehensive Management of Subacute Patients With COVID-19.
|
NA
|
NA
|
|
Guideline for diagnosis and treatment of spine trauma in the epidemic of COVID-19.
|
NA
|
NA
|
|
Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
|
NA
|
NA
|
|
Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement of the Italian Association of Clinical Diabetologists (AMD) and the Italian Diabetes Society (SID), diabetes, and pregnancy study group.
|
NA
|
NA
|
|
Contribution of traditional Chinese medicine to the treatment of COVID-19.
|
NA
|
NA
|
|
Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery.
|
NA
|
NA
|
|
Use of aerosol protective barrier in a patient with impending cholangitis and unknown COVID-19 status undergoing emergency ERCP during COVID-19 pandemic.
|
NA
|
NA
|
|
Lingual compression for acute macroglossia in a COVID-19 positive patient.
|
NA
|
NA
|
|
COVID-19: guidance on palliative care from a European Respiratory Society international task force.
|
NA
|
NA
|
|
Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
|
NA
|
NA
|
|
Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: three case reports.
|
NA
|
NA
|
|
Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America.
|
NA
|
NA
|
|
Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience.
|
NA
|
NA
|
|
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives.
|
NA
|
NA
|
|
Impact of COVID-19 on Orthopaedic and Trauma Service: An Epidemiological Study.
|
NA
|
NA
|
|
Usefulness of PCR screening in the initial triage of trauma patients during COVID-19 pandemic.
|
NA
|
NA
|
|
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases.
|
NA
|
NA
|
|
Tracking clinical resources for coronavirus disease 2019.
|
NA
|
NA
|
|
Role for antimalarials in the management of COVID-19.
|
NA
|
NA
|
|
Descriptive Analysis of Patients Living With HIV Affected by COVID-19.
|
NA
|
NA
|
|
COVID-19 Sepsis and Microcirculation Dysfunction.
|
NA
|
NA
|
|
Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
“Small” Intestinal Immunopathology Plays a “Big” Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.
|
NA
|
NA
|
|
Immune Thrombocytopenia Purpura Secondary to COVID-19.
|
NA
|
NA
|
|
Contingency Nursing Management in Designated Hospitals During COVID-19 Outbreak.
|
NA
|
NA
|
|
The arch bridge sign: a newly described CT feature of the coronavirus disease-19 (COVID-19) pneumonia.
|
NA
|
NA
|
|
Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care.
|
NA
|
NA
|
|
Psychosocial and Socio-Economic Crisis in Bangladesh Due to COVID-19 Pandemic: A Perception-Based Assessment.
|
NA
|
NA
|
|
Transmission of droplet-conveyed infectious agents such as SARS-CoV-2 by speech and vocal exercises during speech therapy: preliminary experiment concerning airflow velocity.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on regional STEMI care in Germany.
|
NA
|
NA
|
|
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
|
NA
|
NA
|
|
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.
|
NA
|
NA
|
|
COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.
|
NA
|
NA
|
|
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.
|
NA
|
NA
|
|
Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.
|
NA
|
NA
|
|
Immune thrombocytopenia in a patient with COVID-19.
|
NA
|
NA
|
|
The lady with the lamp: Amid the COVID-19 haze.
|
NA
|
NA
|
|
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin.
|
NA
|
NA
|
|
“A community system”: A critical foundation for the epidemic prevention and control of SARS-CoV-2.
|
NA
|
NA
|
|
Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak.
|
NA
|
NA
|
|
Usefulness of Mobile Computed Tomography in Patients with Coronavirus Disease 2019 Pneumonia: A Case Series.
|
NA
|
NA
|
|
How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer.
|
NA
|
NA
|
|
The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
Telemedicine for the Spine Surgeon in the Age of COVID-19: Multicenter Experiences of Feasibility and Implementation Strategies.
|
NA
|
NA
|
|
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
|
NA
|
NA
|
|
Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study.
|
NA
|
NA
|
|
COVID-19 and Spine Surgery: A Review and Evolving Recommendations.
|
NA
|
NA
|
|
The latitude hypothesis, vitamin D, and SARS-Co-V2.
|
NA
|
NA
|
|
Clinical presentation and management of COVID-19.
|
NA
|
NA
|
|
COVID-19 Preliminary Case Series: Characteristics of EMS Encounters with Linked Hospital Diagnoses.
|
NA
|
NA
|
|
Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations.
|
NA
|
NA
|
|
Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
|
NA
|
NA
|
|
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report.
|
NA
|
NA
|
|
Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.
|
NA
|
NA
|
|
Healthcare workers’ perspectives on healthcare-associated infections and infection control practices: a video-reflexive ethnography study in the Asir region of Saudi Arabia.
|
NA
|
NA
|
|
The Influence of Telehealth for Better Health Across Communities.
|
NA
|
NA
|
|
COVID-19 and Oncology: Operationalizing Best Practices Across Collaborative Health Systems.
|
NA
|
NA
|
|
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
|
NA
|
NA
|
|
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
|
NA
|
NA
|
|
Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.
|
NA
|
NA
|
|
[Dental recommendations in the COVID-19 pandemic: A narrative review].
|
NA
|
NA
|
|
Lopinavir-ritonavir for COVID-19: A living systematic review.
|
NA
|
NA
|
|
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.
|
NA
|
NA
|
|
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
|
NA
|
NA
|
|
A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
|
NA
|
NA
|
|
The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor.
|
NA
|
NA
|
|
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
|
NA
|
NA
|
|
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
|
NA
|
NA
|
|
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
|
NA
|
NA
|
|
Learning from history: do not flatten the curve of antiviral research!
|
NA
|
NA
|
|
Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
|
NA
|
NA
|
|
Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
|
NA
|
NA
|
|
The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
|
NA
|
NA
|
|
SARS-CoV-2 in river water: Implications in low sanitation countries.
|
NA
|
NA
|
|
Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.
|
NA
|
NA
|
|
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children.
|
NA
|
NA
|
|
Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target.
|
NA
|
NA
|
|
Immunologic Effects of Vitamin D on Human Health and Disease.
|
NA
|
NA
|
|
A false promise of COVID-19 ‘big’ health data? Health data integrity and the ethics and realities of Australia’s health information management practice.
|
NA
|
NA
|
|
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
|
NA
|
NA
|
|
Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report.
|
NA
|
NA
|
|
Older adults’ strategies for obtaining medication refills in hypothetical scenarios in the face of COVID-19 risk.
|
NA
|
NA
|
|
Mental Health and Cancer: Why It Is Time to Innovate and Integrate-A Call to Action.
|
NA
|
NA
|
|
Upside down solutions: palliative care and COVID-19.
|
NA
|
NA
|
|
Virtual visits in palliative care: about time or against the grain?
|
NA
|
NA
|
|
Evaluation and management of shock in patients with COVID-19.
|
NA
|
NA
|
|
Kidney Biopsy Findings in Patients with COVID-19.
|
NA
|
NA
|
|
Oncology-inspired treatment options for COVID-19.
|
NA
|
NA
|
|
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.
|
NA
|
NA
|
|
SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view.
|
NA
|
NA
|
|
Identifying Moral Injury in Healthcare Professionals: The Moral Injury Symptom Scale-HP.
|
NA
|
NA
|
|
Coronaviruses in cattle.
|
NA
|
NA
|
|
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
|
NA
|
NA
|
|
Safety perspectives on presently considered drugs for the treatment of COVID-19.
|
NA
|
NA
|
|
Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?
|
NA
|
NA
|
|
Emergency accesses in Dermatology Department during the Covid-19 pandemic in a referral third level center in the north of Italy.
|
NA
|
NA
|
|
Clinical characteristics and outcome of COVID-19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran.
|
NA
|
NA
|
|
Delivering the power of nanomedicine to patients today.
|
NA
|
NA
|
|
Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19.
|
NA
|
NA
|
|
Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease 2019 in New York City.
|
NA
|
NA
|
|
Hospital suicide due to non-treatment by healthcare staff fearing COVID-19 infection in Bangladesh?
|
NA
|
NA
|
|
A pandemic center’s experience of managing pregnant women with COVID-19 infection in Turkey: A prospective cohort study.
|
NA
|
NA
|
|
The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data.
|
NA
|
NA
|
|
Blocking IL-1 to prevent respiratory failure in COVID-19.
|
NA
|
NA
|
|
Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol.
|
NA
|
NA
|
|
SARS-CoV-2: Should We Be Concerned about the Nervous System?
|
NA
|
NA
|
|
How mental health care should change as a consequence of the COVID-19 pandemic.
|
NA
|
NA
|
|
Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
|
NA
|
NA
|
|
Rapid response: activity from a hospital based Urgent Dental Care Centre during the COVID-19 pandemic.
|
NA
|
NA
|
|
Control of SARS-CoV-2 transmission in orthodontic practice.
|
NA
|
NA
|
|
Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand.
|
NA
|
NA
|
|
Advances in the possible treatment of COVID-19: A review.
|
NA
|
NA
|
|
Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
|
NA
|
NA
|
|
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
|
NA
|
NA
|
|
Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.
|
NA
|
NA
|
|
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective.
|
NA
|
NA
|
|
Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
|
NA
|
NA
|
|
Attitudes of patients with relapsing-remitting form of multiple sclerosis using disease-modifying drugs in Montenegro regarding COVID-19 pandemic.
|
NA
|
NA
|
|
The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic?
|
NA
|
NA
|
|
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach.
|
NA
|
NA
|
|
Overview of management of children with COVID-19.
|
NA
|
NA
|
|
Surgical Critical Care at the Epicenter of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
|
NA
|
NA
|
|
Brugada syndrome.
|
NA
|
NA
|
|
Withaferin A: a potential therapeutic agent against COVID-19 infection.
|
NA
|
NA
|
|
[Expert opinion on diagnosis and treatment of coronavirus disease 2019 with traditional Chinese medicine based on “three syndromes and three methods”].
|
NA
|
NA
|
|
[Application of convalescent plasma for the treatment of adult patients with coronavirus disease 2019].
|
NA
|
NA
|
|
[Exploration on the therapeutic mechanisms and safety of blood components of convalescents without erythrocytes on severe acute respiratory syndrome and coronavirus disease 2019].
|
NA
|
NA
|
|
[Analysis of research hotspot and frontier of severe coronavirus disease 2019: visual analysis based on CiteSpace].
|
NA
|
NA
|
|
[A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation].
|
NA
|
NA
|
|
[Retrospective analysis of the on-site treatment of the coronavirus disease 2019 epidemic on the Costa Crociere cruise].
|
NA
|
NA
|
|
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
|
NA
|
NA
|
|
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence-FAST Evidence.
|
NA
|
NA
|
|
Corona virus (Covid-19) - ITS implications in pediatric orthopedic care.
|
NA
|
NA
|
|
Lessons learnt from COVID 19: An Italian multicentric epidemiological study of orthopaedic and trauma services.
|
NA
|
NA
|
|
The Turkish Neonatal Society proposal for the management of COVID-19 in the neonatal intensive care unit.
|
NA
|
NA
|
|
SARS-CoV-2 infection in children.
|
NA
|
NA
|
|
COVID-19: Progress in diagnostics, therapy and vaccination.
|
NA
|
NA
|
|
ENDOCRINE EFFECTS OF COVID 19: DIFFICULTIES IN THE MANAGEMENT OF ENDOCRINE DISORDERS FROM INDIVIDUAL TO SOCIETIES.
|
NA
|
NA
|
|
A case of Inappropriate Antidiuretic Hormone Secretion Syndrome Associated with COVID-19 Pneumonia.
|
NA
|
NA
|
|
Better preventing and mitigating the effects of Covid-19.
|
NA
|
NA
|
|
The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms.
|
NA
|
NA
|
|
Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?
|
NA
|
NA
|
|
Risk of COVID-19 in oncohematological patients.
|
NA
|
NA
|
|
Telecardiology during the Covid-19 pandemic: past mistakes and future hopes.
|
NA
|
NA
|
|
The Role of Interleukin-6 Inhibitors in the Treatment of COVID-19 Infections: A Case Series.
|
NA
|
NA
|
|
The Dilemma of Renal Involvement in COVID-19: A Systematic Review.
|
NA
|
NA
|
|
A Case Report of Polymerase Chain Reaction-Confirmed COVID-19 in a Patient With Right Ventricular Thrombus and Bilateral Deep Vein Thrombosis.
|
NA
|
NA
|
|
Spontaneous Pneumomediastinum Associated With SARS-CoV-2: Infrequent Complication of the Novel Disease.
|
NA
|
NA
|
|
More reliability of suspicious symptoms plus chest CT-scan than RT_PCR test for the diagnosis of COVID-19 in an 18-days-old neonate.
|
NA
|
NA
|
|
Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
|
NA
|
NA
|
|
Rural America’s Hospitals are Not Prepared to Protect Older Adults From a Surge in COVID-19 Cases.
|
NA
|
NA
|
|
Orthopedic telemedicine encounter during the COVID-19 pandemic: A cautionary tale.
|
NA
|
NA
|
|
China’s model to combat the COVID-19 epidemic: a public health emergency governance approach.
|
NA
|
NA
|
|
A proposal for staging COVID-19 coagulopathy.
|
NA
|
NA
|
|
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome.
|
NA
|
NA
|
|
Commentary: Comment on “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis”.
|
NA
|
NA
|
|
Home-based management of knee osteoarthritis during COVID-19 pandemic: literature review and evidence-based recommendations.
|
NA
|
NA
|
|
Thrombosis centres and AVKs monitoring in COVID-19 pandemic.
|
NA
|
NA
|
|
Senolytic drugs: from discovery to translation.
|
NA
|
NA
|
|
Psoriasis and COVID-19: A narrative review with treatment considerations.
|
NA
|
NA
|
|
Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19.
|
NA
|
NA
|
|
Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Psychological Impact of Quarantine on Caregivers at a Children’s Hospital for Contact with Case of COVID-19.
|
NA
|
NA
|
|
Techniques, Methods, and Dissemination of Community-Based Psychological Support Strategies in Times of the COVID-19 Pandemic.
|
NA
|
NA
|
|
QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
|
NA
|
NA
|
|
Multiple sclerosis and COVID-19.
|
NA
|
NA
|
|
[COVID-19: a gendered disease? Possible interpretations and knowledge limitations].
|
NA
|
NA
|
|
Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
|
NA
|
NA
|
|
Effects of Internet Hospital Consultations on Psychological Burdens and Disease Knowledge During the Early Outbreak of COVID-19 in China: Cross-Sectional Survey Study.
|
NA
|
NA
|
|
COVID-19 pandemic: A global health burden.
|
NA
|
NA
|
|
Rapid design and deployment of intensive outpatient, group-based psychiatric care using telehealth during coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Telemedicine in Neurosurgery: Lessons Learned from a Systematic Review of the Literature for the COVID-19 Era and Beyond.
|
NA
|
NA
|
|
Management of Pediatric Ophthalmology Patients During the COVID-19 Outbreak: Experience From an Italian Tertiary Eye Center.
|
NA
|
NA
|
|
COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease.
|
NA
|
NA
|
|
A 46-Year-Old Woman Who Presented with Diabetic Ketoacidosis and COVID-19 Pneumonia with Multiple Pulmonary Thromboemboli: A Case Report.
|
NA
|
NA
|
|
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.
|
NA
|
NA
|
|
Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
|
NA
|
NA
|
|
Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID-19.
|
NA
|
NA
|
|
Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
|
NA
|
NA
|
|
Recommendations for caring for patients with severe and nonsevere COVID-19.
|
NA
|
NA
|
|
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.
|
NA
|
NA
|
|
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
|
NA
|
NA
|
|
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
|
NA
|
NA
|
|
When the fourth water and digital revolution encountered COVID-19.
|
NA
|
NA
|
|
Containing the spread of coronavirus disease 2019 (COVID-19): Meteorological factors and control strategies.
|
NA
|
NA
|
|
Not all worries were created equal: the case of COVID-19 anxiety.
|
NA
|
NA
|
|
Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Non Pharmaceutical Interventions for Optimal Control of COVID-19.
|
NA
|
NA
|
|
PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open.
|
NA
|
NA
|
|
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?
|
NA
|
NA
|
|
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
|
NA
|
NA
|
|
Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban.
|
NA
|
NA
|
|
Hemorrhagic stroke and anticoagulation in COVID-19.
|
NA
|
NA
|
|
Progressive Renal Impairment in an Older Patient with Coronavirus Disease 2019: A Case Report and Literature Review.
|
NA
|
NA
|
|
Up-to-date review of psychotherapy via videoconference: implications and recommendations for the RANZCP Psychotherapy Written Case during the COVID-19 pandemic.
|
NA
|
NA
|
|
Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
|
NA
|
NA
|
|
The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis.
|
NA
|
NA
|
|
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
|
NA
|
NA
|
|
Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older.
|
NA
|
NA
|
|
Uneventful case of COVID-19 in a kidney transplant recipient.
|
NA
|
NA
|
|
Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks.
|
NA
|
NA
|
|
Management of prostate cancer patients during COVID-19 pandemic.
|
NA
|
NA
|
|
A presentation of E-Cigarette vaping associated lung injury (EVALI) caused by THC-Containing electronic smoking device.
|
NA
|
NA
|
|
Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections.
|
NA
|
NA
|
|
Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines.
|
NA
|
NA
|
|
A consensus guideline of herbal medicine for coronavirus disease 2019.
|
NA
|
NA
|
|
[18F]FDG-PET/CT in different COVID-19 phases.
|
NA
|
NA
|
|
Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective.
|
NA
|
NA
|
|
Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the Evidence.
|
NA
|
NA
|
|
COVID-19 and Myocarditis: What Do We Know So Far?
|
NA
|
NA
|
|
Prone Positioning of Patients With Acute Respiratory Distress Syndrome Related to COVID-19: A Rehabilitation-Based Prone Team.
|
NA
|
NA
|
|
Incidental lowering of otitis-media complaints in otitis-prone children during COVID-19 pandemic: not all evil comes to hurt.
|
NA
|
NA
|
|
Impact of the COVID-19 outbreak on acute stroke care.
|
NA
|
NA
|
|
COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption.
|
NA
|
NA
|
|
Continuing surgical care in cancer patients during the nationwide lockdown in the COVID-19 pandemic-Perioperative outcomes from a tertiary care cancer center in India.
|
NA
|
NA
|
|
“Palliative Pandemic Plan,” Triage and Symptoms Algorithm as a Strategy to Decrease Providers’ Exposure, While Trying to Increase Teams Availability and Guidance for Goals of Care (GOC) and Symptoms Control.
|
NA
|
NA
|
|
A case of severe psoriatic erythroderma with COVID-19.
|
NA
|
NA
|
|
Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis.
|
NA
|
NA
|
|
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
|
NA
|
NA
|
|
Co-infection with SARS-CoV-2 and parainfluenza virus in a hemodialysis patient: A case report.
|
NA
|
NA
|
|
Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
|
NA
|
NA
|
|
Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
|
NA
|
NA
|
|
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
|
NA
|
NA
|
|
Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19.
|
NA
|
NA
|
|
Clinical characteristics and treatment of critically ill patients with COVID-19 in Hebei.
|
NA
|
NA
|
|
Tongue diagnosis and treatment in traditional Chinese medicine for severe COVID-19: a case report.
|
NA
|
NA
|
|
Case analysis of novel coronavirus pneumonia in the Second Hospital of Wuhan Iron and Steel Company, Qingshan District, Wuhan, China.
|
NA
|
NA
|
|
Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status.
|
NA
|
NA
|
|
Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment.
|
NA
|
NA
|
|
HIV/SARS-CoV-2 coinfection: A global perspective.
|
NA
|
NA
|
|
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19.
|
NA
|
NA
|
|
Repurposing Existing Drugs for the Treatment of COVID-19.
|
NA
|
NA
|
|
Speech-Language Pathology Management for Adults With COVID-19 in the Acute Hospital Setting: Initial Recommendations to Guide Clinical Practice.
|
NA
|
NA
|
|
A novel antiviral formulation inhibits a range of enveloped viruses.
|
NA
|
NA
|
|
Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA.
|
NA
|
NA
|
|
Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
|
NA
|
NA
|
|
High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS.
|
NA
|
NA
|
|
COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19.
|
NA
|
NA
|
|
Stem cell therapies for COVID-19: Strategy and application.
|
NA
|
NA
|
|
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19.
|
NA
|
NA
|
|
Lessons from the Transition to Relational Teletherapy During COVID-19.
|
NA
|
NA
|
|
Fibrinolysis and COVID-19: a tale of two sites?
|
NA
|
NA
|
|
Delaying Cancer Cases in Urology during COVID-19: Review of the Literature.
|
NA
|
NA
|
|
Risk for dental healthcare professionals during the COVID-19 global pandemic: An evidence-based assessment.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) and Neurosurgery Residency Action Plan: An Institutional Experience from the United States.
|
NA
|
NA
|
|
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
|
NA
|
NA
|
|
Presence and infectivity of SARS-CoV-2 virus in wastewaters and rivers.
|
NA
|
NA
|
|
COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.
|
NA
|
NA
|
|
Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19.
|
NA
|
NA
|
|
A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
|
NA
|
NA
|
|
Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study.
|
NA
|
NA
|
|
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
|
NA
|
NA
|
|
COVID-19 - Important considerations for developing and using a vaccine.
|
NA
|
NA
|
|
Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.
|
NA
|
NA
|
|
A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research.
|
NA
|
NA
|
|
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
|
NA
|
NA
|
|
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology.
|
NA
|
NA
|
|
Apparent and occult infections of medical staff in a COVID-19 designated hospital.
|
NA
|
NA
|
|
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases.
|
NA
|
NA
|
|
Distinct conformational states of SARS-CoV-2 spike protein.
|
NA
|
NA
|
|
The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report.
|
NA
|
NA
|
|
Artificial intelligence in ophthalmology during COVID-19 and in the post COVID-19 era.
|
NA
|
NA
|
|
Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen.
|
NA
|
NA
|
|
Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19.
|
NA
|
NA
|
|
COVID-19 Pandemic and Dental Practice.
|
NA
|
NA
|
|
Brachytherapy in cervical cancer radiotherapy during COVID-19 pandemic crisis: problems and prospects.
|
NA
|
NA
|
|
Operational considerations for peritoneal dialysis management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans.
|
NA
|
NA
|
|
SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience.
|
NA
|
NA
|
|
Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019.
|
NA
|
NA
|
|
The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice.
|
NA
|
NA
|
|
Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness.
|
NA
|
NA
|
|
Cellular Therapy: Shafts of Light Emerging for COVID-19.
|
NA
|
NA
|
|
Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
|
NA
|
NA
|
|
Review of Viral Testing (Polymerase Chain Reaction) and Antibody/Serology Testing for Severe Acute Respiratory Syndrome-Coronavirus-2 for the Intensivist.
|
NA
|
NA
|
|
Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients-A Proof-of-Principle Trial.
|
NA
|
NA
|
|
HIV and SARS-CoV-2: Intersecting Epidemics with Many Unknowns.
|
NA
|
NA
|
|
Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologists (AITN).
|
NA
|
NA
|
|
A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.
|
NA
|
NA
|
|
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy.
|
NA
|
NA
|
|
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines.
|
NA
|
NA
|
|
The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.
|
NA
|
NA
|
|
Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.
|
NA
|
NA
|
|
[Discussion and prospect of infusion of NK cells in the treatment of SARS-CoV-2 infection].
|
NA
|
NA
|
|
Coronavirus disease and basic sanitation: too early to be worried?
|
NA
|
NA
|
|
Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports.
|
NA
|
NA
|
|
Use of remdesivir for patients with Covid-19: a review article.
|
NA
|
NA
|
|
Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
|
NA
|
NA
|
|
Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis.
|
NA
|
NA
|
|
ADHD as a Risk Factor for Infection With Covid-19.
|
NA
|
NA
|
|
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
|
NA
|
NA
|
|
COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.
|
NA
|
NA
|
|
The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: Results from an online survey conducted in the early stages of the pandemic.
|
NA
|
NA
|
|
Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis.
|
NA
|
NA
|
|
Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.
|
NA
|
NA
|
|
Electroconvulsive therapy protocol adaptation during the COVID-19 pandemic.
|
NA
|
NA
|
|
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
|
NA
|
NA
|
|
Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China.
|
NA
|
NA
|
|
Thyrotoxicosis in patients with COVID-19: the THYRCOV study.
|
NA
|
NA
|
|
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
|
NA
|
NA
|
|
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
|
NA
|
NA
|
|
The Hydra-Headed Coronaviruses: Implications of COVID-19 for Homeopathy.
|
NA
|
NA
|
|
COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.
|
NA
|
NA
|
|
Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis.
|
NA
|
NA
|
|
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.
|
NA
|
NA
|
|
Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.
|
NA
|
NA
|
|
Neurological complications of COVID-19: a systematic review.
|
NA
|
NA
|
|
Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19.
|
NA
|
NA
|
|
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence.
|
NA
|
NA
|
|
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
|
NA
|
NA
|
|
Early Impact of the COVID-19 Pandemic on Acute Stroke Treatment Delays.
|
NA
|
NA
|
|
Provision of a consistent national approach to radiation therapy workforce protection measures in Australia during the COVID-19 pandemic.
|
NA
|
NA
|
|
Perfecting detection through education.
|
NA
|
NA
|
|
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment.
|
NA
|
NA
|
|
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
|
NA
|
NA
|
|
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
|
NA
|
NA
|
|
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
|
NA
|
NA
|
|
A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol.
|
NA
|
NA
|
|
Artificial intelligence mobile health platform for early detection of COVID-19 in quarantine subjects using a wearable biosensor: protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.
|
NA
|
NA
|
|
Occupational risks for SARS-CoV-2 infection: the Polish experience.
|
NA
|
NA
|
|
Going digital: how technology use may influence human brains and behavior
.
|
NA
|
NA
|
|
Kawasaki disease in siblings and a review of drug treatment.
|
NA
|
NA
|
|
Peritoneal dialysis in the time of coronavirus disease 2019.
|
NA
|
NA
|
|
Coronavirus disease 2019 in chronic kidney disease.
|
NA
|
NA
|
|
Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation Support in a Young Patient With COVID-19 Infection.
|
NA
|
NA
|
|
Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.
|
NA
|
NA
|
|
Increasing Critical Care Nurse Engagement of Palliative Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Pulmonary contusion during the COVID-19 pandemic: challenges in diagnosis and treatment.
|
NA
|
NA
|
|
The extended autonomic system, dyshomeostasis, and COVID-19.
|
NA
|
NA
|
|
An analysis of YouTube videos as educational resources for dental practitioners to prevent the spread of COVID-19.
|
NA
|
NA
|
|
Planning for the Post-COVID Syndrome: How Payers Can Mitigate Long-Term Complications of the Pandemic.
|
NA
|
NA
|
|
Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19.
|
NA
|
NA
|
|
The first casualty of an epidemic is evidence.
|
NA
|
NA
|
|
Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
|
NA
|
NA
|
|
Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on orthopaedic specialty in Malaysia: A cross-sectional survey.
|
NA
|
NA
|
|
Treating COVID-19: Review of drug hypersensitivity reactions.
|
NA
|
NA
|
|
No body is expendable: Medical rationing and disability justice during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2.
|
NA
|
NA
|
|
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
|
NA
|
NA
|
|
Treatment of Cytokine Storm in COVID-19 Patients with Immunomodulatory Therapy.
|
NA
|
NA
|
|
Protocols and self-checking plans for the safety of post-COVID-19 balneotherapy.
|
NA
|
NA
|
|
Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.
|
NA
|
NA
|
|
A 29-Year-Old Male with a Fatal Case of COVID-19 Acute Respiratory Distress Syndrome (CARDS) and Ventilator-Induced Lung Injury (VILI).
|
NA
|
NA
|
|
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
|
NA
|
NA
|
|
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
|
NA
|
NA
|
|
Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide.
|
NA
|
NA
|
|
Endoscopic mask innovation and protective measures changes during the coronavirus disease-2019 pandemic: Experience from a Chinese hepato-biliary-pancreatic unit.
|
NA
|
NA
|
|
Clozapine in the Time of COVID-19.
|
NA
|
NA
|
|
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea.
|
NA
|
NA
|
|
Environmental side effects of the injudicious use of antimicrobials in the era of COVID-19.
|
NA
|
NA
|
|
Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak.
|
NA
|
NA
|
|
Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
An infant with coronavirus disease 2019 in China: A case report.
|
NA
|
NA
|
|
Integrative role of traditional and modern technologies to combat COVID-19.
|
NA
|
NA
|
|
Management of peritoneal dialysis under COVID-19: The experience in Sichuan Province People’s Hospital, China.
|
NA
|
NA
|
|
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
|
NA
|
NA
|
|
The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities.
|
NA
|
NA
|
|
Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable.
|
NA
|
NA
|
|
[Protection of nephrology health professionals during the COVID-19 pandemic].
|
NA
|
NA
|
|
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.
|
NA
|
NA
|
|
Financial Risk for COVID-19-like Respiratory Hospitalizations in Consumer-Directed Health Plans.
|
NA
|
NA
|
|
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
|
NA
|
NA
|
|
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
|
NA
|
NA
|
|
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
|
NA
|
NA
|
|
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody.
|
NA
|
NA
|
|
The interface of psychiatry and COVID-19: Challenges for management of psychiatric patients.
|
NA
|
NA
|
|
Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.
|
NA
|
NA
|
|
Coronavirus disease 2019 drug discovery through molecular docking.
|
NA
|
NA
|
|
A scoping review of the impact of COVID-19 pandemic on surgical practice.
|
NA
|
NA
|
|
Mental health issues impacting pharmacists during COVID-19.
|
NA
|
NA
|
|
Estimation of the Hidden Population with COVID-19 Disease.
|
NA
|
NA
|
|
Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide.
|
NA
|
NA
|
|
Time to restart: A comparative compilation of triage recommendations in dentistry during the Covid -19 pandemic.
|
NA
|
NA
|
|
Recurrent positive nucleic acid detection in a recovered COVID-19 patient: A case report and literature review.
|
NA
|
NA
|
|
Hemophagocytic syndrome and COVID-19.
|
NA
|
NA
|
|
Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A case series.
|
NA
|
NA
|
|
Social, ethical and behavioural aspects of COVID-19.
|
NA
|
NA
|
|
Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases.
|
NA
|
NA
|
|
[The virology of SARS-CoV-2].
|
NA
|
NA
|
|
Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention.
|
NA
|
NA
|
|
Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study.
|
NA
|
NA
|
|
Rehabilitation and Covid-19: the Cochrane Rehabilitation 2020 rapid living systematic review.
|
NA
|
NA
|
|
No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations.
|
NA
|
NA
|
|
Palliative Care During COVID-19: Data and Visits From Loved Ones.
|
NA
|
NA
|
|
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.
|
NA
|
NA
|
|
Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2.
|
NA
|
NA
|
|
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials.
|
NA
|
NA
|
|
[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
|
NA
|
NA
|
|
Provision of speech-language pathology services for the treatment of speech and language disorders in children during the COVID-19 pandemic: Problems, concerns, and solutions.
|
NA
|
NA
|
|
A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients.
|
NA
|
NA
|
|
Understanding and implementing alternative solutions to address the COVID-19 pandemic in the sense of public health emergencies.
|
NA
|
NA
|
|
Assisted reproduction and Coronavirus in Italy.
|
NA
|
NA
|
|
Treatment of acute respiratory failure in the course of COVID-19. Practical hints from the expert panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society.
|
NA
|
NA
|
|
High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
|
NA
|
NA
|
|
COVID-19-Related Cardiovascular Disease and Practical Considerations for Perioperative Clinicians.
|
NA
|
NA
|
|
Changing patterns of mortality during the COVID-19 pandemic: Population-based modelling to understand palliative care implications.
|
NA
|
NA
|
|
The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
|
NA
|
NA
|
|
SARS-CoV-2 infection in persons living with HIV: A single center prospective cohort.
|
NA
|
NA
|
|
Coinfection of other respiratory pathogens and HIV in COVID-19 patients: Is there a pattern?
|
NA
|
NA
|
|
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
|
NA
|
NA
|
|
COVID-19 and coagulation dysfunction in adults: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Rapid Decline in Telestroke Consults in the Setting of COVID-19.
|
NA
|
NA
|
|
In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
|
NA
|
NA
|
|
Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios.
|
NA
|
NA
|
|
Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care.
|
NA
|
NA
|
|
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
|
NA
|
NA
|
|
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
|
NA
|
NA
|
|
An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment.
|
NA
|
NA
|
|
Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
|
NA
|
NA
|
|
Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center.
|
NA
|
NA
|
|
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
|
NA
|
NA
|
|
Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results.
|
NA
|
NA
|
|
Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
|
NA
|
NA
|
|
Making waves: Wastewater surveillance of SARS-CoV-2 for population-based health management.
|
NA
|
NA
|
|
Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases.
|
NA
|
NA
|
|
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
|
NA
|
NA
|
|
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
|
NA
|
NA
|
|
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.
|
NA
|
NA
|
|
Evaluation of Current Therapies for COVID-19 Treatment.
|
NA
|
NA
|
|
COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges.
|
NA
|
NA
|
|
COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.
|
NA
|
NA
|
|
Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks.
|
NA
|
NA
|
|
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
|
NA
|
NA
|
|
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
|
NA
|
NA
|
|
Clinical Course and Outcomes of Severe Covid-19: A National Scale Study.
|
NA
|
NA
|
|
Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
|
NA
|
NA
|
|
Advance Care Planning (ACP) vs. Advance Serious Illness Preparations and Planning (ASIPP).
|
NA
|
NA
|
|
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications.
|
NA
|
NA
|
|
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns.
|
NA
|
NA
|
|
The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients.
|
NA
|
NA
|
|
Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections.
|
NA
|
NA
|
|
Assessment of the Economic and Health-Care Impact of COVID-19 (SARS-CoV-2) on Public and Private Dental Surgeries in Spain: A Pilot Study.
|
NA
|
NA
|
|
A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
|
NA
|
NA
|
|
Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain.
|
NA
|
NA
|
|
Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study.
|
NA
|
NA
|
|
Follow-up and Management of Kidney Transplant Recipients During the COVID-19 Lockdown: The Experience of an Italian Transplant Center, Including Two Cases of COVID-19 Pneumonia.
|
NA
|
NA
|
|
A case series of novel coronavirus infection in heart transplantation from 2 centers in the pandemic area in the North of Italy.
|
NA
|
NA
|
|
Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.
|
NA
|
NA
|
|
Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study.
|
NA
|
NA
|
|
How COVID-19 Is Testing and Evolving Our Communication Skills.
|
NA
|
NA
|
|
Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK.
|
NA
|
NA
|
|
Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies.
|
NA
|
NA
|
|
To evaluate the effect of COVID-19 pandemic and national lockdown on patient care at a tertiary-care ophthalmology institute.
|
NA
|
NA
|
|
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
|
NA
|
NA
|
|
Crosstalk between COVID-19 and prostate cancer.
|
NA
|
NA
|
|
[Treatment of severe COVID-19 courses in intensive care medicine].
|
NA
|
NA
|
|
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
|
NA
|
NA
|
|
Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
|
NA
|
NA
|
|
Respiratory rehabilitation for post-COVID19 patients in spa centers: first steps from theory to practice.
|
NA
|
NA
|
|
Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
|
NA
|
NA
|
|
Clinical molecular genetics evaluation in women with reproductive failures.
|
NA
|
NA
|
|
Management of patients with Behçet’s disease during the COVID-19 pandemic.
|
NA
|
NA
|
|
Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain.
|
NA
|
NA
|
|
Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Biochemical Dynamics and Clinical Features of Novel Corona Virus (2019-nCoV).
|
NA
|
NA
|
|
Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
|
NA
|
NA
|
|
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
|
NA
|
NA
|
|
Diabetes and COVID-19: A systematic review on the current evidences.
|
NA
|
NA
|
|
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.
|
NA
|
NA
|
|
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.
|
NA
|
NA
|
|
Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
|
NA
|
NA
|
|
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
|
NA
|
NA
|
|
Coronaviruses in wastewater processes: Source, fate and potential risks.
|
NA
|
NA
|
|
Willingness and beliefs associated with reporting travel history to high-risk coronavirus disease 2019 epidemic regions among the Chinese public: a cross-sectional study.
|
NA
|
NA
|
|
Telemedicine for preoperative assessment during a COVID-19 pandemic: Recommendations for clinical care.
|
NA
|
NA
|
|
Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability-Does One Exist?
|
NA
|
NA
|
|
COVID-19 infection and thrombosis.
|
NA
|
NA
|
|
Psychological stress among health care professionals during the 2019 novel coronavirus disease Outbreak: Cases from online consulting customers.
|
NA
|
NA
|
|
Impact of the SARS-CoV-2 epidemic on private ENT consulting practice during the first month of lockdown in Réunion Island in 2020.
|
NA
|
NA
|
|
Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
|
NA
|
NA
|
|
Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19.
|
NA
|
NA
|
|
Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
|
NA
|
NA
|
|
Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Ribavirin therapy for severe COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy.
|
NA
|
NA
|
|
COVID-19: immunopathogenesis and Immunotherapeutics.
|
NA
|
NA
|
|
Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
|
NA
|
NA
|
|
Medication utilization in patients in New York hospitals during the COVID-19 pandemic.
|
NA
|
NA
|
|
Regional anesthesia in the time of COVID-19: a minireview.
|
NA
|
NA
|
|
Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19.
|
NA
|
NA
|
|
Novel coronavirus and trauma surgery: successful infection control from a level I trauma centre.
|
NA
|
NA
|
|
A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry.
|
NA
|
NA
|
|
Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond.
|
NA
|
NA
|
|
COVID-19: A Perspective from Clinical Neurology and Neuroscience.
|
NA
|
NA
|
|
COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation?
|
NA
|
NA
|
|
Chloroquine in fighting COVID-19: good, bad, or both?
|
NA
|
NA
|
|
Clozapine treatment and risk of COVID-19 infection: retrospective cohort study.
|
NA
|
NA
|
|
Biosafety Measures at the Dental Office After the Appearance of COVID-19: A Systematic Review.
|
NA
|
NA
|
|
Prone Positioning in Non-Intubated Patients With COVID-19 Outside of the Intensive Care Unit: More Evidence Needed.
|
NA
|
NA
|
|
Facing the SARS-CoV-2 Outbreak: What Should Obstetricians and Gynecologists Do?
|
NA
|
NA
|
|
The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis.
|
NA
|
NA
|
|
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.
|
NA
|
NA
|
|
Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.
|
NA
|
NA
|
|
Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.
|
NA
|
NA
|
|
Advances and challenges in the prevention and treatment of COVID-19.
|
NA
|
NA
|
|
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
|
NA
|
NA
|
|
COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges.
|
NA
|
NA
|
|
Gastrointestinal Manifestations in COVID-19 Infection and Its Practical Applications.
|
NA
|
NA
|
|
Suspected Virus-Inducing Severe Acute Respiratory Distress Syndrome Treated by Multimodal Therapy Including Extracorporeal Membrane Oxygenation and Immune Modulation Therapy.
|
NA
|
NA
|
|
Obstetric and intensive-care strategies in a high-risk pregnancy with critical respiratory failure due to COVID-19: A case report.
|
NA
|
NA
|
|
Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies.
|
NA
|
NA
|
|
Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?
|
NA
|
NA
|
|
Association between COVID-19 and cardiovascular disease.
|
NA
|
NA
|
|
Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Urological Services in the Era of COVID-19.
|
NA
|
NA
|
|
The protein expression profile of ACE2 in human tissues.
|
NA
|
NA
|
|
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients with Systemic Lupus Erythematosus.
|
NA
|
NA
|
|
Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.
|
NA
|
NA
|
|
Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic.
|
NA
|
NA
|
|
ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.
|
NA
|
NA
|
|
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 and Drug Shortages: A Call to Action.
|
NA
|
NA
|
|
Successful Maternal and Fetal Outcomes in COVID-19 Pregnant Women: An Institutional Approach.
|
NA
|
NA
|
|
Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study.
|
NA
|
NA
|
|
Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters.
|
NA
|
NA
|
|
Decline in Stroke Presentations During COVID-19 Surge.
|
NA
|
NA
|
|
Pandemic Guidance for Stroke Centers Aiding COVID-19 Treatment Teams.
|
NA
|
NA
|
|
Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?
|
NA
|
NA
|
|
Virtual Consultations and the Role of Technology During the COVID-19 Pandemic for People With Type 2 Diabetes: The UK Perspective.
|
NA
|
NA
|
|
Advance Care Planning Among Users of a Patient Portal During the COVID-19 Pandemic: Retrospective Observational Study.
|
NA
|
NA
|
|
Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study.
|
NA
|
NA
|
|
COVID-19 and implications for dermatological and allergological diseases.
|
NA
|
NA
|
|
The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2.
|
NA
|
NA
|
|
Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.
|
NA
|
NA
|
|
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
|
NA
|
NA
|
|
Global Palliative Care Education in the Time of COVID-19.
|
NA
|
NA
|
|
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
|
NA
|
NA
|
|
Signal of increased opioid overdose during COVID-19 from emergency medical services data.
|
NA
|
NA
|
|
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.
|
NA
|
NA
|
|
Municipal solid waste management during the SARS-COV-2 outbreak and lockdown ease: Lessons from Italy.
|
NA
|
NA
|
|
Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology.
|
NA
|
NA
|
|
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
|
NA
|
NA
|
|
New Points of Departure for More Global Influenza Vaccine Use.
|
NA
|
NA
|
|
Interleukin-6 in Rheumatoid Arthritis.
|
NA
|
NA
|
|
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU.
|
NA
|
NA
|
|
Perspectives for the immune plasma treatment of COVID-19.
|
NA
|
NA
|
|
When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: a survey of real-world nephrology practice.
|
NA
|
NA
|
|
Alpha-MSH Targeted Liposomal Nanoparticle for Imaging in Inflammatory Bowel Disease (IBD).
|
NA
|
NA
|
|
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
|
NA
|
NA
|
|
Implementing Smoking Cessation Interventions in a Preoperative Clinic.
|
NA
|
NA
|
|
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19.
|
NA
|
NA
|
|
Statins in COVID-19: is there any foundation?
|
NA
|
NA
|
|
Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection.
|
NA
|
NA
|
|
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.
|
NA
|
NA
|
|
[Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir].
|
NA
|
NA
|
|
Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Lipid treatment in the period COVID-19].
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.
|
NA
|
NA
|
|
Immune response in COVID-19: A review.
|
NA
|
NA
|
|
SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
|
NA
|
NA
|
|
Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study.
|
NA
|
NA
|
|
COVID-19 pandemic: Radiotherapy precautions and preparedness.
|
NA
|
NA
|
|
An advisory by the association of radiation oncologists of India for radiation therapy patients and staff among COVID 19 pandemic.
|
NA
|
NA
|
|
Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening.
|
NA
|
NA
|
|
Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment.
|
NA
|
NA
|
|
COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies.
|
NA
|
NA
|
|
Modified Bhramari Pranayama in Covid 19 Infection.
|
NA
|
NA
|
|
Screening Strategies for COVID-19 in Patients With Hematologic Malignancies.
|
NA
|
NA
|
|
Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up.
|
NA
|
NA
|
|
Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression.
|
NA
|
NA
|
|
COVID-19 Patient Health Prediction Using Boosted Random Forest Algorithm.
|
NA
|
NA
|
|
Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity.
|
NA
|
NA
|
|
Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China.
|
NA
|
NA
|
|
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study.
|
NA
|
NA
|
|
The impact of SARS-CoV-2 (COVID-19) pandemic on trauma bay management and guideline adherence in a European level-one-trauma centre.
|
NA
|
NA
|
|
Heart failure and COVID-19.
|
NA
|
NA
|
|
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
|
NA
|
NA
|
|
Efficacy and safety of decontamination for N95 respirator reuse: a systematic literature search and narrative synthesis.
|
NA
|
NA
|
|
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
|
NA
|
NA
|
|
A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs.
|
NA
|
NA
|
|
Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia.
|
NA
|
NA
|
|
Early impact of COVID-19 on individuals with self-reported eating disorders: A survey of ~1,000 individuals in the United States and the Netherlands.
|
NA
|
NA
|
|
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
|
NA
|
NA
|
|
COVID-19 Pandemic Response: Development of Outpatient Palliative Care Toolkit Based on Narrative Communication.
|
NA
|
NA
|
|
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
|
NA
|
NA
|
|
Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
|
NA
|
NA
|
|
In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV.
|
NA
|
NA
|
|
[Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts’ Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association].
|
NA
|
NA
|
|
[Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)].
|
NA
|
NA
|
|
A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19.
|
NA
|
NA
|
|
Expanding frontiers of risk management: care safety in nursing home during COVID-19 pandemic.
|
NA
|
NA
|
|
The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City.
|
NA
|
NA
|
|
[MANAGING LUNG CANCER PATIENTS’ CARE DURING THE COVID-19 PANDEMIC].
|
NA
|
NA
|
|
Heparin-Induced Thrombocytopenia in COVID-19.
|
NA
|
NA
|
|
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
|
NA
|
NA
|
|
Ensuring Quality Care in the COVID-19 Era: Applying the Donabedian Model to Tertiary Wound Care Center Practices.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of 2019 novel coronavirus disease patients presenting with initial gastrointestinal symptoms in Wuhan, China: A retrospective cohort study.
|
NA
|
NA
|
|
Immunometabolic Status of COVID-19 Cancer Patients.
|
NA
|
NA
|
|
Evolving Consensus Experience of the IUSG-IOIS-FOIS with Uveitis in the Time of COVID-19 Infection.
|
NA
|
NA
|
|
OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath.
|
NA
|
NA
|
|
Dying From COVID-19: Loneliness, End-of-Life Discussions, and Support for Patients and Their Families in Nursing Homes and Hospitals. A National Register Study.
|
NA
|
NA
|
|
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
|
NA
|
NA
|
|
Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19.
|
NA
|
NA
|
|
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
|
NA
|
NA
|
|
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change.
|
NA
|
NA
|
|
‘The Double-Edged Sword’ - An hypothesis for Covid-19-induced salivary biomarkers.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview.
|
NA
|
NA
|
|
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
|
NA
|
NA
|
|
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
|
NA
|
NA
|
|
Deep transfer learning artificial intelligence accurately stages COVID-19 lung disease severity on portable chest radiographs.
|
NA
|
NA
|
|
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce.
|
NA
|
NA
|
|
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Technique to Minimize Aerosolization During Percutaneous Tracheostomy in COVID-19 Patients.
|
NA
|
NA
|
|
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
|
NA
|
NA
|
|
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia.
|
NA
|
NA
|
|
Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study.
|
NA
|
NA
|
|
Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study.
|
NA
|
NA
|
|
Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic.
|
NA
|
NA
|
|
The efficacy of rituximab in patients with mucous membrane pemphigoid.
|
NA
|
NA
|
|
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
|
NA
|
NA
|
|
Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?
|
NA
|
NA
|
|
COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
|
NA
|
NA
|
|
A Systematic Analysis of Studies on Corona Virus Disease 19 (COVID-19) from Viral Emergence to Treatment.
|
NA
|
NA
|
|
COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management.
|
NA
|
NA
|
|
Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Colorectal surgery obesity-related morbidity during COVID-19.
|
NA
|
NA
|
|
Safe handling of clothing and hygiene of patients and health professionals: Scoping review.
|
NA
|
NA
|
|
Drug Discovery Strategies for SARS-CoV-2.
|
NA
|
NA
|
|
Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection.
|
NA
|
NA
|
|
CoViD-19 and psychiatry: can mental illness justify further exceptions to the obligation to stay at home?
|
NA
|
NA
|
|
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
|
NA
|
NA
|
|
A Comprehensive Strategy for Laser Corneal Refractive Surgery during the COVID-19 Epidemic in a Tertiary Teaching Hospital in Wenzhou, China.
|
NA
|
NA
|
|
COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management.
|
NA
|
NA
|
|
Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?
|
NA
|
NA
|
|
Preliminary results of SARS-CoV-2 detection in sewerage system in Niterói municipality, Rio de Janeiro, Brazil.
|
NA
|
NA
|
|
COVID-19 outbreak: organisation of a geriatric assessment and coordination unit. A French example.
|
NA
|
NA
|
|
Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
|
NA
|
NA
|
|
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
|
NA
|
NA
|
|
Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
|
NA
|
NA
|
|
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review.
|
NA
|
NA
|
|
SARS-CoV-2 infection associated acute kidney injury in patients with pre-existing chronic renal disease: A report of two cases.
|
NA
|
NA
|
|
COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes.
|
NA
|
NA
|
|
Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control.
|
NA
|
NA
|
|
Epidemiology, clinical characteristics of the first cases of COVID-19.
|
NA
|
NA
|
|
Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network.
|
NA
|
NA
|
|
The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.
|
NA
|
NA
|
|
[Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
|
NA
|
NA
|
|
[Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
|
NA
|
NA
|
|
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].
|
NA
|
NA
|
|
[Analysis on formula of Mongolian medicine for prevention of COVID-19].
|
NA
|
NA
|
|
[Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].
|
NA
|
NA
|
|
[Analysis of potential role of Chinese classic prescriptions in treatment of COVID-19 based on TCMATCOV platform].
|
NA
|
NA
|
|
Characteristics of Acute Pulmonary Embolism in Patients With COVID-19 Associated Pneumonia From the City of Wuhan.
|
NA
|
NA
|
|
Nursing Management of Severe COVID-19 Patients Undergoing Extracorporeal Membrane Oxygenation Combined with Prone Position Ventilation.
|
NA
|
NA
|
|
Progress in Treatment of Myocardial Injury in Patients with 2019-nCoV: A Chinese Experience.
|
NA
|
NA
|
|
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature.
|
NA
|
NA
|
|
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
|
NA
|
NA
|
|
Management of Agitation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results.
|
NA
|
NA
|
|
Interplay between SARS-CoV-2 and the type I interferon response.
|
NA
|
NA
|
|
Estimation of COVID-19 spread curves integrating global data and borrowing information.
|
NA
|
NA
|
|
Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
|
NA
|
NA
|
|
Assessment of individuals’ attitude, knowledge and anxiety towards COVID-19 at the first period of the outbreak in Turkey: A web-based cross-sectional survey.
|
NA
|
NA
|
|
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with PAH or CTEPH and Impact on the Process of Care.
|
NA
|
NA
|
|
Appropriate use of tocilizumab in COVID-19 infection.
|
NA
|
NA
|
|
Gamma Knife Radiosurgery for Treatment of Brain Metastases during the COVID-19 Outbreak.
|
NA
|
NA
|
|
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
3D Printing to Support the Shortage in Personal Protective Equipment Caused by COVID-19 Pandemic.
|
NA
|
NA
|
|
A GNSS-Based Crowd-Sensing Strategy for Specific Geographical Areas.
|
NA
|
NA
|
|
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.
|
NA
|
NA
|
|
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
|
NA
|
NA
|
|
[Clinical characteristics and death risk factors of severe COVID-19].
|
NA
|
NA
|
|
[Clinical characteristics and outcome of 64 patients with severe COVID-19].
|
NA
|
NA
|
|
Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study.
|
NA
|
NA
|
|
Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study.
|
NA
|
NA
|
|
Identifying and combating the impacts of COVID-19 on malaria.
|
NA
|
NA
|
|
SARS-CoV-2: characteristics and current advances in research.
|
NA
|
NA
|
|
Recommendations from the Canadian Association of Head and Neck Surgical Oncology for the Management of Head and Neck Cancers during the COVID-19 pandemic.
|
NA
|
NA
|
|
Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
|
NA
|
NA
|
|
RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
COVID-19 and liver disease: An update.
|
NA
|
NA
|
|
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.
|
NA
|
NA
|
|
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
|
NA
|
NA
|
|
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic library.
|
NA
|
NA
|
|
Managing Children With Renal Diseases During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 and its impact on gynaecologic oncology practice in India-results of a nationwide survey.
|
NA
|
NA
|
|
Negative impact of the COVID-19 pandemic on the management of cervical cancer patients in Zambia.
|
NA
|
NA
|
|
The effect of COVID-19 on absolute neutrophil counts in patients taking clozapine.
|
NA
|
NA
|
|
Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019.
|
NA
|
NA
|
|
Gastrointestinal perforation in a critically ill patient with COVID-19 pneumonia.
|
NA
|
NA
|
|
CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury.
|
NA
|
NA
|
|
Decisions on the allocation of intensive care resources in the context of the COVID-19 pandemic : Clinical and ethical recommendations of DIVI, DGINA, DGAI, DGIIN, DGNI, DGP, DGP and AEM.
|
NA
|
NA
|
|
[Decisions on the allocation of intensive care resources in the context of the COVID-19 pandemic : Clinical and ethical recommendations of DIVI, DGINA, DGAI, DGIIN, DGNI, DGP, DGP and AEM. German version].
|
NA
|
NA
|
|
[COVID-19 pneumonia].
|
NA
|
NA
|
|
Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic-results from an observational study at the Oxford Sarcoma Service.
|
NA
|
NA
|
|
What to do in an oncology department to face the new COVID-19 era challenges?
|
NA
|
NA
|
|
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
|
NA
|
NA
|
|
COVID-19: A Concern for Cardiovascular Disease Patients.
|
NA
|
NA
|
|
[Thrombotic complication of severe COVID-19 pneumonia: stroke due to atypical paradoxical embolism].
|
NA
|
NA
|
|
[Telemedicine in pediatric neurology].
|
NA
|
NA
|
|
Children and adolescents with eating disorders during COVID-19 confinement: Difficulties and future challenges.
|
NA
|
NA
|
|
COVID-19 outcomes of patients with gynecologic cancer in New York City.
|
NA
|
NA
|
|
The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up.
|
NA
|
NA
|
|
Development and progress of clinical trials of Coronavirus Disease 2019 antiviral drugs.
|
NA
|
NA
|
|
Coronavirus disease - COVID-19: new perceptives towards epidemic to pandemic.
|
NA
|
NA
|
|
Consequences of chemical impact of disinfectants: safe preventive measures against COVID-19.
|
NA
|
NA
|
|
Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19.
|
NA
|
NA
|
|
The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19.
|
NA
|
NA
|
|
Case Report: Rhabdomyolysis in a Patient with COVID-19: A Proposed Diagnostic-Therapeutic Algorithm.
|
NA
|
NA
|
|
Neuropathogenesis of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis.
|
NA
|
NA
|
|
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
|
NA
|
NA
|
|
COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
|
NA
|
NA
|
|
Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient.
|
NA
|
NA
|
|
Prescription rates of cardiovascular and diabetes therapies prior to and during the COVID-19 lockdown in Germany.
|
NA
|
NA
|
|
Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation.
|
NA
|
NA
|
|
COVID-19: a wreak havoc across the globe.
|
NA
|
NA
|
|
The Impact of COVID-19 on Older Adults Living with HIV: HIV Care and Psychosocial Effects.
|
NA
|
NA
|
|
Pharmacist-Led Chronic Care Management for Medically Underserved Rural Populations in Florida During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A comparative overview of COVID-19, MERS and SARS: Review article.
|
NA
|
NA
|
|
A Rapid, Accurate and Machine-Agnostic Segmentation and Quantification Method for CT-Based COVID-19 Diagnosis.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 Precipitating Status Epilepticus in a Pediatric Patient.
|
NA
|
NA
|
|
Data-driven study of the COVID-19 pandemic via age-structured modelling and prediction of the health system failure in Brazil amid diverse intervention strategies.
|
NA
|
NA
|
|
Persistent minimal sequences of SARS-CoV-2.
|
NA
|
NA
|
|
Patient response, treatments and mortality for acute myocardial infarction during the COVID-19 pandemic.
|
NA
|
NA
|
|
The clinical characteristics and course of COVID-19 in hemodialysis patients.
|
NA
|
NA
|
|
Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
|
NA
|
NA
|
|
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.
|
NA
|
NA
|
|
Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China.
|
NA
|
NA
|
|
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
|
NA
|
NA
|
|
Usage Patterns of a Web-Based Palliative Care Content Platform (PalliCOVID) During the COVID-19 Pandemic.
|
NA
|
NA
|
|
“Staying Home”-Early Changes in Patterns of Neurotrauma in New York City During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Description of 3 patients with myasthenia gravis and COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 and cancer: Are they really partners in crime?
|
NA
|
NA
|
|
Pyrolysis dynamics of two medical plastic wastes: Drivers, behaviors, evolved gases, reaction mechanisms, and pathways.
|
NA
|
NA
|
|
Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19.
|
NA
|
NA
|
|
COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series.
|
NA
|
NA
|
|
[COVID-19 from the Perspective of Haematology and Haemostaseology].
|
NA
|
NA
|
|
[COVID-19: The Intensive Care Point-of-View].
|
NA
|
NA
|
|
[COVID-19: a cardiological point-of-view].
|
NA
|
NA
|
|
[COVID-19: The Perspective Of Nephrology].
|
NA
|
NA
|
|
[COVID-19: A Pneumological Point of View - Long-Term Sequelae of COVID-19 - Implications For Follow-up In Respiratory Medicine].
|
NA
|
NA
|
|
The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections.
|
NA
|
NA
|
|
The Roles of GRKs in Hemostasis and Thrombosis.
|
NA
|
NA
|
|
Lessons Learnt (Clinical Outcomes and Cost Savings) from Virtual Stone Clinic and Their Application in the Era Post-COVID-19: Prospective Outcomes over a 6-Year Period from a University Teaching Hospital.
|
NA
|
NA
|
|
“The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic.
|
NA
|
NA
|
|
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
|
NA
|
NA
|
|
Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
|
NA
|
NA
|
|
Drug treatments for covid-19: living systematic review and network meta-analysis.
|
NA
|
NA
|
|
Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.
|
NA
|
NA
|
|
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
|
NA
|
NA
|
|
COVID-19 in patients with heart failure: the new and the old epidemic.
|
NA
|
NA
|
|
Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study.
|
NA
|
NA
|
|
Remdesivir for severe covid-19: a clinical practice guideline.
|
NA
|
NA
|
|
The relationship between coronary artery disease and clinical outcomes in COVID-19: a single-center retrospective analysis.
|
NA
|
NA
|
|
Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes.
|
NA
|
NA
|
|
Rehabilitation Therapy for a COVID-19 Patient Who Received Mechanical Ventilation in Japan.
|
NA
|
NA
|
|
Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19.
|
NA
|
NA
|
|
Psychiatric face of COVID-19.
|
NA
|
NA
|
|
Activation and evasion of type I interferon responses by SARS-CoV-2.
|
NA
|
NA
|
|
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
|
NA
|
NA
|
|
Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?
|
NA
|
NA
|
|
Role of Autophagy in Lung Inflammation.
|
NA
|
NA
|
|
Potential Fast COVID-19 Containment With Trehalose.
|
NA
|
NA
|
|
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.
|
NA
|
NA
|
|
Innovation policy and the market for vaccines.
|
NA
|
NA
|
|
Management of Advanced Chronic Kidney Disease During the COVID-19 Pandemic: Suggestions From the Canadian Society of Nephrology COVID-19 Rapid Response Team.
|
NA
|
NA
|
|
Early Left Ventricular Thrombus Formation in a COVID-19 Patient with ST-Elevation Myocardial Infarction.
|
NA
|
NA
|
|
SARS-CoV-2: A Piece of Bad News.
|
NA
|
NA
|
|
Ascorbate as Prophylaxis and Therapy for COVID-19-Update From Shanghai and U.S. Medical Institutions.
|
NA
|
NA
|
|
Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.
|
NA
|
NA
|
|
A Perspective on Emerging Therapeutic Interventions for COVID-19.
|
NA
|
NA
|
|
Progress in the Research and Development of Anti-COVID-19 Drugs.
|
NA
|
NA
|
|
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19.
|
NA
|
NA
|
|
False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis.
|
NA
|
NA
|
|
High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19.
|
NA
|
NA
|
|
Bone in the Time of Corona: Suggestions for Managing Pediatric Orthopaedics Conditions in a Resource-limited Environment during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Orthopedic Trauma Surgeries in COVID-19 Pandemic; A Trauma Management Algorithm.
|
NA
|
NA
|
|
Promoting Physical Activity via Telehealth in People With Parkinson Disease: The Path Forward After the COVID-19 Pandemic?
|
NA
|
NA
|
|
The Use of Digital Applications and COVID-19.
|
NA
|
NA
|
|
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency.
|
NA
|
NA
|
|
COVID-19 management in a cancer center: the ICU storm.
|
NA
|
NA
|
|
COVID-19 Among People Living with HIV: A Systematic Review.
|
NA
|
NA
|
|
Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection.
|
NA
|
NA
|
|
Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon.
|
NA
|
NA
|
|
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort.
|
NA
|
NA
|
|
Prognostic value of serum amyloid A in patients with COVID-19.
|
NA
|
NA
|
|
Impact of the pandemic on cancer care: Lessons learnt from a rural cancer center in the first 3 months.
|
NA
|
NA
|
|
Melanoma and COVID-19: A narrative review focused on treatment.
|
NA
|
NA
|
|
The crisis standard of care: Considerations for risk management.
|
NA
|
NA
|
|
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
|
NA
|
NA
|
|
Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations.
|
NA
|
NA
|
|
[Fever, loss of vision and acute promyelocytic leukemia at the pandemic ward].
|
NA
|
NA
|
|
[The endocrine and metabolic link between COVID-19, diabetes and obesity].
|
NA
|
NA
|
|
The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study.
|
NA
|
NA
|
|
COVID-19 in Nursing Homes: Calming the Perfect Storm.
|
NA
|
NA
|
|
Papillophlebitis in a COVID-19 patient: Inflammation and hypercoagulable state.
|
NA
|
NA
|
|
COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications.
|
NA
|
NA
|
|
Potential role of hypovitaminosis D and Vitamin D supplementation during COVID-19 pandemic.
|
NA
|
NA
|
|
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
|
NA
|
NA
|
|
The vascular nature of COVID-19.
|
NA
|
NA
|
|
The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
|
NA
|
NA
|
|
Paediatric/congenital cardiology physician scientists-An endangered species.
|
NA
|
NA
|
|
Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.
|
NA
|
NA
|
|
A hybrid model integrating warm heat and ultraviolet germicidal irradiation might efficiently disinfect respirators and personal protective equipment.
|
NA
|
NA
|
|
Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
|
NA
|
NA
|
|
Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak.
|
NA
|
NA
|
|
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.
|
NA
|
NA
|
|
Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19.
|
NA
|
NA
|
|
The characteristics and outcomes of 681 severe cases with COVID-19 in China.
|
NA
|
NA
|
|
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
|
NA
|
NA
|
|
Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment.
|
NA
|
NA
|
|
Monitoring bronchoalveolar lavage with electrical impedance tomography: first experience in a patient with COVID-19.
|
NA
|
NA
|
|
Gynecological Surgery and COVID-19: What is the Impact and How Should I Manage it?
|
NA
|
NA
|
|
[Surgical treatment of non-small cell lung cancer in the conditions of a new coronavirus infection pandemic (COVID-19)].
|
NA
|
NA
|
|
The need for early referral to palliative care especially for Black, Asian and minority ethnic groups in a COVID-19 pandemic: Findings from a service evaluation.
|
NA
|
NA
|
|
Learning a palliative care approach during the COVID-19 pandemic: A case study in an Infectious Diseases Unit.
|
NA
|
NA
|
|
An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom.
|
NA
|
NA
|
|
The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic.
|
NA
|
NA
|
|
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.
|
NA
|
NA
|
|
COVID-19 and cardiovascular diseases.
|
NA
|
NA
|
|
Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
|
NA
|
NA
|
|
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
|
NA
|
NA
|
|
Distress and resilience of healthcare professionals during the COVID-19 pandemic (DARVID): study protocol for a mixed-methods research project.
|
NA
|
NA
|
|
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.
|
NA
|
NA
|
|
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.
|
NA
|
NA
|
|
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
|
NA
|
NA
|
|
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
|
NA
|
NA
|
|
Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study.
|
NA
|
NA
|
|
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
|
NA
|
NA
|
|
Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran.
|
NA
|
NA
|
|
Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China.
|
NA
|
NA
|
|
A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior.
|
NA
|
NA
|
|
Bilateral Adrenal Hemorrhage in Coronavirus Disease 2019 Patient: A Case Report.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on the care of patients with inflammatory bowel disease: a comparison before and after the outbreak in South China.
|
NA
|
NA
|
|
Effectiveness of a On-Site Medicalization Program for Nursing Homes with COVID-19 Outbreaks.
|
NA
|
NA
|
|
Tumor markers as an entry for SARS-CoV-2 infection?
|
NA
|
NA
|
|
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
|
NA
|
NA
|
|
Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?
|
NA
|
NA
|
|
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.
|
NA
|
NA
|
|
Lactoferrin as potential preventative and adjunct treatment for COVID-19.
|
NA
|
NA
|
|
Computational guided drug repurposing for targeting 2’-O-ribose methyltransferase of SARS-CoV-2.
|
NA
|
NA
|
|
Review of maternal COVID-19 infection: considerations for the pediatric ophthalmologist.
|
NA
|
NA
|
|
Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
|
NA
|
NA
|
|
Strategies to promote access to medications during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Pharmacological treatment in uncertainty times: Hydroxychloroquine/chloroquine use in the COVID-19 treatment].
|
NA
|
NA
|
|
Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
|
NA
|
NA
|
|
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials.
|
NA
|
NA
|
|
Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia.
|
NA
|
NA
|
|
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
|
NA
|
NA
|
|
Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and meta-analysis of 40 studies and 24,527 patients.
|
NA
|
NA
|
|
COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
|
NA
|
NA
|
|
COVID-19 associated coagulopathy and inflammatory response: what do we know already and what are the knowledge gaps?
|
NA
|
NA
|
|
Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents.
|
NA
|
NA
|
|
Artificial intelligence for diabetic retinopathy screening, prediction and management.
|
NA
|
NA
|
|
Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients.
|
NA
|
NA
|
|
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.
|
NA
|
NA
|
|
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse.
|
NA
|
NA
|
|
Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
|
NA
|
NA
|
|
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
[Advances on the asymptomatic infection of COVID-19].
|
NA
|
NA
|
|
Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
|
NA
|
NA
|
|
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study.
|
NA
|
NA
|
|
In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Lessons Learned from the COVID-19 Pandemic: A Call for a National Video-Based Curriculum for Urology Residents.
|
NA
|
NA
|
|
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.
|
NA
|
NA
|
|
Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options.
|
NA
|
NA
|
|
Positive stool test suggests that the discharge standard of COVID-19 needs to be improved.
|
NA
|
NA
|
|
Predictors of coronavirus disease 2019 severity: A retrospective study of 64 cases.
|
NA
|
NA
|
|
Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.
|
NA
|
NA
|
|
Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
|
NA
|
NA
|
|
[COMMENT] Respiratory diseases in the era of COVID-19: Pearls and pitfalls.
|
NA
|
NA
|
|
Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.
|
NA
|
NA
|
|
Turning up the heat on COVID-19: heat as a therapeutic intervention.
|
NA
|
NA
|
|
Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery.
|
NA
|
NA
|
|
Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
|
NA
|
NA
|
|
New-Onset Seizure as the Only Presentation in a Child With COVID-19.
|
NA
|
NA
|
|
Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review.
|
NA
|
NA
|
|
Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh.
|
NA
|
NA
|
|
Acute Kidney Injury in the 2019 Novel Coronavirus Disease.
|
NA
|
NA
|
|
Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?
|
NA
|
NA
|
|
Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase.
|
NA
|
NA
|
|
A modular microarray imaging system for highly specific COVID-19 antibody testing.
|
NA
|
NA
|
|
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19.
|
NA
|
NA
|
|
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit.
|
NA
|
NA
|
|
Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?
|
NA
|
NA
|
|
Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea, January-May 2020.
|
NA
|
NA
|
|
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
|
NA
|
NA
|
|
Experiencing the Pandemic: Narrative Reflection about Two Coronavirus Outbreaks.
|
NA
|
NA
|
|
Management changes for patients with endocrine-related cancers in the COVID-19 pandemic.
|
NA
|
NA
|
|
Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system.
|
NA
|
NA
|
|
Severe COVID-19 patients with liver injury: a seven-case series.
|
NA
|
NA
|
|
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy.
|
NA
|
NA
|
|
An emergency strategy for intensive care unit during COVID-19 outbreak in Chongqing, China.
|
NA
|
NA
|
|
Coping and tolerance of uncertainty: Predictors and mediators of mental health during the COVID-19 pandemic.
|
NA
|
NA
|
|
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects.
|
NA
|
NA
|
|
Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection.
|
NA
|
NA
|
|
Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Outpatient Orthopedic Rehabilitation in New York State During the COVID-19 Pandemic: Therapist Perspectives.
|
NA
|
NA
|
|
Outcome of COVID-19 in multiple myeloma patients in relation to treatment.
|
NA
|
NA
|
|
Profiles of liver function abnormalities in elderly patients with Coronavirus Disease 2019.
|
NA
|
NA
|
|
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
|
NA
|
NA
|
|
The Early Effects of Coronavirus Disease-2019 on Head and Neck Oncology and Microvascular Reconstruction Practice: A National Survey of Oral and Maxillofacial Surgeons Enrolled in the Head and Neck Special Interest Group.
|
NA
|
NA
|
|
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.
|
NA
|
NA
|
|
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
|
NA
|
NA
|
|
Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.
|
NA
|
NA
|
|
Reverse logistics network design for medical waste management in the epidemic outbreak of the novel coronavirus (COVID-19).
|
NA
|
NA
|
|
Coronavirus Disease-2019 (COVID-19): An Updated Review.
|
NA
|
NA
|
|
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
|
NA
|
NA
|
|
The relationship between chronotype, sleep, and autism symptom severity in children with ASD in COVID-19 home confinement period.
|
NA
|
NA
|
|
Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
|
NA
|
NA
|
|
Symptom Relief Is Possible in Elderly Dying COVID-19 Patients: A National Register Study.
|
NA
|
NA
|
|
Clinical practice guidelines and experts’ consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.
|
NA
|
NA
|
|
Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
|
NA
|
NA
|
|
The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
|
NA
|
NA
|
|
Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
|
NA
|
NA
|
|
Urolithiasis in the COVID Era: An Opportunity to Reassess Management Strategies.
|
NA
|
NA
|
|
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.
|
NA
|
NA
|
|
Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19 related pneumonia.
|
NA
|
NA
|
|
COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis.
|
NA
|
NA
|
|
Achieving HIV targets by 2030: the possibility of using debt relief funds for sustainable HIV treatment in sub-Saharan Africa.
|
NA
|
NA
|
|
A Systematic Review of COVID-19 and Myocarditis.
|
NA
|
NA
|
|
Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
|
NA
|
NA
|
|
Nanotechnology-based antiviral therapeutics.
|
NA
|
NA
|
|
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Endo-Lysosomal Cation Channels and Infectious Diseases.
|
NA
|
NA
|
|
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Diagnostic and Treatment Strategies for COVID-19.
|
NA
|
NA
|
|
Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.
|
NA
|
NA
|
|
Current Overview on Hypercoagulability in COVID-19.
|
NA
|
NA
|
|
Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
|
NA
|
NA
|
|
Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening.
|
NA
|
NA
|
|
Evaluating Over-the-Counter Household Insecticide Aerosols for Rapid Vector Control of Pyrethroid-Resistant Aedes aegypti.
|
NA
|
NA
|
|
Prone positioning in patients treated with non-invasive ventilation for COVID-19 pneumonia in an Italian emergency department.
|
NA
|
NA
|
|
Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network.
|
NA
|
NA
|
|
Isolation of Aspergillus spp. in respiratory samples of patients with COVID-19 in a Spanish Tertiary Care Hospital.
|
NA
|
NA
|
|
Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims.
|
NA
|
NA
|
|
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.
|
NA
|
NA
|
|
Impact of Corona Virus Disease-19 (COVID-19) pandemic on gastrointestinal disorders.
|
NA
|
NA
|
|
Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
|
NA
|
NA
|
|
[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
|
NA
|
NA
|
|
[Suicidality in adults].
|
NA
|
NA
|
|
Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Resolution of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study.
|
NA
|
NA
|
|
Big Data, Natural Language Processing, and Deep Learning to Detect and Characterize Illicit COVID-19 Product Sales: Infoveillance Study on Twitter and Instagram.
|
NA
|
NA
|
|
Closing the COVID-19 Psychological Treatment Gap for Cancer Patients in Alberta: Protocol for the Implementation and Evaluation of Text4Hope-Cancer Care.
|
NA
|
NA
|
|
Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19
|
NA
|
NA
|
|
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
|
NA
|
NA
|
|
Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking.
|
NA
|
NA
|
|
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
|
NA
|
NA
|
|
An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment.
|
NA
|
NA
|
|
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
|
NA
|
NA
|
|
COVID-19 and telepsychiatry: Early outpatient experiences and implications for the future.
|
NA
|
NA
|
|
Human virus detection with graphene-based materials.
|
NA
|
NA
|
|
A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era.
|
NA
|
NA
|
|
Preliminary Study of Sars-Cov-2 Occurrence in Wastewater in the Czech Republic.
|
NA
|
NA
|
|
Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application.
|
NA
|
NA
|
|
Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives.
|
NA
|
NA
|
|
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
|
NA
|
NA
|
|
Viral Ubiquitin and Ubiquitin-Like Deconjugases-Swiss Army Knives for Infection.
|
NA
|
NA
|
|
From Concerts to COVID: Transforming the RI Convention Center into an Alternate Hospital Site in under a Month.
|
NA
|
NA
|
|
SARS-CoV-2 Complicated by Sinusitis and Co-Infection with Human Metapneumovirus.
|
NA
|
NA
|
|
In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.
|
NA
|
NA
|
|
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2.
|
NA
|
NA
|
|
The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications.
|
NA
|
NA
|
|
Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
|
NA
|
NA
|
|
Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.
|
NA
|
NA
|
|
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
|
NA
|
NA
|
|
Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry.
|
NA
|
NA
|
|
Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
|
NA
|
NA
|
|
Telestroke in the Time of COVID-19: The Mayo Clinic Experience.
|
NA
|
NA
|
|
Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).
|
NA
|
NA
|
|
SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review.
|
NA
|
NA
|
|
Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Accelerated Intermittent Theta Burst Stimulation in Late-Life Depression: A Possible Option for Older Depressed Adults in Need of ECT During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Population implications of cessation of IVF during the COVID-19 pandemic.
|
NA
|
NA
|
|
BET 1: The role of remdesivir in COVID-19 infection.
|
NA
|
NA
|
|
Close air support: enhancing emergency care in the COVID-19 pandemic.
|
NA
|
NA
|
|
Dying ‘due to’ or ‘with’ COVID-19: a cause of death analysis in hospitalised patients.
|
NA
|
NA
|
|
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case-control study.
|
NA
|
NA
|
|
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
|
NA
|
NA
|
|
Design, usage and review of a cost effective and innovative face shield in a tertiary care teaching hospital during COVID-19 pandemic.
|
NA
|
NA
|
|
Rise in Cases of Alcohol Withdrawal following Lockdown in Dry District of Wardha.
|
NA
|
NA
|
|
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19.
|
NA
|
NA
|
|
Psychological Distress Amongst Health Workers and the General Public During the COVID-19 Pandemic in Saudi Arabia.
|
NA
|
NA
|
|
Rethinking ‘essential’ and ‘nonessential’: the developmental paediatrician’s COVID-19 response.
|
NA
|
NA
|
|
Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review.
|
NA
|
NA
|
|
Leveraging IoTs and Machine Learning for Patient Diagnosis and Ventilation Management in the Intensive Care Unit.
|
NA
|
NA
|
|
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
|
NA
|
NA
|
|
Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
|
NA
|
NA
|
|
The Psychological Impact of the COVID-19 Outbreak on Health Professionals: A Cross-Sectional Study.
|
NA
|
NA
|
|
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study.
|
NA
|
NA
|
|
Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
An Optimized Metagenomic Approach for Virome Detection of Clinical Pharyngeal Samples With Respiratory Infection.
|
NA
|
NA
|
|
Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
|
NA
|
NA
|
|
Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.
|
NA
|
NA
|
|
COVID-19 control in low-income settings and displaced populations: what can realistically be done?
|
NA
|
NA
|
|
Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology.
|
NA
|
NA
|
|
The COVID-19 Pandemic and Planetary Health. A Critical Review of Epidemiology, Prevention, Clinical Characteristics and Treatments for Oral, Head and Neck Health Professionals. Do We Have a Roadmap?
|
NA
|
NA
|
|
[Comment] Ethical and practical considerations on cancer recommendations during COVID-19 pandemic.
|
NA
|
NA
|
|
Adverse Events in Coronavirus Disease Patients Management: A Pictorial Essay.
|
NA
|
NA
|
|
Potential Treatment Options for COVID-19: A Comprehensive Review of Global Pharmacological Development Efforts.
|
NA
|
NA
|
|
The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts.
|
NA
|
NA
|
|
Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19.
|
NA
|
NA
|
|
Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report.
|
NA
|
NA
|
|
How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19?
|
NA
|
NA
|
|
Pneumomediastinum in COVID-19 patients: a case series of a rare complication.
|
NA
|
NA
|
|
COVID-19 in South Korea: epidemiological and spatiotemporal patterns of the spread and the role of aggressive diagnostic tests in the early phase.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
|
NA
|
NA
|
|
High flow nasal cannula in COVID-19: a literature review.
|
NA
|
NA
|
|
How Is Morocco Reacting to COVID-19 Crisis in Anticancer Centers?
|
NA
|
NA
|
|
Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?
|
NA
|
NA
|
|
Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China.
|
NA
|
NA
|
|
MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
|
NA
|
NA
|
|
Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development.
|
NA
|
NA
|
|
Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.
|
NA
|
NA
|
|
COVID-19 and acute inpatient psychiatry: the shape of things to come.
|
NA
|
NA
|
|
Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer.
|
NA
|
NA
|
|
[A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!]
|
NA
|
NA
|
|
A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
|
NA
|
NA
|
|
Teaching Old Drugs New Tricks: Statins for COVID-19?
|
NA
|
NA
|
|
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
|
NA
|
NA
|
|
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus.
|
NA
|
NA
|
|
Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges.
|
NA
|
NA
|
|
“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors - A survey”.
|
NA
|
NA
|
|
Tuberculosis in the era of COVID-19 in India.
|
NA
|
NA
|
|
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians.
|
NA
|
NA
|
|
The efficacy and safety of Chinese traditional medicine injections on patients with coronavirus disease 2019: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview.
|
NA
|
NA
|
|
Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report.
|
NA
|
NA
|
|
Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
SARS-CoV-2 infection associated with micturition syncope: Our experience with 4 case reports.
|
NA
|
NA
|
|
Therapeutic response to corticosteroids in a critically ill patient with COVID-19: A case report.
|
NA
|
NA
|
|
Strategy for the Practice of Spine Oncological Surgery During the Covid-19 Pandemic.
|
NA
|
NA
|
|
What Happened to People with Non-Communicable Diseases during COVID-19: Implications of H-EDRM Policies.
|
NA
|
NA
|
|
COVID-19: The Immune Responses and Clinical Therapy Candidates.
|
NA
|
NA
|
|
Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections.
|
NA
|
NA
|
|
Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers.
|
NA
|
NA
|
|
Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital.
|
NA
|
NA
|
|
Management of acute stroke and urgent neurointerventional procedures during COVID-19 pandemic: recommendations on the Scientific Department on Cerebrovascular Diseases of the Brazilian Academy of Neurology, Brazilian Society of Cerebrovascular Diseases and Brazilian Society of Neuroradiology.
|
NA
|
NA
|
|
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis.
|
NA
|
NA
|
|
Applicability of bedside ultrasonography for the diagnosis of deep venous thrombosis in patients with COVID-19 and treatment with low molecular weight heparin.
|
NA
|
NA
|
|
Effect of Age on Death Due to Coronavirus Disease 2019 (COVID-19): Application of Poisson Regression Model.
|
NA
|
NA
|
|
Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers.
|
NA
|
NA
|
|
Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication.
|
NA
|
NA
|
|
Strategical Preparedness and Response Actions in the Healthcare System Against Coronavirus Disease 2019 according to Transmission Scenario in Korea.
|
NA
|
NA
|
|
Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.
|
NA
|
NA
|
|
Handwashing in averting infectious diseases: Relevance to COVID-19.
|
NA
|
NA
|
|
Gold nanoparticles against respiratory diseases: oncogenic and viral pathogens review.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis.
|
NA
|
NA
|
|
In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19.
|
NA
|
NA
|
|
Acute Olfactory Dysfunction-A Primary Presentation of COVID-19 Infection.
|
NA
|
NA
|
|
Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm.
|
NA
|
NA
|
|
Management of epigenomic networks entailed in coronavirus infections and COVID-19.
|
NA
|
NA
|
|
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Community grid management is an important measure to contain the spread of novel coronavirus pneumonia (COVID-19).
|
NA
|
NA
|
|
Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
|
NA
|
NA
|
|
COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care.
|
NA
|
NA
|
|
In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2.
|
NA
|
NA
|
|
Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
|
NA
|
NA
|
|
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
|
NA
|
NA
|
|
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial.
|
NA
|
NA
|
|
Viruses in wastewater: occurrence, abundance and detection methods.
|
NA
|
NA
|
|
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
|
NA
|
NA
|
|
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.
|
NA
|
NA
|
|
SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).
|
NA
|
NA
|
|
Rethinking interleukin-6 blockade for treatment of COVID-19.
|
NA
|
NA
|
|
Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
|
NA
|
NA
|
|
N-acetycysteine: A potential therapeutic agent in COVID-19 infection.
|
NA
|
NA
|
|
Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater.
|
NA
|
NA
|
|
Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.
|
NA
|
NA
|
|
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.
|
NA
|
NA
|
|
Did the COVID-19 pandemic silence the needs of people with epilepsy?
|
NA
|
NA
|
|
Natural Language Processing for Rapid Response to Emergent Diseases: Case Study of Calcium Channel Blockers and Hypertension in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Convalescent plasma for COVID-19.
|
NA
|
NA
|
|
How do we fight COVID-19? Military medical actions in the war against the COVID-19 pandemic in France.
|
NA
|
NA
|
|
Barriers and facilitators to optimal supportive end-of-life palliative care in long-term care facilities: a qualitative descriptive study of community-based and specialist palliative care physicians’ experiences, perceptions and perspectives.
|
NA
|
NA
|
|
An interdisciplinary approach to the management of critically ill patients during covid-19 pandemic; an experience of a university hospital in England.
|
NA
|
NA
|
|
Hydroxychloroquine is no miracle cure for covid-19 infection -imaging and clinical course in an elderly female.
|
NA
|
NA
|
|
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
|
NA
|
NA
|
|
Vitamin C for COVID-19: A living systematic review.
|
NA
|
NA
|
|
An overview of the expert consensus on the mental health treatment and services for major psychiatric disorders during COVID-19 outbreak: China’s experiences.
|
NA
|
NA
|
|
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
|
NA
|
NA
|
|
Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan.
|
NA
|
NA
|
|
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
|
NA
|
NA
|
|
Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
|
NA
|
NA
|
|
A Case of COVID-19-Induced Vestibular Neuritis.
|
NA
|
NA
|
|
Deep Learning-Based Decision-Tree Classifier for COVID-19 Diagnosis From Chest X-ray Imaging.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
|
NA
|
NA
|
|
Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China.
|
NA
|
NA
|
|
Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation.
|
NA
|
NA
|
|
Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
|
NA
|
NA
|
|
Applying Lessions Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic.
|
NA
|
NA
|
|
Brief Psychotic Disorder during the national lockdown in Italy: an emerging clinical phenomenon of the coronavirus pandemic.
|
NA
|
NA
|
|
Patient experiences of fertility clinic closure during the COVID-19 pandemic: appraisals, coping and emotions.
|
NA
|
NA
|
|
Transforming a surgical department during the outbreak of new coronavirus pandemic. Clinical implications.
|
NA
|
NA
|
|
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
|
NA
|
NA
|
|
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.
|
NA
|
NA
|
|
Successful management of seven cases of critical COVID-19 with early noninvasive-invasive sequential ventilation algorithm and bundle pharmacotherapy.
|
NA
|
NA
|
|
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
|
NA
|
NA
|
|
COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain.
|
NA
|
NA
|
|
Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak.
|
NA
|
NA
|
|
Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois.
|
NA
|
NA
|
|
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation.
|
NA
|
NA
|
|
[Coagulation dysfunction in COVID-19].
|
NA
|
NA
|
|
[Nutritional support for critically ill patients with COVID-19].
|
NA
|
NA
|
|
Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
|
NA
|
NA
|
|
Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
|
NA
|
NA
|
|
Transient Cardiomyopathy in a Patient With Coronavirus Disease-2019.
|
NA
|
NA
|
|
Reinventing Palliative Care Delivery in the Era of COVID-19: How Telemedicine Can Support End of Life Care.
|
NA
|
NA
|
|
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
|
NA
|
NA
|
|
Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.
|
NA
|
NA
|
|
In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia (giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach.
|
NA
|
NA
|
|
Diabetes and COVID-19 risk: an miRNA perspective.
|
NA
|
NA
|
|
Epidemiological and clinical features of pediatric COVID-19.
|
NA
|
NA
|
|
Breastfed 13 month-old infant of a mother with COVID-19 pneumonia: a case report.
|
NA
|
NA
|
|
Low-Dose Chest CT for the Diagnosis of COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry.
|
NA
|
NA
|
|
Role of Anesthesia Nurses in the Treatment and Management of Patients With COVID-19.
|
NA
|
NA
|
|
Thrombolysis in severe COVID-19 pneumonia with massive pulmonary embolism.
|
NA
|
NA
|
|
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
|
NA
|
NA
|
|
Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective.
|
NA
|
NA
|
|
Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
|
NA
|
NA
|
|
A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase.
|
NA
|
NA
|
|
Critical illness myopathy after COVID-19.
|
NA
|
NA
|
|
Single-Center Vascular Hub Experience after 7 weeks of COVID-19 Pandemic in Lombardy (Italy).
|
NA
|
NA
|
|
Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
COVID-19 and Severe Mental Illness: Impact on patients and its relation with their awareness about COVID-19.
|
NA
|
NA
|
|
Implementing an intensive care unit (ICU) diary program at a large academic medical center: Results from a randomized control trial evaluating psychological morbidity associated with critical illness.
|
NA
|
NA
|
|
Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content.
|
NA
|
NA
|
|
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
|
NA
|
NA
|
|
Raising the Digital Profile of Facial Palsy: National Surveys of Patients’ and Clinicians’ Experiences of Changing UK Treatment Pathways and Views on the Future Role of Digital Technology.
|
NA
|
NA
|
|
Reactive arthritis after COVID-19 infection.
|
NA
|
NA
|
|
Nuclear imaging of bacterial infection- state of the art and future directions.
|
NA
|
NA
|
|
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
|
NA
|
NA
|
|
The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.
|
NA
|
NA
|
|
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
|
NA
|
NA
|
|
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.
|
NA
|
NA
|
|
Molecular Basis for Pathogenicity of Human Coronaviruses.
|
NA
|
NA
|
|
Critically Ill Patients with Coronavirus Disease 2019 in a Designated ICU: Clinical Features and Predictors for Mortality.
|
NA
|
NA
|
|
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study.
|
NA
|
NA
|
|
Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19.
|
NA
|
NA
|
|
Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review.
|
NA
|
NA
|
|
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
|
NA
|
NA
|
|
Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
|
NA
|
NA
|
|
Potential Using of Fat-derived Stromal Cells in the Treatment of Active Disease, and also, in Both Pre- and Post-Periods in COVID-19.
|
NA
|
NA
|
|
Decreased Naïve T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
|
NA
|
NA
|
|
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.
|
NA
|
NA
|
|
Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases.
|
NA
|
NA
|
|
Postmastectomy Breast Reconstruction in the Time of the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Evidence map on the contributions of traditional, complementary and integrative medicines for health care in times of COVID-19.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 1 - Clinical research.
|
NA
|
NA
|
|
Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
|
NA
|
NA
|
|
Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report.
|
NA
|
NA
|
|
Covid-19 Kills More Men Than Women: An Overview of Possible Reasons.
|
NA
|
NA
|
|
Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases.
|
NA
|
NA
|
|
Fracture Surgery in Known COVID-19 Infected Patients: What Are the Challenges?
|
NA
|
NA
|
|
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 on STEMI: Second youth for fibrinolysis or time to centralized approach?
|
NA
|
NA
|
|
An evaluation of COVID-19 in Italy: A data-driven modeling analysis.
|
NA
|
NA
|
|
Could It Be Pneumonia? Lung Ultrasound in Children With Low Clinical Suspicion for Pneumonia.
|
NA
|
NA
|
|
Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study.
|
NA
|
NA
|
|
Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait.
|
NA
|
NA
|
|
Relocating IV Pumps for Critically Ill Isolated Coronavirus Disease 2019 Patients From Bedside to Outside the Patient Room.
|
NA
|
NA
|
|
Preparedness and Reorganization of Care for Coronavirus Disease 2019 Patients in a Swiss ICU: Characteristics and Outcomes of 129 Patients.
|
NA
|
NA
|
|
Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter.
|
NA
|
NA
|
|
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey.
|
NA
|
NA
|
|
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Acute Kidney Injury Is Associated With In-hospital Mortality in Older Patients With COVID-19.
|
NA
|
NA
|
|
Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)?
|
NA
|
NA
|
|
Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
|
NA
|
NA
|
|
Accumulated Clinical Experiences from Successful Treatment of 1377 Severe and Critically Ill COVID-19 Cases.
|
NA
|
NA
|
|
Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China.
|
NA
|
NA
|
|
Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions.
|
NA
|
NA
|
|
[Effects of the SARS-CoV-2 pandemic on the otorhinolaryngology university hospitals in the field of medical care].
|
NA
|
NA
|
|
Corticosteroid therapy for patients with severe novel Coronavirus disease 2019.
|
NA
|
NA
|
|
Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
|
NA
|
NA
|
|
Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy.
|
NA
|
NA
|
|
Changing trends in dermatology practice during COVID-19 pandemic: A single tertiary center experience.
|
NA
|
NA
|
|
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19.
|
NA
|
NA
|
|
Stem cell therapy for COVID-19: Possibilities and challenges.
|
NA
|
NA
|
|
PEPFAR’s response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa.
|
NA
|
NA
|
|
Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Factors associated with nurses’ willingness to participate in care of patients with COVID-19: A survey in China.
|
NA
|
NA
|
|
Bulimia nervosa in times of the COVID-19 pandemic-Results from an online survey of former inpatients.
|
NA
|
NA
|
|
The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review.
|
NA
|
NA
|
|
Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?
|
NA
|
NA
|
|
Incidence of surgical abdominal emergencies during SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients.
|
NA
|
NA
|
|
COVID-19 and obesity in childhood and adolescence: a clinical review.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.
|
NA
|
NA
|
|
Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.
|
NA
|
NA
|
|
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.
|
NA
|
NA
|
|
Simultaneous circulation of COVID-19 and flu in Italy: Potential combined effects on the risk of death?
|
NA
|
NA
|
|
Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation.
|
NA
|
NA
|
|
Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity.
|
NA
|
NA
|
|
First proof of the capability of wastewater surveillance for COVID-19 in India through detection of genetic material of SARS-CoV-2.
|
NA
|
NA
|
|
Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
|
NA
|
NA
|
|
Natural history of COVID-19 and current knowledge on treatment therapeutic options.
|
NA
|
NA
|
|
Outbreak of COVID-19: An emerging global pandemic threat.
|
NA
|
NA
|
|
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment.
|
NA
|
NA
|
|
An analysis on self-management and treatment-related functionality and characteristics of highly rated anxiety apps.
|
NA
|
NA
|
|
Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics.
|
NA
|
NA
|
|
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.
|
NA
|
NA
|
|
Effects of MS disease-modifying therapies on responses to vaccinations: A review.
|
NA
|
NA
|
|
Remote Assessment of Functional Mobility and Strength in Older Cancer Survivors: Protocol for a Validity and Reliability Study.
|
NA
|
NA
|
|
Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019.
|
NA
|
NA
|
|
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
|
NA
|
NA
|
|
Professionally responsible advocacy for women and children first during the COVID-19 pandemic: guidance from World Association of Perinatal Medicine and International Academy of Perinatal Medicine.
|
NA
|
NA
|
|
Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
|
NA
|
NA
|
|
Expert panel consensus statement on the applications and precaution strategies of bronchoscopy in patients with COVID-19.
|
NA
|
NA
|
|
Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists.
|
NA
|
NA
|
|
COVID-19: An up-to-date review - from morphology to pathogenesis.
|
NA
|
NA
|
|
Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
|
NA
|
NA
|
|
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19.
|
NA
|
NA
|
|
Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19.
|
NA
|
NA
|
|
The potential public health consequences of COVID-19 on malaria in Africa.
|
NA
|
NA
|
|
AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
|
NA
|
NA
|
|
SARS-CoV-2 associated Guillain-Barré syndrome.
|
NA
|
NA
|
|
Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs.
|
NA
|
NA
|
|
A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand.
|
NA
|
NA
|
|
COVID-19 and ENT SLT services, workforce and research in the UK: A discussion paper.
|
NA
|
NA
|
|
Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19.
|
NA
|
NA
|
|
Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients.
|
NA
|
NA
|
|
Gender differences in the battle against COVID-19: impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes.
|
NA
|
NA
|
|
Evolution of computed tomography manifestations of eleven patients with severe coronavirus disease 2019 (COVID-19) pneumonia.
|
NA
|
NA
|
|
Bacterial co-infections with SARS-CoV-2.
|
NA
|
NA
|
|
Clinical trial to test the efficacy of melatonin in COVID-19.
|
NA
|
NA
|
|
Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor.
|
NA
|
NA
|
|
Liver transplantation and COVID-19: a case report and cross comparison between two identical twins with COVID-19.
|
NA
|
NA
|
|
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.
|
NA
|
NA
|
|
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients.
|
NA
|
NA
|
|
Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
|
NA
|
NA
|
|
A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence (FAST Evidence).
|
NA
|
NA
|
|
Modeling the viral dynamics of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Psychological effects caused by the COVID-19 pandemic in health professionals: A systematic review with meta-analysis.
|
NA
|
NA
|
|
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.
|
NA
|
NA
|
|
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
|
NA
|
NA
|
|
Asthma among hospitalized patients with COVID-19 and related outcomes.
|
NA
|
NA
|
|
New loss of smell and taste: Uncommon symptoms in COVID-19 patients in Nord Franche-Comte cluster, France.
|
NA
|
NA
|
|
Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.
|
NA
|
NA
|
|
Negative impacts of COVID-19 lockdown on mental health service access and follow-up adherence for immigrants and individuals in socio-economic difficulties.
|
NA
|
NA
|
|
Potential treatment methods targeting 2019-nCoV infection.
|
NA
|
NA
|
|
Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population.
|
NA
|
NA
|
|
Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature.
|
NA
|
NA
|
|
Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios.
|
NA
|
NA
|
|
Visitation restrictions: is it right and how do we support families in the NICU during COVID-19?
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on mental health.
|
NA
|
NA
|
|
Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient.
|
NA
|
NA
|
|
Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.
|
NA
|
NA
|
|
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19.
|
NA
|
NA
|
|
Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1).
|
NA
|
NA
|
|
Criticality of physical/social distancing, handwashing, respiratory hygiene and face-masking during the COVID-19 pandemic and beyond.
|
NA
|
NA
|
|
Voice and the new coronavirus.
|
NA
|
NA
|
|
Comparison of COVID-19 Health Risks With Other Viral Occupational Hazards.
|
NA
|
NA
|
|
Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy.
|
NA
|
NA
|
|
Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries.
|
NA
|
NA
|
|
Multiple sclerosis management during the COVID-19 pandemic.
|
NA
|
NA
|
|
In silico designing of multi-epitope vaccine construct against human coronavirus infections.
|
NA
|
NA
|
|
Thromboembolic events and Covid-19.
|
NA
|
NA
|
|
Where are we with understanding of COVID-19?
|
NA
|
NA
|
|
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
|
NA
|
NA
|
|
The clinical impact of COVID-19 epidemic in the hematologic setting.
|
NA
|
NA
|
|
Cancer therapy and treatments during COVID-19 era.
|
NA
|
NA
|
|
Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality.
|
NA
|
NA
|
|
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review.
|
NA
|
NA
|
|
Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de Neurogastroenterología.
|
NA
|
NA
|
|
Potential influence of Nagella sativa (Black cumin) in reinforcing immune system: A hope to decelerate the COVID-19 pandemic.
|
NA
|
NA
|
|
Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan.
|
NA
|
NA
|
|
The COVID-19 Crisis and Clinical Ethics in New York City.
|
NA
|
NA
|
|
Coronavirus disease 2019 in children: Clinical & epidemiological implications.
|
NA
|
NA
|
|
Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India.
|
NA
|
NA
|
|
Hyper- and hypocoagulability in COVID-19 as assessed by thromboelastometry. Two case reports.
|
NA
|
NA
|
|
[Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report].
|
NA
|
NA
|
|
Indian Resuscitation Council (IRC) suggested guidelines for Comprehensive Cardiopulmonary Life Support (CCLS) for suspected or confirmed coronavirus disease (COVID-19) patient.
|
NA
|
NA
|
|
Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure.
|
NA
|
NA
|
|
Accelerating regulation in response to COVID-19.
|
NA
|
NA
|
|
Projections for novel coronavirus (COVID-19) and evaluation of epidemic response strategies for India.
|
NA
|
NA
|
|
Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.
|
NA
|
NA
|
|
The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper.
|
NA
|
NA
|
|
Service delivery during the COVID-19 pandemic: Experience from The Oxford Bone Tumour and Soft Tissue Sarcoma service.
|
NA
|
NA
|
|
Fracture management during COVID-19 pandemic: A systematic review.
|
NA
|
NA
|
|
A comprehensive review of COVID-19 characteristics.
|
NA
|
NA
|
|
Chloroquine and COVID-19: Should We Care about Ototoxicity?
|
NA
|
NA
|
|
Successful aspiration thrombectomy in a patient with submassive, intermediate-risk pulmonary embolism following COVID-19 pneumonia.
|
NA
|
NA
|
|
Genome sequencing and the diagnosis of novel coronavirus (SARS-COV-2) in Africa: how far are we?
|
NA
|
NA
|
|
Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection.
|
NA
|
NA
|
|
COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
|
NA
|
NA
|
|
COVID-19: An Update Regarding the Quest for Finding an Effective Cure.
|
NA
|
NA
|
|
Recommendations for perinatal and neonatal surgical management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical characteristics of patients with COVID-19 presenting with gastrointestinal symptoms as initial symptoms: Retrospective case series.
|
NA
|
NA
|
|
Effects of policies and containment measures on control of COVID-19 epidemic in Chongqing.
|
NA
|
NA
|
|
Optimal control on a mathematical model to pattern the progression of coronavirus disease 2019 (COVID-19) in Indonesia.
|
NA
|
NA
|
|
Radiation Therapy Care During a Major Outbreak of COVID-19 in Wuhan.
|
NA
|
NA
|
|
Radiation Therapy Department Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to Securing Staff and Patients During the First Weeks of the Crisis and Impact on Radiation Therapy Practice from a Single Institution Experience.
|
NA
|
NA
|
|
Practical Challenges of Mask-to-Mask Encounters with Patients with Head and Neck Cancers amid the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Ethical Issues in Radiation Oncology During a Pandemic.
|
NA
|
NA
|
|
Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History.
|
NA
|
NA
|
|
Covert COVID-19: Cone Beam Computed Tomography Lung Changes in an Asymptomatic Patient Receiving Radiation Therapy.
|
NA
|
NA
|
|
Continuing Medical Student Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: Development of a Virtual Radiation Oncology Clerkship.
|
NA
|
NA
|
|
Implementing a Novel Remote Physician Treatment Coverage Practice for Adaptive Radiation Therapy During the Coronavirus Pandemic.
|
NA
|
NA
|
|
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada.
|
NA
|
NA
|
|
Computed Tomography in Radiation Oncology During the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?
|
NA
|
NA
|
|
Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Reflecting on Equity in Perinatal Care During a Pandemic.
|
NA
|
NA
|
|
COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium.
|
NA
|
NA
|
|
Osteopathic Considerations for the Pregnant Patient with COVID-19.
|
NA
|
NA
|
|
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.
|
NA
|
NA
|
|
[Effects of the SARS-CoV-2 pandemic on surgery - a national cross-sectional study].
|
NA
|
NA
|
|
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort.
|
NA
|
NA
|
|
A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society.
|
NA
|
NA
|
|
The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing.
|
NA
|
NA
|
|
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
|
NA
|
NA
|
|
Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia.
|
NA
|
NA
|
|
Disparate effects of methicillin-resistant Staphylococcus aureus infection on renal function in IgA-dominant infection-associated glomerulonephritis and menstrual toxic shock syndrome: a case report and literature review.
|
NA
|
NA
|
|
What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results.
|
NA
|
NA
|
|
Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors.
|
NA
|
NA
|
|
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
|
NA
|
NA
|
|
Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.
|
NA
|
NA
|
|
Impact of COVID-19 on global hepatitis C elimination efforts.
|
NA
|
NA
|
|
Spine surgery in Italy in the COVID-19 era: Proposal for assessing and responding to the regional state of emergency.
|
NA
|
NA
|
|
Hand injuries treated at a hand emergency center during the COVID-19 lockdown.
|
NA
|
NA
|
|
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
|
NA
|
NA
|
|
What every Intensivist should know about COVID-19 associated acute kidney injury.
|
NA
|
NA
|
|
Mild vs severe liver injury in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?
|
NA
|
NA
|
|
Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19.
|
NA
|
NA
|
|
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice.
|
NA
|
NA
|
|
Implementation of Telemedicine in a Laryngology Practice During the COVID-19 Pandemic: Lessons Learned, Experiences Shared.
|
NA
|
NA
|
|
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
|
NA
|
NA
|
|
A Call for Preventive Medicine Attention for Indonesian Physicians.
|
NA
|
NA
|
|
The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.
|
NA
|
NA
|
|
Mass Panic Disaster Management in COVID-19 Pandemic.
|
NA
|
NA
|
|
Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
|
NA
|
NA
|
|
Potential strategies for combating COVID-19.
|
NA
|
NA
|
|
Repurposing of Kinase Inhibitors for Treatment of COVID-19.
|
NA
|
NA
|
|
Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
|
NA
|
NA
|
|
Re Facial aesthetic injections in clinical practice: Pretreatment and post-treatment consensus recommendations to minimise adverse outcome Region-specific changes in line with the Covid-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and Vitamin D: A lesson from the skin.
|
NA
|
NA
|
|
Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.
|
NA
|
NA
|
|
High affinity interaction of Solanum tuberosum and Brassica juncea residue smoke water compounds with proteins involved in coronavirus infection.
|
NA
|
NA
|
|
Potential effects of SARS-CoV-2 infection during pregnancy on fetuses and newborns are worthy of attention.
|
NA
|
NA
|
|
Drugs against SARS-CoV-2: What do we know about their mode of action?
|
NA
|
NA
|
|
Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
|
NA
|
NA
|
|
IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?
|
NA
|
NA
|
|
Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou.
|
NA
|
NA
|
|
[Ocular manifestations of coronavirus infection COVID-19 (clinical observation)].
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan.
|
NA
|
NA
|
|
The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series.
|
NA
|
NA
|
|
Analysis of the application value of serum antibody detection for staging of COVID-19 infection.
|
NA
|
NA
|
|
Editorial Perspective: COVID-19 pandemic-related psychopathology in children and adolescents with mental illness.
|
NA
|
NA
|
|
Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
|
NA
|
NA
|
|
Generalized Status Epilepticus as a Possible Manifestation of COVID-19.
|
NA
|
NA
|
|
QTc prolongation during antiviral therapy in two COVID-19 patients.
|
NA
|
NA
|
|
Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
|
NA
|
NA
|
|
COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: a systematic review of cases.
|
NA
|
NA
|
|
Prevention of COVID-19 infection in a pediatric oncology ward in Wuhan.
|
NA
|
NA
|
|
Should we screen patients with hematologic malignancies for COVID-19?
|
NA
|
NA
|
|
Volatile molecules for COVID-19: A possible pharmacological strategy?
|
NA
|
NA
|
|
Neurology practice during the COVID-19 outbreak and post-pandemic era: experiences and challenges.
|
NA
|
NA
|
|
The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
|
NA
|
NA
|
|
[Prioritising breast cancer care during the corona crisis].
|
NA
|
NA
|
|
Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review.
|
NA
|
NA
|
|
Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure.
|
NA
|
NA
|
|
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
|
NA
|
NA
|
|
The microbial coinfection in COVID-19.
|
NA
|
NA
|
|
Knowledge and Behaviors of Adults with Underlying Health Conditions During the Onset of the COVID-19 U.S. Outbreak: The Chicago COVID-19 Comorbidities Survey.
|
NA
|
NA
|
|
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
|
NA
|
NA
|
|
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
|
NA
|
NA
|
|
Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.
|
NA
|
NA
|
|
In response to letter by Dr. Miles Brown.
|
NA
|
NA
|
|
Medical populism and the COVID-19 pandemic.
|
NA
|
NA
|
|
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.
|
NA
|
NA
|
|
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
|
NA
|
NA
|
|
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
|
NA
|
NA
|
|
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.
|
NA
|
NA
|
|
Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.
|
NA
|
NA
|
|
Physicians’ knowledge of potential covid-19 drug-drug interactions: An online survey in turkey.
|
NA
|
NA
|
|
Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study.
|
NA
|
NA
|
|
Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out?
|
NA
|
NA
|
|
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study).
|
NA
|
NA
|
|
Low-Dose Hypofractionated Total Skin Electron Beam Therapy for Adult Cutaneous T-Cell Lymphoma.
|
NA
|
NA
|
|
Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
|
NA
|
NA
|
|
COVID-19 and endoscopic management of superficial gastrointestinal neoplastic lesions: a multinational cross-sectional survey.
|
NA
|
NA
|
|
Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management.
|
NA
|
NA
|
|
“Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies.
|
NA
|
NA
|
|
Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage.
|
NA
|
NA
|
|
Consideration of the Management of Pediatric fever clinics During the Novel Coronavirus Pneumonia Outbreak.
|
NA
|
NA
|
|
A specialized clinical laboratory center for the coronavirus disease 2019 (COVID-19) in Wuhan Leishenshan Hospital during the COVID-19 outbreak.
|
NA
|
NA
|
|
Internet Public Opinion Evolution in the COVID-19 Event and Coping Strategies.
|
NA
|
NA
|
|
Does the Prosperity of a Country Play a Role in COVID-19 Outcomes?
|
NA
|
NA
|
|
Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.
|
NA
|
NA
|
|
Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
|
NA
|
NA
|
|
Repurposing current therapeutic regimens against SARS-CoV-2 (Review).
|
NA
|
NA
|
|
Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy.
|
NA
|
NA
|
|
When COVID-19 affects muscle: effects of quarantine in older adults.
|
NA
|
NA
|
|
COVID-19 Outbreak in a Hemodialysis Center: A Retrospective Monocentric Case Series.
|
NA
|
NA
|
|
Potential impact and challenges associated with Parkinson’s disease patient care amidst the COVID-19 global pandemic.
|
NA
|
NA
|
|
Can surgery follow the dictates of the pandemic “keep your distance”? Requirements with COVID-19 for hygiene, resources and the team.
|
NA
|
NA
|
|
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2 S donors in COVID-19 therapy.
|
NA
|
NA
|
|
Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CLpro : An in silico approach with 19 structural different hydrolysable tannins.
|
NA
|
NA
|
|
Clinical activity and outcomes during Geelong’s general surgery response to the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Antiviral Activity of Nanomaterials against Coronaviruses.
|
NA
|
NA
|
|
Hospital Diabetes Meeting 2020.
|
NA
|
NA
|
|
Challenges for a Cancer Center in the Novel Coronavirus Pneumonia Epidemic.
|
NA
|
NA
|
|
New anti-viral drugs for the treatment of COVID-19 instead of favipiravir.
|
NA
|
NA
|
|
Host-directed therapies: a potential solution to combat COVID-19.
|
NA
|
NA
|
|
Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.
|
NA
|
NA
|
|
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19-Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis.
|
NA
|
NA
|
|
First environmental surveillance for the presence of SARS-CoV-2 RNA in wastewater and river water in Japan.
|
NA
|
NA
|
|
Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
|
NA
|
NA
|
|
Efficacy of Hydroxychloroquine and Tocilizumab in Patients With COVID-19: Single-Center Retrospective Chart Review.
|
NA
|
NA
|
|
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
|
NA
|
NA
|
|
Acute transverse myelitis in COVID-19 infection.
|
NA
|
NA
|
|
Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease.
|
NA
|
NA
|
|
Emerging Therapeutic Modalities against COVID-19.
|
NA
|
NA
|
|
Are the Clinical Presentations (Phenotypes) of Gitelman’s and Bartter’s Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their “pH” Enotype?
|
NA
|
NA
|
|
Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19.
|
NA
|
NA
|
|
A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review.
|
NA
|
NA
|
|
A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly.
|
NA
|
NA
|
|
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19.
|
NA
|
NA
|
|
Key Aspects in Nutritional Management of COVID-19 Patients.
|
NA
|
NA
|
|
Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy.
|
NA
|
NA
|
|
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
|
NA
|
NA
|
|
Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital.
|
NA
|
NA
|
|
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.
|
NA
|
NA
|
|
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial.
|
NA
|
NA
|
|
Risk factors for anxiety of otolaryngology healthcare workers in Hubei province fighting coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
The “pandemic” increase in lung ultrasound use in response to Covid-19: can we complement computed tomography findings? A narrative review.
|
NA
|
NA
|
|
[COVID-19 Pandemic in Germany: The Current Situation in Thoracic Surgery].
|
NA
|
NA
|
|
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Relevant Nutrition Therapy in COVID-19 and the Constraints on Its Delivery by a Unique Disease Process.
|
NA
|
NA
|
|
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
|
NA
|
NA
|
|
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
|
NA
|
NA
|
|
Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6.
|
NA
|
NA
|
|
A Chemoenzymatic Synthesis of the (RP)-Isomer of the Antiviral Prodrug Remdesivir.
|
NA
|
NA
|
|
Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.
|
NA
|
NA
|
|
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies.
|
NA
|
NA
|
|
Modified rehabilitation exercises for mild cases of COVID-19.
|
NA
|
NA
|
|
An HIV-infected patient with coronavirus disease 2019 has a favourable prognosis: a case report
|
NA
|
NA
|
|
Overview of prognostic factors in adult gliomas
|
NA
|
NA
|
|
End-of-life decision-making capacity in an elderly patient with schizophrenia and terminal cancer.
|
NA
|
NA
|
|
Ventilators are not the answer in Africa.
|
NA
|
NA
|
|
Recommendations for a national Coronavirus disease 2019 response guideline for the care of older persons in Nigeria during and post-pandemic: A family physician’s perspective.
|
NA
|
NA
|
|
Aerosol-generating procedures in thoracic surgery in the COVID-19 era in Malaysia.
|
NA
|
NA
|
|
Probiotics and Covid-19.
|
NA
|
NA
|
|
Model-based Prediction of Critical Illness in Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2?
|
NA
|
NA
|
|
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
|
NA
|
NA
|
|
The status and high risk factors of severe psychological distress in migraine patients during nCOV-2019 outbreak in Southwest China: a cross-sectional study.
|
NA
|
NA
|
|
A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.
|
NA
|
NA
|
|
Disease progression of cancer patients during COVID-19 pandemic: a comprehensive analytical strategy by time-dependent modelling.
|
NA
|
NA
|
|
Coronavirus disease 2019 epidemic in impoverished area: Liangshan Yi autonomous prefecture as an example.
|
NA
|
NA
|
|
Rapid identification of COVID-19 severity in CT scans through classification of deep features.
|
NA
|
NA
|
|
[Correlation between hyponatremia and the severity of coronavirus disease 2019].
|
NA
|
NA
|
|
[Effect of new simple breathing apparatus on oxygen therapy in patients with severe and critical coronavirus disease 2019].
|
NA
|
NA
|
|
Comprehensive review of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study.
|
NA
|
NA
|
|
COVID-19 emergency response assessment study: a prospective longitudinal survey of frontline doctors in the UK and Ireland: study protocol.
|
NA
|
NA
|
|
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
|
NA
|
NA
|
|
SARS-CoV-2 and the pandemic of COVID-19.
|
NA
|
NA
|
|
Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India.
|
NA
|
NA
|
|
Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
|
NA
|
NA
|
|
COVID-19: Clinical aspects and therapeutics responses.
|
NA
|
NA
|
|
The Behaviour Changes in Response to COVID-19 Pandemic within Malaysia.
|
NA
|
NA
|
|
Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China.
|
NA
|
NA
|
|
Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
|
NA
|
NA
|
|
COVID-19 infection recurrence presenting with meningoencephalitis.
|
NA
|
NA
|
|
Adapting Policy Guidelines for Spine Surgeries During COVID-19 Pandemic in View of Evolving Evidences: An Early Experience From a Tertiary Care Teaching Hospital.
|
NA
|
NA
|
|
Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review.
|
NA
|
NA
|
|
Fever and an abnormal chest X-ray during the COVID-19 pandemic.
|
NA
|
NA
|
|
The role of Korean Medicine in the post-COVID-19 era: an online panel discussion part 2 - basic research and education.
|
NA
|
NA
|
|
Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19.
|
NA
|
NA
|
|
COVID-19 Associated Pneumonia and Pleural Effusion Masquerading as Heart Failure in Rheumatic Heart Disease.
|
NA
|
NA
|
|
Pseudoparalytic shoulder in a CoViD-19-positive patient treated with CPAP: A case report.
|
NA
|
NA
|
|
COVID-19 disparities: An urgent call for race reporting and representation in clinical research.
|
NA
|
NA
|
|
Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports.
|
NA
|
NA
|
|
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19.
|
NA
|
NA
|
|
Automated quantification of COVID-19 severity and progression using chest CT images.
|
NA
|
NA
|
|
Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.
|
NA
|
NA
|
|
Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on lung cancer treatment scheduling.
|
NA
|
NA
|
|
A COVID-19 human viral challenge model. Learning from experience.
|
NA
|
NA
|
|
[COVID-19: new challenges for medical science and practical health].
|
NA
|
NA
|
|
COVID-19: Nanomedicine Uncovers Blood-Clot Mystery.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on mental health: Real-time surveillance using Google Trends.
|
NA
|
NA
|
|
A Geroscience Approach to Preventing Pathologic Consequences of COVID-19.
|
NA
|
NA
|
|
Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care.
|
NA
|
NA
|
|
Addressing the Disproportionate Impacts of the COVID-19 Pandemic on Sexual and Gender Minority Populations in the United States: Actions Toward Equity.
|
NA
|
NA
|
|
Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
|
NA
|
NA
|
|
Serious Adverse Health Events, Including Death, Associated with Ingesting Alcohol-Based Hand Sanitizers Containing Methanol - Arizona and New Mexico, May-June 2020.
|
NA
|
NA
|
|
COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.
|
NA
|
NA
|
|
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
|
NA
|
NA
|
|
A simulation modelling toolkit for organising outpatient dialysis services during the COVID-19 pandemic.
|
NA
|
NA
|
|
Defining heart disease risk for death in COVID-19 infection.
|
NA
|
NA
|
|
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil.
|
NA
|
NA
|
|
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
|
NA
|
NA
|
|
Nicotine and the nicotinic cholinergic system in COVID-19.
|
NA
|
NA
|
|
Teleophthalmology: Evaluation of Phone-based Visual Acuity in a Pediatric Population.
|
NA
|
NA
|
|
Acute Lower Limb Ischemia as Clinical Presentation of COVID-19 Infection.
|
NA
|
NA
|
|
Economic Impact of COVID-19 on a High-Volume Academic Neurosurgical Practice.
|
NA
|
NA
|
|
Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2.
|
NA
|
NA
|
|
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
|
NA
|
NA
|
|
SARS-CoV-2 Causes a Specific Dysfunction of the Kidney Proximal Tubule.
|
NA
|
NA
|
|
Clinical course and physiotherapy intervention in 9 patients with COVID-19.
|
NA
|
NA
|
|
App-Based Tracking of Self-Reported COVID-19 Symptoms: Analysis of Questionnaire Data.
|
NA
|
NA
|
|
Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery.
|
NA
|
NA
|
|
[COVID-19 and the impact of cardiovascular comorbidities].
|
NA
|
NA
|
|
A perspective on dental activity during COVID-19: The Italian survey.
|
NA
|
NA
|
|
The effect of acupuncture on the quality of life of patients recovering from COVID-19: A systematic review protocol.
|
NA
|
NA
|
|
The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.
|
NA
|
NA
|
|
Acupuncture and related interventions for anxiety in coronavirus disease 2019: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia.
|
NA
|
NA
|
|
Unexpected SARS-CoV-2 cardiorespiratory arrest in a myopathy patient undergoing immunosuppressive treatment: A case report.
|
NA
|
NA
|
|
Clinical and CT characteristics of healthcare workers with COVID-19: A single-centered, retrospective study.
|
NA
|
NA
|
|
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Anxiety and related factors in frontline clinical nurses fighting COVID-19 in Wuhan.
|
NA
|
NA
|
|
Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic.
|
NA
|
NA
|
|
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.
|
NA
|
NA
|
|
Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure.
|
NA
|
NA
|
|
Technological Developments and Strategic Management for Overcoming the COVID-19 Challenge within the Hospital Setting in Israel.
|
NA
|
NA
|
|
COVID-19 Compared to Other Pandemic Diseases.
|
NA
|
NA
|
|
Treatment of COVID-19 Patients in Italy: A Physician’s Experience and Insights.
|
NA
|
NA
|
|
Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure.
|
NA
|
NA
|
|
Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.
|
NA
|
NA
|
|
The clinical course of COVID in pregnancy.
|
NA
|
NA
|
|
Convalescent Plasma Therapy for COVID-19: State of the Art.
|
NA
|
NA
|
|
E-mental health mindfulness-based and skills-based ‘CoPE It’ intervention to reduce psychological distress in times of COVID-19: study protocol for a bicentre longitudinal study.
|
NA
|
NA
|
|
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.
|
NA
|
NA
|
|
Telemedicine for chronic pain management during COVID-19 pandemic.
|
NA
|
NA
|
|
Joint IFS-ISAR-ACE Recommendations on Resuming/Opening up Assisted Reproductive Technology Services.
|
NA
|
NA
|
|
Recommendations for Cutaneous and Aesthetic Surgeries during COVID-19 Pandemic.
|
NA
|
NA
|
|
Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of IK(M) or IK(DR) and in the Stimulation of IMEP.
|
NA
|
NA
|
|
What Happened to Patients With Obsessive Compulsive Disorder During the COVID-19 Pandemic? A Multicentre Report From Tertiary Clinics in Northern Italy.
|
NA
|
NA
|
|
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis.
|
NA
|
NA
|
|
Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
|
NA
|
NA
|
|
Computational-based drug repurposing methods in COVID-19.
|
NA
|
NA
|
|
Urological Care and COVID-19: Looking Forward.
|
NA
|
NA
|
|
Reopening of dental clinics during SARS-CoV-2 pandemic: an evidence-based review of literature for clinical interventions.
|
NA
|
NA
|
|
COVID-19 and the Kidneys: An Update.
|
NA
|
NA
|
|
Safety and Efficacy of Chest Physiotherapy in Patients With COVID-19: A Critical Review.
|
NA
|
NA
|
|
Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data.
|
NA
|
NA
|
|
A bibliometric analysis using VOSviewer of publications on COVID-19.
|
NA
|
NA
|
|
Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis.
|
NA
|
NA
|
|
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
|
NA
|
NA
|
|
[How severe is the effect of the coronavirus pandemic on the department of surgery of a university hospital? : An analysis of the first 7 weeks].
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
|
NA
|
NA
|
|
Crisis Resource Management and High-Performing Teams in Hyperacute Stroke Care.
|
NA
|
NA
|
|
A Japanese case of COVID-19: An autopsy report.
|
NA
|
NA
|
|
Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.
|
NA
|
NA
|
|
COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care.
|
NA
|
NA
|
|
Tuberculosis and COVID-19: An overlapping situation during pandemic.
|
NA
|
NA
|
|
A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries.
|
NA
|
NA
|
|
Clinical, Radiological Features and Outcome of COVID-19 patients in a Secondary Hospital in Jakarta, Indonesia.
|
NA
|
NA
|
|
[Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)].
|
NA
|
NA
|
|
[Urgent recommendation protective measures of West China Hospital for medical personnel to prevent device related pressure injuries in 2019-nCoV epidemic situation].
|
NA
|
NA
|
|
[A case report on treatment of compartment syndrome with novel coronavirus pneumonia].
|
NA
|
NA
|
|
Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients.
|
NA
|
NA
|
|
Surgical Protocol in a West China Day Surgery Center During the COVID-19 Pandemic: Practice and Experience.
|
NA
|
NA
|
|
COVID-19 Associated Coagulopathy and Thrombotic Complications.
|
NA
|
NA
|
|
Chemotherapy Treatment Modifications During the COVID-19 Outbreak at a Community Cancer Center in New York City.
|
NA
|
NA
|
|
Chemotherapy and COVID-19 Outcomes in Patients With Cancer.
|
NA
|
NA
|
|
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Indirect implications of COVID-19 prevention strategies on non-communicable diseases : An Opinion Paper of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk Assessment in Subjects Living in or Emigrating from Low Resource Settings.
|
NA
|
NA
|
|
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.
|
NA
|
NA
|
|
Universal masking during COVID-19 pandemic: Can textile engineering help public health? Narrative review of the evidence.
|
NA
|
NA
|
|
Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis.
|
NA
|
NA
|
|
Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19.
|
NA
|
NA
|
|
Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?
|
NA
|
NA
|
|
Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.
|
NA
|
NA
|
|
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
|
NA
|
NA
|
|
Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.
|
NA
|
NA
|
|
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review.
|
NA
|
NA
|
|
Developing a Mobile App (iGAM) to Promote Gingival Health by Professional Monitoring of Dental Selfies: User-Centered Design Approach.
|
NA
|
NA
|
|
Rapid Implementation and Innovative Applications of a Virtual Intensive Care Unit During the COVID-19 Pandemic: Case Study.
|
NA
|
NA
|
|
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
|
NA
|
NA
|
|
Big Data Analytics + Virtual Clinical Semantic Network (vCSN): An Approach to Addressing the Increasing Clinical Nuances and Organ Involvement of COVID-19.
|
NA
|
NA
|
|
Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study.
|
NA
|
NA
|
|
Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study.
|
NA
|
NA
|
|
The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases: report from a referral hospital in Milan.
|
NA
|
NA
|
|
Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19.
|
NA
|
NA
|
|
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101).
|
NA
|
NA
|
|
Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report.
|
NA
|
NA
|
|
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19.
|
NA
|
NA
|
|
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.
|
NA
|
NA
|
|
[Evolving Consensus of International Uveitis Study Group, Intraocular Inflammation Society, and Foster Ocular Inflammation Society with Uveitis in the Time of COVID-19 Infection].
|
NA
|
NA
|
|
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation.
|
NA
|
NA
|
|
Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism.
|
NA
|
NA
|
|
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development.
|
NA
|
NA
|
|
COVID-19 Outbreak Among Adolescents at an Inpatient Behavioral Health Hospital.
|
NA
|
NA
|
|
Following COVID-19 clinicians now overwhelmingly accept virtual clinics in Oral and Maxillofacial Surgery.
|
NA
|
NA
|
|
COVID-19 - What does a paediatrician need to know?
|
NA
|
NA
|
|
Nursing Diagnoses for Coronavirus Disease, COVID-19: Identification by Taxonomic Triangulation.
|
NA
|
NA
|
|
Considerations for stakeholder engagement and COVID-19 related clinical trials’ conduct in sub-Saharan Africa.
|
NA
|
NA
|
|
Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
|
NA
|
NA
|
|
Molecular Docking and Virtual Screening based prediction of drugs for COVID-19.
|
NA
|
NA
|
|
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
|
NA
|
NA
|
|
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
|
NA
|
NA
|
|
Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment.
|
NA
|
NA
|
|
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses.
|
NA
|
NA
|
|
Special considerations in the assessment of catastrophic brain injury and determination of brain death in patients with SARS-CoV-2.
|
NA
|
NA
|
|
Severe arterial thromboembolism in patients with Covid-19.
|
NA
|
NA
|
|
Managing Preterm Infants Born to COVID-19 Mothers: Evidence from a Retrospective Cohort Study in Wuhan, China.
|
NA
|
NA
|
|
SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report.
|
NA
|
NA
|
|
Renal Transplant Recipient with Concurrent COVID-19 and Stenotrophomonas maltophilia Pneumonia Treated with Trimethoprim/Sulfamethoxazole Leading to Acute Kidney Injury: A Therapeutic Dilemma.
|
NA
|
NA
|
|
Barriers to seeking emergency care during the COVID-19 pandemic may lead to higher morbidity and mortality - a retrospective study from a Swiss university hospital.
|
NA
|
NA
|
|
From conception to COVID-19: an arduous journey of tribulations of racism and triumphs.
|
NA
|
NA
|
|
Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
|
NA
|
NA
|
|
Emerging therapeutics for the management of COVID 19.
|
NA
|
NA
|
|
Establishing A High Sensitivity Detection Method for SARS-CoV-2 IgM/IgG and Developing a Clinical Application of this Method.
|
NA
|
NA
|
|
Rehabilitation of patients with COVID-19.
|
NA
|
NA
|
|
The pervasive relevance of COVID-19 within routine paediatric palliative care consultations during the pandemic: A conversation analytic study.
|
NA
|
NA
|
|
The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
|
NA
|
NA
|
|
[CPAP for patients with COVID-19].
|
NA
|
NA
|
|
Transmission, start of symptom and morbidity among Danish COVID-19 patients admitted to hospital.
|
NA
|
NA
|
|
Characteristics and early outcomes of patients hospitalised for COVID-19 in North Zealand, Denmark.
|
NA
|
NA
|
|
Pulmonary Embolism in Patients Hospitalized With COVID-19 (From a New York Health System).
|
NA
|
NA
|
|
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
|
NA
|
NA
|
|
Coronavirus Disease 2019 in Immunocompromised Organ Transplant Recipients: A Case Report and Review of the Literature.
|
NA
|
NA
|
|
Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
|
NA
|
NA
|
|
The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Feasibility and Acceptability of Telemedicine to Substitute Outpatient Rehabilitation Services in the COVID-19 Emergency in Italy: An Observational Everyday Clinical-Life Study.
|
NA
|
NA
|
|
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
|
NA
|
NA
|
|
COVID-19 Vaccine: A comprehensive status report.
|
NA
|
NA
|
|
The costs of an expanded screening criteria for COVID-19: A modelling study.
|
NA
|
NA
|
|
Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites.
|
NA
|
NA
|
|
Counseling of people with epilepsy via telemedicine: Experiences at a German tertiary epilepsy center during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study).
|
NA
|
NA
|
|
Dental medicine and COVID-19 pandemic.
|
NA
|
NA
|
|
A Narrative Review of COVID-19: The New Pandemic Disease.
|
NA
|
NA
|
|
On Occasion of the COVID-19 Pandemic - One of the Most Important Dilemma: Vaccinate or Not?
|
NA
|
NA
|
|
Management Strategies for Cancer Patients in the Time of COVID-19 Pandemic.
|
NA
|
NA
|
|
Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients.
|
NA
|
NA
|
|
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach.
|
NA
|
NA
|
|
Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date.
|
NA
|
NA
|
|
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
|
NA
|
NA
|
|
The Coronavirus Disease 2019 (COVID-19) in Children: A Study in an Iranian Children’s Referral Hospital.
|
NA
|
NA
|
|
A Review on Currently Available Potential Therapeutic Options for COVID-19.
|
NA
|
NA
|
|
Middle East Respiratory Syndrome - What Every Otolaryngologist Should Know: A Review.
|
NA
|
NA
|
|
Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable.
|
NA
|
NA
|
|
Prevention and Treatment Strategies for the Cardiology Department of a Non-COVID-19 Designated Hospital in the Post-Epidemic Period.
|
NA
|
NA
|
|
Quality of Novel Coronavirus Related Health Information over the Internet: An Evaluation Study.
|
NA
|
NA
|
|
Pharmacists’ perception of their role during COVID-19: a qualitative content analysis of posts on Facebook pharmacy groups in Jordan.
|
NA
|
NA
|
|
The Predictive Effectiveness of Blood Biochemical Indexes for the Severity of COVID-19.
|
NA
|
NA
|
|
Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review.
|
NA
|
NA
|
|
Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient.
|
NA
|
NA
|
|
Adaptation of a Gamma Knife Icon stereotactic radiosurgery program in the face of the COVID-19 pandemic.
|
NA
|
NA
|
|
Neurological Aspects of Coronavirus Infectious Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Telepsychiatry in Psychotherapy Practice.
|
NA
|
NA
|
|
Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York.
|
NA
|
NA
|
|
Acute Kidney Injury in COVID-19 Pneumonia: A Single-Center Experience in Bahrain.
|
NA
|
NA
|
|
Breast Reconstruction in a Coronavirus Disease 2019 Hub.
|
NA
|
NA
|
|
Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis.
|
NA
|
NA
|
|
Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
|
NA
|
NA
|
|
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.
|
NA
|
NA
|
|
Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance.
|
NA
|
NA
|
|
Data on chloroquine/hydroxychloroquine content in compounded oral suspension after filtration and centrifugation.
|
NA
|
NA
|
|
Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space.
|
NA
|
NA
|
|
Searching potential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking.
|
NA
|
NA
|
|
Study of the structural, chemical descriptors and optoelectronic properties of the drugs Hydroxychloroquine and Azithromycin.
|
NA
|
NA
|
|
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Possible molecular and paracrine involvement underlying the pathogenesis of COVID-19 cardiovascular complications.
|
NA
|
NA
|
|
Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
|
NA
|
NA
|
|
A California Hospital’s Response to COVID-19: From a Ripple to a Tsunami Warning.
|
NA
|
NA
|
|
The United States National Cancer Institute’s Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV.
|
NA
|
NA
|
|
Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.
|
NA
|
NA
|
|
Past Epidemics, Natural Disasters, COVID19, and Mental Health: Learning from History as we Deal with the Present and Prepare for the Future.
|
NA
|
NA
|
|
COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.
|
NA
|
NA
|
|
Management of early breast cancer during the COVID-19 pandemic in Brazil.
|
NA
|
NA
|
|
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).
|
NA
|
NA
|
|
Management of Thrombotic Complications in COVID-19: An Update.
|
NA
|
NA
|
|
The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19.
|
NA
|
NA
|
|
Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.
|
NA
|
NA
|
|
Severe Clostridium difficile colitis as potential late complication associated with COVID-19.
|
NA
|
NA
|
|
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.
|
NA
|
NA
|
|
Operating Room Setup: How to Improve Health Care Professionals Safety During Pandemic COVID-19-A Quality Improvement Study.
|
NA
|
NA
|
|
Artificial Intelligence for Rapid Meta-Analysis: Case Study on Ocular Toxicity of Hydroxychloroquine.
|
NA
|
NA
|
|
Resilience of Alzheimer’s Disease to COVID-19.
|
NA
|
NA
|
|
Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer’s Disease Sleep Disorders.
|
NA
|
NA
|
|
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Adaptation of labor and delivery to COVID-19.
|
NA
|
NA
|
|
Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and ProlixinRX (Fluphenazine) Provides Off-Label Drug Candidates.
|
NA
|
NA
|
|
Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.
|
NA
|
NA
|
|
Effects of COVID-19 pandemic on acute ischemic stroke care. A single-centre retrospective analysis of medical collateral damage.
|
NA
|
NA
|
|
Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series.
|
NA
|
NA
|
|
Outpatient Physical, Occupational, and Speech Therapy Synchronous Telemedicine: A Survey Study of Patient Satisfaction with Virtual Visits During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Images of COVID-19 Infection Cases in Asymptomatic or Paucisymptomatic Patients With Neoplastic Diseases on 18F-FDG PET/CT.
|
NA
|
NA
|
|
Myoclonus in Patients With Coronavirus Disease 2019: A Multicenter Case Series.
|
NA
|
NA
|
|
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients.
|
NA
|
NA
|
|
Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.
|
NA
|
NA
|
|
[Encephalitis associated with COVID-19 in a 13-year-old girl: A case report].
|
NA
|
NA
|
|
Effectiveness of telerehabilitation in physical therapy: A protocol for an overview in a time when rapid responses are needed.
|
NA
|
NA
|
|
Bias at Warp Speed: How AI may Contribute to the Disparities Gap in the Time of COVID-19.
|
NA
|
NA
|
|
CoV-AbDab: the Coronavirus Antibody Database.
|
NA
|
NA
|
|
The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment.
|
NA
|
NA
|
|
It Takes a Village…: Contending With Drug Shortages During Disasters.
|
NA
|
NA
|
|
Updates on community acquired pneumonia management in the ICU.
|
NA
|
NA
|
|
Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
|
NA
|
NA
|
|
The under-reported role of toxic substance exposures in the COVID-19 pandemic.
|
NA
|
NA
|
|
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
|
NA
|
NA
|
|
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
|
NA
|
NA
|
|
Value of electrocardiography in coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Venous Thromboembolism in Hospitalized COVID-19 Patients: Systematic Review.
|
NA
|
NA
|
|
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.
|
NA
|
NA
|
|
The effect of emergency surgery on acute abdomen patients with COVID-19 pneumonia: a retrospective observational study.
|
NA
|
NA
|
|
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19.
|
NA
|
NA
|
|
Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.
|
NA
|
NA
|
|
Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
|
NA
|
NA
|
|
COVID-19 prevalence and fatality rates in association with air pollution emission concentrations and emission sources.
|
NA
|
NA
|
|
COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions.
|
NA
|
NA
|
|
Assessment of Mental Health Factors among Health Professionals Depending on Their Contact with COVID-19 Patients.
|
NA
|
NA
|
|
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.
|
NA
|
NA
|
|
Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19.
|
NA
|
NA
|
|
Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
|
NA
|
NA
|
|
Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies.
|
NA
|
NA
|
|
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.
|
NA
|
NA
|
|
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Unprotected stroke management in an undiagnosed case of Severe Acute Respiratory Syndrome Coronavirus 2 infection.
|
NA
|
NA
|
|
Subarachnoid hemorrhage guidance in the era of the COVID-19 pandemic - An opinion to mitigate exposure and conserve personal protective equipment.
|
NA
|
NA
|
|
Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection.
|
NA
|
NA
|
|
Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic.
|
NA
|
NA
|
|
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2.
|
NA
|
NA
|
|
A dynamic COVID-19 immune signature includes associations with poor prognosis.
|
NA
|
NA
|
|
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
|
NA
|
NA
|
|
Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience.
|
NA
|
NA
|
|
Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Acutely altered mental status as the main clinical presentation of multiple strokes in critically ill patients with COVID-19.
|
NA
|
NA
|
|
Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
|
NA
|
NA
|
|
SARS-CoV: Lessons learned; opportunities missed for SARS-CoV-2.
|
NA
|
NA
|
|
Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID-19 Severity?
|
NA
|
NA
|
|
Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19.
|
NA
|
NA
|
|
Healthcare Concerns of Older Adults during the COVID-19 Outbreak in Low- and Middle-Income Countries: Lessons for Health Policy and Social Work.
|
NA
|
NA
|
|
Bacterial infections and patterns of antibiotic use in patients with COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials.
|
NA
|
NA
|
|
The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research.
|
NA
|
NA
|
|
Coronaphobia among healthcare professionals in Mexico: A psychometric analysis.
|
NA
|
NA
|
|
The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
|
NA
|
NA
|
|
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute COVID-19 in Pediatric Patients.
|
NA
|
NA
|
|
[COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].
|
NA
|
NA
|
|
Oncology patients’ perceptions of and experiences with COVID-19.
|
NA
|
NA
|
|
Anticoagulant treatment in COVID-19: a narrative review.
|
NA
|
NA
|
|
Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review.
|
NA
|
NA
|
|
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.
|
NA
|
NA
|
|
Experiencing Social Isolation (Even in the Era of COVID-19 Pandemic Lockdown): Teachings Through Arts from Adolescents with Cancer.
|
NA
|
NA
|
|
Strategic implementation of dental infection control in resource-poor jurisdictions during COVID-19 pandemic: a perspective from South Africa.
|
NA
|
NA
|
|
Oxytocin’s anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.
|
NA
|
NA
|
|
Severe diabetic ketoacidosis and coronavirus disease 2019 (COVID-19) infection in a teenage patient with newly diagnosed diabetes.
|
NA
|
NA
|
|
Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.
|
NA
|
NA
|
|
Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
|
NA
|
NA
|
|
COVID-19 and Oncology: Service transformation during pandemic.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Guidelines Adaptation to the COVID-19 Outbreak for the Management of Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
|
NA
|
NA
|
|
Thyroid cancer in the age of COVID-19.
|
NA
|
NA
|
|
[Effects on the integrated treatment of colorectal cancer patients during COVID-19 epidemic in China: a cross-sectional study].
|
NA
|
NA
|
|
COVID-19 driven care changes in high risk patients from an outpatient to a community setting.
|
NA
|
NA
|
|
Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects.
|
NA
|
NA
|
|
An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease.
|
NA
|
NA
|
|
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
|
NA
|
NA
|
|
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
|
NA
|
NA
|
|
Psychedelic science in post-COVID-19 psychiatry.
|
NA
|
NA
|
|
Model for ethical triaging of electroconvulsive therapy patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform.
|
NA
|
NA
|
|
Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
The impact of COVID-19 on cervicofacial infection of dental aetiology.
|
NA
|
NA
|
|
Epidemiological & clinical characteristics & early outcome of COVID-19 patients in a tertiary care teaching hospital in India: A preliminary analysis.
|
NA
|
NA
|
|
Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
|
NA
|
NA
|
|
Acute endodontic and dental trauma provision during the COVID-19 crisis.
|
NA
|
NA
|
|
The role of real-time interactive video consultations in dental practice during the recovery and restoration phase of the COVID-19 outbreak.
|
NA
|
NA
|
|
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
|
NA
|
NA
|
|
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
|
NA
|
NA
|
|
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
|
NA
|
NA
|
|
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
|
NA
|
NA
|
|
Is there any potential management against COVID-19? A systematic review and meta-analysis.
|
NA
|
NA
|
|
The level of anxiety in infertile women whose ART cycles are postponed due to the COVID-19 outbreak.
|
NA
|
NA
|
|
Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience.
|
NA
|
NA
|
|
Impact of the COVID-19 Outbreak on Routine Obstetrical Management.
|
NA
|
NA
|
|
COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
|
NA
|
NA
|
|
Role of probiotics to combat viral infections with emphasis on COVID-19.
|
NA
|
NA
|
|
Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak.
|
NA
|
NA
|
|
The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis.
|
NA
|
NA
|
|
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
|
NA
|
NA
|
|
Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: A network meta-analysis.
|
NA
|
NA
|
|
A 28-Year-Old Man from India with SARS-Cov-2 and Pulmonary Tuberculosis Co-Infection with Central Nervous System Involvement.
|
NA
|
NA
|
|
Epidemiologic and clinical features of patients with COVID-19 in Brazil.
|
NA
|
NA
|
|
Study of ongoing registered clinical trials on COVID-19: a narrative review.
|
NA
|
NA
|
|
COVID-19 infection and cardiac arrhythmias.
|
NA
|
NA
|
|
Is ocular toxicity expected in chloroquine/hydroxychloroquine prescription as a therapeutic or prophylactic option in COVID-19?
|
NA
|
NA
|
|
Practical recommendations in the obstetrical patient with a COVID-19 infection.
|
NA
|
NA
|
|
[Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group].
|
NA
|
NA
|
|
The Urgency of Conducting Serological Studies for COVID-19.
|
NA
|
NA
|
|
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.
|
NA
|
NA
|
|
Repurposing calcium channel blockers as antiviral drugs.
|
NA
|
NA
|
|
Guidance on infection control and plume management with Laser and Energy-Based Devices taking into consideration COVID-19.
|
NA
|
NA
|
|
Intensive care and anesthetic management of patients with Brugada syndrome and COVID-19 infection.
|
NA
|
NA
|
|
Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.
|
NA
|
NA
|
|
COVID-19 and eating disorders during confinement: Analysis of factors associated with resilience and aggravation of symptoms.
|
NA
|
NA
|
|
Antibody response in a family with COVID-19.
|
NA
|
NA
|
|
Ventilatory support for hypoxaemic intensive care patients with COVID-19.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
|
NA
|
NA
|
|
Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective.
|
NA
|
NA
|
|
Case Report: COVID-19 Recovery from Triple Infection with Mycobacterium tuberculosis, HIV, and SARS-CoV-2.
|
NA
|
NA
|
|
Case Report: Coronavirus Disease and Pulmonary Tuberculosis in Patients with Human Immunodeficiency Virus: Report of Two Cases.
|
NA
|
NA
|
|
Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
|
NA
|
NA
|
|
Dental services during the COVID-19 pandemic: A tertiary care hospital experience.
|
NA
|
NA
|
|
Increased cardiovascular death rates in a COVID-19 low prevalence area.
|
NA
|
NA
|
|
Mental Health Care Goes Online: Practitioners’ Experiences of Providing Mental Health Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System.
|
NA
|
NA
|
|
Antitussive noscapine and antiviral drug conjugates as arsenal against COVID-19: a comprehensive chemoinformatics analysis.
|
NA
|
NA
|
|
Modification of a Validated Risk Stratification Tool to Characterize Geriatric Hip Fracture Outcomes and Optimize Care in a Post-COVID-19 World.
|
NA
|
NA
|
|
Upscaling Virtual Fracture Clinic Use Is a Safe, Effective Measure in the Delivery of Trauma Care.
|
NA
|
NA
|
|
Delivering esophago-gastric cancer care during the COVID-19 pandemic in the United Kingdom: a surgical perspective.
|
NA
|
NA
|
|
Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.
|
NA
|
NA
|
|
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N).
|
NA
|
NA
|
|
The Psychosocial Effects of the COVID-19 Pandemic on Youth Living with HIV in Western Kenya.
|
NA
|
NA
|
|
Pharmacological treatments of COVID-19.
|
NA
|
NA
|
|
Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak.
|
NA
|
NA
|
|
Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.
|
NA
|
NA
|
|
Enteritis and Severe Abdominal Pain as the First Presentation of Covid-19.
|
NA
|
NA
|
|
The COVID-19 telepsychology revolution: A national study of pandemic-based changes in U.S. mental health care delivery.
|
NA
|
NA
|
|
Disability, Ethics, and Health Care in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Could Sumac Be Effective on COVID-19 Treatment?
|
NA
|
NA
|
|
Access to Healthcare in a time of COVID-19: Sex Workers in Crisis in Nairobi, Kenya.
|
NA
|
NA
|
|
Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.
|
NA
|
NA
|
|
Acute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease.
|
NA
|
NA
|
|
ICI Impact on COVID-19 Severity Modest at Best.
|
NA
|
NA
|
|
The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts.
|
NA
|
NA
|
|
Postacute inpatient rehabilitation for COVID-19.
|
NA
|
NA
|
|
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo.
|
NA
|
NA
|
|
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
|
NA
|
NA
|
|
Chronic hospital nurse understaffing meets COVID-19: an observational study.
|
NA
|
NA
|
|
A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment.
|
NA
|
NA
|
|
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
|
NA
|
NA
|
|
COVID-19 severity scoring systems in radiological imaging - a review.
|
NA
|
NA
|
|
Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study.
|
NA
|
NA
|
|
Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs.
|
NA
|
NA
|
|
Biosensors: frontiers in rapid detection of COVID-19.
|
NA
|
NA
|
|
Virucidal benefits of povidone-iodine use on the ocular surface: a review.
|
NA
|
NA
|
|
COVID-19 and multisystem inflammatory syndrome in children and adolescents.
|
NA
|
NA
|
|
Resumption of Endodontic Practices in COVID-19 Hardest-Hit Area of China: A Web-based Survey.
|
NA
|
NA
|
|
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19.
|
NA
|
NA
|
|
COVID-19: risk accumulation among biologically and socially vulnerable older populations.
|
NA
|
NA
|
|
Emerging health challenges for children with physical disabilities and their parents during the COVID-19 pandemic: The ECHO French survey.
|
NA
|
NA
|
|
ACE2, Metformin, and COVID-19.
|
NA
|
NA
|
|
Evaluating the Efficacy of Therapies in COVID-19 Patients.
|
NA
|
NA
|
|
Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation.
|
NA
|
NA
|
|
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Unspoken inequality: how COVID-19 has exacerbated existing vulnerabilities of asylum-seekers, refugees, and undocumented migrants in South Africa.
|
NA
|
NA
|
|
Radiation oncology in times of COVID-2019: A review article for those in the eye of the storm - An Indian perspective.
|
NA
|
NA
|
|
Regional Mechanical Thrombectomy Imaging Protocol in Patients Presenting with Acute Ischemic Stroke during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements.
|
NA
|
NA
|
|
Modelling resource requirements and physician staffing to provide virtual urgent medical care for residents of long-term care homes: a cross-sectional study.
|
NA
|
NA
|
|
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Compulsory medical intervention versus external constraint in pandemic control.
|
NA
|
NA
|
|
COVID-19 and the burning issue of drug interaction: never forget the ECG.
|
NA
|
NA
|
|
COVID-19 Case Report: An 84-Year-Old Man with Exacerbation of Multiple Comorbidities Due to COVID-19 Managed by a Multidisciplinary Team Using Patient-Reported Outcomes.
|
NA
|
NA
|
|
Animal and translational models of SARS-CoV-2 infection and COVID-19.
|
NA
|
NA
|
|
[Interdisciplinary multimodal pain therapy under the protective measures of the COVID-19 pandemic : Analysis and progress report].
|
NA
|
NA
|
|
A multistage combined approach to promote diabetic wound healing in COVID-19 era.
|
NA
|
NA
|
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.
|
NA
|
NA
|
|
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
|
NA
|
NA
|
|
Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study.
|
NA
|
NA
|
|
Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective.
|
NA
|
NA
|
|
COVID pandemic as an opportunity for improving mental health treatments of the homeless people.
|
NA
|
NA
|
|
Utilizing Telemedicine in a Novel Approach to COVID-19 Management and Patient Experience in the Emergency Department.
|
NA
|
NA
|
|
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
|
NA
|
NA
|
|
Follow-Up CT Results of COVID-19 Patients with Initial Negative Chest CT.
|
NA
|
NA
|
|
Fever with Rash is One of the First Presentations of COVID-19 in Children: A Case Report.
|
NA
|
NA
|
|
COVID-19 pandemic preparation: using simulation for systems-based learning to prepare the largest healthcare workforce and system in Canada.
|
NA
|
NA
|
|
Hospital Course of a Man With Viral Pneumonia Caused by COVID-19.
|
NA
|
NA
|
|
ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review.
|
NA
|
NA
|
|
Medical Abortion Care During a Pandemic.
|
NA
|
NA
|
|
A picture of medically assisted reproduction activities during the COVID-19 pandemic in Europe.
|
NA
|
NA
|
|
The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19.
|
NA
|
NA
|
|
Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Virtual geriatric clinics and the COVID-19 catalyst: a rapid review.
|
NA
|
NA
|
|
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
[Bed capacity management in times of the COVID-19 pandemic : A simulation-based prognosis of normal and intensive care beds using the descriptive data of the University Hospital Augsburg].
|
NA
|
NA
|
|
Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery.
|
NA
|
NA
|
|
Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona.
|
NA
|
NA
|
|
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
|
NA
|
NA
|
|
Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19.
|
NA
|
NA
|
|
Disinfection technology and strategies for COVID-19 hospital and bio-medical waste management.
|
NA
|
NA
|
|
Environmental contamination of SARS-CoV-2 on surfaces, air-conditioner and ventilation systems.
|
NA
|
NA
|
|
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay.
|
NA
|
NA
|
|
The host targeting effect of chloroquine in malaria.
|
NA
|
NA
|
|
[Impact of COVID-19-pandemic on Clinical Care, Work Flows and Staff at a University Hospital: Results of an Interview-study at the UKE].
|
NA
|
NA
|
|
[The impact of SARS-CoV-2 restrictions on medical care in Plastic Surgery].
|
NA
|
NA
|
|
Understanding COVID-19: From Origin to Potential Therapeutics.
|
NA
|
NA
|
|
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Contagion of Sentiments during the COVID-19 Pandemic Crisis: The Case of Isolation in Spain.
|
NA
|
NA
|
|
The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection.
|
NA
|
NA
|
|
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.
|
NA
|
NA
|
|
4,4’-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
|
NA
|
NA
|
|
The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.
|
NA
|
NA
|
|
Novel Antiviral Strategies in the Treatment of COVID-19: A Review.
|
NA
|
NA
|
|
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy.
|
NA
|
NA
|
|
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.
|
NA
|
NA
|
|
Are Myths and Preconceptions Preventing us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?
|
NA
|
NA
|
|
Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective, Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort.
|
NA
|
NA
|
|
Antiviral Potential of Nanoparticles-Can Nanoparticles Fight Against Coronaviruses?
|
NA
|
NA
|
|
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009.
|
NA
|
NA
|
|
White paper on Ivermectin as a potential therapy for COVID-19.
|
NA
|
NA
|
|
Songbirds Must Sing: How Artistic Voice Users Perceive Their Voice in Times of COVID-19.
|
NA
|
NA
|
|
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort.
|
NA
|
NA
|
|
IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
|
NA
|
NA
|
|
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy.
|
NA
|
NA
|
|
High-Flow Nasal Oxygen in Coronavirus Disease 2019 Patients With Acute Hypoxemic Respiratory Failure: A Multicenter, Retrospective Cohort Study.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on the Medical Follow-up and Psychosocial Well-Being of People Living With HIV: A Cross-Sectional Survey.
|
NA
|
NA
|
|
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.
|
NA
|
NA
|
|
Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond.
|
NA
|
NA
|
|
Changing Outdated Methadone Regulations That Harm Pregnant Patients.
|
NA
|
NA
|
|
A Novel Pediatric Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit.
|
NA
|
NA
|
|
Initial Report From a Swedish High-Volume Transplant Center After The First Wave of The COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical Course of 195 Critically Ill COVID-19 Patients: A Retrospective Multicenter Study.
|
NA
|
NA
|
|
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
|
NA
|
NA
|
|
Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
|
NA
|
NA
|
|
Data-Driven Insights on the Effects of COVID-19 on Aesthetics: Part I (Passive Analysis).
|
NA
|
NA
|
|
COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery.
|
NA
|
NA
|
|
Convergence between global BCG vaccination and COVID-19 pandemic.
|
NA
|
NA
|
|
Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
|
NA
|
NA
|
|
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making.
|
NA
|
NA
|
|
Bringing into focus treatment limitation and DNACPR decisions: How COVID-19 has changed practice.
|
NA
|
NA
|
|
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.
|
NA
|
NA
|
|
The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients.
|
NA
|
NA
|
|
Caring for cancer patients in the Covid pandemic: choosing between the devil and deep sea.
|
NA
|
NA
|
|
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
|
NA
|
NA
|
|
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19.
|
NA
|
NA
|
|
Sex and gender: modifiers of health, disease, and medicine.
|
NA
|
NA
|
|
Establishment and validation of a drug-target microarray for SARS-CoV-2.
|
NA
|
NA
|
|
Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review.
|
NA
|
NA
|
|
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19.
|
NA
|
NA
|
|
Erythema nodosum-like rash in a COVID-19 patient: A case report.
|
NA
|
NA
|
|
Urgencies and emergencies in orthodontics during the coronavirus disease 2019 pandemic: Brazilian orthodontists’ experience.
|
NA
|
NA
|
|
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
|
NA
|
NA
|
|
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation.
|
NA
|
NA
|
|
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial.
|
NA
|
NA
|
|
Environmental contamination in the isolation rooms of COVID-19 patients with severe pneumonia requiring mechanical ventilation or high-flow oxygen therapy.
|
NA
|
NA
|
|
A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
|
NA
|
NA
|
|
The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target.
|
NA
|
NA
|
|
Effect of a previous history of antiretroviral treatment on the clinical picture of patients with co-infection of SARS-CoV-2 and HIV: A preliminary study.
|
NA
|
NA
|
|
Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
|
NA
|
NA
|
|
Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking.
|
NA
|
NA
|
|
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Effect of immunosuppressive drugs in immune-mediated inflammatory disease during the coronavirus pandemic.
|
NA
|
NA
|
|
Practitioner review: health anxiety in children and young people in the context of the COVID-19 pandemic.
|
NA
|
NA
|
|
Thromboembolic complications of COVID-19: the combined effect of a pro-coagulant pattern and an endothelial thrombo-inflammatory syndrome.
|
NA
|
NA
|
|
How telemedicine integrated into China’s anti-COVID-19 strategies: case from a National Referral Center.
|
NA
|
NA
|
|
Hospital Preparedness for COVID-19: The Known and The Known Unknown.
|
NA
|
NA
|
|
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
|
NA
|
NA
|
|
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients.
|
NA
|
NA
|
|
A Rapid Qualitative Assessment of the Impact of the COVID-19 Pandemic on a Racially/Ethnically Diverse Sample of Gay, Bisexual, and Other Men who Have Sex with Men Living with HIV in the US South.
|
NA
|
NA
|
|
Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
|
NA
|
NA
|
|
A Study on Challenges to Health Care Delivery Faced by Cancer Patients in India During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19.
|
NA
|
NA
|
|
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
|
NA
|
NA
|
|
Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
|
NA
|
NA
|
|
Adsorption of Uremic Toxins Using Ti3C2Tx MXene for Dialysate Regeneration.
|
NA
|
NA
|
|
Harm reduction in an emergency response to homelessness during South Africa’s COVID-19 lockdown.
|
NA
|
NA
|
|
Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Impact of Shenfu injection on a composite of organ dysfunction development in critically ill patients with coronavirus disease 2019 (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials.
|
NA
|
NA
|
|
Google Trends Insights Into Reduced Acute Coronary Syndrome Admissions During the COVID-19 Pandemic: Infodemiology Study.
|
NA
|
NA
|
|
Mechanical ventilator as a shared resource for the COVID-19 pandemic.
|
NA
|
NA
|
|
Proposal for the management of COVID-19-associated coagulopathy in children.
|
NA
|
NA
|
|
Towards the design of epitope candidates for Coronavirus 2.
|
NA
|
NA
|
|
Putative Natural History of CoViD-19.
|
NA
|
NA
|
|
Amphotericin B as antiviral drug: Possible efficacy against COVID-19.
|
NA
|
NA
|
|
A preliminary clinico-epidemiological portrayal of COVID-19 pandemic at a premier medical institution of North India.
|
NA
|
NA
|
|
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
|
NA
|
NA
|
|
ACE2 enhance viral infection or viral infection aggravate the underlying diseases.
|
NA
|
NA
|
|
Anti-COVID-19 multi-epitope vaccine designs employing global viral genome sequences.
|
NA
|
NA
|
|
Ethical dilemmas in the era of COVID-19.
|
NA
|
NA
|
|
Safer Practice of Aesthetic Dermatology during the COVID-19 Pandemic: Recommendations by SIG Aesthetics (IADVL Academy).
|
NA
|
NA
|
|
Outpatient Parenteral Antimicrobial Therapy in the Time of COVID-19: The Urgent Need for Better Insurance Coverage.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Acute General Surgical Admissions in a District General Hospital in the United Kingdom: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Acute Cord Compression Left Untreated for Fear of Contracting COVID-19: A Case Report and a Call for Health Care Plans for Oncologic Emergencies during Crisis.
|
NA
|
NA
|
|
Shattering barriers toward clinically meaningful MSC therapies.
|
NA
|
NA
|
|
The COVID-19 pandemic and diabetes mellitus.
|
NA
|
NA
|
|
Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment.
|
NA
|
NA
|
|
Impact of Sepsis Intervention Protocol (SIP) on Adherence to Three-hour and Six-hour Bundles and Mortality Outcomes in the Emergency Department.
|
NA
|
NA
|
|
COVID-19 Guidelines Changing Faster than the Virus: Implications of a Clinical Decision Support App.
|
NA
|
NA
|
|
Polymonoclonal (Not Polyclonal) Antibodies Derived from Convalescent Human B Cell Hybridomas Might Be a Better Therapeutic Option than Single Target Monoclonal Antibodies.
|
NA
|
NA
|
|
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.
|
NA
|
NA
|
|
Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
|
NA
|
NA
|
|
Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism.
|
NA
|
NA
|
|
Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications.
|
NA
|
NA
|
|
[Palliative and intensive care collaborative approach in the management of therapeutic withdrawals: lessons learned from the COVID-19 experience].
|
NA
|
NA
|
|
Data Sharing Solutions for Biobanks for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Lessons Learned from Caring for Patients with COVID-19 at the End of Life.
|
NA
|
NA
|
|
Turning Up the Volume for Precision Herbal Medicine in Africa in an Era of COVID-19 and Planetary Biodiversity Loss.
|
NA
|
NA
|
|
Clinical course and characteristics of patients with coronavirus disease 2019 in Wuhan, China: a single-centered, retrospective, observational study.
|
NA
|
NA
|
|
Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection.
|
NA
|
NA
|
|
Therapeutic Options for the Treatment of Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Supportive Management and Interventions for Respiratory Failure Due to SARS-CoV-2.
|
NA
|
NA
|
|
Institutional COVID-19 Protocols: Focused on Preparation, Safety, and Care Consolidation.
|
NA
|
NA
|
|
Leading Through the Unknown: A Network Perspective of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Experience in Neurosurgery During the Prevalence of COVID-19.
|
NA
|
NA
|
|
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.
|
NA
|
NA
|
|
Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking.
|
NA
|
NA
|
|
Deep learning disease prediction model for use with intelligent robots.
|
NA
|
NA
|
|
Small Water Systems Versus COVID-19.
|
NA
|
NA
|
|
Compressed fluids and phytochemical profiling tools to obtain and characterize antiviral and anti-inflammatory compounds from natural sources.
|
NA
|
NA
|
|
Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine.
|
NA
|
NA
|
|
Receptive music therapy to reduce stress and improve wellbeing in Italian clinical staff involved in COVID-19 pandemic: A preliminary study.
|
NA
|
NA
|
|
COVID-19 in South Korea: Lessons for developing countries.
|
NA
|
NA
|
|
The pandemic under siege: A view from the Gaza Strip.
|
NA
|
NA
|
|
An emergency responding mechanism for cruise epidemic prevention-taking COVID-19 as an example.
|
NA
|
NA
|
|
Emerging challenges in urban waste management in Tehran, Iran during the COVID-19 pandemic.
|
NA
|
NA
|
|
A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients.
|
NA
|
NA
|
|
SARS-CoV-2 in sewer systems and connected facilities.
|
NA
|
NA
|
|
Dynamic analysis of a mathematical model with health care capacity for COVID-19 pandemic.
|
NA
|
NA
|
|
Comprehensive identification and isolation policies have effectively suppressed the spread of COVID-19.
|
NA
|
NA
|
|
A mathematical study on the spread of COVID-19 considering social distancing and rapid assessment: The case of Jakarta, Indonesia.
|
NA
|
NA
|
|
Modeling and forecasting the COVID-19 pandemic in India.
|
NA
|
NA
|
|
Analysis on novel coronavirus (COVID-19) using machine learning methods.
|
NA
|
NA
|
|
Optimal Control Design of Impulsive SQEIAR Epidemic Models with Application to COVID-19.
|
NA
|
NA
|
|
Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review.
|
NA
|
NA
|
|
Modeling the impact of non-pharmaceutical interventions on the dynamics of novel coronavirus with optimal control analysis with a case study.
|
NA
|
NA
|
|
Assessment of lockdown effect in some states and overall India: A predictive mathematical study on COVID-19 outbreak.
|
NA
|
NA
|
|
Statistically-based methodology for revealing real contagion trends and correcting delay-induced errors in the assessment of COVID-19 pandemic.
|
NA
|
NA
|
|
Target specific mining of COVID-19 scholarly articles using one-class approach.
|
NA
|
NA
|
|
Occurrence of backward bifurcation and prediction of disease transmission with imperfect lockdown: A case study on COVID-19.
|
NA
|
NA
|
|
Diagnosis and detection of infected tissue of COVID-19 patients based on lung x-ray image using convolutional neural network approaches.
|
NA
|
NA
|
|
A mathematical model for COVID-19 transmission dynamics with a case study of India.
|
NA
|
NA
|
|
Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism.
|
NA
|
NA
|
|
Doctor-patient distancing: an early experience of telemedicine for postoperative neurosurgical care in the time of COVID-19.
|
NA
|
NA
|
|
Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes, influenza and other viral infections.
|
NA
|
NA
|
|
Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs.
|
NA
|
NA
|
|
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19.
|
NA
|
NA
|
|
An IoT-based framework for early identification and monitoring of COVID-19 cases.
|
NA
|
NA
|
|
Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus.
|
NA
|
NA
|
|
[Strategy for the practice of digestive and oncologic surgery in COVID-19 epidemic situation].
|
NA
|
NA
|
|
[SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic].
|
NA
|
NA
|
|
Macrophage activation syndrome and COVID-19.
|
NA
|
NA
|
|
Does hereditary angioedema make COVID-19 worse?
|
NA
|
NA
|
|
COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics.
|
NA
|
NA
|
|
Challenges in a child with asthma and COVID-19.
|
NA
|
NA
|
|
Beyond just “flattening the curve”: Optimal control of epidemics with purely non-pharmaceutical interventions.
|
NA
|
NA
|
|
Antivirus-built environment: Lessons learned from Covid-19 pandemic.
|
NA
|
NA
|
|
Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19.
|
NA
|
NA
|
|
Combating COVID-19 with integrated traditional Chinese and Western medicine in China.
|
NA
|
NA
|
|
Bioactive natural compounds against human coronaviruses: a review and perspective.
|
NA
|
NA
|
|
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
|
NA
|
NA
|
|
Analysis on herbal medicines utilized for treatment of COVID-19.
|
NA
|
NA
|
|
Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model.
|
NA
|
NA
|
|
A contextual behavioral approach for responding to moral dilemmas in the age of COVID-19.
|
NA
|
NA
|
|
Awareness of COVID 19 pandemic among dental practioners of Telangana state, India: A cross sectional survey.
|
NA
|
NA
|
|
SARS-CoV2 induced pulmonary embolism and complications from anticoagulation.
|
NA
|
NA
|
|
How to manage thromboembolic risk in patient with SARS-CoV-2-related disease in the Emergency Department: A case report of cardiogenic shock due to massive pulmonary embolism.
|
NA
|
NA
|
|
A review on presence, survival, disinfection/removal methods of coronavirus in wastewater and progress of wastewater-based epidemiology.
|
NA
|
NA
|
|
Chinese medical drugs for coronavirus disease 2019: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Safety management in urgent endonasal trans-sphenoidal surgery for pituitary adenoma during the COVID-19 pandemic in Japan - A case report.
|
NA
|
NA
|
|
Targeting of renin-angiotensin system in COVID-19 patients affected by stroke: Emerging concerns about detrimental vs. benefit effect.
|
NA
|
NA
|
|
Clipping of a ruptured middle cerebral artery aneurysm in a patient with coronavirus disease 2019 (COVID-19): A case report.
|
NA
|
NA
|
|
Severe headache as the sole presenting symptom of COVID-19 pneumonia: A case report.
|
NA
|
NA
|
|
Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19.
|
NA
|
NA
|
|
Post-lockdown detection of SARS-CoV-2 RNA in the wastewater of Montpellier, France.
|
NA
|
NA
|
|
Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group.
|
NA
|
NA
|
|
Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
|
NA
|
NA
|
|
On the role of governmental action and individual reaction on COVID-19 dynamics in South Africa: A mathematical modelling study.
|
NA
|
NA
|
|
COVID faster R-CNN: A novel framework to Diagnose Novel Coronavirus Disease (COVID-19) in X-Ray images.
|
NA
|
NA
|
|
Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors.
|
NA
|
NA
|
|
Effect of oral l-Glutamine supplementation on Covid-19 treatment.
|
NA
|
NA
|
|
COVID-19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives.
|
NA
|
NA
|
|
In Silico Identification of Potential Inhibitors of ADP-Ribose Phosphatase of SARS-CoV-2 nsP3 by Combining E-Pharmacophore- and Receptor-Based Virtual Screening of Database.
|
NA
|
NA
|
|
Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection.
|
NA
|
NA
|
|
Reorganization of multiple sclerosis health care system in Clinical Centre of Montenegro during the COVID-19 pandemic.
|
NA
|
NA
|
|
CRC COVID: Colorectal cancer services during COVID-19 pandemic. Study protocol for service evaluation.
|
NA
|
NA
|
|
Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management.
|
NA
|
NA
|
|
A twisted tale-radiological imaging features of COVID-19 on 18F-FDG PET/CT.
|
NA
|
NA
|
|
Hospital biosecurity capacitation: Analysis and recommendations for the prevention and control of COVID-19.
|
NA
|
NA
|
|
Applications of digital technology in COVID-19 pandemic planning and response.
|
NA
|
NA
|
|
Clinical characteristics of patients diagnosed with COVID-19 in Beijing.
|
NA
|
NA
|
|
Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation?
|
NA
|
NA
|
|
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.
|
NA
|
NA
|
|
Anakinra for severe forms of COVID-19: a cohort study.
|
NA
|
NA
|
|
The immunology of COVID-19: is immune modulation an option for treatment?
|
NA
|
NA
|
|
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
|
NA
|
NA
|
|
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Safety and Efficacy of Amiodarone in a Patient With COVID-19.
|
NA
|
NA
|
|
Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS.
|
NA
|
NA
|
|
Severe COVID-19 After Recent Heart Transplantation Complicated by Allograft Dysfunction.
|
NA
|
NA
|
|
Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team.
|
NA
|
NA
|
|
Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.
|
NA
|
NA
|
|
Voices from a Pandemic.
|
NA
|
NA
|
|
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
|
NA
|
NA
|
|
Machine-Learning Approaches in COVID-19 Survival Analysis and Discharge-Time Likelihood Prediction Using Clinical Data.
|
NA
|
NA
|
|
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019.
|
NA
|
NA
|
|
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology.
|
NA
|
NA
|
|
State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19.
|
NA
|
NA
|
|
In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.
|
NA
|
NA
|
|
Strengthening resistance to the COVID-19 pandemic and fostering future resilience requires concerted action on obesity.
|
NA
|
NA
|
|
Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19.
|
NA
|
NA
|
|
More than loss of taste and smell: burning watering eyes in coronavirus disease 2019.
|
NA
|
NA
|
|
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID.
|
NA
|
NA
|
|
SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring.
|
NA
|
NA
|
|
Sleep medicine and COVID-19. Has a new era begun?
|
NA
|
NA
|
|
Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19.
|
NA
|
NA
|
|
[Phone sessions in Covid-19 environment: The frame and his limits].
|
NA
|
NA
|
|
[General sanitary containment during the Coronavirus epidemic: Medico-psychological consequences in general population, caregivers, and subjects suffering previously from mental disorders (Retrospective on the repercussions of lethal mass risks, scientific models of collective confinement, first clinical observations, implementation of countermeasures and innovative therapeutic strategies)].
|
NA
|
NA
|
|
[“Crown protection” or protective tendencies of the Corona Covid-19 and its improbable encounters].
|
NA
|
NA
|
|
Orthopedics and COVID-19: Scientific Publications Rush.
|
NA
|
NA
|
|
Adapting Management of Sarcomas in COVID-19: An Evidence-Based Review.
|
NA
|
NA
|
|
Sarcoma Care Practice in India During COVID Pandemic: A Nationwide Survey.
|
NA
|
NA
|
|
Psychological Intervention and COVID-19: What We Know So Far and What We Can Do.
|
NA
|
NA
|
|
Becoming “Teletherapeutic”: Harnessing Accelerated Experiential Dynamic Psychotherapy (AEDP) for Challenges of the Covid-19 Era.
|
NA
|
NA
|
|
Containing the Anxieties of Children, Parents and Families from a Distance During the Coronavirus Pandemic.
|
NA
|
NA
|
|
CBT-Informed Interventions for Essential Workers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Suspected sepsis in a 10-week-old infant and SARS-CoV-2 detection in cerebrospinal fluid and pharynx].
|
NA
|
NA
|
|
The Wider Impacts of the Coronavirus Pandemic on the NHS.
|
NA
|
NA
|
|
Memory-based meso-scale modeling of Covid-19: County-resolved timelines in Germany.
|
NA
|
NA
|
|
REMOTE WORKING DURING THE PANDEMIC: A Q&A WITH GILLIAN ISAACS RUSSELL: Questions from the Editor and Editorial Board of the BJP.
|
NA
|
NA
|
|
[Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry].
|
NA
|
NA
|
|
The dynamical model for COVID-19 with asymptotic analysis and numerical implementations.
|
NA
|
NA
|
|
Coronavirus disease 2019 in India: Post-lockdown scenarios and provisioning for health care.
|
NA
|
NA
|
|
Parental Burnout and Child Maltreatment During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Transmission dynamics of COVID-19 in Wuhan, China: effects of lockdown and medical resources.
|
NA
|
NA
|
|
Linking Human Destruction of Nature to COVID-19 Increases Support for Wildlife Conservation Policies.
|
NA
|
NA
|
|
Effects of Physical Distancing to Control COVID-19 on Public Health, the Economy, and the Environment.
|
NA
|
NA
|
|
Moral Suasion and the Private Provision of Public Goods: Evidence from the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Realtime video consultations by psychotherapists in times of the COVID-19 pandemic].
|
NA
|
NA
|
|
[Histopathological findings following SARS-CoV-2 infection with and without treatment-Report of three autopsies].
|
NA
|
NA
|
|
Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic.
|
NA
|
NA
|
|
Snapshot of COVID-19 Related Clinical Trials in India.
|
NA
|
NA
|
|
Understanding the practice of thoracic surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Breast Cancer Management Guidelines During COVID-19 Pandemic.
|
NA
|
NA
|
|
Awareness and Concerns Among Adult Liver Transplant Recipients in the Current Pandemic Caused by Novel Coronavirus (COVID-19): Strategies to Safeguard a High-risk Population.
|
NA
|
NA
|
|
Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far.
|
NA
|
NA
|
|
Feasibility of telemedicine in maintaining follow-up of orthopaedic patients and their satisfaction: A preliminary study.
|
NA
|
NA
|
|
Two cases of corona virus disease 2019 (COVID-19) treated with the combination of acupuncture and medication in bedridden patients2.
|
NA
|
NA
|
|
Case of professor Xu ZOU’s acupuncture technique for “benefiting kidney and strengthening anti-pathogenic qi” in promoting the absorption of COVID-19.
|
NA
|
NA
|
|
42 cases of coronavirus disease 2019 of the ordinary type with the adjuvant treatment of heat-sensitive moxibustion 42.
|
NA
|
NA
|
|
Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
|
NA
|
NA
|
|
Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy.
|
NA
|
NA
|
|
Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19.
|
NA
|
NA
|
|
Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery.
|
NA
|
NA
|
|
Child Victim Services in the Time of COVID-19: New Challenges and Innovative Solutions.
|
NA
|
NA
|
|
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19.
|
NA
|
NA
|
|
Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey.
|
NA
|
NA
|
|
Paradigm shift of drug information centers during the COVID-19 pandemic.
|
NA
|
NA
|
|
Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage.
|
NA
|
NA
|
|
Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview.
|
NA
|
NA
|
|
Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers.
|
NA
|
NA
|
|
[Acute renal failure during COVID-19 epidemic].
|
NA
|
NA
|
|
[Cardiac complications in critically ill COVID-19 patients].
|
NA
|
NA
|
|
[Nutritional support for critically ill patients suffering from SARS-CoV-2 infection].
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Potential mechanisms of Chinese Herbal Medicine that implicated in the treatment of COVID-19 related renal injury.
|
NA
|
NA
|
|
Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya.
|
NA
|
NA
|
|
In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors.
|
NA
|
NA
|
|
Current perspective of COVID-19 spread across South Korea: exploratory data analysis and containment of the pandemic.
|
NA
|
NA
|
|
Environmental impact of coronavirus (COVID-19) from Turkish perceptive.
|
NA
|
NA
|
|
[Management of diagnostic procedures and treatment of sleep related breathing disorders in the context of the coronavirus pandemic].
|
NA
|
NA
|
|
[Algorithm for flexible decision-making in the intra-hospital management of patients with the changing requirements of the SARS-CoV-2 pandemic].
|
NA
|
NA
|
|
[Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example].
|
NA
|
NA
|
|
Counselling and psychotherapy post-COVID-19.
|
NA
|
NA
|
|
The challenges and experiences of psychotherapists working remotely during the coronavirus pandemic.
|
NA
|
NA
|
|
Research in counselling and psychotherapy Post-COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 on the performance of a radiation oncology department at a major comprehensive cancer centre in Poland during the first ten weeks of the epidemic.
|
NA
|
NA
|
|
The Influence of the COVID-19 Pandemic on Technology: Adoption in Health Care.
|
NA
|
NA
|
|
Rapid Deployment of Critical Care Nurse Education During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Role of Psychiatry in Treating Burnout Among Nurses During the Covid-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 and Advanced Practice Registered Nurses: Frontline Update.
|
NA
|
NA
|
|
Delivering Telerehabilitation to COVID-19 Inpatients:A Retrospective Chart Review Suggests It Is a Viable Option.
|
NA
|
NA
|
|
Clinical Experience with COVID-19 at a Specialty Orthopedic Hospital Converted to a Pandemic Overflow Field Hospital.
|
NA
|
NA
|
|
Coronavirus Stress, Optimism-Pessimism, Psychological Inflexibility, and Psychological Health: Psychometric Properties of the Coronavirus Stress Measure.
|
NA
|
NA
|
|
Utilization of Teleconsultation: Mitigation in Handling Mental Disorders in the COVID-19 Era.
|
NA
|
NA
|
|
Plasma medicine: Opportunities for nanotechnology in a digital age.
|
NA
|
NA
|
|
Estimating the public response to mitigation measures and self-perceived behaviours towards the COVID-19 pandemic.
|
NA
|
NA
|
|
Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.
|
NA
|
NA
|
|
The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic.
|
NA
|
NA
|
|
Guidance for the Treatment and Management of COVID-19 Among People with Intellectual Disabilities.
|
NA
|
NA
|
|
Potential compound from herbal food of rhizoma polygonati for treatment of COVID-19 analyzed by network pharmacology and molecular docking technology.
|
NA
|
NA
|
|
The role of palliative medicine in ICU bed allocation in COVID-19: a joint position statement of the Singapore Hospice Council and the Chapter of Palliative Medicine Physicians.
|
NA
|
NA
|
|
Age Matters but it should not be Used to Discriminate Against the Elderly in Allocating Scarce Resources in the Context of COVID-19.
|
NA
|
NA
|
|
Paediatric Palliative Care during the COVID-19 Pandemic: A Malaysian Perspective.
|
NA
|
NA
|
|
Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development.
|
NA
|
NA
|
|
[Hygiene in nephrology].
|
NA
|
NA
|
|
Emerging Technologies for Use in the Study, Diagnosis, and Treatment of Patients with COVID-19.
|
NA
|
NA
|
|
Animal Models to Study Emerging Technologies Against SARS-CoV-2.
|
NA
|
NA
|
|
Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients.
|
NA
|
NA
|
|
[The Gastein Healing Gallery and a Potential Risk of Viral Infections in the Treatment Area].
|
NA
|
NA
|
|
Use of chest CT-scan images to differentiate between SARS-CoV-2 infection and fat embolism: A clinical case.
|
NA
|
NA
|
|
COVID-19-associated encephalopathy with fulminant cerebral vasoconstriction: CT and MRI findings.
|
NA
|
NA
|
|
Dental care and infection-control procedures during the COVID-19 pandemic: The experience in Taipei City Hospital, Taiwan.
|
NA
|
NA
|
|
Guidance for dental treatment of patients with disabilities during COVID-19 pandemic.
|
NA
|
NA
|
|
Technology to Facilitate Telehealth in Applied Behavior Analysis.
|
NA
|
NA
|
|
A University-Based Social Services Parent-Training Model: A Telehealth Adaptation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Mindful Action Plan: Using the MAP to Apply Acceptance and Commitment Therapy to Productivity and Self-Compassion for Behavior Analysts.
|
NA
|
NA
|
|
Multi-organ failure after acute kidney injury in patient with HIV and COVID-19.
|
NA
|
NA
|
|
Heatstroke management during the COVID-19 epidemic: Recommendations from the experts in Japan.
|
NA
|
NA
|
|
Research on the individualized short-term training model of nurses in emergency isolation wards during the outbreak of COVID-19.
|
NA
|
NA
|
|
Social Distancing and Public Health Guidelines at Workplaces in Korea: Responses to Coronavirus Disease-19.
|
NA
|
NA
|
|
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
|
NA
|
NA
|
|
A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province, China.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study.
|
NA
|
NA
|
|
The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol.
|
NA
|
NA
|
|
Diagnosis and treatment of emergency surgeries in otorhinolaryngology, head and neck surgery during the covid-19 outbreak: A single center experience.
|
NA
|
NA
|
|
Emergent and urgent otologic surgeries during the SARS-CoV-2 pandemic: a protocol and review of literature.
|
NA
|
NA
|
|
Telemedicine: a Bridge Over Knowledge Gaps in Healthcare.
|
NA
|
NA
|
|
Clinical needs and technical requirements for ventilators for COVID-19 treatment critical patients: an evidence-based comparison for adult and pediatric age.
|
NA
|
NA
|
|
Safety measures in selected radiotherapy centres within Africa in the face of Covid-19.
|
NA
|
NA
|
|
COVID-19 & an NGO and university developed interactive portal: a perspective from Iran.
|
NA
|
NA
|
|
Unprecedented economic attack on Sub-Sahara African economies: coronavirus: How severe is the perceived slump?
|
NA
|
NA
|
|
Homeopathy combat against coronavirus disease (Covid-19).
|
NA
|
NA
|
|
Does health securitization affect the role of global surgery?
|
NA
|
NA
|
|
A Randomized, Open-label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, A Pilot Study.
|
NA
|
NA
|
|
Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 Drug Treatment in China.
|
NA
|
NA
|
|
Simulation as a Tool to Illustrate Clinical Pharmacology Concepts to Healthcare Program Learners.
|
NA
|
NA
|
|
Colchicine in COVID-19: an Old Drug, New Use.
|
NA
|
NA
|
|
Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
|
NA
|
NA
|
|
Natural products as LSD1 inhibitors for cancer therapy.
|
NA
|
NA
|
|
Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination.
|
NA
|
NA
|
|
Psychological flexibility in the context of COVID-19 adversity: Associations with distress.
|
NA
|
NA
|
|
Chinese medicine diagnosis and treatment for COVID-2019: Is China ready for implementing a national guideline?
|
NA
|
NA
|
|
The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
|
NA
|
NA
|
|
Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review.
|
NA
|
NA
|
|
The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
|
NA
|
NA
|
|
The effects of vitamin D on acute viral respiratory infections: A rapid review.
|
NA
|
NA
|
|
on viral respiratory infections in humans: A rapid review.
|
NA
|
NA
|
|
Nanomaterial assisted bulk scale synthesis of 2-methyl-6-nitroquinoline.
|
NA
|
NA
|
|
COVID-19: Operational Measures from a Surgeon’s Perspective.
|
NA
|
NA
|
|
Drug repurposing using computational methods to identify therapeutic options for COVID-19.
|
NA
|
NA
|
|
Influence of the coronavirus 2 (SARS-Cov-2) pandemic on acute appendicitis.
|
NA
|
NA
|
|
Known drugs and small molecules in the battle for COVID-19 treatment.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.
|
NA
|
NA
|
|
Pandemic COVID-19: current status and challenges of antiviral therapies.
|
NA
|
NA
|
|
Choosing which COVID-19 patient to save? The ethical triage and rationing dilemma.
|
NA
|
NA
|
|
Follow-up study of clinical and chest CT scans in confirmed COVID-19 patients.
|
NA
|
NA
|
|
CT features of coronavirus disease 2019 (COVID-19) in the original district of this disease (Wuhan): A pictorial review.
|
NA
|
NA
|
|
Semi-quantitative analysis for the dynamic chest CT imaging features from onset to recovery in severe and critical COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2-human protein-protein interaction network.
|
NA
|
NA
|
|
Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention.
|
NA
|
NA
|
|
Rapid translation of clinical guidelines into executable knowledge: a case study of COVID-19 and on-line demonstration.
|
NA
|
NA
|
|
COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic.
|
NA
|
NA
|
|
Vitamin D in COVID - 19: Dousing the fire or averting the storm? - A perspective from the Asia-Pacific.
|
NA
|
NA
|
|
Impact of Coronavirus disease-19 (COVID-19) lockdown on physical activity and energy expenditure among physiotherapy professionals and students using web-based open E-survey sent through WhatsApp, Facebook and Instagram messengers.
|
NA
|
NA
|
|
Knowledge and perceptions about COVID-19 among the medical and allied health science students in India: An online cross-sectional survey.
|
NA
|
NA
|
|
COVID-19 in Patients on Maintenance Dialysis in the Paris Region.
|
NA
|
NA
|
|
The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients.
|
NA
|
NA
|
|
Urgent liver transplantation soon after recovery from COVID-19 in a patient with decompensated liver cirrhosis.
|
NA
|
NA
|
|
STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial.
|
NA
|
NA
|
|
Anticoagulation Practice Patterns in COVID-19: A Global Survey.
|
NA
|
NA
|
|
Guidelines of the Indian Society for Sleep Research (ISSR) for Practice of Sleep Medicine during COVID-19.
|
NA
|
NA
|
|
Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child-Case Report.
|
NA
|
NA
|
|
Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review.
|
NA
|
NA
|
|
CPAP Added to Oxygen Administration Avoid Intubation in Acute Respiratory Distress in COVID-19 Pneumonia. Case Report.
|
NA
|
NA
|
|
Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis? Case Report.
|
NA
|
NA
|
|
The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms.
|
NA
|
NA
|
|
Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar.
|
NA
|
NA
|
|
COVID-19 Infection and Haematological Involvement: a Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings.
|
NA
|
NA
|
|
Wuchang Fangcang Shelter Hospital: Practices, Experiences, and Lessons Learned in Controlling COVID-19.
|
NA
|
NA
|
|
Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage.
|
NA
|
NA
|
|
Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?
|
NA
|
NA
|
|
Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications.
|
NA
|
NA
|
|
COVID-19, Brachytherapy, and Gynecologic Cancers: a Moroccan Experience.
|
NA
|
NA
|
|
The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit.
|
NA
|
NA
|
|
Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.
|
NA
|
NA
|
|
Principles of Disinfectant Use and Safety Operation in Medical Facilities During Coronavirus Disease 2019 (COVID-19) Outbreak.
|
NA
|
NA
|
|
The Multifaceted Engagement of the Dermatologist in the Covid-19 Pandemic.
|
NA
|
NA
|
|
Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19.
|
NA
|
NA
|
|
Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results.
|
NA
|
NA
|
|
Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.
|
NA
|
NA
|
|
Protease Inhibitor Use in COVID-19.
|
NA
|
NA
|
|
Person-Centered Approach to the Diverse Mental Healthcare Needs During COVID 19 Pandemic.
|
NA
|
NA
|
|
COVID-19 Recommendations for Patients with Cancer: The post-COVID-19 Era.
|
NA
|
NA
|
|
Analysis of COVID-19 Cases and Public Measures in China.
|
NA
|
NA
|
|
Factors Affecting Mortality in 1022 COVID-19 Patients Referred to an Emergency Department in Bergamo during the Peak of the Pandemic.
|
NA
|
NA
|
|
Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Suggested guidelines for emergency treatment of medical waste during COVID-19: Chinese experience.
|
NA
|
NA
|
|
A narrative review of emerging therapeutics for COVID-19.
|
NA
|
NA
|
|
Rapid production of clinical-grade SARS-CoV-2 specific T cells.
|
NA
|
NA
|
|
An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations.
|
NA
|
NA
|
|
Ambulatory Care Practice in the COVID-19 Era: Redesigning Clinical Services and Experiential Learning.
|
NA
|
NA
|
|
Role of pharmacists during the COVID-19 pandemic in China - Shanghai Experiences.
|
NA
|
NA
|
|
COVID-19 Pandemic: Challenges and Solutions from the Cardiology Pharmacist’s Perspective.
|
NA
|
NA
|
|
Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19.
|
NA
|
NA
|
|
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
|
NA
|
NA
|
|
Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up.
|
NA
|
NA
|
|
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19.
|
NA
|
NA
|
|
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system.
|
NA
|
NA
|
|
The Clinical Utility of Continuous QT Interval Monitoring in Patients Admitted with COVID-19 Compared to Standard of Care: A Prospective Cohort Study.
|
NA
|
NA
|
|
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.
|
NA
|
NA
|
|
Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment.
|
NA
|
NA
|
|
Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials?
|
NA
|
NA
|
|
Epidemiologic and clinical characteristics of 42 deaths caused by SARS-CoV-2 infection in Wuhan, China: A retrospective study.
|
NA
|
NA
|
|
Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
|
NA
|
NA
|
|
Hyperinflammation with COVID-19: The key to patient deterioration?
|
NA
|
NA
|
|
Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia.
|
NA
|
NA
|
|
Addressing COVID-19 Drug Development with Artificial Intelligence.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on cancer care.
|
NA
|
NA
|
|
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.
|
NA
|
NA
|
|
COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.
|
NA
|
NA
|
|
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.
|
NA
|
NA
|
|
The COVID-19 Drug and Gene Set Library.
|
NA
|
NA
|
|
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.
|
NA
|
NA
|
|
What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials.
|
NA
|
NA
|
|
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.
|
NA
|
NA
|
|
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
|
NA
|
NA
|
|
COVID-19: A review of therapeutics under investigation.
|
NA
|
NA
|
|
Reducing aerosol dispersion by High Flow Therapy in COVID-19: High Resolution Computational Fluid Dynamics Simulations of Particle Behavior during High Velocity Nasal Insufflation with a Simple Surgical Mask.
|
NA
|
NA
|
|
A proposal for selective resuscitation of adult cardiac arrest patients in a pandemic.
|
NA
|
NA
|
|
Viral and atypical respiratory co-infections in COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia.
|
NA
|
NA
|
|
Regulatory T cells: A potential weapon to combat COVID-19?
|
NA
|
NA
|
|
High percentage of smudge cells in a patient with COVID19: Rediscovering their utility.
|
NA
|
NA
|
|
[SARS-CoV-2 and Perinatal Aspects].
|
NA
|
NA
|
|
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.
|
NA
|
NA
|
|
The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking.
|
NA
|
NA
|
|
Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
|
NA
|
NA
|
|
Relationship between anosmia and hospitalisation in patients with coronavirus disease 2019: an otolaryngological perspective.
|
NA
|
NA
|
|
Telemental health for child trauma treatment during and post-COVID-19: Limitations and considerations.
|
NA
|
NA
|
|
STEMI and COVID-19 Pandemic in Saudi Arabia.
|
NA
|
NA
|
|
Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak.
|
NA
|
NA
|
|
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
|
NA
|
NA
|
|
Respiratory follow-up of patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action.
|
NA
|
NA
|
|
Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis.
|
NA
|
NA
|
|
An inflammatory cytokine signature predicts COVID-19 severity and survival.
|
NA
|
NA
|
|
Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches.
|
NA
|
NA
|
|
Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations.
|
NA
|
NA
|
|
Hydroxychloroquine is protective to the heart, not harmful: a systematic review.
|
NA
|
NA
|
|
AI4COVID-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app.
|
NA
|
NA
|
|
Labile PT-INR in a Covid-19 Patient Under Long-term Vitamin K Antagonist Therapy: a Case Report.
|
NA
|
NA
|
|
Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System.
|
NA
|
NA
|
|
Neurological manifestations of COVID-19: available evidences and a new paradigm.
|
NA
|
NA
|
|
Airway management guidance for the endemic phase of COVID-19.
|
NA
|
NA
|
|
[The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].
|
NA
|
NA
|
|
Clinical implications of different specimen types for nucleic acid testing in two cases of COVID-19.
|
NA
|
NA
|
|
Emerging Treatment Options of Regenerative Medicine in Severe Corona Virus/COVID 19 Infections.
|
NA
|
NA
|
|
Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.
|
NA
|
NA
|
|
Syncope and presyncope in patients with COVID-19.
|
NA
|
NA
|
|
The impact of COVID-19 in medical practice. A review focused on Urology.
|
NA
|
NA
|
|
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
|
NA
|
NA
|
|
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies.
|
NA
|
NA
|
|
COVID-19 & Chronic Renal Disease: Clinical characteristics & prognosis.
|
NA
|
NA
|
|
A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children.
|
NA
|
NA
|
|
[Emergency and intensive care medicine aspects of COVID-19 infections].
|
NA
|
NA
|
|
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
|
NA
|
NA
|
|
Pain Management During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Dignity, Autonomy, and Allocation of Scarce Medical Resources During COVID-19.
|
NA
|
NA
|
|
Systems of Care in Crisis: The Changing Nature of Palliative Care During COVID-19.
|
NA
|
NA
|
|
Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.
|
NA
|
NA
|
|
Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach.
|
NA
|
NA
|
|
Association between Body Mass Index and Risk of COVID-19: A Nationwide Case-Control Study in South Korea.
|
NA
|
NA
|
|
Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System.
|
NA
|
NA
|
|
The management of venous thromboembolism in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
Preparedness of the cancer hospitals and changes in oncosurgical practices during COVID-19 pandemic in India: A cross-sectional study.
|
NA
|
NA
|
|
Eating disorders in times of the COVID-19 pandemic-Results from an online survey of patients with anorexia nervosa.
|
NA
|
NA
|
|
Physical exercise as a tool to minimize the consequences of the Covid-19 quarantine: An overview for cystic fibrosis.
|
NA
|
NA
|
|
Cytokines and COVID-19: friends or foes?
|
NA
|
NA
|
|
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
|
NA
|
NA
|
|
Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation.
|
NA
|
NA
|
|
Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19.
|
NA
|
NA
|
|
To Drill or Not to Drill: Management of Endodontic Emergencies and In-Process Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
GRP78 targeting: Hitting two birds with a stone.
|
NA
|
NA
|
|
A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
|
NA
|
NA
|
|
Microwave- and heat-based decontamination of N95 filtering facepiece respirators: a systematic review.
|
NA
|
NA
|
|
Sleep quality in times of Covid-19 pandemic.
|
NA
|
NA
|
|
COVID-19 versus HIT hypercoagulability.
|
NA
|
NA
|
|
COVID-19 surveillance in Southeastern Virginia using wastewater-based epidemiology.
|
NA
|
NA
|
|
[Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic].
|
NA
|
NA
|
|
Viral Vectors Applied for RNAi-Based Antiviral Therapy.
|
NA
|
NA
|
|
Could Vitamins Help in the Fight Against COVID-19?
|
NA
|
NA
|
|
COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot.
|
NA
|
NA
|
|
COVID-19 Pandemic Outbreak and its Psychological Impact on Patients with Rare Lysosomal Diseases.
|
NA
|
NA
|
|
Defining Moments: A Nurse’s Touch.
|
NA
|
NA
|
|
COVID-19 and renin-angiotensin system modulators: what do we know so far?
|
NA
|
NA
|
|
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
|
NA
|
NA
|
|
Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.
|
NA
|
NA
|
|
Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.
|
NA
|
NA
|
|
Differential diagnosis of coronavirus disease 2019 from community-acquired-pneumonia by computed tomography scan and follow-up.
|
NA
|
NA
|
|
High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Use of corticosteroids in asthma and COPD patients with or without COVID-19.
|
NA
|
NA
|
|
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
|
NA
|
NA
|
|
Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review.
|
NA
|
NA
|
|
Prevention and treatment system of novel coronavirus infection in medical and health institutions: experience in West China Hospital of Sichuan University.
|
NA
|
NA
|
|
Clinical course of a 66-year-old man with an acute ischaemic stroke in the setting of a COVID-19 infection.
|
NA
|
NA
|
|
COVID-19 Inflammatory Syndrome With Clinical Features Resembling Kawasaki Disease.
|
NA
|
NA
|
|
Subacute thyroiditis associated with COVID-19.
|
NA
|
NA
|
|
Development of a fluorescence based, high-throughput SARS-CoV-2 3CLpro reporter assay.
|
NA
|
NA
|
|
A case of COVID-19 immediately after liver transplantation: Not only bad news.
|
NA
|
NA
|
|
[Adaptations of an outpatient Dialectical Behavioral Therapy during the COVID-19 pandemic and consequences of the confinement on patients with borderline personality disorder].
|
NA
|
NA
|
|
Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era.
|
NA
|
NA
|
|
Global COVID-19 Efforts as the Platform to Achieving the Sustainable Development Goals.
|
NA
|
NA
|
|
Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19.
|
NA
|
NA
|
|
Helmet CPAP revisited in COVID-19 pneumonia: A case series.
|
NA
|
NA
|
|
Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.
|
NA
|
NA
|
|
Assessment of the Need for Early Initiation of Rehabilitation Treatments in Patients with Coronavirus Disease 2019.
|
NA
|
NA
|
|
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection.
|
NA
|
NA
|
|
Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
|
NA
|
NA
|
|
Be aware of acute kidney injury in critically ill children with COVID-19.
|
NA
|
NA
|
|
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure.
|
NA
|
NA
|
|
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
|
NA
|
NA
|
|
To dispense or not to dispense: Lessons to be learnt from ethical challenges faced by pharmacists in the COVID-19 pandemic.
|
NA
|
NA
|
|
Alpha-1-antitrypsin: A possible host protective factor against Covid-19.
|
NA
|
NA
|
|
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.
|
NA
|
NA
|
|
Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.
|
NA
|
NA
|
|
Systematic Review on Repurposing Use of Favipiravir Against SARS-CoV-2.
|
NA
|
NA
|
|
Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
|
NA
|
NA
|
|
ECMO-Challenges, strategies, and preparation from Spain.
|
NA
|
NA
|
|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
[Impacts of the SARS-CoV-2 pandemic on ophthalmic care in Germany].
|
NA
|
NA
|
|
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
|
NA
|
NA
|
|
Cancer and Risk of COVID-19 Through a General Community Survey.
|
NA
|
NA
|
|
Interleukin-6 in Covid-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships.
|
NA
|
NA
|
|
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
|
NA
|
NA
|
|
Vaccines and routine immunization strategies during the COVID-19 pandemic.
|
NA
|
NA
|
|
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 infection in children and adolescents.
|
NA
|
NA
|
|
Environmental disinfection against COVID-19 in different areas of health care facilities: a review.
|
NA
|
NA
|
|
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
|
NA
|
NA
|
|
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic.
|
NA
|
NA
|
|
Attaching clinical significance to COVID-19-associated diarrhea.
|
NA
|
NA
|
|
Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
|
NA
|
NA
|
|
Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review.
|
NA
|
NA
|
|
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
|
NA
|
NA
|
|
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.
|
NA
|
NA
|
|
Sex differences in immune responses that underlie COVID-19 disease outcomes.
|
NA
|
NA
|
|
Epidemiological and clinical features of 201 COVID-19 patients in Changsha city, Hunan, China.
|
NA
|
NA
|
|
The efficacy and safety of fire needle therapy for COVID-19: Protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol.
|
NA
|
NA
|
|
Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
|
NA
|
NA
|
|
Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors.
|
NA
|
NA
|
|
Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.
|
NA
|
NA
|
|
The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging.
|
NA
|
NA
|
|
Developing thinking around mental health science: the example of intrusive, emotional mental imagery after psychological trauma.
|
NA
|
NA
|
|
Analysis of operation procedure and effect for emergency surgery in general hospital during novel coronavirus pneumonia period.
|
NA
|
NA
|
|
The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
|
NA
|
NA
|
|
The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Systematic review of COVID-19 related myocarditis: Insights on management and outcome.
|
NA
|
NA
|
|
Clinical features of neonates born to mothers with coronavirus disease-2019: A systematic review of 105 neonates.
|
NA
|
NA
|
|
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.
|
NA
|
NA
|
|
A Clinical Pathway for Hospitalized Pediatric Patients With Initial SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
|
NA
|
NA
|
|
Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19).
|
NA
|
NA
|
|
COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) in Children: Prevalence, Diagnosis, Clinical Symptoms, and Treatment.
|
NA
|
NA
|
|
Medical Overuse in the Iranian Healthcare System: A Systematic Scoping Review and Practical Recommendations for Decreasing Medical Overuse During Unexpected COVID-19 Pandemic Opportunity.
|
NA
|
NA
|
|
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.
|
NA
|
NA
|
|
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients.
|
NA
|
NA
|
|
Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
|
NA
|
NA
|
|
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
|
NA
|
NA
|
|
Medicinal Plants as Sources of Active Molecules Against COVID-19.
|
NA
|
NA
|
|
COVID-19 Therapeutic Options Under Investigation.
|
NA
|
NA
|
|
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.
|
NA
|
NA
|
|
Non-invasive Auricular Vagus Nerve Stimulation as a Potential Treatment for Covid19-Originated Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
The Enigma of Endothelium in COVID-19.
|
NA
|
NA
|
|
Psychological Status and Influencing Factors of Hospital Medical Staff During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Stroke Care Services in Singapore During COVID-19 Pandemic-A National Perspective.
|
NA
|
NA
|
|
Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
|
NA
|
NA
|
|
Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
|
NA
|
NA
|
|
CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
|
NA
|
NA
|
|
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
|
NA
|
NA
|
|
Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
|
NA
|
NA
|
|
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
|
NA
|
NA
|
|
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
|
NA
|
NA
|
|
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
|
NA
|
NA
|
|
Urinary stone management during the COVID-19 pandemic: a suggested approach and review of literature.
|
NA
|
NA
|
|
Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review.
|
NA
|
NA
|
|
Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19.
|
NA
|
NA
|
|
Convalescent plasma therapy in a pregnant COVID-19 patient with a dramatic clinical and imaging response: A case report.
|
NA
|
NA
|
|
Coronavirus disease (COVID-19): observations and lessons from primary medical care at a German community hospital.
|
NA
|
NA
|
|
COVID-19 infection and its deadly cytokine storm in a young obese adult.
|
NA
|
NA
|
|
Management of a Parkinson’s disease patient with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Fatal COVID-19 in an MS patient on natalizumab: A case report.
|
NA
|
NA
|
|
The Development of Critical Care Medicine in China: From SARS to COVID-19 Pandemic.
|
NA
|
NA
|
|
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies.
|
NA
|
NA
|
|
COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature.
|
NA
|
NA
|
|
Evans Syndrome Associated with Pregnancy and COVID-19 Infection.
|
NA
|
NA
|
|
Overwhelming COVID-19 Sepsis in a Patient With Idiopathic Pulmonary Fibrosis.
|
NA
|
NA
|
|
Morbilliform Rash: An Uncommon Herald of SARS-CoV-2.
|
NA
|
NA
|
|
Novel 4W (When-Where-What-What) Approach of Training Point-of-Care Ultrasound (POCUS) Application in Resuscitation With High-Fidelity Simulator.
|
NA
|
NA
|
|
Characterization of Critically Ill COVID-19 Patients at a Brooklyn Safety-Net Hospital.
|
NA
|
NA
|
|
Special Issues Encountered When Cancer Patients Confront COVID-19.
|
NA
|
NA
|
|
COVID-19 Emergency and Post-Emergency in Italian Cancer Patients: How Can Patients Be Assisted?
|
NA
|
NA
|
|
Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19: A Multidisciplinary Review.
|
NA
|
NA
|
|
Development and Validation of a Deep Learning-Based Model Using Computed Tomography Imaging for Predicting Disease Severity of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Prospects for RNAi Therapy of COVID-19.
|
NA
|
NA
|
|
Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?
|
NA
|
NA
|
|
Secondary Bacterial Infections in Patients With Viral Pneumonia.
|
NA
|
NA
|
|
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion.
|
NA
|
NA
|
|
Identify the Risk Factors of COVID-19-Related Acute Kidney Injury: A Single-Center, Retrospective Cohort Study.
|
NA
|
NA
|
|
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic.
|
NA
|
NA
|
|
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
|
NA
|
NA
|
|
Treatment Options for COVID-19: A Review.
|
NA
|
NA
|
|
Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Clinical Characteristics and Prognosis of 218 Patients With COVID-19: A Retrospective Study Based on Clinical Classification.
|
NA
|
NA
|
|
Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders.
|
NA
|
NA
|
|
Care for Critical Ill Patients With COVID-19: Establishment of a Temporary Intensive Care Unit in an Isolated Hospital.
|
NA
|
NA
|
|
Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease.
|
NA
|
NA
|
|
A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment.
|
NA
|
NA
|
|
Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
|
NA
|
NA
|
|
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.
|
NA
|
NA
|
|
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review.
|
NA
|
NA
|
|
Clinical Characteristics of Diabetic Patients with COVID-19.
|
NA
|
NA
|
|
Pediatric Surgery during the COVID-19 Pandemic: An International Survey of Current Practice.
|
NA
|
NA
|
|
In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.
|
NA
|
NA
|
|
Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples.
|
NA
|
NA
|
|
Uninterrupted Continuous and Intermittent Nebulizer Therapy in a COVID-19 Patient Using Sequential Vibratory Mesh Nebulizers: A Case Report.
|
NA
|
NA
|
|
Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional Survey.
|
NA
|
NA
|
|
A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.
|
NA
|
NA
|
|
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.
|
NA
|
NA
|
|
Are the Anxiety Levels of Pediatric Hematology-Oncology Patients Different From Healthy Peers During the COVID-19 Outbreak?
|
NA
|
NA
|
|
Military Teleophthalmology in Afghanistan Using Mobile Phone Application.
|
NA
|
NA
|
|
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
|
NA
|
NA
|
|
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
|
NA
|
NA
|
|
Immune Modulation to Improve Survival of Viral Pneumonia in Mice.
|
NA
|
NA
|
|
Azithromycin in the treatment of COVID-19: a review.
|
NA
|
NA
|
|
COVID-19-Related Ethics Consultations at a Cancer Center in New York City: A Content Review of Ethics Consultations During the Early Stages of the Pandemic.
|
NA
|
NA
|
|
[Promising and potential drugs for the treatment of COVID-19].
|
NA
|
NA
|
|
Neglecting the effect of COVID-19 on neglected tropical diseases: the Ethiopian perspective.
|
NA
|
NA
|
|
Cytokine release syndrome-associated encephalopathy in patients with COVID-19.
|
NA
|
NA
|
|
What Nurses Should Know About COVID-19.
|
NA
|
NA
|
|
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.
|
NA
|
NA
|
|
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
|
NA
|
NA
|
|
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
|
NA
|
NA
|
|
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
|
NA
|
NA
|
|
An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants.
|
NA
|
NA
|
|
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
|
NA
|
NA
|
|
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
|
NA
|
NA
|
|
Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
|
NA
|
NA
|
|
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
|
NA
|
NA
|
|
Job-related factors associated with changes in sleep quality among healthcare workers screening for 2019 novel coronavirus infection: a longitudinal study.
|
NA
|
NA
|
|
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
|
NA
|
NA
|
|
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients.
|
NA
|
NA
|
|
Sleep Breathing Disorders in the COVID-19 Era: Italian Thoracic Society Organizational Models for a Correct Approach to Diagnosis and Treatment.
|
NA
|
NA
|
|
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
|
NA
|
NA
|
|
Three months of COVID-19 in a pediatric setting in the center of Milan.
|
NA
|
NA
|
|
Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines.
|
NA
|
NA
|
|
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2.
|
NA
|
NA
|
|
Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis.
|
NA
|
NA
|
|
Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
The effective use of an e-dentistry service during the COVID-19 crisis.
|
NA
|
NA
|
|
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
|
NA
|
NA
|
|
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome.
|
NA
|
NA
|
|
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
|
NA
|
NA
|
|
Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
How to follow-up a patient who received tocilizumab in severe COVID-19: a case report.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
|
NA
|
NA
|
|
Lung ultrasonography in patients with COVID-19: comparison with CT.
|
NA
|
NA
|
|
Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
|
NA
|
NA
|
|
Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
|
NA
|
NA
|
|
Experience of ST segment elevation myocardial infarction management during COVID-19 pandemic from the mainland of China.
|
NA
|
NA
|
|
A Double-Edged Sword: Neurologic Complications and Mortality in Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Severe Acute Respiratory Distress Syndrome at a Tertiary Care Center.
|
NA
|
NA
|
|
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
|
NA
|
NA
|
|
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
|
NA
|
NA
|
|
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
|
NA
|
NA
|
|
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.
|
NA
|
NA
|
|
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
|
NA
|
NA
|
|
Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China.
|
NA
|
NA
|
|
The value of serum amyloid A for predicting the severity and recovery of COVID-19.
|
NA
|
NA
|
|
Natural Antioxidants: A Review of Studies on Human and Animal Coronavirus.
|
NA
|
NA
|
|
Drug Interactions of Psychiatric and COVID-19 Medications.
|
NA
|
NA
|
|
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms.
|
NA
|
NA
|
|
Psychological Impact of the Acute COVID-19 Period on Patients With Substance Use Disorders: We are all in this Together.
|
NA
|
NA
|
|
COVID-19 and Central Nervous System: Entry Routes And.
|
NA
|
NA
|
|
Treatment of the novel COVID-19: why Costa Rica’s proposal for the creation of a global pooling mechanism deserves serious consideration?
|
NA
|
NA
|
|
A Case of Steroid-Responsive, COVID-19 Immune Reconstitution Inflammatory Syndrome Following the Use of Granulocyte Colony-Stimulating Factor.
|
NA
|
NA
|
|
Addressing Palliative Care Needs of COVID-19 Patients in New Orleans, LA: A Team-Based Reflective Analysis.
|
NA
|
NA
|
|
Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States.
|
NA
|
NA
|
|
Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
|
NA
|
NA
|
|
A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort.
|
NA
|
NA
|
|
A COVID-19 screening tool for oncology telephone triage.
|
NA
|
NA
|
|
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.
|
NA
|
NA
|
|
The impact of COVID-19 epidemic on eating disorders: A longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls.
|
NA
|
NA
|
|
Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions.
|
NA
|
NA
|
|
Regen med therapeutic opportunities for fighting COVID-19.
|
NA
|
NA
|
|
Viral dynamics and immune correlates of COVID-19 disease severity.
|
NA
|
NA
|
|
Management of SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
COVID-19 in patients with inflammatory bowel disease.
|
NA
|
NA
|
|
The Essential Role of Technology in the Public Health Battle Against COVID-19.
|
NA
|
NA
|
|
Nano-clays as Potential Pseudo-antibodies for COVID-19.
|
NA
|
NA
|
|
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
|
NA
|
NA
|
|
Obesity: A critical risk factor in the COVID-19 pandemic.
|
NA
|
NA
|
|
Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2.
|
NA
|
NA
|
|
Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
|
NA
|
NA
|
|
Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection?
|
NA
|
NA
|
|
Current Ultrasound Technologies and Instrumentation in the Assessment and Monitoring of COVID-19 Positive Patients.
|
NA
|
NA
|
|
Knowledge and attitude towards COVID-19 and associated factors among health care providers in Northwest Ethiopia.
|
NA
|
NA
|
|
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers.
|
NA
|
NA
|
|
Collateral Impact of the Covid-19 Pandemic on Tuberculosis Control in Jiangsu Province, China.
|
NA
|
NA
|
|
Thrombosis in COVID-19.
|
NA
|
NA
|
|
Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic).
|
NA
|
NA
|
|
Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important?
|
NA
|
NA
|
|
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
|
NA
|
NA
|
|
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers.
|
NA
|
NA
|
|
Observational study on Effect of Lock Down due to COVID 19 on glycemic control in patients with Diabetes: Experience from Central India.
|
NA
|
NA
|
|
Self- management of diabetes mellitus during the Covid-19 pandemic: Recommendations for a resource limited setting.
|
NA
|
NA
|
|
A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India.
|
NA
|
NA
|
|
Pulmonary Embolism After Acute Spinal Cord Injury and COVID-19.
|
NA
|
NA
|
|
Using lung ultrasound changes to evaluate the response of recruitment maneuver in a patient recovering from coronavirus disease 2019 with acute respiratory distress syndrome.
|
NA
|
NA
|
|
Caution With the Use of Lopinavir/Ritonavir in Severely Ill Patients for the Treatment of SARS-CoV-2: A Report of Severe Jaundice.
|
NA
|
NA
|
|
Coronavirus disease 2019 and cardiovascular implications.
|
NA
|
NA
|
|
Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
|
NA
|
NA
|
|
The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study.
|
NA
|
NA
|
|
Easy-to-prescribe nutrition support in the intensive care in the era of COVID-19.
|
NA
|
NA
|
|
Is the psychological impact of exposure to COVID-19 stronger in adolescents with pre-pandemic maltreatment experiences? A survey of rural Chinese adolescents.
|
NA
|
NA
|
|
Stress and parenting during the global COVID-19 pandemic.
|
NA
|
NA
|
|
Building an obstetric intensive care unit during the COVID-19 pandemic at a tertiary hospital and selected maternal-fetal and delivery considerations.
|
NA
|
NA
|
|
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.
|
NA
|
NA
|
|
Protocol for the process evaluation of the Promoting Activity, Independence and Stability in Early Dementia (PrAISED), following changes required by the COVID-19 pandemic.
|
NA
|
NA
|
|
ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics.
|
NA
|
NA
|
|
Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson’s Disease.
|
NA
|
NA
|
|
Neurological manifestations of COVID-19: A brief review.
|
NA
|
NA
|
|
Impact of restrictions on parental presence in neonatal intensive care units related to coronavirus disease 2019.
|
NA
|
NA
|
|
Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High Risk Outpatients with COVID-19 by Dr. Harvey Risch.
|
NA
|
NA
|
|
Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain.
|
NA
|
NA
|
|
What we have to know about corticosteroids use during Sars-Cov-2 infection.
|
NA
|
NA
|
|
Risk factors for Covid-19 severity and fatality: a structured literature review.
|
NA
|
NA
|
|
The Impact of COVID-19 on Access to Parkinson’s Disease Medication.
|
NA
|
NA
|
|
COVID-19 in a state of Brazilian Northeast: Prevalence and associated factors in people with flu-like syndrome.
|
NA
|
NA
|
|
Response to Maccio et al., “Multifactorial Pathogenesis of COVID-19-related Coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”
|
NA
|
NA
|
|
Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis.
|
NA
|
NA
|
|
Nanocarriers in the delivery of hydroxychloroquine to the respiratory system: An alternative to COVID-19?
|
NA
|
NA
|
|
COVID-19 pandemic: Implications for radionuclide therapy in Nuclear Medicine departments.
|
NA
|
NA
|
|
Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
|
NA
|
NA
|
|
Tocilizumab use in COVID-19-associated pneumonia.
|
NA
|
NA
|
|
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.
|
NA
|
NA
|
|
Conjunctivitis in COVID-19 patients: frequency and clinical presentation.
|
NA
|
NA
|
|
Clinical characteristics and factors affecting the duration of positive nucleic acid test for patients of COVID-19 in XinYu, China.
|
NA
|
NA
|
|
Early coagulation tests predict risk stratification and prognosis of COVID-19.
|
NA
|
NA
|
|
A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU.
|
NA
|
NA
|
|
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
|
NA
|
NA
|
|
Proficiency of virtual follow-up amongst tinnitus patients who underwent intratympanic steroid therapy amidst COVID 19 pandemic.
|
NA
|
NA
|
|
Status epilepticus and other EEG findings in patients with COVID-19: A case series.
|
NA
|
NA
|
|
Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risks.
|
NA
|
NA
|
|
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes.
|
NA
|
NA
|
|
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
|
NA
|
NA
|
|
Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper From the National PERT Consortium.
|
NA
|
NA
|
|
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis.
|
NA
|
NA
|
|
Early experience with arterial thromboembolic complications in patents with COVID-19.
|
NA
|
NA
|
|
Surviving 2019 novel coronavirus pneumonia: A successful critical case report.
|
NA
|
NA
|
|
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
|
NA
|
NA
|
|
Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2.
|
NA
|
NA
|
|
Emergency conversion to telehealth in hospital-based psychiatric outpatient services: Strategy and early observations.
|
NA
|
NA
|
|
Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis.
|
NA
|
NA
|
|
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.
|
NA
|
NA
|
|
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial.
|
NA
|
NA
|
|
Thirty-day mortality following surgical management of hip fractures during the COVID-19 pandemic: findings from a prospective multi-centre UK study.
|
NA
|
NA
|
|
Taizhou’s COVID-19 prevention and control experience with telemedicine features.
|
NA
|
NA
|
|
Tocilizumab use in Kidney Transplant Patients with COVID-19.
|
NA
|
NA
|
|
Critical care ultrasonography during COVID-19 pandemic: The ORACLE protocol.
|
NA
|
NA
|
|
Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival.
|
NA
|
NA
|
|
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
|
NA
|
NA
|
|
Ultrasensitive detection of pathogenic viruses with electrochemical biosensor: State of the art.
|
NA
|
NA
|
|
Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation.
|
NA
|
NA
|
|
Mental distress in orthodontic patients during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Examining persuasive message type to encourage staying at home during the COVID-19 pandemic and social lockdown: A randomized controlled study in Japan.
|
NA
|
NA
|
|
Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement.
|
NA
|
NA
|
|
Complicated appendicitis are common during the epidemic period of 2019 novel coronavirus (2019-nCoV).
|
NA
|
NA
|
|
Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.
|
NA
|
NA
|
|
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
|
NA
|
NA
|
|
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
|
NA
|
NA
|
|
Awareness and Prophylaxis of Venous Thromboembolism in Patients with COVID-19: A National Cross-Sectional Survey in Epidemic Era.
|
NA
|
NA
|
|
Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report.
|
NA
|
NA
|
|
Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies.
|
NA
|
NA
|
|
Suffering in silence: How COVID-19 school closures inhibit the reporting of child maltreatment.
|
NA
|
NA
|
|
[Clinical and epidemiological characteristics of COVID-19].
|
NA
|
NA
|
|
[COVID-19, management, therapeutic and vaccine approaches].
|
NA
|
NA
|
|
The impact of COVID-19 in plastic surgery departments: a comparative retrospective study in a COVID-19 and in a non-COVID-19 hospital.
|
NA
|
NA
|
|
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
|
NA
|
NA
|
|
Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India.
|
NA
|
NA
|
|
Principles of Rajayakshma management for COVID-19.
|
NA
|
NA
|
|
Aerosol generating procedures in orthopaedics and recommended protective gear.
|
NA
|
NA
|
|
Ivermectin: Potential Role as Repurposed Drug for COVID-19.
|
NA
|
NA
|
|
Recent advances and challenges in electrochemical biosensors for emerging and re-emerging infectious diseases.
|
NA
|
NA
|
|
[COVID-19 in children and adolescents with chronic lung diseases].
|
NA
|
NA
|
|
Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries.
|
NA
|
NA
|
|
Should cancer treatment be continued during the COVID-19 pandemic? A single Egyptian institution experience.
|
NA
|
NA
|
|
Telerehabilitation for people with breast cancer through the COVID-19 pandemic in Chile.
|
NA
|
NA
|
|
Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections.
|
NA
|
NA
|
|
Conjunctivitis: A Systematic Review.
|
NA
|
NA
|
|
Pharmacogenomics of COVID-19 therapies.
|
NA
|
NA
|
|
Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19.
|
NA
|
NA
|
|
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
|
NA
|
NA
|
|
Bilateral Pulmonary Embolism in a Discharged Patient With Resolved COVID-19 Pneumonia.
|
NA
|
NA
|
|
COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Right Atrial Thrombus in a Patient With COVID-19.
|
NA
|
NA
|
|
Predicting COVID-19 Pneumonia Severity on Chest X-ray With Deep Learning.
|
NA
|
NA
|
|
Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature.
|
NA
|
NA
|
|
COVID-19 - The Availability of ICU Beds in Brazil during the Onset of Pandemic.
|
NA
|
NA
|
|
An edible vaccine development for coronavirus disease 2019: the concept.
|
NA
|
NA
|
|
Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
|
NA
|
NA
|
|
Lessons Learned in Implementing VA Video Connect for Evidence-Based Psychotherapies for Anxiety and Depression in the Veterans Healthcare Administration.
|
NA
|
NA
|
|
Update to Drugs, Devices, and the FDA: How Recent Legislative Changes Have Impacted Approval of New Therapies.
|
NA
|
NA
|
|
Cohort study of outpatient hemodialysis management strategies for COVID-19 in North-West London.
|
NA
|
NA
|
|
Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China.
|
NA
|
NA
|
|
Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective.
|
NA
|
NA
|
|
Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure.
|
NA
|
NA
|
|
Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.
|
NA
|
NA
|
|
Posterior Reversible Encephalopathy Syndrome in COVID-19 Disease: a Case-Report.
|
NA
|
NA
|
|
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.
|
NA
|
NA
|
|
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China.
|
NA
|
NA
|
|
Ambulatory TAVR: early feasibility experience during Covid-19 pandemic.
|
NA
|
NA
|
|
Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.
|
NA
|
NA
|
|
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
|
NA
|
NA
|
|
Antibody detection assays for COVID-19 diagnosis: an early overview.
|
NA
|
NA
|
|
COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.
|
NA
|
NA
|
|
Cardiovascular involvement in COVID-19: not to be missed.
|
NA
|
NA
|
|
Epistaxis in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
A Retrospective Analysis and Comparison of Prisoners and Community-Based Patients with COVID-19 Requiring Intensive Care During the First Phase of the Pandemic in West Texas.
|
NA
|
NA
|
|
Global public health significances, health care perception of community, treatments, prevention and control methods of Coronavirus Disease 2019 Outbreak.
|
NA
|
NA
|
|
Biosafety procedures for handling intraoperative surgical samples during COVID-19 pandemic: an Italian pathology laboratory experience.
|
NA
|
NA
|
|
Characteristics and Management of Children with COVID-19 in Turkey
|
NA
|
NA
|
|
The Pathology of Severe COVID-19-Related Lung Damage.
|
NA
|
NA
|
|
A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19.
|
NA
|
NA
|
|
[COVID-19: epidemiology and clinical facts].
|
NA
|
NA
|
|
Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study.
|
NA
|
NA
|
|
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy.
|
NA
|
NA
|
|
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.
|
NA
|
NA
|
|
Best Practices for Approaching Cognitive Processing Therapy and Prolonged Exposure During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The effect of drugs used in rheumatology for treating SARS-CoV2 infection.
|
NA
|
NA
|
|
Changes in Interventional Pain Physician Decision-Making, Practice Patterns, and Mental Health During the Early Phase of the SARS-CoV-2 Global Pandemic.
|
NA
|
NA
|
|
Telemedicine and Healthcare Disparities: A cohort study in a large healthcare system in New York City during COVID-19.
|
NA
|
NA
|
|
Implications of SARS-CoV-2 on current and future operation and management of wastewater systems.
|
NA
|
NA
|
|
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
|
NA
|
NA
|
|
Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area.
|
NA
|
NA
|
|
Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
|
NA
|
NA
|
|
In the middle of the COVID-19 outbreak: Early practical guidelines for psychosocial aspects of COVID-19 in East Java, Indonesia.
|
NA
|
NA
|
|
Influence of COVID-19 pandemic on the psychological status of infertile couples.
|
NA
|
NA
|
|
Embitterment: The Nature of the Construct and Critical Issues in the Light of COVID-19.
|
NA
|
NA
|
|
Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress.
|
NA
|
NA
|
|
Probiotics: Versatile Bioactive Components in Promoting Human Health.
|
NA
|
NA
|
|
Establishing an Office-Based Framework for Resuming Otolaryngology Care in Academic Practice During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Comment on “Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di Milano”.
|
NA
|
NA
|
|
A serological survey of SARS-CoV-2 in cat in Wuhan.
|
NA
|
NA
|
|
Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach.
|
NA
|
NA
|
|
Repositioning of drugs to counter COVID-19 pandemic - An Insight.
|
NA
|
NA
|
|
Feasibility of mesenchymal stem cell therapy for COVID-19:A mini review.
|
NA
|
NA
|
|
COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.
|
NA
|
NA
|
|
Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients.
|
NA
|
NA
|
|
An outbreak of intestinal schistosomiasis, alongside increasing urogenital schistosomiasis prevalence, in primary school children on the shoreline of Lake Malawi, Mangochi District, Malawi.
|
NA
|
NA
|
|
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.
|
NA
|
NA
|
|
In-patient psychiatry management of COVID-19: rates of asymptomatic infection and on-unit transmission.
|
NA
|
NA
|
|
COVID-19: Therapeutics and interventions currently under consideration.
|
NA
|
NA
|
|
Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing.
|
NA
|
NA
|
|
Recommendations for interventional pulmonology during COVID-19 outbreak: a consensus statement from the Portuguese Pulmonology Society.
|
NA
|
NA
|
|
Recommendations for interventional pulmonology during COVID-19 outbreak: a consensus statement from the Portuguese Pulmonology Society.
|
NA
|
NA
|
|
Recommendations for interventional pulmonology during COVID-19 outbreak: a consensus statement from the Portuguese Pulmonology Society.
|
NA
|
NA
|
|
Recommendations for interventional pulmonology during COVID-19 outbreak: a consensus statement from the Portuguese Pulmonology Society.
|
NA
|
NA
|
|
Clinical placements for undergraduate diagnostic radiography students amidst the COVID-19 pandemic in Singapore: Preparation, challenges and strategies for safe resumption.
|
NA
|
NA
|
|
Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care.
|
NA
|
NA
|
|
Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.
|
NA
|
NA
|
|
Amyotrophic lateral sclerosis: update on clinical management.
|
NA
|
NA
|
|
Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons.
|
NA
|
NA
|
|
Signal amplification by reversible exchange for COVID-19 antiviral drug candidates.
|
NA
|
NA
|
|
Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological treatments.
|
NA
|
NA
|
|
A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection.
|
NA
|
NA
|
|
How COVID-19 Patients Were Moved to Speak: A Rehabilitation Interdisciplinary Case Series.
|
NA
|
NA
|
|
Unethical not to Investigate Radiotherapy for COVID-19.
|
NA
|
NA
|
|
Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2.
|
NA
|
NA
|
|
Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD.
|
NA
|
NA
|
|
Urology during a Crisis: A Management Algorithm.
|
NA
|
NA
|
|
A Universal Screening Strategy for SARS-CoV-2 Infection in Intensive Care Units: Korean Experience in a Single Hospital.
|
NA
|
NA
|
|
Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence.
|
NA
|
NA
|
|
The 1711 rinderpest in Bernardino Ramazzini’s XIII Oration and the COVID-19 public health emergency: facts and common aspects.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Update as of July 31st, 2020.
|
NA
|
NA
|
|
Future perspective: high-throughput construction of new ultrasensitive cytokine and virion liquid chips for high-throughput screening (HTS) of anti-inflammatory drugs or clinical diagnosis and treatment of inflammatory diseases.
|
NA
|
NA
|
|
The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
|
NA
|
NA
|
|
What Should Be Known by a Urologist About the Medical Management of COVID-19’s Patients?
|
NA
|
NA
|
|
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.
|
NA
|
NA
|
|
Remdesivir: First Approval.
|
NA
|
NA
|
|
Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome: a rapid review.
|
NA
|
NA
|
|
Evidence, Junk Science, and Hope in a Time of Pandemic: On the Front Lines in Dentistry.
|
NA
|
NA
|
|
Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.
|
NA
|
NA
|
|
Ocular Features and Associated Systemic Findings in SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Application of Critical Care Ultrasound in Patients With COVID-19: Our Experience and Perspective.
|
NA
|
NA
|
|
A simple protein-based surrogate neutralization assay for SARS-CoV-2.
|
NA
|
NA
|
|
Remote rehabilitation for patients with COVID-19.
|
NA
|
NA
|
|
Ventricular Fibrillation Storm in Coronavirus 2019.
|
NA
|
NA
|
|
An index to quantify environmental risk of exposure to future epidemics of the COVID-19 and similar viral agents: Theory and Practice.
|
NA
|
NA
|
|
Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
|
NA
|
NA
|
|
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”.
|
NA
|
NA
|
|
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
|
NA
|
NA
|
|
Comparison of the accuracy of telehealth examination versus clinical examination in the detection of shoulder pathology.
|
NA
|
NA
|
|
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
|
NA
|
NA
|
|
Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study.
|
NA
|
NA
|
|
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.
|
NA
|
NA
|
|
Prevalence of depression and its impact on quality of life among frontline nurses in emergency departments during the COVID-19 outbreak.
|
NA
|
NA
|
|
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2.
|
NA
|
NA
|
|
Effect of Lockdown in Surgical Emergency Accesses: Experience of a COVID-19 Hospital.
|
NA
|
NA
|
|
COVID-19 in hematological malignancy patients: A protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
|
NA
|
NA
|
|
Efficacy and safety of ACEI/ARB drugs in patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis of randomized controlled trials.
|
NA
|
NA
|
|
Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.
|
NA
|
NA
|
|
Efficacy and safety of traditional Chinese medicine combined with routine western medicine for the asymptomatic novel coronavirus disease (COVID-19): A Bayesian network meta-analysis protocol.
|
NA
|
NA
|
|
Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania: Three case reports.
|
NA
|
NA
|
|
A child infected with severe acute respiratory syndrome coronavirus 2 presenting with diarrhea without fever and cough: A case report.
|
NA
|
NA
|
|
Pediatric massage therapy for restoring pediatric lung function from COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?
|
NA
|
NA
|
|
Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19.
|
NA
|
NA
|
|
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
|
NA
|
NA
|
|
The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond.
|
NA
|
NA
|
|
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Decision Aide for the Risk Stratification of GU Cancer Patients at Risk of SARS-CoV-2 Infection, COVID-19 Related Hospitalization, Intubation, and Mortality.
|
NA
|
NA
|
|
Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu.
|
NA
|
NA
|
|
How lessons learned from the 2015 MERS outbreak affected the effective response to the COVID-19 epidemic in the Republic of Korea.
|
NA
|
NA
|
|
Characteristics and Outcomes of Mechanically Ventilated COVID-19 Patients-An Observational Cohort Study.
|
NA
|
NA
|
|
Mental health implications of COVID-19 pandemic and its response in India.
|
NA
|
NA
|
|
Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study.
|
NA
|
NA
|
|
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.
|
NA
|
NA
|
|
Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro.
|
NA
|
NA
|
|
Children with COVID-19 behaving milder may challenge the public policies: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status.
|
NA
|
NA
|
|
Covid-19 and Priorities for Research in Aging.
|
NA
|
NA
|
|
Changes in psychological wellbeing, attitude and information-seeking behaviour among people at the epicentre of the COVID-19 pandemic: a panel survey of residents in Hubei province, China.
|
NA
|
NA
|
|
Systemic inflammation as fuel for acute liver injury in COVID-19.
|
NA
|
NA
|
|
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.
|
NA
|
NA
|
|
Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19.
|
NA
|
NA
|
|
COVID-19 Challenges Status Quo for Cancer Care.
|
NA
|
NA
|
|
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel.
|
NA
|
NA
|
|
Changing Pattern of Orthopaedic Trauma Admissions During COVID-19 Pandemic: Experience at a Tertiary Trauma Centre in India.
|
NA
|
NA
|
|
Potential Benefits from the Use of the Supraclavicular Artery Island Flap for Immediate Soft-Tissue Reconstruction During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic).
|
NA
|
NA
|
|
Exploring the impact of the COVID-19 pandemic and UK lockdown on individuals with experience of eating disorders.
|
NA
|
NA
|
|
Agranulocytosis Following COVID-19 Recovery.
|
NA
|
NA
|
|
COVID-19 Pandemic in the United States.
|
NA
|
NA
|
|
Policies and innovations to battle Covid-19 - A Case study of South Korea.
|
NA
|
NA
|
|
The Dutch COVID-19 approach: Regional differences in a small country.: The Dutch COVID-19 approach.
|
NA
|
NA
|
|
Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial.
|
NA
|
NA
|
|
Medical research during the COVID-19 pandemic.
|
NA
|
NA
|
|
Review of possible psychological impacts of COVID-19 on frontline medical staff and reduction strategies.
|
NA
|
NA
|
|
Two mechanically ventilated cases of COVID-19 successfully managed with a sequential ventilation weaning protocol: Two case reports.
|
NA
|
NA
|
|
COVID-19 with asthma: A case report.
|
NA
|
NA
|
|
Hydroxy-chloroquine to treat COVID-19 - infected patients: Some lessons from medical anthropology and history of medicine.
|
NA
|
NA
|
|
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors.
|
NA
|
NA
|
|
Capacity-need gap in hospital resources for varying mitigation and containment strategies in India in the face of COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy.
|
NA
|
NA
|
|
Models of service delivery for optimizing a patient’s first six months on antiretroviral therapy for HIV: an applied research agenda.
|
NA
|
NA
|
|
RNA interference as a promising treatment against SARS-CoV-2.
|
NA
|
NA
|
|
Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.
|
NA
|
NA
|
|
Therapeutic plasma exchange in a critically ill Covid-19 patient.
|
NA
|
NA
|
|
SARS-CoV-2 infection in people living with HIV: a systematic review.
|
NA
|
NA
|
|
Analysis and prediction of the COVID-19 outbreak in Pakistan.
|
NA
|
NA
|
|
Exploitation of some natural products for prevention and/or nutritional treatment of SARS-CoV2 infection.
|
NA
|
NA
|
|
CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE.
|
NA
|
NA
|
|
Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19.
|
NA
|
NA
|
|
Estimated conditions to control the covid-19 pandemic in peruvian pre- and post-quarantine scenarios.
|
NA
|
NA
|
|
Description of patients with severe COVID-19 treated in a national referral hospital in Peru.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Challenges and proposals for scaling up COVID-19 testing and diagnosis in Brazil.
|
NA
|
NA
|
|
Off label, compassionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues.
|
NA
|
NA
|
|
Pharmacological therapies for patients with human coronavirus infections: a rapid systematic review.
|
NA
|
NA
|
|
Pneumothorax as a late complication of COVID-19.
|
NA
|
NA
|
|
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
|
NA
|
NA
|
|
[Impact of COVID-19 on liver disease and the public health in Peru].
|
NA
|
NA
|
|
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
|
NA
|
NA
|
|
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
|
NA
|
NA
|
|
[Quality of cochlear implant rehabilitation under COVID-19 conditions. German version].
|
NA
|
NA
|
|
African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
|
NA
|
NA
|
|
Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea, Iran and Italy.
|
NA
|
NA
|
|
A public-private partnership for the express development of antiviral leads: a perspective view.
|
NA
|
NA
|
|
Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19.
|
NA
|
NA
|
|
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report.
|
NA
|
NA
|
|
[Cardiovascular implications of SARS-CoV-2 infection: A literature review].
|
NA
|
NA
|
|
Recommendations from the Brazilian Society of Nephrology for approaching Covid-19 Diagnostic Testing in Dialysis Units.
|
NA
|
NA
|
|
Good Practice Recommendations from the Brazilian Society of Nephrology to Dialysis Units Concerning the Pandemic of the New Coronavirus (Covid-19).
|
NA
|
NA
|
|
Good practices recommendations from the Brazilian Society of Nephrology to Peritoneal Dialysis Services related to the new coronavirus (Covid-19) epidemic.
|
NA
|
NA
|
|
Recommendations Of The Brazilian Society Of Nephrology Regarding Pediatric Patients On Renal Replacement Therapy During The Covid-19 Pandemic.
|
NA
|
NA
|
|
COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic.
|
NA
|
NA
|
|
Hemodialysis Vascular access maintenance in the Covid-19 pandemic: Positioning paper from the Interventional Nephrology Committee of the Brazilian Society of Nephrology.
|
NA
|
NA
|
|
Palliative Renal Care and the Covid-19 Pandemic.
|
NA
|
NA
|
|
Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.
|
NA
|
NA
|
|
Fertility patients under COVID-19: Attitudes, Perceptions, and Psychological Reactions.
|
NA
|
NA
|
|
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.
|
NA
|
NA
|
|
Immunotherapeutic approaches to curtail COVID-19.
|
NA
|
NA
|
|
The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences.
|
NA
|
NA
|
|
Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration.
|
NA
|
NA
|
|
Risk factors of non-adherence to guidelines for the prevention of COVID-19 among young adults with asthma in a region with a high risk of a COVID-19 outbreak.
|
NA
|
NA
|
|
COVID-19 Concerns Among Persons With Mental Illness.
|
NA
|
NA
|
|
Management of appendicitis during COVID-19 pandemic; short-term outcomes.
|
NA
|
NA
|
|
COVID-19 length of hospital stay: a systematic review and data synthesis.
|
NA
|
NA
|
|
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
|
NA
|
NA
|
|
Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases.
|
NA
|
NA
|
|
Plastic surgery practices amidst global COVID-19 pandemic: Indian consensus.
|
NA
|
NA
|
|
Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis.
|
NA
|
NA
|
|
Voice Therapy in the Context of the COVID-19 Pandemic: Guidelines for Clinical Practice.
|
NA
|
NA
|
|
Rhabdomyolysis and acute kidney injury in severe COVID-19 infection.
|
NA
|
NA
|
|
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
|
NA
|
NA
|
|
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
|
NA
|
NA
|
|
Clinical characteristics of 71 patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Demands and countermeasures for outpatients and emergency patients during the outbreak of coronavirus disease 2019 in large general hospital.
|
NA
|
NA
|
|
Coagulation and immune function indicators for monitoring of coronavirus disease 2019 and the clinical significance.
|
NA
|
NA
|
|
Relation between blood glucose and the prognosis of severe coronavirus disease 2019.
|
NA
|
NA
|
|
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
|
NA
|
NA
|
|
Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.
|
NA
|
NA
|
|
Coronavirus disease 2019 in the elderly: Clinical characteristics, diagnosis and treatment strategies.
|
NA
|
NA
|
|
Application of antibiotics in treatment of coronavirus disease 2019 in a designated hospital.
|
NA
|
NA
|
|
Antiviral therapy for coronavirus disease 2019.
|
NA
|
NA
|
|
Airway management strategies under the situation of prevention and control of nosocomial infections for coronavirus disease 2019.
|
NA
|
NA
|
|
Perioperative management for patients with coronavirus disease 2019.
|
NA
|
NA
|
|
COVID-19 pneumonia in a patient with adult T-cell leukemia-lymphoma.
|
NA
|
NA
|
|
Esophageal cancer: challenges, concerns, and recommendations for management amidst the COVID-19 pandemic.
|
NA
|
NA
|
|
Gastrointestinal involvement in COVID-19 patients: a retrospective study from a Greek COVID-19 referral hospital.
|
NA
|
NA
|
|
A comparison of COVID-19, SARS and MERS.
|
NA
|
NA
|
|
GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
|
NA
|
NA
|
|
Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.
|
NA
|
NA
|
|
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
|
NA
|
NA
|
|
Consent for critical care research after death from COVID-19: Arguments for a waiver.
|
NA
|
NA
|
|
Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
|
NA
|
NA
|
|
Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
|
NA
|
NA
|
|
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results.
|
NA
|
NA
|
|
Variation and multilevel selection of SARS-CoV-2.
|
NA
|
NA
|
|
Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis.
|
NA
|
NA
|
|
A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion.
|
NA
|
NA
|
|
Hypothesis: The Potential Therapeutic Role of Nicorandil in COVID-19.
|
NA
|
NA
|
|
Three cases of COVID-19 patients presenting with erythema.
|
NA
|
NA
|
|
Telemedicine in cardiovascular surgery during COVID-19 pandemic: A systematic review and our experience.
|
NA
|
NA
|
|
Delivering Prolonged Exposure Therapy via Videoconferencing During the COVID-19 Pandemic: An Overview of the Research and Special Considerations for Providers.
|
NA
|
NA
|
|
Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings.
|
NA
|
NA
|
|
General Health Status of Asthmatic Children During COVID-19 Pandemic.
|
NA
|
NA
|
|
Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection.
|
NA
|
NA
|
|
COVID-19 in the pre-pandemic period: a survey of the time commitment and perceptions of infectious diseases physicians in Australia and New Zealand.
|
NA
|
NA
|
|
Modulation of endothelial organelle size as an antithrombotic strategy.
|
NA
|
NA
|
|
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients.
|
NA
|
NA
|
|
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study.
|
NA
|
NA
|
|
Tackling brain metastases from lung cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
|
NA
|
NA
|
|
Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19.
|
NA
|
NA
|
|
Targeting COVID-19 in Parkinson’s patients: Drugs repurposed.
|
NA
|
NA
|
|
Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.
|
NA
|
NA
|
|
Pilot Study of Robot-Assisted Teleultrasound Based on 5G Network: A New Feasible Strategy for Early Imaging Assessment During COVID-19 Pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.
|
NA
|
NA
|
|
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
|
NA
|
NA
|
|
Observational study of azithromycin in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
AAID White Paper: Management of the Dental Implant Patient During the Coronavirus Pandemic and Beyond.
|
NA
|
NA
|
|
Palliative dental care: Ignored dimension of dentistry amidst COVID-19 pandemic.
|
NA
|
NA
|
|
Brief online certification course for measuring blood pressure with an automated blood pressure device. A free new resource to support World Hypertension Day Oct 17, 2020.
|
NA
|
NA
|
|
Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice.
|
NA
|
NA
|
|
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
|
NA
|
NA
|
|
When to Consider Deferral of Surgery in Acute Type A Aortic Dissection: A Review.
|
NA
|
NA
|
|
The prophylaxis and treatment potential of supplements for COVID-19.
|
NA
|
NA
|
|
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
|
NA
|
NA
|
|
Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system.
|
NA
|
NA
|
|
The Experience of Emergency Department Providers With Embedded Palliative Care During COVID.
|
NA
|
NA
|
|
Potential anti-influenza effective plants used in Turkish folk medicine: A review.
|
NA
|
NA
|
|
Normal antibody response after COVID-19 during treatment with cladribine.
|
NA
|
NA
|
|
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
|
NA
|
NA
|
|
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.
|
NA
|
NA
|
|
COVID-19 is, in the end, an endothelial disease.
|
NA
|
NA
|
|
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.
|
NA
|
NA
|
|
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.
|
NA
|
NA
|
|
Dental Care during COVID-19 Outbreak: A Web-Based Survey.
|
NA
|
NA
|
|
Current Clinical Dental Practice Guidelines and the Financial Impact of COVID-19 on Dental Care Providers.
|
NA
|
NA
|
|
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Zinc(II)-The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?
|
NA
|
NA
|
|
Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2.
|
NA
|
NA
|
|
“A Chain Only as Strong as Its Weakest Link”: An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19.
|
NA
|
NA
|
|
Methodological Issues and Controversies in COVID-19 Coagulopathy: A Tale of Two Storms.
|
NA
|
NA
|
|
Fibrinolytic Strategy for ST-Segment-Elevation Myocardial Infarction: A Contemporary Review in Context of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical features and outcomes of seven patients with COVID-19 in a family cluster.
|
NA
|
NA
|
|
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
A protein interaction map identifies existing drugs targeting SARS-CoV-2.
|
NA
|
NA
|
|
The role of dedicated biocontainment patient care units in preparing for COVID-19 and other infectious disease outbreaks.
|
NA
|
NA
|
|
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma.
|
NA
|
NA
|
|
The Impact of COVID-19 on Emergent Large-Vessel Occlusion: Delayed Presentation Confirmed by ASPECTS.
|
NA
|
NA
|
|
Asthma and COVID-19: review of evidence on risks and management considerations.
|
NA
|
NA
|
|
A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits.
|
NA
|
NA
|
|
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
|
NA
|
NA
|
|
Summary of respiratory rehabilitation and physical therapy guidelines for patients with COVID-19 based on recommendations of World Confederation for Physical Therapy and National Association of Physical Therapy.
|
NA
|
NA
|
|
Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey.
|
NA
|
NA
|
|
Employment of Telemedicine in Nursing Homes: Clinical Requirement Analysis, System Development and First Test Results.
|
NA
|
NA
|
|
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era.
|
NA
|
NA
|
|
Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
|
NA
|
NA
|
|
The most recent advances in understanding and managing hidradenitis suppurativa.
|
NA
|
NA
|
|
COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
|
NA
|
NA
|
|
Intracranial Hemorrhage in a Patient With COVID-19: Possible Explanations and Considerations.
|
NA
|
NA
|
|
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside.
|
NA
|
NA
|
|
Clinical Outcomes in Critically Ill Coronavirus Disease 2019 Patients: A Unique New York City Public Hospital Experience.
|
NA
|
NA
|
|
Intracranial Pressure Dynamics and Cerebral Vasomotor Reactivity in Coronavirus Disease 2019 Patient With Acute Encephalitis.
|
NA
|
NA
|
|
COVID-19 and ocular implications: an update.
|
NA
|
NA
|
|
The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.
|
NA
|
NA
|
|
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
An observational study of the demographic and treatment changes in a tertiary colorectal cancer center during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19-related disease severity in pregnancy.
|
NA
|
NA
|
|
“I am terrified of something happening to me” The lived experience of people with obesity during the COVID-19 pandemic.
|
NA
|
NA
|
|
Nanotechnology Responses to COVID-19.
|
NA
|
NA
|
|
[ENT care in the context of the new coronavirus infection COVID-19].
|
NA
|
NA
|
|
One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
|
NA
|
NA
|
|
Malaria Situation in the Peruvian Amazon during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Adapting to disruption of research during the COVID-19 pandemic while testing nonpharmacological approaches to pain management.
|
NA
|
NA
|
|
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.
|
NA
|
NA
|
|
Has Covid-19 Gone Viral? An Overview of Research by Subject Area.
|
NA
|
NA
|
|
Progress in the diagnosis and treatment of COVID-19 and the role of surgeons in the front line of the pandemic.
|
NA
|
NA
|
|
Takotsubo syndrome as a complication in a critically ill COVID-19 patient.
|
NA
|
NA
|
|
Knowledge, Awareness, and Attitudes Relating to the COVID-19 Pandemic Among Different Populations in Central China: Cross-Sectional Survey.
|
NA
|
NA
|
|
Know your epidemic, know your response: Early perceptions of COVID-19 and self-reported social distancing in the United States.
|
NA
|
NA
|
|
Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios.
|
NA
|
NA
|
|
Chest computed tomography (CT) findings and semiquantitative scoring of 60 patients with coronavirus disease 2019 (COVID-19): A retrospective imaging analysis combining anatomy and pathology.
|
NA
|
NA
|
|
Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
|
NA
|
NA
|
|
Operational Considerations for Physical Therapy During COVID-19: A Rapid Review.
|
NA
|
NA
|
|
Comprehensive gastroenterology endoscopy unit workflow and infection prevention during the COVID-19 Pandemic: Experience with 159 cases in Wuhan, China.
|
NA
|
NA
|
|
The influence of COVID-19 on routine hematological parameters of hospitalized patients.
|
NA
|
NA
|
|
Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
|
NA
|
NA
|
|
Anxiety and depression symptoms in the same pregnant women before and during the COVID-19 pandemic.
|
NA
|
NA
|
|
Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Mycogenic Metal Nanoparticles for the Treatment of Mycobacterioses.
|
NA
|
NA
|
|
Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
|
NA
|
NA
|
|
The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).
|
NA
|
NA
|
|
A living WHO guideline on drugs for covid-19.
|
NA
|
NA
|
|
Cell and animal models of SARS-CoV-2 pathogenesis and immunity.
|
NA
|
NA
|
|
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
|
NA
|
NA
|
|
COVİD-19 infection in a membranous nephropathy patient treated with rituximab.
|
NA
|
NA
|
|
The Impetus of COVID -19 in Multiple Organ Affliction apart from Res-piratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy.
|
NA
|
NA
|
|
Case Report: Recurrent Clinical Symptoms of COVID-19 in Healthcare Professionals: A Series of Cases from Brazil.
|
NA
|
NA
|
|
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs.
|
NA
|
NA
|
|
Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Impact of the pandemic on surgical activity in colorectal cancer in Spain. Results of a national survey.
|
NA
|
NA
|
|
Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
|
NA
|
NA
|
|
Cardiac Arrhythmias in Critically Ill Patients With COVID-19: A Brief Review.
|
NA
|
NA
|
|
Successful Use of Extracorporeal Membrane Oxygenation Postpartum as Rescue Therapy in a Woman With COVID-19.
|
NA
|
NA
|
|
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics.
|
NA
|
NA
|
|
From SARS to COVID-19: What lessons have we learned?
|
NA
|
NA
|
|
Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy.
|
NA
|
NA
|
|
The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus.
|
NA
|
NA
|
|
Vascular Surgery Practice Guidelines during COVID-19 Pandemic in a Setting of High Work Volume Against Limited Resources: Perspective of a Developing Country.
|
NA
|
NA
|
|
Outcome of COVID-19 patients with use of Tocilizumab: A single center experience.
|
NA
|
NA
|
|
Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study.
|
NA
|
NA
|
|
Haemoptysis treated by bronchial artery embolisation in severe acute respiratory syndrome coronavirus 2: case report.
|
NA
|
NA
|
|
Coronaviruses and stress: from cellular to global.
|
NA
|
NA
|
|
Drug repurposing approach to fight COVID-19.
|
NA
|
NA
|
|
A lasting impression: telemedicine in urogynecology during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Update on antimalarials and systemic lupus erythematosus.
|
NA
|
NA
|
|
Coronavirus disease 2019 infection in patients with recent cardiac surgery: does chronic anticoagulant therapy have a protective effect?
|
NA
|
NA
|
|
COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-Control Study.
|
NA
|
NA
|
|
COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management.
|
NA
|
NA
|
|
Hypercoagulability and COVID-19 associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.
|
NA
|
NA
|
|
Dramatic decrease of surgical emergencies during COVID-19 outbreak.
|
NA
|
NA
|
|
Tobacco Use Cessation in Three Patients Suffering from Psychotic Disorders: The Impact of the COVID-19 Pandemic.
|
NA
|
NA
|
|
CoV3D: a database of high resolution coronavirus protein structures.
|
NA
|
NA
|
|
Initial Impact and Operational Responses to the COVID-19 Pandemic by American Radiation Oncology Practices.
|
NA
|
NA
|
|
COVID’s Impact on Radiation Oncology: A Latin American Survey Study.
|
NA
|
NA
|
|
Telemedicine in Radiation Oncology Post-COVID-19 Pandemic: There Is No Turning Back.
|
NA
|
NA
|
|
Telemedicine in Radiation Oncology: Is It Here to Stay? Impacts on Patient Care and Resident Education.
|
NA
|
NA
|
|
Radiation Oncologist Perceptions of Telemedicine from Consultation to Treatment Planning: A Mixed-Methods Study.
|
NA
|
NA
|
|
Time-Driven Activity-Based Costing Analysis of Telemedicine Services in Radiation Oncology.
|
NA
|
NA
|
|
Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine.
|
NA
|
NA
|
|
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis.
|
NA
|
NA
|
|
Assessment of ecological hazards and environmental fate of disinfectant quaternary ammonium compounds.
|
NA
|
NA
|
|
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
|
NA
|
NA
|
|
Pharmacy and Pharm.D students’ knowledge and information needs about COVID-19.
|
NA
|
NA
|
|
How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
|
NA
|
NA
|
|
Potential Role of Acacia Senegal (Gum Arabic) as Immunomodulatory Agent among newly diagnosed COVID 19 Patients: A structured summary of a protocol for a randomised, controlled, clinical trial.
|
NA
|
NA
|
|
A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis.
|
NA
|
NA
|
|
Paracervical blocks facilitate timely brachytherapy amidst COVID-19.
|
NA
|
NA
|
|
Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.
|
NA
|
NA
|
|
Concomitant infection with COVID-19 and Mycoplasma pneumoniae.
|
NA
|
NA
|
|
Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA.
|
NA
|
NA
|
|
Proposed Algorithm for Treatment of Pulmonary Embolism in COVID-19 Patients.
|
NA
|
NA
|
|
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
|
NA
|
NA
|
|
A proposed ABCD scoring system for better triage of patients with COVID-19: Use of clinical features and radiopathological findings.
|
NA
|
NA
|
|
Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
|
NA
|
NA
|
|
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.
|
NA
|
NA
|
|
Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Managing rheumatoid arthritis during COVID-19.
|
NA
|
NA
|
|
Clinical Analysis of Neonates Born to Mothers with or without COVID-19: A Retrospective Analysis of 48 Cases from Two Neonatal Intensive Care Units in Hubei Province.
|
NA
|
NA
|
|
Characteristics and outcomes of patients with COVID-19 admitted to ICU in a tertiary hospital in Stockholm, Sweden.
|
NA
|
NA
|
|
The shifting preferences of patients and physicians in nonsurgical hair loss treatment.
|
NA
|
NA
|
|
Higher psychogeriatric admissions in COVID-19 than in severe acute respiratory syndrome.
|
NA
|
NA
|
|
Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.
|
NA
|
NA
|
|
Neutrophil/Lymphocyte Ratio - A Marker of COVID-19 Pneumonia Severity.
|
NA
|
NA
|
|
Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.
|
NA
|
NA
|
|
The impact of the “low molecular weight heparin” administration on the clinical course of COVID-19 disease.
|
NA
|
NA
|
|
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology.
|
NA
|
NA
|
|
National survey on the treatment of cholelitiasis in Spain during the initial period of the COVID-19 pandemic.
|
NA
|
NA
|
|
Child Maltreatment during the COVID-19 Pandemic: Consequences of Parental Job Loss on Psychological and Physical Abuse Towards Children.
|
NA
|
NA
|
|
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future.
|
NA
|
NA
|
|
Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate.
|
NA
|
NA
|
|
Regional trauma patterns during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
|
NA
|
NA
|
|
Brachytherapy care during the COVID-19 pandemic: Practice statement from a cancer center in Wuhan, China.
|
NA
|
NA
|
|
Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Complicated by Multiple Simultaneous Intracerebral Hemorrhages.
|
NA
|
NA
|
|
The role of Connected Health technologies in supporting families affected by paediatric cancer: A systematic review.
|
NA
|
NA
|
|
Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Characteristics of Acute Stroke in Patients with Coronavirus Disease 2019 and Challenges in Stroke Management during an Epidemic.
|
NA
|
NA
|
|
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.
|
NA
|
NA
|
|
Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic.
|
NA
|
NA
|
|
Review of Ebola virus disease in children - how far have we come?
|
NA
|
NA
|
|
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.
|
NA
|
NA
|
|
Will a tumor pandemic come after the COVID-19 pandemic? Head and Neck cancer perspective.
|
NA
|
NA
|
|
Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications.
|
NA
|
NA
|
|
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
|
NA
|
NA
|
|
Three critical clinicobiological phases of the human SARS-associated coronavirus infections.
|
NA
|
NA
|
|
Clinical manifestations and maternal and perinatal outcomes with COVID-19.
|
NA
|
NA
|
|
Radiation oncology during COVID-19: Strategies to avoid compromised care.
|
NA
|
NA
|
|
Collapsing Glomerulopathy Affecting Native and Transplant Kidneys in Individuals with COVID-19.
|
NA
|
NA
|
|
[Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
|
NA
|
NA
|
|
[Recommendation of respiratory rehabilitation for PICS in critically ill patients with COVID-19].
|
NA
|
NA
|
|
Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Interdisciplinary Information for Infectious Disease Response: Exercising for Improved Medical/Public Health Communication and Collaboration.
|
NA
|
NA
|
|
[Impact of the Timing of Traditional Chinese Medicine Therapy on the Therapeutic Effect and Prognosis of Severe Coronavirus Disease 2019].
|
NA
|
NA
|
|
[Chloroquine phosphate: therapeutic drug for COVID-19].
|
NA
|
NA
|
|
[A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].
|
NA
|
NA
|
|
[Clinical characteristics and outcomes of adult critically ill patients with COVID-19 in Honghu, Hubei Province].
|
NA
|
NA
|
|
Early conscious prone positioning in patients with COVID-19 receiving continuous positive airway pressure: a retrospective analysis.
|
NA
|
NA
|
|
COVID-19-associated meningoencephalitis treated with intravenous immunoglobulin.
|
NA
|
NA
|
|
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
|
NA
|
NA
|
|
Developing a COVID-19 mortality risk prediction model when individual-level data are not available.
|
NA
|
NA
|
|
Quantitative proteomic analysis of the tizoxanide effect in vero cells.
|
NA
|
NA
|
|
Human dignity and cross-border migrants in the era of the COVID-19 pandemic.
|
NA
|
NA
|
|
Acute acalculous cholecystitis on a COVID-19 patient: a case report.
|
NA
|
NA
|
|
Safe sexual practices in the COVID-19 pandemic period.
|
NA
|
NA
|
|
Crystal structure of SARS-CoV-2 papain-like protease.
|
NA
|
NA
|
|
Occurrence, fates and potential treatment approaches for removal of viruses from wastewater: A review with emphasis on SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 in Children: Clinical Characteristics and Follow-Up Study.
|
NA
|
NA
|
|
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.
|
NA
|
NA
|
|
Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
|
NA
|
NA
|
|
Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy.
|
NA
|
NA
|
|
Managing rheumatic diseases during COVID-19.
|
NA
|
NA
|
|
In vitro comparison of surgical techniques in times of the SARS-CoV-2 pandemic: electrocautery generates more droplets and aerosol than laser surgery or drilling.
|
NA
|
NA
|
|
Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
|
NA
|
NA
|
|
Remdesivir, a remedy or a ripple in severe COVID-19?
|
NA
|
NA
|
|
Delayed surgery versus nonoperative treatment for hip fractures in post-COVID-19 arena: a retrospective study of 145 patients.
|
NA
|
NA
|
|
Barriers and challenges faced by Brazilian physiotherapists during the COVID-19 pandemic and innovative solutions: lessons learned and to be shared with other countries.
|
NA
|
NA
|
|
In-silico screening of plant-derived antivirals against main protease, 3CLpro and endoribonuclease, NSP15 proteins of SARS-CoV-2.
|
NA
|
NA
|
|
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
|
NA
|
NA
|
|
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group.
|
NA
|
NA
|
|
Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
|
NA
|
NA
|
|
Use of Telemedicine for Chronic Liver Disease at a Single Care Center During the COVID-19 Pandemic: Prospective Observational Study.
|
NA
|
NA
|
|
Insights from an interprofessional post-COVID-19 rehabilitation unit: A speech and language therapy and respiratory medicine perspective.
|
NA
|
NA
|
|
[Mechanism of QingfeiPaidu decoction for treatment of COVID-19: analysis based on network pharmacology and molecular docking technology].
|
NA
|
NA
|
|
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Assessment of Brain Injury Using Portable, Low-Field Magnetic Resonance Imaging at the Bedside of Critically Ill Patients.
|
NA
|
NA
|
|
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
|
NA
|
NA
|
|
Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study.
|
NA
|
NA
|
|
Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Androgen Deprivation Therapy in Men With Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2.
|
NA
|
NA
|
|
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.
|
NA
|
NA
|
|
Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina.
|
NA
|
NA
|
|
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
|
NA
|
NA
|
|
Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
|
NA
|
NA
|
|
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy.
|
NA
|
NA
|
|
Association of contact to small children with a mild course of COVID-19.
|
NA
|
NA
|
|
On-site analysis of COVID-19 on the surfaces in wards.
|
NA
|
NA
|
|
Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents.
|
NA
|
NA
|
|
Advances in Neonatal Infections.
|
NA
|
NA
|
|
Impact of COVID-19 on Lung Transplant Activity in Germany-A Cross-Sectional Survey.
|
NA
|
NA
|
|
Coronavirus disease 2019 associated with aggressive neurological and mental abnormalities confirmed based on cerebrospinal fluid antibodies: A case report.
|
NA
|
NA
|
|
Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report.
|
NA
|
NA
|
|
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
|
NA
|
NA
|
|
Qingfei Paidu decoction for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
|
NA
|
NA
|
|
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).
|
NA
|
NA
|
|
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.
|
NA
|
NA
|
|
Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
|
NA
|
NA
|
|
Recycling Old Antibiotics with Ionic Liquids.
|
NA
|
NA
|
|
Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System.
|
NA
|
NA
|
|
Resilience Moderates Negative Outcome from Stress during the COVID-19 Pandemic: A Moderated-Mediation Approach.
|
NA
|
NA
|
|
Malaria and COVID-19: Common and Different Findings.
|
NA
|
NA
|
|
Pan-Echinocandin-Resistant Candida glabrata Bloodstream Infection Complicating COVID-19: A Fatal Case Report.
|
NA
|
NA
|
|
COVID-19 and Kidney Injury.
|
NA
|
NA
|
|
COVID-19 and ESKD, A Rapid Review.
|
NA
|
NA
|
|
Patient with severe COVID-19 treated with corticosteroids.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy.
|
NA
|
NA
|
|
Current scenario and future prospect in the management of COVID-19.
|
NA
|
NA
|
|
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions.
|
NA
|
NA
|
|
Invasive and Non-Invasive Ventilation in Patients With COVID-19.
|
NA
|
NA
|
|
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease.
|
NA
|
NA
|
|
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.
|
NA
|
NA
|
|
Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19.
|
NA
|
NA
|
|
Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19.
|
NA
|
NA
|
|
Pneumatosis intestinalis in a patient with COVID-19.
|
NA
|
NA
|
|
Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda.
|
NA
|
NA
|
|
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
|
NA
|
NA
|
|
Recommendations for Prevention and Control of Influenza in Children, 2020-2021.
|
NA
|
NA
|
|
Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report.
|
NA
|
NA
|
|
Frontiers in the COVID-19 vaccines development.
|
NA
|
NA
|
|
A case of corticosteroid-responsive SARS-CoV-2 related massive rhabdomyolysis.
|
NA
|
NA
|
|
A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19.
|
NA
|
NA
|
|
Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019.
|
NA
|
NA
|
|
Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic.
|
NA
|
NA
|
|
Coagulation disorders in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Self-reported dental treatment needs during the COVID-19 outbreak in Brazil: an infodemiological study.
|
NA
|
NA
|
|
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
|
NA
|
NA
|
|
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
|
NA
|
NA
|
|
Proof-of-concept calculations to determine the health-adjusted life-year trade-off between intravitreal anti-VEGF injections and transmission of COVID-19.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London.
|
NA
|
NA
|
|
Urticaria and COVID-19: A review.
|
NA
|
NA
|
|
A review of current strategies to improve HIV prevention and treatment in sexual and gender minority Latinx (SGML) communities.
|
NA
|
NA
|
|
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
|
NA
|
NA
|
|
Rapid deployment of virtual mind-body interventions during the COVID-19 outbreak: feasibility, acceptability, and implications for future care.
|
NA
|
NA
|
|
Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study.
|
NA
|
NA
|
|
A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus-2 and the deduction effect of angiotensin-converting enzyme 2 in pregnancy.
|
NA
|
NA
|
|
Heterogeneous groups of alveolar type II cells in lung homeostasis and repair.
|
NA
|
NA
|
|
Immune response and blood-brain barrier dysfunction during viral neuroinvasion.
|
NA
|
NA
|
|
System-Wide Accelerated Implementation of Telemedicine in Response to COVID-19: Mixed Methods Evaluation.
|
NA
|
NA
|
|
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study.
|
NA
|
NA
|
|
Is COVID-19 spreading and curing silently: an observation of three family clusters in Bangladesh.
|
NA
|
NA
|
|
COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana.
|
NA
|
NA
|
|
Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea?
|
NA
|
NA
|
|
Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
|
NA
|
NA
|
|
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy’s Cancer Center in London.
|
NA
|
NA
|
|
Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China.
|
NA
|
NA
|
|
A Dental Response to the COVID-19 Pandemic-Safer Aerosol-Free Emergent (SAFER) Dentistry.
|
NA
|
NA
|
|
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.
|
NA
|
NA
|
|
Evaluation of Four Commercial Kits for SARS-CoV-2 Real-Time Reverse-Transcription Polymerase Chain Reaction Approved by Emergency-Use-Authorization in Korea.
|
NA
|
NA
|
|
A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine’s Prophylactic Effect Against Infection With SARS-CoV-2.
|
NA
|
NA
|
|
Immunomodulatory Drugs in the Management of SARS-CoV-2.
|
NA
|
NA
|
|
Comorbidity Assessment Is Essential During COVID-19 Treatment.
|
NA
|
NA
|
|
Available Evidence and Ongoing Hypothesis on Corona Virus (COVID-19) and Psychosis: Is Corona Virus and Psychosis Related? A Narrative Review.
|
NA
|
NA
|
|
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation.
|
NA
|
NA
|
|
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety.
|
NA
|
NA
|
|
Impact of the pandemic on non-infected cardiometabolic patients. A survey in countries of Latin America Rationale and design of CorCOVID LATAM Study.
|
NA
|
NA
|
|
COVID-19-Related Knowledge, Attitude and Practice Among Hospital and Community Pharmacists in Addis Ababa, Ethiopia.
|
NA
|
NA
|
|
Largest democracy in the world crippled by COVID-19: current perspective and experience from India.
|
NA
|
NA
|
|
A Single Large Dose of Vitamin D Could be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment.
|
NA
|
NA
|
|
Complex dynamics in susceptible-infected models for COVID-19 with multi-drug resistance.
|
NA
|
NA
|
|
Knowledge, Attitudes, and Practice Regarding COVID-19 among Patients with Musculoskeletal and Rheumatic Diseases in Nepal: A Web-Based Cross-Sectional Study.
|
NA
|
NA
|
|
Awareness of Health Professionals on COVID-19 and Factors Affecting It Before and During Index Case in North Shoa Zone, Ethiopia, 2020.
|
NA
|
NA
|
|
Chest CT accuracy in the diagnosis of SARS-CoV-2 infection: initial experience in a cancer center.
|
NA
|
NA
|
|
Nanomedicine strategies to target coronavirus.
|
NA
|
NA
|
|
A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
|
NA
|
NA
|
|
COVID-19 and Gynecological Cancers: A Summary of International Recommendations.
|
NA
|
NA
|
|
Pandemic Dementia Scarce Resource Allocation.
|
NA
|
NA
|
|
Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: a cross-sectional study in Saudi Arabia.
|
NA
|
NA
|
|
Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications.
|
NA
|
NA
|
|
Amplifying the Patient Voice: Key Priorities and Opportunities for Improved Transplant and Living Donor Advocacy and Outcomes During COVID-19 and Beyond.
|
NA
|
NA
|
|
Reopening dentistry after COVID-19: Complete suppression of aerosolization in dental procedures by viscoelastic Medusa Gorgo.
|
NA
|
NA
|
|
Mesenchymal Stem Cell Therapy-Is the Vessel Half Full or Half Empty?
|
NA
|
NA
|
|
Empirical assessment of government policies and flattening of the COVID19 curve.
|
NA
|
NA
|
|
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.
|
NA
|
NA
|
|
Hybrid-CERAB (Covered Endovascular Reconstruction of the Aortic Bifurcation) Procedure is preferable to Aorto-Bi-Femoral Bypass for Limb-threatening Aortoiliac Occlusive Disease during the COVID-19 Crisis.
|
NA
|
NA
|
|
Addressing the Consequences of School Closure Due to COVID-19 on Children’s Physical and Mental Well-Being.
|
NA
|
NA
|
|
EVAR in an asymptomatic COVID-19 positive patient with a symptomatic inflammatory abdominal aortic aneurysm.
|
NA
|
NA
|
|
COMPARTMENT SYNDROME SECONDARY TO VIRAL MYOSITIS AS INITIAL PRESENTATION IN COVID-19 PATIENT.
|
NA
|
NA
|
|
COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications.
|
NA
|
NA
|
|
Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients.
|
NA
|
NA
|
|
How Partisanship Affected Public Reaction to Potential Treatments for COVID-19.
|
NA
|
NA
|
|
Tailored breast imaging during the first wave and preparedness for the second wave of COVID-19 pandemic.
|
NA
|
NA
|
|
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.
|
NA
|
NA
|
|
[COVID-19 infection-Risk of thromboembolic complications].
|
NA
|
NA
|
|
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
|
NA
|
NA
|
|
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection.
|
NA
|
NA
|
|
Capped borrower credit risk and insurer hedging during the COVID-19 outbreak.
|
NA
|
NA
|
|
Perceptual breakdown during a global pandemic: introducing phenomenological insights for digital mental health purposes.
|
NA
|
NA
|
|
Avoiding the Banality of Evil in Times of COVID-19: Thinking Differently with a Biopsychosocial Perspective for Future Health and Social Policies Development.
|
NA
|
NA
|
|
[Operate, cancel, postpone or select?]
|
NA
|
NA
|
|
Recommendations for Safely Performing Major Head and Neck Surgery During the COVID-19 Pandemic: Experience with Implementation of a Workflow.
|
NA
|
NA
|
|
Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature.
|
NA
|
NA
|
|
Reflections on treatment of COVID-19 with traditional Chinese medicine.
|
NA
|
NA
|
|
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19.
|
NA
|
NA
|
|
Evaluation of Remote Monitoring Device for Monitoring Vital Parameters against Reference Standard: A Diagnostic Validation Study for COVID-19 Preparedness.
|
NA
|
NA
|
|
Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
|
NA
|
NA
|
|
An Intriguing Presentation of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
|
NA
|
NA
|
|
Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic.
|
NA
|
NA
|
|
The Association of Renin-Angiotensin-Aldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience.
|
NA
|
NA
|
|
Role of point of care ultrasound in COVID-19 pandemic: what lies beyond the horizon?
|
NA
|
NA
|
|
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
|
NA
|
NA
|
|
Implementation of an online treatment planning exercise focused on vulnerable patient groups.
|
NA
|
NA
|
|
Thrombolysis and bridging therapy in patients with acute ischaemic stroke and Covid-19.
|
NA
|
NA
|
|
Susceptibility to COVID-19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants.
|
NA
|
NA
|
|
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.
|
NA
|
NA
|
|
State and federal abortion restrictions increase risk of COVID-19 exposure by mandating unnecessary clinic visits.
|
NA
|
NA
|
|
The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations.
|
NA
|
NA
|
|
Detection of severe acute respiratory syndrome coronavirus 2 in nasopharynx according to clinical phenotype of affected patients.
|
NA
|
NA
|
|
PTSD treatment in times of COVID-19: A systematic review of the effects of online EMDR.
|
NA
|
NA
|
|
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".
|
NA
|
NA
|
|
Comparative Clinical Evaluation of the Roche Elecsys and Abbott SARS-CoV-2 Serology assays for COVID-19.
|
NA
|
NA
|
|
Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.
|
NA
|
NA
|
|
Traditional Chinese Medicine as Potential Therapy for COVID-19.
|
NA
|
NA
|
|
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
|
NA
|
NA
|
|
COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes.
|
NA
|
NA
|
|
SARS-CoV Mpro inhibitory activity of aromatic disulfide compounds: QSAR model.
|
NA
|
NA
|
|
The coronavirus diseases 2019 (COVID-19) pneumonia with spontaneous pneumothorax: a case report.
|
NA
|
NA
|
|
Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child.
|
NA
|
NA
|
|
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
|
NA
|
NA
|
|
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
COVID-19: an update and cardiac involvement.
|
NA
|
NA
|
|
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Brazilian primary and secondary public oral health attention: are dentists ready to face COVID-19 Pandemic?
|
NA
|
NA
|
|
COVID-19 Models for Hospital Surge Capacity Planning: A Systematic Review.
|
NA
|
NA
|
|
Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience.
|
NA
|
NA
|
|
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.
|
NA
|
NA
|
|
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 and Pneumothorax: A Multicentre Retrospective Case Series.
|
NA
|
NA
|
|
[Retrospective analysis of nosocomial COVID-19: a comparison between patients with hematological disorders and other diseases].
|
NA
|
NA
|
|
Management of Atrial Fibrillation in COVID-19 Pandemic.
|
NA
|
NA
|
|
Trauma-Informed Telehealth in the COVID-19 Era and Beyond.
|
NA
|
NA
|
|
Creating an Intensive Care Unit From a Postanesthesia Care Unit for the COVID-19 Surge at the Veterans Affairs Ann Arbor Healthcare System.
|
NA
|
NA
|
|
Molecular and Immunological Diagnostic Techniques of Medical Viruses.
|
NA
|
NA
|
|
Applying the proportionality principle to COVID-19 antibody testing.
|
NA
|
NA
|
|
Possible Retinal Impairment Secondary to Ritonavir Use in SARS-CoV-2 Patients: A Narrative Systematic Review.
|
NA
|
NA
|
|
Depression and Its Relationship with Coping Strategies and Illness Perceptions during the COVID-19 Lockdown in Greece: A Cross-Sectional Survey of the Population.
|
NA
|
NA
|
|
Scaling the Need, Benefits, and Risks Associated with COVID-19 Acute and Postacute Care Rehabilitation: A Review.
|
NA
|
NA
|
|
Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs.
|
NA
|
NA
|
|
COVID-19 in a Patient with Accidental Drug-Induced Neutropenia.
|
NA
|
NA
|
|
Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
|
NA
|
NA
|
|
[Lung ultrasonography in COVID-19 pneumonia].
|
NA
|
NA
|
|
A rare case of emphysematous pyelonephritis caused by Candida parapsilosis and Finegoldia magna complicated by medical care avoidance.
|
NA
|
NA
|
|
Prevention and practice during the COVID-19 emergency declaration period in Japanese obstetrical/gynecological facilities.
|
NA
|
NA
|
|
Integrating a Multidisciplinary Pain Team and Chiropractic Care in a Community Health Center: An Observational Study of Managing Chronic Spinal Pain.
|
NA
|
NA
|
|
Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2.
|
NA
|
NA
|
|
An auspicious triumph of recovery from dialysis-requiring acute kidney injury in COVID-19 in a patient with chronic kidney disease, α-1 antitrypsin deficiency, and liver transplant: A case report.
|
NA
|
NA
|
|
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
|
NA
|
NA
|
|
Hypernatremia-A Manifestation of COVID-19: A Case Series.
|
NA
|
NA
|
|
Potential statin drug interactions in elderly patients: a review.
|
NA
|
NA
|
|
Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
|
NA
|
NA
|
|
Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries.
|
NA
|
NA
|
|
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
|
NA
|
NA
|
|
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Spinal epidural abscess in COVID-19 patients.
|
NA
|
NA
|
|
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants?
|
NA
|
NA
|
|
Clinical characteristics and risk factors for mortality in hematologic patients affected By COVID-19.
|
NA
|
NA
|
|
Electroconvulsive therapy, personal protective equipment and aerosol generating procedures: a review to guide practice during Coronavirus Disease 2019 (COVID-19) pandemic.
|
NA
|
NA
|
|
Coronavirus disease 19 with gastrointestinal symptoms as initial manifestations: a case report.
|
NA
|
NA
|
|
A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
|
NA
|
NA
|
|
New normal: two aspects of adipose tissue in COVID-19-treat and threat?
|
NA
|
NA
|
|
Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor binding domain IgG correlate with virus neutralization.
|
NA
|
NA
|
|
Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
|
NA
|
NA
|
|
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
|
NA
|
NA
|
|
Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience.
|
NA
|
NA
|
|
Biosensor and molecular-based methods for the detection of human coronaviruses: A review.
|
NA
|
NA
|
|
Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.
|
NA
|
NA
|
|
Deep vein thrombosis in non-critically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in non-intensive care unit patients.
|
NA
|
NA
|
|
Metropolitan wastewater analysis for COVID-19 epidemiological surveillance.
|
NA
|
NA
|
|
Quantitative microbial risk assessment of SARS-CoV-2 for workers in wastewater treatment plants.
|
NA
|
NA
|
|
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists.
|
NA
|
NA
|
|
Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip.
|
NA
|
NA
|
|
COVID-19: Fear, quackery, false representations and the law.
|
NA
|
NA
|
|
Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients.
|
NA
|
NA
|
|
Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.
|
NA
|
NA
|
|
Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework.
|
NA
|
NA
|
|
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.
|
NA
|
NA
|
|
Duplex Shiny app quantification of the sepsis biomarkers C-reactive protein and interleukin-6 in a fast quantum dot labeled lateral flow assay.
|
NA
|
NA
|
|
Adapting an emotional regulation and social communication skills group programme to teletherapy, in response to the Covid-19 pandemic.
|
NA
|
NA
|
|
The Deployment and Operation of Outdoor Treatment Tents During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19.
|
NA
|
NA
|
|
[Whole-process prevention and treatment model of traditional Chinese medicine for coronavirus disease 2019 epidemics].
|
NA
|
NA
|
|
[A single arm clinical study of 86 patients with common type of coronavirus disease 2019 treated by integrated traditional Chinese and Western medicine: multicenter case observation from 7 designated hospitals in Henan Province].
|
NA
|
NA
|
|
[Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
|
NA
|
NA
|
|
The effect of COVID-19 on stroke hospitalizations in New York City.
|
NA
|
NA
|
|
Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
|
NA
|
NA
|
|
Public awareness in Egypt about COVID-19 spread in the early phase of the pandemic.
|
NA
|
NA
|
|
Clinical and Neuroimaging Correlation in Patients with COVID-19.
|
NA
|
NA
|
|
Respiratory patient experience of measures to reduce risk of COVID-19: findings from a descriptive cross-sectional UK wide survey.
|
NA
|
NA
|
|
Observational study on off-label use of tocilizumab in patients with severe COVID-19.
|
NA
|
NA
|
|
COVID-19 prevention and treatment information on the internet: a systematic analysis and quality assessment.
|
NA
|
NA
|
|
Vimentin as a target for the treatment of COVID-19.
|
NA
|
NA
|
|
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
|
NA
|
NA
|
|
Cross-sectional study on the role of public awareness in preventing the spread of COVID-19 outbreak in India.
|
NA
|
NA
|
|
Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.
|
NA
|
NA
|
|
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.
|
NA
|
NA
|
|
Single-cell transcriptomic atlas of primate cardiopulmonary aging.
|
NA
|
NA
|
|
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
|
NA
|
NA
|
|
Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
|
NA
|
NA
|
|
Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection.
|
NA
|
NA
|
|
The problem with relying on profit-driven models to produce pandemic drugs.
|
NA
|
NA
|
|
Heterogeneous Perfusion in COVID-19 and High Altitude Pulmonary Edema: A Review of Two Cases Followed by Implications for Hypoxic Pulmonary Vasoconstriction, Thrombosis Development, Ventilation Perfusion Mismatch and Emergence of Treatment Approaches.
|
NA
|
NA
|
|
Management of cancer patients during COVID-19 pandemic at developing countries.
|
NA
|
NA
|
|
Spontaneous pneumomediastinum in an elderly COVID-19 patient: A case report.
|
NA
|
NA
|
|
Early Research on COVID-19: A Bibliometric Analysis.
|
NA
|
NA
|
|
Availability of Personal Protective Equipment in NHS Hospitals During COVID-19: A National Survey.
|
NA
|
NA
|
|
Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.
|
NA
|
NA
|
|
Why nobody discusses the adverse psychiatric effects of chloroquine in case it might become the future treatment against COVID-19?
|
NA
|
NA
|
|
Social Isolation and Psychological Distress Among Older Adults Related to COVID-19: A Narrative Review of Remotely-Delivered Interventions and Recommendations.
|
NA
|
NA
|
|
Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?
|
NA
|
NA
|
|
Oral Manifestations in Patients with COVID-19: A Living Systematic Review.
|
NA
|
NA
|
|
Oxytocin as a Potential Adjuvant against COVID-19 Infection.
|
NA
|
NA
|
|
What Are the Odds of Finding a COVID-19 Drug from a Lab Repurposing Screen?
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research.
|
NA
|
NA
|
|
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H.
|
NA
|
NA
|
|
Role of eosinophils in the diagnosis and prognostic evaluation of COVID-19.
|
NA
|
NA
|
|
In-hospital mortality in heart failure in Germany during the Covid-19 pandemic.
|
NA
|
NA
|
|
Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.
|
NA
|
NA
|
|
Are open-source approaches the most efficient way forward for COVID-19 drug discovery?
|
NA
|
NA
|
|
Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood.
|
NA
|
NA
|
|
Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
|
NA
|
NA
|
|
Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue seems downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon.
|
NA
|
NA
|
|
Cardiac arrest and drug-related cardiac toxicity in the Covid-19 era. Epidemiology, pathophysiology and management.
|
NA
|
NA
|
|
Integrated control of COVID-19 in resource poor countries.
|
NA
|
NA
|
|
Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis.
|
NA
|
NA
|
|
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
|
NA
|
NA
|
|
A narrative review of venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
|
NA
|
NA
|
|
Rapid and quantitative detection of SARS-CoV-2 specific IgG for convalescent serum evaluation.
|
NA
|
NA
|
|
[COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs].
|
NA
|
NA
|
|
Clinical endodontic management during the COVID-19 pandemic: a literature review and clinical recommendations.
|
NA
|
NA
|
|
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
|
NA
|
NA
|
|
Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children.
|
NA
|
NA
|
|
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience.
|
NA
|
NA
|
|
Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Terapia de voz en el contexto de la pandemia covid-19; recomendaciones para la práctica clínica.
|
NA
|
NA
|
|
Terapia Vocal No Contexto Da Pandemia Do Covid-19; Orientações Para A Prática Clínica.
|
NA
|
NA
|
|
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.
|
NA
|
NA
|
|
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
|
NA
|
NA
|
|
The Importance of Proper Use of N95 Respirators by Health-Care Workers.
|
NA
|
NA
|
|
Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
|
NA
|
NA
|
|
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
|
NA
|
NA
|
|
Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
|
NA
|
NA
|
|
COVID-19, smoking, vaping and quitting: a representative population survey in England.
|
NA
|
NA
|
|
Clinical characteristics of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) patients in Hospital Tengku Ampuan Afzan.
|
NA
|
NA
|
|
SCOR: A secure international informatics infrastructure to investigate COVID-19.
|
NA
|
NA
|
|
Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2.
|
NA
|
NA
|
|
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
|
NA
|
NA
|
|
HIV Care Experiences During the COVID-19 Pandemic: Mixed-Methods Telephone Interviews with Clinic-Enrolled HIV-Infected Adults in Uganda.
|
NA
|
NA
|
|
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.
|
NA
|
NA
|
|
Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.
|
NA
|
NA
|
|
Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.
|
NA
|
NA
|
|
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
|
NA
|
NA
|
|
Gastrointestinal Infection is the Risk Factor for COVID-19 Inpatients with Assisted Ventilation.
|
NA
|
NA
|
|
Unusual arterial thrombotic events in Covid-19 patients.
|
NA
|
NA
|
|
Parameters predicting COVID-19-induced myocardial injury and mortality.
|
NA
|
NA
|
|
COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review.
|
NA
|
NA
|
|
Drug repurposing and cytokine management in response to COVID-19: A review.
|
NA
|
NA
|
|
Can CT performed in the early disease phase predict outcome of patients with COVID 19 pneumonia? Analysis of a cohort of 64 patients from Germany.
|
NA
|
NA
|
|
Unfolding the future: Self-controlled catalytic nanomotor in healthcare system.
|
NA
|
NA
|
|
Surge capacity for critical care specialised allied health professionals in Australia during COVID-19.
|
NA
|
NA
|
|
Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
|
NA
|
NA
|
|
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.
|
NA
|
NA
|
|
Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
|
NA
|
NA
|
|
Macrophage responses associated with COVID-19: A pharmacological perspective.
|
NA
|
NA
|
|
Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
|
NA
|
NA
|
|
Magnetic particle targeting for diagnosis and therapy of lung cancers.
|
NA
|
NA
|
|
Modeling COVID-19 pandemic using Bayesian analysis with application to Slovene data.
|
NA
|
NA
|
|
Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history.
|
NA
|
NA
|
|
May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?
|
NA
|
NA
|
|
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach.
|
NA
|
NA
|
|
Antibody-dependent enhancement of coronavirus.
|
NA
|
NA
|
|
COVID-19: Poor outcomes in patients with zinc deficiency.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
|
NA
|
NA
|
|
Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey.
|
NA
|
NA
|
|
An update of COVID-19 influence on waste management.
|
NA
|
NA
|
|
Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational.
|
NA
|
NA
|
|
The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
|
NA
|
NA
|
|
Dynamic analysis of the mathematical model of COVID-19 with demographic effects.
|
NA
|
NA
|
|
Out-patient management of patients with COVID-19 on home isolation.
|
NA
|
NA
|
|
The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
|
NA
|
NA
|
|
The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline.
|
NA
|
NA
|
|
COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
|
NA
|
NA
|
|
Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2.
|
NA
|
NA
|
|
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.
|
NA
|
NA
|
|
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper.
|
NA
|
NA
|
|
Multisystem effects of COVID-19: A concise review for practitioners.
|
NA
|
NA
|
|
Men and COVID-19: the aftermath.
|
NA
|
NA
|
|
Exploration of turn-positive RT-PCR results and factors related to treatment outcome in COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
|
NA
|
NA
|
|
Old age mental health services in Southern Balkans: Features, geospatial distribution, current needs, and future perspectives.
|
NA
|
NA
|
|
Prevalence and severity of Coronavirus disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide study.
|
NA
|
NA
|
|
Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.
|
NA
|
NA
|
|
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy?
|
NA
|
NA
|
|
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly).
|
NA
|
NA
|
|
How to overcome cardiovascular challenges in COVID-19 patients: a guide for common practice.
|
NA
|
NA
|
|
Implications of Telemedicine in Oncology during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Negative nasopharyngeal swabs in COVID-19 pneumonia: the experience of an Italian Emergengy Department (Piacenza) during the first month of the Italian epidemic.
|
NA
|
NA
|
|
Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features.
|
NA
|
NA
|
|
The “perfect” storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Therapeutic strategies against COVID-19.
|
NA
|
NA
|
|
Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.
|
NA
|
NA
|
|
Surgical activity organization during COVID-19 outbreak: a teaching hospital experience.
|
NA
|
NA
|
|
Intrauterine transmission of COVID-19 in Pregnancy: case report and review of literature.
|
NA
|
NA
|
|
Elevated transaminases in a COVID-19 positive patient at term of gestation: a case report.
|
NA
|
NA
|
|
Coronaviruses - Potential human threat from foodborne transmission?
|
NA
|
NA
|
|
[Trendsetting Ideas of the Children’s Hospital “Kinderklinik Glanzing” Since 1915].
|
NA
|
NA
|
|
Rheumatological aspects of pathogenesis and treatment of COVID-19 infection.
|
NA
|
NA
|
|
A deep learning approach to detect Covid-19 coronavirus with X-Ray images.
|
NA
|
NA
|
|
Concerns and strategies for wastewater treatment during COVID-19 pandemic to stop plausible transmission.
|
NA
|
NA
|
|
[Ethics, communication and interdisciplinary collaboration-by law?!]
|
NA
|
NA
|
|
[Risks of the stay at home policy during the COVID-19 pandemic].
|
NA
|
NA
|
|
How hand and wrist trauma has changed during covid-19 emergency in Italy: Incidence and distribution of acute injuries. What to learn?
|
NA
|
NA
|
|
Etiology and management of liver injury in patients with COVID-19.
|
NA
|
NA
|
|
Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.
|
NA
|
NA
|
|
Coinfection of SARS-CoV-2 and Other Respiratory Pathogens.
|
NA
|
NA
|
|
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
|
NA
|
NA
|
|
COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.
|
NA
|
NA
|
|
Determination of risk factors for predicting the onset of symptoms in asymptomatic COVID-19 infected patients.
|
NA
|
NA
|
|
Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
|
NA
|
NA
|
|
CT features and outcomes of newly developed pulmonary lesions in patients with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
|
NA
|
NA
|
|
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.
|
NA
|
NA
|
|
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers.
|
NA
|
NA
|
|
Connect, Engage: Televists for Children With Asthma During COVID-19.
|
NA
|
NA
|
|
COVID-19 Usurps Host Regulatory Networks.
|
NA
|
NA
|
|
Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment.
|
NA
|
NA
|
|
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
|
NA
|
NA
|
|
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.
|
NA
|
NA
|
|
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes.
|
NA
|
NA
|
|
A survey of UK general practitioners about depression, antidepressants and withdrawal: implementing the 2019 Public Health England report.
|
NA
|
NA
|
|
Tongue reconstruction post partial glossectomy during the COVID-19 pandemic. A case report.
|
NA
|
NA
|
|
Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection.
|
NA
|
NA
|
|
Unusual lesion in the splenium of the corpus callosum and coronavirus infectious disease-19.
|
NA
|
NA
|
|
Efficacy and safety of triazavirin therapy for coronavirus disease 2019: A pilot randomized controlled trial.
|
NA
|
NA
|
|
Aplastic anemia and COVID-19: how to break the vicious circuit?
|
NA
|
NA
|
|
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
|
NA
|
NA
|
|
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
|
NA
|
NA
|
|
Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge.
|
NA
|
NA
|
|
Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Vasculitis Presented as Pulmonary Hemorrhage in a Positive COVID-19 Patient: A Case Report.
|
NA
|
NA
|
|
Management of Prostate Cancer During COVID-19 Pandemic: Perspective From Urologists and Radiation Oncologists in COVID Dense Metro Detroit.
|
NA
|
NA
|
|
Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection.
|
NA
|
NA
|
|
Short-Term Impact of Staying Home on Bone Health in Patients With Osteoporosis During a State of Emergency Declaration Due to COVID-19 in Kanagawa, Japan.
|
NA
|
NA
|
|
Modeling suicide risk among parents during the COVID-19 pandemic: Psychological inflexibility exacerbates the impact of COVID-19 stressors on interpersonal risk factors for suicide.
|
NA
|
NA
|
|
Potential use of polyphenols in the battle against COVID-19.
|
NA
|
NA
|
|
Geometric architecture of viruses.
|
NA
|
NA
|
|
Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned.
|
NA
|
NA
|
|
Case Report: Opportunities for Treatment of Severe COVID-19 Patients-Lessons From a Death Case.
|
NA
|
NA
|
|
COVID-19, Companion Animals, Comparative Medicine, and One Health.
|
NA
|
NA
|
|
Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.
|
NA
|
NA
|
|
C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis.
|
NA
|
NA
|
|
Digital advantage in the COVID-19 response: perspective from Canada’s largest integrated digitalized healthcare system.
|
NA
|
NA
|
|
Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report.
|
NA
|
NA
|
|
Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy.
|
NA
|
NA
|
|
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma.
|
NA
|
NA
|
|
Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey.
|
NA
|
NA
|
|
Cold agglutinin syndrome as a complication of Covid-19 in two cases.
|
NA
|
NA
|
|
Should I use steroid injections to treat shoulder pain during the COVID-19 pandemic?
|
NA
|
NA
|
|
The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review.
|
NA
|
NA
|
|
Kawasaki Disease: an Update.
|
NA
|
NA
|
|
An Antioxidant Enzyme Therapeutic for COVID-19.
|
NA
|
NA
|
|
COVID-19 in older adults: Retrospective cohort study in a tertiary hospital in Japan.
|
NA
|
NA
|
|
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
|
NA
|
NA
|
|
Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Stability in Multiple Water Matrices.
|
NA
|
NA
|
|
Critically-ill pediatric patients with COVID-19. An update.
|
NA
|
NA
|
|
ECT in the time of the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
|
NA
|
NA
|
|
The effect of antivirals on COVID-19: a systematic review.
|
NA
|
NA
|
|
Computational insight of dexamethasone against potential targets of SARS-CoV-2.
|
NA
|
NA
|
|
Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study.
|
NA
|
NA
|
|
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
|
NA
|
NA
|
|
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.
|
NA
|
NA
|
|
A review of studies on the COVID-19 epidemic crisis disease with a preventive approach.
|
NA
|
NA
|
|
The role of Yoga in working from home during the COVID-19 global lockdown.
|
NA
|
NA
|
|
Telehealth in school-based practice: Perceived viability to bridge global OT practitioner shortages prior to COVID-19 global health emergency.
|
NA
|
NA
|
|
Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology.
|
NA
|
NA
|
|
SARS-CoV-2 Infection During Induction Chemotherapy in a Child With High-risk T-Cell Acute Lymphoblastic Leukemia (T-ALL).
|
NA
|
NA
|
|
COVID-19 Shines a Spotlight on the Age-Old Problem of Social Isolation.
|
NA
|
NA
|
|
Timing of invasive mechanic ventilation in critically ill patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Telehealth for Wound Management During the COVID-19 Pandemic: Case Studies.
|
NA
|
NA
|
|
Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Evaluating the efficacy and safety of bromhexine hydrochloride tablets in treating pediatric COVID-19: A protocol for meta-analysis and systematic review.
|
NA
|
NA
|
|
The effect of Baduanjin exercise on the quality of life in patients recovering from COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.
|
NA
|
NA
|
|
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
|
NA
|
NA
|
|
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro”.
|
NA
|
NA
|
|
Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
|
NA
|
NA
|
|
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection.
|
NA
|
NA
|
|
A Case Report: Co-presenting COVID-19 Infection and Acute Drug Intoxication.
|
NA
|
NA
|
|
Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report.
|
NA
|
NA
|
|
A Case Report of Acute Motor and Sensory Polyneuropathy as the Presenting Symptom of SARS-CoV-2.
|
NA
|
NA
|
|
Cancer care in a Western Indian tertiary center during the pandemic: Surgeon’s perspective.
|
NA
|
NA
|
|
Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers.
|
NA
|
NA
|
|
The COVID-19 Pandemic’s Impact on Critical Care Resources and Providers: A Global Survey.
|
NA
|
NA
|
|
Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2.
|
NA
|
NA
|
|
COVID-19 associated complications and potential therapeutic targets.
|
NA
|
NA
|
|
New insights on possible vaccine development against SARS-CoV-2.
|
NA
|
NA
|
|
Clinical Outcomes of CoVid-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate: A Multi-Center Research Network Study.
|
NA
|
NA
|
|
Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19.
|
NA
|
NA
|
|
Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study.
|
NA
|
NA
|
|
Management of West syndrome during COVID-19 pandemic: A viewpoint from South Asian West Syndrome Research Group.
|
NA
|
NA
|
|
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
|
NA
|
NA
|
|
Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls.
|
NA
|
NA
|
|
Impact of HVAC-Systems on the Dispersion of Infectious Aerosols in a Cardiac Intensive Care Unit.
|
NA
|
NA
|
|
Vitamin D Deficiency and Outcome of COVID-19 Patients.
|
NA
|
NA
|
|
Assessing Viral Shedding and Infectivity of Asymptomatic or Mildly Symptomatic Patients with COVID-19 in a Later Phase.
|
NA
|
NA
|
|
Prevalence of Anxiety in Medical Students during the COVID-19 Pandemic: A Rapid Systematic Review with Meta-Analysis.
|
NA
|
NA
|
|
Severe hemoptysis in post-tuberculosis bronchiectasis precipitated by SARS-CoV-2 infection.
|
NA
|
NA
|
|
A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Diagnostic techniques for COVID-19 and new developments.
|
NA
|
NA
|
|
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data.
|
NA
|
NA
|
|
Fulminant myocarditis as an early presentation of SARS-CoV-2.
|
NA
|
NA
|
|
Guillain-Barré syndrome presenting with COVID-19 infection.
|
NA
|
NA
|
|
Atypical case of COVID-19 in a critically unwell 5-week old infant.
|
NA
|
NA
|
|
Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.
|
NA
|
NA
|
|
Gastrointestinal implications in COVID-19.
|
NA
|
NA
|
|
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
|
NA
|
NA
|
|
The New Coronavirus COVID-19 Infection.
|
NA
|
NA
|
|
What are the drugs having potential against COVID-19?
|
NA
|
NA
|
|
The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting Challenge.
|
NA
|
NA
|
|
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials.
|
NA
|
NA
|
|
Geospatial modelling on the spread and dynamics of 154 day outbreak of the novel coronavirus (COVID-19) pandemic in Bangladesh towards vulnerability zoning and management approaches.
|
NA
|
NA
|
|
A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.
|
NA
|
NA
|
|
COVID-19 in hematology: data from a hematologic and transplant unit.
|
NA
|
NA
|
|
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People’s Republic of China.
|
NA
|
NA
|
|
Critical Care Guidance for Tracheostomy Care During the COVID-19 Pandemic: A Global, Multidisciplinary Approach.
|
NA
|
NA
|
|
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
|
NA
|
NA
|
|
Palliative care provision at a tertiary cancer center during a global pandemic.
|
NA
|
NA
|
|
Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark-A nationwide, observational study.
|
NA
|
NA
|
|
Liquid biopsy technologies for hematological diseases.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study.
|
NA
|
NA
|
|
Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients.
|
NA
|
NA
|
|
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
|
NA
|
NA
|
|
Naltrexone a potential therapeutic candidate for COVID-19.
|
NA
|
NA
|
|
Pathological Post Mortem Findings in Lungs Infected With Sars-Cov 2.
|
NA
|
NA
|
|
Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
|
NA
|
NA
|
|
Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.
|
NA
|
NA
|
|
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases.
|
NA
|
NA
|
|
Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified.
|
NA
|
NA
|
|
Derivation and validation of the clinical prediction model for COVID-19.
|
NA
|
NA
|
|
Application of lung ultrasonography in critically ill patients with COVID-19.
|
NA
|
NA
|
|
Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic.
|
NA
|
NA
|
|
The Impact of Social Distancing on People with Borderline Personality Disorder: The Views of Dialectical Behavioural Therapists.
|
NA
|
NA
|
|
COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals.
|
NA
|
NA
|
|
Digital Health in Physicians’ and Pharmacists’ Office: A Comparative Study of e-Prescription Systems’ Architecture and Digital Security in Eight Countries.
|
NA
|
NA
|
|
Mental Health Practitioners’ Immediate Practical Response During the COVID-19 Pandemic: Observational Questionnaire Study.
|
NA
|
NA
|
|
A Computer-Interpretable Guideline for COVID-19: Rapid Development and Dissemination.
|
NA
|
NA
|
|
To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
|
NA
|
NA
|
|
Incidence and case fatality rate of COVID-19 in patients with inflammatory articular diseases.
|
NA
|
NA
|
|
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
|
NA
|
NA
|
|
[Case Series of 103 Children with SARS-CoV-2 Infection in Portugal].
|
NA
|
NA
|
|
Possibility of magnesium supplementation for supportive treatment in patients with COVID-19.
|
NA
|
NA
|
|
Curcumin, a traditional spice component, can hold the promise against COVID-19?
|
NA
|
NA
|
|
An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
|
NA
|
NA
|
|
Etoposide as Salvage Therapy for Cytokine Storm Due to COVID-19.
|
NA
|
NA
|
|
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.
|
NA
|
NA
|
|
COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
|
NA
|
NA
|
|
A Multicentered Study on Epidemiologic and Clinical Characteristics of 37 Neonates With Community-acquired COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 and Dentistry-Review.
|
NA
|
NA
|
|
Care Dependency in Non-Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
The Wide Spectrum of COVID-19 Clinical Presentation in Children.
|
NA
|
NA
|
|
Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry.
|
NA
|
NA
|
|
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.
|
NA
|
NA
|
|
Autism and COVID-19: A Case Series in a Neurodevelopmental Unit.
|
NA
|
NA
|
|
Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy.
|
NA
|
NA
|
|
Correlation of COVID-19 Pandemic with Healthcare System Response and Prevention Measures in Saudi Arabia.
|
NA
|
NA
|
|
Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations.
|
NA
|
NA
|
|
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.
|
NA
|
NA
|
|
Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach.
|
NA
|
NA
|
|
Pathophysiology and treatment strategies for COVID-19.
|
NA
|
NA
|
|
Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
|
NA
|
NA
|
|
Interleukin-6 and severe COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Cytokine storm and use of anakinra in a patient with COVID-19.
|
NA
|
NA
|
|
Severe thrombocytopaenia secondary to COVID-19.
|
NA
|
NA
|
|
A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat.
|
NA
|
NA
|
|
Attitudes and Behaviors of Patients With Rheumatic Diseases During the Early Stages of the COVID-19 Outbreak.
|
NA
|
NA
|
|
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
|
NA
|
NA
|
|
Management of Orthopaedic Accidental Emergencies Amidst COVID-19 Pandemic: Our Experience in Preparing to Live with Corona.
|
NA
|
NA
|
|
Public and healthcare providers awareness of Coronavirus (COVID-19) in Qassim Region, Saudi Arabia.
|
NA
|
NA
|
|
Electroconvulsive therapy during a highly contagious respiratory pandemic-A framework during COVID-19.
|
NA
|
NA
|
|
Molecular diagnosis of COVID-19: Current situation and trend in China (Review).
|
NA
|
NA
|
|
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.
|
NA
|
NA
|
|
Prediction of repurposed drugs for treating lung injury in COVID-19.
|
NA
|
NA
|
|
Cerium nitrate enhances anti-bacterial effects and imparts anti-inflammatory properties to silver dressings in a rat scald burn model.
|
NA
|
NA
|
|
Bibliometric analysis of global scientific research on Coronavirus (COVID-19).
|
NA
|
NA
|
|
Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?
|
NA
|
NA
|
|
Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis.
|
NA
|
NA
|
|
Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry.
|
NA
|
NA
|
|
Early experience with critically ill patients with COVID-19 in Montreal.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on mental health of patients with inherited bleeding disorders in Germany.
|
NA
|
NA
|
|
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin.
|
NA
|
NA
|
|
Central Venous Catheter Insertion in the Prone Position-A Last Resort in Critically Ill COVID-19 Patients.
|
NA
|
NA
|
|
A short report on an interprofessional mobilizer team: innovation and impact during the COVID-19 pandemic.
|
NA
|
NA
|
|
Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients.
|
NA
|
NA
|
|
A pragmatic approach and treatment of coronavirus disease 2019 (COVID-19) in intensive care unit.
|
NA
|
NA
|
|
Identification of the RNase-binding site of SARS-CoV-2 RNA for anchor primer-PCR detection of viral loading in 306 COVID-19 patients.
|
NA
|
NA
|
|
SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease.
|
NA
|
NA
|
|
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
|
NA
|
NA
|
|
Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment.
|
NA
|
NA
|
|
Clinical Characteristics and Outcome of Pneumomediastinum in Patients with COVID-19 Pneumonia.
|
NA
|
NA
|
|
Creating a Colocation Unit for End-of-Life Care during a Pandemic.
|
NA
|
NA
|
|
Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
|
NA
|
NA
|
|
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection.
|
NA
|
NA
|
|
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Kawasaki-like disease in children with COVID-19.
|
NA
|
NA
|
|
[Provisioning of personal protective equipment in hospitals in preparation for a pandemic].
|
NA
|
NA
|
|
Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.
|
NA
|
NA
|
|
The COVID-19 pandemic: Psychological and behavioral responses to the shutdown of the beauty industry.
|
NA
|
NA
|
|
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review.
|
NA
|
NA
|
|
Men and COVID-19: A Pathophysiologic Review.
|
NA
|
NA
|
|
Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.
|
NA
|
NA
|
|
Adapting an Outpatient Psychiatric Clinic to Telehealth During the COVID-19 Pandemic: A Practice Perspective.
|
NA
|
NA
|
|
Identification of Risk Factors and Symptoms of COVID-19: Analysis of Biomedical Literature and Social Media Data.
|
NA
|
NA
|
|
Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study.
|
NA
|
NA
|
|
Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
|
NA
|
NA
|
|
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.
|
NA
|
NA
|
|
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.
|
NA
|
NA
|
|
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol.
|
NA
|
NA
|
|
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
National Disaster Management System: COVID-19 Case in Korea.
|
NA
|
NA
|
|
Role of novel drug delivery systems in coronavirus disease-2019 (covid-19): time to act now.
|
NA
|
NA
|
|
Male gender and kidney illness are associated with an increased risk of severe laboratory-confirmed coronavirus disease.
|
NA
|
NA
|
|
Pneumothorax in COVID-19 disease- incidence and clinical characteristics.
|
NA
|
NA
|
|
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
|
NA
|
NA
|
|
Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers.
|
NA
|
NA
|
|
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
|
NA
|
NA
|
|
Potential Predictors of Poor Prognosis among Critical COVID-19 Pneumonia Patients Requiring Tracheal Intubation.
|
NA
|
NA
|
|
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design.
|
NA
|
NA
|
|
Laparoscopy during the COVID-19 Pandemic: Absence of Evidence is not Evidence of Absence.
|
NA
|
NA
|
|
Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
|
NA
|
NA
|
|
Immune responses during COVID-19 infection.
|
NA
|
NA
|
|
Navigating assisted reproduction treatment in the time of COVID-19: concerns and considerations.
|
NA
|
NA
|
|
Emergency management of the COVID-19 pandemic in a vascular surgery department of a large metropolitan hospital in Italy. Preparation, escalation, de-escalation, and normal activity.
|
NA
|
NA
|
|
Being on hemodialysis during the COVID-19 outbreak: A mixed-methods’ study exploring the impacts on dialysis adequacy, analytical data, and patients’ experiences.
|
NA
|
NA
|
|
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
|
NA
|
NA
|
|
Changes in access to educational and healthcare services for individuals with intellectual and developmental disabilities during COVID-19 restrictions.
|
NA
|
NA
|
|
Targeting RNA G-quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?
|
NA
|
NA
|
|
Managing patients with prostate cancer during COVID-19 pandemic: the experience of a high-volume robotic surgery center.
|
NA
|
NA
|
|
Responding to a COVID-19 Outbreak at a Long-Term Care Facility.
|
NA
|
NA
|
|
A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor.
|
NA
|
NA
|
|
The Use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus. A mini-review.
|
NA
|
NA
|
|
Tocilizumab in Sars-cov-2 Patients with the Syndrome of Cytokine Storm; a Narrative review.
|
NA
|
NA
|
|
Management of Idiopathic Intracranial Hypertension during the COVID19 Pandemic.
|
NA
|
NA
|
|
Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy.
|
NA
|
NA
|
|
Social Distancing to Mitigate COVID-19 Risks Is Associated With COVID-19 Discriminatory Attitudes Among People Living with HIV.
|
NA
|
NA
|
|
Gynaecologic cancer care during COVID-19 pandemic in India: a social media survey.
|
NA
|
NA
|
|
In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
|
NA
|
NA
|
|
Implementing Group Parent Training in Telepsychology: Lessons Learned During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on rheumatic patients’ perceptions and behaviors: A cross-sectional study.
|
NA
|
NA
|
|
Obesity, vitamin D deficiency and old age a serious combination with respect to coronavirus disease-2019 severity and outcome.
|
NA
|
NA
|
|
Impact of Corona Virus Disease 2019 on Oral- and Maxillofacial Surgery: Preliminary Results After the Curfew.
|
NA
|
NA
|
|
The Use of Non-Steroidal Anti-inflammatory Drugs for Coronavirus Disease 2019: Adjunct Therapy.
|
NA
|
NA
|
|
Preferences for Tobacco Cessation Information and Support During Covid-19.
|
NA
|
NA
|
|
Changing landscape: psychological care in the era of cystic fibrosis transmembrane conductance regulator modulators.
|
NA
|
NA
|
|
COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management.
|
NA
|
NA
|
|
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
|
NA
|
NA
|
|
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
|
NA
|
NA
|
|
No SARS-CoV-2 neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic.
|
NA
|
NA
|
|
The First 60 Days: Physical Therapy in a Neurosurgical Center Converted Into a COVID-19 Center in Brazil.
|
NA
|
NA
|
|
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.
|
NA
|
NA
|
|
The Inhibitory Effect of a Coronavirus Spike Protein Fragment with ACE2.
|
NA
|
NA
|
|
Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing.
|
NA
|
NA
|
|
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
|
NA
|
NA
|
|
Critically Ill Adults with COVID-19 in New Orleans and Care with an Evidence-based Protocol.
|
NA
|
NA
|
|
Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients.
|
NA
|
NA
|
|
Advances in point-of-care nucleic acid extraction technologies for rapid diagnosis of human and plant diseases.
|
NA
|
NA
|
|
Candesartan could ameliorate the COVID-19 cytokine storm.
|
NA
|
NA
|
|
Potential inhibitors for the novel coronavirus (SARS-CoV-2).
|
NA
|
NA
|
|
Are Adequate Vitamin D Levels Helpful in Fighting COVID-19? A Look at the Evidence.
|
NA
|
NA
|
|
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
|
NA
|
NA
|
|
Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
|
NA
|
NA
|
|
Triaging Interventional Pain Procedures During COVID-19 or Related Elective Surgery Restrictions: Evidence-Informed Guidance from the American Society of Interventional Pain Physicians (ASIPP).
|
NA
|
NA
|
|
Considerations for Epidural Blood Patch and Other Postdural Puncture Headache Treatments in Patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 Pandemic: Implications on Interventional Pain Practice-a Narrative Review.
|
NA
|
NA
|
|
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
|
NA
|
NA
|
|
The Technological Impact of COVID-19 on the Future of Education and Health Care Delivery.
|
NA
|
NA
|
|
Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
|
NA
|
NA
|
|
Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
|
NA
|
NA
|
|
The Other Side of the COVID-19 Curve: A Model for the Safe Reintegration of Elective Interventional Pain Procedures.
|
NA
|
NA
|
|
Telemedicine During COVID-19 and Beyond: A Practical Guide and Best Practices Multidisciplinary Approach for the Orthopedic and Neurologic Pain Physical Examination.
|
NA
|
NA
|
|
The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership.
|
NA
|
NA
|
|
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.
|
NA
|
NA
|
|
Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
|
NA
|
NA
|
|
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
|
NA
|
NA
|
|
Impact of visitor restriction rules on the postoperative experience of COVID-19 negative patients undergoing surgery.
|
NA
|
NA
|
|
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
|
NA
|
NA
|
|
Expectations of therapeutic radiography students in Wales about transitioning to practice during the Covid-19 pandemic as registrants on the HCPC temporary register.
|
NA
|
NA
|
|
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
|
NA
|
NA
|
|
Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma.
|
NA
|
NA
|
|
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.
|
NA
|
NA
|
|
PTSD and bipolar II disorder in Fukushima disaster relief workers after the 2011 nuclear accident.
|
NA
|
NA
|
|
COVID-19 and the heart: what we have learnt so far.
|
NA
|
NA
|
|
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
|
NA
|
NA
|
|
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
|
NA
|
NA
|
|
Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
|
NA
|
NA
|
|
Clinical Experience in the Administration of Intravitreal Injection Therapy at a Tertiary University Hospital in Jordan During the COVID-19 Lockdown.
|
NA
|
NA
|
|
Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis.
|
NA
|
NA
|
|
Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?
|
NA
|
NA
|
|
Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness.
|
NA
|
NA
|
|
Treatment of Coronavirus Disease 2019: Shooting in the Dark.
|
NA
|
NA
|
|
The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine.
|
NA
|
NA
|
|
Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?
|
NA
|
NA
|
|
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.
|
NA
|
NA
|
|
The public health response to the COVID-19 outbreak in mainland China: a narrative review.
|
NA
|
NA
|
|
COVID-19 in cancer patients: risk, clinical features, and management.
|
NA
|
NA
|
|
Predictive Factors Associated With Fear Faced by Healthcare Workers During COVID-19 Pandemic: A Questionnaire-Based Study.
|
NA
|
NA
|
|
Policy Implications for the COVID-19 Pandemic in Light of Most Patients (≥72%) Spending at Most One Night at the Hospital After Elective, Major Therapeutic Procedures.
|
NA
|
NA
|
|
Searching for Digital Technologies in Containment and Mitigation Strategies: Experience from South Korea COVID-19.
|
NA
|
NA
|
|
Management of Critically Ill Patients with COVID-19: What We Learned and What We Do.
|
NA
|
NA
|
|
Single-Use (Disposable) Flexible Bronchoscopes: The Future of Bronchoscopy?
|
NA
|
NA
|
|
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.
|
NA
|
NA
|
|
Changing trends in surgical hair restoration: Use of Google Trends and the ISHRS practice census survey.
|
NA
|
NA
|
|
Awareness and perceptions related to COVID-19 among cancer patients: A survey in oncology department.
|
NA
|
NA
|
|
Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand.
|
NA
|
NA
|
|
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
|
NA
|
NA
|
|
Irrigation System and COVID-19 Recurrence: A Potential Risk Factor in the Transmission of SARS-CoV-2.
|
NA
|
NA
|
|
Invisible No More: The Impact of COVID-19 on Essential Food Production Workers.
|
NA
|
NA
|
|
Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2).
|
NA
|
NA
|
|
Changes in alcohol consumption associated with social distancing and self-isolation policies triggered by COVID-19 in South Australia: a wastewater analysis study.
|
NA
|
NA
|
|
Hospital-in-the-Home experience of first 23 COVID-19 patients at a regional NSW hospital.
|
NA
|
NA
|
|
The patient-doctor relationship: new insights in light of the current Ministerial recommendations regarding Phase 2 of the COVID-19 pandemic.
|
NA
|
NA
|
|
Public Risk-Taking and Rewards During the COVID-19 Pandemic - A Case Study of Remdesivir in the Context of Global Health Equity.
|
NA
|
NA
|
|
Different presentation of pulmonary parenchymal disruption in COVID-19 pneumonia. Case series of Sub-Intensive Care Unit in Naples, Italy.
|
NA
|
NA
|
|
Clinical features predicting mortality risk in older patients with COVID-19.
|
NA
|
NA
|
|
Acute oxygen therapy: a cross-sectional study of prescribing practices at an English hospital immediately before COVID-19 pandemic.
|
NA
|
NA
|
|
Social Isolation: Managing Psychological Distress in Hospitalized Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Imaging of children with COVID-19: experience from a tertiary children’s hospital in the United States.
|
NA
|
NA
|
|
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
|
NA
|
NA
|
|
The impacts of the COVID-19 outbreak on emergency department visits of surgical patients.
|
NA
|
NA
|
|
Artificial Intelligence for COVID-19: A Rapid Review.
|
NA
|
NA
|
|
The psychological impact of fertility treatment suspensions during the COVID-19 pandemic.
|
NA
|
NA
|
|
Ischemic stroke in COVID-19: An urgent need for early identification and management.
|
NA
|
NA
|
|
SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model.
|
NA
|
NA
|
|
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician’s point of view.
|
NA
|
NA
|
|
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
|
NA
|
NA
|
|
Chloroquine against malaria, cancers and viral diseases.
|
NA
|
NA
|
|
COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
|
NA
|
NA
|
|
Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
|
NA
|
NA
|
|
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19.
|
NA
|
NA
|
|
Effectiveness of prone positioning in non-intubated ICU patients with moderate to severe ARDS by COVID-19.
|
NA
|
NA
|
|
The Preventive and Control Recommendations on Patient With Cleft Lip and Palate During COVID-19 Pandemic in Shanghai.
|
NA
|
NA
|
|
Nurses’ Role in Providing Comprehensive Communication, Prognostication, and Palliative Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Thrombotic Complications of COVID-19 Infection: A Review.
|
NA
|
NA
|
|
Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in Treating COVID-19 Patients.
|
NA
|
NA
|
|
A Direct Injection Technique to Improve Biosafety to Analyze Levetiracetam Concentrations in Human Serum and its Application in Therapeutic Drug Monitoring.
|
NA
|
NA
|
|
Usefulness of PCR Screening in the Initial Triage of Trauma Patients During COVID-19 Pandemic.
|
NA
|
NA
|
|
Fractures in Patients With COVID-19 Infection: Early Prognosis and Management. A Case Series of 20 Patients in a Single Institution in Lombardy, Northern Italy.
|
NA
|
NA
|
|
Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia.
|
NA
|
NA
|
|
A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients’ Lives and Allografts.
|
NA
|
NA
|
|
Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
|
NA
|
NA
|
|
Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review.
|
NA
|
NA
|
|
Relationship between Influenza Vaccination Coverage Rate and COVID-19 Outbreak: An Italian Ecological Study.
|
NA
|
NA
|
|
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.
|
NA
|
NA
|
|
Sex differences in severity and mortality from COVID-19: are males more vulnerable?
|
NA
|
NA
|
|
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.
|
NA
|
NA
|
|
Child welfare in the midst of the coronavirus pandemic-Emerging evidence from Germany.
|
NA
|
NA
|
|
First successful treatment of a COVID-19 pregnant woman with severe ARDS by combining early mechanical ventilation and ECMO.
|
NA
|
NA
|
|
Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis.
|
NA
|
NA
|
|
Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19.
|
NA
|
NA
|
|
An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research.
|
NA
|
NA
|
|
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.
|
NA
|
NA
|
|
Early estimates of COVID-19 infections in small, medium and large population clusters.
|
NA
|
NA
|
|
SARS-CoV-2: recommendations for treatment in intensive care medicine.
|
NA
|
NA
|
|
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.
|
NA
|
NA
|
|
Management practices of emergency departments in general hospitals based on blockage of chain of infection during a COVID-19 epidemic.
|
NA
|
NA
|
|
The Pediatric Solid Organ Transplant Experience with COVID-19: An Initial Multi-Center, Multi-Organ Case Series.
|
NA
|
NA
|
|
Mobile ECMO in COVID-19 patient: case report.
|
NA
|
NA
|
|
Impact of Treatment with Renin-Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19.
|
NA
|
NA
|
|
Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19.
|
NA
|
NA
|
|
Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Preparedness of African palliative care services to respond to the COVID-19 pandemic: A rapid assessment.
|
NA
|
NA
|
|
Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
|
NA
|
NA
|
|
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
|
NA
|
NA
|
|
Dental care management during the COVID-19 outbreak.
|
NA
|
NA
|
|
Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
|
NA
|
NA
|
|
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
|
NA
|
NA
|
|
Antimalarials as antivirals for COVID-19: Believe it or not!
|
NA
|
NA
|
|
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
|
NA
|
NA
|
|
Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
|
NA
|
NA
|
|
Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach.
|
NA
|
NA
|
|
[Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection].
|
NA
|
NA
|
|
Use of Nasoil® via intranasal to control the harmful effects of Covid-19.
|
NA
|
NA
|
|
High anxiety and health-related quality of life in families with children with food allergy during coronavirus disease 2019.
|
NA
|
NA
|
|
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
|
NA
|
NA
|
|
Improved night shift schedule related to the mortality of critically ill patients with Corona Virus Disease 2019.
|
NA
|
NA
|
|
When Therapeutic IgA Antibodies Might Come of Age.
|
NA
|
NA
|
|
Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Defibrotide for the treatment of PIMS-TS in two pediatric patients.
|
NA
|
NA
|
|
Safety and efficacy of tracheotomy for critically ill patients with coronavirus disease 2019 (COVID-19) in Wuhan: a case series of 14 patients.
|
NA
|
NA
|
|
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
|
NA
|
NA
|
|
Towards new models of cancer care in Australia: lessons from Victoria’s response to the COVID-19 pandemic.
|
NA
|
NA
|
|
Ebola, COVID-19 and Africa: What we expected and what we got.
|
NA
|
NA
|
|
Case of “relapsing” COVID-19 in a kidney transplant recipient.
|
NA
|
NA
|
|
Hospital-acquired SARS-CoV-2 pneumonia in a person living with HIV.
|
NA
|
NA
|
|
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
|
NA
|
NA
|
|
The success of virtual clinics during COVID-19: A closed loop audit of the British orthopaedic association (BOAST) guidelines of outpatient orthopaedic fracture management.
|
NA
|
NA
|
|
Emergency Department Management of the Sexual Assault Victim in the COVID Era: A Model SAFET-I Guideline From San Diego County.
|
NA
|
NA
|
|
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex.
|
NA
|
NA
|
|
Management of acute coronary syndrome during the MERS-CoV outbreak - Single center experience.
|
NA
|
NA
|
|
Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
|
NA
|
NA
|
|
Perioral pressure ulcers in patients with COVID-19 requiring invasive mechanical ventilation.
|
NA
|
NA
|
|
[SARS-CoV-2-How can and must medical personnel protect themselves?]
|
NA
|
NA
|
|
Perioperative Nonsteroidal Anti-Inflammatory Agents in the COVID-19 Orthopedic Patient.
|
NA
|
NA
|
|
The LNT Issue Is About Politics and Economics, Not Safety.
|
NA
|
NA
|
|
[Epidemic trends of COVID-19 in ten countries compared with Turkey].
|
NA
|
NA
|
|
Ramatroban as a Novel Immunotherapy for COVID-19.
|
NA
|
NA
|
|
Nanoceria as a possible agent for the management of COVID-19.
|
NA
|
NA
|
|
Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review.
|
NA
|
NA
|
|
A misleading CMV myocarditis during the COVID-19 pandemic: case report.
|
NA
|
NA
|
|
[Anosmia without aguesia in COVID-19 patients: about 2 cases].
|
NA
|
NA
|
|
Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations.
|
NA
|
NA
|
|
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.
|
NA
|
NA
|
|
Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?
|
NA
|
NA
|
|
Management of hepatitis C in children and adolescents during COVID-19 pandemic.
|
NA
|
NA
|
|
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature.
|
NA
|
NA
|
|
COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center.
|
NA
|
NA
|
|
Cardiorespiratory physiological perturbations after acute smoke-induced lung injury and during extracorporeal membrane oxygenation support in sheep.
|
NA
|
NA
|
|
Similarity Studies of Corona Viruses through Chaos Game Representation.
|
NA
|
NA
|
|
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand.
|
NA
|
NA
|
|
Spontaneous Retroperitoneal Bleed Coincided With Massive Acute Deep Vein Thrombosis as Initial Presentation of COVID-19.
|
NA
|
NA
|
|
Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.
|
NA
|
NA
|
|
How the first cases of COVID-19 in 10 countries become infected? a case series.
|
NA
|
NA
|
|
Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients.
|
NA
|
NA
|
|
The patterns and management of fracture patients under COVID-19 outbreak in China.
|
NA
|
NA
|
|
A psychological investigation of coronavirus disease 2019 (COVID-19) patients in mobile cabin hospitals in Wuhan.
|
NA
|
NA
|
|
Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy.
|
NA
|
NA
|
|
Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression.
|
NA
|
NA
|
|
Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.
|
NA
|
NA
|
|
Diagnosis and treatment of an elderly patient with 2019-nCoV pneumonia and acute exacerbation of chronic obstructive pulmonary disease in Gansu Province: A case report.
|
NA
|
NA
|
|
COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients.
|
NA
|
NA
|
|
Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir.
|
NA
|
NA
|
|
Pandemics and Mental Health: an Unfortunate Alliance.
|
NA
|
NA
|
|
Trans-thoracic Echocardiography in Prone Positioning COVID-19 Patients: a Small Case Series.
|
NA
|
NA
|
|
Cytokine Hemoadsorption in the Management of a Pregnant Woman with COVID-19 Pneumonia: Case Report.
|
NA
|
NA
|
|
HIV testing amid COVID-19: community efforts to reach men who have sex with men in three Kenyan counties.
|
NA
|
NA
|
|
Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey.
|
NA
|
NA
|
|
Therapeutic Options in the Treatment of SARS-CoV-2 in the Pregnant Patient.
|
NA
|
NA
|
|
Stroke care in Italy at the time of the COVID-19 pandemic: a lesson to learn.
|
NA
|
NA
|
|
Covid-19 pandemic and the skin.
|
NA
|
NA
|
|
The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19.
|
NA
|
NA
|
|
Impact of the initial response to COVID-19 on long-term care for people with intellectual disability: an interrupted time series analysis of incident reports.
|
NA
|
NA
|
|
COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study.
|
NA
|
NA
|
|
The clinical findings and outcomes of symptomatic pregnant women diagnosed with or suspected of having coronavirus disease 2019 in a tertiary pandemic hospital in Istanbul, Turkey.
|
NA
|
NA
|
|
Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?
|
NA
|
NA
|
|
Nursing perspectives and strategies in patients with respiratory insufficiency.
|
NA
|
NA
|
|
Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.
|
NA
|
NA
|
|
Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
|
NA
|
NA
|
|
Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2.
|
NA
|
NA
|
|
Occupational Heat Stress and Practical Cooling Solutions for Healthcare and Industry Workers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide – a Single-Center, Randomized, Controlled Clinical Trial.
|
NA
|
NA
|
|
Creation and maintenance of a table for assessment of evolving evidence for COVID-19-related treatments.
|
NA
|
NA
|
|
Virtual Trauma-Focused Therapy for Military Members, Veterans, and Public Safety Personnel With Posttraumatic Stress Injury: Systematic Scoping Review.
|
NA
|
NA
|
|
Individual, interpersonal and economic challenges of underemployment in the wake of COVID-19.
|
NA
|
NA
|
|
[Most important vaccinations in patients with rheumatological diseases and why].
|
NA
|
NA
|
|
Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
|
NA
|
NA
|
|
Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
|
NA
|
NA
|
|
Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.
|
NA
|
NA
|
|
The impact of a dedicated coronavirus disease 2019 primary angioplasty protocol on time components related to ST-segment elevation myocardial infarction management in a 24/7 primary percutaneous coronary intervention-capable hospital.
|
NA
|
NA
|
|
Decontamination of SARS-CoV-2 and Other RNA Viruses from N95 Level Meltblown Polypropylene Fabric Using Heat under Different Humidities.
|
NA
|
NA
|
|
How do arbidol and its analogs inhibit the SARS-CoV-2?
|
NA
|
NA
|
|
Dental treatment recommendations and coronavirus disease 19 (COVID-19).
|
NA
|
NA
|
|
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19.
|
NA
|
NA
|
|
[Reducing the impact of COVID-19 on radiation oncology units of developing countries: A rapid review and expert consensus].
|
NA
|
NA
|
|
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
|
NA
|
NA
|
|
A review of medications used to control and improve the signs and symptoms of COVID-19 patients.
|
NA
|
NA
|
|
Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach.
|
NA
|
NA
|
|
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
|
NA
|
NA
|
|
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
|
NA
|
NA
|
|
Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India.
|
NA
|
NA
|
|
Electroencephalographic findings in COVID-19 patients: A systematic review.
|
NA
|
NA
|
|
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
|
NA
|
NA
|
|
COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
|
NA
|
NA
|
|
Probiotics for treating novel coronavirus with diarrhea: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
The effect of qigong for pulmonary function and quality of life in patients with covid-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Effectiveness and safety of acupuncture for anxiety disorder of coronavirus disease 2019: A protocol of systematic review and meta-analysis.
|
NA
|
NA
|
|
The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
The effects of exercise on COVID-19 therapeutics: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study.
|
NA
|
NA
|
|
Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease?
|
NA
|
NA
|
|
Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic.
|
NA
|
NA
|
|
Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview.
|
NA
|
NA
|
|
Understanding the Role of Corona Virus based on Current Scientific Evidence - a Review with Emerging Important in Pandemic.
|
NA
|
NA
|
|
Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
|
NA
|
NA
|
|
Epidemiological surveillance of common respiratory viruses in patients with suspected COVID-19 in Southwest China.
|
NA
|
NA
|
|
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review.
|
NA
|
NA
|
|
The effect of vascular risk factor burden on the severity of COVID-19 illness, a retrospective cohort study.
|
NA
|
NA
|
|
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report.
|
NA
|
NA
|
|
Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes.
|
NA
|
NA
|
|
National survey on the treatment of acute appendicitis in Spain during the initial period of the COVID-19 pandemic.
|
NA
|
NA
|
|
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
|
NA
|
NA
|
|
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era.
|
NA
|
NA
|
|
A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
Informatics X-Men™ Evolution to Combat COVID-19.
|
NA
|
NA
|
|
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC.
|
NA
|
NA
|
|
A case report on spontaneous hemoperitoneum in COVID-19 patient.
|
NA
|
NA
|
|
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease.
|
NA
|
NA
|
|
National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
|
NA
|
NA
|
|
Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers.
|
NA
|
NA
|
|
Anakinra for COVID-19: how to interpret elevations in serum liver enzymes.
|
NA
|
NA
|
|
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
|
NA
|
NA
|
|
Knowledge, Attitude and Practices of Health Care Workers about Corona Virus Disease 2019 in Saudi Arabia.
|
NA
|
NA
|
|
A Bottom-Up Approach Addressing Patient Care and Differential Diagnosis Amidst the Covid-19 Response.
|
NA
|
NA
|
|
Reducing the Risk and Impact of Brachial Plexus Injury Sustained From Prone Positioning-A Clinical Commentary.
|
NA
|
NA
|
|
Bacterial coinfections in COVID-19: an underestimated adversary.
|
NA
|
NA
|
|
The Interpersonal and Psychological Impacts of COVID-19 on Risk for Late-Life Suicide.
|
NA
|
NA
|
|
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
|
NA
|
NA
|
|
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
|
NA
|
NA
|
|
A PHARMACOLOGICAL FRAMEWORK FOR INTEGRATING TREATING THE HOST, REPURPOSING AND THE DAMAGE RESPONSE FRAMEWORK IN COVID-19.
|
NA
|
NA
|
|
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?
|
NA
|
NA
|
|
Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature.
|
NA
|
NA
|
|
Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics.
|
NA
|
NA
|
|
Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
|
NA
|
NA
|
|
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
|
NA
|
NA
|
|
Thrombo-inflammatory features predicting mortality in patients with COVID-19: The FAD-85 score.
|
NA
|
NA
|
|
Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience.
|
NA
|
NA
|
|
Multidisciplinary Safety Recommendations After Tracheostomy During COVID-19 Pandemic: State of the Art Review.
|
NA
|
NA
|
|
[Adaptive immunity against SARS-CoV-2].
|
NA
|
NA
|
|
Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”.
|
NA
|
NA
|
|
[Comparison of expert recommendations on clinical nutrition for hospitalized patients with COVID-19].
|
NA
|
NA
|
|
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study.
|
NA
|
NA
|
|
Palliative and Supportive Care Prescribing Considerations Around QT Prolongation Risk in the Context of COVID-19 (Coronavirus Disease 2019) Management.
|
NA
|
NA
|
|
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
|
NA
|
NA
|
|
The efficiency in the ordinary hospital bed management in Italy: An in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak.
|
NA
|
NA
|
|
Challenges and Experiences of Dental Medicine in Combating the COVID-19 Pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine early in pregnancy and risk of birth defects.
|
NA
|
NA
|
|
How the COVID-19 pandemic highlights the necessity of animal research.
|
NA
|
NA
|
|
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
|
NA
|
NA
|
|
Collateral damage: Hidden impact of the COVID-19 pandemic on the out-of-hospital cardiac arrest system-of-care.
|
NA
|
NA
|
|
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
|
NA
|
NA
|
|
COVID-19 hits a trial: Arguments against hastily deviating from the plan.
|
NA
|
NA
|
|
Data monitoring committees for clinical trials evaluating treatments of COVID-19.
|
NA
|
NA
|
|
Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?
|
NA
|
NA
|
|
Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study.
|
NA
|
NA
|
|
COVID-19 survey among people who use drugs in three cities in Norway.
|
NA
|
NA
|
|
What should we prepare for the next coronavirus disease 2019 outbreak? A survey on the opinions of infectious diseases specialists in South Korea.
|
NA
|
NA
|
|
Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain.
|
NA
|
NA
|
|
Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
|
NA
|
NA
|
|
A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach.
|
NA
|
NA
|
|
Psychological Impact of COVID-19 Emergency on Health Professionals: Burnout Incidence at the Most Critical Period in Spain.
|
NA
|
NA
|
|
Possible effect of epinephrine in minimizing COVID-19 severity: a review.
|
NA
|
NA
|
|
COVID-19: benefits and risks of passive immunotherapeutics.
|
NA
|
NA
|
|
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
|
NA
|
NA
|
|
The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of a group of deaths with COVID-19 pneumonia in Wuhan, China: a retrospective case series.
|
NA
|
NA
|
|
COVID-19 confirmed patients with negative antibodies results.
|
NA
|
NA
|
|
Inflammatory phenotyping predicts clinical outcome in COVID-19.
|
NA
|
NA
|
|
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
|
NA
|
NA
|
|
Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma.
|
NA
|
NA
|
|
Facility-Level Case Report of Nursing Care Processes for Patients With Suspected 2019 Novel Coronavirus Disease in Shanghai, China.
|
NA
|
NA
|
|
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
|
NA
|
NA
|
|
Novel Use of Telepalliative Care in a New York City Emergency Department During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A treatment that eliminates SARS-CoV-2 replication in human airway epithelial cells and is safe for inhalation as an aerosol in healthy human subjects.
|
NA
|
NA
|
|
SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
|
NA
|
NA
|
|
Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
|
NA
|
NA
|
|
Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease.
|
NA
|
NA
|
|
Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19.
|
NA
|
NA
|
|
A Study on the Predictors of Disease Severity of COVID-19.
|
NA
|
NA
|
|
A Severe COVID-19 Case Complicated by Right Atrium Thrombus.
|
NA
|
NA
|
|
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
|
NA
|
NA
|
|
Consensus transcriptional regulatory networks of coronavirus-infected human cells.
|
NA
|
NA
|
|
Additive manufacturing in fighting against novel coronavirus COVID-19.
|
NA
|
NA
|
|
[Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak].
|
NA
|
NA
|
|
Systemic Involvement of Novel Coronavirus (COVID-19): A Review of Literature.
|
NA
|
NA
|
|
Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times.
|
NA
|
NA
|
|
Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis.
|
NA
|
NA
|
|
Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro.
|
NA
|
NA
|
|
Antiviral nanoagents: More attention and effort needed?
|
NA
|
NA
|
|
Hydrogen: A Novel Option in Human Disease Treatment.
|
NA
|
NA
|
|
Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye.
|
NA
|
NA
|
|
Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change.
|
NA
|
NA
|
|
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab.
|
NA
|
NA
|
|
Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants.
|
NA
|
NA
|
|
In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2.
|
NA
|
NA
|
|
QT interval measurement with portable device during COVID-19 outbreak.
|
NA
|
NA
|
|
CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.
|
NA
|
NA
|
|
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
|
NA
|
NA
|
|
Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.
|
NA
|
NA
|
|
Coronavirus interactions with the cellular autophagy machinery.
|
NA
|
NA
|
|
Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action.
|
NA
|
NA
|
|
Design and in-silico screening of Peptide Nucleic Acid (PNA) inspired novel pronucleotide scaffolds targeting COVID-19.
|
NA
|
NA
|
|
Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies.
|
NA
|
NA
|
|
Regional extracorporeal membrane oxygenation retrieval service during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic: an interdisciplinary team approach to maintain service provision despite increased demand.
|
NA
|
NA
|
|
Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.
|
NA
|
NA
|
|
A contemporary look at COVID-19 medications: available and potentially effective drugs.
|
NA
|
NA
|
|
Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China.
|
NA
|
NA
|
|
SARS-CoV-2 RNA contamination on surfaces of a COVID-19 ward in a hospital of Northern Italy: what risk of transmission?
|
NA
|
NA
|
|
Advances in SARS-CoV-2: a systematic review.
|
NA
|
NA
|
|
Artificial intelligence technology for diagnosing COVID-19 cases: a review of substantial issues.
|
NA
|
NA
|
|
[; PROBLEMS OF MONITORING THE QUALITY OF HOSPITALS IN GEORGIA IN THE CONTEXT OF THE COVID 19 PANDEMIC (REVIEW)].
|
NA
|
NA
|
|
Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 and acute myocarditis: current literature review and diagnostic challenges.
|
NA
|
NA
|
|
The effects of favipiravir on hematological parameters of covıd-19 patients.
|
NA
|
NA
|
|
Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19.
|
NA
|
NA
|
|
The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection.
|
NA
|
NA
|
|
Clinical and socioeconomic characteristics of older adults with COVID-19: A protocol for a rapid systematic review.
|
NA
|
NA
|
|
Repercussions of the COVID-19 Pandemic on the Care Practices of a Tertiary Hospital.
|
NA
|
NA
|
|
Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease.
|
NA
|
NA
|
|
Evidence, rationality, and ignorance: Agnotological issues in COVID-19 science.
|
NA
|
NA
|
|
Early public research funding response to COVID-19 pandemic in Brazil.
|
NA
|
NA
|
|
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
|
NA
|
NA
|
|
[Specific treatment of acute lung failure].
|
NA
|
NA
|
|
Fahr’s syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia-a case report.
|
NA
|
NA
|
|
Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort.
|
NA
|
NA
|
|
Two Retrospective Analyses Show No Associated Adverse Outcomes With Delayed RP.
|
NA
|
NA
|
|
N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
|
NA
|
NA
|
|
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
|
NA
|
NA
|
|
SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
|
NA
|
NA
|
|
Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
|
NA
|
NA
|
|
The COVID-19 pandemic should not jeopardize dengue control.
|
NA
|
NA
|
|
AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
|
NA
|
NA
|
|
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
|
NA
|
NA
|
|
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
|
NA
|
NA
|
|
Tracking and Analyzing Public Emotion Evolutions During COVID-19: A Case Study from the Event-Driven Perspective on Microblogs.
|
NA
|
NA
|
|
Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19.
|
NA
|
NA
|
|
Immune Checkpoints in Viral Infections.
|
NA
|
NA
|
|
Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
|
NA
|
NA
|
|
Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center.
|
NA
|
NA
|
|
Early impact of COVID-19 outbreak on eye care: Insights from EUROCOVCAT group.
|
NA
|
NA
|
|
Practical strategies to reduce nosocomial transmission to healthcare professionals providing respiratory care to patients with COVID-19.
|
NA
|
NA
|
|
The impact of eHealth group interventions on the mental, behavioral, and physical health of adults: a systematic review protocol.
|
NA
|
NA
|
|
Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV2 Infection (COVID-19).
|
NA
|
NA
|
|
Mental health management of elite athletes during COVID-19: a narrative review and recommendations.
|
NA
|
NA
|
|
Psychological and behavioural responses to COVID-19: a China-Britain comparison.
|
NA
|
NA
|
|
Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
|
NA
|
NA
|
|
[Impact of the COVID-19 pandemic on the management of heart failure outpatient clinics. Lessons during the lockdown restrictions].
|
NA
|
NA
|
|
Correlations of CT scan with high-sensitivity C-reactive protein and D-dimer in patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
|
NA
|
NA
|
|
The use of remdesivir outside of clinical trials during the COVID-19 pandemic.
|
NA
|
NA
|
|
The behavioural challenge of the COVID-19 pandemic: indirect measurements and personalized attitude changing treatments (IMPACT).
|
NA
|
NA
|
|
A Case of Isolated Dysarthria in a COVID-19 Infected Stroke Patient: A Nondisabling Neurological Symptom With Grave Prognosis.
|
NA
|
NA
|
|
Evaluating Trends in COVID-19 Research Activity in Early 2020: The Creation and Utilization of a Novel Open-Access Database.
|
NA
|
NA
|
|
Making Data Reports Useful During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Research advances in myocardial injury caused by COVID-19.
|
NA
|
NA
|
|
Pulmonary vascular endothelial injury and acute pulmonary hypertension caused by COVID-19: the fundamental cause of refractory hypoxemia?
|
NA
|
NA
|
|
COVID-19 pandemic and stent thrombosis in a post percutaneous coronary intervention patient-a case report highlighting the selection of P2Y12 inhibitor.
|
NA
|
NA
|
|
Are SAARC countries prepared to combat COVID-19 to save young, working-age population?
|
NA
|
NA
|
|
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.
|
NA
|
NA
|
|
Azithromycin in viral infections.
|
NA
|
NA
|
|
How to Restart the Interventional Activity in the COVID-19 Era: The Experience of a Private Pain Unit in Spain.
|
NA
|
NA
|
|
The Role of the School Nurse in Detecting and Preventing Child Abuse During This Age of Online Education.
|
NA
|
NA
|
|
Investigating the Impact of COVID-19 Lockdown on the Psychological Health of University Students and Their Attitudes Toward Mobile Mental Health Solutions: Two-Part Questionnaire Study.
|
NA
|
NA
|
|
A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
|
NA
|
NA
|
|
Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
|
NA
|
NA
|
|
The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS-CoV-2 targets.
|
NA
|
NA
|
|
Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy.
|
NA
|
NA
|
|
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak. A review of the literature.
|
NA
|
NA
|
|
Implementation and Patient Satisfaction of Telemedicine in Spine Physical Medicine and Rehabilitation Patients during the COVID-19 Shutdown.
|
NA
|
NA
|
|
Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Genomic and proteomic mutation landscapes of SARS-CoV-2.
|
NA
|
NA
|
|
Applications of Office-Based 445 nm Blue Laser Transnasal Flexible Laser Surgery: A Case Series and Review of Practice.
|
NA
|
NA
|
|
Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID.
|
NA
|
NA
|
|
Protective Behavior against COVID-19 among the Public in Kuwait: An Examination of the Protection Motivation Theory, Trust in Government, and Sociodemographic Factors.
|
NA
|
NA
|
|
Streamlining Care in Crisis: Rapid Creation and Implementation of a Digital Support Tool for COVID-19.
|
NA
|
NA
|
|
A 29-Year-Old Male Construction Worker from India Who Presented with Left- Sided Abdominal Pain Due to Isolated Superior Mesenteric Vein Thrombosis Associated with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
The impact of social distancing and public behavior changes on COVID-19 transmission dynamics in the Republic of Korea.
|
NA
|
NA
|
|
A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient’s severity.
|
NA
|
NA
|
|
Characteristics, laboratories, and prognosis of severe COVID-19 in the Tokyo metropolitan area: A retrospective case series.
|
NA
|
NA
|
|
Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures.
|
NA
|
NA
|
|
Impact of COVID-19 on cancer patients: A review.
|
NA
|
NA
|
|
Identifying #addiction concerns on twitter during the COVID-19 pandemic: A text mining analysis.
|
NA
|
NA
|
|
Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis.
|
NA
|
NA
|
|
Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
|
NA
|
NA
|
|
Elevated plasma sTIM-3 levels in patients with severe COVID-19.
|
NA
|
NA
|
|
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.
|
NA
|
NA
|
|
Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective.
|
NA
|
NA
|
|
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
|
NA
|
NA
|
|
Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes.
|
NA
|
NA
|
|
Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19.
|
NA
|
NA
|
|
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
|
NA
|
NA
|
|
Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases.
|
NA
|
NA
|
|
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak.
|
NA
|
NA
|
|
Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.
|
NA
|
NA
|
|
MicroCLOTS pathophysiology in COVID 19.
|
NA
|
NA
|
|
Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Arterial hypertension and COVID-19 infections: A brief commentary.
|
NA
|
NA
|
|
Distant diabetes care: what can the patient, nurse and patient do.
|
NA
|
NA
|
|
Psychotherapy at a Distance.
|
NA
|
NA
|
|
Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
|
NA
|
NA
|
|
Mesenchymal stem cell research progress for the treatment of COVID-19.
|
NA
|
NA
|
|
Clinical strategies for optimizing infusion center care through a pandemic.
|
NA
|
NA
|
|
Improving mental health in U.S. Veterans using mHealth tools: A pilot study.
|
NA
|
NA
|
|
High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients.
|
NA
|
NA
|
|
Targeting host cell proteases to prevent SARS-CoV-2 invasion.
|
NA
|
NA
|
|
Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study.
|
NA
|
NA
|
|
Mechanical Thrombectomy of COVID-19 positive acute ischemic stroke patient: a case report and call for preparedness.
|
NA
|
NA
|
|
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis.
|
NA
|
NA
|
|
Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease.
|
NA
|
NA
|
|
Arrhythmias and COVID-19: A Review.
|
NA
|
NA
|
|
Point of view: Should COVID-19 patients be supplemented with vitamin D?
|
NA
|
NA
|
|
[Gastrointestinal symptoms revealing COVID-19 in Malian breast cancer patient undergoing chemotherapy].
|
NA
|
NA
|
|
Mucormycosis with orbital compartment syndrome in a patient with COVID-19.
|
NA
|
NA
|
|
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study.
|
NA
|
NA
|
|
Incidence, features, outcome and impact on health system of de-novo abdominal surgical diseases in patients admitted with COVID-19.
|
NA
|
NA
|
|
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
|
NA
|
NA
|
|
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
|
NA
|
NA
|
|
Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic.
|
NA
|
NA
|
|
Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report.
|
NA
|
NA
|
|
Reshaping Community Mental Health Services during the COVID-19 Epidemic - Report from the 59G21 Service in Lille, France.
|
NA
|
NA
|
|
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
|
NA
|
NA
|
|
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.
|
NA
|
NA
|
|
Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review.
|
NA
|
NA
|
|
Harnessing Memory NK Cell to Protect Against COVID-19.
|
NA
|
NA
|
|
Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
|
NA
|
NA
|
|
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report.
|
NA
|
NA
|
|
Psychological and Behavioral Responses to the COVID-19 Pandemic in Greece.
|
NA
|
NA
|
|
Videoconferencing Psychotherapy for Panic Disorder and Agoraphobia: Outcome and Treatment Processes From a Non-randomized Non-inferiority Trial.
|
NA
|
NA
|
|
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
|
NA
|
NA
|
|
Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
|
NA
|
NA
|
|
PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
|
NA
|
NA
|
|
The prognosis and prevention measures for mental health in COVID-19 patients: through the experience of SARS.
|
NA
|
NA
|
|
Untreated Stroke as Collateral Damage of COVID-19: “Time Is Brain” Versus “Stay at Home”.
|
NA
|
NA
|
|
A descriptive study of random forest algorithm for predicting COVID-19 patients outcome.
|
NA
|
NA
|
|
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.
|
NA
|
NA
|
|
Attitudinal, regional and sex related vulnerabilities to COVID-19: Considerations for early flattening of curve in Nigeria.
|
NA
|
NA
|
|
Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020.
|
NA
|
NA
|
|
New-Onset Nephrotic Syndrome in a Child Associated With COVID-19 Infection.
|
NA
|
NA
|
|
Overview of the First 6 Months of Clinical Trials for COVID-19 Pharmacotherapy: The Most Studied Drugs.
|
NA
|
NA
|
|
Late Reactivation of SARS-CoV-2: A Case Report.
|
NA
|
NA
|
|
The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care.
|
NA
|
NA
|
|
Minimally Invasive Surgery and Surgical Smoke, Decoding Fear and Ensuring Safety: Adaptations and Safety Modifications During COVID Pandemic.
|
NA
|
NA
|
|
Rationalizing Treatment for Gynecological Cancers During the COVID-19 Pandemic: An Indian Experience.
|
NA
|
NA
|
|
The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review.
|
NA
|
NA
|
|
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic: A Single Center Experience from a New York City Public Hospital.
|
NA
|
NA
|
|
Evaluation of Regeneration Processes for Filtering Facepiece Respirators in Terms of the Bacteria Inactivation Efficiency and Influences on Filtration Performance.
|
NA
|
NA
|
|
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
|
NA
|
NA
|
|
COVID 19: Prioritise Autonomy, Beneficence and Conversations Before Score-based Triage.
|
NA
|
NA
|
|
Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis.
|
NA
|
NA
|
|
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.
|
NA
|
NA
|
|
Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
|
NA
|
NA
|
|
Management of Juvenile Idiopathic Arthritis-associated Uveitis during the COVID-19 Pandemic in a Pediatric Referral Center in Lombardy.
|
NA
|
NA
|
|
Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome.
|
NA
|
NA
|
|
A Report of 85 Cases of COVID-19 and Abdominal Transplantation From a Single Center: What Are the Associated Factors With Death Among Organ Transplantation Patients.
|
NA
|
NA
|
|
Public discourse and sentiment during the COVID 19 pandemic: Using Latent Dirichlet Allocation for topic modeling on Twitter.
|
NA
|
NA
|
|
How COVID-19 Changed Advance Care Planning: Insights From the West Virginia Center for End-of-Life Care.
|
NA
|
NA
|
|
Seeing With My Ears.
|
NA
|
NA
|
|
Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: results from a Department of Mental Health and Addiction of northern Italy.
|
NA
|
NA
|
|
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
|
NA
|
NA
|
|
The Application of Porphyrins and Their Analogues for Inactivation of Viruses.
|
NA
|
NA
|
|
Potential of Cell-Free Supernatant from Lactobacillus plantarum NIBR97, Including Novel Bacteriocins, as a Natural Alternative to Chemical Disinfectants.
|
NA
|
NA
|
|
Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report.
|
NA
|
NA
|
|
Pre-graduation medical training including virtual reality during COVID-19 pandemic: a report on students’ perception.
|
NA
|
NA
|
|
Challenges to peer support in low- and middle-income countries during COVID-19.
|
NA
|
NA
|
|
Mental health impacts among health workers during COVID-19 in a low resource setting: a cross-sectional survey from Nepal.
|
NA
|
NA
|
|
Implications of human activities for (re)emerging infectious diseases, including COVID-19.
|
NA
|
NA
|
|
Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage.
|
NA
|
NA
|
|
[Fighting against COVID-19: clinical activities of spanish rehabilitation physicians: A cross-sectional study].
|
NA
|
NA
|
|
Redeployment of Surgical Trainees to Intensive Care During the COVID-19 Pandemic: Evaluation of the Impact on Training and Wellbeing.
|
NA
|
NA
|
|
Presence of hyaluronan in lung alveoli in severe Covid-19 - an opening for new treatment options?
|
NA
|
NA
|
|
SARS-CoV-2 challenge studies: ethics and risk minimisation.
|
NA
|
NA
|
|
Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
|
NA
|
NA
|
|
Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
|
NA
|
NA
|
|
COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment.
|
NA
|
NA
|
|
Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region.
|
NA
|
NA
|
|
Protecting sex workers in Thailand during the COVID-19 pandemic: opportunities to build back better.
|
NA
|
NA
|
|
Community action for people with HIV and sex workers during the COVID-19 pandemic in India.
|
NA
|
NA
|
|
SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
|
NA
|
NA
|
|
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
|
NA
|
NA
|
|
[The Impact of the COVID-19 Pandemic on the Health and Coping Behaviors of Patients With Treatment-Resistant Depression].
|
NA
|
NA
|
|
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations.
|
NA
|
NA
|
|
A five-step risk management process for geriatric dental practice during SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Multiple sclerosis and COVID-19: how many are at risk?
|
NA
|
NA
|
|
Preliminary Observations and Experiences of Physiotherapy Practice in Acute Care Setup of COVID 19: A Retrospective Observational Study.
|
NA
|
NA
|
|
Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.
|
NA
|
NA
|
|
Liver Transplant in a Recently COVID-19 Positive Child with Hepatoblastoma.
|
NA
|
NA
|
|
Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study.
|
NA
|
NA
|
|
History of the Plague: An Ancient Pandemic for the Age of COVID-19.
|
NA
|
NA
|
|
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
|
NA
|
NA
|
|
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
|
NA
|
NA
|
|
Deferring Elective Urologic Surgery During the COVID-19 Pandemic: The Patients’ Perspective.
|
NA
|
NA
|
|
Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran.
|
NA
|
NA
|
|
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
|
NA
|
NA
|
|
IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
|
NA
|
NA
|
|
Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
|
NA
|
NA
|
|
Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center.
|
NA
|
NA
|
|
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.
|
NA
|
NA
|
|
Pediatric Neurology Research in the Twenty-First Century: Status, Challenges, and Future Directions Post-COVID-19.
|
NA
|
NA
|
|
What is the best treatment option for head and neck cancers in COVID-19 pandemic? A rapid review.
|
NA
|
NA
|
|
COVID-2019 - A comprehensive pathology insight.
|
NA
|
NA
|
|
The assessment of the serum levels of TWEAK and prostaglandin F2? in COVID - 19.
|
NA
|
NA
|
|
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
|
NA
|
NA
|
|
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.
|
NA
|
NA
|
|
Child maltreatment online education for healthcare and social service providers: Implications for the COVID-19 context and beyond.
|
NA
|
NA
|
|
Social support and clinical improvement in COVID-19 positive patients in China.
|
NA
|
NA
|
|
A case series of pediatric croup with COVID-19.
|
NA
|
NA
|
|
Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease.
|
NA
|
NA
|
|
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
|
NA
|
NA
|
|
Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study.
|
NA
|
NA
|
|
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy.
|
NA
|
NA
|
|
Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics.
|
NA
|
NA
|
|
COVID-19 and sickle cell disease in Bahrain.
|
NA
|
NA
|
|
Asthma Disparities During the COVID-19 Pandemic: A Survey of Patients and Physicians.
|
NA
|
NA
|
|
A systematic review of COVID-19 and obstructive sleep apnoea.
|
NA
|
NA
|
|
COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection.
|
NA
|
NA
|
|
Mechanical complications of myocardial infarction during COVID-19 pandemic: An Italian single-centre experience.
|
NA
|
NA
|
|
Investigation on sleep and mental health of patients with Parkinson’s disease during the Coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Paranoia, hallucinations and compulsive buying during the early phase of the COVID-19 outbreak in the United Kingdom: A preliminary experimental study.
|
NA
|
NA
|
|
COVID-19 and OCD: Potential impact of exposure and response prevention therapy.
|
NA
|
NA
|
|
COVID-19 in multiple sclerosis patients and risk factors for severe infection.
|
NA
|
NA
|
|
Metal-organic frameworks for virus detection.
|
NA
|
NA
|
|
Delayed Diagnosis and Treatment of a Critically Ill Patient with Infective Endocarditis Due to a False-Positive Molecular Diagnostic Test for SARS-CoV-2.
|
NA
|
NA
|
|
Emergency Biosafety Management Practice in Laboratory of Shelter Hospital.
|
NA
|
NA
|
|
Telemedicine Implementation on a Bariatric Outpatient Clinic During COVID-19 Pandemic in Italy: an Unexpected Hill-Start.
|
NA
|
NA
|
|
Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural models.
|
NA
|
NA
|
|
A Case of Guillain-Barré Syndrome Associated With COVID-19.
|
NA
|
NA
|
|
High Sensitivity Troponin-T for Prediction of Adverse Events in Patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 Infection: Concise Review Based on the Immunological Perspective.
|
NA
|
NA
|
|
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
|
NA
|
NA
|
|
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals.
|
NA
|
NA
|
|
Bioactive Lipids in COVID-19-Further Evidence.
|
NA
|
NA
|
|
Recommendations for Maintaining the Cardiovascular Care System Under the Conditions of the COVID-19 Pandemic - 1st Edition, April 2020.
|
NA
|
NA
|
|
Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report.
|
NA
|
NA
|
|
Vaccines Against Tuberculosis: Problems and Prospects (Review).
|
NA
|
NA
|
|
Covid-19 pandemic and the unprecedented mobilisation of scholarly efforts prompted by a health crisis: Scientometric comparisons across SARS, MERS and 2019-nCoV literature.
|
NA
|
NA
|
|
anti-HCoV: A web resource to collect natural compounds against human coronaviruses.
|
NA
|
NA
|
|
Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19.
|
NA
|
NA
|
|
Taking Charge: A Proposed Psychological Intervention to Improve Pulmonary Rehabilitation Outcomes for People with COPD.
|
NA
|
NA
|
|
ACEIs and ARBs and Their Correlation with COVID-19: A Review.
|
NA
|
NA
|
|
Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.
|
NA
|
NA
|
|
Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.
|
NA
|
NA
|
|
Clinical Challenges in an Outbreak of COVID-19 in Wuhan, China: Concerns from Frontiers.
|
NA
|
NA
|
|
Rheumatic Disease-Related Symptoms During the Height of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Flavonoids: A complementary approach to conventional therapy of COVID-19?
|
NA
|
NA
|
|
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.
|
NA
|
NA
|
|
Reduction of COVID-19 Anxiety Levels Through Relaxation Techniques: A Study Carried Out in Northern Spain on a Sample of Young University Students.
|
NA
|
NA
|
|
Mitigating the Impact of the Novel Coronavirus Pandemic on Neuroscience and Music Research Protocols in Clinical Populations.
|
NA
|
NA
|
|
Health Anxiety and Mental Health Outcome During COVID-19 Lockdown in Italy: The Mediating and Moderating Roles of Psychological Flexibility.
|
NA
|
NA
|
|
Neurological Implications of Non-critically Ill Patients With Coronavirus Disease 2019 in a Fangcang Shelter Hospital in Wuhan, China.
|
NA
|
NA
|
|
MENA-SINO Consensus Statement on Implementing Care Pathways for Acute Neurovascular Emergencies During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Respiratory Microbial Co-infection With SARS-CoV-2.
|
NA
|
NA
|
|
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis.
|
NA
|
NA
|
|
Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”.
|
NA
|
NA
|
|
Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
|
NA
|
NA
|
|
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic.
|
NA
|
NA
|
|
COVID-19 in children: what did we learn from the first wave?
|
NA
|
NA
|
|
Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology.
|
NA
|
NA
|
|
Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.
|
NA
|
NA
|
|
Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19.
|
NA
|
NA
|
|
Effects of the COVID-19 Pandemic on Stroke Patients.
|
NA
|
NA
|
|
Clinical Presentation, Management and In-Hospital Outcome of Healthcare Personnel With COVID-19 Disease.
|
NA
|
NA
|
|
A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19.
|
NA
|
NA
|
|
Diabetic Ketoacidosis Precipitated by COVID-19 in Patients Without Respiratory Symptoms: Case Reports.
|
NA
|
NA
|
|
Reduction in Chronic Disease Risk and Burden in a 70-Individual Cohort Through Modification of Health Behaviors.
|
NA
|
NA
|
|
Micronutrients in COVID-19 Positive Pregnancies.
|
NA
|
NA
|
|
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
|
NA
|
NA
|
|
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.
|
NA
|
NA
|
|
Multiple cranial nerve palsies in malignant external otitis: A rare presentation of a rare condition.
|
NA
|
NA
|
|
Machine Learning and Image Analysis Applications in the Fight against COVID-19 Pandemic: Datasets, Research Directions, Challenges and Opportunities.
|
NA
|
NA
|
|
The Application of Corticosteroids in COVID-19: A Two-edged Sword.
|
NA
|
NA
|
|
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial.
|
NA
|
NA
|
|
Seizures and Epilepsy in Times of Corona Virus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab.
|
NA
|
NA
|
|
Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience.
|
NA
|
NA
|
|
Regulation of Biobanks in Italy.
|
NA
|
NA
|
|
Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics.
|
NA
|
NA
|
|
The Recommendations for the Management of Chinese Children With Epilepsy During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Research Collaboration and Outcome Measures of Interventional Clinical Trial Protocols for COVID-19 in China.
|
NA
|
NA
|
|
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
|
NA
|
NA
|
|
The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Identifying pathophysiological bases of disease in COVID-19.
|
NA
|
NA
|
|
Encephalopathy in COVID-19 patients; viral, parainfectious, or both?
|
NA
|
NA
|
|
Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report.
|
NA
|
NA
|
|
Nucleic acid-based therapy for coronavirus disease 2019.
|
NA
|
NA
|
|
Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19.
|
NA
|
NA
|
|
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges.
|
NA
|
NA
|
|
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19.
|
NA
|
NA
|
|
Artificial intelligence in COVID-19 drug repurposing.
|
NA
|
NA
|
|
Left ventricular thrombus with COVID-19 complication in a patient with dilated cardiomyopathy.
|
NA
|
NA
|
|
Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients.
|
NA
|
NA
|
|
In Silico Modeling of Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Pathophysiologic Insights and Potential Management Implications.
|
NA
|
NA
|
|
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019.
|
NA
|
NA
|
|
Disseminated Multifocal Intracerebral Bleeding Events in Three Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation As Rescue Therapy.
|
NA
|
NA
|
|
Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study.
|
NA
|
NA
|
|
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.
|
NA
|
NA
|
|
Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies.
|
NA
|
NA
|
|
Fear of COVID-19, psychological distress, work satisfaction and turnover intention among frontline nurses.
|
NA
|
NA
|
|
Comparative optimism about infection and recovery from COVID-19; Implications for adherence with lockdown advice.
|
NA
|
NA
|
|
SARS-CoV-2 and COVID-19: How much do we know?
|
NA
|
NA
|
|
Potential therapeutic effects of Resveratrol against SARS-CoV-2.
|
NA
|
NA
|
|
Ocular Complications in the Prone Position in the Critical Care Setting: The COVID-19 Pandemic.
|
NA
|
NA
|
|
Characteristics of US Adults Delaying Dental Care Due to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Extracorporeal multiorgan support including CO2-removal with the ADVanced Organ Support (ADVOS) system for COVID-19: A case report.
|
NA
|
NA
|
|
Epidemiological Investigation of OHCWs with COVID-19.
|
NA
|
NA
|
|
The Role of Primary Care in a Pandemic: Reflections During the COVID-19 Pandemic in Canada.
|
NA
|
NA
|
|
Maintaining access to maternal fetal medicine care by telemedicine during a global pandemic.
|
NA
|
NA
|
|
Structural and functional modelling of SARS-CoV-2 entry in animal models.
|
NA
|
NA
|
|
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
|
NA
|
NA
|
|
COVID-19: The Greek perspective.
|
NA
|
NA
|
|
Cardiac surgery during the COVID-19 sine wave: Preparation once, preparation twice. The view from Houston.
|
NA
|
NA
|
|
Applying Psychotherapeutic Principles to Bolster Resilience Among Health Care Workers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Current treatment of COVID-19 in renal patients: hope or hype?
|
NA
|
NA
|
|
A guide to physiotherapy in urogynecology for patient care during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Patient volume, diagnosis and injury mechanisms in a level 1 trauma center at the beginning of the COVID-19 pandemic in comparison to the mean of the 3 previous years : A retrospective, epidemiological evaluation of 4967 patients].
|
NA
|
NA
|
|
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Identifying the Risk of SARS-CoV-2 Infection and Environmental Monitoring in Airborne Infectious Isolation Rooms (AIIRs).
|
NA
|
NA
|
|
Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.
|
NA
|
NA
|
|
A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach.
|
NA
|
NA
|
|
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
|
NA
|
NA
|
|
Management of urticaria in COVID-19 patients: A systematic review.
|
NA
|
NA
|
|
Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
|
NA
|
NA
|
|
Infection Prevention and Control Strategies for the Peri-Operative Period of Emergency Surgery during the Coronavirus Disease 2019 (COVID-19) Outbreak in a Neurosurgery Department in Wuhan, China.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.
|
NA
|
NA
|
|
COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study.
|
NA
|
NA
|
|
COVID-19: Significance of antibodies.
|
NA
|
NA
|
|
Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
|
NA
|
NA
|
|
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study.
|
NA
|
NA
|
|
Frequency of Physical Therapist Intervention Is Associated With Mobility Status and Disposition at Hospital Discharge for Patients With COVID-19.
|
NA
|
NA
|
|
Neprilysin expression and functions in development, ageing and disease.
|
NA
|
NA
|
|
Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019.
|
NA
|
NA
|
|
Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
|
NA
|
NA
|
|
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
|
NA
|
NA
|
|
Slow Recovery from Critical Coronavirus Disease 2019 Pneumonia in an Immunosuppressed Renal Transplant Recipient with Early Acute Cardiorenal Syndrome.
|
NA
|
NA
|
|
The within-host viral kinetics of SARS-CoV-2.
|
NA
|
NA
|
|
Mitochondrial Glutathione: Recent Insights and Role in Disease.
|
NA
|
NA
|
|
Information on COVID-19 and Psychological Distress in a Sample of Non-Health Workers during the Pandemic Period.
|
NA
|
NA
|
|
Peptides: Prospects for Use in the Treatment of COVID-19.
|
NA
|
NA
|
|
The Impacts of Antivirals on the Coronavirus Genome Structure and Subsequent Pathogenicity, Virus Fitness and Antiviral Design.
|
NA
|
NA
|
|
How to Mitigate the Mental Health Care Consequences of the COVID-19 Financial Crisis.
|
NA
|
NA
|
|
HLA genetic polymorphisms and prognosis of patients with COVID-19.
|
NA
|
NA
|
|
Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: A report of two cases and literature review.
|
NA
|
NA
|
|
COVID 19 and liver: An A-Z literature review.
|
NA
|
NA
|
|
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2.
|
NA
|
NA
|
|
Captisol and GS-704277, but not GS-441524, are credible mediators of remdesivir’s nephrotoxicity.
|
NA
|
NA
|
|
Learning distinctive filters for COVID-19 detection from chest X-ray using shuffled residual CNN.
|
NA
|
NA
|
|
Late-onset pneumothorax in a COVID-19 patient treated with ventilation and ECMO: A case report and literature review.
|
NA
|
NA
|
|
Leveraging Computational Modeling to Understand Infectious Diseases.
|
NA
|
NA
|
|
Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19.
|
NA
|
NA
|
|
Accidental diagnosis of COVID-19 pneumonia after 18F FDG PET/CT: a case series.
|
NA
|
NA
|
|
Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design.
|
NA
|
NA
|
|
Polymorphic Ventricular Tachycardia with a Normal QTc Interval in a Patient with COVID-19 and Fever: Case Report.
|
NA
|
NA
|
|
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020.
|
NA
|
NA
|
|
Brain tumors and COVID-19: the patient and caregiver experience.
|
NA
|
NA
|
|
Acute Post-operative Thrombosis of an Aortic Valve Prosthesis and Embolic Myocardial Infarction in a COVID-positive patient - An Unrecognised Complication.
|
NA
|
NA
|
|
Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems.
|
NA
|
NA
|
|
Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity.
|
NA
|
NA
|
|
SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain.
|
NA
|
NA
|
|
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
|
NA
|
NA
|
|
Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.
|
NA
|
NA
|
|
Treatment of Immunocompromised COVID-19 patients with Convalescent Plasma.
|
NA
|
NA
|
|
COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward.
|
NA
|
NA
|
|
Convalescent Plasma Therapy for Coronavirus Disease 2019.
|
NA
|
NA
|
|
Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19.
|
NA
|
NA
|
|
Few Insights on the problem of COVID-19.
|
NA
|
NA
|
|
Analysis of general surgery outpatient clinic admissions and operations during COVID-19 pandemic in Turkey: Reactions of 12728 patients.
|
NA
|
NA
|
|
The increasing importance of the novel Coronavirus.
|
NA
|
NA
|
|
Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
|
NA
|
NA
|
|
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
|
NA
|
NA
|
|
Mathematical modelling on COVID-19 transmission impacts with preventive measures: a case study of Tanzania.
|
NA
|
NA
|
|
A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia.
|
NA
|
NA
|
|
[Investigation of anxiety and depression in patients from the emergency department during COVID-19 epidemic].
|
NA
|
NA
|
|
The Effect of Atrial Septal Defect in the Treatment of ARDS with Left Ventricular Dysfunction Simulating Severe COVID-19.
|
NA
|
NA
|
|
Introduction to Health Law.
|
NA
|
NA
|
|
Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure.
|
NA
|
NA
|
|
Epilepsy and lockdown: A survey of patients normally attending a Spanish center.
|
NA
|
NA
|
|
Assessment and Characterization of Post-COVID-19 manifestations.
|
NA
|
NA
|
|
The COVID-19 Pandemic: A Global Health Crisis.
|
NA
|
NA
|
|
The impact of COVID-19 on intestinal flora: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
External treatment of traditional Chinese medicine for COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.
|
NA
|
NA
|
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
|
NA
|
NA
|
|
Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation.
|
NA
|
NA
|
|
Operational recommendations for scarce resource allocation in a public health crisis.
|
NA
|
NA
|
|
Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19.
|
NA
|
NA
|
|
Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.
|
NA
|
NA
|
|
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.
|
NA
|
NA
|
|
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
|
NA
|
NA
|
|
Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Where are we with understanding of COVID-19?
|
NA
|
NA
|
|
COVID-19 therapy: What weapons do we bring into battle?
|
NA
|
NA
|
|
A Time Frame for Testing Negative for SARS-COV2 in People with Obesity.
|
NA
|
NA
|
|
SARS-CoV-2 and Pregnancy: A Review of the Facts.
|
NA
|
NA
|
|
SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.
|
NA
|
NA
|
|
[Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
|
NA
|
NA
|
|
[Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].
|
NA
|
NA
|
|
Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription.
|
NA
|
NA
|
|
Apitherapy for Age-Related Skeletal Muscle Dysfunction (Sarcopenia): A Review on the Effects of Royal Jelly, Propolis, and Bee Pollen.
|
NA
|
NA
|
|
CT Findings in Negative Pressure Pulmonary Edema.
|
NA
|
NA
|
|
Glutathione Supplementation as an Adjunctive Therapy in COVID-19.
|
NA
|
NA
|
|
Mental Health and the SARS-COV-2 Epidemic-Polish Research Study.
|
NA
|
NA
|
|
Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
|
NA
|
NA
|
|
Chemically Diverse and Biologically Active Secondary Metabolites from Marine Phylum chlorophyta.
|
NA
|
NA
|
|
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review.
|
NA
|
NA
|
|
Repurposing existing drugs for COVID-19: an endocrinology perspective.
|
NA
|
NA
|
|
COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy.
|
NA
|
NA
|
|
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.
|
NA
|
NA
|
|
Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial.
|
NA
|
NA
|
|
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.
|
NA
|
NA
|
|
Assessment of trends and clinical presentation in the emergency department of patients with renal colic during the COVID-19 pandemic era.
|
NA
|
NA
|
|
COVID-19 and Cancer in Cuba.
|
NA
|
NA
|
|
A Review of Venous Thromboembolism Phenomena in COVID-19 Patients.
|
NA
|
NA
|
|
The Emerging Role of Artificial Intelligence in the Fight Against COVID-19.
|
NA
|
NA
|
|
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia.
|
NA
|
NA
|
|
SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression.
|
NA
|
NA
|
|
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.
|
NA
|
NA
|
|
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
|
NA
|
NA
|
|
Clinical manifestations and outcomes of COVID-19 in the paediatric population: a systematic review.
|
NA
|
NA
|
|
A decision support system for scheduling the shifts of physicians during COVID-19 pandemic.
|
NA
|
NA
|
|
The Association Between Chronic Kidney Disease and New Onset Renal Replacement Therapy on the Outcome of COVID-19 Patients: A Meta-analysis.
|
NA
|
NA
|
|
Middle East Respiratory Syndrome (MERS) and Novel Coronavirus Disease-2019 (COVID-19): From causes to preventions in Saudi Arabia.
|
NA
|
NA
|
|
Methylprednisolone pulse therapy: An alternative management of severe COVID-19.
|
NA
|
NA
|
|
Practical recommendations for kidney transplantation in the COVID-19 pandemic.
|
NA
|
NA
|
|
Case Report: 100-year-old COVID-positive Hip Fracture Patient for Hemiarthroplasty Under Spinal Anesthesia.
|
NA
|
NA
|
|
COVID-19 and Guillain-Barre Syndrome: a systematic review of case reports.
|
NA
|
NA
|
|
Strategies to maximize available resources with minimum cost escalation for improving radiotherapy accessibility in the post COVID-19 era : An analysis for Asia.
|
NA
|
NA
|
|
Estimative of real number of infections by COVID-19 in Brazil and possible scenarios.
|
NA
|
NA
|
|
Lung Ultrasound and Respiratory Pathophysiology in Mechanically Ventilated COVID-19 Patients-an Observational Trial.
|
NA
|
NA
|
|
Effects of psychological stress on adverse pregnancy outcomes and non-pharmacologic approaches for reduction: an expert review.
|
NA
|
NA
|
|
Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review.
|
NA
|
NA
|
|
Adapting HIV services for pregnant and breastfeeding women, infants, children, adolescents and families in resource-constrained settings during the COVID-19 pandemic.
|
NA
|
NA
|
|
Continuous positive airway pressure and pronation outside the intensive care unit in COVID 19 ARDS.
|
NA
|
NA
|
|
VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC.
|
NA
|
NA
|
|
Practice observed in managing gynaecological problems in post-menopausal women during the COVID-19 pandemic.
|
NA
|
NA
|
|
Is Mesenteric Ischemia In COVID-19 Patients A Surprise?
|
NA
|
NA
|
|
Flexibility in Treatment: A Trial of Walking Psychotherapy.
|
NA
|
NA
|
|
Die COVID-19-Pandemie im akutstationären Setting aus Sicht von Führungspersonen und Hygienefachkräften in der Pflege.
|
NA
|
NA
|
|
COVID-19 pneumonia following double-sleeve lobectomy for lung cancer.
|
NA
|
NA
|
|
The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
|
NA
|
NA
|
|
A multimodal deep learning-based drug repurposing approach for treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
|
NA
|
NA
|
|
Immature platelets in patients hospitalized with Covid-19.
|
NA
|
NA
|
|
Impact of lockdown on patients with congestive heart failure during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
[Ethical questions regarding the medical care of adults with disabilities].
|
NA
|
NA
|
|
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars.
|
NA
|
NA
|
|
Teleoncology: The Youngest Pillar of Oncology.
|
NA
|
NA
|
|
External validation of a clinical risk score to predict hospital admission and in-hospital mortality in COVID-19 patients.
|
NA
|
NA
|
|
The impact of the COVID-19 epidemic on mental health of undergraduate students in New Jersey, cross-sectional study.
|
NA
|
NA
|
|
Analysis of COVID-19 clinical trials: A data-driven, ontology-based, and natural language processing approach.
|
NA
|
NA
|
|
Framing COVID-19: How we conceptualize and discuss the pandemic on Twitter.
|
NA
|
NA
|
|
Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
|
NA
|
NA
|
|
Advances and recent developments in asthma in 2020.
|
NA
|
NA
|
|
Telehealth for delivery of haemophilia comprehensive care during the COVID-19 pandemic.
|
NA
|
NA
|
|
An integrated biosensor system with mobile health and wastewater-based epidemiology (iBMW) for COVID-19 pandemic.
|
NA
|
NA
|
|
Frontiers of Robotic Gastroscopy: A Comprehensive Review of Robotic Gastroscopes and Technologies.
|
NA
|
NA
|
|
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations.
|
NA
|
NA
|
|
Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.
|
NA
|
NA
|
|
Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature.
|
NA
|
NA
|
|
Managing the Oral Health of Cancer Patients During the COVID-19 Pandemic: Perspective of a Dental Clinic in a Cancer Center.
|
NA
|
NA
|
|
Underlying conditions in adults with COVID-19.
|
NA
|
NA
|
|
The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
|
NA
|
NA
|
|
Typical CT findings of COVID-19 pneumonia in patients presenting with repetitive negative RT-PCR.
|
NA
|
NA
|
|
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.
|
NA
|
NA
|
|
A case of tocilizumab-induced leukoencephalopathy with a reversible clinical course.
|
NA
|
NA
|
|
Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.
|
NA
|
NA
|
|
A 47-Year-Old Hispanic Man Who Developed Cutaneous Vasculitic Lesions and Gangrene of the Toes Following Admission to Hospital with COVID-19 Pneumonia.
|
NA
|
NA
|
|
Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs.
|
NA
|
NA
|
|
Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.
|
NA
|
NA
|
|
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?
|
NA
|
NA
|
|
COVID-19 in Seattle-Early lessons learned.
|
NA
|
NA
|
|
Characteristics and Outcomes of COVID-19 Patients with Respiratory Failure Admitted to a “Pandemic Ready” Intensive Care Unit - Lessons from Singapore.
|
NA
|
NA
|
|
Overview of Early Cases of Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Centre in North India.
|
NA
|
NA
|
|
Increased dengue transmissions in Singapore attributable to SARS-CoV-2 social distancing measures.
|
NA
|
NA
|
|
Locally produced personal protective equipment can offer hospital staff protection against Covid-19 if combined with surgical masks and rigorous personal protective equipment cleaning routine.
|
NA
|
NA
|
|
Telehealth tinnitus therapy during the COVID-19 outbreak in the UK: uptake and related factors.
|
NA
|
NA
|
|
Ethical dilemmas, perceived risk, and motivation among nurses during the COVID-19 pandemic.
|
NA
|
NA
|
|
Early rehabilitation in a critically ill inpatient with coronavirus disease 2019: a case report.
|
NA
|
NA
|
|
Rehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Update as of August 31st, 2020.
|
NA
|
NA
|
|
Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.
|
NA
|
NA
|
|
Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: A data mining Approach.
|
NA
|
NA
|
|
Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China.
|
NA
|
NA
|
|
Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.
|
NA
|
NA
|
|
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Remote CBT for Psychosis During the COVID-19 Pandemic: Challenges and Opportunities.
|
NA
|
NA
|
|
A Cross-Sectional Analysis of Tobacco Use and Concurrent Alcohol and Substance Use Among Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center.
|
NA
|
NA
|
|
Cancer and Coronavirus Disease (COVID-19): Comorbidity, Mechanical Ventilation, and Death Risk.
|
NA
|
NA
|
|
Unicorn Poo and Blessed Waters: COVID-19 Quackery and FDA Warning Letters.
|
NA
|
NA
|
|
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
|
NA
|
NA
|
|
First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”.
|
NA
|
NA
|
|
Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications.
|
NA
|
NA
|
|
The intersection of the online vaping narrative with COVID-19: Topic modelling study.
|
NA
|
NA
|
|
Integration of Online Treatment Into the “New Normal” in Mental Health Care in Post-COVID-19 Times: Exploratory Qualitative Study.
|
NA
|
NA
|
|
Application of Big Data Technology for COVID-19 Prevention and Control in China: Lessons and Recommendations.
|
NA
|
NA
|
|
Online Health Information Seeking Using “#COVID-19 Patient Seeking Help” on Weibo in Wuhan, China: Descriptive Study.
|
NA
|
NA
|
|
Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
|
NA
|
NA
|
|
In-silico design of a potential inhibitor of SARS-CoV-2 S protein.
|
NA
|
NA
|
|
Obesity in patients with COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Asthma-associated risk for COVID-19 development.
|
NA
|
NA
|
|
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence.
|
NA
|
NA
|
|
Diabetes and technology: A pilot study on the management of patients with insulin pumps during the COVID-19 pandemic.
|
NA
|
NA
|
|
The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey.
|
NA
|
NA
|
|
Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies.
|
NA
|
NA
|
|
Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM).
|
NA
|
NA
|
|
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
|
NA
|
NA
|
|
Infections and diabetes: Risks and mitigation with reference to India.
|
NA
|
NA
|
|
Rehabilitation of Post-ICU Patient after Severe Covid-19 Pneumonia - A Case Report.
|
NA
|
NA
|
|
Treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
Telehealth and the Community SMI Population: Reflections on the Disrupter Experience of COVID-19.
|
NA
|
NA
|
|
A Case of Lemierre Syndrome in the Era of COVID-19: All That Glitters Is Not Gold.
|
NA
|
NA
|
|
Simulation-Based Up-Training in Response to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children’s Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up.
|
NA
|
NA
|
|
Caring for Critically Ill Children With Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections’ Collaborative of the European Society of Pediatric and Neonatal Intensive Care.
|
NA
|
NA
|
|
Adverse events associated with potential drugs for COVID-19: a case study from real-world data.
|
NA
|
NA
|
|
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
|
NA
|
NA
|
|
Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.
|
NA
|
NA
|
|
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
|
NA
|
NA
|
|
Effective Immune Functions of Micronutrients against SARS-CoV-2.
|
NA
|
NA
|
|
Safely Administering Potential QTc Prolonging Therapy Across a Large Healthcare System in the COVID-19 Era.
|
NA
|
NA
|
|
Susceptibility of swine cells and domestic pigs to SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry.
|
NA
|
NA
|
|
Optimizing Pandemic Preparedness and Response through Health Information Systems: Lessons Learned from Ebola to COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care.
|
NA
|
NA
|
|
The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology.
|
NA
|
NA
|
|
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
|
NA
|
NA
|
|
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis.
|
NA
|
NA
|
|
Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review.
|
NA
|
NA
|
|
Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19.
|
NA
|
NA
|
|
COVID-19 Epidemic in Argentina: Worsening of Behavioral Symptoms in Elderly Subjects With Dementia Living in the Community.
|
NA
|
NA
|
|
Clinical Characteristics of Asymptomatic Patients with SARS-CoV-2 in Zhejiang: An Imperceptible Source of Infection.
|
NA
|
NA
|
|
Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Late i.v. steroid treatment for severe COVID-19-induced acute respiratory distress syndrome: a case report.
|
NA
|
NA
|
|
COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy.
|
NA
|
NA
|
|
A Novel Case of Hypoparathyroidism Secondary to SARS-CoV-2 Infection.
|
NA
|
NA
|
|
The Role of Sex in the Risk of Mortality From COVID-19 Amongst Adult Patients: A Systematic Review.
|
NA
|
NA
|
|
Managing a Locally Advanced Cervix Cancer Patient With COVID-19: Lessons Learned.
|
NA
|
NA
|
|
Triage Decisions in the Context of COVID-19: Old Burden, New Challenge-The Structured Approach for Intensive Care Unit Triage (SAINT) Protocol.
|
NA
|
NA
|
|
Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study.
|
NA
|
NA
|
|
Palliative care for cancer patients with severe COVID-19: the challenge of uncertainty.
|
NA
|
NA
|
|
Managing COVID-19 from the epicenter: adaptations and suggestions based on experience.
|
NA
|
NA
|
|
Acetylcysteine for the Treatment of Suspected Remdesivir-Associated Acute Liver Failure in COVID-19: A Case Series.
|
NA
|
NA
|
|
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
|
NA
|
NA
|
|
Mitigating strategies and nursing response for cancer care management during the COVID-19 pandemic: an Italian experience.
|
NA
|
NA
|
|
Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension.
|
NA
|
NA
|
|
COVID-19, Lockdown, and Intimate Partner Violence: Some Data from an Italian Service and Suggestions for Future Approaches.
|
NA
|
NA
|
|
Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US.
|
NA
|
NA
|
|
Assessment of Cardiac Arrhythmic Risk in Children With Covid-19 Infection.
|
NA
|
NA
|
|
Impact of COVID-19 on patient-doctor interaction in a complex radiation therapy facility.
|
NA
|
NA
|
|
Utility of Deep Brain Stimulation Telemedicine for Patients With Movement Disorders During the COVID-19 Outbreak in China.
|
NA
|
NA
|
|
Decrease in Stroke Diagnoses During the COVID-19 Pandemic: Where Did All Our Stroke Patients Go?
|
NA
|
NA
|
|
Topics, Trends, and Sentiments of Tweets About the COVID-19 Pandemic: Temporal Infoveillance Study.
|
NA
|
NA
|
|
Performance of digital contact tracing tools for COVID-19 response in Singapore.
|
NA
|
NA
|
|
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
|
NA
|
NA
|
|
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model.
|
NA
|
NA
|
|
Training During a Pandemic: Successes, Challenges, and Practical Guidance From a Virtual Facilitated Learning Collaborative Training Program for Written Exposure Therapy.
|
NA
|
NA
|
|
COVID-19: the novel coronavirus disease and its manifestations and management in ophthalmology.
|
NA
|
NA
|
|
Clinical management of sepsis resulting from infections including COVID-19.
|
NA
|
NA
|
|
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
|
NA
|
NA
|
|
Zoonotic evolution and implications of microbiome in viral transmission and infection.
|
NA
|
NA
|
|
“Cytokine storm”, not only in COVID-19 patients. Mini-review.
|
NA
|
NA
|
|
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
|
NA
|
NA
|
|
COVID-19 in clinical practice: A narrative synthesis.
|
NA
|
NA
|
|
Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.
|
NA
|
NA
|
|
Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients.
|
NA
|
NA
|
|
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.
|
NA
|
NA
|
|
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
|
NA
|
NA
|
|
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
|
NA
|
NA
|
|
An in-silico evaluation of COVID-19 main protease with clinically approved drugs.
|
NA
|
NA
|
|
Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic.
|
NA
|
NA
|
|
The Adoption of Preventive Behaviors during the COVID-19 Pandemic in China and Israel.
|
NA
|
NA
|
|
A Systematic Review of Non-Contact Sensing for Developing a Platform to Contain COVID-19.
|
NA
|
NA
|
|
COVID19 Acute respiratory distress syndrome and extra-corporeal membrane oxygenation; A mere option or ultimate necessity.
|
NA
|
NA
|
|
Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study.
|
NA
|
NA
|
|
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
|
NA
|
NA
|
|
Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
|
NA
|
NA
|
|
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Effectiveness of COVID-19 diagnosis and management tools: A review.
|
NA
|
NA
|
|
Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Review on therapeutic targets for COVID-19: insights from cytokine storm.
|
NA
|
NA
|
|
Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing.
|
NA
|
NA
|
|
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
|
NA
|
NA
|
|
How Satisfied Are Patients and Surgeons with Telemedicine in Orthopaedic Care During the COVID-19 Pandemic? A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
Brief Report: Hypercoagulable viscoelastic blood clot characteristics in critically-ill COVID-19 patients and associations with thrombotic complications.
|
NA
|
NA
|
|
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
|
NA
|
NA
|
|
COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences.
|
NA
|
NA
|
|
Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics.
|
NA
|
NA
|
|
Prevalence of Voice Disorders in Healthcare Workers in the Universal Masking COVID-19 Era.
|
NA
|
NA
|
|
Pride and Prejudice during the COVID-19 Pandemic: The Misfortune of Inappropriate Clinical Trial Design.
|
NA
|
NA
|
|
Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.
|
NA
|
NA
|
|
Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19.
|
NA
|
NA
|
|
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well.
|
NA
|
NA
|
|
Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.
|
NA
|
NA
|
|
Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility.
|
NA
|
NA
|
|
Internet search volume for chest pain during the COVID-19 pandemic.
|
NA
|
NA
|
|
IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study.
|
NA
|
NA
|
|
Exploring the Impact of the Coronavirus Pandemic on Pediatric Palliative Care Clinician Personal and Professional Well-Being: a qualitative analysis of U.S. Survey Data.
|
NA
|
NA
|
|
Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
|
NA
|
NA
|
|
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
|
NA
|
NA
|
|
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
|
NA
|
NA
|
|
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
|
NA
|
NA
|
|
[Impact of the COVID-19 Outbreak on the management of patients with gynecological cancers].
|
NA
|
NA
|
|
How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms.
|
NA
|
NA
|
|
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
|
NA
|
NA
|
|
Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases.
|
NA
|
NA
|
|
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
|
NA
|
NA
|
|
Planning for the assistance of critically ill patients in a Pandemic Situation: The experience of Vall d’Hebron University Hospital.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.
|
NA
|
NA
|
|
Convalescent plasma therapy in patients with COVID-19.
|
NA
|
NA
|
|
Pneumonia after bacterial or viral infection preceded or followed by radiation exposure - a reanalysis of older radiobiological data and implications for low dose radiotherapy for COVID-19 pneumonia.
|
NA
|
NA
|
|
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.
|
NA
|
NA
|
|
Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles.
|
NA
|
NA
|
|
Providing essential clinical care for non-COVID-19 patients in a Seoul metropolitan acute care hospital amidst ongoing treatment of COVID-19 patients.
|
NA
|
NA
|
|
Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: A single center retrospective, observational study from the Abu Dhabi, United Arab Emirates.
|
NA
|
NA
|
|
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY).
|
NA
|
NA
|
|
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
|
NA
|
NA
|
|
Lung ultrasound as diagnostic tool for SARS-CoV-2 infection.
|
NA
|
NA
|
|
Continuous extracorporeal treatments in a dialysis patient with COVID-19.
|
NA
|
NA
|
|
Antiviral therapies: advances and perspectives.
|
NA
|
NA
|
|
Paediatric Oral Health during and after the COVID-19 Pandemic.
|
NA
|
NA
|
|
Vitamin D AND COVID-19: It is time to act.
|
NA
|
NA
|
|
Running of high patient volume radiation oncology department during COVID-19 crisis in India: our institutional strategy.
|
NA
|
NA
|
|
Searching for effective antiviral small molecules against influenza A virus: A patent review.
|
NA
|
NA
|
|
Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and Sex Differences: Mechanisms and Biomarkers.
|
NA
|
NA
|
|
Ischemic-hemorrhagic stroke in patients with Covid-19.
|
NA
|
NA
|
|
Interhospital teleproctoring of endovascular intracranial aneurysm treatment using a dedicated live-streaming technology: first experiences during the COVID-19 pandemic.
|
NA
|
NA
|
|
Non-convulsive status epilepticus: COVID-19 or clozapine induced?
|
NA
|
NA
|
|
Lung Sonography in Obstetrics during COVID-19.
|
NA
|
NA
|
|
COVID-19 and the Heart.
|
NA
|
NA
|
|
The recent advancement of low-dimensional nanostructured materials for drug delivery and drug sensing application: A brief review.
|
NA
|
NA
|
|
Control of a multigroup COVID-19 model with immunity: treatment and test elimination.
|
NA
|
NA
|
|
Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview.
|
NA
|
NA
|
|
Glomerular Diseases with Reference to COVID-19.
|
NA
|
NA
|
|
COVID 19 and Acute Kidney Injury.
|
NA
|
NA
|
|
Peritoneal Dialysis Patients During COVID 19 Pandemic.
|
NA
|
NA
|
|
Studying the Clinical Data of COVID Positive Patients Admitted to a Tertiary Care Academic Hospital.
|
NA
|
NA
|
|
Topical Review On Nano-vaccinology: Biochemical Promises and Key Challenges.
|
NA
|
NA
|
|
[Introduction of emergency paramedic investigators in the context of the COVID-19 pandemic in the Berlin emergency medical service].
|
NA
|
NA
|
|
Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments.
|
NA
|
NA
|
|
Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease.
|
NA
|
NA
|
|
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence.
|
NA
|
NA
|
|
Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.
|
NA
|
NA
|
|
Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis.
|
NA
|
NA
|
|
Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
A Review of the Pharmacological Properties of Psoralen.
|
NA
|
NA
|
|
Coping With COVID-19: Emergency Stress, Secondary Trauma and Self-Efficacy in Healthcare and Emergency Workers in Italy.
|
NA
|
NA
|
|
Challenges to the Emergence of Telerehabilitation in a Developing Country: A Systematic Review.
|
NA
|
NA
|
|
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations.
|
NA
|
NA
|
|
Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes.
|
NA
|
NA
|
|
Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
|
NA
|
NA
|
|
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients.
|
NA
|
NA
|
|
Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.
|
NA
|
NA
|
|
Can human overcome viral hijack-? Comprehensive review on COVID-19 in the view of diagnosis and mitigation across countries.
|
NA
|
NA
|
|
COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
|
NA
|
NA
|
|
Effective Anti-SARS-CoV-2 RNA Dependent RNA Polymerase Drugs Based on Docking Methods: The Case of Milbemycin, Ivermectin, and Baloxavir Marboxil.
|
NA
|
NA
|
|
Convalescent Blood Products in COVID-19: A Narrative Review.
|
NA
|
NA
|
|
Does IHU Mediterranean Infection influence Gilead stock price?
|
NA
|
NA
|
|
Diagnostic approaches and potential therapeutic options for coronavirus disease 2019.
|
NA
|
NA
|
|
Lactate Arterial-Central Venous Gradient among COVID-19 Patients in ICU: A Potential Tool in the Clinical Practice.
|
NA
|
NA
|
|
A Fatal Case of COVID-19 in an Infant with Severe Acute Malnutrition Admitted to a Paediatric Ward in Niger.
|
NA
|
NA
|
|
Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study.
|
NA
|
NA
|
|
Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
|
NA
|
NA
|
|
Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
|
NA
|
NA
|
|
Involvement of Medical Students During the Coronavirus Disease 2019 Pandemic: A Cross-Sectional Survey Study.
|
NA
|
NA
|
|
Pediatric surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
|
NA
|
NA
|
|
Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19.
|
NA
|
NA
|
|
Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2.
|
NA
|
NA
|
|
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
|
NA
|
NA
|
|
Iran’s Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study.
|
NA
|
NA
|
|
What Can We Estimate From Fatality and Infectious Case Data Using the Susceptible-Infected-Removed (SIR) Model? A Case Study of Covid-19 Pandemic.
|
NA
|
NA
|
|
The Impact of SARS-CoV-2 on the Most Common Comorbidities-A Retrospective Study on 814 COVID-19 Deaths in Romania.
|
NA
|
NA
|
|
Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
|
NA
|
NA
|
|
Enhancing Mentoring in Palliative Care: An Evidence Based Mentoring Framework.
|
NA
|
NA
|
|
Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group.
|
NA
|
NA
|
|
Are there overlapping clinical features between thoracic radiotherapy side effects and covid-19 pneumonia? radiation pneumonitis outside the radiation ports : three case reports.
|
NA
|
NA
|
|
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR-/- mice.
|
NA
|
NA
|
|
Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration.
|
NA
|
NA
|
|
Credible Protein Targets and Curative Strategies for COVID-19: a Review.
|
NA
|
NA
|
|
COVID-19-Induced Psychosis and Suicidal Behavior: Case Report.
|
NA
|
NA
|
|
SARS-CoV-2, an Underestimated Pathogen of the Nervous System.
|
NA
|
NA
|
|
Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic.
|
NA
|
NA
|
|
Recommendations for bariatric and metabolic surgical operations during the COVID-19 pandemic in Turkey.
|
NA
|
NA
|
|
The attitude of Turkish general surgeons during the COVID-19 pandemic: Results of “general surgery COVID-19 pandemic attitude survey”.
|
NA
|
NA
|
|
Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak.
|
NA
|
NA
|
|
Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds.
|
NA
|
NA
|
|
The successful use of extracorporeal carbon dioxide removal as a rescue therapy in a patient with severe COVID-19 pneumonitis.
|
NA
|
NA
|
|
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial.
|
NA
|
NA
|
|
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.
|
NA
|
NA
|
|
Management of conjunctivitis and other causes of red eye during the COVID-19 pandemic.
|
NA
|
NA
|
|
What GI Physicians Need to Know During COVID-19 Pandemic.
|
NA
|
NA
|
|
Italian SARS-CoV-2 patients in intensive care: towards an identikit for subjects at risk?
|
NA
|
NA
|
|
Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis.
|
NA
|
NA
|
|
Remdesivir-COVID-19: drug interactions in dentistry.
|
NA
|
NA
|
|
Maternal and fetal outcomes of COVID-19, SARS, and MERS: a narrative review on the current knowledge.
|
NA
|
NA
|
|
Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China - Preliminary results.
|
NA
|
NA
|
|
Homeless persons and migrants in precarious housing conditions and COVID-19 pandemic: peculiarities and prevention strategies.
|
NA
|
NA
|
|
Identification, protein antiglycation, antioxidant, antiproliferative, and molecular docking of novel bioactive peptides produced from hydrolysis of Lens culinaris.
|
NA
|
NA
|
|
Dental education in the time of SARS-CoV-2.
|
NA
|
NA
|
|
A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in two pediatric patients with kidney disease on chronic immunosuppression: A case series.
|
NA
|
NA
|
|
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
|
NA
|
NA
|
|
Hypothesis: The electrical properties of coronavirus.
|
NA
|
NA
|
|
Utilizing Pharmacists to Optimize Medication Management Strategies During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2’-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
|
NA
|
NA
|
|
[SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].
|
NA
|
NA
|
|
How the pandemic spread of COVID-19 affected children’s traumatology in Italy: changes of numbers, anatomical locations, and severity.
|
NA
|
NA
|
|
Existential positive psychology and integrative meaning therapy.
|
NA
|
NA
|
|
Patient and Clinician Perspectives on Adolescent Opioid Use Disorder Treatment During a Pandemic: One Step Back, but Two Forward?
|
NA
|
NA
|
|
VIRTUS: a pipeline for comprehensive virus analysis from conventional RNA-seq data.
|
NA
|
NA
|
|
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
|
NA
|
NA
|
|
Remdesivir for Adults With COVID-19 : A Living Systematic Review for an American College of Physicians Practice Points.
|
NA
|
NA
|
|
COVID-19: Between Past and Present.
|
NA
|
NA
|
|
Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
|
NA
|
NA
|
|
Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19.
|
NA
|
NA
|
|
Sampling manholes to home in on SARS-CoV-2 infections.
|
NA
|
NA
|
|
The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic.
|
NA
|
NA
|
|
Incidence of Deep Venous Thrombosis in Patients With COVID-19 and Pulmonary Embolism: Compression Ultrasound COVID Study.
|
NA
|
NA
|
|
Use of povidone as a mouthrinse to decrease the viral load of Covid-19 before dental care: Review of the literature.
|
NA
|
NA
|
|
Filling the gaps on stroke research: Focus on inflammation and immunity.
|
NA
|
NA
|
|
Gravity Steam Reprocessing in Healthcare Facilities for the Reuse of N95 Respirators.
|
NA
|
NA
|
|
Clinical characteristics of 30 COVID-19 patients with epilepsy: a retrospective study in Wuhan.
|
NA
|
NA
|
|
Chloroquine commonly induces hormetic dose responses.
|
NA
|
NA
|
|
Peritoneal Dialysis Is an Option for Acute Kidney Injury Management in Patients with COVID-19.
|
NA
|
NA
|
|
Increased Use of Blood Transfusions to Manage Urological Conditions during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population.
|
NA
|
NA
|
|
Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19.
|
NA
|
NA
|
|
Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease.
|
NA
|
NA
|
|
A new approach for COVID-19 treatment by micro-RNA.
|
NA
|
NA
|
|
Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome.
|
NA
|
NA
|
|
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.
|
NA
|
NA
|
|
DoMoMEA: a Home-Based Telerehabilitation System for Stroke Patients.
|
NA
|
NA
|
|
Acupuncture for corona virus disease 2019: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.
|
NA
|
NA
|
|
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers.
|
NA
|
NA
|
|
The Impact of COVID-19 on Telemedicine Utilization Across Multiple Service Lines in the United States.
|
NA
|
NA
|
|
Feasibility Trial of an eHealth Intervention for Health-Related Quality of Life: Implications for Managing Patients with Chronic Pain during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Nano Antiviral Photodynamic Therapy: a Probable Biophysicochemical Management Modality in SARS-CoV-2.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort.
|
NA
|
NA
|
|
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
|
NA
|
NA
|
|
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).
|
NA
|
NA
|
|
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis.
|
NA
|
NA
|
|
A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City.
|
NA
|
NA
|
|
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK.
|
NA
|
NA
|
|
Test, Trace, and Treatment Strategy to Control COVID-19 Infection Among Hospital Staff in a COVID-19 Referral Hospital in Indonesia.
|
NA
|
NA
|
|
Factors Related to Knowledge, Perception, and Practices Towards COVID-19 Among Patients with Autoimmune Diseases: A Multicenter Online Survey.
|
NA
|
NA
|
|
Report of Two COVID-19 ARDS (CARDS) Cases Who Survived without Intubation and Mechanical Ventilation.
|
NA
|
NA
|
|
Prevention of Ventricular Arrhythmia and Sudden Cardiac Death in COVID-19 Patients.
|
NA
|
NA
|
|
The Management of Cytokine Storm in COVID-19.
|
NA
|
NA
|
|
Compact development and adherence to stay-at-home order during the COVID-19 pandemic: A longitudinal investigation in the United States.
|
NA
|
NA
|
|
Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.
|
NA
|
NA
|
|
Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.
|
NA
|
NA
|
|
Analysis of the global situation of COVID-19 research based on bibliometrics.
|
NA
|
NA
|
|
Behavioral changes in patients with diabetes during the COVID-19 pandemic.
|
NA
|
NA
|
|
Promising effect of in-situ lyticase enzyme therapy on peritoneal dialysis catheter obstruction from Acremonium fungal biofilm: A case report.
|
NA
|
NA
|
|
Otolaryngology Surgical Activity in Tertiary Care Center During the Covid-19 Lockdown.
|
NA
|
NA
|
|
The Impact of Novel Coronavirus COVID-19 on Non-Communicable Disease Patients and Health Systems: A Review.
|
NA
|
NA
|
|
Outcomes of COVID-19 in living donor liver transplant (LDLT) recipients.
|
NA
|
NA
|
|
Benefits of bariatric surgery prior to SARS CoV 2 infection in modulating the response to COVID-19.
|
NA
|
NA
|
|
Value of Advance Care Directives for Patients With Serious Illness in the Era of COVID Pandemic: A Review of Challenges and Solutions.
|
NA
|
NA
|
|
Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer.
|
NA
|
NA
|
|
SARS-CoV-2 pandemic: implications in the management of patients with colorectal cancer.
|
NA
|
NA
|
|
Smartphone-enabled Telehealth for Palliative Care Family Conference during the COVID - 19 Pandemic: Pilot Observational Study.
|
NA
|
NA
|
|
COVID-19 and myeloid cells: complex interplay correlates with lung severity.
|
NA
|
NA
|
|
Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.
|
NA
|
NA
|
|
MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions.
|
NA
|
NA
|
|
Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom.
|
NA
|
NA
|
|
Angiotensin-Converting Enzyme Inhibitors Or Angiotensin Ii Receptor Blockers And Prognosis Of Hypertensive Patients Hospitalized With Covid-19.
|
NA
|
NA
|
|
Evaluation of medical practices in oncology in the context of the COVID-19 pandemic in France: Physicians’ point of view: the PRATICOVID study.
|
NA
|
NA
|
|
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
|
NA
|
NA
|
|
Clinical trial protocols of repurposed prophylaxis for COVID-19: a review.
|
NA
|
NA
|
|
Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
|
NA
|
NA
|
|
Targeting acute kidney injury in COVID-19.
|
NA
|
NA
|
|
[Rational therapeutic decisions in intensive care patients].
|
NA
|
NA
|
|
Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists.
|
NA
|
NA
|
|
Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.
|
NA
|
NA
|
|
SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy.
|
NA
|
NA
|
|
COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics.
|
NA
|
NA
|
|
A Review of the State of the Art in Non-Contact Sensing for COVID-19.
|
NA
|
NA
|
|
Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review.
|
NA
|
NA
|
|
TriPla Regimen: A new treatment approach for patients with neovascular age-related macular degeneration in the COVID-19 “era”.
|
NA
|
NA
|
|
Harnessing COVID-Driven Technical Innovations for Improved Multi-Disciplinary Cancer Care in the Post-COVID Era: The Virtual Patient Room.
|
NA
|
NA
|
|
Making a case for using γδ T cells against SARS-CoV-2.
|
NA
|
NA
|
|
Therapeutic Options for Treatment of COVID-19: A Review from Repur-posed Drugs to New Drug Targets.
|
NA
|
NA
|
|
Epidemiological Situation and Efficacy of Dexamethasone for the treatment planning of COVID-19: A perspective review.
|
NA
|
NA
|
|
Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review.
|
NA
|
NA
|
|
SARS-COV-2 infection during pregnancy, a risk factor for eclampsia or neurological manifestations of COVID-19? Case report.
|
NA
|
NA
|
|
Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study.
|
NA
|
NA
|
|
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019.
|
NA
|
NA
|
|
Risk of Mortality in Elderly Coronavirus Disease 2019 Patients With Mental Health Disorders: A Nationwide Retrospective Study in South Korea.
|
NA
|
NA
|
|
COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients.
|
NA
|
NA
|
|
Maintaining plasma quality and safety in the state of ongoing epidemic - The role of pathogen reduction.
|
NA
|
NA
|
|
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
|
NA
|
NA
|
|
High burden of acute kidney injury in COVID-19 pandemic: systematic review and meta-analysis.
|
NA
|
NA
|
|
Frauds in scientific research and how to possibly overcome them.
|
NA
|
NA
|
|
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.
|
NA
|
NA
|
|
End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments.
|
NA
|
NA
|
|
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.
|
NA
|
NA
|
|
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.
|
NA
|
NA
|
|
Characteristics of SARS-CoV-2 and COVID-19.
|
NA
|
NA
|
|
A Multicenter Cross-sectional Questionnaire-based Study to Know the Practices and Strategies of Ventilatory Management of COVID-19 Patients among the Treating Physicians.
|
NA
|
NA
|
|
Management of pandemic or large-scale emergencies in Germany with a focus on the current and potential role of university schools of dentistry: Can it help in COVID-19 time?
|
NA
|
NA
|
|
Outlook of IL-6 signaling blockade for COVID-19 pneumonia.
|
NA
|
NA
|
|
Immunological aspects of COVID-19: What do we know?
|
NA
|
NA
|
|
Current status of COVID-19 treatment: An opinion review.
|
NA
|
NA
|
|
Special features of SARS-CoV-2 in daily practice.
|
NA
|
NA
|
|
ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
|
NA
|
NA
|
|
[Psychosocial support during the COVID-19 pandemic: interdisciplinary concept of care at a university hospital].
|
NA
|
NA
|
|
Intussusception in a child with COVID-19 in the USA.
|
NA
|
NA
|
|
Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study.
|
NA
|
NA
|
|
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
|
NA
|
NA
|
|
Clinical and angiographic characteristics of patients with STEMI and confirmed diagnosis of COVID-19: an experience of Tanta University Hospital.
|
NA
|
NA
|
|
Glucocorticoid excess and COVID-19 disease.
|
NA
|
NA
|
|
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia.
|
NA
|
NA
|
|
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy.
|
NA
|
NA
|
|
Integrated network pharmacology and molecular docking strategy to explore the mechanism of medicinal and edible Astragali Radix-Atractylodis Macrocephalae Rhizoma acting on pneumonia via immunomodulation.
|
NA
|
NA
|
|
Fine Aerosols and Perceived Risk of COVID-19 among Italian Dental Practitioners: An Experimental Survey.
|
NA
|
NA
|
|
Discovery of potent inhibitors for SARS-CoV-2’s main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
|
NA
|
NA
|
|
Global perspective of COVID-19 epidemiology for a full-cycle pandemic.
|
NA
|
NA
|
|
[The peak of the Coronavirus emergency and hemodialysis patients: the experience of the Dialysis Center in Crema].
|
NA
|
NA
|
|
[Multidisciplinary management of a typical case of acute kidney failure in the course of COVID-19 infection].
|
NA
|
NA
|
|
[Resilience in COVID-19 times: general considerations on the recovery of a 93-year-old patient on haemodialysis treatment].
|
NA
|
NA
|
|
Redesigning operating room booking in a tertiary care academic centre during the COVID-19 pandemic.
|
NA
|
NA
|
|
Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?
|
NA
|
NA
|
|
Outpatient Plastic Surgery Is Safe During the Covid-19 Pandemic: Results of a July 2020 Los Angeles Survey and Literature Review.
|
NA
|
NA
|
|
Filter clotting with continuous renal replacement therapy in COVID-19.
|
NA
|
NA
|
|
Challenges and possible solutions in dental practice during and post COVID-19.
|
NA
|
NA
|
|
Autopsy findings in COVID-19-related deaths: a literature review.
|
NA
|
NA
|
|
Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
|
NA
|
NA
|
|
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
|
NA
|
NA
|
|
A Call to Action to Address Disparities in Palliative Care Access: A Conceptual Framework for Individualizing Care Needs.
|
NA
|
NA
|
|
Pain management programmes via video conferencing: a rapid review.
|
NA
|
NA
|
|
What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response.
|
NA
|
NA
|
|
COVID-19 in children: current evidence and key questions.
|
NA
|
NA
|
|
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience.
|
NA
|
NA
|
|
Barriers and facilitators of adherence to social distancing recommendations during COVID-19 among a large international sample of adults.
|
NA
|
NA
|
|
Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19.
|
NA
|
NA
|
|
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
|
NA
|
NA
|
|
Comment on “The importance of physical exercise during the coronavirus (COVID-19) pandemic”.
|
NA
|
NA
|
|
Are smoking, environmental pollution, and weather conditions risk factors for COVID-19?
|
NA
|
NA
|
|
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
|
NA
|
NA
|
|
Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.
|
NA
|
NA
|
|
Emergency management in dental clinic during the Coronavirus Disease 2019 (COVID-19) epidemic in Beijing.
|
NA
|
NA
|
|
Spontaneous pneumomediastinum, pneumopericardium, pneumothorax and subcutaneous emphysema in patients with COVID-19 pneumonia, a case report.
|
NA
|
NA
|
|
Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
|
NA
|
NA
|
|
Reduced PICU respiratory admissions during COVID-19.
|
NA
|
NA
|
|
Metastatic pulmonary dissemination as differential diagnosis of COVID-19 disease.
|
NA
|
NA
|
|
COVID-19 Trial Enrollment for Those Who Cannot Consent: Ethical Challenges Posed by a Pandemic.
|
NA
|
NA
|
|
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.
|
NA
|
NA
|
|
Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
|
NA
|
NA
|
|
Pneumothorax in a COVID-19 Pneumonia Patient Without Underlying Risk Factors.
|
NA
|
NA
|
|
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
|
NA
|
NA
|
|
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.
|
NA
|
NA
|
|
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
|
NA
|
NA
|
|
Using Artificial Intelligence for COVID-19 Chest X-ray Diagnosis.
|
NA
|
NA
|
|
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
|
NA
|
NA
|
|
Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy.
|
NA
|
NA
|
|
Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors.
|
NA
|
NA
|
|
Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling.
|
NA
|
NA
|
|
Assessment of the Potential Adverse Events Related to Ribavirin-Interferon Combination for Novel Coronavirus Therapy.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis.
|
NA
|
NA
|
|
Treating posttraumatic stress disorder remotely with cognitive therapy for PTSD.
|
NA
|
NA
|
|
Coronavirus Disease 2019 in Neonates - What Is Known and What Needs to Be Known.
|
NA
|
NA
|
|
Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study.
|
NA
|
NA
|
|
Convalescent Plasma: A Challenging Tool to Treat COVID-19 Patients-A Lesson from the Past and New Perspectives.
|
NA
|
NA
|
|
Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study.
|
NA
|
NA
|
|
How the COVID-19 Pandemic Impacted Oncological Molecular Diagnosis: A Picture from a National Reference Center for Molecular Pathology.
|
NA
|
NA
|
|
Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
|
NA
|
NA
|
|
Metal Nanoparticles: a Promising Treatment for Viral and Arboviral Infections.
|
NA
|
NA
|
|
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
|
NA
|
NA
|
|
A multiscale absorption and transit model for oral delivery of hydroxychloroquine: Pharmacokinetic modeling and intestinal concentration prediction to assess toxicity and drug-induced damage in healthy subjects.
|
NA
|
NA
|
|
[Surgical care during the new coronavirus (Covid-19) pandemic].
|
NA
|
NA
|
|
Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA.
|
NA
|
NA
|
|
Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.
|
NA
|
NA
|
|
[A new Spanish enemy; the Spanish flu in the Netherlands in the period 1918-1920].
|
NA
|
NA
|
|
[Viral transmission in COVID-19: the role of the aerosol].
|
NA
|
NA
|
|
Collaboration between a tertiary pain centre and community teams during the pandemic.
|
NA
|
NA
|
|
[Psychological treatment of headache in times of COVID-19].
|
NA
|
NA
|
|
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy.
|
NA
|
NA
|
|
The stroke mothership model survived during COVID-19 era: an observational single-center study in Emilia-Romagna, Italy.
|
NA
|
NA
|
|
The impact of COVID-19 lockdown in a developing country: narratives of self-employed women in Ndola, Zambia.
|
NA
|
NA
|
|
Evaluation of Telepharmacy Services in Light of COVID-19.
|
NA
|
NA
|
|
Strategic use of patent opposition safeguard to improve equitable access to innovative health technologies: A case study of CAR T-cell therapy Kymriah.
|
NA
|
NA
|
|
Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS).
|
NA
|
NA
|
|
The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
|
NA
|
NA
|
|
Digital phenotyping to enhance substance use treatment during the COVID-19 pandemic: Viewpoint.
|
NA
|
NA
|
|
Case Report: Virtual Reality Behavioral Activation as an Intervention for Major Depressive Disorder.
|
NA
|
NA
|
|
Scientific Publications During the Early Phase of the COVID-19 Pandemic: A Topic Modeling Study.
|
NA
|
NA
|
|
Efficacy and safety of tocilizumab in COVID-19 patients.
|
NA
|
NA
|
|
Could “trained immunity” be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
|
NA
|
NA
|
|
Existing drug treatments cannot significantly shorten the clinical cure time of children with COVID-19.
|
NA
|
NA
|
|
Nitazoxanide against COVID-19 in three explorative scenarios.
|
NA
|
NA
|
|
The Direct and Indirect Impact of SARS-CoV-2 Infections on Neonates: A Series of 26 Cases in Bangladesh.
|
NA
|
NA
|
|
Angiotensin II Administration in Patients with COVID-19 Shock.
|
NA
|
NA
|
|
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas.
|
NA
|
NA
|
|
Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Efficacy and safety of acupuncture therapy for asymptomatic infection of COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Rapid Transition of a PICU Space and Staff to Adult Coronavirus Disease 2019 ICU Care.
|
NA
|
NA
|
|
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.
|
NA
|
NA
|
|
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia.
|
NA
|
NA
|
|
Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic.
|
NA
|
NA
|
|
Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.
|
NA
|
NA
|
|
Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study.
|
NA
|
NA
|
|
Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.
|
NA
|
NA
|
|
Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options.
|
NA
|
NA
|
|
A Study to Evaluate Depression and Perceived Stress Among Frontline Indian Doctors Combating the COVID-19 Pandemic.
|
NA
|
NA
|
|
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
|
NA
|
NA
|
|
Lung Cancer Management in COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 Pregnant Patient Management with a Case of COVID-19 Patient with An Uncomplicated Delivery.
|
NA
|
NA
|
|
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study.
|
NA
|
NA
|
|
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
|
NA
|
NA
|
|
Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment.
|
NA
|
NA
|
|
COVID-19 in children: Could pertussis vaccine play the protective role?
|
NA
|
NA
|
|
Severity assessment of COVID-19 using CT image features and laboratory indices.
|
NA
|
NA
|
|
Sudden Cardiac Death in Haemodialysis Patients under Hydroxychloroquine Treatment for COVID-19: A Report of Two Cases.
|
NA
|
NA
|
|
Utilization of Teledentistry in Antimicrobial Prescribing and Diagnosis of Infectious Diseases during COVID-19 Lockdown.
|
NA
|
NA
|
|
Management of acute and chronic aortic disease during the COVID-19 pandemic-Results from a web-based ad hoc platform.
|
NA
|
NA
|
|
COVID-19 transmission risk and protective protocols in dentistry: a systematic review.
|
NA
|
NA
|
|
Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric orthopaedic patients during the COVID19 pandemic and post-pandemic period in Italy.
|
NA
|
NA
|
|
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
|
NA
|
NA
|
|
Impact of Public Health Emergency Response to COVID-19 on Management and Outcome for STEMI Patients in Beijing-A Single-Center Historic Control Study.
|
NA
|
NA
|
|
Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?
|
NA
|
NA
|
|
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?
|
NA
|
NA
|
|
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
|
NA
|
NA
|
|
COVID-19: Combined supply-side and demand-side shocks, so lift restrictions (carefully) lest GPD declines ultimately kill more than COVID-19.
|
NA
|
NA
|
|
Fertility preservation during the COVID-19 pandemic: mitigating the viral contamination risk to reproductive cells in cryostorage.
|
NA
|
NA
|
|
[Scoping Review of the Effectiveness of Screen-to-Screen-Therapy compared to Face-to-Face-Therapy on Naming Performance for Patients with Aphasia].
|
NA
|
NA
|
|
Integrating New Staff into Endovascular Stroke-Treatment Workflows in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Metagenomics of Wastewater Influent from Southern California Wastewater Treatment Facilities in the Era of COVID-19.
|
NA
|
NA
|
|
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
|
NA
|
NA
|
|
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.
|
NA
|
NA
|
|
Two distinct immunopathological profiles in autopsy lungs of COVID-19.
|
NA
|
NA
|
|
Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
|
NA
|
NA
|
|
Preemptive interleukin-6 blockade in patients with COVID-19.
|
NA
|
NA
|
|
Cancer patients in SARS-CoV-2 infection: a single-center experience from Wuhan.
|
NA
|
NA
|
|
Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
|
NA
|
NA
|
|
Computer-generated “synthetic contingency” plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir.
|
NA
|
NA
|
|
COVID-IP: staring down the Bayh-Dole Act with 2020 vision.
|
NA
|
NA
|
|
Icosapent Ethyl - A Successful Treatment for Symptomatic COVID-19 Infection.
|
NA
|
NA
|
|
Medical affairs post-COVID 19: Are we ready to take the baton?
|
NA
|
NA
|
|
Pharmacovigilance and assessment of drug safety reports during COVID 19.
|
NA
|
NA
|
|
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses.
|
NA
|
NA
|
|
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.
|
NA
|
NA
|
|
Umbilical cord: an allogenic tissue for potential treatment of COVID-19.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
|
NA
|
NA
|
|
Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.
|
NA
|
NA
|
|
UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID-19 pandemic.
|
NA
|
NA
|
|
Characteristics and Management of Children With COVID-19 in a Tertiary Care Hospital in Turkey.
|
NA
|
NA
|
|
Thoracic Aortic Mural Thrombus, Right Ventricular Clot and Pulmonary Embolism in a Patient With COVID-19 Pneumonia.
|
NA
|
NA
|
|
A critical review of methods for decontaminating filtering facepiece respirators.
|
NA
|
NA
|
|
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.
|
NA
|
NA
|
|
COVID-19 Related Strokes are associated with increased mortality and morbidity: A multi-center comparative study from Bengaluru, south India.
|
NA
|
NA
|
|
A case of heart failure mimicking COVID-19 pneumonia: The role of clinical and chest computed tomography findings in the differential diagnosis.
|
NA
|
NA
|
|
Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
|
NA
|
NA
|
|
Quality of cochlear implant rehabilitation under COVID-19 conditions.
|
NA
|
NA
|
|
[Hospital paramedic. An interprofessional blended learning concept to qualify paramedics and medical personnel for deployment in intensive care units and emergency departments during the COVID-19 pandemic].
|
NA
|
NA
|
|
[Monoclonal antibodies for anti-infective therapy].
|
NA
|
NA
|
|
Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
|
NA
|
NA
|
|
Prognostic Assessment of COVID-19 in ICU by Machine Learning Methods: A Retrospective Study.
|
NA
|
NA
|
|
openEHR archetype use and reuse within multilingual clinical data sets: a case study.
|
NA
|
NA
|
|
Role of time-normalized laboratory findings in predicting COVID-19 outcome.
|
NA
|
NA
|
|
Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors.
|
NA
|
NA
|
|
Innovations in HIV care delivery during the COVID-19 pandemic: Policies to strengthen the Ending the Epidemic Initiative - A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
|
NA
|
NA
|
|
Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings.
|
NA
|
NA
|
|
Beekeepers who tolerate bee stings are not protected against SARS-CoV-2 infections.
|
NA
|
NA
|
|
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
|
NA
|
NA
|
|
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.
|
NA
|
NA
|
|
Were clinical routines for good end-of-life care maintained in hospitals and nursing homes during the first three months of the outbreak of COVID-19? A national register study.
|
NA
|
NA
|
|
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign.
|
NA
|
NA
|
|
Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness.
|
NA
|
NA
|
|
COVID-19, myocardial edema and dexamethasone.
|
NA
|
NA
|
|
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
|
NA
|
NA
|
|
Mitigation of Covid-19 infection in substance use disorder residential settings.
|
NA
|
NA
|
|
COVID-19 multidisciplinary high dependency unit: the Milan model.
|
NA
|
NA
|
|
Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
[Nomadism of patients treated by radiotherapy in Île-de-France: Does our health system have as much money to waste?]
|
NA
|
NA
|
|
Postpartum consciousness disturbance: can covid-19 cause posterior reversible encephalopathy syndrome?
|
NA
|
NA
|
|
Analysis of the care management protocol for COVID pregnant women and detection of improvement proposals applying clinical simulation methodology.
|
NA
|
NA
|
|
Prehospital management of acute respiratory distress in suspected COVID-19 patients.
|
NA
|
NA
|
|
Myocardial injury in a patient with severe coronavirus disease: A case report.
|
NA
|
NA
|
|
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists.
|
NA
|
NA
|
|
Alaska pharmacists: First responders to the pandemic in the last frontier.
|
NA
|
NA
|
|
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
|
NA
|
NA
|
|
Development and evaluation of an artificial intelligence system for COVID-19 diagnosis.
|
NA
|
NA
|
|
Managing dental caries against the backdrop of COVID-19: approaches to reduce aerosol generation.
|
NA
|
NA
|
|
An aberrant STAT pathway is central to COVID-19.
|
NA
|
NA
|
|
[Intensive care back up for infectious disease disasters].
|
NA
|
NA
|
|
Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review.
|
NA
|
NA
|
|
Report on a lactating patient with COVID-19.
|
NA
|
NA
|
|
Answer to the Letter to Editor by Rodriguez-Peralvarez et al.
|
NA
|
NA
|
|
Videotherapy and therapeutic alliance in the age of COVID-19.
|
NA
|
NA
|
|
Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.
|
NA
|
NA
|
|
Management of odonto-stomatological emergencies during the COVID-19 alarm state in dental clinics in the Autonomous Community of Madrid (CAM), Spain: An observational study.
|
NA
|
NA
|
|
[Treatment of retinal detachment during the COVID-19 pandemic : Did patients with retinal detachment seek treatment later during the COVID-19 pandemic? Results from a German university eye hospital].
|
NA
|
NA
|
|
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
|
NA
|
NA
|
|
Depression, Anxiety and Lifestyle Among Essential Workers: A Websurvey From Brazil And Spain During The Covid-19 Pandemic.
|
NA
|
NA
|
|
Depression, Anxiety and Lifestyle Among Essential Workers: A Websurvey From Brazil And Spain During The Covid-19 Pandemic.
|
NA
|
NA
|
|
Depression, Anxiety and Lifestyle Among Essential Workers: A Websurvey From Brazil And Spain During The Covid-19 Pandemic.
|
NA
|
NA
|
|
Depression, Anxiety and Lifestyle Among Essential Workers: A Websurvey From Brazil And Spain During The Covid-19 Pandemic.
|
NA
|
NA
|
|
Prediction of COVID-19 Severity from Chest CT and Laboratory Measurements: Evaluation of a Machine Learning Approach.
|
NA
|
NA
|
|
Interim Guidance on the Preparticipation Physical Examination for Athletes During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Convalescent plasma for patients with severe COVID-19: a matched cohort study.
|
NA
|
NA
|
|
The role of the critical care pharmacist during the COVID-19 pandemic.
|
NA
|
NA
|
|
Maintaining surgical treatment of non-small cell lung cancer during the COVID-19 pandemic in Paris.
|
NA
|
NA
|
|
Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
|
NA
|
NA
|
|
SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease.
|
NA
|
NA
|
|
Ethics of kidney care in the era of COVID-19.
|
NA
|
NA
|
|
COVID-19: discovery, diagnostics and drug development.
|
NA
|
NA
|
|
Targeted Rapid Testing for SARS-CoV-2 in the Emergency Department is Associated with Large Reductions in Uninfected Patient Exposure Time.
|
NA
|
NA
|
|
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic.
|
NA
|
NA
|
|
Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Association of immune checkpoint inhibitors with respiratory infections: A review.
|
NA
|
NA
|
|
SARS-CoV-2 pandemic and the population with dementia. Recommendations under the auspices of the Polish Psychiatric Association.
|
NA
|
NA
|
|
Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2.
|
NA
|
NA
|
|
Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia.
|
NA
|
NA
|
|
Cytokine Storms in Cancer and COVID-19.
|
NA
|
NA
|
|
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy.
|
NA
|
NA
|
|
[Association of hypertension and antihypertensive agents and the severity of COVID-19 pneumonia. A monocentric French prospective study].
|
NA
|
NA
|
|
Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report.
|
NA
|
NA
|
|
Non-respiratory presentations of COVID-19, a clinical review.
|
NA
|
NA
|
|
Effect of COVID-19 outbreak on the treatment time of patients with acute ST-segment elevation myocardial infarction.
|
NA
|
NA
|
|
Covid-19 associated Guillain-Barre Syndrome: Contrasting tale of four patients from a tertiary care centre in India.
|
NA
|
NA
|
|
Holidays over: A review of actual COVID-19 school outbreaks up to September 2020.
|
NA
|
NA
|
|
A critical care pandemic staffing framework in Australia.
|
NA
|
NA
|
|
From chaos to a new norm: The Birmingham experience of restructuring the largest plastics department in the UK in response to the COVID-19 pandemic.
|
NA
|
NA
|
|
The therapeutic importance of acid-base balance.
|
NA
|
NA
|
|
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Medical device related pressure ulcer of the lip in a patient with COVID-19: Case report and review of the literature.
|
NA
|
NA
|
|
Postpartum Atypical Posterior Reversible Encephalopathy Syndrome in a COVID-19 Patient - An Obstetric Emergency.
|
NA
|
NA
|
|
Stroke Systems of Care During the COVID-19 Epidemic in Kobe City.
|
NA
|
NA
|
|
SARS-CoV-2 in wastewater: Challenges for developing countries.
|
NA
|
NA
|
|
Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19).
|
NA
|
NA
|
|
Classification of aerosol-generating procedures: a rapid systematic review.
|
NA
|
NA
|
|
Late presentation of ‘Lemierre’s syndrome’: how a delay in seeking healthcare and reduced access to routine services resulted in widely disseminated Fusobacterium necrophorum infection during the global COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19: a risk factor for fatal outcomes in patients with comorbid cardiovascular disease.
|
NA
|
NA
|
|
COVID-19 and Gastrointestinal Disease. Implications for the Gastroenterologist.
|
NA
|
NA
|
|
An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study.
|
NA
|
NA
|
|
COVID-19 and Cardiovascular Health Among Patients with Cancer.
|
NA
|
NA
|
|
Observational study of people infected with SARS-Cov-2, treated with amantadine.
|
NA
|
NA
|
|
Clinical characteristics and outcomes in elderly with coronavirus disease 2019 in Beijing, China: a retrospective cohort study.
|
NA
|
NA
|
|
Sperm cryopreservation during the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic - an original epidemiological, clinical, dermoscopic, and laboratory-based study.
|
NA
|
NA
|
|
COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes.
|
NA
|
NA
|
|
The novel coronavirus disease in patients with end-stage kidney disease.
|
NA
|
NA
|
|
Stem Cell Transplantation Therapy: A Potential Method for Treating Cytokine Storm Syndromes Induced by COVID-19.
|
NA
|
NA
|
|
Scalable In-hospital Decontamination of N95 Filtering Facepiece Respirator with a Peracetic Acid Room Disinfection System.
|
NA
|
NA
|
|
Risk of depression in family caregivers: unintended consequence of COVID-19.
|
NA
|
NA
|
|
Management of a Nursing Unit in a Temporary COVID-19 Specialized Hospital in Wuhan, China.
|
NA
|
NA
|
|
ALL FOR ONE AND ONE FOR ALL: VOLUNTARY PHYSICIANS IN THE INTENSIVE MEDICINE UNITS DURING THE COVID-19 OUTBREAK IN SPAIN.
|
NA
|
NA
|
|
Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length.
|
NA
|
NA
|
|
Cytosorb filter: An adjunct for survival in the COVID-19 patient in cytokine storm? a case report.
|
NA
|
NA
|
|
Spectrum of Coronavirus Disease 2019 Outcomes in Kidney Transplant Recipients: A Single-Center Experience.
|
NA
|
NA
|
|
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence.
|
NA
|
NA
|
|
Early predictors of mortality for moderate to severely ill patients with Covid-19.
|
NA
|
NA
|
|
COVID-19 cardiac arrest management: A review for emergency clinicians.
|
NA
|
NA
|
|
Fungal co-infection in COVID-19 patients: Should we be concerned?
|
NA
|
NA
|
|
The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19.
|
NA
|
NA
|
|
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.
|
NA
|
NA
|
|
Using 3D-printed nose models in nasopharyngeal swab training.
|
NA
|
NA
|
|
Neuroprotective immunity by essential nutrient “Choline” for the prevention of SARS CoV2 infections: An in silico study by molecular dynamics approach.
|
NA
|
NA
|
|
Changes in the Management of Clubfoot Cases During COVID-19 Pandemic-A Survey Among Orthopaedic Specialists.
|
NA
|
NA
|
|
Hypoproteinemia is an independent risk factor for the prognosis of severe COVID-19 patients.
|
NA
|
NA
|
|
Secondary Causes of Myositis.
|
NA
|
NA
|
|
From the hospital scale to nationwide: observability and identification of models for the COVID-19 epidemic waves.
|
NA
|
NA
|
|
Characterization of SARS-CoV-2 Dynamics in the Host.
|
NA
|
NA
|
|
The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents.
|
NA
|
NA
|
|
COVID-19 Pandemic and Children: A Review.
|
NA
|
NA
|
|
In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis.
|
NA
|
NA
|
|
Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital.
|
NA
|
NA
|
|
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives.
|
NA
|
NA
|
|
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence.
|
NA
|
NA
|
|
Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19.
|
NA
|
NA
|
|
Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena.
|
NA
|
NA
|
|
COVID-19: Infection or Autoimmunity.
|
NA
|
NA
|
|
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective.
|
NA
|
NA
|
|
MH-COVIDNet: Diagnosis of COVID-19 using deep neural networks and meta-heuristic-based feature selection on X-ray images.
|
NA
|
NA
|
|
Transcription factor-mediated signaling pathways’ contribution to the pathology of acute lung injury and acute respiratory distress syndrome.
|
NA
|
NA
|
|
SARS-CoV2 in Different Body Fluids, Risks of Transmission, and Preventing COVID-19: A Comprehensive Evidence-Based Review.
|
NA
|
NA
|
|
Review of novel human β-coronavirus (2019-nCoV or SARS-CoV-2) from the food industry perspective-Appropriate approaches to food production technology.
|
NA
|
NA
|
|
A virus as an icon: the 2020 pandemic in images.
|
NA
|
NA
|
|
Severe coronavirus disease 2019 (COVID-19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series.
|
NA
|
NA
|
|
Hydroxychloroquine is effective, and consistently so used early, for Covid-19: A systematic review.
|
NA
|
NA
|
|
Preventing thrombosis in a COVID-19 patient by combinatorial therapy with nafamostat and heparin during extracorporeal membrane oxygenation.
|
NA
|
NA
|
|
Gone, but not Forgotten.
|
NA
|
NA
|
|
Pharmacological approaches to the treatment of COVID-19 patients.
|
NA
|
NA
|
|
Impact of COVID-19 on clinical trials and clinical research: A systematic review.
|
NA
|
NA
|
|
The Possibility and Cause of Relapse After Previously Recovering From COVID-19: A Systematic Review.
|
NA
|
NA
|
|
Six Gynecological Cancer Patients Infected With SARS-CoV-2 After Surgery or Radio-/Chemo-Therapy Treatment: Case Series.
|
NA
|
NA
|
|
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
|
NA
|
NA
|
|
Analysis of Risk Factors for 24 Patients With COVID-19 Developing From Moderate to Severe Condition.
|
NA
|
NA
|
|
Implications of Public Understanding of COVID-19 in Saudi Arabia for Fostering Effective Communication Through Awareness Framework.
|
NA
|
NA
|
|
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
|
NA
|
NA
|
|
Therapeutic Options Against the New Coronavirus: Updated Clinical and Laboratory Evidences.
|
NA
|
NA
|
|
Reflections on the Collaborative Fight Against COVID-19.
|
NA
|
NA
|
|
Direct Clinical Evidence Recommending the Use of Proteinase K or Dithiothreitol to Pretreat Sputum for Detection of SARS-CoV-2.
|
NA
|
NA
|
|
Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database.
|
NA
|
NA
|
|
A Cyclodextrin-Stabilized Spermine-Tagged Drug Triplex that Targets Theophylline to the Lungs Selectively in Respiratory Emergency.
|
NA
|
NA
|
|
Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report.
|
NA
|
NA
|
|
The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
|
NA
|
NA
|
|
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven.
|
NA
|
NA
|
|
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan.
|
NA
|
NA
|
|
The Impact of COVID-19 on Organ Donation, Procurement and Liver Transplantation in the United States.
|
NA
|
NA
|
|
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents.
|
NA
|
NA
|
|
Thrombosis and Bleeding as Presentation of COVID-19 Infection with Polycythemia Vera. A Case Report.
|
NA
|
NA
|
|
Redesigning COVID 19 Care with Network Medicine and Machine Learning: A review.
|
NA
|
NA
|
|
Global contributions of pharmacists during the COVID-19 pandemic.
|
NA
|
NA
|
|
Furin: A Potential Therapeutic Target for COVID-19.
|
NA
|
NA
|
|
Sarilumab use in severe SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study.
|
NA
|
NA
|
|
Synthea™ Novel coronavirus (COVID-19) model and synthetic data set.
|
NA
|
NA
|
|
Kidney function indicators predict adverse outcomes of COVID-19.
|
NA
|
NA
|
|
Ibrutinib for chronic lymphocytic leukemia in the setting of respiratory failure from severe COVID-19 infection: Case report and literature review.
|
NA
|
NA
|
|
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: a systematic review.
|
NA
|
NA
|
|
Helping Couples Connect during the COVID-19 Pandemic: A Pilot Randomised Controlled Trial of an Awareness, Courage, and Love Intervention.
|
NA
|
NA
|
|
Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?
|
NA
|
NA
|
|
Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease.
|
NA
|
NA
|
|
High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 Pandemic’s Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
|
NA
|
NA
|
|
Hydroxychloroquine in hospitalized COVID-19 patients: Real world experience assessing mortality.
|
NA
|
NA
|
|
Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths.
|
NA
|
NA
|
|
Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom.
|
NA
|
NA
|
|
What Is the Impact of the COVID-19 Pandemic on Quality of Life and Other Patient-reported Outcomes? An Analysis of the Hand-Wrist Study Cohort.
|
NA
|
NA
|
|
Dematiaceous Fungal Colonization of the Bandage Contact Lens in a Patient Lost to Follow-up During the COVID-19 Crisis.
|
NA
|
NA
|
|
Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
|
NA
|
NA
|
|
Chinese Medicine, Which Targets Body’s Response State, Is An Effective Way to Treat Epidemic Infectious Diseases.
|
NA
|
NA
|
|
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
|
NA
|
NA
|
|
To Transplant or Not to Transplant During the SARS-CoV-2 Pandemic? That Is the Question.
|
NA
|
NA
|
|
Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
|
NA
|
NA
|
|
Overlaying COVID-19 mitigation plans on malaria control infrastructures.
|
NA
|
NA
|
|
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
|
NA
|
NA
|
|
Familiar Dermatologic Drugs as Therapies for COVID-19.
|
NA
|
NA
|
|
Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2.
|
NA
|
NA
|
|
CRISPR-based assays for rapid detection of SARS-CoV-2.
|
NA
|
NA
|
|
The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design.
|
NA
|
NA
|
|
Susceptibility of obese population to COVID-19.
|
NA
|
NA
|
|
Emergent carotid artery stenting following intravenous alteplase infusion after rapid negative diagnosis for COVID-19 by loop-mediated isothermal amplification assay: A case report.
|
NA
|
NA
|
|
Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease.
|
NA
|
NA
|
|
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.
|
NA
|
NA
|
|
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.
|
NA
|
NA
|
|
The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities.
|
NA
|
NA
|
|
Stem Cell Therapy: A Promising Approach in Treatment of COVID 19.
|
NA
|
NA
|
|
Clinical characteristics and laboratory indicator analysis of 67 COVID-19 pneumonia patients in Suzhou, China.
|
NA
|
NA
|
|
Spontaneous pneumothorax as unusual presenting symptom of COVID-19 pneumonia: surgical management and pathological findings.
|
NA
|
NA
|
|
Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study.
|
NA
|
NA
|
|
Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E.
|
NA
|
NA
|
|
Identifying and quantifying robust risk factors for mortality in critically ill patients with COVID-19 using quantile regression.
|
NA
|
NA
|
|
Cardiopulmonary resuscitation in prone position: A scoping review.
|
NA
|
NA
|
|
Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: A multicenter observational study.
|
NA
|
NA
|
|
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
|
NA
|
NA
|
|
Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis.
|
NA
|
NA
|
|
[COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
|
NA
|
NA
|
|
CT Quantification and Machine-learning Models for Assessment of Disease Severity and Prognosis of COVID-19 Patients.
|
NA
|
NA
|
|
Hoping for the best, planning for the worst: Palliative care approach to Parkinson disease during the COVID-19 pandemic.
|
NA
|
NA
|
|
Ethical challenges for women’s healthcare highlighted by the COVID-19 pandemic.
|
NA
|
NA
|
|
A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2.
|
NA
|
NA
|
|
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
|
NA
|
NA
|
|
Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients.
|
NA
|
NA
|
|
Prevalence of post-traumatic symptomatology and anxiety among residential nursing and care home workers following the first COVID-19 outbreak in Northern Italy.
|
NA
|
NA
|
|
Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
Right Atrial Thrombus in Transient in a COVID-19 Patient: Clinical Echocardiographic Features-Case Report and Literature Review.
|
NA
|
NA
|
|
What chances do children have against COVID-19? Is the answer hidden within the thymus?
|
NA
|
NA
|
|
Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
|
NA
|
NA
|
|
The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Dental care during COVID-19 pandemic: survey of experts’ opinion.
|
NA
|
NA
|
|
T cell and antibody responses to SARS-CoV-2: experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.
|
NA
|
NA
|
|
Exploring metastatic breast cancer treatment changes during COVID-19 pandemic.
|
NA
|
NA
|
|
Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2.
|
NA
|
NA
|
|
[Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff’s protective equipment].
|
NA
|
NA
|
|
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases.
|
NA
|
NA
|
|
Imposed mutational meltdown as an antiviral strategy.
|
NA
|
NA
|
|
Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
|
NA
|
NA
|
|
Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study.
|
NA
|
NA
|
|
Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study.
|
NA
|
NA
|
|
Uniform infection screening allowed safe head and neck surgery during the coronavirus disease 2019 pandemic in Japan.
|
NA
|
NA
|
|
Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
|
NA
|
NA
|
|
The social and clinical impact of the Covid-19 epidemic on the Strasbourg lung transplant cohort - a single-center retrospective cohort study.
|
NA
|
NA
|
|
Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
|
NA
|
NA
|
|
M3Lung-Sys: A Deep Learning System for Multi-Class Lung Pneumonia Screening from CT Imaging.
|
NA
|
NA
|
|
Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions.
|
NA
|
NA
|
|
[Convalescent plasma therapy in COVID-19 patients, in the Province of Buenos Aires].
|
NA
|
NA
|
|
[Cardiovascular admissions in Intensive Care Units during COVID-19 pandemic].
|
NA
|
NA
|
|
[Initial experience in the attention of patients with COVID-19 in a private third-level hospital in Buenos Aires City].
|
NA
|
NA
|
|
[Adverse effects of lopinavir/ritonavir in critically ill patients with COVID-19].
|
NA
|
NA
|
|
[Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV].
|
NA
|
NA
|
|
A COVID-19 Outcome Prediction and Monitoring Solution for Military Hospitals in South Korea: Development and Evaluation of a Platform.
|
NA
|
NA
|
|
COVID-19 and Cancer: Current Challenges and Perspectives.
|
NA
|
NA
|
|
Myocardial injury associated with coronavirus disease 2019 in pregnancy.
|
NA
|
NA
|
|
Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
|
NA
|
NA
|
|
The impact of COVID-19 on acute ischemic stroke admissions: Analysis from a community-based tertiary care center.
|
NA
|
NA
|
|
Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019-2020.
|
NA
|
NA
|
|
Pharmaconutrition revisited for critically ill patients with coronavirus disease 2019 (COVID-19): Does selenium have a place?
|
NA
|
NA
|
|
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies.
|
NA
|
NA
|
|
Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.
|
NA
|
NA
|
|
Tele-health and Palliative Care for Cancer Patients: Implications for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Pentoxifylline, a drug with antiviral, anti-inflammatory and bronchodilatory effects may be a possible drug candidate for SARS-CoV-2.
|
NA
|
NA
|
|
A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers.
|
NA
|
NA
|
|
Telemedicine in Oral and Maxillo-Facial Surgery: An Effective Alternative in Post COVID-19 Pandemic.
|
NA
|
NA
|
|
NMR as a “Gold Standard” Method in Drug Design and Discovery.
|
NA
|
NA
|
|
Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19.
|
NA
|
NA
|
|
The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19).
|
NA
|
NA
|
|
Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature.
|
NA
|
NA
|
|
Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives.
|
NA
|
NA
|
|
Clouds and Silver Linings: COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through Telehealth.
|
NA
|
NA
|
|
Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.
|
NA
|
NA
|
|
COVID-19 and Renal Diseases: An Update.
|
NA
|
NA
|
|
COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail.
|
NA
|
NA
|
|
Anesthesia departments’ readiness for the COVID-19 pandemic; a nationwide cross-sectional study in Israel.
|
NA
|
NA
|
|
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
|
NA
|
NA
|
|
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
|
NA
|
NA
|
|
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China.
|
NA
|
NA
|
|
Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
|
NA
|
NA
|
|
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Sudden irreversible hearing loss post COVID-19.
|
NA
|
NA
|
|
Management of cardiovascular emergencies during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of comorbidities on clinical prognosis in 1280 patients with different types of COVID-19.
|
NA
|
NA
|
|
[The Peripheral Neuropathy and Myopathy Associated with Severe Acute Respiratory Syndrome-Correlated New Coronavirus (SARS-Cov-2)].
|
NA
|
NA
|
|
[COVID-19 and the Hospital Neurologist: How should we confront the COVID pandemic?]
|
NA
|
NA
|
|
[Treatment of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic].
|
NA
|
NA
|
|
Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies.
|
NA
|
NA
|
|
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series.
|
NA
|
NA
|
|
Early Treatment of COVID-19 Disease: A Missed Opportunity.
|
NA
|
NA
|
|
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.
|
NA
|
NA
|
|
Management of COVID-19 patients in Fangcang shelter hospital: clinical practice and effectiveness analysis.
|
NA
|
NA
|
|
Exploring the role of triazole functionalized heteroatom co-doped carbon quantum dots against human coronaviruses.
|
NA
|
NA
|
|
Translating evidence-based treatment for digital health delivery: a protocol for family-based treatment for anorexia nervosa using telemedicine.
|
NA
|
NA
|
|
Ground Glass Opacities Observed in a 26-Year-Old Coronavirus Disease 2019 (COVID-19) Rule-Out Patient With a History of Vape Use.
|
NA
|
NA
|
|
Breast cancer patients with hormone neoadjuvant bridging therapy due to asymptomatic Corona virus infection. Case report, clinical and histopathologic findings.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio/chemoinformatics tools.
|
NA
|
NA
|
|
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
|
NA
|
NA
|
|
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?
|
NA
|
NA
|
|
Impact of the initial phase of COVID-19 pandemic on surgical oncology services at a tertiary care center in Eastern India.
|
NA
|
NA
|
|
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.
|
NA
|
NA
|
|
EMDR in Telemental Health Counseling for Healthcare Workers Caring for COVID-19 Patients: A Pilot Study.
|
NA
|
NA
|
|
Practical Diagnostic Accuracy of Nasopharyngeal Swab Testing for Novel Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Emergency Department Management of COVID-19: An Evidence-Based Approach.
|
NA
|
NA
|
|
CEdRIC: Strategy for Patient Education During COVID-19 Triage.
|
NA
|
NA
|
|
The urological practice and contribution to the general health system of the EBU accredited urology clinic during the first month of COVID-19 pandemic: An analysis from a tertiary center declared as a national COVID-19 pandemic hospital in Turkey.
|
NA
|
NA
|
|
Particle removal from air by face masks made from Sterilization Wraps: Effectiveness and Reusability.
|
NA
|
NA
|
|
Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study.
|
NA
|
NA
|
|
Characteristics and outcomes of patients infected with nCoV19 requiring invasive mechanical ventilation in Argentina.
|
NA
|
NA
|
|
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial.
|
NA
|
NA
|
|
ELSI-COVID-19 initiative: methodology of the telephone survey on coronavirus in the Brazilian Longitudinal Study of Aging.
|
NA
|
NA
|
|
Survival analysis of treatment efficacy in comparative COVID-19 studies.
|
NA
|
NA
|
|
SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study.
|
NA
|
NA
|
|
Treatment for COVID-19: An overview.
|
NA
|
NA
|
|
From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors.
|
NA
|
NA
|
|
Ethical guidelines for clinical research related to public health emergencies.
|
NA
|
NA
|
|
Bioethics in the COVID-19 Pandemic Research: Challenges and Strategies.
|
NA
|
NA
|
|
Early phase dose-finding trials in virology.
|
NA
|
NA
|
|
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).
|
NA
|
NA
|
|
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.
|
NA
|
NA
|
|
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19.
|
NA
|
NA
|
|
Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies.
|
NA
|
NA
|
|
(COVID-19).
|
NA
|
NA
|
|
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Deciphering Vaccines for COVID-19: where do we stand today?
|
NA
|
NA
|
|
From Hospital to Home: An Intensive Transitional Care Management Intervention for Patients with COVID-19.
|
NA
|
NA
|
|
The challenge of maintaining necessary vascular and endovascular services at a referral center in Northern Italy during the COVID-19 outbreak.
|
NA
|
NA
|
|
Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis.
|
NA
|
NA
|
|
Clinical and imaging features of pediatric COVID-19.
|
NA
|
NA
|
|
Venous thromboembolism and COVID-19: a case report and review of the literature.
|
NA
|
NA
|
|
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
|
NA
|
NA
|
|
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
|
NA
|
NA
|
|
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach.
|
NA
|
NA
|
|
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
|
NA
|
NA
|
|
Remdesivir against COVID-19 and Other Viral Diseases.
|
NA
|
NA
|
|
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.
|
NA
|
NA
|
|
Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy.
|
NA
|
NA
|
|
Third Cranial Nerve Palsy Presenting with Unilateral Diplopia and Strabismus in a 24-Year-Old Woman with COVID-19.
|
NA
|
NA
|
|
Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness.
|
NA
|
NA
|
|
ACE2 mouse models: a toolbox for cardiovascular and pulmonary research.
|
NA
|
NA
|
|
Considerations for diagnostic COVID-19 tests.
|
NA
|
NA
|
|
Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients.
|
NA
|
NA
|
|
How confidence in health care systems affects mobility and compliance during the COVID-19 pandemic.
|
NA
|
NA
|
|
Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies.
|
NA
|
NA
|
|
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.
|
NA
|
NA
|
|
Update and Recommendations for Ocular Manifestations of COVID-19 in Adults and Children: A Narrative Review.
|
NA
|
NA
|
|
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.
|
NA
|
NA
|
|
Considerations for the Management of Oncology Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
|
NA
|
NA
|
|
EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic.
|
NA
|
NA
|
|
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome.
|
NA
|
NA
|
|
Management of Rheumatic Diseases During the COVID-19 pandemic: A National Veterans Affairs Survey of Rheumatologists.
|
NA
|
NA
|
|
Characterization of community-wide transmission of SARS-CoV-2 in congregate living settings and local public health-coordinated response during the initial phase of the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 Emergency Sick Leave Has Helped Flatten The Curve In The United States.
|
NA
|
NA
|
|
Immediate and Long-Term Implications of the COVID-19 Pandemic for People With Disabilities.
|
NA
|
NA
|
|
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.
|
NA
|
NA
|
|
Genetics of COVID-19.
|
NA
|
NA
|
|
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer.
|
NA
|
NA
|
|
A Cross-sectional Survey on the Impact of Coronavirus Disease 2019 on the Clinical Practice of Endodontists across the United States.
|
NA
|
NA
|
|
Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic: A Historical Cohort Study.
|
NA
|
NA
|
|
Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review.
|
NA
|
NA
|
|
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.
|
NA
|
NA
|
|
Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview.
|
NA
|
NA
|
|
Supporting the well-being of health care providers during the COVID-19 pandemic: The CopeColumbia response.
|
NA
|
NA
|
|
The endless quarantine: the impact of the COVID-19 outbreak on healthcare workers after three months of mandatory social isolation in Argentina.
|
NA
|
NA
|
|
Effect of COVID19 pandemic and national lockdown on persons with diabetes from rural areas availing care in a tertiary care center, southern India.
|
NA
|
NA
|
|
Change in Allergy Practice during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
|
NA
|
NA
|
|
Clinical management of Lupus patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors.
|
NA
|
NA
|
|
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy.
|
NA
|
NA
|
|
Cardiac Complications Attributed to Hydroxychloroquine: A systematic review of the Literature Pre-COVID-19.
|
NA
|
NA
|
|
A commentary on podiatry during the Covid-19 pandemic : Podiatry during the Covid-19 pandemic.
|
NA
|
NA
|
|
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
|
NA
|
NA
|
|
[Association of age distribution with the expression of angiotensin-converting enzyme 2 in lung tissues in severe acute respiratory syndrome coronavirus 2 infection: reflections from the study of RAS pathway expression in mice].
|
NA
|
NA
|
|
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review.
|
NA
|
NA
|
|
Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
|
NA
|
NA
|
|
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
|
NA
|
NA
|
|
Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review.
|
NA
|
NA
|
|
SARS-CoV-2 Versus Influenza-associated Acute Respiratory Distress Syndrome Requiring Veno-venous Extracorporeal Membrane Oxygenation Support.
|
NA
|
NA
|
|
Murine Typhus Outbreak Presenting as Multisystem Inflammatory Syndrome in Children During SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Clinical characteristics of “re-positive” discharged COVID-19 pneumonia patients in Wuhan, China.
|
NA
|
NA
|
|
Statin use is associated with lower disease severity in COVID-19 infection.
|
NA
|
NA
|
|
Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
|
NA
|
NA
|
|
Unique immunological profile in patients with COVID-19.
|
NA
|
NA
|
|
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
|
NA
|
NA
|
|
Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential.
|
NA
|
NA
|
|
Early Impact of COVID-19 Outbreak on the Availability of Cornea Donors: Warnings and Recommendations.
|
NA
|
NA
|
|
The Role of the Ocular Tissue in SARS-CoV-2 Transmission.
|
NA
|
NA
|
|
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.
|
NA
|
NA
|
|
Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report.
|
NA
|
NA
|
|
Coinfection on a COVID-19 Pneumonia in a Breast Cancer Patient.
|
NA
|
NA
|
|
Herpes Zoster and Postherpetic Neuralgia in an Elderly Patient with Critical COVID-19: A Case Report.
|
NA
|
NA
|
|
The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations.
|
NA
|
NA
|
|
The Impact of Emotional Intelligence on Job Performance During COVID-19 Crisis: A Cross-Sectional Analysis.
|
NA
|
NA
|
|
Management Strategies for Patients After CABG Surgery in the Outbreak of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Cancer Care Management During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission.
|
NA
|
NA
|
|
The development of the ‘COVID-19 Psychological Resilience Model’ and its efficacy during the COVID-19 pandemic in China.
|
NA
|
NA
|
|
Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19.
|
NA
|
NA
|
|
Artificial Intelligence-Based Classification of Chest X-Ray Images into COVID-19 and Other Infectious Diseases.
|
NA
|
NA
|
|
Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy.
|
NA
|
NA
|
|
Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future.
|
NA
|
NA
|
|
Comparative Analysis of 95 Patients with Different Severity in the Early Outbreak of COVID-19 in Wuhan, China.
|
NA
|
NA
|
|
Influence of the COVID-19 Pandemic on Quality of Life of Patients with Parkinson’s Disease.
|
NA
|
NA
|
|
Convalescent plasma appears efficacious and safe in COVID-19.
|
NA
|
NA
|
|
Pregnancy and Neonatal Outcomes in SARS-CoV-2 Infection: A Systematic Review.
|
NA
|
NA
|
|
Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma.
|
NA
|
NA
|
|
COVID-19: An International Public Health Concern.
|
NA
|
NA
|
|
A Review of the Risk Factors Associated With Poor Outcomes in Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians: A Comprehensive Literature Review.
|
NA
|
NA
|
|
Ivermectin: A Closer Look at a Potential Remedy.
|
NA
|
NA
|
|
Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) Accompanied by Maculopapular Rash: A Case Study.
|
NA
|
NA
|
|
Use of Dexmedetomidine in Early Prone Positioning Combined With High-Flow Nasal Cannula and Non-Invasive Positive Pressure Ventilation in a COVID-19 Positive Patient.
|
NA
|
NA
|
|
Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine.
|
NA
|
NA
|
|
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization.
|
NA
|
NA
|
|
Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.
|
NA
|
NA
|
|
The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
|
NA
|
NA
|
|
SCHEDULING DELAYED TREATMENT AND SURGERIES POST-PANDEMIC: A STAKEHOLDER ANALYSIS.
|
NA
|
NA
|
|
Challenges in Teaching Palliative Care Module Virtually during COVID-19 Era.
|
NA
|
NA
|
|
How pets factor into healthcare decisions for COVID-19: A One Health perspective.
|
NA
|
NA
|
|
These Are Still Good Days to Heal: Cancer Care and the Covid-19 Pandemic.
|
NA
|
NA
|
|
Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections.
|
NA
|
NA
|
|
SARS-CoV-2 Vaccine Development: An Overview and Perspectives.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation Retrieval in Coronavirus Disease 2019: A Case-Series of 19 Patients Supported at a High-Volume Extracorporeal Membrane Oxygenation Center.
|
NA
|
NA
|
|
Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
|
NA
|
NA
|
|
Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients.
|
NA
|
NA
|
|
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
|
NA
|
NA
|
|
Antiviral Dosing Modification for Coronavirus Disease 2019-Infected Patients Receiving Extracorporeal Therapy.
|
NA
|
NA
|
|
Molecular Diagnosis of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients’ Recovery.
|
NA
|
NA
|
|
Breathing Aid Devices to Support Novel Coronavirus (COVID-19)Infected Patients.
|
NA
|
NA
|
|
A Study on Fight Against COVID-19 from Latest Technological Intervention.
|
NA
|
NA
|
|
Wearable Technology to Assist the Patients Infected with Novel Coronavirus (COVID-19).
|
NA
|
NA
|
|
Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.
|
NA
|
NA
|
|
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
|
NA
|
NA
|
|
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.
|
NA
|
NA
|
|
QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
|
NA
|
NA
|
|
Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment.
|
NA
|
NA
|
|
Development of a Child and Adolescent Tele-Partial Hospitalization Program (tele-PHP) in Response to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.
|
NA
|
NA
|
|
Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.
|
NA
|
NA
|
|
From COVID-19 to clot: the involvement of the complement system.
|
NA
|
NA
|
|
Infusion of Antineoplastic Therapies in the Home.
|
NA
|
NA
|
|
Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
eHealth Literacy of German Physicians in the Pre-COVID-19 Era: Questionnaire Study.
|
NA
|
NA
|
|
Association between opioid dose escalation and time to death in a comfort measures only population.
|
NA
|
NA
|
|
[Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab].
|
NA
|
NA
|
|
Disorders of sodium balance and its clinical implications in COVID-19 patients: a multicenter retrospective study.
|
NA
|
NA
|
|
Outpatient Management of COVID-19: Rapid Evidence Review.
|
NA
|
NA
|
|
Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.
|
NA
|
NA
|
|
The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.
|
NA
|
NA
|
|
Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 pandemic: challenges ahead.
|
NA
|
NA
|
|
Survival in pediatric patients with cancer during the COVID-19 pandemic: scoping systematic review.
|
NA
|
NA
|
|
Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic.
|
NA
|
NA
|
|
Experience in the management of severe COVID-19 patients in an intensive care unit.
|
NA
|
NA
|
|
Anxiety, depression, and stress in response to the coronavirus disease-19 pandemic.
|
NA
|
NA
|
|
Comparison of IV oncology infusions compounded via robotics and gravimetrics-assisted workflow processes.
|
NA
|
NA
|
|
Commonalities Between COVID-19 and Radiation Injury.
|
NA
|
NA
|
|
COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy.
|
NA
|
NA
|
|
Africa Needs a New Public Health Order to Tackle Infectious Disease Threats.
|
NA
|
NA
|
|
Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic.
|
NA
|
NA
|
|
Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2.
|
NA
|
NA
|
|
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
|
NA
|
NA
|
|
Low dose radiation therapy for COVID-19: Effective dose and estimation of cancer risk.
|
NA
|
NA
|
|
The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection.
|
NA
|
NA
|
|
Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection.
|
NA
|
NA
|
|
Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on lung cancer patients.
|
NA
|
NA
|
|
Recommendations, Practices and Infrastructural Model for the Dental Radiology Set-up in Clinical and Academic Institutions in the COVID-19 Era.
|
NA
|
NA
|
|
COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness.
|
NA
|
NA
|
|
Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
|
NA
|
NA
|
|
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
|
NA
|
NA
|
|
Silent hypoxia: higher NO in red blood cells of COVID-19 patients.
|
NA
|
NA
|
|
Adapting hospital capacity to meet changing demands during the COVID-19 pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on pediatric operations: a retrospective study of Chinese children.
|
NA
|
NA
|
|
Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy.
|
NA
|
NA
|
|
In the Turkish News: Coronavirus and “Alternative & complementary” medicine methods.
|
NA
|
NA
|
|
Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature.
|
NA
|
NA
|
|
COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center.
|
NA
|
NA
|
|
Current Recommendations for the Management of Stroke Patients in the Middle East in the Era of COVID-19 Pandemic; Statement from the MENA SINO.
|
NA
|
NA
|
|
Coagulation and anticoagulation in COVID-19.
|
NA
|
NA
|
|
[Physiotherapy and COVID-19. From intensive care unit to home care-An overview of international guidelines].
|
NA
|
NA
|
|
Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
|
NA
|
NA
|
|
Retinal findings in hospitalised patients with severe COVID-19.
|
NA
|
NA
|
|
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
|
NA
|
NA
|
|
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
|
NA
|
NA
|
|
Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics.
|
NA
|
NA
|
|
Development of a prognostic model for mortality in COVID-19 infection using machine learning.
|
NA
|
NA
|
|
Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study.
|
NA
|
NA
|
|
Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China.
|
NA
|
NA
|
|
Recommended measures for the efficient care of patients with genetic disorders during the COVID-19 pandemic in low and middle income countries.
|
NA
|
NA
|
|
Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics.
|
NA
|
NA
|
|
A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2.
|
NA
|
NA
|
|
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
|
NA
|
NA
|
|
Rotational thromboelastometry results are associated with care level in COVID-19.
|
NA
|
NA
|
|
The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia.
|
NA
|
NA
|
|
[Moxibustion therapy in prevention and treatment of coronavirus disease 2019 (COVID-19): construction and application of non-contact diagnosis and treatment mode].
|
NA
|
NA
|
|
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
|
NA
|
NA
|
|
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19.
|
NA
|
NA
|
|
Perspectives on mechanistic implications of ROS inducers for targeting viral infections.
|
NA
|
NA
|
|
Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic.
|
NA
|
NA
|
|
Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
|
NA
|
NA
|
|
Outcomes of persons with coronavirus disease 2019 in hospitals with and without standard treatment with (hydroxy)chloroquine.
|
NA
|
NA
|
|
Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
|
NA
|
NA
|
|
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
|
NA
|
NA
|
|
Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results.
|
NA
|
NA
|
|
Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support: A Case Series.
|
NA
|
NA
|
|
Transfer Factor as an Option for Managing the COVID-19 Pandemic.
|
NA
|
NA
|
|
Anxiety, Insomnia and Body Mass Index scores in Italian nurses engaged in the care of COVID-19 patients.
|
NA
|
NA
|
|
Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
|
NA
|
NA
|
|
Association between early childhood oral health impact scale (ECOHIS) scores and pediatric dental surgery wait times.
|
NA
|
NA
|
|
[SARS-COV-2 myocarditis. An update].
|
NA
|
NA
|
|
Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
Precautions in dentistry against the outbreak of corona virus disease 2019.
|
NA
|
NA
|
|
ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors.
|
NA
|
NA
|
|
COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.
|
NA
|
NA
|
|
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
|
NA
|
NA
|
|
The role of dysregulated immune responses in COVID-19 pathogenesis.
|
NA
|
NA
|
|
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study.
|
NA
|
NA
|
|
Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.
|
NA
|
NA
|
|
Primed for global coronavirus pandemic: Emerging research and clinical outcome.
|
NA
|
NA
|
|
Status epilepticus 2020.
|
NA
|
NA
|
|
High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
|
NA
|
NA
|
|
International travel to obtain medical treatment for primary retinoblastoma: A global cohort study.
|
NA
|
NA
|
|
Pivots and pirouettes: adapting a robust departmental CPD and training program to the COVID-19 crisis.
|
NA
|
NA
|
|
Beyond SARS-CoV-2: Lessons That African Governments Can Apply in Preparation for Possible Future Epidemics.
|
NA
|
NA
|
|
Usefulness of machine learning in COVID-19 for the detection and prognosis of cardiovascular complications.
|
NA
|
NA
|
|
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review.
|
NA
|
NA
|
|
Cardiovascular system and COVID-19: manifestations and therapeutics.
|
NA
|
NA
|
|
Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients.
|
NA
|
NA
|
|
Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
|
NA
|
NA
|
|
Locked-In with COVID-19.
|
NA
|
NA
|
|
Mitigating the transmission of infection and death due to SARS-CoV-2 through non-pharmaceutical interventions and repurposing drugs.
|
NA
|
NA
|
|
COVID-19: Clouds Over the Antimicrobial Resistance Landscape.
|
NA
|
NA
|
|
Invisible children and non-essential workers: Child protection during COVID-19 in Israel according to policy documents and media coverage.
|
NA
|
NA
|
|
Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS.
|
NA
|
NA
|
|
Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.
|
NA
|
NA
|
|
The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Mitigating the effects of COVID-19 pandemic on controlling vascular risk factors among participants in a carotid stenosis trial.
|
NA
|
NA
|
|
A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.
|
NA
|
NA
|
|
‘Return to the New Normal’: Innovative Solutions for Safe Ponseti Casting in Clubfoot Clinics during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study.
|
NA
|
NA
|
|
[Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience].
|
NA
|
NA
|
|
A survey on artificial intelligence approaches in supporting frontline workers and decision makers for the COVID-19 pandemic.
|
NA
|
NA
|
|
Outcomes of Ayurvedic care in a COVID-19 patient with hypoxia - A Case Report.
|
NA
|
NA
|
|
COVID-19 Creating another problem? Sustainable solution for PPE disposal through LCA approach.
|
NA
|
NA
|
|
Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.
|
NA
|
NA
|
|
Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells.
|
NA
|
NA
|
|
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.
|
NA
|
NA
|
|
COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
|
NA
|
NA
|
|
Conspiracy Beliefs, Rejection of Vaccination, and Support for hydroxychloroquine: A Conceptual Replication-Extension in the COVID-19 Pandemic Context.
|
NA
|
NA
|
|
Practical Considerations for the Management of Cushing’s Disease and COVID-19: A Case Report.
|
NA
|
NA
|
|
Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses.
|
NA
|
NA
|
|
Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
|
NA
|
NA
|
|
Probiotics in Medicine: A Long Debate.
|
NA
|
NA
|
|
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors-The Current Status.
|
NA
|
NA
|
|
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.
|
NA
|
NA
|
|
Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
|
NA
|
NA
|
|
Familial Mediterranean Fever and COVID-19: Friends or Foes?
|
NA
|
NA
|
|
Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2.
|
NA
|
NA
|
|
Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia.
|
NA
|
NA
|
|
Case series of four pregnant women with COVID-19 in Ilam, Iran.
|
NA
|
NA
|
|
Early Treatment of COVID-19 Disease: A Missed Opportunity.
|
NA
|
NA
|
|
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.
|
NA
|
NA
|
|
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.
|
NA
|
NA
|
|
Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia.
|
NA
|
NA
|
|
ts During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept.
|
NA
|
NA
|
|
Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused.
|
NA
|
NA
|
|
The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 Outbreak.
|
NA
|
NA
|
|
Covid-19 Pandemic: Maximizing Future Vaccination Treatments Considering Aging and Frailty.
|
NA
|
NA
|
|
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia.
|
NA
|
NA
|
|
Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality.
|
NA
|
NA
|
|
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest.
|
NA
|
NA
|
|
Stroke care in Italy: An overview of strategies to manage acute stroke in COVID-19 time.
|
NA
|
NA
|
|
Maintaining stroke care in Europe during the COVID-19 pandemic: Results from an international survey of stroke professionals and practice recommendations from the European Stroke Organisation.
|
NA
|
NA
|
|
An efficient planning technique for low dose whole lung radiation therapy for covid-19 pandemic patients.
|
NA
|
NA
|
|
Prevalence and risk factors of COVID-19 suicidal behavior in Bangladeshi population: are healthcare professionals at greater risk?
|
NA
|
NA
|
|
Implementation of Telehealth in Radiation Oncology: Rapid Integration During COVID-19 and Its Future Role in Our Practice.
|
NA
|
NA
|
|
Time to Treat: Applying Lessons Learned from Other Viral Syndromes to SARS-CoV-2.
|
NA
|
NA
|
|
Oh, the Frustration of Antibodies!
|
NA
|
NA
|
|
Ivermectin, Famotidine, and Doxycycline: A Suggested Combinatorial Therapeutic for the Treatment of COVID-19.
|
NA
|
NA
|
|
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study.
|
NA
|
NA
|
|
Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis.
|
NA
|
NA
|
|
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
|
NA
|
NA
|
|
B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection?
|
NA
|
NA
|
|
Pathogenesis-directed therapy of 2019 novel coronavirus disease.
|
NA
|
NA
|
|
Repurposing of drugs for Covid-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Infusion of HLA-matched and static magnetic field-exposed allogenic lymphocytes treating lymphocytopenia and cytokine storm syndrome: A treatment proposal for COVID-19 patients.
|
NA
|
NA
|
|
Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection.
|
NA
|
NA
|
|
Covid-19 Pandemic: Through the Lens of Science, a Painstaking Review.
|
NA
|
NA
|
|
An Overview on the Common Laboratory Parameter Alterations and their Related Molecular Pathways in Screening for COVID-19 Patients.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China.
|
NA
|
NA
|
|
Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.
|
NA
|
NA
|
|
Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer’s Disease.
|
NA
|
NA
|
|
The cognitive consequences of the COVID-19 epidemic: collateral damage?
|
NA
|
NA
|
|
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment.
|
NA
|
NA
|
|
COVID-19 and Hypercoagulability: A Review.
|
NA
|
NA
|
|
Reconnecting: Strategies for Supporting Isolated Older Adults during COVID-19 through Tele-palliative Care.
|
NA
|
NA
|
|
Postoperative Onset and Detection of SARS-CoV-2 in Surgically Resected Specimens From Gastrointestinal Cancer Patients With Pre/Asymptomatic COVID-19.
|
NA
|
NA
|
|
Ethics of Codes and Codes of Ethics: When Is It Ethical to Provide Cardiopulmonary Resuscitation During the COVID-19 Pandemic?
|
NA
|
NA
|
|
Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
|
NA
|
NA
|
|
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - An EAACI Position Paper.
|
NA
|
NA
|
|
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
|
NA
|
NA
|
|
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.
|
NA
|
NA
|
|
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem.
|
NA
|
NA
|
|
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
|
NA
|
NA
|
|
Methylene blue inhibits replication of SARS-CoV-2 in vitro.
|
NA
|
NA
|
|
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
|
NA
|
NA
|
|
Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
|
NA
|
NA
|
|
Home-made masks with filtration efficiency for nano-aerosols for community mitigation of COVID-19 pandemic.
|
NA
|
NA
|
|
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial.
|
NA
|
NA
|
|
Longitudinal Survey of COVID-19 Burden and Related Policies in U.S. Neonatal Intensive Care Units.
|
NA
|
NA
|
|
Operation and Management of Seoul Metropolitan City Community Treatment Center for Mild Condition COVID-19 Patients.
|
NA
|
NA
|
|
Kinetic Monte Carlo model for the COVID-19 epidemic: Impact of mobility restriction on a COVID-19 outbreak.
|
NA
|
NA
|
|
Case report of sequential bilateral spontaneous pneumothorax in a never-ventilated, lung-healthy COVID-19-patient.
|
NA
|
NA
|
|
Sepsis, Phages, and COVID-19.
|
NA
|
NA
|
|
Medicinal Plants to Strengthen Immunity during a Pandemic.
|
NA
|
NA
|
|
[Interpretation for the group standards in the handling of accidental leak coronavirus disease 2019 sample].
|
NA
|
NA
|
|
The Early Impact of the COVID-19 Pandemic on Acute Care Mental Health Services.
|
NA
|
NA
|
|
New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review.
|
NA
|
NA
|
|
Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months.
|
NA
|
NA
|
|
Inpatient antibiotic utilization in the Veterans’ Health Administration during the coronavirus disease 2019 (COVID-19) pandemic.
|
NA
|
NA
|
|
Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study.
|
NA
|
NA
|
|
Critically ill COVID-19 patients attended by anesthesiologists in northwestern Spain: a multicenter prospective observational study.
|
NA
|
NA
|
|
Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?
|
NA
|
NA
|
|
A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities.
|
NA
|
NA
|
|
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.
|
NA
|
NA
|
|
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.
|
NA
|
NA
|
|
Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
|
NA
|
NA
|
|
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
|
NA
|
NA
|
|
[Care path for non-deferred elective hospitalizations in cardiology in the Covid-19 period].
|
NA
|
NA
|
|
[The reorganization of the strategies of a surgical department and the nosocomial diffusion of Covid-19].
|
NA
|
NA
|
|
[How hospitals, Intensive Care Units and nursing care of critically ill patients have changed during the Covid-19 outbreak? Results from an exploratory research in some European countries].
|
NA
|
NA
|
|
Case reports of first psychiatric presentations during CoViD-19 pandemic.
|
NA
|
NA
|
|
Corona COVID-19 spread - a nonlinear modeling and simulation.
|
NA
|
NA
|
|
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs.
|
NA
|
NA
|
|
A materials-science perspective on tackling COVID-19.
|
NA
|
NA
|
|
Recent perspectives and awareness on transmission, clinical manifestation, quarantine measures, prevention and treatment of COVID-19 among people living in Malaysia in 2020.
|
NA
|
NA
|
|
COVID-19 in a patient with a flare of systemic lupus erythematosus: A rare case-report.
|
NA
|
NA
|
|
Impacts of COVID-19 on Liver Cancers: During and after the Pandemic.
|
NA
|
NA
|
|
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
|
NA
|
NA
|
|
Epidemiological changes on the Isle of Wight after the launch of the NHS Test and Trace programme: a preliminary analysis.
|
NA
|
NA
|
|
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma.
|
NA
|
NA
|
|
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease.
|
NA
|
NA
|
|
Drive-through transcutaneous bilirubin screening for neonatal jaundice: A safe and efficient system during the COVID-19 pandemic.
|
NA
|
NA
|
|
Group teletherapy for first-episode psychosis: Piloting its integration with coordinated specialty care during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups.
|
NA
|
NA
|
|
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
|
NA
|
NA
|
|
Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.
|
NA
|
NA
|
|
Metronomic chemotherapy for scheduling oral cancer surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab.
|
NA
|
NA
|
|
The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Characteristics of coagulation alteration in patients with COVID-19.
|
NA
|
NA
|
|
Targeting the Vascular Endothelium in the Treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19-Associated Coagulopathy and Inflammatory Response: What Do We Know Already and What Are the Knowledge Gaps?
|
NA
|
NA
|
|
Brief Report: Virologic and Immunologic Outcomes for HIV Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
|
NA
|
NA
|
|
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
|
NA
|
NA
|
|
Designed variants of ACE2-Fc that decouple anti-SARS-CoV-2 activities from unwanted cardiovascular effects.
|
NA
|
NA
|
|
Practical nursing recommendations for palliative care for people with dementia living in long-term care facilities during the COVID-19 pandemic: A rapid scoping review.
|
NA
|
NA
|
|
Objective evaluation of odor loss in COVID-19 and other suspected cases.
|
NA
|
NA
|
|
Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions.
|
NA
|
NA
|
|
Nitric oxide’s physiologic effects and potential as a therapeutic agent against COVID-19.
|
NA
|
NA
|
|
Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: A case report.
|
NA
|
NA
|
|
A systematic review of etiology, epidemiology, clinical manifestations, image findings, and medication of 2019 Corona Virus Disease-19 in Wuhan, China.
|
NA
|
NA
|
|
The therapeutic efficacy of Huashi Baidu Formula combined with antiviral drugs in the treatment of COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Investigation on the Inhibiting Role of Nicotine/Caffeine by Blocking the S Protein of SARS-CoV-2 Versus ACE2 Receptor.
|
NA
|
NA
|
|
Identification and Tracking of Antiviral Drug Combinations.
|
NA
|
NA
|
|
The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air.
|
NA
|
NA
|
|
Viral Related Tools against SARS-CoV-2.
|
NA
|
NA
|
|
Lessons Learned from Battling COVID-19: The Korean Experience.
|
NA
|
NA
|
|
[Features of neurological manifestations of the COVID-19 in children and adults].
|
NA
|
NA
|
|
Nursing’s Response to the Executive Order to Advance American Kidney Health.
|
NA
|
NA
|
|
Rethinking the Role of Advance Care Planning in the Context of Infectious Disease.
|
NA
|
NA
|
|
Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
|
NA
|
NA
|
|
A model based on CT radiomic features for predicting RT-PCR becoming negative in coronavirus disease 2019 (COVID-19) patients.
|
NA
|
NA
|
|
The immediate effect of COVID-19 pandemic on children and adolescents with obsessive compulsive disorder.
|
NA
|
NA
|
|
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
|
NA
|
NA
|
|
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Obsessive-compulsive disorder-contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19).
|
NA
|
NA
|
|
[Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?]
|
NA
|
NA
|
|
[Possibility of mesenchymal stem cell transplantation in the treatment of coronavirus disease 2019].
|
NA
|
NA
|
|
[COVID-19 and venous thromboembolism].
|
NA
|
NA
|
|
Management Trends in the Cath Lab During the COVID-19 Period, an Egyptian Survey.
|
NA
|
NA
|
|
Managing Patients With ST-Elevation Myocardial Infarction at the Epicenter of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Effect of IBD medications on COVID-19 outcomes: results from an international registry.
|
NA
|
NA
|
|
Republished: Interhospital teleproctoring of endovascular intracranial aneurysm treatment using a dedicated live-streaming technology: first experiences during the COVID-19 pandemic.
|
NA
|
NA
|
|
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.
|
NA
|
NA
|
|
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 and its impact on genitourinary malignancies.
|
NA
|
NA
|
|
Cancer treatment during the COVID-19 pandemic in the Kurdistan Region of northern Iraq.
|
NA
|
NA
|
|
SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review.
|
NA
|
NA
|
|
Rapidly established telehealth care for blood cancer patients in Nepal during the COVID-19 pandemic using the free app Viber.
|
NA
|
NA
|
|
The ongoing COVID-19 pandemic will create a disease surge among cancer patients.
|
NA
|
NA
|
|
Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
|
NA
|
NA
|
|
[Treatment of severe COVID-19 courses in intensive care medicine].
|
NA
|
NA
|
|
The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.
|
NA
|
NA
|
|
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study.
|
NA
|
NA
|
|
Impact of COVID-19 on people living with HIV: A review.
|
NA
|
NA
|
|
Incomplete Trifascicular Block and Mobitz Type II Atrioventricular Block in COVID-19.
|
NA
|
NA
|
|
Behavioral Changes Without Respiratory Symptoms as a Presenting Sign of COVID-19 Encephalitis.
|
NA
|
NA
|
|
A Novel Case of Severe Respiratory Symptoms and Persistent Pulmonary Hypertension in a Saudi Neonate With SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Acute mesenteric thrombosis in two patients with COVID-19. Two cases report and literature review.
|
NA
|
NA
|
|
Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis.
|
NA
|
NA
|
|
Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis.
|
NA
|
NA
|
|
Transient ST Segment Elevation in a Patient with COVID-19 and a Normal Transthoracic Echocardiogram.
|
NA
|
NA
|
|
Role of monoclonal antibody drugs in the treatment of COVID-19.
|
NA
|
NA
|
|
Liver injury in COVID-19: A minireview.
|
NA
|
NA
|
|
Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection.
|
NA
|
NA
|
|
2019-nCoV: a worldwide concern and facts.
|
NA
|
NA
|
|
Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain.
|
NA
|
NA
|
|
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19.
|
NA
|
NA
|
|
Virtual On-Treatment Visits: Implementation, Patient Perspectives, Barriers, Limitations, Benefits, and Opportunities.
|
NA
|
NA
|
|
How has the COVID-19 pandemic affected tobacco users in India: Lessons from an ongoing tobacco cessation program.
|
NA
|
NA
|
|
Unexpected cancellation on a catatonic patient’s electroconvulsive therapy due to the coronavirus pandemic.
|
NA
|
NA
|
|
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity.
|
NA
|
NA
|
|
Satisfaction with the use of telehealth during COVID-19: An integrative review.
|
NA
|
NA
|
|
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Hemoadsorption cartridge and coronavirus disease 2019 infections: A case report and brief literature review.
|
NA
|
NA
|
|
Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
|
NA
|
NA
|
|
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases.
|
NA
|
NA
|
|
COVID-19 and the Case for Medical Management and Primary Care.
|
NA
|
NA
|
|
Aspergillosis Complicating Severe Coronavirus Disease.
|
NA
|
NA
|
|
Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19.
|
NA
|
NA
|
|
Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience.
|
NA
|
NA
|
|
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
|
NA
|
NA
|
|
Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study.
|
NA
|
NA
|
|
Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
|
NA
|
NA
|
|
Suspected COVID-19-related reticulated purpura of the soles in an infant.
|
NA
|
NA
|
|
Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United States.
|
NA
|
NA
|
|
Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase.
|
NA
|
NA
|
|
Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.
|
NA
|
NA
|
|
Systemic mycoses: a potential alert for complications in COVID-19 patients.
|
NA
|
NA
|
|
Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.
|
NA
|
NA
|
|
Public perceptions of conflicting information surrounding COVID-19: Results from a nationally representative survey of U.S. adults.
|
NA
|
NA
|
|
A flexible method for optimising sharing of healthcare resources and demand in the context of the COVID-19 pandemic.
|
NA
|
NA
|
|
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.
|
NA
|
NA
|
|
Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Modifications in Systemic Rheumatic Disease Medications: Patients’ Perspectives during the Height of the COVID-19 Pandemic in New York City.
|
NA
|
NA
|
|
Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
|
NA
|
NA
|
|
COVID-19: Staging of a New Disease.
|
NA
|
NA
|
|
Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
|
NA
|
NA
|
|
The potential use of ABO blood group system for risk stratification of COVID-19.
|
NA
|
NA
|
|
The Caregiver Experience After Stroke in a COVID-19 Environment: A Qualitative Study in Inpatient Rehabilitation.
|
NA
|
NA
|
|
Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic.
|
NA
|
NA
|
|
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19.
|
NA
|
NA
|
|
Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
|
NA
|
NA
|
|
The duration of SARS-CoV-2 shedding in patients recovering from COVID-19.
|
NA
|
NA
|
|
Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease.
|
NA
|
NA
|
|
The role of advanced technologies supplemented with traditional methods in pharmacovigilance sciences.
|
NA
|
NA
|
|
Research and Patents on Coronavirus and COVID-19: A Review.
|
NA
|
NA
|
|
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial.
|
NA
|
NA
|
|
Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study.
|
NA
|
NA
|
|
Comparison of hospital worker anxiety in COVID-19 treating and non-treating hospitals in the same city during the COVID-19 pandemic.
|
NA
|
NA
|
|
Efficacy of an online cognitive behavioral therapy program developed for healthcare workers during the COVID-19 pandemic: the REduction of STress (REST) study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Understanding the role of neutrophils in acute respiratory distress syndrome.
|
NA
|
NA
|
|
Reusability of filtering facepiece respirators after decontamination through drying and germicidal UV irradiation.
|
NA
|
NA
|
|
Humidity and Deposition Solution Play a Critical Role in Virus Inactivation by Heat Treatment of N95 Respirators.
|
NA
|
NA
|
|
Survival Analysis of COVID-19 Patients in Russia Using Machine Learning.
|
NA
|
NA
|
|
COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia.
|
NA
|
NA
|
|
Palliative Care in Coronavirus Disease 2019 Pandemic: Position Statement of the Indian Association of Palliative Care.
|
NA
|
NA
|
|
Responding to Palliative Care Training Needs in the Coronavirus Disease 2019 Era: The Context and Process of Developing and Disseminating Training Resources and Guidance for Low- and Middle-Income Countries from Kerala, South India.
|
NA
|
NA
|
|
How the COVID-19 Pandemic Experience has Affected Pediatric Palliative Care in Mumbai.
|
NA
|
NA
|
|
Experience of Palliative Care Services at Tertiary Comprehensive Cancer Center during COVID-19 Lockdown Phase: An Analytical Original Study.
|
NA
|
NA
|
|
Smartphone-Based Telemedicine Service at Palliative Care Unit during Nationwide Lockdown: Our Initial Experience at a Tertiary Care Cancer Hospital.
|
NA
|
NA
|
|
An Update on Initial Epidemiological Profile, Clinical Course, and Outcome of COVID-19 Patients at a Tertiary Care Center in India.
|
NA
|
NA
|
|
Patients’/Caregivers’ Perspectives on Telemedicine Service for Advanced Cancer Patients during the COVID-19 Pandemic: An Exploratory Survey.
|
NA
|
NA
|
|
Effect of Nation-wide Lockdown on Palliative Care Services in a Tertiary Care Centre in India: A Retrospective Observational Study.
|
NA
|
NA
|
|
Running Palliative Care Services at the Institute of Palliative Medicine, Kozhikode, Amid COVID-19 Pandemic: A Strengths, Weaknesses, Opportunities, and Threats Analysis.
|
NA
|
NA
|
|
Providing Palliative Home Care during COVID-19 Pandemic Lockdown in India.
|
NA
|
NA
|
|
Palliative Care Interventions from a Social Work Perspective and the Challenges Faced by Patients and Caregivers during COVID-19.
|
NA
|
NA
|
|
Homecare and the COVID-19 Pandemic - Experience at an Urban Specialist Cancer Palliative Center.
|
NA
|
NA
|
|
Opioid Dispensing Patterns from a Tertiary Care Cancer Hospital during the Nationwide Lockdown in COVID-19 Pandemic.
|
NA
|
NA
|
|
To Study the Barriers in Palliative Care to Nonmalignant Cases in COVID-19 Crisis in a Tertiary Health-Care Center.
|
NA
|
NA
|
|
COVID 19: The New Normal in the Clinic: Overcoming Challenges in Palliative Care.
|
NA
|
NA
|
|
Psychosocial Aspects of COVID-19 in the Context of Palliative Care - A Quick Review.
|
NA
|
NA
|
|
Palliative Care Challenges and Strategies for the Management Amid COVID-19 Pandemic in India: Perspectives of Palliative Care Nurses, Cancer Patients, and Caregivers.
|
NA
|
NA
|
|
The Psychosocial Implications on Cancer Patients: The Hidden Collateral of the War on Coronavirus Disease 2019.
|
NA
|
NA
|
|
Palliative Care Delivery in Cancer Patients in the Era of Covid-19 Outbreak: Unique Needs, Barriers, and Tools for Solutions.
|
NA
|
NA
|
|
Aplastic Anemia: Non-COVID Casualties in the COVID-19 Era.
|
NA
|
NA
|
|
Concerns of a Post-Chemotherapy/Radiotherapy Patient of Nasopharyngeal Carcinoma Presenting with Sustained COVID-19 Infection.
|
NA
|
NA
|
|
Unraveling the Role of Palliative Surgery in the Era of COVID-19 Pandemic.
|
NA
|
NA
|
|
Challenging Concerns of Transgender Community Amidst COVID-19.
|
NA
|
NA
|
|
Psychosocial Burdens of a Renal Transplant Recipient with COVID-19.
|
NA
|
NA
|
|
A Child with Acute Lymphoblastic Leukemia in Institutional Isolation during the COVID Pandemic: A Multifaceted Responsibility.
|
NA
|
NA
|
|
COVID-19-Positive Report Posing a Delay in Treatment Course in a Middle-Aged Metastatic Neuroendocrine Tumor Patient.
|
NA
|
NA
|
|
Feasibility of Treatment Planning System in Localizing the COVID-19 Pneumonia Lesions and Evaluation of Volume Indices of Lung Involvement.
|
NA
|
NA
|
|
Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19).
|
NA
|
NA
|
|
Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world.
|
NA
|
NA
|
|
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences.
|
NA
|
NA
|
|
SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
|
NA
|
NA
|
|
Perceived Impacts of the COVID-19 Pandemic on Pediatric Care in Canada: A Roundtable Discussion.
|
NA
|
NA
|
|
A stance data set on polarized conversations on Twitter about the efficacy of hydroxychloroquine as a treatment for COVID-19.
|
NA
|
NA
|
|
Cardiac sequelae of novel coronavirus disease 2019 (COVID-19): a clinical case series.
|
NA
|
NA
|
|
Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report.
|
NA
|
NA
|
|
COVID19: a case report of thrombus in transit.
|
NA
|
NA
|
|
COVID-19 treatment with lopinavir-ritonavir resulting in sick sinus syndrome: a case report.
|
NA
|
NA
|
|
Drug-induced ‘Torsade de Pointes’ in a COVID-19 patient despite discontinuation of chloroquine. Importance of its long half-life: a case report.
|
NA
|
NA
|
|
Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report.
|
NA
|
NA
|
|
COVID-19 fulminant myocarditis: a case report.
|
NA
|
NA
|
|
Management of COVID-19 myopericarditis with reversal of cardiac dysfunction after blunting of cytokine storm: a case report.
|
NA
|
NA
|
|
Protecting the most vulnerable during COVID-19 and beyond: a case report on the remote management of heart failure patients with cardiac implantable electronic devices.
|
NA
|
NA
|
|
Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: A modelling study.
|
NA
|
NA
|
|
[Shanghai municipal expert consensus on standardized prevention and control of COVID-19 during procedures of oral radiology].
|
NA
|
NA
|
|
[Suggestions for selection and use of masks for dental medical staff during outbreaks of novel coronavirus pneumonia].
|
NA
|
NA
|
|
Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein.
|
NA
|
NA
|
|
Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019-20 data.
|
NA
|
NA
|
|
COVID-19 in lung transplant recipients: A multicenter study.
|
NA
|
NA
|
|
Perspective on the increasing role of optical wearables and remote patient monitoring in the COVID-19 era and beyond.
|
NA
|
NA
|
|
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
|
NA
|
NA
|
|
COVID-19 and financial toxicity in patients with renal cell carcinoma.
|
NA
|
NA
|
|
Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients.
|
NA
|
NA
|
|
Impact of COVID-19 on the cerebrovascular system and the prevention of RBC lysis.
|
NA
|
NA
|
|
Prognosis of COVID-19 in patients with vein thrombosis: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Comparative effectiveness of Lopinavir/Ritonavir-based regimens in COVID-19.
|
NA
|
NA
|
|
Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
|
NA
|
NA
|
|
The impact of nationwide alcohol ban during the COVID-19 lockdown on alcohol use-related internet searches and behaviour in India: An infodemiology study.
|
NA
|
NA
|
|
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown.
|
NA
|
NA
|
|
Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China.
|
NA
|
NA
|
|
Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease.
|
NA
|
NA
|
|
Targeting Proteases for Treating COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
|
NA
|
NA
|
|
Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020.
|
NA
|
NA
|
|
Physician preparedness for resource allocation decisions under pandemic conditions: A cross-sectional survey of Canadian physicians, April 2020.
|
NA
|
NA
|
|
Treatment of out-of-hospital cardiac arrest in the COVID-19 era: A 100 days experience from the Lombardy region.
|
NA
|
NA
|
|
Time-lapse sentinel surveillance of SARS-CoV-2 spread in India.
|
NA
|
NA
|
|
Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
|
NA
|
NA
|
|
Modeling the Impact of Delaying the Diagnosis of Non-Small Cell Lung Cancer during COVID-19.
|
NA
|
NA
|
|
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
|
NA
|
NA
|
|
A Kidney International “journal of the COVID-19 year” in kidney transplantation.
|
NA
|
NA
|
|
The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience.
|
NA
|
NA
|
|
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on mental health and perceived strain among caregivers tending children with special needs.
|
NA
|
NA
|
|
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
|
NA
|
NA
|
|
Joint prediction and time estimation of COVID-19 developing severe symptoms using chest CT scan.
|
NA
|
NA
|
|
The role of androgens in COVID-19.
|
NA
|
NA
|
|
Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
|
NA
|
NA
|
|
Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era.
|
NA
|
NA
|
|
COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature.
|
NA
|
NA
|
|
Are Viral Vectors Any Good for RNAi Antiviral Therapy?
|
NA
|
NA
|
|
Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.
|
NA
|
NA
|
|
Precautionary Measures and Illness Attitudes toward COVID-19 among a Sample of the Kuwaiti Population.
|
NA
|
NA
|
|
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
|
NA
|
NA
|
|
Medical student support for vulnerable patients during COVID-19 - a convergent mixed-methods study.
|
NA
|
NA
|
|
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial”.
|
NA
|
NA
|
|
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.
|
NA
|
NA
|
|
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Preventive Measures for COVID-19 in Dental Treatments.
|
NA
|
NA
|
|
Adapting a Federal Disaster Medical Assistance Team to Operate During a Pandemic.
|
NA
|
NA
|
|
Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar.
|
NA
|
NA
|
|
Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.
|
NA
|
NA
|
|
[COVID-19 and mechanical circulatory support].
|
NA
|
NA
|
|
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.
|
NA
|
NA
|
|
The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment.
|
NA
|
NA
|
|
Has COVID-19 halted winter-spring wildfires in the Mediterranean? Insights for wildfire science under a pandemic context.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on radiographers in the Republic of Cyprus. A questionnaire survey.
|
NA
|
NA
|
|
Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
|
NA
|
NA
|
|
Ten Years of National Seasonal Surveillance for Severe Complications of Influenza in Australian Children.
|
NA
|
NA
|
|
Clinical manifestations and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Case Report (Precis): Two Telemedicine Consultants Miss Foot Drop: When To See Patients in Person.
|
NA
|
NA
|
|
Coronavirus Disease 2019 in a Premature Infant: Vertical Transmission and Antibody Response or Lack Thereof.
|
NA
|
NA
|
|
Establishing Better Evidence on Remote Monitoring for Postpartum Hypertension: A Silver Lining of the Coronavirus Pandemic.
|
NA
|
NA
|
|
Longitudinal Quantitative Analysis of Radiation Oncology Staff Illness in a New York City Center during COVID-19: The Impact of New Guidelines on Operations and Employee Health.
|
NA
|
NA
|
|
COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature.
|
NA
|
NA
|
|
Rapid deployment of virtual ICU support during the COVID-19 pandemic.
|
NA
|
NA
|
|
Communication in the time of COVID.
|
NA
|
NA
|
|
Care of the dying person before and during the COVID-19 pandemic: A quality improvement project.
|
NA
|
NA
|
|
Remodelling elective hospital services in the COVID-19 era - designing the new normal.
|
NA
|
NA
|
|
Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID-19.
|
NA
|
NA
|
|
Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID-19 Pandemic in Mexico.
|
NA
|
NA
|
|
Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.
|
NA
|
NA
|
|
A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.
|
NA
|
NA
|
|
Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study.
|
NA
|
NA
|
|
Therapist-Supported Online Interventions for Children and Young People With Tic Disorders: Lessons Learned From a Randomized Controlled Trial and Considerations for Future Practice.
|
NA
|
NA
|
|
How to ventilate obese patients in the ICU.
|
NA
|
NA
|
|
Infectious Waste Management Strategy during COVID-19 Pandemic in Africa: an Integrated Decision-Making Framework for Selecting Sustainable Technologies.
|
NA
|
NA
|
|
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.
|
NA
|
NA
|
|
Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
|
NA
|
NA
|
|
Nutrition Support During Prone Positioning: An Old Technique Reawakened by COVID-19.
|
NA
|
NA
|
|
The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Suicide and the Elderly During the COVID-19 Pandemic: An Overview of Different Suicide Theories.
|
NA
|
NA
|
|
Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis.
|
NA
|
NA
|
|
Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
|
NA
|
NA
|
|
Structure-altering mutations of the SARS-CoV-2 frameshifting RNA element.
|
NA
|
NA
|
|
A multi-institutional assessment of COVID-19-related risk in radiation oncology.
|
NA
|
NA
|
|
Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.
|
NA
|
NA
|
|
Microcirculation alterations in severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Citation Network Analysis of the Novel Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India.
|
NA
|
NA
|
|
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.
|
NA
|
NA
|
|
ACE2 contributes to the maintenance of mouse epithelial barrier function.
|
NA
|
NA
|
|
Coronavirus (SARS-CoV-2) in the environment: Occurrence, persistence, analysis in aquatic systems and possible management.
|
NA
|
NA
|
|
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.
|
NA
|
NA
|
|
Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL).
|
NA
|
NA
|
|
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.
|
NA
|
NA
|
|
Is health politically irrelevant? Experimental evidence during a global pandemic.
|
NA
|
NA
|
|
Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020.
|
NA
|
NA
|
|
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy.
|
NA
|
NA
|
|
Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
|
NA
|
NA
|
|
Artificial lungs–Where are we going with the lung replacement therapy?
|
NA
|
NA
|
|
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
|
NA
|
NA
|
|
Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
|
NA
|
NA
|
|
COVID-19 Mediated by Basigin Can Affect Male and Female Fertility.
|
NA
|
NA
|
|
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification.
|
NA
|
NA
|
|
COVID-19 in Parkinson’s disease: what holds the key?
|
NA
|
NA
|
|
QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry.
|
NA
|
NA
|
|
Utilization cost of maternity services for childbirth among pregnant women with coronavirus disease 2019 in Nigeria’s epicenter.
|
NA
|
NA
|
|
Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: A Danish cohort study.
|
NA
|
NA
|
|
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation.
|
NA
|
NA
|
|
Self-medication practice with analgesics (NSAIDs and acetaminophen), and antibiotics among nursing undergraduates in University College Farasan Campus, Jazan University, KSA.
|
NA
|
NA
|
|
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
|
NA
|
NA
|
|
Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective.
|
NA
|
NA
|
|
Venous Thromboembolism in COVID-19.
|
NA
|
NA
|
|
Living with covid-19.
|
NA
|
NA
|
|
Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.
|
NA
|
NA
|
|
Treating COVID-19: are we missing out the window of opportunity?
|
NA
|
NA
|
|
Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience.
|
NA
|
NA
|
|
Management of gestational diabetes in women with a concurrent severe acute respiratory syndrome coronavirus 2 infection, experience of a single center in Northern Italy.
|
NA
|
NA
|
|
High prevalence of Afro-Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalized with COVID-19.
|
NA
|
NA
|
|
COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?
|
NA
|
NA
|
|
Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
|
NA
|
NA
|
|
Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case report.
|
NA
|
NA
|
|
Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A hypothetical view.
|
NA
|
NA
|
|
Effectiveness of steroid treatment for SARS-CoV-2 pneumonia with COP-like reaction: a case report.
|
NA
|
NA
|
|
Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team.
|
NA
|
NA
|
|
COVID-19 surge capacity solutions: our experience of converting a concert hall into a temporary hospital for mild and moderate COVID-19 patients.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on obstructive sleep apnea: recommendations for symptom management.
|
NA
|
NA
|
|
Medical management of COVID-19 clinic.
|
NA
|
NA
|
|
An overview of potential therapeutic agents to treat COVID-19.
|
NA
|
NA
|
|
The development of a quarantine strategy is an important path to a normalized response to COVID-19.
|
NA
|
NA
|
|
COVID-19 Policy-Making in a Country Divided: Catholic Social Teaching as a Path to Unity.
|
NA
|
NA
|
|
Analytical insights of COVID-19 pandemic.
|
NA
|
NA
|
|
CGNet: A graph-knowledge embedded convolutional neural network for detection of pneumonia.
|
NA
|
NA
|
|
[Development of an information website on the proper use of medicines during the pandemic].
|
NA
|
NA
|
|
The dynamic treatment of SARS-CoV-2 disease.
|
NA
|
NA
|
|
Pooling Samples to Increase SARS-CoV-2 Testing.
|
NA
|
NA
|
|
Fast tracking intensive care units and operation rooms during the COVID-19 pandemic in resource limited settings.
|
NA
|
NA
|
|
Peripartum cardiomyopathy mimicking COVID-19 infection.
|
NA
|
NA
|
|
What a pediatric anesthesiologist should know about COVID-19.
|
NA
|
NA
|
|
Management of pregnant laboring women during COVID-19 pandemic.
|
NA
|
NA
|
|
Anesthesia for oral surgeries during the COVID-19 pandemic.
|
NA
|
NA
|
|
Emergency neurological procedures during COVID-19 pandemic: Practical issues.
|
NA
|
NA
|
|
Preventing exposure to COVID-19 in the operation theatre and intensive care unit.
|
NA
|
NA
|
|
Traditional Indian practices: Time to revisit and re-adopt for a healthier lifestyle.
|
NA
|
NA
|
|
The Role of the Computed Tomography (CT) Thorax in the Diagnosis of COVID-19 for Patients Presenting with Acute Surgical Emergencies. A Single Institute Experience.
|
NA
|
NA
|
|
A prospective clinical study of an Ayurveda regimen in COVID 19 patients.
|
NA
|
NA
|
|
Conducting Prolonged Exposure for PTSD During the COVID-19 Pandemic: Considerations for Treatment.
|
NA
|
NA
|
|
A deep learning model and machine learning methods for the classification of potential coronavirus treatments on a single human cell.
|
NA
|
NA
|
|
Patient Satisfaction for Telehealth Physical Therapy Services Was Comparable to that of In-Person Services During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Design, Implementation, and Acceptability of a Telehealth Comprehensive Recovery Service for People With Complex Psychosis Living in NYC During the COVID-19 Crisis.
|
NA
|
NA
|
|
Psychological Behavior of Frontline Medical Staff in the Use of Preventive Medication for COVID-19: A Cross-Sectional Study.
|
NA
|
NA
|
|
Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig.
|
NA
|
NA
|
|
Perspective: The Potential Effects of Naringenin in COVID-19.
|
NA
|
NA
|
|
Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
|
NA
|
NA
|
|
Traditional Herbal Medicine Candidates as Complementary Treatments for COVID-19: A Review of Their Mechanisms, Pros and Cons.
|
NA
|
NA
|
|
COVID-19 Epidemic in Sri Lanka: A Mathematical and Computational Modelling Approach to Control.
|
NA
|
NA
|
|
Tocilizumab and liver injury in patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review).
|
NA
|
NA
|
|
Head and Neck Practice in the COVID-19 Pandemics Today: A Rapid Systematic Review.
|
NA
|
NA
|
|
ABA Finding Its Heart During a Pandemic: An Exploration in Social Validity.
|
NA
|
NA
|
|
Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: The case for COVID-19.
|
NA
|
NA
|
|
The intersection of viral illnesses: A seasonal influenza epidemic amidst the COVID-19 pandemic.
|
NA
|
NA
|
|
Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: A case series.
|
NA
|
NA
|
|
To Anticoagulate or Not: Acute Stroke in a COVID-19 Patient With Gastrointestinal Bleed.
|
NA
|
NA
|
|
Subcutaneous Emphysema in Patients With COVID-19 Infection: A Report of Three Cases.
|
NA
|
NA
|
|
Telerehabilitation: Development, Application, and Need for Increased Usage in the COVID-19 Era for Patients with Spinal Pathology.
|
NA
|
NA
|
|
A Clinical Challenge in the Emergency Department: A Case of Klebsiella Infective Endocarditis Presenting With Splenic Abscess.
|
NA
|
NA
|
|
Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era.
|
NA
|
NA
|
|
Community-based palliative care during the COVID 19 pandemic.
|
NA
|
NA
|
|
Novel coronavirus- A comprehensive review.
|
NA
|
NA
|
|
Short Term Home Oxygen Therapy for COVID-19 patients: The COVID-HOT algorithm.
|
NA
|
NA
|
|
A Suggested Approach for Management of Pediatric Asthma During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
|
NA
|
NA
|
|
Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
|
NA
|
NA
|
|
Case Report: A Recovered SARS CoV-2 Patient Protected From Reinfection.
|
NA
|
NA
|
|
Thrombosis and COVID-19: The Potential Role of Nutrition.
|
NA
|
NA
|
|
QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment.
|
NA
|
NA
|
|
COVID-19 in Human, Animal, and Environment: A Review.
|
NA
|
NA
|
|
.
|
NA
|
NA
|
|
The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Acute aortoiliac and infrainguinal arterial thrombotic events in four patients diagnosed with the novel coronavirus 2019.
|
NA
|
NA
|
|
Phlegmasia cerulea dolens associated with acute coronavirus disease 2019 pneumonia despite supratherapeutic warfarin anticoagulation.
|
NA
|
NA
|
|
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal.
|
NA
|
NA
|
|
Safety in endoscopy for patients and healthcare workers during the COVID-19 pandemic.
|
NA
|
NA
|
|
Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19.
|
NA
|
NA
|
|
[PHYSIOLOGICAL GENDER DIFFERENCES AND THEIR EFFECT ON COVID-19 CAUSED MORBIDITY].
|
NA
|
NA
|
|
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
|
NA
|
NA
|
|
Pediatric Teleneuropsychology: Feasibility and Recommendations.
|
NA
|
NA
|
|
Clinical impact of COVID-19 on people with substance use disorders.
|
NA
|
NA
|
|
From adversity to resilience in the COVID-19 era: strengthening mental health systems in the Eastern Mediterranean Region.
|
NA
|
NA
|
|
State anxiety levels of nurses providing care to patients with COVID-19 in Turkey.
|
NA
|
NA
|
|
Preclinical validation of occupational and environmental safety of an isolation system for noninvasive ventilation in COVID-19 and other aerosol-transmitted infections.
|
NA
|
NA
|
|
Video visits and access to care in pediatric rehabilitation therapies in the time of a pandemic.
|
NA
|
NA
|
|
High-throughput wastewater analysis for substance use assessment in central New York during the COVID-19 pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein.
|
NA
|
NA
|
|
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
|
NA
|
NA
|
|
COVID-19 - Lessons Learned and Questions Remaining.
|
NA
|
NA
|
|
FDA Emergency Use Authorization: Glass Half Empty?
|
NA
|
NA
|
|
Bone fractures during the time of coronavirus.
|
NA
|
NA
|
|
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
|
NA
|
NA
|
|
COVID-19: a user’s guide, status of the art and an original proposal to terminate viral recurrence.
|
NA
|
NA
|
|
COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2.
|
NA
|
NA
|
|
Neurorehabilitation in the times of Covid-19: insights from the Spanish Neurorehabilitation Society (SENR).
|
NA
|
NA
|
|
Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute.
|
NA
|
NA
|
|
Management of Parkinson’s disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV.
|
NA
|
NA
|
|
Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
|
NA
|
NA
|
|
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing.
|
NA
|
NA
|
|
Impact of COVID-19 on Dental Emergency Services in Cluj-Napoca Metropolitan Area: A Cross-Sectional Study.
|
NA
|
NA
|
|
Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.
|
NA
|
NA
|
|
Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
|
NA
|
NA
|
|
[Elimination of hepatitis C, our progress, challenges and hopes].
|
NA
|
NA
|
|
Health Service Utilization in Hong Kong During the COVID-19 Pandemic - A Cross-sectional Public Survey.
|
NA
|
NA
|
|
Evidence and the main adverse effects regarding drug therapies in the war against COVID-19.
|
NA
|
NA
|
|
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
|
NA
|
NA
|
|
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
|
NA
|
NA
|
|
Fifteen-minute consultation: Does this child have COVID-19 (and does it matter)?
|
NA
|
NA
|
|
Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
|
NA
|
NA
|
|
Spike mutation D614G alters SARS-CoV-2 fitness.
|
NA
|
NA
|
|
A potential treatment for COVID-19 based on modal characteristics and dynamic responses analysis of 2019-nCoV.
|
NA
|
NA
|
|
Discovery of small molecule PLpro inhibitor against COVID-19 using structure-based virtual screening, molecular dynamics simulation, and molecular mechanics/Generalized Born surface area (MM/GBSA) calculation.
|
NA
|
NA
|
|
Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020.
|
NA
|
NA
|
|
Effect of COVID-19 on Mental Health Rehabilitation Centers.
|
NA
|
NA
|
|
Appropriate orthodontic appliances during the COVID-19 pandemic: A scoping review.
|
NA
|
NA
|
|
Undergoing active treatment for gynecologic cancer during COVID-19: A qualitative study of the impact on healthcare and social support.
|
NA
|
NA
|
|
Potential of graphene-based materials to combat COVID-19: properties, perspectives, and prospects.
|
NA
|
NA
|
|
Paraneoplastic Syndrome and SARS-CoV-2-Incremental Effect of 2 Thrombogenic Conditions?
|
NA
|
NA
|
|
COVID-19 in Patients Undergoing Hemodialysis: Prevalence and Asymptomatic Screening During a Period of High Community Prevalence in a Large Paris Center.
|
NA
|
NA
|
|
Agile clinical research: A data science approach to scrumban in clinical medicine.
|
NA
|
NA
|
|
[Structure of SARS-CoV-2 and treatment of COVID-19].
|
NA
|
NA
|
|
Waiting in Pain II: An Updated Review of the Provision of Persistent Pain Services in Australia.
|
NA
|
NA
|
|
Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda.
|
NA
|
NA
|
|
COVID-19: An overview for dermatologists.
|
NA
|
NA
|
|
Trend of Olfactory and Gustatory Dysfunction in COVID-19 Patients in a Quarantine Facility.
|
NA
|
NA
|
|
Clinical features and physiotherapy management for Covid-19 in children.
|
NA
|
NA
|
|
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
|
NA
|
NA
|
|
A critical review of the safety of minimally invasive surgery in the era of COVID-19.
|
NA
|
NA
|
|
Laboratory Biomarkers in the Management of Patients With COVID-19.
|
NA
|
NA
|
|
Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary centre.
|
NA
|
NA
|
|
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
|
NA
|
NA
|
|
A Large-Scale Survey on Trauma, Burnout, and Posttraumatic Growth among Nurses during the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Mobile Health Intervention (LifeBuoy App) to Help Young People Manage Suicidal Thoughts: Protocol for a Mixed-Methods Randomized Controlled Trial.
|
NA
|
NA
|
|
Shorter incubation period is associated with severe disease progression in patients with COVID-19.
|
NA
|
NA
|
|
A Deep Learning Prognosis Model Help Alert for COVID-19 Patients at High-Risk of Death: A Multi-Center Study.
|
NA
|
NA
|
|
Psychological Effects of the COVID-19 Imposed Lockdown on Adults with Attention Deficit/Hyperactivity Disorder: Cross-Sectional Survey Study.
|
NA
|
NA
|
|
Facing COVID-19: Early Recognition and Triage Tool for Medical Treatment Facilities With Limited Resources.
|
NA
|
NA
|
|
Favipiravir use for SARS CoV-2 infection.
|
NA
|
NA
|
|
Comparing Chinese and US practitioners’ attitudes towards teletherapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
The first cancer patient with COVID-19 in Slovakia.
|
NA
|
NA
|
|
Beyond the mask: a multidisciplinary reflection on palliating patients with COVID-19 receiving continuous positive airway pressure ventilation.
|
NA
|
NA
|
|
Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV).
|
NA
|
NA
|
|
Natural Products in Mitigation of SARS CoV Infections.
|
NA
|
NA
|
|
COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases.
|
NA
|
NA
|
|
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment.
|
NA
|
NA
|
|
Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19).
|
NA
|
NA
|
|
The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation.
|
NA
|
NA
|
|
Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework.
|
NA
|
NA
|
|
Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic.
|
NA
|
NA
|
|
ping (AbMap) of hundred antibodies in a single run.
|
NA
|
NA
|
|
Brainstem Dysfunction in SARS-COV-2 Infection can be a Potential Cause of Respiratory Distress.
|
NA
|
NA
|
|
Modified Suction Apparatus to Reduce the Transmission Risk of COVID-19 among Healthcare Providers.
|
NA
|
NA
|
|
Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 Infection: A Case Series.
|
NA
|
NA
|
|
Severe COVID-19 Pneumonia in a 30-Year-Old Woman in the 36th Week of Pregnancy Treated with Postpartum Extracorporeal Membrane Oxygenation.
|
NA
|
NA
|
|
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
|
NA
|
NA
|
|
Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets.
|
NA
|
NA
|
|
Bibliometric Analysis of Early COVID-19 Research: The Top 50 Cited Papers.
|
NA
|
NA
|
|
Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study.
|
NA
|
NA
|
|
Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia.
|
NA
|
NA
|
|
Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Healthcare worker attendance during the early stages of the COVID-19 pandemic: A longitudinal analysis of fingerprint-verified data from all public-sector secondary and tertiary care facilities in Bangladesh.
|
NA
|
NA
|
|
Early prediction and identification for severe patients during the pandemic of COVID-19: A severe COVID-19 risk model constructed by multivariate logistic regression analysis.
|
NA
|
NA
|
|
Coronavirus-2019 Disease (COVID-19) in Children.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.
|
NA
|
NA
|
|
Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients.
|
NA
|
NA
|
|
Rehabilitation During a Pandemic: Psychiatrists as First Responders?
|
NA
|
NA
|
|
Coronavirus disease (COVID-19) prevention and treatment methods and effective parameters: A systematic literature review.
|
NA
|
NA
|
|
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.
|
NA
|
NA
|
|
Management of diabetes during fasting and COVID-19 - Challenges and solutions.
|
NA
|
NA
|
|
A review on exploring evidence-based approach to harnessing the immune system in times of corona virus pandemic: Best of modern and traditional Indian system of medicine.
|
NA
|
NA
|
|
Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report.
|
NA
|
NA
|
|
Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients.
|
NA
|
NA
|
|
Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications.
|
NA
|
NA
|
|
COVID-19-The largest isolation study in history: the value of shared learnings from spaceflight analogs.
|
NA
|
NA
|
|
Implementation Science to Address Health Disparities During the Coronavirus Pandemic.
|
NA
|
NA
|
|
Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment.
|
NA
|
NA
|
|
No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19.
|
NA
|
NA
|
|
ESSD Commentary on Dysphagia Management During COVID Pandemia.
|
NA
|
NA
|
|
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study.
|
NA
|
NA
|
|
The impact of COVID-19 on the hospice and palliative care workforce.
|
NA
|
NA
|
|
Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV Study.
|
NA
|
NA
|
|
Approach to skin malignancies in COVID-19 pandemic days.
|
NA
|
NA
|
|
Capsule endoscopy - Recent developments and future directions.
|
NA
|
NA
|
|
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection.
|
NA
|
NA
|
|
study.
|
NA
|
NA
|
|
Covid-19 pandemic and the motivations for demanding health service in indigenous villages.
|
NA
|
NA
|
|
Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial.
|
NA
|
NA
|
|
Cutaneous lymphomas and COVID-19: What is known so far?
|
NA
|
NA
|
|
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
|
NA
|
NA
|
|
Targeting Crucial Host Factors of SARS-CoV-2.
|
NA
|
NA
|
|
Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
|
NA
|
NA
|
|
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
|
NA
|
NA
|
|
Happy hypoxia in critical COVID-19 patient: A case report in Tangerang, Indonesia.
|
NA
|
NA
|
|
Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV2.
|
NA
|
NA
|
|
Literature review on Virus and Host Response Proteins in COVID-19: Pathobiology, Management, Diagnosis and Treatment.
|
NA
|
NA
|
|
Escalation and de-escalation of the radiology response to COVID-19 in a tertiary hospital in South London: The King’s College Hospital experience.
|
NA
|
NA
|
|
Caution warranted for low-dose radiation therapy for Covid-19.
|
NA
|
NA
|
|
[Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation].
|
NA
|
NA
|
|
Overview of the possible role of vitamin C in management of COVID-19.
|
NA
|
NA
|
|
T cell immunobiology and cytokine storm of COVID-19.
|
NA
|
NA
|
|
Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris®) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case Series.
|
NA
|
NA
|
|
Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
|
NA
|
NA
|
|
Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh.
|
NA
|
NA
|
|
Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19.
|
NA
|
NA
|
|
Comparison of Psychological Distress and Demand Induced by COVID-19 during the Lockdown Period in Patients Undergoing Peritoneal Dialysis and Hemodialysis: A Cross-Section Study in a Tertiary Hospital.
|
NA
|
NA
|
|
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.
|
NA
|
NA
|
|
COVID-19 Pandemic and Death Anxiety in Security Forces in Spain.
|
NA
|
NA
|
|
Psychotherapy by Telephone or Internet in Austria and Germany Which CBT Psychotherapists Rate It more Comparable to Face-to-Face Psychotherapy in Personal Contact and Have more Positive Actual Experiences Compared to Previous Expectations?
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Student and Resident Teaching and Training in Surgical Oncology.
|
NA
|
NA
|
|
Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations.
|
NA
|
NA
|
|
COVID-19 and Adverse Pregnancy Outcome: A Systematic Review of 104 Cases.
|
NA
|
NA
|
|
Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study.
|
NA
|
NA
|
|
Hydroxychloroquine Exhibits a Strong Complex Interaction with DNA: Unraveling the Mechanism of Action.
|
NA
|
NA
|
|
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) Mechanical Ventilation Research Theme Analysis: Co-word Cluster Analysis.
|
NA
|
NA
|
|
COVID-19 Outbreak and Dentistry: Guidelines and Recommendations for the Provision of Dental Healthcare Services.
|
NA
|
NA
|
|
Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
|
NA
|
NA
|
|
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
|
NA
|
NA
|
|
Ozone therapy in COVID-19: A narrative review.
|
NA
|
NA
|
|
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial.
|
NA
|
NA
|
|
HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.
|
NA
|
NA
|
|
Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia.
|
NA
|
NA
|
|
Developing new models of care at speed: learning from healthcare redesign for children with COVID-related multisystem inflammation.
|
NA
|
NA
|
|
Implementation of a novel home delivery service during pandemic.
|
NA
|
NA
|
|
Virtual risk assessment pathway for deep venous thrombosis: a preliminary model.
|
NA
|
NA
|
|
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
|
NA
|
NA
|
|
Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?
|
NA
|
NA
|
|
Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID syndrome?
|
NA
|
NA
|
|
Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia.
|
NA
|
NA
|
|
Molecular Detection of Human Coronavirus from North Central Part of Bangladesh Depending on ORF1ab and N Gene.
|
NA
|
NA
|
|
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
|
NA
|
NA
|
|
Identification of SARS-CoV-2 entry inhibitors among already approved drugs.
|
NA
|
NA
|
|
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
|
NA
|
NA
|
|
Coronavirus biology and replication: implications for SARS-CoV-2.
|
NA
|
NA
|
|
Hybrid Telehealth Medical Retina Clinic Due to Provider Exposure and Quarantine During COVID-19 Pandemic.
|
NA
|
NA
|
|
Glycopeptides as Potential Interventions for COVID-19.
|
NA
|
NA
|
|
Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing.
|
NA
|
NA
|
|
The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study.
|
NA
|
NA
|
|
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt.
|
NA
|
NA
|
|
Analysis of Influencing Factors and Pharmaceutical Care of Patients with COVID-19 in Fangcang Shelter Hospital.
|
NA
|
NA
|
|
The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission.
|
NA
|
NA
|
|
Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection.
|
NA
|
NA
|
|
Cytokine Response in SARS-CoV-2 Infection in the Elderly.
|
NA
|
NA
|
|
Inpatient Dialysis Planning During the COVID-19 Pandemic: A Single-Center Experience and Review of the Literature.
|
NA
|
NA
|
|
Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.
|
NA
|
NA
|
|
Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?
|
NA
|
NA
|
|
Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route.
|
NA
|
NA
|
|
COVID-19 Emergency Department Protocols: Experience of Protocol Implementation Through in-situ Simulation.
|
NA
|
NA
|
|
Current Options in the Treatment of COVID-19: A Review.
|
NA
|
NA
|
|
Mapping Evidence of Pharmacy Services for COVID-19 in China.
|
NA
|
NA
|
|
COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence.
|
NA
|
NA
|
|
Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
|
NA
|
NA
|
|
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.
|
NA
|
NA
|
|
Managing Diabetes During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome - Clearing Safety Issues and Good Clinical Practice.
|
NA
|
NA
|
|
Inverse Association between Serotonin 2A Receptor Antagonist Medication Use and Mortality in Severe COVID-19 Infection.
|
NA
|
NA
|
|
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.
|
NA
|
NA
|
|
It’s complicated: A case report on a COVID-19-positive HIV patient presenting with rhabdomyolysis and acute kidney injury.
|
NA
|
NA
|
|
Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy.
|
NA
|
NA
|
|
COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.
|
NA
|
NA
|
|
2019 Tabletop Exercise for Laboratory Diagnosis and Analyses of Unknown Disease Outbreaks by the Korea Centers for Disease Control and Prevention.
|
NA
|
NA
|
|
Tackling the COVID-19 pandemic: The Bangladesh perspective.
|
NA
|
NA
|
|
Fangcang shelter hospitals are a One Health approach for responding to the COVID-19 outbreak in Wuhan, China.
|
NA
|
NA
|
|
The COVID-19 era: the view from Nigeria.
|
NA
|
NA
|
|
Clinical features of patients undergoing hemodialysis with COVID-19.
|
NA
|
NA
|
|
Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.
|
NA
|
NA
|
|
(cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling.
|
NA
|
NA
|
|
SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy.
|
NA
|
NA
|
|
The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients.
|
NA
|
NA
|
|
SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
|
NA
|
NA
|
|
HIV Prevention and Treatment in the Context of the COVID-19 in the Bronx, New York: Implications for Practice and Research.
|
NA
|
NA
|
|
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Challenges of drug development during the COVID-19 pandemic: Key considerations for clinical trial designs.
|
NA
|
NA
|
|
Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce.
|
NA
|
NA
|
|
COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses.
|
NA
|
NA
|
|
Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.
|
NA
|
NA
|
|
Threat, Coping, and Social Distance Adherence During COVID-19: Cross-Continental Comparison Using an Online Cross-Sectional Survey.
|
NA
|
NA
|
|
Impact of sars-cov-2 interventions on dengue transmission.
|
NA
|
NA
|
|
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
|
NA
|
NA
|
|
DFT calculations towards the geometry optimization, electronic structure, infrared spectroscopy and UV-vis analyses of Favipiravir adsorption on the first-row transition metals doped fullerenes; a new strategy for COVID-19 therapy.
|
NA
|
NA
|
|
Innate and adaptive immune responses against coronavirus.
|
NA
|
NA
|
|
Infusion of Convalescent Plasma is associated with Clinical Improvement in Critically Ill Patients With Covid-19: A Comment.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic, national lockdown, and unlocking on an apex tertiary care ophthalmic institute.
|
NA
|
NA
|
|
Analysis of dynamic disturbance in blood coagulation function of patients with Coronavirus Disease 2019: A retrospective observational study.
|
NA
|
NA
|
|
Association of digestive symptoms with severity and mortality of COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Reduning injection combined with western medicine for pneumonia: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
The adverse effects of novel coronavirus on diabetic foot patients: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.
|
NA
|
NA
|
|
Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations.
|
NA
|
NA
|
|
The COVID-19 research landscape: Measuring topics and collaborations using scientific literature.
|
NA
|
NA
|
|
The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 vaccine candidates in rapid development.
|
NA
|
NA
|
|
Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic.
|
NA
|
NA
|
|
Perfect storm: a rheumatologist’s point of view on COVID-19 infection.
|
NA
|
NA
|
|
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review.
|
NA
|
NA
|
|
Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway.
|
NA
|
NA
|
|
Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
|
NA
|
NA
|
|
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study.
|
NA
|
NA
|
|
Contamination of SARS-CoV-2 in patient surroundings and on personal protective equipment in a non-ICU isolation ward for COVID-19 patients with prolonged PCR positive status.
|
NA
|
NA
|
|
The psychotherapeutic practice and potential of mental health nurses: an Australian survey.
|
NA
|
NA
|
|
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study.
|
NA
|
NA
|
|
Critically ill patients with COVID-19 in Tokyo, Japan: A single-center case series.
|
NA
|
NA
|
|
Comparative epidemiology between the 2009 H1N1 influenza and COVID-19 pandemics.
|
NA
|
NA
|
|
Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.
|
NA
|
NA
|
|
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro.
|
NA
|
NA
|
|
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
|
NA
|
NA
|
|
Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis.
|
NA
|
NA
|
|
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.
|
NA
|
NA
|
|
Health Literacy, eHealth Literacy, Adherence to Infection Prevention and Control Procedures, Lifestyle Changes, and Suspected COVID-19 Symptoms Among Health Care Workers During Lockdown: Online Survey.
|
NA
|
NA
|
|
Follicular eruption as a cutaneous manifestation in COVID-19.
|
NA
|
NA
|
|
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
|
NA
|
NA
|
|
Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.
|
NA
|
NA
|
|
Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.
|
NA
|
NA
|
|
IL-4/IL-13 remodeling pathway of COVID-19 lung injury.
|
NA
|
NA
|
|
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine.
|
NA
|
NA
|
|
Adherence to Lifestyle Modifications and Associated Factors Among Adult Hypertensive Patients Attending Chronic Follow-Up Units of Dessie Referral Hospital, North East Ethiopia, 2020.
|
NA
|
NA
|
|
Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines.
|
NA
|
NA
|
|
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
|
NA
|
NA
|
|
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
|
NA
|
NA
|
|
Increased Plasma Heparanase Activity in COVID-19 Patients.
|
NA
|
NA
|
|
Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
|
NA
|
NA
|
|
Complement and protection from tissue injury in COVID-19.
|
NA
|
NA
|
|
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia.
|
NA
|
NA
|
|
Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19.
|
NA
|
NA
|
|
Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?
|
NA
|
NA
|
|
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy.
|
NA
|
NA
|
|
Epidemiological and Clinical Findings of Short-Term Recurrence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid Polymerase Chain Reaction Positivity in 1282 Discharged Coronavirus Disease 2019 Cases: A Multicenter, Retrospective, Observational Study.
|
NA
|
NA
|
|
The psychological impact of the COVID-19 pandemic and associated risk factors during the initial stage among the general population in India.
|
NA
|
NA
|
|
Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital.
|
NA
|
NA
|
|
SARS-CoV-2 will continue to circulate in the human population: no worries with state-of-the-art research and dependably useful results.
|
NA
|
NA
|
|
A Snapshot of Pediatric Patients with COVID-19 in a Pandemic Hospital.
|
NA
|
NA
|
|
Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
|
NA
|
NA
|
|
ECMO therapy in COVID-19: An experience from Zurich.
|
NA
|
NA
|
|
The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
|
NA
|
NA
|
|
Family Physicians’ Knowledge about and Attitudes towards COVID-19 - A Cross-sectional Multicentric Study.
|
NA
|
NA
|
|
Self-care strategies in response to nurses’ moral injury during COVID-19 pandemic.
|
NA
|
NA
|
|
Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and psoriasis: Recommendation for patients on regular infliximab therapy.
|
NA
|
NA
|
|
Roadmap to the Bioanalytical Testing of COVID-19: From Sample Collection to Disease Surveillance.
|
NA
|
NA
|
|
Cardiology and COVID-19: do we have sufficient information?
|
NA
|
NA
|
|
The effects of the COVID-19 pandemic on patients with narcolepsy.
|
NA
|
NA
|
|
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2.
|
NA
|
NA
|
|
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
|
NA
|
NA
|
|
On the whereabouts of SARS-CoV-2 in the human body: A systematic review.
|
NA
|
NA
|
|
Perspectives of cancer patients and their health during the COVID-19 pandemic.
|
NA
|
NA
|
|
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.
|
NA
|
NA
|
|
Medical Nutrition Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection in a Non-critical Care Setting: Knowledge in Progress.
|
NA
|
NA
|
|
Analysis of clinical features and pulmonary CT features of coronavirus disease 2019 (COVID-19) patients with diabetes mellitus.
|
NA
|
NA
|
|
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
|
NA
|
NA
|
|
Repurposing anticancer drugs for the management of COVID-19.
|
NA
|
NA
|
|
In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor.
|
NA
|
NA
|
|
The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Management of a “suspected ward” in a COVID-19 designated hospital in Wuhan.
|
NA
|
NA
|
|
Clinical analysis of 132 cases COVID-19 from Wuhan.
|
NA
|
NA
|
|
Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.
|
NA
|
NA
|
|
Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Transition to Home-Based Treatment Plans for Center-Based Cardiac, Pulmonary, and Vascular Rehabilitation during COVID-19.
|
NA
|
NA
|
|
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
|
NA
|
NA
|
|
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China.
|
NA
|
NA
|
|
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.
|
NA
|
NA
|
|
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group.
|
NA
|
NA
|
|
Effects of Coronavirus Disease 2019 on Solid Organ Transplantation.
|
NA
|
NA
|
|
A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders.
|
NA
|
NA
|
|
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns.
|
NA
|
NA
|
|
Supplying synthetic opioids during a pandemic: An early look at North America.
|
NA
|
NA
|
|
[Assessment model for evaluating the preparedness plan for COVID-19 in a tertiary care hospital].
|
NA
|
NA
|
|
COVID-19 in people living with HIV: A multicenter case-series study.
|
NA
|
NA
|
|
Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
|
NA
|
NA
|
|
A Preclinical Safety Study of Thyroid Hormone Instilled into the Lungs of Healthy Rats-an Investigational Therapy for ARDS.
|
NA
|
NA
|
|
Assessment of the direct quantitation of SARS-CoV-2 by droplet digital PCR.
|
NA
|
NA
|
|
Central Nervous System Manifestations Associated with COVID-19.
|
NA
|
NA
|
|
Emerging treatment strategies for COVID-19 infection.
|
NA
|
NA
|
|
Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19.
|
NA
|
NA
|
|
Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
|
NA
|
NA
|
|
Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID-19.
|
NA
|
NA
|
|
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment.
|
NA
|
NA
|
|
A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell’s Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
|
NA
|
NA
|
|
Crisis standards of care in a pandemic: navigating the ethical, clinical, psychological and policy-making maelstrom.
|
NA
|
NA
|
|
Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs.
|
NA
|
NA
|
|
A single-centre, prospective cohort study of COVID-19 patients admitted to ICU for mechanical ventilatory support.
|
NA
|
NA
|
|
Clinical characteristics and progression of COVID-19 confirmed cases admitted to a single British clinical centre-A brief case series report.
|
NA
|
NA
|
|
Intricate interplay between Covid-19 and cardiovascular diseases.
|
NA
|
NA
|
|
Catecholamine physiology and its implications in patients with COVID-19.
|
NA
|
NA
|
|
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction.
|
NA
|
NA
|
|
A multiple therapy hypothesis for treatment of COVID-19 patients.
|
NA
|
NA
|
|
Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.
|
NA
|
NA
|
|
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
|
NA
|
NA
|
|
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on help-seeking behaviors in individuals suffering from eating disorders and their caregivers.
|
NA
|
NA
|
|
Hospital and ICU patient volume per physician at peak of COVID pandemic: State-level estimates.
|
NA
|
NA
|
|
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
[Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study].
|
NA
|
NA
|
|
[Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic].
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Emergency Department Use: Focus on Patients Requiring Urgent Revascularization.
|
NA
|
NA
|
|
COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange.
|
NA
|
NA
|
|
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond.
|
NA
|
NA
|
|
Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes.
|
NA
|
NA
|
|
Odontogenic Infections: Disease Burden During COVID-19 at a Single Institution.
|
NA
|
NA
|
|
Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
|
NA
|
NA
|
|
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.
|
NA
|
NA
|
|
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Effects of COVID-19 pandemic on out-of-hospital cardiac arrests: A systematic review.
|
NA
|
NA
|
|
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
|
NA
|
NA
|
|
The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.
|
NA
|
NA
|
|
COVID-19 cumulative incidence, intensive care, and mortality in Italian regions compared to selected European countries.
|
NA
|
NA
|
|
Role of favipiravir in the treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19 and antimalarials. Have we been doing it wrong all along?
|
NA
|
NA
|
|
Science unites a troubled world: Lessons from the pandemic.
|
NA
|
NA
|
|
In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain.
|
NA
|
NA
|
|
Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies.
|
NA
|
NA
|
|
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm.
|
NA
|
NA
|
|
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
|
NA
|
NA
|
|
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
|
NA
|
NA
|
|
Clinical course of COVID-19 among immunocompromised children: a clinical case series.
|
NA
|
NA
|
|
Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic
|
NA
|
NA
|
|
Examining the Emergency Medical Treatment and Active Labor Act: impact on telemedicine for neurotrauma.
|
NA
|
NA
|
|
[COVID-19: TOPICAL ISSUES OF CLINIC ACTIVITIES DURING A PANDEMIC].
|
NA
|
NA
|
|
The actual threat of COVID-19.
|
NA
|
NA
|
|
The toll of noninfected CRS patients to the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.
|
NA
|
NA
|
|
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.
|
NA
|
NA
|
|
Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: A prospective cohort study from Turkey.
|
NA
|
NA
|
|
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
|
NA
|
NA
|
|
Online pharmacy navigation skills are associated with prospective memory in HIV disease.
|
NA
|
NA
|
|
[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
|
NA
|
NA
|
|
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.
|
NA
|
NA
|
|
Detection and quantification of SARS-CoV-2 RNA in wastewater and treated effluents: Surveillance of COVID-19 epidemic in the United Arab Emirates.
|
NA
|
NA
|
|
Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data.
|
NA
|
NA
|
|
The importance of early use of beta blockers and gastric decontamination in caffeine overdose: A case report.
|
NA
|
NA
|
|
[Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)].
|
NA
|
NA
|
|
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
|
NA
|
NA
|
|
Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City.
|
NA
|
NA
|
|
Anxiety, Depression, and Resilience of Healthcare Workers in Japan During the Coronavirus Disease 2019 Outbreak.
|
NA
|
NA
|
|
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan.
|
NA
|
NA
|
|
Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene?
|
NA
|
NA
|
|
The Precedent of Good Enough Therapy During Unprecedented Times.
|
NA
|
NA
|
|
Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.
|
NA
|
NA
|
|
State of Personal Protective Equipment Practice in Indian Intensive Care Units amidst COVID-19 Pandemic: A Nationwide Survey.
|
NA
|
NA
|
|
Percutaneous Tracheostomy in COVID-19 Patients: A Four-step Safe Protocol.
|
NA
|
NA
|
|
Modified Barrier Enclosure for Noninvasive Respiratory Support in COVID-19 Outbreak.
|
NA
|
NA
|
|
Current Approaches to COVID-19: Therapy and Prevention.
|
NA
|
NA
|
|
Ethical Issues in Intensive Care Units during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The COVID-19: Current understanding.
|
NA
|
NA
|
|
Impact of pain, psychological-distress, SARS-CoV2 fear on adults’ OHRQOL during COVID-19 pandemic.
|
NA
|
NA
|
|
A time-varying SIRD model for the COVID-19 contagion in Italy.
|
NA
|
NA
|
|
Where do we stand to oversee the coronaviruses in aqueous and aerosol environment? Characteristics of transmission and possible curb strategies.
|
NA
|
NA
|
|
Responsible innovation in synthetic biology in response to COVID-19: the role of data positionality.
|
NA
|
NA
|
|
[The virology of SARS-CoV-2].
|
NA
|
NA
|
|
[Fatality and risk factors for severe courses of COVID-19 pneumonia].
|
NA
|
NA
|
|
“Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study.
|
NA
|
NA
|
|
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions.
|
NA
|
NA
|
|
Being a Psychotherapist in Times of the Novel Coronavirus Disease: Stress-Level, Job Anxiety, and Fear of Coronavirus Disease Infection in More Than 1,500 Psychotherapists in Austria.
|
NA
|
NA
|
|
The Psychological and Social Impact of Covid-19: New Perspectives of Well-Being.
|
NA
|
NA
|
|
For the Greater Good? The Devastating Ripple Effects of the Covid-19 Crisis.
|
NA
|
NA
|
|
SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
|
NA
|
NA
|
|
Targeting Lipid Rafts-A Potential Therapy for COVID-19.
|
NA
|
NA
|
|
Anti-COVID-19 drug screening: Frontier concepts and core technologies.
|
NA
|
NA
|
|
Gout management and outcomes during the COVID-19 pandemic: a cross-sectional internet survey.
|
NA
|
NA
|
|
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection.
|
NA
|
NA
|
|
Chinese guidelines related to novel coronavirus pneumonia.
|
NA
|
NA
|
|
Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients.
|
NA
|
NA
|
|
Curcumin (a constituent of turmeric): New treatment option against COVID-19.
|
NA
|
NA
|
|
Observational study of the suspected or confirmed cases of sars COV-2 infection needing emergency surgical intervention during the first months of the pandemic in a third level hospital: Case series.
|
NA
|
NA
|
|
Coronavirus disease 2019: scientific overview of the global pandemic.
|
NA
|
NA
|
|
Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, and Control Measures.
|
NA
|
NA
|
|
Massive Pulmonary Embolism Complicating Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.
|
NA
|
NA
|
|
Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy.
|
NA
|
NA
|
|
Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin.
|
NA
|
NA
|
|
COVID-19-Associated Acute Limb Ischemia in a Patient on Therapeutic Anticoagulation.
|
NA
|
NA
|
|
COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report.
|
NA
|
NA
|
|
Intoxication by hand sanitizer due to delirium after infectious spondylitis surgery during the COVID-19 pandemic: A case report and literature review.
|
NA
|
NA
|
|
COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures.
|
NA
|
NA
|
|
An Updated Understanding of the Current Emerging Respiratory Infection: COVID-19.
|
NA
|
NA
|
|
Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region.
|
NA
|
NA
|
|
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
|
NA
|
NA
|
|
Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections.
|
NA
|
NA
|
|
Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment.
|
NA
|
NA
|
|
Unintended consequences of COVID-19 safety measures on patients with chronic knee pain forced to defer joint replacement surgery.
|
NA
|
NA
|
|
COVID-19: The Impact in Oncology Care.
|
NA
|
NA
|
|
COVID-19 and Hematology-What Do We Know So Far?
|
NA
|
NA
|
|
Impaired spermatogenesis in COVID-19 patients.
|
NA
|
NA
|
|
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis.
|
NA
|
NA
|
|
Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response.
|
NA
|
NA
|
|
A Method to Improve Continuous Renal Replacement Therapy Circuit Survival Time in Critically Ill Coronavirus Disease 2019 Patients With Acute Kidney Injury.
|
NA
|
NA
|
|
Resolution of Coronavirus Disease 2019 Infection and Pulmonary Pathology With Nebulized DAS181: A Pilot Study.
|
NA
|
NA
|
|
Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review.
|
NA
|
NA
|
|
The Prevalence of Underlying Diseases and Comorbidities in COVID-19 Patients; an Updated Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED.
|
NA
|
NA
|
|
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
|
NA
|
NA
|
|
Preparing for an Increased Need for Abortion Access in India during and after COVID-19: Challenges and Strategies.
|
NA
|
NA
|
|
Transcatheter aortic valve implantation versus surgical aortic valve replacement during the COVID-19 pandemic-Current practice and concerns.
|
NA
|
NA
|
|
A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.
|
NA
|
NA
|
|
Basic Demographic Parameters Help Predict Outcomes in Patients Hospitalized With COVID-19 During the First Wave of Infection in West Texas.
|
NA
|
NA
|
|
Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
|
NA
|
NA
|
|
Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
|
NA
|
NA
|
|
In-hospital care in acute heart failure during the COVID-19 pandemic: insights from the German-wide Helios hospital network.
|
NA
|
NA
|
|
COVID-19 infection and the kidney.
|
NA
|
NA
|
|
COVID-19: the epidemiology and treatment.
|
NA
|
NA
|
|
How to maximize the efficacy of shockwave lithotripsy.
|
NA
|
NA
|
|
Development and Performance of a Clinical Decision Support Tool to Inform Resource Utilization for Elective Operations.
|
NA
|
NA
|
|
Person-centered communication between healthcare professionals and COVID-19 infected older adults in acute care settings: Findings from Wuhan, China.
|
NA
|
NA
|
|
Remdesivir for the Treatment of Severe COVID-19: A Community Hospital’s Experience.
|
NA
|
NA
|
|
Tetracycline and viruses: a possible treatment for COVID-19?
|
NA
|
NA
|
|
Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter study.
|
NA
|
NA
|
|
COVID-19 basics and vaccine development with a Canadian perspective.
|
NA
|
NA
|
|
A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.
|
NA
|
NA
|
|
Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.
|
NA
|
NA
|
|
Characteristics and Outcomes of Patients 80 Years and Older Hospitalized With Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy.
|
NA
|
NA
|
|
COVID-19 will forever change the landscape of telemedicine.
|
NA
|
NA
|
|
Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina.
|
NA
|
NA
|
|
The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors.
|
NA
|
NA
|
|
Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care.
|
NA
|
NA
|
|
Functional and druggability analysis of the SARS-CoV-2 proteome.
|
NA
|
NA
|
|
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT).
|
NA
|
NA
|
|
Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.
|
NA
|
NA
|
|
Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis.
|
NA
|
NA
|
|
COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems.
|
NA
|
NA
|
|
Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19.
|
NA
|
NA
|
|
Covid-19 mimicking symptoms in emergency gastrointestinal surgery cases during pandemic: A case series.
|
NA
|
NA
|
|
Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?
|
NA
|
NA
|
|
[Potential therapeutic drugs for novel coronavirus pneumonia].
|
NA
|
NA
|
|
Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies.
|
NA
|
NA
|
|
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
|
NA
|
NA
|
|
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
|
NA
|
NA
|
|
Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions.
|
NA
|
NA
|
|
Topological epidemic model: Theoretical insight into underlying networks.
|
NA
|
NA
|
|
Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial.
|
NA
|
NA
|
|
Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
|
NA
|
NA
|
|
Knowledge of dental academics about the COVID-19 pandemic: a multi-country online survey.
|
NA
|
NA
|
|
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
|
NA
|
NA
|
|
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Difficulties in Treating a Patient with Multiple Cancers in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Late Bowel Iischemia and Colovaginal Fistula after Low Anterior Resection in a COVID-19 Patient.
|
NA
|
NA
|
|
Treatment experience for opioid use disorder during COVID-19 in India: Learning from patients.
|
NA
|
NA
|
|
Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
|
NA
|
NA
|
|
Access to substance use disorder treatment during COVID-19: Implications from reduced local jail populations.
|
NA
|
NA
|
|
Substance use disorder treatment, parenting, and COVID-19.
|
NA
|
NA
|
|
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
|
NA
|
NA
|
|
Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study.
|
NA
|
NA
|
|
Three-Tiered COVID-19 Cohorting Strategy and Implications for Memory-Care.
|
NA
|
NA
|
|
Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study.
|
NA
|
NA
|
|
Pattern of anticoagulation prescription for patients with Covid-19 acute respiratory distress syndrome admitted to ICU. Does it impact outcome?
|
NA
|
NA
|
|
Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
|
NA
|
NA
|
|
Effective communication is key to intensive care nurses’ willingness to provide nursing care amidst the COVID-19 pandemic.
|
NA
|
NA
|
|
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
|
NA
|
NA
|
|
Chilblain-like lesions with prominent bullae in a patient with COVID-19.
|
NA
|
NA
|
|
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
|
NA
|
NA
|
|
A 67-Year-Old Woman with Sudden Hearing Loss Associated with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Hypertension management in 2030: a kaleidoscopic view.
|
NA
|
NA
|
|
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
|
NA
|
NA
|
|
[Challenges in visceral medicine during COVID-19].
|
NA
|
NA
|
|
A case of coronavirus disease 2019 in acquired immunodeficiency syndrome patient: a case report and review of the literature.
|
NA
|
NA
|
|
Medical Imaging Engineering and Technology Branch of the Chinese Society of Biomedical Engineering expert consensus on the application of Emergency Mobile Cabin CT.
|
NA
|
NA
|
|
The Impact of COVID-19 on Intravitreal Injection Compliance.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on an interdisciplinary endoscopy unit in a German “hotspot” area: a single center experience.
|
NA
|
NA
|
|
Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19.
|
NA
|
NA
|
|
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
|
NA
|
NA
|
|
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients.
|
NA
|
NA
|
|
Tobacco use disorder and the lungs.
|
NA
|
NA
|
|
Electronic medical record platform enhancements during COVID-19 to support identify-isolate-inform strategy for initial detection and management of patients.
|
NA
|
NA
|
|
leaves.
|
NA
|
NA
|
|
Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.
|
NA
|
NA
|
|
P Beauv. (Labiatae).
|
NA
|
NA
|
|
Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2’s main protease.
|
NA
|
NA
|
|
).
|
NA
|
NA
|
|
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
|
NA
|
NA
|
|
Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
|
NA
|
NA
|
|
Lessons Learned: Using the Caprini Risk Assessment Model to Provide Safe and Efficacious Thromboprophylaxis Following Hip and Knee Arthroplasty.
|
NA
|
NA
|
|
Digital Health Technologies Respond to the COVID-19 Pandemic In a Tertiary Hospital in China: Development and Usability Study.
|
NA
|
NA
|
|
Identification and analysis of ongoing registered clinical intervention trials on COVID-19.
|
NA
|
NA
|
|
Characteristics and outcomes of hospitalised patients with acute kidney injury and COVID-19.
|
NA
|
NA
|
|
Clinical features of pregnant women in Iran who died due to COVID-19.
|
NA
|
NA
|
|
Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
|
NA
|
NA
|
|
Psychological impact of infectious disease outbreaks on pregnant women: rapid evidence review.
|
NA
|
NA
|
|
Mental Health Outcomes of the COVID-19 Pandemic and a Collapsing Economy: Perspectives from a Developing Country.
|
NA
|
NA
|
|
A model for rapid emergency department expansion for the COVID-19 pandemic.
|
NA
|
NA
|
|
Coronavirus (SARS-CoV-2) Pandemic: Future Challenges for Dental Practitioners.
|
NA
|
NA
|
|
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 and Parkinson’s Disease: Shared Inflammatory Pathways Under Oxidative Stress.
|
NA
|
NA
|
|
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study.
|
NA
|
NA
|
|
Hyperthrombotic Milieu in COVID-19 Patients.
|
NA
|
NA
|
|
-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19.
|
NA
|
NA
|
|
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19.
|
NA
|
NA
|
|
Adverse drug reactions associated with concurrent acute psychiatric treatment and Covid-19 drug therapy.
|
NA
|
NA
|
|
Rediscovery of caffeine: an excellent drug for improving patient outcomes while fighting WARS.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on harm reduction services in Spain.
|
NA
|
NA
|
|
Planning considerations prior to laryngectomy for a patient infected with severe acute respiratory syndrome coronavirus-2 pre-operatively.
|
NA
|
NA
|
|
Survey of cancer care providers’ attitude toward care for older adults with cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
The hospitalized patient with COVID-19 on the medical ward: Cleveland Clinic approach to management.
|
NA
|
NA
|
|
Rationale for the use of sphingosine analogues in COVID-19 patients.
|
NA
|
NA
|
|
Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy.
|
NA
|
NA
|
|
Radiotherapy in the COVID-19 Pandemic Era.
|
NA
|
NA
|
|
A Nasopharyngeal Carcinoma Patient With COVID-19 Infection After Immunotherapy: A Case Report and Literature Review.
|
NA
|
NA
|
|
A proposal for testing kit of corona viruses using 3D photonic structure.
|
NA
|
NA
|
|
Pseudofungi in an Immunocompromised Patient with Breast Cancer and COVID-19.
|
NA
|
NA
|
|
COVID-19 and haematology services in a cancer centre from a middle-income country: adapting service delivery, balancing the known and unknown during the pandemic.
|
NA
|
NA
|
|
[The virology of SARS-CoV-2].
|
NA
|
NA
|
|
Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope?
|
NA
|
NA
|
|
Evolution of chest CT manifestations of COVID-19: a longitudinal study.
|
NA
|
NA
|
|
A Case of Multisystem Inflammatory Syndrome in Children Mimicking Acute Appendicitis in a COVID-19 Pandemic Area.
|
NA
|
NA
|
|
Rhino-Orbital Mucormycosis Associated With COVID-19.
|
NA
|
NA
|
|
Modeling and analysis of COVID-19 epidemics with treatment in fractional derivatives using real data from Pakistan.
|
NA
|
NA
|
|
General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients.
|
NA
|
NA
|
|
Coronavirus disease 2019: MRI examination procedures and infection prevention and protection.
|
NA
|
NA
|
|
Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.
|
NA
|
NA
|
|
Current role of imaging in COVID-19 infection with recent recommendations of point of care ultrasound in the contagion: a narrative review.
|
NA
|
NA
|
|
Running a Radiation Oncology Department at the Time of Coronavirus: An Italian Experience.
|
NA
|
NA
|
|
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.
|
NA
|
NA
|
|
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology.
|
NA
|
NA
|
|
The Impact of COVID-19 on Interventional Radiology Services in the UK.
|
NA
|
NA
|
|
Using telehealth to provide outpatient follow-up to children with avoidant/restrictive food intake disorder.
|
NA
|
NA
|
|
Immunology of COVID-19.
|
NA
|
NA
|
|
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
|
NA
|
NA
|
|
Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
|
NA
|
NA
|
|
Modelling the spread of SARS-CoV-2 pandemic - Impact of lockdowns & interventions.
|
NA
|
NA
|
|
Rapid chromatographic immunoassay-based evaluation of COVID-19: A cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India.
|
NA
|
NA
|
|
Problems of Interpreting Diagnostic Tests for SARS-CoV-2: Analytical Chemistry Concerns.
|
NA
|
NA
|
|
Unwrapping the long-term impacts of COVID-19 pandemic on Brazilian academic mothers: the urgency of short, medium, and long-term measures.
|
NA
|
NA
|
|
Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System.
|
NA
|
NA
|
|
Head and neck cancer therapy-related oral manifestation management in the COVID-19 pandemic: a critical review.
|
NA
|
NA
|
|
Differences in endodontic emergency management by endodontists and general dental practitioners in COVID-19 times.
|
NA
|
NA
|
|
Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement.
|
NA
|
NA
|
|
Gastrointestinal Manifestations and Associated Health Outcomes of COVID-19: A Brazilian Experience From the Largest South American Public Hospital.
|
NA
|
NA
|
|
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
|
NA
|
NA
|
|
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.
|
NA
|
NA
|
|
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.
|
NA
|
NA
|
|
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
|
NA
|
NA
|
|
A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
|
NA
|
NA
|
|
Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter.
|
NA
|
NA
|
|
Trends in COVID-19 Risk-Adjusted Mortality Rates.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System.
|
NA
|
NA
|
|
Leveraging a Cloud-Based Critical Care Registry for COVID-19 Pandemic Surveillance and Research in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
COVID-19-Related Internet Search Patterns Among People in the United States: Exploratory Analysis.
|
NA
|
NA
|
|
Vocal Cord Ulcer Following Endotracheal Intubation for Mechanical Ventilation in COVID-19 Pneumonia: A Case Report from Northern Italy.
|
NA
|
NA
|
|
Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: A retrospective cohort study.
|
NA
|
NA
|
|
Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
|
NA
|
NA
|
|
Streamlining follicular monitoring during controlled ovarian stimulation: a data-driven approach to efficient IVF care in the new era of social distancing.
|
NA
|
NA
|
|
[The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care].
|
NA
|
NA
|
|
HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon.
|
NA
|
NA
|
|
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research.
|
NA
|
NA
|
|
Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
|
NA
|
NA
|
|
Prototype Development of an Expert System of Computerized Clinical Guidelines for COVID-19 Diagnosis and Management in Saudi Arabia.
|
NA
|
NA
|
|
Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid.
|
NA
|
NA
|
|
Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation.
|
NA
|
NA
|
|
Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study.
|
NA
|
NA
|
|
Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Development of Rapid Advice Guidelines for the Treatment of Coronavirus Disease 2019 with Traditional Chinese Medicine.
|
NA
|
NA
|
|
Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
|
NA
|
NA
|
|
Successful Anesthesia Management in a Patient With Type A Aortic Dissection Complicated by Renal Failure and Suspected Coronavirus Disease.
|
NA
|
NA
|
|
Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19.
|
NA
|
NA
|
|
Informed consent, duty of disclosure and chiropractic: where are we?
|
NA
|
NA
|
|
Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review.
|
NA
|
NA
|
|
The role of haematological parameters in patients with COVID-19 and influenza virus infection.
|
NA
|
NA
|
|
Update of takotsubo syndrome in the era of COVID-19.
|
NA
|
NA
|
|
Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct.
|
NA
|
NA
|
|
Murine typhus mistaken for COVID-19 in a young man.
|
NA
|
NA
|
|
Rapid implementation and improvement of a virtual student placement model in response to the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data.
|
NA
|
NA
|
|
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.
|
NA
|
NA
|
|
Harmonizing Heterogeneous Endpoints in Coronavirus Disease 2019 Trials Without Loss of Information.
|
NA
|
NA
|
|
COVID-19 and Solid Organ Transplantation: A Review Article.
|
NA
|
NA
|
|
Pediatric Dentistry during Coronavirus Disease-2019 Pandemic: A Paradigm Shift in Treatment Options.
|
NA
|
NA
|
|
New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
|
NA
|
NA
|
|
Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.
|
NA
|
NA
|
|
Depression, Anxiety and Associated Factors Among Chronic Medical Patients Amid COVID-19 Pandemic in Mettu Karl Referral Hospital, Mettu, Ethiopia, 2020.
|
NA
|
NA
|
|
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase.
|
NA
|
NA
|
|
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.
|
NA
|
NA
|
|
Computerized monitoring of COVID-19 trials, studies and registries in ClinicalTrials.gov registry.
|
NA
|
NA
|
|
COVID-19: Implications for People with Chagas Disease.
|
NA
|
NA
|
|
COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.
|
NA
|
NA
|
|
Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.
|
NA
|
NA
|
|
COVID-19: smoke testing of surgical mask and respirators.
|
NA
|
NA
|
|
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.
|
NA
|
NA
|
|
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2.
|
NA
|
NA
|
|
Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action.
|
NA
|
NA
|
|
Treatment considerations for Behçet disease in the era of COVID-19: A narrative review.
|
NA
|
NA
|
|
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India.
|
NA
|
NA
|
|
Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation.
|
NA
|
NA
|
|
SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin.
|
NA
|
NA
|
|
Kidney involvement in COVID-19 and its treatments.
|
NA
|
NA
|
|
Digestive system manifestations and clinical significance of coronavirus disease 2019: A systematic literature review.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Associated Urogenital Disease: A Current Update.
|
NA
|
NA
|
|
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies.
|
NA
|
NA
|
|
Sitagliptin: a potential drug for the treatment of COVID-19?
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review.
|
NA
|
NA
|
|
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.
|
NA
|
NA
|
|
Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.
|
NA
|
NA
|
|
How critical activities within COVID-19 intensive care units increase nurses’ daily occupational calling.
|
NA
|
NA
|
|
Predictors of psychological distress among the public in Oman amid coronavirus disease 2019 pandemic: a cross-sectional analytical study.
|
NA
|
NA
|
|
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National Survey.
|
NA
|
NA
|
|
An overview on the use of antivirals for the treatment of patients with COVID19 disease.
|
NA
|
NA
|
|
Concerns Expressed by Chinese Social Media Users During the COVID-19 Pandemic: Content Analysis of Sina Weibo Microblogging Data.
|
NA
|
NA
|
|
Impact of Trump’s Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
|
NA
|
NA
|
|
Experiences of Psychotherapists With Remote Psychotherapy During the COVID-19 Pandemic: Cross-sectional Web-Based Survey Study.
|
NA
|
NA
|
|
COVID-19 and Tuberculosis Coinfection in a 51-Year-Old Taxi Driver in Mexico City.
|
NA
|
NA
|
|
Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
|
NA
|
NA
|
|
A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study.
|
NA
|
NA
|
|
Physical Therapist Management of COVID-19 in the Intensive Care Unit: The West China Hospital Experience.
|
NA
|
NA
|
|
Pandemic’s glossary: The ABC of coronavirus concepts
|
NA
|
NA
|
|
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia
|
NA
|
NA
|
|
SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia
|
NA
|
NA
|
|
Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia
|
NA
|
NA
|
|
Active-Site Cavity Facilitates Binding of Clinical Antivirals.
|
NA
|
NA
|
|
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
|
NA
|
NA
|
|
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics.
|
NA
|
NA
|
|
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics.
|
NA
|
NA
|
|
Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead.
|
NA
|
NA
|
|
Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic.
|
NA
|
NA
|
|
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
|
NA
|
NA
|
|
COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
|
NA
|
NA
|
|
Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis.
|
NA
|
NA
|
|
Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
|
NA
|
NA
|
|
Coronavirus Pandemic - SARS-CoV-2 in Orthopedics and Trauma Surgery.
|
NA
|
NA
|
|
CRISPR/Cas13: A potential therapeutic option of COVID-19.
|
NA
|
NA
|
|
Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects.
|
NA
|
NA
|
|
Consideration of the Psychological and Mental Health of the Elderly during COVID-19: A Theoretical Review.
|
NA
|
NA
|
|
Is Quarantine for COVID-19 Pandemic Associated with Psychological Burden in Primary Ciliary Dyskinesia?
|
NA
|
NA
|
|
Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19.
|
NA
|
NA
|
|
Nurse Reports of Stressful Situations during the COVID-19 Pandemic: Qualitative Analysis of Survey Responses.
|
NA
|
NA
|
|
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
|
NA
|
NA
|
|
Impact of the SARS-CoV-2 Pandemic on Emergency Department Presentations in an Integrated Health System.
|
NA
|
NA
|
|
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation.
|
NA
|
NA
|
|
The effect of apnea management on novel coronavirus infection: A study on patients with obstructive sleep apnea.
|
NA
|
NA
|
|
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
|
NA
|
NA
|
|
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2.
|
NA
|
NA
|
|
Convalescent plasma - Is it useful for treating SARS Co-V2 infection?
|
NA
|
NA
|
|
Can quantitative RT-PCR for SARS-CoV-2 help in better management of patients and control of coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Comparison of two real-time polymerase chain reaction assays for the detection of severe acute respiratory syndrome-CoV-2 from combined nasopharyngeal-throat swabs.
|
NA
|
NA
|
|
COVID-19: A review of the effectiveness of non-pharmacological interventions.
|
NA
|
NA
|
|
Epidemiological determinants of COVID-19 infection and mortality: A study among patients presenting with severe acute respiratory illness during the pandemic in Bihar, India.
|
NA
|
NA
|
|
Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
|
NA
|
NA
|
|
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
|
NA
|
NA
|
|
Combined Interventions for Severe Novel Coronavirus Disease (COVID-19): Experience from 350 Patients.
|
NA
|
NA
|
|
Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Neuroticism and Fear of COVID-19. The Interplay Between Boredom, Fantasy Engagement, and Perceived Control Over Time.
|
NA
|
NA
|
|
Proposal for a provisional protocol for the care and identification of dental transmission routes of COVID-19 in Latin America: A Literature review.
|
NA
|
NA
|
|
Medical Education, Pre- and Post-Pandemic Era: A Review Article.
|
NA
|
NA
|
|
COVID-19 and the Brain: Acute Encephalitis as a Clinical Manifestation.
|
NA
|
NA
|
|
Baseline results of a living systematic review for COVID-19 clinical trial registrations.
|
NA
|
NA
|
|
Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues.
|
NA
|
NA
|
|
The provision of neuro-oncology and glioma neurosurgery during the SARS-CoV-2 pandemic: a single national tertiary centre experience.
|
NA
|
NA
|
|
COVID-19 - gastrointestinal and gut microbiota-related aspects.
|
NA
|
NA
|
|
China’s experience in COVID-19 prevention and control among children in its different regions.
|
NA
|
NA
|
|
Clinical features of 17 patients with 2019-nCoV.
|
NA
|
NA
|
|
Living with Coronavirus (COVID-19): a brief report.
|
NA
|
NA
|
|
Lived experiences of patients with COVID-19 infection: a phenomenology study.
|
NA
|
NA
|
|
Saporin, a Polynucleotide-Adenosine Nucleosidase, May Be an Efficacious Therapeutic Agent for SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Identification and characterization of novel RdRp and Nsp15 inhibitors for SARS-COV2 using computational approach.
|
NA
|
NA
|
|
COVID-19 in chronic hemodialysis patients: A report of 9 cases in Madrid, Spain.
|
NA
|
NA
|
|
Risk Factors for Mortality in 220 Patients With COVID-19 in Wuhan, China: A Single-Center, Retrospective Study.
|
NA
|
NA
|
|
Observation of Retropharyngeal Fluid Collection in 2 COVID-19 Positive Patients.
|
NA
|
NA
|
|
A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2.
|
NA
|
NA
|
|
Properties of Ethno-Medicinal Plants and Their Bioactives-Possible Use for Prevention and Treatment of COVID-19: A Review.
|
NA
|
NA
|
|
[Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical].
|
NA
|
NA
|
|
[QT Interval in Patients With COVID-19].
|
NA
|
NA
|
|
[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)”].
|
NA
|
NA
|
|
[ECG changes in COVID-19].
|
NA
|
NA
|
|
Possible role of Unani Pharmacology in COVID-19 - a narrative review.
|
NA
|
NA
|
|
Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: A systematic review of a globally representative sample.
|
NA
|
NA
|
|
Interim Guidance on the Preparticipation Physical Examination for Athletes During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes.
|
NA
|
NA
|
|
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies.
|
NA
|
NA
|
|
[Risk stratification through implementation and evaluation of a COVID-19 score : A retrospective diagnostic study].
|
NA
|
NA
|
|
Current and evolving standards of care for patients with ARDS.
|
NA
|
NA
|
|
An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.
|
NA
|
NA
|
|
First Intraoperative Radiation Therapy Center in Africa: First 2 Years in Operation, Including COVID-19 Experiences.
|
NA
|
NA
|
|
Recent advances in vaccine and immunotherapy for COVID-19.
|
NA
|
NA
|
|
A Weakly-Supervised Framework for COVID-19 Classification and Lesion Localization From Chest CT.
|
NA
|
NA
|
|
Ethics of Digital Mental Health During COVID-19: Crisis and Opportunities.
|
NA
|
NA
|
|
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
|
NA
|
NA
|
|
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG.
|
NA
|
NA
|
|
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.
|
NA
|
NA
|
|
Successful Catheter-Directed Thrombolysis for Acute Lower Limb Ischemia Secondary to COVID-19 Infection.
|
NA
|
NA
|
|
Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications.
|
NA
|
NA
|
|
Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19-An exploratory study.
|
NA
|
NA
|
|
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
|
NA
|
NA
|
|
Preventing infectious diseases in Intensive Care Unit by medical devices remote control: Lessons from COVID-19.
|
NA
|
NA
|
|
Early acute rejection after lung transplantation mimicking viral pneumonia in the middle of COVID-19 pandemic: A case report.
|
NA
|
NA
|
|
Efficacy of human coronavirus immune convalescent plasma for the treatment of corona virus disease -19 disease in hospitalized children: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic: A randomized clinical trial protocol.
|
NA
|
NA
|
|
Clinical, inflammatory, and immune differences between COVID-19 patients with and without cancer: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Traditional Chinese exercise for COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation.
|
NA
|
NA
|
|
Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result.
|
NA
|
NA
|
|
Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review.
|
NA
|
NA
|
|
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies.
|
NA
|
NA
|
|
Post liver transplant recurrent and de novo viral infections.
|
NA
|
NA
|
|
Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study.
|
NA
|
NA
|
|
Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.
|
NA
|
NA
|
|
Evidence-based assessment of potential therapeutic effects of adjunct osteopathic medicine for multidisciplinary care of acute and convalescent COVID-19 patients.
|
NA
|
NA
|
|
Case report of a neonate with high viral SARSCoV-2 loads and long-term virus shedding.
|
NA
|
NA
|
|
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
|
NA
|
NA
|
|
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
|
NA
|
NA
|
|
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study.
|
NA
|
NA
|
|
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population.
|
NA
|
NA
|
|
A pharmacology-based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID-19.
|
NA
|
NA
|
|
Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.
|
NA
|
NA
|
|
[SYSVENT: Proof of Concept Study of a Prototype to Ventilate Critical Care Patients].
|
NA
|
NA
|
|
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
|
NA
|
NA
|
|
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the Future.
|
NA
|
NA
|
|
Biclonal gammopathay in a case of severe COVID-19.
|
NA
|
NA
|
|
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
|
NA
|
NA
|
|
Arginine depletion as a therapeutic approach for patients with COVID-19.
|
NA
|
NA
|
|
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity.
|
NA
|
NA
|
|
De-escalation of medical therapy in inflammatory bowel disease.
|
NA
|
NA
|
|
COVID-19: Is there a role for immunonutrition in obese patient?
|
NA
|
NA
|
|
Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception.
|
NA
|
NA
|
|
Pandemic danger to the deep: The risk of marine mammals contracting SARS-CoV-2 from wastewater.
|
NA
|
NA
|
|
COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study.
|
NA
|
NA
|
|
Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection.
|
NA
|
NA
|
|
Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.
|
NA
|
NA
|
|
Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization.
|
NA
|
NA
|
|
Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19.
|
NA
|
NA
|
|
Incidence of acute coronary syndrome during national lock-down: Insights from nationwide data during the Coronavirus disease 2019 (COVID-19) pandemic.
|
NA
|
NA
|
|
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
|
NA
|
NA
|
|
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.
|
NA
|
NA
|
|
General Anxiety in Dental Staff and Hemodynamic Changes over Endodontists’ Workday during the Coronavirus Disease 2019 Pandemic: A Prospective Longitudinal Study.
|
NA
|
NA
|
|
Dental Anxiety, Fear, and Root Canal Treatment Monitoring of Heart Rate and Oxygen Saturation in Patients Treated during the Coronavirus Disease 2019 Pandemic: An Observational Clinical Study.
|
NA
|
NA
|
|
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.
|
NA
|
NA
|
|
Emerging Palliative Care Innovations in the ED: A Qualitative Analysis of Programmatic Elements During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
|
NA
|
NA
|
|
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study.
|
NA
|
NA
|
|
COVID-19 update: The race to therapeutic development.
|
NA
|
NA
|
|
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
|
NA
|
NA
|
|
COVID-19 and the ethical issues of justice and rationing in health care, with particular regard to the Italian experience
|
NA
|
NA
|
|
[The importance of flu vaccination during CoViD time].
|
NA
|
NA
|
|
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.
|
NA
|
NA
|
|
COVID-19-associated coagulopathy and disseminated intravascular coagulation.
|
NA
|
NA
|
|
Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.
|
NA
|
NA
|
|
Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19.
|
NA
|
NA
|
|
Plume Effect of Fractional Radiofrequency Verus Laser Resurfacing: Considerations in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Evidence-based point-of-care technology development during the COVID-19 pandemic.
|
NA
|
NA
|
|
A comprehensive review on sarilumab in COVID-19.
|
NA
|
NA
|
|
Virtual Fracture Clinics in Orthopaedic Surgery - A Systematic Review of Current Evidence.
|
NA
|
NA
|
|
Reporting of child maltreatment during the SARS-CoV-2 pandemic in New York City from March to May 2020.
|
NA
|
NA
|
|
Motivating social distancing during the COVID-19 pandemic: An online experiment.
|
NA
|
NA
|
|
[Acute kidney failure in patients admitted due to COVID-19].
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children.
|
NA
|
NA
|
|
The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas.
|
NA
|
NA
|
|
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.
|
NA
|
NA
|
|
Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study.
|
NA
|
NA
|
|
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy.
|
NA
|
NA
|
|
Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.
|
NA
|
NA
|
|
The impact of COVID-19 on pharmacy transitions of care services.
|
NA
|
NA
|
|
The novel zoonotic Coronavirus disease 2019 (COVID-19) pandemic: Health perspective on the outbreak.
|
NA
|
NA
|
|
COVID-19 pandemic: Psychological impact on anaesthesiologists.
|
NA
|
NA
|
|
Trust and compliance to public health policies in times of COVID-19.
|
NA
|
NA
|
|
Determination of the structural, electronic, optoelectronic and thermodynamic properties of the methylxanthine molecules theophylline and theobromine.
|
NA
|
NA
|
|
Experimental and numerical study on the transport of droplet aerosols generated by occupants in a fever clinic.
|
NA
|
NA
|
|
Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey.
|
NA
|
NA
|
|
The COVID-19 era: How therapists can diminish burnout symptoms through self-care.
|
NA
|
NA
|
|
Cardiotoxicity of Contemporary Anticancer Immunotherapy.
|
NA
|
NA
|
|
Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
|
NA
|
NA
|
|
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
|
NA
|
NA
|
|
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection.
|
NA
|
NA
|
|
Pathophysiology of Cardiovascular Complications in COVID-19.
|
NA
|
NA
|
|
The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
|
NA
|
NA
|
|
Exploring the potential therapeutic effect of traditional Chinese medicine on coronavirus disease 2019 (COVID-19) through a combination of data mining and network pharmacology analysis.
|
NA
|
NA
|
|
Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19.
|
NA
|
NA
|
|
Spontaneous Brainstem Hemorrhagic Stroke in the Setting of Novel Coronavirus Disease 2019 - A Case Report.
|
NA
|
NA
|
|
COVID-19 misinformation: Accuracy of articles about coronavirus prevention mostly shared on social media.
|
NA
|
NA
|
|
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.
|
NA
|
NA
|
|
Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country.
|
NA
|
NA
|
|
A modeling informed quantitative approach to salvage clinical trials interrupted due to COVID-19.
|
NA
|
NA
|
|
Profile of distress callers and service utilisation of tele-counselling among the population of Assam, India: an exploratory study during COVID-19.
|
NA
|
NA
|
|
A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies.
|
NA
|
NA
|
|
Infection control in dentistry during COVID - 19 pandemic: what has changed?
|
NA
|
NA
|
|
Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins.
|
NA
|
NA
|
|
Partisan public health: how does political ideology influence support for COVID-19 related misinformation?
|
NA
|
NA
|
|
The Impact of COVID-19 on Brachytherapy During the Pandemic: A Rutgers-Robert Wood Johnson Barnabas Health Multisite Experience.
|
NA
|
NA
|
|
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review.
|
NA
|
NA
|
|
Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.
|
NA
|
NA
|
|
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
|
NA
|
NA
|
|
COVID-19-associated encephalitis successfully treated with combination therapy.
|
NA
|
NA
|
|
Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines -two case reports.
|
NA
|
NA
|
|
Lessons from Severe Acute Respiratory Syndrome Coronavirus 2003 Pandemic as Evidence to Advocate for Stroke Public Education During the Current Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
|
NA
|
NA
|
|
COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
|
NA
|
NA
|
|
Pleural complications in patients with coronavirus disease 2019 (COVID-19): how to safely apply and follow-up with a chest tube during the pandemic?
|
NA
|
NA
|
|
Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
|
NA
|
NA
|
|
Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?
|
NA
|
NA
|
|
Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.
|
NA
|
NA
|
|
Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
|
NA
|
NA
|
|
The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case.
|
NA
|
NA
|
|
Adaptation or Revolution: Telemental Health and Advanced Practice Psychiatric Nursing During COVID-19.
|
NA
|
NA
|
|
Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.
|
NA
|
NA
|
|
Using artificial intelligence to assist radiologists in distinguishing COVID-19 from other pulmonary infections.
|
NA
|
NA
|
|
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.
|
NA
|
NA
|
|
Development and validation of a simple and rapid UHPLC-MS/MS method for the quantification of hydroxychloroquine in plasma and blood samples in the emergency context of SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium.
|
NA
|
NA
|
|
Necrotizing Enterocolitis-like Pneumatosis Intestinalis in an Infant With COVID-19.
|
NA
|
NA
|
|
Breakthrough healthcare technologies in the COVID-19 era: a unique opportunity for cardiovascular practitioners and patients.
|
NA
|
NA
|
|
State of mental health services in various training centers in India during the lockdown and COVID-19 pandemic.
|
NA
|
NA
|
|
Cardiovascular view of intermediate and high-risk COVID-19 patients: single-centre experience with low mortality and intensive care hospitalisation rates.
|
NA
|
NA
|
|
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
The effect of tocilizumab on cytokine release syndrome in COVID-19 patients.
|
NA
|
NA
|
|
Triage during the COVID-19 pandemic.
|
NA
|
NA
|
|
Research initiatives of blood services worldwide in response to the covid-19 pandemic.
|
NA
|
NA
|
|
Behavioral economics of substance use: Understanding and reducing harmful use during the COVID-19 pandemic.
|
NA
|
NA
|
|
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.
|
NA
|
NA
|
|
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial.
|
NA
|
NA
|
|
COVID-19 unfolding filariasis: The first case of SARS-CoV-2 and Wuchereria bancrofti coinfection.
|
NA
|
NA
|
|
Comparative effectiveness and safety of antiviral agents for patients with COVID-19: Protocol for a systematic review and individual-patient data network meta-analysis.
|
NA
|
NA
|
|
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics.
|
NA
|
NA
|
|
A Consensus Statement for the Management and Rehabilitation of Communication and Swallowing Function in the ICU: A Global Response to COVID-19.
|
NA
|
NA
|
|
Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19.
|
NA
|
NA
|
|
LPD-12: a promising lipopeptide to control COVID-19.
|
NA
|
NA
|
|
Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.
|
NA
|
NA
|
|
The Impact of Covid-19 Lockdown on Stroke Admissions and Treatments in Campania.
|
NA
|
NA
|
|
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice.
|
NA
|
NA
|
|
A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.
|
NA
|
NA
|
|
Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.
|
NA
|
NA
|
|
Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.
|
NA
|
NA
|
|
[Problems in treating patients with chronic HCV infection due to the COVID-19 pandemic and during the lockdown phase in Germany].
|
NA
|
NA
|
|
SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis.
|
NA
|
NA
|
|
Impact of COVID-19 Lockdown Measures on Spanish People with Chronic Pain: An Online Study Survey.
|
NA
|
NA
|
|
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases.
|
NA
|
NA
|
|
Antibody-Based Immunotherapeutic Strategies for COVID-19.
|
NA
|
NA
|
|
Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines.
|
NA
|
NA
|
|
Psychotherapy via the Internet: What Programs Do Psychotherapists Use, How Well-Informed Do They Feel, and What Are Their Wishes for Continuous Education?
|
NA
|
NA
|
|
The future of rehabilitation in the United Kingdom National Health Service: Using the COVID-19 crisis to promote change, increasing efficiency and effectiveness.
|
NA
|
NA
|
|
Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
|
NA
|
NA
|
|
The use of nebulized pharmacotherapies during the COVID-19 pandemic.
|
NA
|
NA
|
|
An overview on COVID-19 pandemic: from discovery to treatment.
|
NA
|
NA
|
|
Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial.
|
NA
|
NA
|
|
The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study.
|
NA
|
NA
|
|
Dysphagia presentation and management following COVID-19: an acute care tertiary centre experience.
|
NA
|
NA
|
|
Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
|
NA
|
NA
|
|
[Ocular manifestations of viral diseases].
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on clinical radiography practice in low resource settings: The Ghanaian radiographers’ perspective.
|
NA
|
NA
|
|
Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up.
|
NA
|
NA
|
|
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach.
|
NA
|
NA
|
|
The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician’s attitudes toward hypertension treatment.
|
NA
|
NA
|
|
Management and Treatment of Myocarditis in Athletes.
|
NA
|
NA
|
|
SARS-CoV-2 associated COVID-19 in geriatric population: A brief narrative review.
|
NA
|
NA
|
|
The Efficacy of Telehealth for the Treatment of Spinal Disorders: Patient-Reported Experiences During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A suspected case of COVID-19 turned into a confirmed case: a case report.
|
NA
|
NA
|
|
[Colon cancer screening in times of COVID-19].
|
NA
|
NA
|
|
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.
|
NA
|
NA
|
|
What surgeons should know about emergency operation for COVID-19 confirmed patients: A case report.
|
NA
|
NA
|
|
Containing the impact of COVID-19: Review of Ghana’s response approach.
|
NA
|
NA
|
|
Submillisievert chest CT in patients with COVID-19 - experiences of a German Level-I center.
|
NA
|
NA
|
|
Why will it never be known if convalescent plasma is effective for COVID-19.
|
NA
|
NA
|
|
Comparative Sensitivity of Different Respiratory Specimen Types for Molecular Diagnosis and Monitoring of SARS-CoV-2 Shedding.
|
NA
|
NA
|
|
Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.
|
NA
|
NA
|
|
Ought Conscientious Refusals to Implement Reverse Triage Decisions be Accommodated?
|
NA
|
NA
|
|
Ethical Challenges in Clinical Research During the COVID-19 Pandemic.
|
NA
|
NA
|
|
What Matters? Palliative Care, Ethics, and the COVID-19 Pandemic.
|
NA
|
NA
|
|
Healthcare Professional Standards in Pandemic Conditions: The Duty to Obtain Consent to Treatment.
|
NA
|
NA
|
|
We Need to Talk About Rationing: The Need to Normalize Discussion About Healthcare Rationing in a Post COVID-19 Era.
|
NA
|
NA
|
|
Telling the Truth to Child Cancer Patients in COVID-19 Times.
|
NA
|
NA
|
|
Mental Capacity Assessments for COVID-19 Patients: Emergency Admissions and the CARD Approach.
|
NA
|
NA
|
|
Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
|
NA
|
NA
|
|
Turn down of acute aortic syndrome cases during COVID-19: Results from UK multicentre studies.
|
NA
|
NA
|
|
Does therapy with biological drugs influence COVID-19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020.
|
NA
|
NA
|
|
[Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
|
NA
|
NA
|
|
[Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
|
NA
|
NA
|
|
Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
|
NA
|
NA
|
|
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study.
|
NA
|
NA
|
|
Basics of mechanical ventilation for non-anaesthetists. Part 1: Theoretical aspects.
|
NA
|
NA
|
|
COVID-19: Impacts on oral healthcare delivery in dependent older adults.
|
NA
|
NA
|
|
Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19.
|
NA
|
NA
|
|
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.
|
NA
|
NA
|
|
ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
|
NA
|
NA
|
|
Analgesia and sedation in patients with ARDS.
|
NA
|
NA
|
|
Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients.
|
NA
|
NA
|
|
Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter Study.
|
NA
|
NA
|
|
In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Caregiver Satisfaction and Effectiveness of Teleconsultation in Children and Adolescents With Migraine During the Ongoing COVID-19 Pandemic.
|
NA
|
NA
|
|
Tweets by People With Arthritis During the COVID-19 Pandemic: Content and Sentiment Analysis.
|
NA
|
NA
|
|
Age separation dramatically reduces COVID-19 mortality rate in a computational model of a large population.
|
NA
|
NA
|
|
Unprecedented environmental and energy impacts and challenges of COVID-19 pandemic.
|
NA
|
NA
|
|
Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
|
NA
|
NA
|
|
Association between red blood cell distribution width and mortality of COVID-19 patients.
|
NA
|
NA
|
|
AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia.
|
NA
|
NA
|
|
Renal ultrasound findings secondary to COVID-19 related collapsing focal segmental glomerulosclerosis - A case report.
|
NA
|
NA
|
|
Expressive writing to combat distress associated with the COVID-19 pandemic in people with inflammatory bowel disease (WriteForIBD): A trial protocol.
|
NA
|
NA
|
|
Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.
|
NA
|
NA
|
|
Food-derived antioxidants and COVID-19.
|
NA
|
NA
|
|
Extensive Testing and Public Health Interventions for the Control of COVID-19 in the Republic of Cyprus between March and May 2020.
|
NA
|
NA
|
|
Dangerous Pathogens as a Potential Problem for Public Health.
|
NA
|
NA
|
|
Recent Patents and Advances on Nanotechnologies against Coronavirus.
|
NA
|
NA
|
|
COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines.
|
NA
|
NA
|
|
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
|
NA
|
NA
|
|
COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks.
|
NA
|
NA
|
|
Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium.
|
NA
|
NA
|
|
Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review.
|
NA
|
NA
|
|
Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis.
|
NA
|
NA
|
|
Air Quality Response in China Linked to the 2019 Novel Coronavirus (COVID-19) Lockdown.
|
NA
|
NA
|
|
Asthma and COVID-19: What do we know now.
|
NA
|
NA
|
|
Musculoskeletal oncology: patient triage and management during the COVID-19 pandemic.
|
NA
|
NA
|
|
Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications.
|
NA
|
NA
|
|
COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden of Coronavirus.
|
NA
|
NA
|
|
Management of Pregnancy during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Decreased Mortality in Patients With Severe Bronchospasm Associated With SARS-CoV-2: An Alternative to Invasive Mechanical Ventilation.
|
NA
|
NA
|
|
Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series.
|
NA
|
NA
|
|
The Race for a COVID-19 Vaccine: Current Trials, Novel Technologies, and Future Directions.
|
NA
|
NA
|
|
Bioinspired DNase-I-Coated Melanin-Like Nanospheres for Modulation of Infection-Associated NETosis Dysregulation.
|
NA
|
NA
|
|
Biomimetic Human Disease Model of SARS-CoV-2 Induced Lung Injury and Immune Responses on Organ Chip System.
|
NA
|
NA
|
|
Field grand challenge with emerging superbugs and the novel coronavirus (SARS-CoV-2) on plastics and in water.
|
NA
|
NA
|
|
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.
|
NA
|
NA
|
|
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.
|
NA
|
NA
|
|
Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2.
|
NA
|
NA
|
|
Effect of pre-existing diseases on COVID-19 infection and role of new sensors and biomaterials for its detection and treatment.
|
NA
|
NA
|
|
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study.
|
NA
|
NA
|
|
Coronavirus in human diseases: Mechanisms and advances in clinical treatment.
|
NA
|
NA
|
|
Hematological changes in patients with COVID‑19 (Review).
|
NA
|
NA
|
|
Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic?
|
NA
|
NA
|
|
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19.
|
NA
|
NA
|
|
The Need for Digital Health Solutions in Deep Brain Stimulation for Parkinson’s Disease in the Time of COVID-19 and Beyond.
|
NA
|
NA
|
|
Contextualizing cardiac dysfunction in critically ill patients with COVID-19.
|
NA
|
NA
|
|
2 induce expression of furin.
|
NA
|
NA
|
|
Peritoneal dialysis for acute kidney injury: Equations for dosing in pandemics, disasters, and beyond.
|
NA
|
NA
|
|
Why does COVID-19 pathology have several clinical forms?
|
NA
|
NA
|
|
Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice.
|
NA
|
NA
|
|
Postdischarge Intervention for Stroke Caregivers: Protocol for a Randomized Controlled Trial.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic in patient admission to a high-complexity cancer center in Southern Brasil.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on a daily-based outpatient treatment routine: experience of a radiotherapy department of a tertiary public/university hospital in Brazil.
|
NA
|
NA
|
|
COVID-19 and myositis - unique challenges for patients.
|
NA
|
NA
|
|
Impact of the coronavirus disease 2019 (COVID-19) pandemic on the Italian congenital cardiac surgery system: a national survey.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children Associated With Severe Acute Respiratory Syndrome Coronavirus-2 in an 8-Week-Old Infant.
|
NA
|
NA
|
|
Telehealth in the rehabilitation of female pelvic floor dysfunction: a systematic literature review.
|
NA
|
NA
|
|
Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study.
|
NA
|
NA
|
|
Characterising and managing paediatric SARSCoV-2 infection: Learning about the virus in a global classroom.
|
NA
|
NA
|
|
Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).
|
NA
|
NA
|
|
Insights From Rapid Deployment of a “Virtual Hospital” as Standard Care During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.
|
NA
|
NA
|
|
COVID-19 Pandemic: How is Bangladesh coping with the rapid spread of coronavirus infection?
|
NA
|
NA
|
|
Dental care during the Covid-19 pandemic - To treat or not to treat?
|
NA
|
NA
|
|
No new community COVID-19 infection in four consecutive weeks: what lesson can be learned from Vietnam.
|
NA
|
NA
|
|
Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient.
|
NA
|
NA
|
|
Availability of personal protective equipment and diagnostic and treatment facilities for healthcare workers involved in COVID-19 care: A cross-sectional study in Brazil, Colombia, and Ecuador.
|
NA
|
NA
|
|
COVID-19, thromboembolic risk, and Virchow’s triad: Lesson from the past.
|
NA
|
NA
|
|
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
|
NA
|
NA
|
|
Favipiravir and COVID-19: A Simplified Summary.
|
NA
|
NA
|
|
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
|
NA
|
NA
|
|
Experience of percutaneous tracheostomy in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Safety, pitfalls, and misunderstandings about the use of ozone therapy as a regenerative medicine tool. A narrative review.
|
NA
|
NA
|
|
Potential implications of black seed and its principal constituent Thymoquinone in the treatment of COVID-19 patients.
|
NA
|
NA
|
|
Are Hsp90 inhibitors good candidates against Covid-19?
|
NA
|
NA
|
|
First patient management of COVID-19 in Changsha, China: a case report.
|
NA
|
NA
|
|
National survey of home injuries during the time of COVID-19: who is at risk?
|
NA
|
NA
|
|
Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Detection of SARS-CoV-2 RNA in hospital wastewater from a low COVID-19 disease prevalence area.
|
NA
|
NA
|
|
Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.
|
NA
|
NA
|
|
Network interventions for managing the COVID-19 pandemic and sustaining economy.
|
NA
|
NA
|
|
A case of postpartum thyroiditis following SARS-CoV-2 infection.
|
NA
|
NA
|
|
Aspiration of periodontopathic bacteria due to poor oral hygiene potentially contributes to the aggravation of COVID-19.
|
NA
|
NA
|
|
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-Net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray images.
|
NA
|
NA
|
|
Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review.
|
NA
|
NA
|
|
N-Acetylcysteine to Combat COVID-19: An Evidence Review.
|
NA
|
NA
|
|
Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19.
|
NA
|
NA
|
|
Scenarios to Manage the Demand for N95 Respirators for Healthcare Workers During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
|
NA
|
NA
|
|
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.
|
NA
|
NA
|
|
Current Prevention of COVID-19: Natural Products and Herbal Medicine.
|
NA
|
NA
|
|
The AGE Effect on Protective Behaviors During the COVID-19 Outbreak: Sociodemographic, Perceptions and Psychological Accounts.
|
NA
|
NA
|
|
An Example of a Stroke Unit Reshaping in the Context of a Regional Hub and Spoke System in the COVID-19 Era.
|
NA
|
NA
|
|
Manufacturing and Management of CAR T-Cell Therapy in “COVID-19’s Time”: Central Versus Point of Care Proposals.
|
NA
|
NA
|
|
Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak.
|
NA
|
NA
|
|
Insights from nanotechnology in COVID-19 treatment.
|
NA
|
NA
|
|
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
|
NA
|
NA
|
|
Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
|
NA
|
NA
|
|
Could Virtual Reality play a role in the rehabilitation after COVID-19 infection?
|
NA
|
NA
|
|
Providing Culturally Competent Care for COVID-19 Intensive Care Unit Delirium: A Case Report and Review.
|
NA
|
NA
|
|
From Standard to Escalated Anticoagulant Prophylaxis in Fractured Older Adults With SARS-CoV-2 Undergoing Accelerated Orthopedic Surgery.
|
NA
|
NA
|
|
The impact of new modes of electronic communication in the treatment of severe acute respiratory syndrome coronavirus 2 infection.
|
NA
|
NA
|
|
Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19.
|
NA
|
NA
|
|
Sex differences in COVID-19: the role of androgens in disease severity and progression.
|
NA
|
NA
|
|
Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils.
|
NA
|
NA
|
|
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.
|
NA
|
NA
|
|
Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Access considerations for a COVID-19 vaccine for South Africa.
|
NA
|
NA
|
|
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19.
|
NA
|
NA
|
|
Standalone Smartphone Cognitive Behavioral Therapy-Based Ecological Momentary Interventions to Increase Mental Health: Narrative Review.
|
NA
|
NA
|
|
Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
|
NA
|
NA
|
|
Treatment With Tocilizumab for Patients With COVID-19 Infections: A Case-Series Study.
|
NA
|
NA
|
|
Videoconferencing-Based Telemental Health: Important Questions for the COVID-19 Era From Clinical and Patient-Centered Perspectives.
|
NA
|
NA
|
|
Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation.
|
NA
|
NA
|
|
SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study.
|
NA
|
NA
|
|
Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
|
NA
|
NA
|
|
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany.
|
NA
|
NA
|
|
Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression.
|
NA
|
NA
|
|
Women with Mild Fasting Hyperglycemia in Early Pregnancy Have More Neonatal Intensive Care Admissions.
|
NA
|
NA
|
|
The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis.
|
NA
|
NA
|
|
Perspectives on Telephone and Video Communication in the ICU during COVID-19.
|
NA
|
NA
|
|
Russelioside B; A pregnane glycoside for treatment of gastric ulcer via modulation of heat shock protein-70 and vascular endothelial growth factor.
|
NA
|
NA
|
|
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
|
NA
|
NA
|
|
Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.
|
NA
|
NA
|
|
COVID-19 and Neurosurgery Consultation Call Volume at a Single Large Tertiary Center With a Propensity-Adjusted Analysis.
|
NA
|
NA
|
|
The effect of favipiravir on QTc interval in patients hospitalized with coronavirus disease 2019.
|
NA
|
NA
|
|
Under which conditions are changes in the treatment of people under involuntary commitment justified during the COVID-19 pandemic? An ethical evaluation of current developments in Germany.
|
NA
|
NA
|
|
Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Sexually Transmitted Infection Clinic Visits.
|
NA
|
NA
|
|
The curative effect of Reduning injection combined with Xuanfeibaidu formula on COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Efficacy and safety of Xiyanping for COVID-2019: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Adjuvant therapeutic effects of moxibustion on COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Sputum characteristics and airway clearance methods in patients with severe COVID-19.
|
NA
|
NA
|
|
Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
|
NA
|
NA
|
|
Re-organising primary health care to respond to the Coronavirus epidemic in Cape Town, South Africa.
|
NA
|
NA
|
|
COVID-19 containment and its unrestrained impact on epilepsy management in resource-limited areas of Pakistan.
|
NA
|
NA
|
|
Telemedicine, drug-resistant epilepsy, and ketogenic dietary therapies: A patient survey of a pediatric remote-care program during the COVID-19 pandemic.
|
NA
|
NA
|
|
Review on the contamination of wastewater by COVID-19 virus: Impact and treatment.
|
NA
|
NA
|
|
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
|
NA
|
NA
|
|
CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
|
NA
|
NA
|
|
Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
|
NA
|
NA
|
|
Awareness, Attitudes, Prevention, and Perceptions of COVID-19 Outbreak among Nurses in Saudi Arabia.
|
NA
|
NA
|
|
SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.
|
NA
|
NA
|
|
Diagnostic Value of Initial Chest CT Findings for the Need of ICU Treatment/Intubation in Patients with COVID-19.
|
NA
|
NA
|
|
Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV-A Case Report from Argentina and Literature Review.
|
NA
|
NA
|
|
First Wave of COVID-19 in French Patients with Cystic Fibrosis.
|
NA
|
NA
|
|
High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2.
|
NA
|
NA
|
|
Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report.
|
NA
|
NA
|
|
Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza.
|
NA
|
NA
|
|
Time-course analysis reveals that corticosteroids resuscitate diminished CD8+ T cells in COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Changes in pediatric emergency department visits for mental health during the COVID-19 pandemic: A cross-sectional study.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 patients with asthma in Wuhan, China: a retrospective cohort study.
|
NA
|
NA
|
|
Telephone surveillance during 2019 novel coronavirus disease: Is it a helpful diagnostic tool for detecting acute pulmonary exacerbations in children with chronic lung disease?
|
NA
|
NA
|
|
Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
|
NA
|
NA
|
|
Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses.
|
NA
|
NA
|
|
Age, ageing, ageism and “age-itation” in the Age of COVID-19: rights and obligations relating to older persons in Israel as observed through the lens of medical ethics.
|
NA
|
NA
|
|
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
|
NA
|
NA
|
|
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI.
|
NA
|
NA
|
|
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma.
|
NA
|
NA
|
|
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial.
|
NA
|
NA
|
|
COVID-19 associated variations in liver function parameters: a retrospective study.
|
NA
|
NA
|
|
Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
|
NA
|
NA
|
|
Genetic influences on viral-induced cytokine responses in the lung.
|
NA
|
NA
|
|
The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).
|
NA
|
NA
|
|
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2.
|
NA
|
NA
|
|
Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology.
|
NA
|
NA
|
|
Principles of approach to suspected or infected patients related Covid-19 in newborn intensive care unit and pediatric intensive care unit.
|
NA
|
NA
|
|
What can a home hemodialysis program offer to patients in a nursing home setting? A case series and feasibility analysis.
|
NA
|
NA
|
|
Resource scarcity and prioritization decisions in medical care: A lab experiment with heterogeneous patient types.
|
NA
|
NA
|
|
Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement.
|
NA
|
NA
|
|
[Challenges of schistosomiasis control in China during the coronavirus disease 2019 (COVID-19) epidemic].
|
NA
|
NA
|
|
Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19.
|
NA
|
NA
|
|
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
|
NA
|
NA
|
|
Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study.
|
NA
|
NA
|
|
Clinical course of COVID-19 disease in immunosuppressed renal transplant patients.
|
NA
|
NA
|
|
Challenges of following patients with inherited metabolic diseases during the COVID-19 outbreak. A cross-sectional online survey study.
|
NA
|
NA
|
|
COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
|
NA
|
NA
|
|
Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019.
|
NA
|
NA
|
|
Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Lung ultrasound in COVID-19].
|
NA
|
NA
|
|
Current state of research on psychotherapy for home-living vulnerable older adults with depression.
|
NA
|
NA
|
|
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
|
NA
|
NA
|
|
Potential approaches to combat COVID-19: a mini-review.
|
NA
|
NA
|
|
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID-19 pandemic.
|
NA
|
NA
|
|
Risk factors for severe and critically ill COVID-19 patients: A review.
|
NA
|
NA
|
|
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
|
NA
|
NA
|
|
PRIMoRDiA: A Software to Explore Reactivity and Electronic Structure in Large Biomolecules.
|
NA
|
NA
|
|
Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses.
|
NA
|
NA
|
|
De Novo Renal Failure and Clinical Outcomes of Patients With Critical Coronavirus Disease 2019.
|
NA
|
NA
|
|
Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic.
|
NA
|
NA
|
|
Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.
|
NA
|
NA
|
|
Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
|
NA
|
NA
|
|
Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2.
|
NA
|
NA
|
|
The interplay between HIV and COVID-19: summary of the data and responses to date.
|
NA
|
NA
|
|
Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.
|
NA
|
NA
|
|
Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.
|
NA
|
NA
|
|
Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm.
|
NA
|
NA
|
|
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.
|
NA
|
NA
|
|
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids.
|
NA
|
NA
|
|
Thrombosis at hospital presentation in patients with and without coronavirus disease 2019.
|
NA
|
NA
|
|
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 Pulmonary Failure and Extracorporeal Membrane Oxygenation: First Experience from Three European Extracorporeal Membrane Oxygenation Centers.
|
NA
|
NA
|
|
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.
|
NA
|
NA
|
|
Exposome and Immunity Training: How Pathogen Exposure Order Influences Innate Immune Cell Lineage Commitment and Function.
|
NA
|
NA
|
|
Self-Medication-Related Behaviors and Poland’s COVID-19 Lockdown.
|
NA
|
NA
|
|
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety-Particularities in the Context of COVID-19.
|
NA
|
NA
|
|
Professional Assessment of the Impact of COVID-19 on Handling NET Patients.
|
NA
|
NA
|
|
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review.
|
NA
|
NA
|
|
Clinical and radiographic characteristics, management and short-term outcomes of patients with COVID-19 in Wenzhou, China.
|
NA
|
NA
|
|
Perspectives on the Impact of the COVID-19 Pandemic on the Sports Medicine Surgeon: Implications for Current and Future Care.
|
NA
|
NA
|
|
SARS-CoV-2 RNA detection and persistence in wastewater samples: An experimental network for COVID-19 environmental surveillance in Padua, Veneto Region (NE Italy).
|
NA
|
NA
|
|
Chinese Expert Consensus on Protection for Ultrasound Healthcare Workers against COVID-19.
|
NA
|
NA
|
|
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
|
NA
|
NA
|
|
Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19.
|
NA
|
NA
|
|
Coinfection with SARS-CoV-2 and Influenza A Virus in a 32-Year-Old Man.
|
NA
|
NA
|
|
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.
|
NA
|
NA
|
|
Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis.
|
NA
|
NA
|
|
SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome.
|
NA
|
NA
|
|
Time to Surgery and Survival in Head and Neck Cancer.
|
NA
|
NA
|
|
Point-of-care lung ultrasound findings in the pediatric emergency clinic during the COVID-19 pandemic.
|
NA
|
NA
|
|
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
|
NA
|
NA
|
|
Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study.
|
NA
|
NA
|
|
Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19.
|
NA
|
NA
|
|
Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19.
|
NA
|
NA
|
|
Causal inference methods for small non-randomized studies: Methods and an application in COVID-19.
|
NA
|
NA
|
|
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
|
NA
|
NA
|
|
SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants.
|
NA
|
NA
|
|
Ivermectin: An Anthelmintic, an Insecticide, and Much More.
|
NA
|
NA
|
|
Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope.
|
NA
|
NA
|
|
Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
|
NA
|
NA
|
|
The flexibility of ACE2 in the context of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Peptide and peptide-based inhibitors of SARS-CoV-2 entry.
|
NA
|
NA
|
|
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.
|
NA
|
NA
|
|
The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.
|
NA
|
NA
|
|
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.
|
NA
|
NA
|
|
Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020.
|
NA
|
NA
|
|
Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs.
|
NA
|
NA
|
|
Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients.
|
NA
|
NA
|
|
Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.
|
NA
|
NA
|
|
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
|
NA
|
NA
|
|
Bioinformatic analysis of SMN1-ACE/ACE2 interactions hinted at a potential protective effect of spinal muscular atrophy against COVID-19-induced lung injury.
|
NA
|
NA
|
|
COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury.
|
NA
|
NA
|
|
Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients with a normal or abnormal liver.
|
NA
|
NA
|
|
Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID-19.
|
NA
|
NA
|
|
Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.
|
NA
|
NA
|
|
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
|
NA
|
NA
|
|
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
|
NA
|
NA
|
|
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia.
|
NA
|
NA
|
|
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review.
|
NA
|
NA
|
|
Recent progress of antiviral therapy for coronavirus disease 2019.
|
NA
|
NA
|
|
Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.
|
NA
|
NA
|
|
Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications.
|
NA
|
NA
|
|
Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
|
NA
|
NA
|
|
Clinical characteristics of adult patients hospitalized with laboratory-confirmed COVID-19 pneumonia.
|
NA
|
NA
|
|
Communication Tools to Support Advance Care Planning and Hospital Care During the COVID-19 Pandemic: A Design Process.
|
NA
|
NA
|
|
COVID-19 Infection in Men on Testosterone Replacement Therapy.
|
NA
|
NA
|
|
Innovations in Geroscience to enhance mobility in older adults.
|
NA
|
NA
|
|
Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial.
|
NA
|
NA
|
|
Mechanisms of COVID-19-induced heart failure: a short review.
|
NA
|
NA
|
|
Renin-angiotensin system inhibition and risk of infection and mortality in COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
A case report of hydroxychloroquine-induced auditory and visual hallucination.
|
NA
|
NA
|
|
Drug therapy strategies for COVID-19 infection during pregnancy.
|
NA
|
NA
|
|
[The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19].
|
NA
|
NA
|
|
Implications of the coronavirus (COVID-19) outbreak for innovation: Which technologies will improve our lives?
|
NA
|
NA
|
|
Pneumolysis and “Silent Hypoxemia” in COVID-19.
|
NA
|
NA
|
|
Claiming Health as a Public Good in the Post-COVID-19 Era.
|
NA
|
NA
|
|
Virtual Reality Exposure Therapy (VRET) for Anxiety Due to Fear of COVID-19 Infection: A Case Series.
|
NA
|
NA
|
|
Online cognitive behavioral group therapy (iCBT-I) for insomnia for school children and their parents: Adaptation of an established treatment (KiSS training).
|
NA
|
NA
|
|
Food preservation techniques and nanotechnology for increased shelf life of fruits, vegetables, beverages and spices: a review.
|
NA
|
NA
|
|
Negative impact of COVID-19 pandemic on sleep quantitative parameters, quality, and circadian alignment: Implications for health and psychological well-being.
|
NA
|
NA
|
|
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
|
NA
|
NA
|
|
Role of Traditional Chinese Medicine in the Management of Viral Pneumonia.
|
NA
|
NA
|
|
Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series.
|
NA
|
NA
|
|
Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin.
|
NA
|
NA
|
|
Tumor Patients´ Perceived Changes of Specific Attitudes, Perceptions, and Behaviors Due to the COVID-19 Pandemic and Its Relation to Reduced Wellbeing.
|
NA
|
NA
|
|
Depression, Environmental Reward, Coping Motives and Alcohol Consumption During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Mental Violence: The COVID-19 Nightmare.
|
NA
|
NA
|
|
“Now It’s Just Old Habits and Misery”-Understanding the Impact of the Covid-19 Pandemic on People With Current or Life-Time Eating Disorders: A Qualitative Study.
|
NA
|
NA
|
|
Ahead of the Curve: Responses From Patients in Treatment for Obsessive-Compulsive Disorder to Coronavirus Disease 2019.
|
NA
|
NA
|
|
How Do Nocebo Phenomena Provide a Theoretical Framework for the COVID-19 Pandemic?
|
NA
|
NA
|
|
Psychotherapy During COVID-19: How the Clinical Practice of Italian Psychotherapists Changed During the Pandemic.
|
NA
|
NA
|
|
Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China.
|
NA
|
NA
|
|
Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.
|
NA
|
NA
|
|
Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition.
|
NA
|
NA
|
|
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
|
NA
|
NA
|
|
A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
|
NA
|
NA
|
|
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.
|
NA
|
NA
|
|
The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19.
|
NA
|
NA
|
|
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
|
NA
|
NA
|
|
The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be.
|
NA
|
NA
|
|
Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database.
|
NA
|
NA
|
|
Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2.
|
NA
|
NA
|
|
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction.
|
NA
|
NA
|
|
The Effect of Brief Crisis Intervention Package on Improving Quality of Life and Mental Health in Patients with COVID-19.
|
NA
|
NA
|
|
Anxiety, Self-Compassion, Gender Differences and COVID-19: Predicting Self-Care Behaviors and Fear of COVID-19 Based on Anxiety and Self-Compassion with an Emphasis on Gender Differences.
|
NA
|
NA
|
|
COVID-19 in China: From epidemiology to treatment (Review).
|
NA
|
NA
|
|
Palliative and end-of-life care in COVID-19 management in sub-Saharan Africa: a matter of concern.
|
NA
|
NA
|
|
[SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease].
|
NA
|
NA
|
|
Collateral damage: the impact of the COVID-19 pandemic on the care of a patient with tuberculous neuroretinitis in Lagos, Nigeria.
|
NA
|
NA
|
|
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
|
NA
|
NA
|
|
Continuous venous hemodialysis integrated to the ECMO circuit in critically ill patient with COVID-19, a case report in Morocco.
|
NA
|
NA
|
|
COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages.
|
NA
|
NA
|
|
Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Serum triglyceride level and hypertension are highly associated with the recovery of COVID-19 patients.
|
NA
|
NA
|
|
Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Back to basics: review on vitamin D and respiratory viral infections including COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 Infected Patient: from a Hematologist’s Perspective.
|
NA
|
NA
|
|
Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).
|
NA
|
NA
|
|
Conservatively Treated Femoral Intertrochanteric Fracture With Early Asymptomatic Novel Coronavirus Disease 2019 (COVID-19): A Case Report.
|
NA
|
NA
|
|
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.
|
NA
|
NA
|
|
A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2 Induced Focal Segmental Glomerulosclerosis.
|
NA
|
NA
|
|
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving PaO2/FiO2 Ratio Among COVID-19 Patients.
|
NA
|
NA
|
|
Management of Native Joint Septic Arthritis, Serial Aspiration vs. Arthroscopic Washout During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Case Report: A Nasopharyngeal Cancer Patient Got COVID-19 During Radiochemotherapy in Wuhan.
|
NA
|
NA
|
|
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments.
|
NA
|
NA
|
|
Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis.
|
NA
|
NA
|
|
COVID-19-Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
|
NA
|
NA
|
|
The Discrepancies of COVID-19 Clinical Spectrum Between Infancy and Adolescence - Two Case Reports and a Review of the Literature.
|
NA
|
NA
|
|
Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain.
|
NA
|
NA
|
|
Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2.
|
NA
|
NA
|
|
Childhood Immunization and COVID-19: An Early Narrative Review.
|
NA
|
NA
|
|
Education in Academic Emergency Medicine During the COVID-19 Pandemic - Our Experience From an Ongoing Crisis.
|
NA
|
NA
|
|
The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients.
|
NA
|
NA
|
|
Current Understanding of COVID-19 Clinical Course and Investigational Treatments.
|
NA
|
NA
|
|
Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
|
NA
|
NA
|
|
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid).
|
NA
|
NA
|
|
Delirium During Recovery in Patients With Severe COVID-19: Two Case Reports.
|
NA
|
NA
|
|
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
|
NA
|
NA
|
|
Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19.
|
NA
|
NA
|
|
Clinical Impact Potential of Supplemental Nutrients as Adjuncts of Therapy in High-Risk COVID-19 for Obese Patients.
|
NA
|
NA
|
|
Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations.
|
NA
|
NA
|
|
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).
|
NA
|
NA
|
|
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus.
|
NA
|
NA
|
|
The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2.
|
NA
|
NA
|
|
Coronavirus Infection of the Central Nervous System: Animal Models in the Time of COVID-19.
|
NA
|
NA
|
|
Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19.
|
NA
|
NA
|
|
Therapeutic experience of an 89-year-old high-risk patient with incarcerated cholecystolithiasis: A case report and literature review.
|
NA
|
NA
|
|
Binding of the small-molecule kinase inhibitor ruxolitinib to membranes does not disturb membrane integrity.
|
NA
|
NA
|
|
The Rheumatologist’s Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the Future.
|
NA
|
NA
|
|
Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
|
NA
|
NA
|
|
Kawasaki Disease and COVID-19.
|
NA
|
NA
|
|
COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment.
|
NA
|
NA
|
|
Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey.
|
NA
|
NA
|
|
SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment.
|
NA
|
NA
|
|
Artificial intelligence and COVID-19: Present state and future vision.
|
NA
|
NA
|
|
Medical home visit programs during COVID-19 state of emergency.
|
NA
|
NA
|
|
A Self-Administered Multicomponent Web-Based Mental Health Intervention for the Mexican Population During the COVID-19 Pandemic: Protocol for a Randomized Controlled Trial.
|
NA
|
NA
|
|
COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV.
|
NA
|
NA
|
|
Acute stroke treatment during coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
What Proportion of Patients with Bone and Soft-Tissue Tumors Contracted Coronavirus-19 and Died From Surgical Procedures During the Initial Period of the COVID-19 Pandemic? Results From the Multicenter British Orthopaedic Oncology Society Observational Study.
|
NA
|
NA
|
|
Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 Environment.
|
NA
|
NA
|
|
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.
|
NA
|
NA
|
|
Therapies for Psoriasis: Clinical and Economic Comparisons.
|
NA
|
NA
|
|
PROMISCUOUS 2.0: a resource for drug-repositioning.
|
NA
|
NA
|
|
COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials.
|
NA
|
NA
|
|
Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
|
NA
|
NA
|
|
Prophylactic or therapeutic doses of heparins for COVID-19 infection? A retrospective study.
|
NA
|
NA
|
|
Continuing care for patients affected by urologic chronic pelvic pain in the era of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic.
|
NA
|
NA
|
|
The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.
|
NA
|
NA
|
|
COVID-19 Mobile Apps: A Systematic Review of the Literature.
|
NA
|
NA
|
|
Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
|
NA
|
NA
|
|
The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.
|
NA
|
NA
|
|
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
|
NA
|
NA
|
|
A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome.
|
NA
|
NA
|
|
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
|
NA
|
NA
|
|
COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report.
|
NA
|
NA
|
|
Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study.
|
NA
|
NA
|
|
Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19.
|
NA
|
NA
|
|
Assessment of clinical characteristics and mortality-associated factors in COVID-19 Critical cases in Kuwait.
|
NA
|
NA
|
|
[Current status of COVID-19 pandemic and progress in response strategy].
|
NA
|
NA
|
|
Management of complicated pediatric rhinosinusitis in the COVID-19 era.
|
NA
|
NA
|
|
Neuroprognostication of Consciousness Recovery in a Patient with COVID-19 Related Encephalitis: Preliminary Findings from a Multimodal Approach.
|
NA
|
NA
|
|
The Challenges of a Children’s Hospital during the COVID-19 Pandemic: The Pediatric Surgeon’s Point of View.
|
NA
|
NA
|
|
Dental Aerosol as a Hazard Risk for Dental Workers.
|
NA
|
NA
|
|
Second Wave of COVID-19 Global Pandemic and Athletes’ Confinement: Recommendations to Better Manage and Optimize the Modified Lifestyle.
|
NA
|
NA
|
|
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
|
NA
|
NA
|
|
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
|
NA
|
NA
|
|
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
|
NA
|
NA
|
|
[Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of “pathogen hiding in the pleurodiaphragmatic interspace”].
|
NA
|
NA
|
|
[Clinical characteristics of coronavirus disease 2019 patients complicated with pneumothorax: analysis of 7 cases].
|
NA
|
NA
|
|
[Diagnosis and treatment of community-acquired pneumonia in elderly patients combined with coronavirus disease 2019: analysis of 1 case].
|
NA
|
NA
|
|
[Empirical and experiential analysis of pre-hospital coronavirus disease 2019 epidemic emergency care resource allocation and usage in Jinan].
|
NA
|
NA
|
|
Outcomes of Cricothyroid Visor Maneuver (CVM) for Treatment of Vocal Polyp: A Case Report.
|
NA
|
NA
|
|
A review on how to do hematology consults during COVID-19 pandemic.
|
NA
|
NA
|
|
In-line treatments and clinical initiatives to fight against COVID-19 outbreak.
|
NA
|
NA
|
|
The pharmacist’s active role in combating COVID-19 medication misinformation.
|
NA
|
NA
|
|
Images of the month: An incidental finding of spontaneous pneumomediastinum (Hamman’s syndrome) secondary to diabetic ketoacidosis during the coronavirus pandemic.
|
NA
|
NA
|
|
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
|
NA
|
NA
|
|
[Proinflammatory cytokines and cardio-vascular risk: From myocardial infarction tocytokine storm of COVID-19].
|
NA
|
NA
|
|
A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum.
|
NA
|
NA
|
|
Current COVID-19 vaccine candidates: Implications in the Saudi population.
|
NA
|
NA
|
|
The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking.
|
NA
|
NA
|
|
Lactoferrin for the treatment of COVID-19 (Review).
|
NA
|
NA
|
|
[COVID-19 pneumonia].
|
NA
|
NA
|
|
Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports.
|
NA
|
NA
|
|
Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.
|
NA
|
NA
|
|
Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
|
NA
|
NA
|
|
Immunotherapeutics for Covid-19 and post vaccination surveillance.
|
NA
|
NA
|
|
An Unusual Case of a Pediatric Nasal Septal Abscess with Life-Threatening Complications in COVID-19 Pandemic.
|
NA
|
NA
|
|
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
|
NA
|
NA
|
|
Anticoagulation in COVID - 19: An Update.
|
NA
|
NA
|
|
The Prolonged Use of VV ECMO Support in COVID-19: A Case Report.
|
NA
|
NA
|
|
Delayed stroke after hospitalization for coronavirus disease 2019 pneumonia from common and internal carotid artery thrombosis.
|
NA
|
NA
|
|
Coronary and cerebral thrombosis in a young patient after mild COVID-19 illness: a case report.
|
NA
|
NA
|
|
Collateral damages in the SARS-CoV-2 pandemia- two cases.
|
NA
|
NA
|
|
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Bilateral Renal Artery Thrombosis in a Patient With COVID-19.
|
NA
|
NA
|
|
Compassionate use of remdesivir in children with COVID-19.
|
NA
|
NA
|
|
Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization.
|
NA
|
NA
|
|
Guidelines on newly identified limitations of diagnostic tools for COVID-19 and consequences.
|
NA
|
NA
|
|
COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission.
|
NA
|
NA
|
|
Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19.
|
NA
|
NA
|
|
Comparison of the emergency and oncological surgery before and during the COVID-19 pandemic. A single-center retrospective study.
|
NA
|
NA
|
|
Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
|
NA
|
NA
|
|
Implementation and Evaluation of a Text Message-Based Addiction Counseling Program (Text4Hope-Addiction Support): Protocol for a Questionnaire Study.
|
NA
|
NA
|
|
The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report.
|
NA
|
NA
|
|
Validation of Inflammopathic, Adaptive, and Coagulopathic Sepsis Endotypes in Coronavirus Disease 2019.
|
NA
|
NA
|
|
Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study.
|
NA
|
NA
|
|
Clinical profile and predictors of in-hospital mortality among older patients admitted for COVID-19.
|
NA
|
NA
|
|
Provider-patient communication and hospital ratings: perceived gaps and forward thinking about the effects of COVID-19.
|
NA
|
NA
|
|
Prone ventilation as treatment of acute respiratory distress syndrome related to COVID-19.
|
NA
|
NA
|
|
Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2.
|
NA
|
NA
|
|
[A young lady with shortness of breath during the coronavirus crisis].
|
NA
|
NA
|
|
Psychological characteristics of parents in a Paediatric Outpatient during the SARS-CoV-2 Epidemic.
|
NA
|
NA
|
|
A Giant Right-Heart Thrombus-in-Transit in a Patient with COVID-19 Pneumonia.
|
NA
|
NA
|
|
Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
|
NA
|
NA
|
|
Mechanical Ventilation Supply and Options for the COVID-19 Pandemic: Leveraging All Available Resources for a Limited Resource in a Crisis.
|
NA
|
NA
|
|
The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS.
|
NA
|
NA
|
|
Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
|
NA
|
NA
|
|
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
|
NA
|
NA
|
|
Vitamin D3 as Potential Treatment Adjuncts for COVID-19.
|
NA
|
NA
|
|
The Demand for Elective Neurosurgery at a German University Hospital during the First Wave of COVID-19.
|
NA
|
NA
|
|
Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.
|
NA
|
NA
|
|
Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?
|
NA
|
NA
|
|
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19.
|
NA
|
NA
|
|
Polymer microarrays rapidly identify competitive adsorbents of virus-like particles.
|
NA
|
NA
|
|
Notes from the Field: Effectiveness of Prevention and Control Measures for Imported COVID-19 in Guangming District of Shenzhen.
|
NA
|
NA
|
|
Epidemiological and clinical based study on four passages of COVID-19 patients: intervention at asymptomatic period contributes to early recovery.
|
NA
|
NA
|
|
Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report.
|
NA
|
NA
|
|
Assessing preventive health behaviors from COVID-19: a cross sectional study with health belief model in Golestan Province, Northern of Iran.
|
NA
|
NA
|
|
Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
|
NA
|
NA
|
|
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
|
NA
|
NA
|
|
COVID-19 Planning Among Radiologic Science Programs: Response Mitigation Activities.
|
NA
|
NA
|
|
Potential SARS-CoV-2 protease Mpro inhibitors: Repurposing FDA-approved drugs.
|
NA
|
NA
|
|
Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2.
|
NA
|
NA
|
|
Immune suppression in the early stage of COVID-19 disease.
|
NA
|
NA
|
|
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.
|
NA
|
NA
|
|
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents.
|
NA
|
NA
|
|
REAC Cervicobrachial Neuromodulation Treatment of Depression, Anxiety, and Stress During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
|
NA
|
NA
|
|
Chaotic-map based authenticated security framework with privacy preservation for remote point-of-care.
|
NA
|
NA
|
|
Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
|
NA
|
NA
|
|
Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review.
|
NA
|
NA
|
|
drug repurposing for COVID-19.
|
NA
|
NA
|
|
Evolutionary perspectives on human behavior during the coronavirus pandemic: Insights from game theory.
|
NA
|
NA
|
|
Use of convalescent plasma therapy in eight individuals with mild COVID-19.
|
NA
|
NA
|
|
Natural history of COVID-19: back to basics.
|
NA
|
NA
|
|
Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine.
|
NA
|
NA
|
|
E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) Mimicking COVID-19 Disease.
|
NA
|
NA
|
|
Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
|
NA
|
NA
|
|
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy.
|
NA
|
NA
|
|
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19.
|
NA
|
NA
|
|
Assessment of Respiratory Bacterial Coinfections Among Severe Acute Respiratory Syndrome Coronavirus 2-Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire, FilmArray Pneumonia Panel Plus Assay.
|
NA
|
NA
|
|
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
|
NA
|
NA
|
|
Information technology in emergency management of COVID-19 outbreak.
|
NA
|
NA
|
|
An integrated fog and Artificial Intelligence smart health framework to predict and prevent COVID-19.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations.
|
NA
|
NA
|
|
Ischemic stroke and purpuric dermatitis as COVID-19-related complications in a peritoneal dialysis patient.
|
NA
|
NA
|
|
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study.
|
NA
|
NA
|
|
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.
|
NA
|
NA
|
|
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).
|
NA
|
NA
|
|
Investigational Treatments for COVID-19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions.
|
NA
|
NA
|
|
Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.
|
NA
|
NA
|
|
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments.
|
NA
|
NA
|
|
Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa.
|
NA
|
NA
|
|
Fighting COVID-19 at the Expense of Malaria in Africa: The Consequences and Policy Options.
|
NA
|
NA
|
|
[There is no progress without school. Postgraduate specialization school completes the paradigm shift in palliative care.]
|
NA
|
NA
|
|
Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial.
|
NA
|
NA
|
|
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
|
NA
|
NA
|
|
Phenotypes and personalized medicine in the acute respiratory distress syndrome.
|
NA
|
NA
|
|
The relation between left ventricular global longitudinal strain and troponin levels in patients hospitalized with COVID-19 pneumonia.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.
|
NA
|
NA
|
|
Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19.
|
NA
|
NA
|
|
Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.
|
NA
|
NA
|
|
COVID-19 and the gastrointestinal tract: what do we already know?
|
NA
|
NA
|
|
HOSPITAL PHYSICAL THERAPY MANAGEMENT IN PEDIATRIC PATIENTS WITH COVID-19: CASE REPORTS.
|
NA
|
NA
|
|
The IMEx coronavirus interactome: an evolving map of Coronaviridae-host molecular interactions.
|
NA
|
NA
|
|
Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
|
NA
|
NA
|
|
Early Experience with Virtual Pediatric Orthopedics in New York CityPearls for Incorporating Telemedicine into Your Practice.
|
NA
|
NA
|
|
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
|
NA
|
NA
|
|
The Role of Glucocorticoids in the Management of COVID-19.
|
NA
|
NA
|
|
Sources and routes of SARS-CoV-2 transmission in water systems in Africa: Are there any sustainable remedies?
|
NA
|
NA
|
|
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Urgent Creation of a Palliative Care Team in a Small Hospital During the COVID Crisis.
|
NA
|
NA
|
|
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV-2 Infection (COVID-19).
|
NA
|
NA
|
|
Addressing the importance of Stem cell-based therapy: a Perspective in the treatment of COVID-19’.
|
NA
|
NA
|
|
Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country.
|
NA
|
NA
|
|
Misinformation, chiropractic, and the COVID-19 pandemic.
|
NA
|
NA
|
|
Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19.
|
NA
|
NA
|
|
Bergamo Field Hospital Confronting Covid-19: Operating Instructions.
|
NA
|
NA
|
|
Wound care during the COVID-19 emergency in Padua Hospital (Italy).
|
NA
|
NA
|
|
The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study.
|
NA
|
NA
|
|
Live Video Adaptations to a Mind-Body Activity Program for Chronic Pain and Cognitive Decline: Protocol for the Virtual Active Brains Study.
|
NA
|
NA
|
|
Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.
|
NA
|
NA
|
|
Solid Organ Transplantation in the Era of COVID-19: Lessons from France.
|
NA
|
NA
|
|
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19.
|
NA
|
NA
|
|
Reduced Sleep in the Week Prior to Diagnosis of COVID-19 is Associated with the Severity of COVID-19.
|
NA
|
NA
|
|
Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey.
|
NA
|
NA
|
|
Updated general recommendations in cancer management during the COVID-19 pandemic in the Philippines.
|
NA
|
NA
|
|
COVID-19 and paediatric challenges: An interview with Professor of Paediatrics Vana Papaevangelou (University of Athens School of Medicine).
|
NA
|
NA
|
|
Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
|
NA
|
NA
|
|
Use of domestic tools to downstage the reconstructive ladder in a patient with severe crush and degloving injury: a case report.
|
NA
|
NA
|
|
Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.
|
NA
|
NA
|
|
Petechiae, Purpura, and a Pandemic: A Recipe for Scurvy.
|
NA
|
NA
|
|
Pneumatosis Intestinalis in COVID-19: Case Series.
|
NA
|
NA
|
|
A narrative review of lung cancer cytology in the times of coronavirus: what physicians should know.
|
NA
|
NA
|
|
COVID 19 and diabetes: An endocrinologist’s perspective.
|
NA
|
NA
|
|
Coronavirus and Its effect on the respiratory system: Is there any association between pneumonia and immune cells.
|
NA
|
NA
|
|
Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
|
NA
|
NA
|
|
Clinical course of COVID-19 infection in inflammatory rheumatological patients: a monocentric Belgian experience.
|
NA
|
NA
|
|
Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?
|
NA
|
NA
|
|
Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article.
|
NA
|
NA
|
|
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California.
|
NA
|
NA
|
|
Cancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer.
|
NA
|
NA
|
|
Potential of algal metabolites for the development of broad-spectrum antiviral therapeutics: Possible implications in COVID-19 therapy.
|
NA
|
NA
|
|
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
|
NA
|
NA
|
|
[Reuse process of positive pressure powered air-filter protective hoods].
|
NA
|
NA
|
|
The management of “fragile” and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.
|
NA
|
NA
|
|
Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study.
|
NA
|
NA
|
|
Structure-based identification of potential SARS-CoV-2 main protease inhibitors.
|
NA
|
NA
|
|
[Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
|
NA
|
NA
|
|
Knowledge and Attitude about COVID 19 among Health Care Workers Working in Seti Provincial Hospital.
|
NA
|
NA
|
|
Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.
|
NA
|
NA
|
|
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
|
NA
|
NA
|
|
The potential effects of clinical antidiabetic agents on SARS-CoV-2.
|
NA
|
NA
|
|
A digital protein microarray for COVID-19 cytokine storm monitoring.
|
NA
|
NA
|
|
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.
|
NA
|
NA
|
|
Delirium in Older Patients With COVID-19 Presenting to the Emergency Department.
|
NA
|
NA
|
|
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.
|
NA
|
NA
|
|
Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective.
|
NA
|
NA
|
|
Routine laboratory testing to determine if a patient has COVID-19.
|
NA
|
NA
|
|
Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
|
NA
|
NA
|
|
Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID-19.
|
NA
|
NA
|
|
[Coagulopathies, thrombotic risk and anticoagulation in COVID-19].
|
NA
|
NA
|
|
[Kidney injury in COVID-19].
|
NA
|
NA
|
|
[On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia].
|
NA
|
NA
|
|
[Covid-19 and diabetes].
|
NA
|
NA
|
|
[Severe COVID-19, a new complication to be added to numerous comorbidities associated to obesity].
|
NA
|
NA
|
|
[Psychopharmacotherapeutic guidelines : a challenge during health crisis].
|
NA
|
NA
|
|
[Pharmacological therapies against COVID-19 : state of the art, between hopes and disappointments].
|
NA
|
NA
|
|
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic.
|
NA
|
NA
|
|
Blood Donation and COVID-19: Reconsidering the 3-Month Deferral Policy for Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men.
|
NA
|
NA
|
|
Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism.
|
NA
|
NA
|
|
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy.
|
NA
|
NA
|
|
Oncology nursing workforce: challenges, solutions, and future strategies.
|
NA
|
NA
|
|
IMPLICATIONS OF THE COVID-19 PANDEMIC FOR CARDIOVASCULAR DISEASE AND RISK FACTOR MANAGEMENT.
|
NA
|
NA
|
|
Brief Online Cognitive Behavioural Intervention for Dysfunctional Worry Related to the COVID-19 Pandemic: A Randomised Controlled Trial.
|
NA
|
NA
|
|
Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy?
|
NA
|
NA
|
|
Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric Oncology.
|
NA
|
NA
|
|
Is it Possible to Mechanical Recycle the Materials of the Disposable Filtering Masks?
|
NA
|
NA
|
|
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
|
NA
|
NA
|
|
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
|
NA
|
NA
|
|
Healthcare Workers Exposure Risk Assessment: A Survey among Frontline Workers in Designated COVID-19 Treatment Centers in Ghana.
|
NA
|
NA
|
|
The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment.
|
NA
|
NA
|
|
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
|
NA
|
NA
|
|
The unusual experience of managing a severe COVID-19 case at home: what can we do and where do we go?
|
NA
|
NA
|
|
Acute portal vein thrombosis secondary to COVID-19: a case report.
|
NA
|
NA
|
|
How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario.
|
NA
|
NA
|
|
GIS-based approaches on the accessibility of referral hospital using network analysis and the spatial distribution model of the spreading case of COVID-19 in Jakarta, Indonesia.
|
NA
|
NA
|
|
Intensive and pharmacological care in times of COVID-19: A “special ethics” for emergency?
|
NA
|
NA
|
|
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
|
NA
|
NA
|
|
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
|
NA
|
NA
|
|
Therapeutic modalities and novel approaches in regenerative medicine for COVID-19.
|
NA
|
NA
|
|
Managing the pandemic from the radiology department’s point of view.
|
NA
|
NA
|
|
A model based on cellular automata to estimate the social isolation impact on COVID-19 spreading in Brazil.
|
NA
|
NA
|
|
Personal protective equipment preparedness in Asia-Pacific intensive care units during the coronavirus disease 2019 pandemic: A multinational survey.
|
NA
|
NA
|
|
Expedited Mitra clip: Rapid evaluation, treatment, and discharge in the COVID-19 era.
|
NA
|
NA
|
|
Drive-thru anticoagulation clinic: Can we supersize your care today?
|
NA
|
NA
|
|
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
|
NA
|
NA
|
|
Breast reconstruction with immediate autologous free tissue transfer in a peri-operative COVID-19 positive patient: A case report illustrating feasibility of aftercare.
|
NA
|
NA
|
|
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy.
|
NA
|
NA
|
|
Establishment of a high-dependency unit in Malawi.
|
NA
|
NA
|
|
Sleep Laboratories Reopening and COVID-19: A European Perspective.
|
NA
|
NA
|
|
Life in lockdown: experiences of patients with IBD during COVID-19.
|
NA
|
NA
|
|
The COVID-19 Outbreak and Subjects With Mental Disorders Who Presented to an Italian Psychiatric Emergency Department.
|
NA
|
NA
|
|
Ocular surface impairment after COVID-19: a cohort study.
|
NA
|
NA
|
|
Acute Care Management During a Pandemic.
|
NA
|
NA
|
|
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
|
NA
|
NA
|
|
Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study.
|
NA
|
NA
|
|
Peripheral Neuropathy as a Complication of SARS-Cov-2.
|
NA
|
NA
|
|
COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19.
|
NA
|
NA
|
|
Paediatric orthopaedics in lockdown: A study on the effect of the SARS-Cov-2 pandemic on acute paediatric orthopaedics and trauma.
|
NA
|
NA
|
|
Early outcomes of patients undergoing total hip arthroplasty for trauma during COVID-19.
|
NA
|
NA
|
|
Effect of COVID-19 on a rural orthopaedic hip fracture service.
|
NA
|
NA
|
|
Waiting lists for symptomatic joint arthritis are not benign: prioritizing patients for surgery in the setting of COVID-19.
|
NA
|
NA
|
|
Effects of the COVID-19 lockdown on orthopaedic trauma: a multicentre study across Scotland.
|
NA
|
NA
|
|
Acute, non-COVID related medical admissions during the first wave of COVID-19: A retrospective comparison of changing patterns of disease.
|
NA
|
NA
|
|
Point-of-care lung ultrasound in the assessment of suspected COVID-19: a retrospective service evaluation with a severity score.
|
NA
|
NA
|
|
Diabetes and COVID-19: a major challenge in pandemic period?
|
NA
|
NA
|
|
New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a “Second Phase” also for cancer patients.
|
NA
|
NA
|
|
Saliva NMR-Based Metabolomics in the War Against COVID-19.
|
NA
|
NA
|
|
The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic.
|
NA
|
NA
|
|
[Multisystem inflammatory syndrome in children after SARS-CoV-2 infection].
|
NA
|
NA
|
|
An effective drug against COVID-19: reality or dream?
|
NA
|
NA
|
|
UV-Photokeratitis Associated with Germicidal Lamps Purchased during the COVID-19 Pandemic.
|
NA
|
NA
|
|
A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center.
|
NA
|
NA
|
|
Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
|
NA
|
NA
|
|
Management of COVID-19-associated coagulopathy in persons with haemophilia.
|
NA
|
NA
|
|
Clustered Regularly Interspaced Short Palindromic Repeats-Mediated Surface-Enhanced Raman Scattering Assay for Multidrug-Resistant Bacteria.
|
NA
|
NA
|
|
Management of cervical cancer during the corona virus disease-19 (COVID-19) era.
|
NA
|
NA
|
|
Can google glass™ technology improve freezing of gait in parkinsonism? A pilot study.
|
NA
|
NA
|
|
Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters.
|
NA
|
NA
|
|
Immunomodulation as Treatment for Severe COVID-19: a systematic review of current modalities and future directions.
|
NA
|
NA
|
|
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
|
NA
|
NA
|
|
The Black Lives Matter Movement: A Call to Action for Couple and Family Therapists.
|
NA
|
NA
|
|
Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis.
|
NA
|
NA
|
|
The Zika virus: Lurking behind the COVID-19 pandemic?
|
NA
|
NA
|
|
Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia.
|
NA
|
NA
|
|
Rhinovirus and asthma: Challenges and opportunities.
|
NA
|
NA
|
|
Coronavirus disease-19 deaths among children and adolescents in an area of Northeast, Brazil: why so many?
|
NA
|
NA
|
|
Prevent or Cure-The Unprecedented Need for Self-Reporting Materials.
|
NA
|
NA
|
|
A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.
|
NA
|
NA
|
|
Mechanisms of a Sustained Anti-inflammatory Drug Response in Alveolar Macrophages Unraveled with Mathematical Modeling.
|
NA
|
NA
|
|
Isolated COVID-19 Infection Precipitates Myasthenia Gravis Crisis: A Case Report.
|
NA
|
NA
|
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
|
NA
|
NA
|
|
Urgent Dental Care During Italian Lockdown: A Cross-sectional Survey.
|
NA
|
NA
|
|
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study.
|
NA
|
NA
|
|
Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
|
NA
|
NA
|
|
Effects of progressive muscle relaxation training on negative emotions and sleep quality in COVID-19 patients: A clinical observational study.
|
NA
|
NA
|
|
The effect of meditative movement on the quality of life in patients recovering from COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical features and short-term outcomes of patients with COVID-19 due to different exposure history.
|
NA
|
NA
|
|
The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of 2019 novel coronavirus disease (COVID-19) in Jilin, China: A descriptive study.
|
NA
|
NA
|
|
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2.
|
NA
|
NA
|
|
Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review.
|
NA
|
NA
|
|
Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database.
|
NA
|
NA
|
|
Review of care and management of pregnant women during COVID-19 pandemic.
|
NA
|
NA
|
|
Proctologic emergency consultation during COVID-19: Comparative cross-sectional cohort study.
|
NA
|
NA
|
|
A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction.
|
NA
|
NA
|
|
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients.
|
NA
|
NA
|
|
The Role of Telehealth During the COVID-19 Pandemic Across the Interdisciplinary Cancer Team: Implications for Practice.
|
NA
|
NA
|
|
[SARS-CoV-2 infection and ischemic stroke].
|
NA
|
NA
|
|
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain.
|
NA
|
NA
|
|
Interferon therapy for COVID-19 and emerging infections: Prospects and concerns.
|
NA
|
NA
|
|
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management.
|
NA
|
NA
|
|
Systematic review on current antiviral therapy in COVID-19 pandemic.
|
NA
|
NA
|
|
Endoscopic retrograde cholangiopancreatography for acute gallstone pancreatitis: Implementation of an institution safety protocol during the COVID-19 outbreak in Malaysia.
|
NA
|
NA
|
|
Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.
|
NA
|
NA
|
|
Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy.
|
NA
|
NA
|
|
Older cancer patients and COVID-19 outbreak: Practical considerations and recommendations.
|
NA
|
NA
|
|
[ORGANIZATION OF MEDICAL CARE FOR ELDERLY PATIENTS UNDER THE CONDITIONS OF THE COVID-19 PANDEMIC].
|
NA
|
NA
|
|
[Recreational potential of medical tourism of Russia].
|
NA
|
NA
|
|
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses.
|
NA
|
NA
|
|
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
|
NA
|
NA
|
|
Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study.
|
NA
|
NA
|
|
Prospective implementation of a same-day discharge protocol for catheter ablation of paroxysmal atrial fibrillation.
|
NA
|
NA
|
|
Timing and volume of information produced for the Otolaryngologist during the COVID-19 pandemic in the UK: A review of the volume of online literature.
|
NA
|
NA
|
|
Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study.
|
NA
|
NA
|
|
HOW CAN I SURVIVE THIS? Coping during COVID-19 pandemic.
|
NA
|
NA
|
|
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
|
NA
|
NA
|
|
Workers at long-term care facilities and their risk for severe COVID-19 illness.
|
NA
|
NA
|
|
Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
|
NA
|
NA
|
|
Veno-venous extracorporeal membrane oxygenation allocation in the COVID-19 pandemic.
|
NA
|
NA
|
|
Midwifery and Nursing Strategies to protect against COVID-19 During the Third Trimester of Pregnancy.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.
|
NA
|
NA
|
|
Wide-awake local anaesthesia no tourniquet (WALANT) vs regional or general anaesthesia for flexor tendon repair in adults: protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Delayed presentation and sub-optimal outcomes of pediatric patients with acute appendicitis during the COVID-19 pandemic.
|
NA
|
NA
|
|
Detection of SARS-CoV-2 in wastewater in Japan during a COVID-19 outbreak.
|
NA
|
NA
|
|
Antidepressant drugs as emerging contaminants: Occurrence in urban and non-urban waters and analytical methods for their detection.
|
NA
|
NA
|
|
COVID-19, its novel vaccination and fake news - What a brew.
|
NA
|
NA
|
|
Panic and pandemic: Narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism.
|
NA
|
NA
|
|
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
|
NA
|
NA
|
|
COVID-19 highlights the pitfalls of reliance on the carceral system as a response to addiction.
|
NA
|
NA
|
|
Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
|
NA
|
NA
|
|
Potential role of interferons in treating COVID-19 patients.
|
NA
|
NA
|
|
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on patients receiving orthodontic treatment: An online questionnaire cross-sectional study.
|
NA
|
NA
|
|
Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic.
|
NA
|
NA
|
|
An overview of viruses discovered over the last decades and drug development for the current pandemic.
|
NA
|
NA
|
|
Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19.
|
NA
|
NA
|
|
Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.
|
NA
|
NA
|
|
extracts modulate ACE2 expression in COVID-19 gateway tissues.
|
NA
|
NA
|
|
Simultaneous Determination of Paracetamol, Propyphenazone and Caffeine in Presence of Paracetamol Impurities Using Dual-Mode Gradient HPLC and TLC Densitometry Methods.
|
NA
|
NA
|
|
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
|
NA
|
NA
|
|
Psychological and neuropsychiatric implications of COVID-19.
|
NA
|
NA
|
|
Neurosurgery and coronavirus: impact and challenges-lessons learnt from the first wave of a global pandemic.
|
NA
|
NA
|
|
Renin-angiotensin system inhibitors and mortality in patients with COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift.
|
NA
|
NA
|
|
Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment.
|
NA
|
NA
|
|
Characteristics of cancer patients with COVID-19 in a cancer hospital.
|
NA
|
NA
|
|
Is your vision blurry? A systematic review of home-based visual acuity for telemedicine.
|
NA
|
NA
|
|
Knowledge, attitudes, and practices towards influenza among Chinese adults during the epidemic of COVID-19: a cross-sectional online survey.
|
NA
|
NA
|
|
European Multicenter Study of ET-COVID-19.
|
NA
|
NA
|
|
Enhanced photochemical formation of secondary organic aerosols during the COVID-19 lockdown in Northern China.
|
NA
|
NA
|
|
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak.
|
NA
|
NA
|
|
Overcoming the paracetamol dose challenge with wrinkled mesoporous carbon spheres.
|
NA
|
NA
|
|
Challenges, limitations, and solutions for orthodontists during the coronavirus pandemic: A review.
|
NA
|
NA
|
|
Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
|
NA
|
NA
|
|
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
|
NA
|
NA
|
|
The Feasibility of Exercise Interventions Delivered via Telehealth for People Affected by Cancer: A Rapid Review of the Literature.
|
NA
|
NA
|
|
Acute kidney injury and renal replacement therapy in COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Availability of psychological support for medical students in Poland.
|
NA
|
NA
|
|
COVID-19 lockdown impact on common general surgical acute presentations to a regional centre in New Zealand.
|
NA
|
NA
|
|
Selection of the best healthcare waste disposal techniques during and post COVID-19 pandemic era.
|
NA
|
NA
|
|
Neurology and COVID-19: Acting now. Preparing for Future.
|
NA
|
NA
|
|
Neurological Complications with COVID-19: A Contemporaneous Review.
|
NA
|
NA
|
|
Adaptations and Safety Modifications to Perform Safe Minimal Access Surgery (MIS: Laparoscopy and Robotic) During the COVID-19 Pandemic: Practice Modifications Expert Panel Consensus Guidelines from Academia of Minimal Access Surgical Oncology (AMASO).
|
NA
|
NA
|
|
COVID-19 and Private Health: Market and Governance Failure.
|
NA
|
NA
|
|
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
|
NA
|
NA
|
|
Analysis of the Risk Factors for Nosocomial Bacterial Infection in Patients with COVID-19 in a Tertiary Hospital.
|
NA
|
NA
|
|
Obesity Management in Primary Care During and Beyond the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Pathophysiology, diagnostics and treatment of the respiratory pump].
|
NA
|
NA
|
|
A comprehensive review about SARS-CoV-2.
|
NA
|
NA
|
|
Contribution of CT Features in the Diagnosis of COVID-19.
|
NA
|
NA
|
|
Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy.
|
NA
|
NA
|
|
E-health applications in the field of traumatic stress.
|
NA
|
NA
|
|
Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting.
|
NA
|
NA
|
|
Rare case of COVID-19 presenting as acute abdomen and sepsis.
|
NA
|
NA
|
|
Clinical Presentation of Acute Pulmonary Embolism in Patients with Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Gastric Perforation with Omental Patch Repair: A Rare Complication of Pulmonary Resuscitation in COVID-19 Pneumonia.
|
NA
|
NA
|
|
Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study).
|
NA
|
NA
|
|
Cardiovascular risk in COVID-19 infection.
|
NA
|
NA
|
|
Cardiovascular risk and complications associated with COVID-19.
|
NA
|
NA
|
|
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak.
|
NA
|
NA
|
|
Trends in Social Media Topics During COVID-19 Among Women Undergoing Assisted Reproductive Technology Treatments.
|
NA
|
NA
|
|
Rapidly progressive organizing pneumonia associated with COVID-19.
|
NA
|
NA
|
|
Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2.
|
NA
|
NA
|
|
Recurrent neural network based prediction of number of COVID-19 cases in India.
|
NA
|
NA
|
|
Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
|
NA
|
NA
|
|
COVID-19 pandemic crisis-a complete outline of SARS-CoV-2.
|
NA
|
NA
|
|
Making impressions count: An evaluation of the quality of information provided by orthodontic practices in London in response to the COVID-19 pandemic.
|
NA
|
NA
|
|
A smartphone-based online tool for prehospital self-triage of COVID-19.
|
NA
|
NA
|
|
Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles.
|
NA
|
NA
|
|
Spinal surgery and related management on patients with COVID-19: experience of a regional medical centre in Wuhan.
|
NA
|
NA
|
|
Rescue Treatment With High-Dose Gaseous Nitric Oxide in Spontaneously Breathing Patients With Severe Coronavirus Disease 2019.
|
NA
|
NA
|
|
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019.
|
NA
|
NA
|
|
A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation.
|
NA
|
NA
|
|
Stay connected and up to date. GI meetings and seminars and the COVID-19 pandemic.
|
NA
|
NA
|
|
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan.
|
NA
|
NA
|
|
An Educational Experiment Resulting from COVID-19: The Use of At-Home Waxing and Webinars for Teaching a 3-Week Intensive Course in Tooth Morphology to First Year Dental Students.
|
NA
|
NA
|
|
The impact of COVID-19 in hemodialysis patients: Experience in a hospital dialysis unit.
|
NA
|
NA
|
|
Atypical bilateral acute retinal necrosis in a coronavirus disease 2019 positive immunosuppressed patient.
|
NA
|
NA
|
|
and polyadenylation inhibitor with therapeutic potential against COVID-19.
|
NA
|
NA
|
|
Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases.
|
NA
|
NA
|
|
Global research trends at the intersection of coronavirus disease 2019 (COVID-19) and traditional, integrative, and complementary and alternative medicine: a bibliometric analysis.
|
NA
|
NA
|
|
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
|
NA
|
NA
|
|
Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
[Medicalization of nursing facilities as a real alternative to hospitalization during the COVID-19 pandemic.]
|
NA
|
NA
|
|
Prioritizing IVF treatment in the post-COVID 19 era: a predictive modelling study based on UK national data.
|
NA
|
NA
|
|
Differential impact of BTK active site inhibitors on the conformational state of full-length BTK.
|
NA
|
NA
|
|
Consensus of multiple national guidelines: agreed strategies for initial stone management during COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders.
|
NA
|
NA
|
|
Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19.
|
NA
|
NA
|
|
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient with COVID-19.
|
NA
|
NA
|
|
An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
|
NA
|
NA
|
|
Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes.
|
NA
|
NA
|
|
Clinical characteristics of the first known cases of death caused by COVID-19 pneumonia.
|
NA
|
NA
|
|
Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19.
|
NA
|
NA
|
|
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020).
|
NA
|
NA
|
|
Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure.
|
NA
|
NA
|
|
Prevention of occupational stress in health-care workers during COVID-19 pandemic.
|
NA
|
NA
|
|
Emerging mental health issues during the COVID-19 pandemic: An Indian perspective.
|
NA
|
NA
|
|
Organization of mental healthcare in Bosnia and Herzegovina during coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
The psychological impact of COVID-19 on the families of first-line rescuers.
|
NA
|
NA
|
|
Features of minor depressive disorder subtypes in conditions of COVID-19 pandemic.
|
NA
|
NA
|
|
Mental health in the age of COVID-19, a Mexican experience.
|
NA
|
NA
|
|
COVID-19 pandemic hype: Losers and gainers.
|
NA
|
NA
|
|
A comparative study of access to inpatient psychiatric treatment in a public mental health service in Melbourne during COVID-19.
|
NA
|
NA
|
|
Changes in Neuroendovascular Procedural Volume During the COVID-19 Pandemic: An International Multicenter Study.
|
NA
|
NA
|
|
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19.
|
NA
|
NA
|
|
A comprehensive review on potential therapeutics interventions for COVID-19.
|
NA
|
NA
|
|
What Is the Preparedness and Capacity of Palliative Care Services in Middle-Eastern and North African Countries to Respond to COVID-19? A Rapid Survey.
|
NA
|
NA
|
|
Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
|
NA
|
NA
|
|
Economic evaluation of programs against COVID-19: A systematic review.
|
NA
|
NA
|
|
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.
|
NA
|
NA
|
|
Usability of Remote Assessment of Exercise Capacity for Pulmonary Telerehabilitation Program.
|
NA
|
NA
|
|
User-Centred Design with a Remote Approach: Experiences from the Chronic Pain Project.
|
NA
|
NA
|
|
Challenges in Urology during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Simulation and Improvement of Patients’ Workflow in Heart Clinics during COVID-19 Pandemic Using Timed Coloured Petri Nets.
|
NA
|
NA
|
|
The Acquisition of Multidrug-Resistant Bacteria in Patients Admitted to COVID-19 Intensive Care Units: A Monocentric Retrospective Case Control Study.
|
NA
|
NA
|
|
Molluscan Compounds Provide Drug Leads for the Treatment and Prevention of Respiratory Disease.
|
NA
|
NA
|
|
Management of critically ill patients with COVID-19: suggestions and instructions from the coordination of intensive care units of Lombardy.
|
NA
|
NA
|
|
Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients.
|
NA
|
NA
|
|
[Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]
|
NA
|
NA
|
|
Trends in intensive neonatal care during the COVID-19 outbreak in Japan.
|
NA
|
NA
|
|
Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities.
|
NA
|
NA
|
|
COVID-19 emergency and palliative medicine: an intervention model’.
|
NA
|
NA
|
|
Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair.
|
NA
|
NA
|
|
Successful and Safe Reinstitution of Chemotherapy for Pancreatic Cancer after COVID-19.
|
NA
|
NA
|
|
[COVID-19 and stroke].
|
NA
|
NA
|
|
Management of Endovascular Treatment for Acute Ischemic Stroke During the COVID-19 Pandemic at a Single Institution in Beijing, China: A Brief Report.
|
NA
|
NA
|
|
COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research.
|
NA
|
NA
|
|
Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Autism and Access to Care During the COVID-19 Crisis.
|
NA
|
NA
|
|
Coronavirus 2019: clinical and neuropathological aspects.
|
NA
|
NA
|
|
Organizational Health Literacy: Opportunities for Patient-Centered Care in the Wake of COVID-19.
|
NA
|
NA
|
|
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
|
NA
|
NA
|
|
Telemedicine for neuro-ophthalmology: challenges and opportunities.
|
NA
|
NA
|
|
Challenges of treatment adherence with direct oral anticoagulants in pandemic.
|
NA
|
NA
|
|
Maintaining high thrombectomy rates during pandemics.
|
NA
|
NA
|
|
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
|
NA
|
NA
|
|
What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review.
|
NA
|
NA
|
|
Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange.
|
NA
|
NA
|
|
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series.
|
NA
|
NA
|
|
Important updates from the AACR virtual meeting: COVID-19 and cancer.
|
NA
|
NA
|
|
Cerebrospinal Analysis in Patients With COVID-19.
|
NA
|
NA
|
|
Protein-ligand binding interactions of imidazolium salts with SARS CoV-2.
|
NA
|
NA
|
|
Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis.
|
NA
|
NA
|
|
Successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low-dose methylprednisolone.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic in patients with a previous history of premature myocardial infarction.
|
NA
|
NA
|
|
Influence of COVID-19 outbreak on emergency department Press Ganey scores of emergency physicians.
|
NA
|
NA
|
|
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper.
|
NA
|
NA
|
|
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study.
|
NA
|
NA
|
|
Reduction of severe acute respiratory syndrome coronavirus-2 infectivity by admissible concentration of ozone gas and water.
|
NA
|
NA
|
|
Application of Testing-Tracing-Treatment Strategy in Response to the COVID-19 Outbreak in Seoul, Korea.
|
NA
|
NA
|
|
Clinical Features of COVID-19 in Uzbekistan.
|
NA
|
NA
|
|
Patients assisted at the Department of Medicine of a pediatric hospital at the beginning of the COVID-19 pandemic in Buenos Aires, Argentina.
|
NA
|
NA
|
|
Recommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents.
|
NA
|
NA
|
|
Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: a Critical Review.
|
NA
|
NA
|
|
Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
|
NA
|
NA
|
|
Malignant Bowel Obstruction in the Time of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
|
NA
|
NA
|
|
[Inpatient equivalent treatment : A new form of care also in gerontopsychiatry].
|
NA
|
NA
|
|
Management of Arrhythmias Associated with COVID-19.
|
NA
|
NA
|
|
Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders: a feasibility and effectiveness study with 6 month-follow-up.
|
NA
|
NA
|
|
Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial.
|
NA
|
NA
|
|
A comprehensive review on the antiviral activities of chalcones.
|
NA
|
NA
|
|
Recombinant vaccines for COVID-19.
|
NA
|
NA
|
|
Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.
|
NA
|
NA
|
|
Deep-learning algorithms for the interpretation of chest radiographs to aid in the triage of COVID-19 patients: A multicenter retrospective study.
|
NA
|
NA
|
|
Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic.
|
NA
|
NA
|
|
Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
|
NA
|
NA
|
|
Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry.
|
NA
|
NA
|
|
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
|
NA
|
NA
|
|
Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2.
|
NA
|
NA
|
|
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
|
NA
|
NA
|
|
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
|
NA
|
NA
|
|
Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.
|
NA
|
NA
|
|
Collective aeromedical transport of COVID-19 critically ill patients in Europe: A retrospective study.
|
NA
|
NA
|
|
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza.
|
NA
|
NA
|
|
Challenges in telemedicine for adult patients with drug-resistant epilepsy undergoing ketogenic diet treatment during the COVID-19 pandemic in the public healthcare system in Brazil.
|
NA
|
NA
|
|
A Feasibility Pilot Study on the Use of Telemedicine for the Examination of the Knee Joint.
|
NA
|
NA
|
|
In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital.
|
NA
|
NA
|
|
Pregnancy and Childbirth in the COVID-19 Era-The Course of Disease and Maternal-Fetal Transmission.
|
NA
|
NA
|
|
Newly Developed Pediatric Membrane Oxygenator that Suppresses Excessive Pressure Drop in Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation (ECMO).
|
NA
|
NA
|
|
The Management of Children with Cancer during the COVID-19 Pandemic: A Rapid Review.
|
NA
|
NA
|
|
Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review.
|
NA
|
NA
|
|
Endothelial Damage in Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?
|
NA
|
NA
|
|
Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
|
NA
|
NA
|
|
A Methodology Based on Expert Systems for the Early Detection and Prevention of Hypoxemic Clinical Cases.
|
NA
|
NA
|
|
Inter-hospital COVID ECMO air transportation.
|
NA
|
NA
|
|
Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19.
|
NA
|
NA
|
|
Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak.
|
NA
|
NA
|
|
Could KL-6 levels in COVID-19 help to predict lung disease?
|
NA
|
NA
|
|
The impact of caring for dying patients in intensive care units on a physician’s personhood: a systematic scoping review.
|
NA
|
NA
|
|
Evidence for treatment with estradiol for women with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age.
|
NA
|
NA
|
|
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report.
|
NA
|
NA
|
|
Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents.
|
NA
|
NA
|
|
Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montréal, Canada: a descriptive analysis.
|
NA
|
NA
|
|
Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study.
|
NA
|
NA
|
|
Household medication safety practices during the COVID-19 pandemic: a descriptive qualitative study protocol.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children: An International Survey.
|
NA
|
NA
|
|
Characteristics of mortal COVID-19 cases compared to the survivors.
|
NA
|
NA
|
|
Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
COVID-19: An Update on the Epidemiological, Clinical, Preventive, and Therapeutic Management of 2019 Novel Coronavirus Disease.
|
NA
|
NA
|
|
Maxingshigan decoction for treating COVID-19: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.
|
NA
|
NA
|
|
Effect of pharmaceutical care on the treatment of COVID-19: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.
|
NA
|
NA
|
|
Chest imaging representing a COVID-19 positive rural U.S. population.
|
NA
|
NA
|
|
Establishment of an African green monkey model for COVID-19 and protection against re-infection.
|
NA
|
NA
|
|
Dentistry for children during and post COVID-19 pandemic outbreak.
|
NA
|
NA
|
|
Emerging Alternatives to Conventional Clinic Visits in the Era of COVID-19: Adoption of Telehealth at VCU Adult Cystic Fibrosis Center.
|
NA
|
NA
|
|
COVID-19 outbreak, disruption of dental education, and the role of teledentistry.
|
NA
|
NA
|
|
An Exercise Prescription for COVID-19 Pandemic.
|
NA
|
NA
|
|
Treatment and prognosis of COVID-19: Current scenario and prospects (Review).
|
NA
|
NA
|
|
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2.
|
NA
|
NA
|
|
A review of covid 19 in tamilnadu with regression and correlation co-efficient.
|
NA
|
NA
|
|
Colchicine in Dermatology: Rediscovering an Old Drug with Novel Uses.
|
NA
|
NA
|
|
Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare.
|
NA
|
NA
|
|
Zinc as nutritional intervention and prevention measure for COVID-19 disease.
|
NA
|
NA
|
|
Combating COVID-19 with tissue engineering: a review.
|
NA
|
NA
|
|
Acute Myocarditis Related to COVID-19: Comparison to SARS and MERS.
|
NA
|
NA
|
|
Approaches towards fighting the COVID‑19 pandemic (Review).
|
NA
|
NA
|
|
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
|
NA
|
NA
|
|
Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.
|
NA
|
NA
|
|
Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality.
|
NA
|
NA
|
|
HMGB1: A pleiotropic activity.
|
NA
|
NA
|
|
COVID-19 and allergy: How to take care of allergic patients during a pandemic?
|
NA
|
NA
|
|
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy.
|
NA
|
NA
|
|
Part 2: Blockchain technology in health care.
|
NA
|
NA
|
|
Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience.
|
NA
|
NA
|
|
Impact of the COVID-19 Outbreak on Routine Obstetrical Management.
|
NA
|
NA
|
|
[Retrospective Analysis of Neurological Symptoms of Severe/Critical COVID-19 Patients in Sichuan Province].
|
NA
|
NA
|
|
The Anticoagulant Therapy for Otogenic Sigmoid Sinus Thrombophlebitis: A Case Report and Literature Review.
|
NA
|
NA
|
|
Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study.
|
NA
|
NA
|
|
The Spectrum of Neuroimaging findings on CT and MRI in Adults with Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
|
NA
|
NA
|
|
Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis: Results of a Survey of Participants in the Dutch PROFILES Registry.
|
NA
|
NA
|
|
COVID-19, de novo seizures, and epilepsy: a systematic review.
|
NA
|
NA
|
|
[Intensive care unit treatment for patients suffering from COVID-19: the Neuchâtel experience].
|
NA
|
NA
|
|
Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey.
|
NA
|
NA
|
|
Computational simulation to assess patient safety of uncompensated COVID-19 two-patient ventilator sharing using the Pulse Physiology Engine.
|
NA
|
NA
|
|
Digital health interventions in children with asthma.
|
NA
|
NA
|
|
Can food and food supplements be deployed in the fight against the COVID 19 pandemic?
|
NA
|
NA
|
|
Examining the impacts of the COVID-19 pandemic on the well-being and virtual care of patients with epilepsy.
|
NA
|
NA
|
|
Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses.
|
NA
|
NA
|
|
Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.
|
NA
|
NA
|
|
Psychological and Emotional Impact of Patients Living in Psychiatric Treatment Communities during Covid-19 Lockdown in Italy.
|
NA
|
NA
|
|
Ocular oncology service during the COVID-19 outbreak in Florence (Italy): Practical considerations for the management of patients.
|
NA
|
NA
|
|
A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19.
|
NA
|
NA
|
|
Mesenchymal stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
|
NA
|
NA
|
|
Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
|
NA
|
NA
|
|
Therapeutic management of COVID-19 patients: Clinical manifestation and limitations.
|
NA
|
NA
|
|
Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study.
|
NA
|
NA
|
|
T cell exhaustion are associated with progression of COVID-19.
|
NA
|
NA
|
|
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
|
NA
|
NA
|
|
[Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19].
|
NA
|
NA
|
|
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
|
NA
|
NA
|
|
Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trial.
|
NA
|
NA
|
|
Reversal of the Pathophysiological Responses to Gram-Negative Sepsis by Megadose Vitamin C.
|
NA
|
NA
|
|
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.
|
NA
|
NA
|
|
Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence.
|
NA
|
NA
|
|
Repurposing Anti-Cancer Drugs for COVID-19 Treatment.
|
NA
|
NA
|
|
COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.
|
NA
|
NA
|
|
Global Current Practices of Ventilatory Support Management in COVID-19 Patients: An International Survey.
|
NA
|
NA
|
|
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
|
NA
|
NA
|
|
SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19.
|
NA
|
NA
|
|
Identifying Predictors of Psychological Distress During COVID-19: A Machine Learning Approach.
|
NA
|
NA
|
|
Effectiveness of Expressive Writing in the Reduction of Psychological Distress During the COVID-19 Pandemic: A Randomized Controlled Trial.
|
NA
|
NA
|
|
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
|
NA
|
NA
|
|
The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation.
|
NA
|
NA
|
|
Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report.
|
NA
|
NA
|
|
A rare case of co-occurrence of pulmonary embolism and left ventricular thrombus in a patient with COVID-19.
|
NA
|
NA
|
|
Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group.
|
NA
|
NA
|
|
Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.
|
NA
|
NA
|
|
COVID-19 infection: Disease detection and mobile technology.
|
NA
|
NA
|
|
Cardiac Adverse Events With Remdesivir in COVID-19 Infection.
|
NA
|
NA
|
|
Acute Generalized Exanthematous Pustulosis After COVID-19 Infection: A Case Report From Saudi Arabia.
|
NA
|
NA
|
|
An asthmatic pregnant woman with COVID-19: A case report study.
|
NA
|
NA
|
|
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2.
|
NA
|
NA
|
|
.
|
NA
|
NA
|
|
Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic.
|
NA
|
NA
|
|
The effects of a UK lockdown on orthopaedic trauma admissions and surgical cases: A multicentre comparative study.
|
NA
|
NA
|
|
COVID-19 and orthopaedic surgery: evolving strategies and early experience.
|
NA
|
NA
|
|
Contact Dermatitis from Hand Hygiene Practices in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 on the thyroid gland: an update.
|
NA
|
NA
|
|
Photobiomodulation therapy as a high potential treatment modality for COVID-19.
|
NA
|
NA
|
|
The first COVID-19 triadic (homicide!)-suicide pact: Do economic distress, disability, sickness, and treatment negligence matter?
|
NA
|
NA
|
|
Telehealth mask wearing training for children with autism during the COVID-19 pandemic.
|
NA
|
NA
|
|
Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
|
NA
|
NA
|
|
Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreak.
|
NA
|
NA
|
|
Ventilation use in nonmedical settings during COVID-19: Cleaning protocol, maintenance, and recommendations.
|
NA
|
NA
|
|
[Diabetes mellitus in old age].
|
NA
|
NA
|
|
Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020.
|
NA
|
NA
|
|
Supporting recovery from COVID-19.
|
NA
|
NA
|
|
[Patient safety in real time at covid-19 units in Region Jönköping County].
|
NA
|
NA
|
|
Options for Teens with No Options: A Self-Managed Second Trimester Abortion.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on pediatric patients with epilepsy - The caregiver perspective.
|
NA
|
NA
|
|
A safety consideration of mesenchymal stem cell therapy on COVID-19.
|
NA
|
NA
|
|
The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.
|
NA
|
NA
|
|
SEX DISPARITIES IN COVID-19 SEVERITY AND OUTCOME: ARE MEN WEAKER OR WOMEN STRONGER?
|
NA
|
NA
|
|
Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.
|
NA
|
NA
|
|
The effectiveness of early anticoagulant treatment in Covid-19 patients.
|
NA
|
NA
|
|
How does the covid-19 pandemic affect the target 90-90-90?
|
NA
|
NA
|
|
COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases.
|
NA
|
NA
|
|
Analysis of anxiety-related factors amongst frontline dental staff during the COVID-19 pandemic in Yichang, China.
|
NA
|
NA
|
|
The effects of containment measures in the Italian outbreak of COVID-19.
|
NA
|
NA
|
|
The differences of clinical characteristics and outcomes between imported and local patients of COVID-19 in Hunan: a two-center retrospective study.
|
NA
|
NA
|
|
Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China.
|
NA
|
NA
|
|
Evaluating the efficacy and safety of the myrtle (Myrtus communis) in treatment and prognosis of patients suspected to novel coronavirus disease (COVID-19): study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
|
NA
|
NA
|
|
Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions’ approaches to an evolving healthcare landscape.
|
NA
|
NA
|
|
Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020.
|
NA
|
NA
|
|
Thrombosis and Coagulopathy in COVID-19.
|
NA
|
NA
|
|
Changes in Social Media Impact of the Radiological Literature During the Covid-19 Pandemic.
|
NA
|
NA
|
|
[Effect of hypertension on outcomes of patients with COVID-19].
|
NA
|
NA
|
|
Delayed healthcare seeking and prolonged illness in healthcare workers during the COVID-19 pandemic: a single-centre observational study.
|
NA
|
NA
|
|
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
|
NA
|
NA
|
|
Cold atmospheric plasma for SARS-CoV-2 inactivation.
|
NA
|
NA
|
|
Clinical Characteristics and Predictors of Mortality in Patients with COVID-19 Infection Outside Intensive Care.
|
NA
|
NA
|
|
Nutrition, the digestive system and immunity in COVID-19 infection.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology.
|
NA
|
NA
|
|
Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19.
|
NA
|
NA
|
|
Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
|
NA
|
NA
|
|
Vasculopathy-related cutaneous lesions and intrahepatic cholestasis as synchronous manifestations in a COVID-19 patient; a case report.
|
NA
|
NA
|
|
Pulmonary Thromboembolism and Infarction Mimicking COVID-19 Symptoms; Report of three Cases.
|
NA
|
NA
|
|
Opportunistic Diagnosis of Extensive Pulmonary Embolus Following “COVID-19 Blood Battery” in Very Frail Older Patients.
|
NA
|
NA
|
|
Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations.
|
NA
|
NA
|
|
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19.
|
NA
|
NA
|
|
Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study.
|
NA
|
NA
|
|
Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.
|
NA
|
NA
|
|
Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials.
|
NA
|
NA
|
|
Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease and Implications for Clinical Trial Methodologies.
|
NA
|
NA
|
|
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot.
|
NA
|
NA
|
|
Tubaramure, a Food-Assisted Integrated Health and Nutrition Program, Reduces Child Wasting in Burundi: A Cluster-Randomized Controlled Intervention Trial.
|
NA
|
NA
|
|
The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients.
|
NA
|
NA
|
|
Emerging mental health challenges, strategies, and opportunities in the context of the COVID-19 pandemic: Perspectives from South American decision-makers.
|
NA
|
NA
|
|
Recommendations for treatment of critically ill patients with COVID-19 : Version 3 S1 guideline.
|
NA
|
NA
|
|
Molecular docking and simulation investigation: effect of beta-sesquiphellandrene with ionic integration on SARS-CoV2 and SFTS viruses.
|
NA
|
NA
|
|
Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.
|
NA
|
NA
|
|
N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.
|
NA
|
NA
|
|
COVID-19 mortality risk factors in older people in a long-term care center.
|
NA
|
NA
|
|
Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review.
|
NA
|
NA
|
|
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
|
NA
|
NA
|
|
Correlation of Covid-19 With Stomatognathic System With Homeopathic Proposal for Adjunct Treatment to Increase Oral and General Health.
|
NA
|
NA
|
|
Physical Activity for Improving the Immune System of Older Adults During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A.B.C. approach proposal for POCUS in COVID-19 critically ill patients.
|
NA
|
NA
|
|
PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.
|
NA
|
NA
|
|
Development of a Novel Communication Liaison Program to Support COVID-19 Patients and Their Families.
|
NA
|
NA
|
|
COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.
|
NA
|
NA
|
|
Understanding and Informing Community Emergency Cardiovascular Disease Preparedness during the COVID-19 Pandemic: Stroke Ready.
|
NA
|
NA
|
|
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians.
|
NA
|
NA
|
|
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective.
|
NA
|
NA
|
|
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
|
NA
|
NA
|
|
Development of concomitant diseases in COVID-19 critically ill patients.
|
NA
|
NA
|
|
Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19?
|
NA
|
NA
|
|
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
|
NA
|
NA
|
|
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial.
|
NA
|
NA
|
|
Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
|
NA
|
NA
|
|
GeoSentinel: past, present and future†.
|
NA
|
NA
|
|
Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management.
|
NA
|
NA
|
|
Effectiveness of Convalescent Plasma Therapy in the Treatment of Moderate to Severe COVID 19 Patients: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Anosmia, Ageusia and COVID-19.
|
NA
|
NA
|
|
Beyond COVID-19: Evidence-Based Consensus Statement on the Role of Physiotherapy in Pulmonary Rehabilitation in the Indian Context.
|
NA
|
NA
|
|
Clinical Informatics during the COVID-19 Pandemic: Lessons Learned and Implications for Emergency Department and Inpatient Operations.
|
NA
|
NA
|
|
Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?
|
NA
|
NA
|
|
Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective.
|
NA
|
NA
|
|
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
|
NA
|
NA
|
|
Guidance on nebulization during the current COVID-19 pandemic.
|
NA
|
NA
|
|
Case report: Nutrition therapy and side-effects monitoring in critically ill coronavirus disease 2019 patients.
|
NA
|
NA
|
|
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
|
NA
|
NA
|
|
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
|
NA
|
NA
|
|
Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
|
NA
|
NA
|
|
Telehealth sustains patient engagement in OUD treatment during COVID-19.
|
NA
|
NA
|
|
Taking on a pandemic’s challenge: Emergent solutions from a single Hemophlia treatment center in North India.
|
NA
|
NA
|
|
Ophthalmology and Ethics in the COVID-19 Era.
|
NA
|
NA
|
|
Caring Advanced Cancer Patients at Home During COVID-19 Outbreak: Burnout and Psychological Morbidity Among Palliative Care Professionals in Italy.
|
NA
|
NA
|
|
Antiviral Photodynamic Therapy: Inactivation and Inhibition of SARS-CoV-2 In Vitro Using Methylene Blue and Radahlorin.
|
NA
|
NA
|
|
Safety and Adherence to Venom Immunotherapy During COVID-19 Pandemic.
|
NA
|
NA
|
|
Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report.
|
NA
|
NA
|
|
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations.
|
NA
|
NA
|
|
No obviously adverse pregnancy complications and outcomes of the recovered pregnant women from COVID-19.
|
NA
|
NA
|
|
SARS-COV-2 (Covid-19) and male fertility: Where are we?
|
NA
|
NA
|
|
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study.
|
NA
|
NA
|
|
Hypoxic preconditioning - A nonpharmacological approach in COVID-19 prevention.
|
NA
|
NA
|
|
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
|
NA
|
NA
|
|
Digital Cognitive Behavioral Therapy for Insomnia Promotes Later Health Resilience During the Coronavirus Disease 19 (COVID-19) Pandemic.
|
NA
|
NA
|
|
Controversies in the use of new bone-modifying therapies in multiple myeloma.
|
NA
|
NA
|
|
Knowledge of social distancing measures and adherence to restrictions during the COVID-19 pandemic.
|
NA
|
NA
|
|
Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.
|
NA
|
NA
|
|
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
|
NA
|
NA
|
|
Iran, sanctions, and the COVID-19 crisis.
|
NA
|
NA
|
|
Clinical course of novel COVID-19 infection in pregnant women.
|
NA
|
NA
|
|
Venous thromboembolism in the era of COVID-19.
|
NA
|
NA
|
|
Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke: The Society of Vascular and Interventional Neurology Multicenter Collaboration.
|
NA
|
NA
|
|
Dentists’ knowledge, attitudes, and professional behavior toward the COVID-19 pandemic: A multisite survey of dentists’ perspectives.
|
NA
|
NA
|
|
Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program.
|
NA
|
NA
|
|
Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany.
|
NA
|
NA
|
|
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.
|
NA
|
NA
|
|
An outbreak can hide another.
|
NA
|
NA
|
|
Comparison of clinical and laboratory features and treatment options of 237 Comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey.
|
NA
|
NA
|
|
The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020.
|
NA
|
NA
|
|
Pore-Scale Transport and Two-Phase Fluid Structures in Fibrous Porous Layers: Application to Fuel Cells and Beyond.
|
NA
|
NA
|
|
Crowding has consequences: Prevention and management of COVID-19 in informal urban settlements.
|
NA
|
NA
|
|
Understanding the Relationships between Parenting Stress and Mental Health with Grandparent Kinship Caregivers’ Risky Parenting Behaviors in the Time of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 and ECMO: early results and experience.
|
NA
|
NA
|
|
Protective measures undertaken during chest tube thoracostomy in COVID-19 outbreak.
|
NA
|
NA
|
|
nanofiber membrane, which is better for fabricating personal protective equipments.
|
NA
|
NA
|
|
DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19.
|
NA
|
NA
|
|
A brief review of the neurological manifestations of the coronavirus disease.
|
NA
|
NA
|
|
Urolithiasis treatment options during COVID-19 pandemic: review of current recommendations and triage systems.
|
NA
|
NA
|
|
Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.
|
NA
|
NA
|
|
COVID-CheXNet: hybrid deep learning framework for identifying COVID-19 virus in chest X-rays images.
|
NA
|
NA
|
|
A fuzzy rough hybrid decision making technique for identifying the infected population of COVID-19.
|
NA
|
NA
|
|
An Assessment of Distress Levels of Patients Undergoing Lung Cancer Treatment and Surveillance During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Adaptation and Validation of the Brazilian Version of the Fear of COVID-19 Scale.
|
NA
|
NA
|
|
Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology.
|
NA
|
NA
|
|
A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients.
|
NA
|
NA
|
|
Risk Perception and Media in Shaping Protective Behaviors: Insights From the Early Phase of COVID-19 Italian Outbreak.
|
NA
|
NA
|
|
Considerations for planning COVID-19 treatment services in humanitarian responses.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on the continuity of care for dermatologic patients on systemic therapy during the period of strict lockdown.
|
NA
|
NA
|
|
Assessment of schistosomiasis endemicity and preventive treatment on coronavirus disease 2019 outcomes in Africa.
|
NA
|
NA
|
|
A systematic review of contamination (aerosol, splatter and droplet generation) associated with oral surgery and its relevance to COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?
|
NA
|
NA
|
|
Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers’?
|
NA
|
NA
|
|
Intelligent computing with Levenberg-Marquardt artificial neural networks for nonlinear system of COVID-19 epidemic model for future generation disease control.
|
NA
|
NA
|
|
SARS-COV-2 infection in the perioperative of pulmonary lobectomy. About a case.
|
NA
|
NA
|
|
A review on hospital wastewater treatment: A special emphasis on occurrence and removal of pharmaceutically active compounds, resistant microorganisms, and SARS-CoV-2.
|
NA
|
NA
|
|
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics.
|
NA
|
NA
|
|
Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients.
|
NA
|
NA
|
|
Case Series: COVID-19 in African American Patients With Sarcoidosis.
|
NA
|
NA
|
|
Dataset of potential Rhizoma Polygonati compound-druggable targets and partial pharmacokinetics for treatment of COVID-19.
|
NA
|
NA
|
|
Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019.
|
NA
|
NA
|
|
Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19.
|
NA
|
NA
|
|
Combination Therapy for COVID-19.
|
NA
|
NA
|
|
Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.
|
NA
|
NA
|
|
COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.
|
NA
|
NA
|
|
COVID-19 in Children With Kidney Disease: A Report of 2 Cases.
|
NA
|
NA
|
|
Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer.
|
NA
|
NA
|
|
Review of registered clinical trials for the treatment of COVID-19.
|
NA
|
NA
|
|
An ensemble approach to short-term forecast of COVID-19 intensive care occupancy in Italian regions.
|
NA
|
NA
|
|
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
|
NA
|
NA
|
|
Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
|
NA
|
NA
|
|
A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
|
NA
|
NA
|
|
Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
|
NA
|
NA
|
|
The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
fertilization treatment interrupted or postponed due to COVID-19 pandemic: a cross-sectional study.
|
NA
|
NA
|
|
The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman.
|
NA
|
NA
|
|
Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination.
|
NA
|
NA
|
|
British Journal of Biomedical Science in 2020. What have we learned?
|
NA
|
NA
|
|
The Precision Health and Everyday Democracy (PHED) Project: Protocol for a Transdisciplinary Collaboration on Health Equity and the Role of Health in Society.
|
NA
|
NA
|
|
Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19: Results of the UMC-19-S12.
|
NA
|
NA
|
|
Transpacific Aeromedical Evacuation for a Ruptured Brain Arteriovenous Malformation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
[Do COVID-19 restrictions lead to a decrease in severely injured patients at a level 1 trauma center in Germany?]
|
NA
|
NA
|
|
Feasibility of using a handheld ultrasound device to detect and characterize shunt and deep vein thrombosis in patients with COVID-19: an observational study.
|
NA
|
NA
|
|
Top POEMs of 2019 Consistent with the Principles of the Choosing Wisely Campaign.
|
NA
|
NA
|
|
Aligning dissemination and implementation science with health policies to improve children’s mental health.
|
NA
|
NA
|
|
Low-dose X-ray therapy for COVID-19: lessons from the past.
|
NA
|
NA
|
|
Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors.
|
NA
|
NA
|
|
Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Forecasting COVID-19 in Pakistan.
|
NA
|
NA
|
|
Myths, beliefs, and perceptions about COVID-19 in Ethiopia: A need to address information gaps and enable combating efforts.
|
NA
|
NA
|
|
KN95 and N95 Respirators Retain Filtration Efficiency despite a Loss of Dipole Charge during Decontamination.
|
NA
|
NA
|
|
The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis.
|
NA
|
NA
|
|
One year update on the COVID-19 pandemic: Where are we now?
|
NA
|
NA
|
|
Response to the COVID-19 Pandemic Among Posthospital Brain Injury Rehabilitation Providers.
|
NA
|
NA
|
|
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
|
NA
|
NA
|
|
Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
|
NA
|
NA
|
|
Vascular surgery triage during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
|
NA
|
NA
|
|
Tobacco use as a well-recognized cause of severe COVID-19 manifestations.
|
NA
|
NA
|
|
Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection.
|
NA
|
NA
|
|
De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
|
NA
|
NA
|
|
Alteraciones de la coagulación en la COVID-19.
|
NA
|
NA
|
|
The psychiatric impact of COVID-19 on healthcare workers.
|
NA
|
NA
|
|
Diagnosis and treatment of post-traumatic stress disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Undertaking medication review by telehealth.
|
NA
|
NA
|
|
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
|
NA
|
NA
|
|
[What can pulmonary rehabilitation accomplish?]
|
NA
|
NA
|
|
Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature.
|
NA
|
NA
|
|
Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review.
|
NA
|
NA
|
|
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances.
|
NA
|
NA
|
|
Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2.
|
NA
|
NA
|
|
Methylene blue may have a role in the treatment of COVID-19.
|
NA
|
NA
|
|
Can charcoal improve outcomes in COVID-19 infections?
|
NA
|
NA
|
|
The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients.
|
NA
|
NA
|
|
It is time to drop hydroxychloroquine from our COVID-19 armamentarium.
|
NA
|
NA
|
|
Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
|
NA
|
NA
|
|
Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19.
|
NA
|
NA
|
|
Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?
|
NA
|
NA
|
|
Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities.
|
NA
|
NA
|
|
Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19.
|
NA
|
NA
|
|
Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
|
NA
|
NA
|
|
A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
|
NA
|
NA
|
|
COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome.
|
NA
|
NA
|
|
Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis.
|
NA
|
NA
|
|
Potential of electric stimulation for the management of COVID-19.
|
NA
|
NA
|
|
Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
|
NA
|
NA
|
|
The viral protein fragment theory of COVID-19 pathogenesis.
|
NA
|
NA
|
|
Host - virus - drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis.
|
NA
|
NA
|
|
Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?
|
NA
|
NA
|
|
Environmental impacts on the transmission and evolution of COVID-19 combing the knowledge of pathogenic respiratory coronaviruses.
|
NA
|
NA
|
|
Prospects of nanomaterials-enabled biosensors for COVID-19 detection.
|
NA
|
NA
|
|
Decay of SARS-CoV-2 RNA along the wastewater treatment outfitted with Upflow Anaerobic Sludge Blanket (UASB) system evaluated through two sample concentration techniques.
|
NA
|
NA
|
|
Synthesis and characterization of novel organo-hydrogel based agar, glycerol and peppermint oil as a natural drug carrier/release material.
|
NA
|
NA
|
|
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies.
|
NA
|
NA
|
|
The Evolution of Covid-19 in Italy after the Spring of 2020: An Unpredicted Summer Respite Followed by a Second Wave.
|
NA
|
NA
|
|
Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil.
|
NA
|
NA
|
|
COVID-19: Short and Long-Term Effects of Hospitalization on Muscular Weakness in the Elderly.
|
NA
|
NA
|
|
Effects of Spirituality, Knowledge, Attitudes, and Practices toward Anxiety Regarding COVID-19 among the General Population in INDONESIA: A Cross-Sectional Study.
|
NA
|
NA
|
|
Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population.
|
NA
|
NA
|
|
Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein.
|
NA
|
NA
|
|
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.
|
NA
|
NA
|
|
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY Trial.
|
NA
|
NA
|
|
Burnout in Spanish Security Forces during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.
|
NA
|
NA
|
|
The emerging COVID-19 research: dynamic and regularly updated science maps and analyses.
|
NA
|
NA
|
|
Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.
|
NA
|
NA
|
|
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC.
|
NA
|
NA
|
|
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic.
|
NA
|
NA
|
|
The Winter Respiratory Viral Season During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Protocol for Telehealth Evaluation and Follow-up of Patients With Chronic Heart Failure During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies.
|
NA
|
NA
|
|
Stem cell therapy in coronavirus disease 2019: current evidence and future potential.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic in pediatric patients with epilepsy with neuropsychiatric comorbidities: A telemedicine evaluation.
|
NA
|
NA
|
|
Lung transplantation for patients with severe COVID-19.
|
NA
|
NA
|
|
[Telephone information service for psychiatric patients during the COVID-19 pandemic: Experience with a direct phone line in the Nyírő Gyula National Institute of Psychiatry and Addictions in Hungary].
|
NA
|
NA
|
|
Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
|
NA
|
NA
|
|
Control measures of a 400-year-old plague epidemic: an example of past efficiency at controlling disease and similarities with current epidemics.
|
NA
|
NA
|
|
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
|
NA
|
NA
|
|
Pharmacists’ roles in emergency and disasters: COVID-19 as an example.
|
NA
|
NA
|
|
D614G Spike Variant Does Not Alter IgG, IgM, or IgA Spike Seroassay Performance.
|
NA
|
NA
|
|
[Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?]
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion.
|
NA
|
NA
|
|
Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: The patient perspective.
|
NA
|
NA
|
|
Identifying public concerns and reactions during the COVID-19 pandemic on Twitter: A text-mining analysis.
|
NA
|
NA
|
|
Establishment of a Nationwide Korean Imaging Cohort of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Traditional Chinese Medicine guidelines for coronavirus disease 2019.
|
NA
|
NA
|
|
Why Communities Should Be the Focus to Reduce Stigma Attached to COVID-19.
|
NA
|
NA
|
|
Development and implementation of telehealth for peritoneal dialysis and kidney transplant patients monitoring during the COVID-19 pandemic.
|
NA
|
NA
|
|
Caring for acute coronary syndrome and other time-sensitive medical emergencies during the coronavirus disease 2019 pandemic in Northern Italy: report from a hub centre.
|
NA
|
NA
|
|
COVID-19 pandemic and elderly: is the curtain dropped for urgent pacemaker implantations?
|
NA
|
NA
|
|
The Best Medicine is Not Always Medicine.
|
NA
|
NA
|
|
A pocket guide on how to structure SARS-CoV-2 drugs and therapies.
|
NA
|
NA
|
|
Evidence of Social and Structural COVID-19 Disparities by Sexual Orientation, Gender Identity, and Race/Ethnicity in an Urban Environment.
|
NA
|
NA
|
|
Dosing Considerations for Antibodies Against COVID-19.
|
NA
|
NA
|
|
Venovenous ECMO treatment, outcomes, and complications in adults according to large case series: A systematic review.
|
NA
|
NA
|
|
High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients.
|
NA
|
NA
|
|
Mental Health Impacts From COVID-19 and the Necessary Public Health Measures.
|
NA
|
NA
|
|
Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community.
|
NA
|
NA
|
|
Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study.
|
NA
|
NA
|
|
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
|
NA
|
NA
|
|
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.
|
NA
|
NA
|
|
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair Response.
|
NA
|
NA
|
|
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
|
NA
|
NA
|
|
A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin.
|
NA
|
NA
|
|
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
|
NA
|
NA
|
|
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.
|
NA
|
NA
|
|
Role of interventional radiology in the treatment of COVID-19 patients: Early experience from an epicenter.
|
NA
|
NA
|
|
COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.
|
NA
|
NA
|
|
Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
|
NA
|
NA
|
|
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial.
|
NA
|
NA
|
|
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
|
NA
|
NA
|
|
Deep brain stimulation telemedicine programming during the COVID-19 pandemic: treatment of patients with psychiatric disorders.
|
NA
|
NA
|
|
Reconversion of neurosurgical practice in times of the SARS-CoV-2 pandemic: a narrative review of the literature and guideline implementation in a Mexican neurosurgical referral center.
|
NA
|
NA
|
|
Neurosurgery at the epicenter of the COVID-19 pandemic in Indonesia: experience from a Surabaya academic tertiary hospital.
|
NA
|
NA
|
|
Neurosurgery in times of a pandemic: a survey of neurosurgical services during the COVID-19 outbreak in the Veneto region in Italy.
|
NA
|
NA
|
|
Treatment of patients with glioma during the COVID-19 pandemic: what we learned and what we take home for the future.
|
NA
|
NA
|
|
Spontaneous Pneumothorax: A Complication of Coronavirus Disease 2019 (COVID-19) Patients.
|
NA
|
NA
|
|
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study.
|
NA
|
NA
|
|
Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics.
|
NA
|
NA
|
|
ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.
|
NA
|
NA
|
|
Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia.
|
NA
|
NA
|
|
Modeling and control of COVID-19: A short-term forecasting in the context of India.
|
NA
|
NA
|
|
The impact of SARS-CoV-2 infection on the surgical management of colorectal cancer: lessons learned from a multicenter study in Spain.
|
NA
|
NA
|
|
Chronic Diseases and COVID-19: A Review.
|
NA
|
NA
|
|
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.
|
NA
|
NA
|
|
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
|
NA
|
NA
|
|
Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations.
|
NA
|
NA
|
|
Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.
|
NA
|
NA
|
|
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder.
|
NA
|
NA
|
|
Understanding COVID - 19 pandemic - A comprehensive Ayurvedic perspective.
|
NA
|
NA
|
|
Vascular Surgery During COVID-19 Emergency in Hub Hospitals of Lombardy: Experience on 305 Patients.
|
NA
|
NA
|
|
Orodispersible and transmucosal alternative medications for symptom control in adults.
|
NA
|
NA
|
|
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.
|
NA
|
NA
|
|
Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus.
|
NA
|
NA
|
|
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19.
|
NA
|
NA
|
|
High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment.
|
NA
|
NA
|
|
Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection.
|
NA
|
NA
|
|
A critical analysis of CTRI registered AYUSH studies for COVID- 19.
|
NA
|
NA
|
|
Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review.
|
NA
|
NA
|
|
Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients.
|
NA
|
NA
|
|
Immunological Evaluation on Potential Treatment Window for Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.
|
NA
|
NA
|
|
Understanding the Clinical Features of Coronavirus Disease 2019 From the Perspective of Aging: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Current and Future Direct-Acting Antivirals Against COVID-19.
|
NA
|
NA
|
|
Causal Inference for Genetic Obesity, Cardiometabolic Profile and COVID-19 Susceptibility: A Mendelian Randomization Study.
|
NA
|
NA
|
|
Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View.
|
NA
|
NA
|
|
Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review).
|
NA
|
NA
|
|
Biventricular Takotsubo Syndrome with COVID-19 in an Asian Male.
|
NA
|
NA
|
|
Probiotics in the prophylaxis of COVID-19: something is better than nothing.
|
NA
|
NA
|
|
Prediction on the number of confirmed Covid-19 with the FUDAN-CCDC mathematical model and its epidemiology, clinical manifestations, and prevention and treatment effects.
|
NA
|
NA
|
|
Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
|
NA
|
NA
|
|
COVID-19 Like Findings in a Fatal Case of Idiopathic Desquamative Interstitial Pneumonia Associated With IgA Glomerulonephritis in a 13-Month-Old Child.
|
NA
|
NA
|
|
Predicting Hospital Demand During the COVID-19 Outbreak in Bogotá, Colombia.
|
NA
|
NA
|
|
COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres.
|
NA
|
NA
|
|
Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums.
|
NA
|
NA
|
|
The Impact of COVID-19 on the Treatment of Craniomaxillofacial Trauma and Head and Neck Infections.
|
NA
|
NA
|
|
Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: Cohort study.
|
NA
|
NA
|
|
The role of orthopaedic trainees during the COVID-19 pandemic and impact on post-graduate orthopaedic education: a four-nation survey of over 100 orthopaedic trainees.
|
NA
|
NA
|
|
Supervised Machine Learning Models for Prediction of COVID-19 Infection using Epidemiology Dataset.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on women’s mental health.
|
NA
|
NA
|
|
Do Face Masks become Worthless after Only One Use in the COVID-19 Pandemic?
|
NA
|
NA
|
|
Decision on Chemotherapy Amidst COVID-19 Pandemic: a Review and a Practical Approach from Iran.
|
NA
|
NA
|
|
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
|
NA
|
NA
|
|
Nursing Home Residents Face Severe Functional Limitation or Death After Hospitalization for Pneumonia.
|
NA
|
NA
|
|
Post-traumatic stress disorder symptoms in healthcare workers: a ten-year systematic review.
|
NA
|
NA
|
|
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
|
NA
|
NA
|
|
Update on the diagnosis and management of COVID-19 in pediatric patients.
|
NA
|
NA
|
|
Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.
|
NA
|
NA
|
|
[Pandemic COVID-19: what about patients with mental health disorders?]
|
NA
|
NA
|
|
A Comprehensive Approach to Palliative Care during the Coronavirus Pandemic.
|
NA
|
NA
|
|
A Mindfulness-Based Intervention for Student Depression, Anxiety, and Stress: Randomized Controlled Trial.
|
NA
|
NA
|
|
COVID-19 Misinformation Spread in Eight Countries: Exponential Growth Modeling Study.
|
NA
|
NA
|
|
Field Notes From the Frontline of a COVID-19 Outbreak: Dyspnea Management for Hospitalized Patients at End-of-Life.
|
NA
|
NA
|
|
Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases.
|
NA
|
NA
|
|
A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
|
NA
|
NA
|
|
In silico immune infiltration profiling combined with functional enrichment analysis reveals a potential role for naïve B cells as a trigger for severe immune responses in the lungs of COVID-19 patients.
|
NA
|
NA
|
|
Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.
|
NA
|
NA
|
|
Continuous focus on COVID-19 epidemic: Changes in China’s clinical guidance.
|
NA
|
NA
|
|
COVID-19 and hematology findings based on the current evidences: A puzzle with many missing pieces.
|
NA
|
NA
|
|
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
|
NA
|
NA
|
|
Can we predict who will be more anxious and depressed in the COVID-19 ward?
|
NA
|
NA
|
|
Social Isolation and Loneliness of Older Adults in Times of the COVID-19 Pandemic: Can Use of Online Social Media Sites and Video Chats Assist in Mitigating Social Isolation and Loneliness?
|
NA
|
NA
|
|
A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.
|
NA
|
NA
|
|
SARS-CoV-2 Inhibition by Sulfonated Compounds.
|
NA
|
NA
|
|
The Management of Dental Practices in the Post-COVID 19 Era: An Economic and Operational Perspective.
|
NA
|
NA
|
|
Serpiginous choroiditis presenting after SARS-CoV-2 infection: A new immunological trigger?
|
NA
|
NA
|
|
Safety of bedside placement of tunneled dialysis catheter in COVID-19 patients.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Patients With Severe COVID-19 Induced Acute Kidney Injury.
|
NA
|
NA
|
|
Experiences and Beliefs of Low-Income Patients With Hypertension in Louisiana and Mississippi During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19?
|
NA
|
NA
|
|
Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
|
NA
|
NA
|
|
Covid-19: Urgent call to action.
|
NA
|
NA
|
|
Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait.
|
NA
|
NA
|
|
A Pan-Canadian narrative review on the protocols for reopening dental services during the COVID-19 pandemic.
|
NA
|
NA
|
|
A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.
|
NA
|
NA
|
|
Respiratory Particle Emission During Voice Assessment and Therapy Tasks in a Single Subject.
|
NA
|
NA
|
|
A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful.
|
NA
|
NA
|
|
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
|
NA
|
NA
|
|
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.
|
NA
|
NA
|
|
Design and rationale of the COVID-19 Critical Care Consortium international, multicentre, observational study.
|
NA
|
NA
|
|
Palliative care in critically ill COVID-19 patients: the early New York City experience.
|
NA
|
NA
|
|
Influential factor and trend of specific IgG antibody titer in coronavirus disease 2019 convalescents.
|
NA
|
NA
|
|
related renal injury.
|
NA
|
NA
|
|
COVID-19, host response treatment, and the need for political leadership.
|
NA
|
NA
|
|
A Review of Decontamination Methods for Filtering Facepiece Respirators.
|
NA
|
NA
|
|
New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease.
|
NA
|
NA
|
|
Data privacy considerations for telehealth consumers amid COVID-19.
|
NA
|
NA
|
|
COVID-19 and Acute Sarcopenia.
|
NA
|
NA
|
|
A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19.
|
NA
|
NA
|
|
Immune Thrombocytopenic Purpura - Different Presentations in Two COVID-19 Patients.
|
NA
|
NA
|
|
Does Nicotine Prevent Cytokine Storms in COVID-19?
|
NA
|
NA
|
|
Treatment strategies for gastric cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Emergency surgical workflow and experience of suspected cases of COVID-19: A case report.
|
NA
|
NA
|
|
Investigating the interaction between nifedipine- and ritonavir-containing antiviral regimens: A physiologically based pharmacokinetic/pharmacodynamic analysis.
|
NA
|
NA
|
|
COVID-19 and Tuberculosis-Related Catastrophic Costs.
|
NA
|
NA
|
|
Could Artesunate Have a Positive Effect on the Neurological Complications Related to Infection When It Is Used in the Treatment of COVID-19?
|
NA
|
NA
|
|
Therapeutic targeting of interleukin-6 for the treatment of COVID-19.
|
NA
|
NA
|
|
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer.
|
NA
|
NA
|
|
Radiology imaging management in an Italian cancer center (IRST IRCCS) during the COVID-19 pandemic.
|
NA
|
NA
|
|
Israeli underground hospital conversion for treating COVID-19 patients.
|
NA
|
NA
|
|
Follow-up after oral cancer treatment-Transition to a personalized approach.
|
NA
|
NA
|
|
Pathways to Severe COVID-19 for People with Obesity.
|
NA
|
NA
|
|
Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit.
|
NA
|
NA
|
|
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects.
|
NA
|
NA
|
|
THE MAIN CAUSES OF THE COMPLICATED COURSE OF COVID-19 IN PATIENTS WITH DIABETES MELLITUS AND TREATMENT (REVIEW).
|
NA
|
NA
|
|
BIOCHEMICAL ASPECTS OF SYMPTOMATIC TREATMENT IN PATIENTS WITH COVID-19 (REVIEW).
|
NA
|
NA
|
|
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
|
NA
|
NA
|
|
Retinal changes in COVID-19 hospitalized cases.
|
NA
|
NA
|
|
A snapshot of COVID-19 infection in patients with solid tumors.
|
NA
|
NA
|
|
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis.
|
NA
|
NA
|
|
Effects of nitrite and far-red light on coagulation.
|
NA
|
NA
|
|
Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
|
NA
|
NA
|
|
“Compassion Outside of the Box”: The Role of Allied Healthcare Professionals in Providing a Companion Service for Patients at the End of Life During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service.
|
NA
|
NA
|
|
Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Distance support and online intervention to blind and visually impaired children during the pandemic COVID-19.
|
NA
|
NA
|
|
Psychological Screening and Tracking of Athletes and Digital Mental Health Solutions in a Hybrid Model of Care: Mini Review.
|
NA
|
NA
|
|
Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Making mental health more accessible in light of COVID-19: Scalable digital health with digital navigators in low and middle-income countries.
|
NA
|
NA
|
|
Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.
|
NA
|
NA
|
|
Non-Coding RNAs and SARS-Related Coronaviruses.
|
NA
|
NA
|
|
Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin.
|
NA
|
NA
|
|
Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2.
|
NA
|
NA
|
|
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
|
NA
|
NA
|
|
Impact of SARS-CoV-2 pandemic on bariatric care in Poland: results of national survey.
|
NA
|
NA
|
|
The COVID-19 pandemic: impact on surgical departments of non-university hospitals.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on dental practice in Iran: a questionnaire-based report.
|
NA
|
NA
|
|
The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.
|
NA
|
NA
|
|
A double-edged sword of using opioids and COVID-19: a toxicological view.
|
NA
|
NA
|
|
Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET).
|
NA
|
NA
|
|
Dying alone and lonely dying: Media discourse and pandemic conditions.
|
NA
|
NA
|
|
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
|
NA
|
NA
|
|
Adolescent substance use: Challenges and opportunities related to COVID-19.
|
NA
|
NA
|
|
A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19.
|
NA
|
NA
|
|
Health-, medication- and dietary supplement-related behaviors and beliefs relatively unchanged during the COVID-19 pandemic lockdown.
|
NA
|
NA
|
|
Management of COVID-19 in special populations with kidney disease.
|
NA
|
NA
|
|
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations.
|
NA
|
NA
|
|
Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis.
|
NA
|
NA
|
|
Mask-induced Artifact Impacts Intraocular Pressure Measurement Using Goldmann Applanation Tonometry.
|
NA
|
NA
|
|
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension.
|
NA
|
NA
|
|
COVID-19 Pandemic and Thalassemia Major Patients: Transfusion Practice and Treatment Assessment.
|
NA
|
NA
|
|
Safety Considerations for In Situ Simulation in Closed SARS-CoV-2 Units.
|
NA
|
NA
|
|
Primidone blocks RIPK1-driven cell death and inflammation.
|
NA
|
NA
|
|
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets.
|
NA
|
NA
|
|
Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment.
|
NA
|
NA
|
|
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers.
|
NA
|
NA
|
|
Expectant Management of a Critically Ill Pregnant Patient with COVID-19 with Good Maternal and Neonatal Outcomes.
|
NA
|
NA
|
|
Effect of coronavirus disease 2019 pandemic on case volume, spectrum, and perioperative coronavirus disease 2019 incidence in neurosurgical patients: An experience at a tertiary care center in India.
|
NA
|
NA
|
|
Orbital-Conjunctival-Eyelid Hemorrhage-Hematoma due to Inappropriate use of FFP2/NK95 Facial Mask in COVID-19.
|
NA
|
NA
|
|
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
An Experimental Model for Peri-conceptual COVID-19 Pregnancy Loss and Proposed Interventions to Optimize Outcomes.
|
NA
|
NA
|
|
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020.
|
NA
|
NA
|
|
A Novel Approach to Hematology Testing at the Point of Care.
|
NA
|
NA
|
|
Decreased dengue transmission in migrant worker populations in Singapore attributable to SARS-CoV-2 quarantine measures.
|
NA
|
NA
|
|
[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany’s region with the highest infection rate].
|
NA
|
NA
|
|
[Nursing Experience Caring for a COVID-19 Patient With Hearing Loss].
|
NA
|
NA
|
|
[Experience Caring for a Severe COVID-19 Patient With ARDS in the Intensive Care Unit].
|
NA
|
NA
|
|
COVID-19 associated with severe autoimmune hemolytic anemia.
|
NA
|
NA
|
|
Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
|
NA
|
NA
|
|
Multimorbidity, Polyiatrogenesis, and COVID-19.
|
NA
|
NA
|
|
Management of gynecological cancers in the COVID-19 era: a survey from Turkey
|
NA
|
NA
|
|
Gynecological cancers and the global COVID-19 pandemic
|
NA
|
NA
|
|
USA stockpiling of remdesivir: How should the world respond?
|
NA
|
NA
|
|
Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?
|
NA
|
NA
|
|
The missing acute coronary syndromes in the COVID-19 era.
|
NA
|
NA
|
|
Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
|
NA
|
NA
|
|
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.
|
NA
|
NA
|
|
SARS-CoV-2 systemic infection in a kidney transplant recipient: sequence analysis in clinical specimens.
|
NA
|
NA
|
|
Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
|
NA
|
NA
|
|
The dual role of anti-viral therapy in the treatment of Coronavirus disease 2019.
|
NA
|
NA
|
|
Extracorporeal membrane oxygenation (ECMO) in patients with COVID-19: a rapid systematic review of case studies.
|
NA
|
NA
|
|
Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
|
NA
|
NA
|
|
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
|
NA
|
NA
|
|
Current status of COVID-19 among hemodialysis patients in the East Azerbaijan Province of Iran.
|
NA
|
NA
|
|
Factors associated with revisits by patients with SARS-CoV-2 infection discharged from a hospital emergency department.
|
NA
|
NA
|
|
Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions?
|
NA
|
NA
|
|
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome.
|
NA
|
NA
|
|
Comparison of the clinical manifestations between different age groups of patients with overseas imported COVID-19.
|
NA
|
NA
|
|
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
|
NA
|
NA
|
|
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
|
NA
|
NA
|
|
Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
|
NA
|
NA
|
|
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
|
NA
|
NA
|
|
Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.
|
NA
|
NA
|
|
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
|
NA
|
NA
|
|
Use of WhatsApp for Polyclinic Consultation of Suspected Patients With COVID-19: Retrospective Case Control Study.
|
NA
|
NA
|
|
Correlates of protection against SARS-CoV-2 in rhesus macaques.
|
NA
|
NA
|
|
Bio-Inspired Systems in Nonsurgical Periodontal Therapy to Reduce Contaminated Aerosol during COVID-19: A Comprehensive and Bibliometric Review.
|
NA
|
NA
|
|
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.
|
NA
|
NA
|
|
Emergency and urgent dental visits among Medicaid enrollees from 2013 to 2017.
|
NA
|
NA
|
|
The effect of national lockdown due to COVID-19 on emergency department visits.
|
NA
|
NA
|
|
Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial.
|
NA
|
NA
|
|
Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook.
|
NA
|
NA
|
|
[COVID-19, state of medical knowledge].
|
NA
|
NA
|
|
Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19.
|
NA
|
NA
|
|
Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
|
NA
|
NA
|
|
Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic.
|
NA
|
NA
|
|
Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era.
|
NA
|
NA
|
|
High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome.
|
NA
|
NA
|
|
Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports.
|
NA
|
NA
|
|
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.
|
NA
|
NA
|
|
Assembly Line ICU: what the Long Shops taught us about managing surge capacity for COVID-19.
|
NA
|
NA
|
|
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.
|
NA
|
NA
|
|
Stroke care during the COVID-19 outbreak in Spain: the experience of Spanish stroke units.
|
NA
|
NA
|
|
Host genetics and infectious disease: new tools, insights and translational opportunities.
|
NA
|
NA
|
|
The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons.
|
NA
|
NA
|
|
Transition to telephone genetic counseling services during the COVID-19 pandemic.
|
NA
|
NA
|
|
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
|
NA
|
NA
|
|
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
|
NA
|
NA
|
|
Inpatient Hyperglycemia Management and COVID-19.
|
NA
|
NA
|
|
Medication access difficulty and COVID-related distress are associated with disease flares in rheumatology patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Emerging cellular and pharmacologic therapies for acute respiratory distress syndrome.
|
NA
|
NA
|
|
Implementation of the Stroke Action Plan for Europe 2018–2030 during coronavirus disease-2019.
|
NA
|
NA
|
|
Hidden in plain sight: sex and gender in global pandemics.
|
NA
|
NA
|
|
Coronavirus Disease 2019 (COVID-19)-Related Multisystem Inflammatory Syndrome in a Pregnant Woman.
|
NA
|
NA
|
|
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
|
NA
|
NA
|
|
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
|
NA
|
NA
|
|
Challenges in activation of remote monitoring in patients with cardiac rhythm devices during the coronavirus (COVID-19) pandemic.
|
NA
|
NA
|
|
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
|
NA
|
NA
|
|
Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19.
|
NA
|
NA
|
|
Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study.
|
NA
|
NA
|
|
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options.
|
NA
|
NA
|
|
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
|
NA
|
NA
|
|
Systematic Duplex Ultrasound Screening in Conventional Units for COVID-19 Patients with Follow-up of 5 Days.
|
NA
|
NA
|
|
Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
|
NA
|
NA
|
|
COVID-19; current situation and recommended interventions.
|
NA
|
NA
|
|
The role of mesenchymal stem/stromal cells in the acute clinical setting.
|
NA
|
NA
|
|
Socially distant and out of reach: Unintended consequences of COVID-19 prevention efforts on transgender and gender non-binary populations in Puerto Rico.
|
NA
|
NA
|
|
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
|
NA
|
NA
|
|
SALVAGE LOBECTOMY TO TREAT NECROTIZING SARS-CoV-2 PNEUMONIA COMPLICATED BY A BRONCHOPLEURAL FISTULA.
|
NA
|
NA
|
|
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.
|
NA
|
NA
|
|
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
|
NA
|
NA
|
|
“Door to Treatment” Outcomes of Cancer Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
A review of COVID-19 biomarkers and drug targets: resources and tools.
|
NA
|
NA
|
|
Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities.
|
NA
|
NA
|
|
Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients.
|
NA
|
NA
|
|
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.
|
NA
|
NA
|
|
Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia.
|
NA
|
NA
|
|
Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravis.
|
NA
|
NA
|
|
Retrospective analysis of asymptomatic COVID-19 patients presenting to emergency department.
|
NA
|
NA
|
|
Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
|
NA
|
NA
|
|
Public perceptions about pharmacists’ role in prescribing, providing education and delivering medications during COVID-19 pandemic era.
|
NA
|
NA
|
|
COVID-19: How do emergency departments fare after normalisation steps?
|
NA
|
NA
|
|
Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages.
|
NA
|
NA
|
|
An Unusual Case of COVID-19 Presenting as Acute Psychosis.
|
NA
|
NA
|
|
COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review.
|
NA
|
NA
|
|
Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19.
|
NA
|
NA
|
|
Infection control challenges in setting up community isolation and treatment facilities for patients with coronavirus disease 2019 (COVID-19): Implementation of directly observed environmental disinfection.
|
NA
|
NA
|
|
[Functional disorders in previously healthy children during the COVID-19 pandemic].
|
NA
|
NA
|
|
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020].
|
NA
|
NA
|
|
Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS.
|
NA
|
NA
|
|
Combining Antivirals and Immunomodulators to Fight COVID-19.
|
NA
|
NA
|
|
approach.
|
NA
|
NA
|
|
Cardiovascular manifestations of COVID-19: An evidence-based narrative review.
|
NA
|
NA
|
|
in a small child, a (clinical or laboratory chemical) visual diagnosis?]
|
NA
|
NA
|
|
[On the way to telemedicine].
|
NA
|
NA
|
|
Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Treatment: It is Time for Stewardship!
|
NA
|
NA
|
|
Role of Noninvasive Oxygen Therapy Strategies in COVID-19 Patients: Where are We Going?
|
NA
|
NA
|
|
Evidence-based National Consensus: Recommendations for Physiotherapy Management in COVID-19 in Acute Care Indian Setup.
|
NA
|
NA
|
|
Awake Prone Positioning in COVID-19 Patients.
|
NA
|
NA
|
|
A Multicenter Questionnaire-based Study to Know the Awareness and Medical Treatment Plan of Physicians Involved in the Management of COVID-19 Patients.
|
NA
|
NA
|
|
Noninvasive Oxygen Strategies to Manage Confirmed COVID-19 Patients in Indian Intensive Care Units: A Survey.
|
NA
|
NA
|
|
Acute Necrotizing Encephalitis as a Probable Association of COVID-19.
|
NA
|
NA
|
|
Comparative study of orthopaedic trauma pattern in covid lockdown versus non-covid period in a tertiary care centre.
|
NA
|
NA
|
|
SARS-CoV-2 and limb ischemia: A systematic review.
|
NA
|
NA
|
|
The Need for Recovering the Subjugated Knowledge of Traditional Chinese Medicine.
|
NA
|
NA
|
|
The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp.
|
NA
|
NA
|
|
Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19 Symptoms.
|
NA
|
NA
|
|
Biopsychosocial and Spiritual Implications of Patients With COVID-19 Dying in Isolation.
|
NA
|
NA
|
|
Identification of Potential Key Agents for Targeting RNA-Dependent RNA Polymerase of SARS-CoV-2 by Integrated Analysis and Virtual Drug Screening.
|
NA
|
NA
|
|
Cancer and COVID-19: economic impact on households in Southeast Asia.
|
NA
|
NA
|
|
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
|
NA
|
NA
|
|
How chemical engineers can contribute to fight the COVID-19.
|
NA
|
NA
|
|
Overcoming COVID-19 in West African countries: is herd immunity an option?
|
NA
|
NA
|
|
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin.
|
NA
|
NA
|
|
Treatment of COVID-19: implications for antimicrobial resistance in Africa.
|
NA
|
NA
|
|
Managing cancer care during the COVID-19 pandemic: brief report from a North African single center.
|
NA
|
NA
|
|
Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19.
|
NA
|
NA
|
|
The number of obstructive colorectal cancers in Japan has increased during the COVID-19 pandemic: A retrospective single-center cohort study.
|
NA
|
NA
|
|
Baseline characteristics and outcomes of COVID-19 patients admitted to a Respiratory Intensive Care Unit (RICU) in Southern Italy.
|
NA
|
NA
|
|
COVID-19: general overview, pharmacological options and ventilatory support strategies.
|
NA
|
NA
|
|
Improvement of COVID-19 with renal failure and paralytic ileus by using steroids.
|
NA
|
NA
|
|
Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing.
|
NA
|
NA
|
|
Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic review.
|
NA
|
NA
|
|
Managements of 13 emergency cardiac surgeries under COVID-19 pandemic in a Sentinel Hospital.
|
NA
|
NA
|
|
Micro-RNAs in the regulation of immune response against SARS COV-2 and other viral infections.
|
NA
|
NA
|
|
An Interesting Case of COVID-19 Induced Reversed Takotsubo Cardiomyopathy and Insight on Cardiac Biomarkers.
|
NA
|
NA
|
|
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
|
NA
|
NA
|
|
Occurrence, fate and removal of SARS-CoV-2 in wastewater: Current knowledge and future perspectives.
|
NA
|
NA
|
|
Dental Risks and Precautions during COVID-19 Pandemic: A Systematic Review.
|
NA
|
NA
|
|
Increasing Age, the Existence of Comorbidities, and Corticosteroid Treatment in Combination With Antiviral Therapy Prolongs the Recovery of SARS-COV-2-Infected Patients, Measured as the Conversion From Positive to Negative rtPCR: A 239 Patients’ Retrospective Study.
|
NA
|
NA
|
|
Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.
|
NA
|
NA
|
|
The cardiac complications of COVID-19: many publications, multiple uncertainties.
|
NA
|
NA
|
|
The “sex gap” in COVID-19 trials: a scoping review.
|
NA
|
NA
|
|
COVID-19 in New Orleans: A Nephrology Clinical and Education Perspective and Lessons Learned.
|
NA
|
NA
|
|
Awake proning of a 2-year-old extubated child with severe COVID-19 pneumonitis.
|
NA
|
NA
|
|
Spectrum of cardiovascular diseases in children during high peak COVID-19 period infection in Northern Italy: is there a link?
|
NA
|
NA
|
|
An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.
|
NA
|
NA
|
|
SARS-CoV-2 RNA in Wastewater Settled Solids Is Associated with COVID-19 Cases in a Large Urban Sewershed.
|
NA
|
NA
|
|
Repurposing drugs for the management of COVID-19.
|
NA
|
NA
|
|
virus and its clinical features’ similarity with COVID-19.
|
NA
|
NA
|
|
The Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.
|
NA
|
NA
|
|
Mental health and psychological responses during the coronavirus disease 2019 (COVID-19) epidemic: A comparison between Wuhan and other areas in China.
|
NA
|
NA
|
|
Evaluation of Pragmatic Telehealth Physical Therapy Implementation During the COVID-19 Pandemic.
|
NA
|
NA
|
|
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
|
NA
|
NA
|
|
Home-based exercise is associated with improved cardiac functional performance in patients after acute myocardial infarction.
|
NA
|
NA
|
|
Psychological Impacts of COVID-19 During the First Nationwide Lockdown in Vietnam: Web-Based, Cross-Sectional Survey Study.
|
NA
|
NA
|
|
Molecular detection of SARS-CoV-2 using a reagent-free approach.
|
NA
|
NA
|
|
ACE2: from protection of liver disease to propagation of COVID-19.
|
NA
|
NA
|
|
Public health emergencies of international concern: a historic overview.
|
NA
|
NA
|
|
Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.
|
NA
|
NA
|
|
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
|
NA
|
NA
|
|
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic.
|
NA
|
NA
|
|
High Prevalence of Deep Venous Thrombosis in Non-Severe COVID-19 Patients Hospitalized for a Neurovascular Disease.
|
NA
|
NA
|
|
Lung Ultrasound in the Emergency Department for Early Identification of COVID-19 Pneumonia.
|
NA
|
NA
|
|
Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
|
NA
|
NA
|
|
Corona Virus Disease 2019 patients with different disease severity or age range: A single-center study of clinical features and prognosis.
|
NA
|
NA
|
|
The efficacy and safety of Yuxingcao eye drops in the treatment of COVID-19 conjunctivitis: A protocol for a systematic review.
|
NA
|
NA
|
|
Successful treatment of a critically ill patient with acute respiratory distress syndrome from COVID-19 using mechanical ventilation strategy with low levels of positive end-expiratory pressure: A CARE-compliant case report.
|
NA
|
NA
|
|
The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis.
|
NA
|
NA
|
|
Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia: A case report.
|
NA
|
NA
|
|
Modelling Excess Mortality in Covid-19-Like Epidemics.
|
NA
|
NA
|
|
Effects of Ozone Treatment on Personal Protective Equipment Contaminated with SARS-CoV-2.
|
NA
|
NA
|
|
, Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach.
|
NA
|
NA
|
|
Psychosocial challenges and concerns of COVID-19: A qualitative study in Iran.
|
NA
|
NA
|
|
The association between COVID-19 cases and deaths and web-based public inquiries.
|
NA
|
NA
|
|
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic.
|
NA
|
NA
|
|
A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol.
|
NA
|
NA
|
|
Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study.
|
NA
|
NA
|
|
COVID-19 and treating incarcerated populations for opioid use disorder.
|
NA
|
NA
|
|
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.
|
NA
|
NA
|
|
Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients.
|
NA
|
NA
|
|
Baculovirus-free insect cell expression system for high yield antibody and antigen production.
|
NA
|
NA
|
|
Evaluating antibody response pattern in asymptomatic virus infected pregnant females: Human well-being study.
|
NA
|
NA
|
|
A fractional order approach to modeling and simulations of the novel COVID-19.
|
NA
|
NA
|
|
Ethical Advice for an Intensive Care Triage Protocol in the COVID-19 Pandemic: Lessons Learned from The Netherlands.
|
NA
|
NA
|
|
Tension pneumothorax in patient with COVID-19 infection.
|
NA
|
NA
|
|
Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema.
|
NA
|
NA
|
|
Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19.
|
NA
|
NA
|
|
A survey of US hospitals’ criteria for the allocation of remdesivir to treat COVID-19.
|
NA
|
NA
|
|
Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
|
NA
|
NA
|
|
Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future.
|
NA
|
NA
|
|
Now more than ever, nurses need to be involved in technology design: lessons from the COVID-19 pandemic.
|
NA
|
NA
|
|
Tracing the path of inhaled nitric oxide: Biological consequences of protein nitrosylation.
|
NA
|
NA
|
|
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
|
NA
|
NA
|
|
Psychological Consequences of Survivors of COVID-19 Pneumonia 1 Month after Discharge.
|
NA
|
NA
|
|
Utility of Screening Chest Radiographs in Patients with Asymptomatic or Minimally Symptomatic COVID-19 in Singapore.
|
NA
|
NA
|
|
Social Media Use and Monitoring for Adolescents With Depression and Implications for the COVID-19 Pandemic: Qualitative Study of Parent and Child Perspectives.
|
NA
|
NA
|
|
Waitlisted Transplant Candidates’ Attitudes and Concerns Toward Transplantation During COVID-19.
|
NA
|
NA
|
|
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease.
|
NA
|
NA
|
|
Care of patients with mental illness and SARS-CoV-2 infection at the Department of Psychiatry and Psychotherapy LMU Munich, Germany
|
NA
|
NA
|
|
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
|
NA
|
NA
|
|
A Study of Policies and Guidelines for Collecting, Processing, and Storing Coronavirus Disease 2019 Patient Biospecimens for Biobanking and Research.
|
NA
|
NA
|
|
Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
|
NA
|
NA
|
|
Predictive value of CT imaging findings in COVID-19 pneumonia at the time of first-screen regarding the need for hospitalization or intensive care unit.
|
NA
|
NA
|
|
Using the Online Psychotherapy Tool to Address Mental Health Problems in the Context of the COVID-19 Pandemic: Protocol for an Electronically Delivered Cognitive Behavioral Therapy Program.
|
NA
|
NA
|
|
Battle for supremacy: nucleic acid interactions between viruses and cells.
|
NA
|
NA
|
|
Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19.
|
NA
|
NA
|
|
COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience.
|
NA
|
NA
|
|
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.
|
NA
|
NA
|
|
Prevalence of anxiety towards COVID-19 and its associated factors among healthcare workers in a Hospital of Ethiopia.
|
NA
|
NA
|
|
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients.
|
NA
|
NA
|
|
Role of different tautomers in the base-pairing abilities of some of the vital antiviral drugs used against COVID-19.
|
NA
|
NA
|
|
Trends in suicide in Japan by gender during the COVID-19 pandemic, up to September 2020.
|
NA
|
NA
|
|
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2.
|
NA
|
NA
|
|
Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
|
NA
|
NA
|
|
COVID-19 in Renal Transplant Recipients: Case Series and a Brief Review of Current Evidence.
|
NA
|
NA
|
|
Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis.
|
NA
|
NA
|
|
A Patient with COVID-19 Treated with ECMO for 26 Days.
|
NA
|
NA
|
|
Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic on Mental Health and Psychological Well-Being of Young People Living in Austria and Turkey: A Multicenter Study.
|
NA
|
NA
|
|
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
|
NA
|
NA
|
|
Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications.
|
NA
|
NA
|
|
Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab.
|
NA
|
NA
|
|
On Cancer, COVID-19, and CT Scans: A Monocentric Retrospective Study.
|
NA
|
NA
|
|
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
|
NA
|
NA
|
|
Biosensors for the Detection of Bacterial and Viral Clinical Pathogens.
|
NA
|
NA
|
|
of COVID-19 and Acts as Superoxide Radical Scavenger.
|
NA
|
NA
|
|
Challenging behavior of nursing home residents during COVID-19 measures in the Netherlands.
|
NA
|
NA
|
|
root against the main protease of SARS CoV-2 using computational approaches.
|
NA
|
NA
|
|
Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.
|
NA
|
NA
|
|
Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study.
|
NA
|
NA
|
|
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing.
|
NA
|
NA
|
|
Anti-COVID-19 drug screening: Frontier concepts and core technologies.
|
NA
|
NA
|
|
COVID-19 testing acceptability and uptake amongst the Rohingya and host community in Camp 21, Teknaf, Bangladesh.
|
NA
|
NA
|
|
The clinical and translational research activities at the INT - IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic.
|
NA
|
NA
|
|
Considerations for planning COVID-19 treatment services in humanitarian responses.
|
NA
|
NA
|
|
FDA efficiency for approval process of COVID-19 therapeutics.
|
NA
|
NA
|
|
Impact of COVID-19 lockdown measures on a cohort of eating disorders patients.
|
NA
|
NA
|
|
Transitioning to digital first line intervention - validation of a brief online screener for early identification of a suspected eating disorder: study protocol.
|
NA
|
NA
|
|
Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review.
|
NA
|
NA
|
|
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey.
|
NA
|
NA
|
|
High serum nitrates levels in non-survivor COVID-19 patients.
|
NA
|
NA
|
|
The use of mindfulness dialogue for life in substance use disorder treatment in the time of COVID-19.
|
NA
|
NA
|
|
The effect of Emotional Freedom Techniques on nurses’ stress, anxiety, and burnout levels during the COVID-19 pandemic: A randomized controlled trial.
|
NA
|
NA
|
|
Knowledge, Perceived Beliefs, and Preventive Behaviors Related to COVID-19 Among Chinese Older Adults: Cross-Sectional Web-Based Survey.
|
NA
|
NA
|
|
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
|
NA
|
NA
|
|
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis.
|
NA
|
NA
|
|
Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.
|
NA
|
NA
|
|
Which factors should be included in triage? An online survey of the attitudes of the UK general public to pandemic triage dilemmas.
|
NA
|
NA
|
|
Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study.
|
NA
|
NA
|
|
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.
|
NA
|
NA
|
|
Lessons from a COVID-19 hospital, Republic of Korea.
|
NA
|
NA
|
|
Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of COVID-19.
|
NA
|
NA
|
|
Brachytherapy practice during the COVID-19 pandemic: a review on the practice changes.
|
NA
|
NA
|
|
Coronavirus Disease 2019 and Cardiac Arrhythmias.
|
NA
|
NA
|
|
Epidemiological characteristics and treatment outcomes of hospitalized patients with COVID-19 in Ethiopia.
|
NA
|
NA
|
|
Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study.
|
NA
|
NA
|
|
Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah.
|
NA
|
NA
|
|
Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team.
|
NA
|
NA
|
|
Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare.
|
NA
|
NA
|
|
Living With a Trifecta of Pain and Cancer With Personal Reflections of COVID-19.
|
NA
|
NA
|
|
Evaluating the Telehealth Experience of Patients With COVID-19 Symptoms: Recommendations on Best Practices.
|
NA
|
NA
|
|
Patient Perspectives on Telepsychiatry on the Inpatient Psychiatric Unit During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Pandemics Past and Present: A Guided Inquiry Approach.
|
NA
|
NA
|
|
A Randomized, Crossover Pilot Study of a Novel Web-Based/Mobile Platform for Collaborative Small Group Practice in Therapeutic Reasoning.
|
NA
|
NA
|
|
studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease.
|
NA
|
NA
|
|
Widespread testing, case isolation and contact tracing may allow safe school reopening with continued moderate physical distancing: A modeling analysis of King County, WA data.
|
NA
|
NA
|
|
Protocol for a Systematic Review Assessing Surgery versus Primary Endocrine Therapy in Operable Breast Cancer. Prep for Pandemic.
|
NA
|
NA
|
|
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19.
|
NA
|
NA
|
|
Stress and psychological resilience among general surgery residents during COVID-19 pandemic.
|
NA
|
NA
|
|
Evaluation of the chronic disease management and depression levels of people over 65 years of age during the COVID-19 pandemic period.
|
NA
|
NA
|
|
Pain During COVID-19: A Comprehensive Review and Guide for the Interventionalist.
|
NA
|
NA
|
|
An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission.
|
NA
|
NA
|
|
Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic.
|
NA
|
NA
|
|
Factors associated with mental health outcomes among health care workers in the Fangcang shelter hospital in China.
|
NA
|
NA
|
|
Two sides of a coin: differential response to COVID-19 distancing measures in children with narcolepsy.
|
NA
|
NA
|
|
To comfort always: Are we ignoring this duty in Covid protocols?
|
NA
|
NA
|
|
Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
|
NA
|
NA
|
|
Early Action, Applied Research & Collaboration to Combat COVID-19: María Guadalupe Guzmán MD PhD DSc.
|
NA
|
NA
|
|
[Impact of COVID-19 pandemic on structural heart interventions in Italy].
|
NA
|
NA
|
|
COVID-19 pandemic: report on the use of auriculotherapy to optimize emergency workers’ health.
|
NA
|
NA
|
|
Telemedicine in neurology: current evidence.
|
NA
|
NA
|
|
Social distancing measures and demands for the reorganization of hemotherapy services in the context of Covid-19.
|
NA
|
NA
|
|
[Healthcare challenges for people with diabetes during the national state of emergency due to COVID-19 in Lima, Peru: primary healthcare recommendations].
|
NA
|
NA
|
|
A glance upon Epigenetic and COVID-19.
|
NA
|
NA
|
|
Biotechnology, nanotechnology and medicine.
|
NA
|
NA
|
|
[SARS CoV-2 related disease features in a population of chronic hemodialysis patients].
|
NA
|
NA
|
|
Cutaneous manifestations in an Italian military COVID hub.
|
NA
|
NA
|
|
Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.
|
NA
|
NA
|
|
Phytotherapics in COVID19: Why palmitoylethanolamide?
|
NA
|
NA
|
|
Recent Insights into Emerging Coronavirus: SARS-CoV-2.
|
NA
|
NA
|
|
Empirical model for short-time prediction of COVID-19 spreading.
|
NA
|
NA
|
|
Knowledge of prevention of COVID-19 among the general people in Bangladesh: A cross-sectional study in Rajshahi district.
|
NA
|
NA
|
|
Withdrawal of intensive care during times of severe scarcity: Triage during a pandemic only upon arrival or with the inclusion of patients who are already under treatment?
|
NA
|
NA
|
|
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?
|
NA
|
NA
|
|
Anticipating the Need for Healthcare Resources Following the Escalation of the COVID-19 Outbreak in the Republic of Kazakhstan.
|
NA
|
NA
|
|
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges.
|
NA
|
NA
|
|
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
|
NA
|
NA
|
|
Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study.
|
NA
|
NA
|
|
Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature.
|
NA
|
NA
|
|
Technology Enabled Clinical Care (TECC): Protocol for a Prospective Longitudinal Cohort Study of Smartphone-Augmented Mental Health Treatment.
|
NA
|
NA
|
|
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.
|
NA
|
NA
|
|
Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.
|
NA
|
NA
|
|
Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19.
|
NA
|
NA
|
|
Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.
|
NA
|
NA
|
|
Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.
|
NA
|
NA
|
|
[Preliminary analysis on COVID-19 case spectrum and spread intensity in different provinces in China except Hubei province].
|
NA
|
NA
|
|
Production and use of convalescent plasma in COVID-19 treatment, taking into account the experience in the Central Millitary Hospital Prague.
|
NA
|
NA
|
|
A case of severe course of COVID-19 treated with experimental therapy.
|
NA
|
NA
|
|
Severe asthma and COVID-19: lessons from the first wave.
|
NA
|
NA
|
|
The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19.
|
NA
|
NA
|
|
Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study.
|
NA
|
NA
|
|
Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
|
NA
|
NA
|
|
Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Impact of the SARS-CoV-2 pandemic on emergency surgery services-a multi-national survey among WSES members.
|
NA
|
NA
|
|
Considerations for remote delivery of behavioral economic interventions for substance use disorder during COVID-19 and beyond.
|
NA
|
NA
|
|
Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic.
|
NA
|
NA
|
|
A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose.
|
NA
|
NA
|
|
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum.
|
NA
|
NA
|
|
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
|
NA
|
NA
|
|
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials.
|
NA
|
NA
|
|
Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.
|
NA
|
NA
|
|
Roles of genetics and blood type in clinical responses to COVID-19: ethical and policy concerns.
|
NA
|
NA
|
|
Repurposed Tocilizumab in Patients with Severe COVID-19.
|
NA
|
NA
|
|
Levamisole - A Toxic Adulterant in Illicit Drug Preparations: A Review.
|
NA
|
NA
|
|
Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Pediatric COVID-19 and Appendicitis: A Gut Reaction to SARS-CoV-2?
|
NA
|
NA
|
|
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
|
NA
|
NA
|
|
Identifying side effects of commonly used drugs in the treatment of Covid 19.
|
NA
|
NA
|
|
Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project.
|
NA
|
NA
|
|
Knowledge, Attitude, and Precautionary Measures Towards COVID-19 Among Medical Visitors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia.
|
NA
|
NA
|
|
Pediatric Intensive Care Unit Admissions for COVID-19: Insights Using State-Level Data.
|
NA
|
NA
|
|
Insights from the Perspective of Traditional Chinese Medicine to Elucidate Association of Lily Disease and Yin Deficiency and Internal Heat of Depression.
|
NA
|
NA
|
|
COVID-19: A Therapeutic Approach Based on Pathophysiological Staging.
|
NA
|
NA
|
|
Case Report: Renal potassium wasting in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability.
|
NA
|
NA
|
|
Effect of COVID-19 Pandemic on the Cardiac Outpatients’ Perception of Seeking Medical Advice.
|
NA
|
NA
|
|
Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.
|
NA
|
NA
|
|
Repurposing of some anti-infective drugs for COVID-19 treatment: A surveillance study supported by an in silico investigation.
|
NA
|
NA
|
|
Examination of the effect of COVID-19 on sexual dysfunction in women.
|
NA
|
NA
|
|
Innovating and adapting in pediatric pulmonology and sleep medicine during the COVID-19 pandemic: ATS pediatric assembly web committee consensus statement for initial COVID-19 virtual response.
|
NA
|
NA
|
|
Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement.
|
NA
|
NA
|
|
Current status and associated factors of psychological resilience among the Chinese residents during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
|
NA
|
NA
|
|
Predictors of stress among emergency medical personnel during the COVID-19 pandemic.
|
NA
|
NA
|
|
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
|
NA
|
NA
|
|
Protracted viral shedding and viral load are associated with ICU mortality in Covid-19 patients with acute respiratory failure.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey.
|
NA
|
NA
|
|
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
|
NA
|
NA
|
|
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
|
NA
|
NA
|
|
[Surgical management of cancer patients within the COVID-19 pandemic].
|
NA
|
NA
|
|
An Artificial Intelligence Model to Predict the Mortality of COVID-19 Patients at Hospital Admission Time Using Routine Blood Samples: Development and Validation of an Ensemble Model.
|
NA
|
NA
|
|
A Mobile Serious Game About the Pandemic (COVID-19 - Did You Know?): Design and Evaluation Study.
|
NA
|
NA
|
|
Retinoic acid improves baseline barrier function and attenuates TNF-α-induced barrier leak in human bronchial epithelial cell culture model, 16HBE 14o.
|
NA
|
NA
|
|
The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
|
NA
|
NA
|
|
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
A Surge in Pediatric Coronavirus Disease 2019 Cases: The Experience of Texas Children’s Hospital from March to June 2020.
|
NA
|
NA
|
|
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York.
|
NA
|
NA
|
|
COVID-19-related myocarditis and cholinergic anti-inflammatory pathways.
|
NA
|
NA
|
|
Corticosteroids in patients hospitalised for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
|
NA
|
NA
|
|
Next-generation computational tools and resources for coronavirus research: From detection to vaccine discovery.
|
NA
|
NA
|
|
Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome - A multicenter feasibility study.
|
NA
|
NA
|
|
COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus.
|
NA
|
NA
|
|
Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective.
|
NA
|
NA
|
|
A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2.
|
NA
|
NA
|
|
Patient Attitudes Toward Telepsychiatry During the COVID-19 Pandemic: A Nationwide, Multisite Survey.
|
NA
|
NA
|
|
iDMer: an integrative and mechanism-driven response system for identifying compound interventions for sudden virus outbreak.
|
NA
|
NA
|
|
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules.
|
NA
|
NA
|
|
Exploration of CT manifestations of different clinical types of novel coronavirus pneumonia.
|
NA
|
NA
|
|
Infection-prevention measures against COVID-19 during anesthesia: a narrative review of current clinical literature.
|
NA
|
NA
|
|
Protease-activated receptor 1 as a potential therapeutic target for COVID-19.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Patients With Idiopathic Subglottic Stenosis.
|
NA
|
NA
|
|
Natural Products Homoharringtonine and Emetine Alkaloids for SARSCoV-2 Treatment Options.
|
NA
|
NA
|
|
Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence.
|
NA
|
NA
|
|
Risk factors and clinical features of deterioration in COVID-19 patients in Zhejiang, China: a single-centre, retrospective study.
|
NA
|
NA
|
|
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study.
|
NA
|
NA
|
|
Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency.
|
NA
|
NA
|
|
Rapid diagnostics of coronavirus disease 2019 in early stages using nanobiosensors: Challenges and opportunities.
|
NA
|
NA
|
|
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
|
NA
|
NA
|
|
The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
|
NA
|
NA
|
|
Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response.
|
NA
|
NA
|
|
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges.
|
NA
|
NA
|
|
Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19.
|
NA
|
NA
|
|
Rethinking the nature of the person at the heart of the biopsychosocial model: Exploring social changeways not just personal pathways.
|
NA
|
NA
|
|
Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19.
|
NA
|
NA
|
|
Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care.
|
NA
|
NA
|
|
Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain.
|
NA
|
NA
|
|
Transoesophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA) for poorly accessible thoracic lesions: a case series.
|
NA
|
NA
|
|
Modelling interventions to control COVID-19 outbreaks in a refugee camp.
|
NA
|
NA
|
|
Viable virus aerosol propagation by positive airway pressure (PAP) circuit leak and mitigation with a ventilated patient hood.
|
NA
|
NA
|
|
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
|
NA
|
NA
|
|
A data-driven approach to identify risk profiles and protective drugs in COVID-19.
|
NA
|
NA
|
|
Remote monitoring using donor-derived, cell-free DNA after kidney transplantation during the coronavirus disease 2019 pandemic.
|
NA
|
NA
|
|
Design and evaluation of a data anonymization pipeline to promote Open Science on COVID-19.
|
NA
|
NA
|
|
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.
|
NA
|
NA
|
|
In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice.
|
NA
|
NA
|
|
Lockdown During COVID-19 and the Increase of Frailty in People With Neurological Conditions.
|
NA
|
NA
|
|
Appropriateness of intensive care treatments near the end of life during the COVID-19 pandemic.
|
NA
|
NA
|
|
Utilizing microbiome approaches to assist source tracking, treatment and prevention of COVID-19: Review and assessment.
|
NA
|
NA
|
|
COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
|
NA
|
NA
|
|
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
|
NA
|
NA
|
|
Characteristics and outcomes of hemodialysis patients with COVID-19: a retrospective single center study.
|
NA
|
NA
|
|
CALL Score and RAS Score as Predictive Models for Coronavirus Disease 2019.
|
NA
|
NA
|
|
Physicochemical susceptibility of SARS-CoV-2 to disinfection and physical approach of prophylaxis.
|
NA
|
NA
|
|
Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19.
|
NA
|
NA
|
|
Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy.
|
NA
|
NA
|
|
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential.
|
NA
|
NA
|
|
COVID-19: Virology, biology and novel laboratory diagnosis.
|
NA
|
NA
|
|
COVID-19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi-Center Comparative Cohort Study.
|
NA
|
NA
|
|
Clinical and epidemiological profile of patients infected by COVID-19 at a tertiary care centre in North India.
|
NA
|
NA
|
|
Gender differences in treatment of Coronavirus Disease-2019.
|
NA
|
NA
|
|
Distinct phenotypes in COVID-19 may require distinct pulmonary rehabilitation strategies.
|
NA
|
NA
|
|
Addictive behaviors and craving during the COVID-19 pandemic of people who have recovered from substance use disorder.
|
NA
|
NA
|
|
COVID-19 Severity: Lung-Heart Interplay.
|
NA
|
NA
|
|
Insights on Kawasaki disease and multisystem inflammatory syndrome; relationship with COVID-19 infection.
|
NA
|
NA
|
|
Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
|
NA
|
NA
|
|
Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens.
|
NA
|
NA
|
|
Rethinking Clinical Trials and Personalized Medicine with Placebogenomics and Placebo Dose.
|
NA
|
NA
|
|
Ethical considerations and interdisciplinary approach to research on COVID-19 pandemic: The response of Iran University of Medical Sciences.
|
NA
|
NA
|
|
SARS-CoV-2 infection as a trigger of autoimmune response.
|
NA
|
NA
|
|
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
|
NA
|
NA
|
|
COVID 19 SCIENTIFIC PUBLICATIONS FROM TURKEY.
|
NA
|
NA
|
|
Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.
|
NA
|
NA
|
|
Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model.
|
NA
|
NA
|
|
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies.
|
NA
|
NA
|
|
The Impact of COVID-19 on Speakers With Aphasia: What Is Currently Known and Missing?
|
NA
|
NA
|
|
Cardiac Magnetic Resonance Imaging in Coronavirus Disease 2019 (COVID-19): A Systematic Review of Cardiac Magnetic Resonance Imaging Findings in 199 Patients.
|
NA
|
NA
|
|
Cognitive flexibility and perceived threat from COVID-19 mediate the relationship between childhood maltreatment and state anxiety.
|
NA
|
NA
|
|
Rapid Conversion of a Palliative Care Outpatient Clinic to Telehealth.
|
NA
|
NA
|
|
Trends in Intensive Care for Patients with COVID-19 in England, Wales and Northern Ireland.
|
NA
|
NA
|
|
Small molecular fluorescence dyes for immuno cell analysis.
|
NA
|
NA
|
|
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
|
NA
|
NA
|
|
A pregnancy-specific reference interval for procalcitonin.
|
NA
|
NA
|
|
Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients.
|
NA
|
NA
|
|
Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
|
NA
|
NA
|
|
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology.
|
NA
|
NA
|
|
Genetic mechanisms of critical illness in COVID-19.
|
NA
|
NA
|
|
[Efficacy of Low-Frequency Magnetic Therapy in Patients with COVID-19 Pneumonia].
|
NA
|
NA
|
|
Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
|
NA
|
NA
|
|
Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection.
|
NA
|
NA
|
|
Built Environment Airborne Infection Control Strategies in Pandemic Alternative Care Sites.
|
NA
|
NA
|
|
Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania.
|
NA
|
NA
|
|
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
|
NA
|
NA
|
|
Fatal intracranial haemorrhage in a hypertensive patient with atrial fibrillation and coronavirus disease 2019.
|
NA
|
NA
|
|
Bail-out extracorporeal membrane oxygenation for hydroxychloroquine intoxication: a warning for COVID-19 health-care givers.
|
NA
|
NA
|
|
New approaches for hydrogen therapy of various diseases.
|
NA
|
NA
|
|
An Overview of Natural and Synthetic Analogs of Quinoline for the Prophylaxis of COVID-19. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents.
|
NA
|
NA
|
|
Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
|
NA
|
NA
|
|
Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients.
|
NA
|
NA
|
|
Management of Acute Kidney Injury in Coronavirus Disease 2019.
|
NA
|
NA
|
|
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
|
NA
|
NA
|
|
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
|
NA
|
NA
|
|
Home Dialysis in the Coronavirus Disease 2019 Era.
|
NA
|
NA
|
|
[Nurses in multi-disciplinary team to face Sars-CoV-2 in intensive care].
|
NA
|
NA
|
|
[Managers and caregivers, together in the fight against COVID-19].
|
NA
|
NA
|
|
[COVID-19: what protection for hospital staff?]
|
NA
|
NA
|
|
[Ensuring continuity of cancer treatment despite the COVID-19 epidemic].
|
NA
|
NA
|
|
[Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine].
|
NA
|
NA
|
|
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Life® (M101).
|
NA
|
NA
|
|
Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
|
NA
|
NA
|
|
Persistent hiccup: A rare presentation of COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.
|
NA
|
NA
|
|
A state-of-the-art review on WWTP associated bioaerosols: Microbial diversity, potential emission stages, dispersion factors, and control strategies.
|
NA
|
NA
|
|
Identification of antiviral antihistamines for COVID-19 repurposing.
|
NA
|
NA
|
|
Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.
|
NA
|
NA
|
|
Nucleic Acid-Based Technologies Targeting Coronaviruses.
|
NA
|
NA
|
|
Gas in Joints After Diving: Computed Tomography May Be Useful for Diagnosing Decompression Sickness.
|
NA
|
NA
|
|
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.
|
NA
|
NA
|
|
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.
|
NA
|
NA
|
|
Impact of COVID-19 on hand surgery in Italy: A comparison between the Northern and the Southern regions.
|
NA
|
NA
|
|
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.
|
NA
|
NA
|
|
Clinician Attitudes to Using Low-Dose Radiation Therapy to Treat COVID-19 Lung Disease.
|
NA
|
NA
|
|
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
|
NA
|
NA
|
|
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
|
NA
|
NA
|
|
Performing sleep studies after the COVID-19 outbreak: practical suggestions from Bologna’s sleep unit.
|
NA
|
NA
|
|
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion.
|
NA
|
NA
|
|
Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown.
|
NA
|
NA
|
|
Zoonotic coronavirus epidemics: SARS, MERS, and COVID-19.
|
NA
|
NA
|
|
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience.
|
NA
|
NA
|
|
Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
|
NA
|
NA
|
|
Clinical outcomes of pleural drainage on pneumothorax and hydrothorax in critically ill patients with COVID-19: A case series with literature review.
|
NA
|
NA
|
|
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
|
NA
|
NA
|
|
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil.
|
NA
|
NA
|
|
Survival Factors ID’d for Patients with Blood Cancer + COVID-19.
|
NA
|
NA
|
|
.
|
NA
|
NA
|
|
Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review.
|
NA
|
NA
|
|
Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
|
NA
|
NA
|
|
.
|
NA
|
NA
|
|
The role of ibuprofen in the treatment of coronavirus infection
|
NA
|
NA
|
|
HOME DIALYSIS DURING COVID-19 OUTBREAK - IT IS WORTH TO CONSIDER.
|
NA
|
NA
|
|
Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment.
|
NA
|
NA
|
|
The COVID-19 pandemic and dentistry: the clinical, legal and economic consequences - part 1: clinical.
|
NA
|
NA
|
|
COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report.
|
NA
|
NA
|
|
Reviewing the Effects of Miltefosine and Suggesting It for the Treatment of Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease.
|
NA
|
NA
|
|
COVID-19 Management in Newborn Babies in the Light of Recent Data: Breastfeeding, Rooming-in and Clinical Symptoms.
|
NA
|
NA
|
|
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.
|
NA
|
NA
|
|
Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.
|
NA
|
NA
|
|
COVID-19 Infection and Children: A Comprehensive Review.
|
NA
|
NA
|
|
HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19) pandemic: how countries should build more resilient health systems for preparedness and response.
|
NA
|
NA
|
|
Deep Venous Thrombosis in a 62-Year-Old Female With Schizoaffective Disorder Who Developed COVID-19.
|
NA
|
NA
|
|
Treating COVID-19 Positive Cancer Patients With Radiation Therapy: A Case Report From Epicenter of the Pandemic.
|
NA
|
NA
|
|
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19.
|
NA
|
NA
|
|
COVID-19 infection in a kidney transplant recipient-special emphasis on pharmacokinetic interactions: A case report.
|
NA
|
NA
|
|
Restructuring nephrology services to combat COVID-19 pandemic: Report from a Middle Eastern country.
|
NA
|
NA
|
|
Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy.
|
NA
|
NA
|
|
Meralgia Paraesthetica after Prone Position Ventilation in a Patient with COVID-19.
|
NA
|
NA
|
|
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.
|
NA
|
NA
|
|
Chasing COVID-19 through SARS-CoV-2 spike glycoprotein.
|
NA
|
NA
|
|
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
|
NA
|
NA
|
|
Radiotherapy delivery challenges in elderly patients during Coronavirus 19 (Covid-19) pandemic.
|
NA
|
NA
|
|
Diagnostic and Therapeutic Approaches to Novel COVID-19 in Intensive Care Unit: A Narrative Review.
|
NA
|
NA
|
|
Paediatric surgery and COVID-19: urgent lessons to be learned.
|
NA
|
NA
|
|
Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease.
|
NA
|
NA
|
|
Innovative Care Delivery of Acute Rehabilitation for Patients With COVID-19: A Case Report.
|
NA
|
NA
|
|
Screening, Brief Intervention, and Referral to Treatment for Pain Management for Veterans Seeking Service-Connection Payments for Musculoskeletal Disorders: SBIRT-PM Study Protocol.
|
NA
|
NA
|
|
Co-Operative Pain Education and Self-management (COPES) Expanding Treatment for Real-World Access (ExTRA): Pragmatic Trial Protocol.
|
NA
|
NA
|
|
History of the Military Nurse Corps and the 1918 Influenza Pandemic: Lessons for the 2019 Coronavirus Pandemic.
|
NA
|
NA
|
|
Modelling the impact of COVID-19-related control programme interruptions on progress towards the WHO 2030 target for soil-transmitted helminths.
|
NA
|
NA
|
|
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.
|
NA
|
NA
|
|
Can the hyperthermia-mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS-CoV-2 infection?
|
NA
|
NA
|
|
The Effect of Orthostatic Hypotension Detected Pre-Operatively on Post-Operative Outcome.
|
NA
|
NA
|
|
Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
|
NA
|
NA
|
|
Administration of intravenous immunoglobulin in the treatment of COVID-19: A review of available evidence.
|
NA
|
NA
|
|
mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
|
NA
|
NA
|
|
Characteristics and mechanisms to control a COVID-19 outbreak on a leukemia and stem cell transplantation unit.
|
NA
|
NA
|
|
Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care.
|
NA
|
NA
|
|
Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?
|
NA
|
NA
|
|
The effect of perceived stress on anxiety and sleep quality among healthcare professionals in intensive care units during the coronavirus pandemic.
|
NA
|
NA
|
|
Comparison of 2 Triage Scoring Guidelines for Allocation of Mechanical Ventilators.
|
NA
|
NA
|
|
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.
|
NA
|
NA
|
|
[Hemoptysis and acute kidney injury in COVID-19].
|
NA
|
NA
|
|
[The ESC recommendations for COVID-19-no guideline, but a learning guidance].
|
NA
|
NA
|
|
SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
|
NA
|
NA
|
|
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
|
NA
|
NA
|
|
Stress and sleep in college students prior to and during the COVID-19 pandemic.
|
NA
|
NA
|
|
Factors affecting mortality in geriatric patients hospitalized with COVID-19.
|
NA
|
NA
|
|
Influence of aluminum salts on COVID-19 infected patients
|
NA
|
NA
|
|
Hospital care: improving outcomes in type 1 diabetes.
|
NA
|
NA
|
|
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections.
|
NA
|
NA
|
|
Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients.
|
NA
|
NA
|
|
Comorbidity of Coronavirus disease (COVID-19) and the first episode of bipolar disorder and its treatment challenges: A case report.
|
NA
|
NA
|
|
Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.
|
NA
|
NA
|
|
Pulmonary rehabilitation and exercise therapy in a patient with COVID-19: A Case report.
|
NA
|
NA
|
|
Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak.
|
NA
|
NA
|
|
Use of medicines for covid-19 treatment in patients with loss of kidney function: a narrative review.
|
NA
|
NA
|
|
CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2.
|
NA
|
NA
|
|
Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: Results of a quality improvement survey.
|
NA
|
NA
|
|
Thermovaccination - thermoheliox as a stimulator of the immune response. Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection.
|
NA
|
NA
|
|
Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Coronavirus Disease 2019 Patients With Hyperinflammatory Phenotype.
|
NA
|
NA
|
|
Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.
|
NA
|
NA
|
|
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy.
|
NA
|
NA
|
|
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort.
|
NA
|
NA
|
|
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
|
NA
|
NA
|
|
Clinical Features and Outcomes of Acute Kidney Injury in Patients Infected with COVID-19 in Xiangyang, China.
|
NA
|
NA
|
|
Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
|
NA
|
NA
|
|
Changing Patterns of Medical Visits and Factors Associated with No-show in Patients with Rheumatoid Arthritis during COVID-19 Pandemic.
|
NA
|
NA
|
|
Update on COVID-19 Myocarditis.
|
NA
|
NA
|
|
COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome.
|
NA
|
NA
|
|
Advances in Microbiome Research for Animal Health.
|
NA
|
NA
|
|
The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.
|
NA
|
NA
|
|
Clinical and Scientific Rationale for the “MATH+” Hospital Treatment Protocol for COVID-19.
|
NA
|
NA
|
|
COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
|
NA
|
NA
|
|
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.
|
NA
|
NA
|
|
Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report.
|
NA
|
NA
|
|
A graphic elicitation technique to represent patient rights.
|
NA
|
NA
|
|
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.
|
NA
|
NA
|
|
Considerations on the restriction of Assisted Reproductive Technology (ART) due to COVID-19.
|
NA
|
NA
|
|
The nervous system-A new territory being explored of SARS-CoV-2.
|
NA
|
NA
|
|
Structural and operational redesigning of patient-centered ambulatory care pharmacy services and its effectiveness during the COVID-19 pandemic.
|
NA
|
NA
|
|
On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study.
|
NA
|
NA
|
|
Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies.
|
NA
|
NA
|
|
Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases.
|
NA
|
NA
|
|
Predicting severe or critical symptoms in hospitalized patients with COVID-19 from Yichang, China.
|
NA
|
NA
|
|
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
|
NA
|
NA
|
|
Gene expression network analysis provides potential targets against SARS-CoV-2.
|
NA
|
NA
|
|
Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens.
|
NA
|
NA
|
|
Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.
|
NA
|
NA
|
|
Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers.
|
NA
|
NA
|
|
[Experiences from the German COVID-19 register].
|
NA
|
NA
|
|
A successful case of extracorporeal membrane oxygenation treatment for intractable pneumothorax in a patient with COVID-19.
|
NA
|
NA
|
|
and in a mouse model expressing human ACE2.
|
NA
|
NA
|
|
Theoretical and numerical analysis of novel COVID-19 via fractional order mathematical model.
|
NA
|
NA
|
|
Post-transplant patients with COVID-19 associated acute respiratory distress syndrome, a role for Tociluzumab: A case series.
|
NA
|
NA
|
|
Successful treatment with methyl-prednisolone pulses for the late phase of COVID-19 with respiratory failure: A single-center case series.
|
NA
|
NA
|
|
Transitioning from face-to-face treatment to iCBT for youths in primary care - therapists’ attitudes and experiences.
|
NA
|
NA
|
|
Clinical trials, adaptability and the COVID-19 pandemic.
|
NA
|
NA
|
|
Investigating healthcare practitioners’ attitudes towards the COVID-19 outbreak in Saudi Arabia: A general qualitative framework for managing the pandemic.
|
NA
|
NA
|
|
Gastrointestinal manifestation as clinical predictor of severe COVID-19: A retrospective experience and literature review of COVID-19 in Association of Southeast Asian Nations (ASEAN).
|
NA
|
NA
|
|
The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
Nano-based methods for novel coronavirus 2019 (2019-nCoV) diagnosis: A review.
|
NA
|
NA
|
|
Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany.
|
NA
|
NA
|
|
Impact of COVID-19 in solid organ transplant recipients.
|
NA
|
NA
|
|
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
|
NA
|
NA
|
|
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak.
|
NA
|
NA
|
|
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
|
NA
|
NA
|
|
Chronic Pain and COVID-19: pathophysiological, clinical and organizational issues.
|
NA
|
NA
|
|
[A surgically relevant summary of the addendum to the S3 guidelines of the DGVS on Crohn’s disease and ulcerative colitis : Treatment of chronic inflammatory bowel diseases in the COVID-19 pandemic].
|
NA
|
NA
|
|
Collateral damage of the COVID-19 pandemic: an alarming decline in critical procedures in otorhinolaryngology in a German university hospital.
|
NA
|
NA
|
|
Human Bocavirus as a Possible Contributor to Respiratory Disease in the Georgian Military Population.
|
NA
|
NA
|
|
Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation.
|
NA
|
NA
|
|
Acute kidney injury in COVID 19 - an update on pathophysiology and management modalities.
|
NA
|
NA
|
|
Management and Data Sharing of COVID-19 Pandemic Information.
|
NA
|
NA
|
|
Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approach.
|
NA
|
NA
|
|
Global Infectious Disease Surveillance and Case Tracking System for COVID-19: Development Study.
|
NA
|
NA
|
|
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
|
NA
|
NA
|
|
COVID-19: Spatial analysis of hospital case-fatality rate in France.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study.
|
NA
|
NA
|
|
Development of pancreatic injuries in the course of COVID-19.
|
NA
|
NA
|
|
A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
|
NA
|
NA
|
|
Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.
|
NA
|
NA
|
|
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series.
|
NA
|
NA
|
|
Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic.
|
NA
|
NA
|
|
Experience during COVID-19 lockdown and self-managing strategies among caregivers of children with epilepsy: A study from low middle income country.
|
NA
|
NA
|
|
Ischemic Stroke in Patients with COVID-19 Disease: A Report of 10 Cases from Iran.
|
NA
|
NA
|
|
COVID-19 in ESRD and Acute Kidney Injury.
|
NA
|
NA
|
|
Evaluation of Patient’s Knowledge, Attitude, and Practice of Cross-Infection Control in Dentistry during COVID-19 Pandemic.
|
NA
|
NA
|
|
Coronavirus Disease 2019 Coexistence in the Daily Practice.
|
NA
|
NA
|
|
Changes in Mass Treatment of the Canine Parvovirus ICU Population in Relation to Public Policy Changes during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
|
NA
|
NA
|
|
How Have Public Safety Personnel Seeking Digital Mental Healthcare Been Affected by the COVID-19 Pandemic? An Exploratory Mixed Methods Study.
|
NA
|
NA
|
|
Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction.
|
NA
|
NA
|
|
Taming the Autophagy as a Strategy for Treating COVID-19.
|
NA
|
NA
|
|
Risk Perception, Protective Behaviors, and General Anxiety during the Coronavirus Disease 2019 Pandemic among Affiliated Health Care Professionals in Taiwan: Comparisons with Frontline Health Care Professionals and the General Public.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Manual Therapy Service Utilization within the Australian Private Healthcare Setting.
|
NA
|
NA
|
|
Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome.
|
NA
|
NA
|
|
High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
|
NA
|
NA
|
|
Ethical Challenges in Health Care Policy during COVID-19 Pandemic in Italy.
|
NA
|
NA
|
|
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
|
NA
|
NA
|
|
Analysis of COVID-19 Prevention and Control Effects Based on the SEITRD Dynamic Model and Wuhan Epidemic Statistics.
|
NA
|
NA
|
|
Seventy patients treated for COVID-19 by Østfold Hospital Trust.
|
NA
|
NA
|
|
Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study.
|
NA
|
NA
|
|
Diagnosing and managing childhood absence epilepsy by telemedicine.
|
NA
|
NA
|
|
Treatment gaps and challenges in epilepsy care in the Philippines.
|
NA
|
NA
|
|
Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis.
|
NA
|
NA
|
|
COVID-19 and Cannabidiol (CBD).
|
NA
|
NA
|
|
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia: Consideration of Problem Gambling and Psychological Distress.
|
NA
|
NA
|
|
Feasibility of subacute rehabilitation for mechanically ventilated patients with COVID-19 disease: a retrospective case series.
|
NA
|
NA
|
|
Psychiatry’s Past Can Be Psychiatry’s Future.
|
NA
|
NA
|
|
A 61-Year-Old Man with SARS-CoV-2 Infection and Venous Thrombosis Presenting with Painful Swelling and Gangrene of the Lower Limb Consistent with Phlegmasia Cerulea Dolens.
|
NA
|
NA
|
|
[Impact of the COVID-19 pandemic on Neonatal Screening for Congenital Hypothyroidism.]
|
NA
|
NA
|
|
[Fewer cancer diagnoses during the COVID-19 epidemic according to diagnosis, age and region].
|
NA
|
NA
|
|
An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2.
|
NA
|
NA
|
|
Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration.
|
NA
|
NA
|
|
Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic.
|
NA
|
NA
|
|
An Intervention to Increase Situational Awareness and the Culture of Mutual Care (Foco) and Its Effects During COVID-19 Pandemic: A Randomized Controlled Trial and Qualitative Analysis.
|
NA
|
NA
|
|
Korth.) Supply and Use.
|
NA
|
NA
|
|
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.
|
NA
|
NA
|
|
Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review.
|
NA
|
NA
|
|
Activities of Serum Ferritin and Treatment Outcomes Among COVID-19 Patients Treated With Vitamin C and Dexamethasone: An Uncontrolled Single-Center Observational Study.
|
NA
|
NA
|
|
Modeling and prediction of COVID-19 spread in the Philippines by October 13, 2020, by using the VARMAX time series method with preventive measures.
|
NA
|
NA
|
|
Gut Microbiota Status in COVID-19: An Unrecognized Player?
|
NA
|
NA
|
|
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
|
NA
|
NA
|
|
Recent updates on COVID-19: A holistic review.
|
NA
|
NA
|
|
Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic.
|
NA
|
NA
|
|
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
|
NA
|
NA
|
|
T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
|
NA
|
NA
|
|
The impact of family engagement in opioid assisted treatment: Results from a randomised controlled trial.
|
NA
|
NA
|
|
Dental Treatments During the COVID-19 Pandemic in Three Hospitals in Jordan: Retrospective Study.
|
NA
|
NA
|
|
Saving the most lives-A comparison of European triage guidelines in the context of the COVID-19 pandemic.
|
NA
|
NA
|
|
Peptide Correlation Analysis (PeCorA) Reveals Differential Proteoform Regulation.
|
NA
|
NA
|
|
Biocatalytic routes to anti-viral agents and their synthetic intermediates.
|
NA
|
NA
|
|
Adult COVID-19 Patients Cared For in a Pediatric ICU Embedded in a Regional Biothreat Center: Disease Severity and Outcomes.
|
NA
|
NA
|
|
Therapeutic interventions for COVID-19: a living overview of reviews.
|
NA
|
NA
|
|
Role of Machine Learning Techniques to Tackle the COVID-19 Crisis: Systematic Review.
|
NA
|
NA
|
|
Implementation of Telehealth Services to Assess, Monitor, and Treat Neurodevelopmental Disorders: Systematic Review.
|
NA
|
NA
|
|
Secondary Prevention of Hip Fragility Fractures During the COVID-19 Pandemic: Service Evaluation of “MRS BAD BONES”.
|
NA
|
NA
|
|
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
|
NA
|
NA
|
|
Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic.
|
NA
|
NA
|
|
Decontamination of N95 masks for re-use employing 7 widely available sterilization methods.
|
NA
|
NA
|
|
Effect of Artificial Liver Blood Purification Treatment on the Survival of Critical Ill COVID-19 Patients.
|
NA
|
NA
|
|
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.
|
NA
|
NA
|
|
Robots as intelligent assistants to face COVID-19 pandemic.
|
NA
|
NA
|
|
Rapid Implementation of a Complex, Multimodal Technology Response to COVID-19 at an Integrated Community-Based Health Care System.
|
NA
|
NA
|
|
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis.
|
NA
|
NA
|
|
Acupuncture for COVID-19 patient after ventilator weaning: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Post-Acute COVID-19 Rehabilitation Network Proposal: From Intensive to Extensive and Home-Based IT Supported Services.
|
NA
|
NA
|
|
COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment.
|
NA
|
NA
|
|
Effect of Surgical Mask on Setup Error in Head and Neck Radiotherapy.
|
NA
|
NA
|
|
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy.
|
NA
|
NA
|
|
Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
|
NA
|
NA
|
|
An Updated Review on COVID-19.
|
NA
|
NA
|
|
Psychiatry during the Covid-19 pandemic: a survey on mental health departments in Italy.
|
NA
|
NA
|
|
Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs.
|
NA
|
NA
|
|
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
|
NA
|
NA
|
|
High-flow nasal cannula in COVID-19: Outcomes of application and examination of the ROX index to predict success.
|
NA
|
NA
|
|
Brief psychotic disorder associated with quarantine and mild COVID-19.
|
NA
|
NA
|
|
Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin.
|
NA
|
NA
|
|
Dynamic profiles of SARS-Cov-2 infection from five Chinese family clusters in the early stage of the COVID-19 pandemic.
|
NA
|
NA
|
|
Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience.
|
NA
|
NA
|
|
COVID-19 Concerns Among Old Age Psychiatric In- and Out-Patients and the Employees Caring for Them, a Preliminary Study.
|
NA
|
NA
|
|
Adverse Mental Health Impact of the COVID-19 Lockdown in Individuals With Tourette Syndrome in Italy: An Online Survey.
|
NA
|
NA
|
|
Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients.
|
NA
|
NA
|
|
Effects of COVID-19 Infection Control Measures on Appointment Cancelation in an Italian Outpatient Memory Clinic.
|
NA
|
NA
|
|
Written Emotional Disclosure Can Promote Athletes’ Mental Health and Performance Readiness During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Neuromuscular Diseases Care in the Era of COVID-19.
|
NA
|
NA
|
|
Modification of Acute Stroke Pathway in Korea After the Coronavirus Disease 2019 Outbreak.
|
NA
|
NA
|
|
Difficulties and Countermeasures in Hospital Emergency Management for Fast-Lane Treatment of Acute Stroke During the COVID-19 Epidemic Prevention and Control.
|
NA
|
NA
|
|
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors.
|
NA
|
NA
|
|
Controlling Cytokine Storm Is Vital in COVID-19.
|
NA
|
NA
|
|
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
|
NA
|
NA
|
|
Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.
|
NA
|
NA
|
|
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report.
|
NA
|
NA
|
|
Field-Effect Sensors for Virus Detection: From Ebola to SARS-CoV-2 and Plant Viral Enhancers.
|
NA
|
NA
|
|
A case series report of hospitalized children with severe acute respiratory syndrome coronavirus-2 infection in Jinan, China.
|
NA
|
NA
|
|
Protecting the Well-Being of Medical Residents and Faculty Physicians During the COVID-19 Pandemic: Making the Case for Accessible, Comprehensive Wellness Resources.
|
NA
|
NA
|
|
Further Reduction in Help-Seeking Behaviors Amidst Additional Barriers to Mental Health Treatment in Asian Populations: A Contemporary Review.
|
NA
|
NA
|
|
Modeling the pandemic trend of 2019 Coronavirus with optimal control analysis.
|
NA
|
NA
|
|
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
|
NA
|
NA
|
|
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.
|
NA
|
NA
|
|
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report.
|
NA
|
NA
|
|
An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting.
|
NA
|
NA
|
|
Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy.
|
NA
|
NA
|
|
Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline.
|
NA
|
NA
|
|
Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research.
|
NA
|
NA
|
|
Severe COVID-19 Illness: Risk Factors and Its Burden on Critical Care Resources.
|
NA
|
NA
|
|
Underlying Kidney Diseases and Complications for COVID-19: A Review.
|
NA
|
NA
|
|
COVID-19 in Pediatric Patients: A Focus on CHD Patients.
|
NA
|
NA
|
|
Coronavirus disease 2019 (COVID-19): research progress and clinical practice.
|
NA
|
NA
|
|
COVID-19 in China: the role and activities of Internet-based healthcare platforms.
|
NA
|
NA
|
|
Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan.
|
NA
|
NA
|
|
Nursing care for patients with COVID-19 on extracorporeal membrane oxygenation (ECMO) support.
|
NA
|
NA
|
|
COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States.
|
NA
|
NA
|
|
A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan.
|
NA
|
NA
|
|
Corticosteroid therapy for severe COVID-19 pneumonia: optimal dose and duration of administration.
|
NA
|
NA
|
|
COVID-19: emerging challenges for oncological surgery.
|
NA
|
NA
|
|
Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles.
|
NA
|
NA
|
|
Antiviral Screening Revive Therapeutic Drugs for COVID-19.
|
NA
|
NA
|
|
Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19.
|
NA
|
NA
|
|
The Risk Factors for the Exacerbation of COVID-19 Disease: A Case-control Study.
|
NA
|
NA
|
|
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia.
|
NA
|
NA
|
|
The COVID-19 pandemic: a target for surfactant therapy?
|
NA
|
NA
|
|
Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
|
NA
|
NA
|
|
Case Report: Dengue and COVID-19 Coinfection in Thailand.
|
NA
|
NA
|
|
Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
|
NA
|
NA
|
|
A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant.
|
NA
|
NA
|
|
Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes.
|
NA
|
NA
|
|
COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review.
|
NA
|
NA
|
|
“Say Ninetynine”: It’s Never too Late to Recover from COVID-19.
|
NA
|
NA
|
|
[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].
|
NA
|
NA
|
|
[Heterotopic ossifications after COVID-19 pneumonia].
|
NA
|
NA
|
|
[The medicinal treatment of COVID-19: a brief update].
|
NA
|
NA
|
|
[Post-COVID-19 rehabilitation; a matter of customisation].
|
NA
|
NA
|
|
COVID-19 patients in the operating room: a concise review of existing literature.
|
NA
|
NA
|
|
Bringing evidence from press release to the clinic in the era of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
|
NA
|
NA
|
|
COVID-19 and Speech-Language Pathology Clinical Practice of Voice and Upper Airway Disorders.
|
NA
|
NA
|
|
Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California.
|
NA
|
NA
|
|
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy.
|
NA
|
NA
|
|
Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
|
NA
|
NA
|
|
Increased unemployment from the COVID-19 pandemic, what might be the adverse impacts on cardiovascular disease in Aotearoa/New Zealand and how might this be prevented?
|
NA
|
NA
|
|
Coronavirus-induced coagulopathy during the course of disease.
|
NA
|
NA
|
|
Real-time neural network based predictor for cov19 virus spread.
|
NA
|
NA
|
|
Clinical features and risk factors for severe inpatients with COVID-19: A retrospective study in China.
|
NA
|
NA
|
|
A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
|
NA
|
NA
|
|
How to rapidly convert general wards to ICUs during the COVID-19 epidemic: Experience from Wuhan, China.
|
NA
|
NA
|
|
Dexamethasone vs COVID-19: An experimental study in line with the preliminary findings of a large trial.
|
NA
|
NA
|
|
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
|
NA
|
NA
|
|
ICU preparedness in pandemics: lessons learned from the coronavirus disease-2019 outbreak.
|
NA
|
NA
|
|
COVID-19 and autoimmune diseases.
|
NA
|
NA
|
|
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
|
NA
|
NA
|
|
A retrospective comparison of drugs against COVID-19.
|
NA
|
NA
|
|
Re-organization of the Vascular Surgery Department During the Acute Phase of the COVID19 Outbreak: Lessons Learned and Future Perspectives.
|
NA
|
NA
|
|
A high-throughput drug screening strategy against coronaviruses.
|
NA
|
NA
|
|
Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients.
|
NA
|
NA
|
|
Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study.
|
NA
|
NA
|
|
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
|
NA
|
NA
|
|
Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19.
|
NA
|
NA
|
|
Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study.
|
NA
|
NA
|
|
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
|
NA
|
NA
|
|
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels.
|
NA
|
NA
|
|
[Emergency laboratory construction and reflection in infectious hospital under the epidemic situation].
|
NA
|
NA
|
|
[Research progress on application of laboratory indicators detection of COVID-19].
|
NA
|
NA
|
|
[Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
|
NA
|
NA
|
|
Pandemic-Driven Development of a Medical-Grade, Economic and Decentralized Applicable Polyolefin Filament for Additive Fused Filament Fabrication.
|
NA
|
NA
|
|
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review.
|
NA
|
NA
|
|
The Psychological Impact of ‘Mild Lockdown’ in Japan during the COVID-19 Pandemic: A Nationwide Survey under a Declared State of Emergency.
|
NA
|
NA
|
|
SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure.
|
NA
|
NA
|
|
A short review on important drugs under clinical trial against Covid-19.
|
NA
|
NA
|
|
Clinical characteristics of 41 patients with pneumonia due to 2019 novel coronavirus disease (COVID-19) in Jilin, China.
|
NA
|
NA
|
|
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.
|
NA
|
NA
|
|
Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water, Greater Paris, France, 5 March to 23 April 2020.
|
NA
|
NA
|
|
Acute Kidney Injury in COVID-19: The Chinese Experience.
|
NA
|
NA
|
|
Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications.
|
NA
|
NA
|
|
A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy.
|
NA
|
NA
|
|
Reactivation of BCG inoculation site in a child with febrile exanthema of 3 days duration: an early indicator of incomplete Kawasaki disease.
|
NA
|
NA
|
|
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2.
|
NA
|
NA
|
|
Impact of Diabetes in Patients Diagnosed With COVID-19.
|
NA
|
NA
|
|
Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster.
|
NA
|
NA
|
|
Evolutionary medical insights into the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
JAAM Nationwide Survey on the response to the first wave of COVID-19 in Japan. Part I: How to set up a treatment system in each hospital.
|
NA
|
NA
|
|
Bacteremia in a Patient with Small Bowel Obstruction.
|
NA
|
NA
|
|
Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase.
|
NA
|
NA
|
|
Acute Limb Ischemia: A Rare Complication of COVID-19.
|
NA
|
NA
|
|
Thoracic ultrasonic narration of Covid-19 pneumonia.
|
NA
|
NA
|
|
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan.
|
NA
|
NA
|
|
Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland.
|
NA
|
NA
|
|
CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China.
|
NA
|
NA
|
|
Problems and solutions of personal protective equipment doffing in COVID-19.
|
NA
|
NA
|
|
Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients.
|
NA
|
NA
|
|
Combination of chest CT and clinical features for diagnosis of 2019 novel coronavirus pneumonia.
|
NA
|
NA
|
|
Predictive factors of progression to severe COVID-19.
|
NA
|
NA
|
|
A case of SLE with COVID-19 and multiple infections.
|
NA
|
NA
|
|
Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
|
NA
|
NA
|
|
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
|
NA
|
NA
|
|
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
|
NA
|
NA
|
|
COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicine.
|
NA
|
NA
|
|
Duodenal perforation in a SARS-CoV-2-positive patient with negative PCR results for SARS-CoV-2 in the peritoneal fluid.
|
NA
|
NA
|
|
Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury.
|
NA
|
NA
|
|
Possible treatment and strategies for COVID-19: review and assessment.
|
NA
|
NA
|
|
Was a global pandemic needed to adopt the use of telehealth in occupational therapy?
|
NA
|
NA
|
|
[Equity and the Cuban National Health System’s response to COVID-19Equidade e resposta do Sistema Nacional de Saúde de Cuba à pandemia de COVID-19].
|
NA
|
NA
|
|
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes fromCoViD-19: systematic review and meta-analysis.
|
NA
|
NA
|
|
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020.
|
NA
|
NA
|
|
Use of Telepresence Robots in Glaucoma Patient Education.
|
NA
|
NA
|
|
Clinical effectiveness of inhalation conscious sedation with nitrous oxide and oxygen for dental treatment in uncooperative paediatric patients during COVID-19 outbreak.
|
NA
|
NA
|
|
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.
|
NA
|
NA
|
|
Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery.
|
NA
|
NA
|
|
COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
|
NA
|
NA
|
|
Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study.
|
NA
|
NA
|
|
War against the COVID-19 pandemic: reflection in light of Florence Nightingale’s nursing theory.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on care of oncological patients: experience of a cancer center in a Latin American pandemic epicenter.
|
NA
|
NA
|
|
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
|
NA
|
NA
|
|
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
|
NA
|
NA
|
|
Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study.
|
NA
|
NA
|
|
COVID-19 and thrombosis: From bench to bedside.
|
NA
|
NA
|
|
Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis.
|
NA
|
NA
|
|
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
|
NA
|
NA
|
|
Changes in Characteristics, Treatment and Outcome in Patients with Hemorrhagic Stroke During COVID-19.
|
NA
|
NA
|
|
Myricetin: A review of the most recent research.
|
NA
|
NA
|
|
Impact of COVID-19 infection among cancer patients treated at the Los Angeles County Medical Center.
|
NA
|
NA
|
|
Convalescent plasma may be a possible treatment for COVID-19: A systematic review.
|
NA
|
NA
|
|
Effects of ACT Out! Social Issue Theater on Social-Emotional Competence and Bullying in Youth and Adolescents: Cluster Randomized Controlled Trial.
|
NA
|
NA
|
|
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment.
|
NA
|
NA
|
|
as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders.
|
NA
|
NA
|
|
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations.
|
NA
|
NA
|
|
Developing Diagnostic and Therapeutic Approaches to Bacterial Infections for a New Era: Implications of Globalization.
|
NA
|
NA
|
|
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg.
|
NA
|
NA
|
|
Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic.
|
NA
|
NA
|
|
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases.
|
NA
|
NA
|
|
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
|
NA
|
NA
|
|
Prevalence and correlates of fatigue and its association with quality of life among clinically stable older psychiatric patients during the COVID-19 outbreak: a cross-sectional study.
|
NA
|
NA
|
|
Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry.
|
NA
|
NA
|
|
When pneumonia is not COVID-19.
|
NA
|
NA
|
|
Radiologic diagnosis of patients with COVID-19.
|
NA
|
NA
|
|
Addressing a rapidly changing service landscape during the COVID-19 pandemic: Creation of the Oregon substance use disorder resource collaborative.
|
NA
|
NA
|
|
Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adults Patients With and Without Type 2 Diabetes: A Cohort Study.
|
NA
|
NA
|
|
Emergency Cesarean Section at 38 Weeks of Gestation with COVID-19 Pneumonia: A Case Report.
|
NA
|
NA
|
|
The COVID-19 pandemic and dentistry: the clinical, legal and economic consequences - part 2: consequences of withholding dental care.
|
NA
|
NA
|
|
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets.
|
NA
|
NA
|
|
HIV care models during the COVID-19 era.
|
NA
|
NA
|
|
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response.
|
NA
|
NA
|
|
Cortisol level dysregulation and its prevalence-Is it nature’s alarm clock?
|
NA
|
NA
|
|
Altitude and COVID-19: Friend or foe? A narrative review.
|
NA
|
NA
|
|
[Direct and indirect neurological manifestations of COVID-19].
|
NA
|
NA
|
|
[Poststroke motor and cognitive impairments: clinical features and current approaches to rehabilitation].
|
NA
|
NA
|
|
Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
|
NA
|
NA
|
|
Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.
|
NA
|
NA
|
|
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
|
NA
|
NA
|
|
Infectious bronchitis virus: Identification of Gallus gallus APN high-affinity ligands with antiviral effects.
|
NA
|
NA
|
|
Accountable Care Organizations during Covid-19: Routine care for older adults with multiple chronic conditions.
|
NA
|
NA
|
|
Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19.
|
NA
|
NA
|
|
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
|
NA
|
NA
|
|
Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak.
|
NA
|
NA
|
|
Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases.
|
NA
|
NA
|
|
Recommendations on intervention for hepatobiliary oncological surgery during the COVID-19 pandemic.
|
NA
|
NA
|
|
Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre.
|
NA
|
NA
|
|
Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study.
|
NA
|
NA
|
|
Nanotechnology in pulmonary medicine.
|
NA
|
NA
|
|
Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm.
|
NA
|
NA
|
|
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
|
NA
|
NA
|
|
Neutralizing antibodies targeting SARS-CoV-2 spike protein.
|
NA
|
NA
|
|
Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors.
|
NA
|
NA
|
|
Effect of lockdown on wastewater characteristics: a comparison of two large urban areas.
|
NA
|
NA
|
|
Sewage surveillance for the presence of SARS-CoV-2 genome as a useful wastewater based epidemiology (WBE) tracking tool in India.
|
NA
|
NA
|
|
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
|
NA
|
NA
|
|
Nursing Management of Prone Positioning in Patients With COVID-19.
|
NA
|
NA
|
|
From fragmented levels of care to integrated health care: Framework toward improved maternal and newborn health.
|
NA
|
NA
|
|
Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study.
|
NA
|
NA
|
|
[Evaluation of the efficacy of Chinese Children’s Asthma Action Plan on the long-term management of children with asthma at home].
|
NA
|
NA
|
|
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit.
|
NA
|
NA
|
|
The management of hematologic malignancies during the COVID-19 pandemic.
|
NA
|
NA
|
|
Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker.
|
NA
|
NA
|
|
A systematic review assessing the under-representation of elderly adults in COVID-19 trials.
|
NA
|
NA
|
|
Vitamin D deficiency among patients with COVID-19: case series and recent literature review.
|
NA
|
NA
|
|
Prevalence of malnutrition in coronavirus disease 19: the NUTRICOV study.
|
NA
|
NA
|
|
Chest Computed Tomography findings in patients with corona virus disease 2019 (COVID-19): An initial experience in three centres in Ghana, West Africa.
|
NA
|
NA
|
|
Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.
|
NA
|
NA
|
|
Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan.
|
NA
|
NA
|
|
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.
|
NA
|
NA
|
|
Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study.
|
NA
|
NA
|
|
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China.
|
NA
|
NA
|
|
[Task Force against COVID-19 Coordinated by Cancer-Associated Societies in Japan].
|
NA
|
NA
|
|
[COVID-19 Pneumonia].
|
NA
|
NA
|
|
[Oncology and COVID-19 Pandemic Era-Impact on Medical Oncology Care].
|
NA
|
NA
|
|
[The Effects of COVID-19 Pandemic on Surgery of Cancer Patients].
|
NA
|
NA
|
|
Increased Interest for Mindfulness Online.
|
NA
|
NA
|
|
Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.
|
NA
|
NA
|
|
Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic.
|
NA
|
NA
|
|
Biosensor and Lab-on-a-chip Biomarker-identifying Technologies for Oral and Periodontal Diseases.
|
NA
|
NA
|
|
Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.
|
NA
|
NA
|
|
Hydroxychloroquine as Prophylaxis for COVID-19: A Review.
|
NA
|
NA
|
|
COVID-19: A Challenge to Physiology of Aging.
|
NA
|
NA
|
|
A Narrative Review of Stigma Related to Infectious Disease Outbreaks: What Can Be Learned in the Face of the Covid-19 Pandemic?
|
NA
|
NA
|
|
Tele-Psychiatry Assessment of Post-traumatic Stress Symptoms in 100 Patients With Bipolar Disorder During the COVID-19 Pandemic Social-Distancing Measures in Italy.
|
NA
|
NA
|
|
A Potential Bioelectromagnetic Method to Slow Down the Progression and Prevent the Development of Ultimate Pulmonary Fibrosis by COVID-19.
|
NA
|
NA
|
|
The Recent Progress and Applications of Digital Technologies in Healthcare: A Review.
|
NA
|
NA
|
|
Cancer care and COVID-19: tailoring recommendations for the African radiation oncology context.
|
NA
|
NA
|
|
[Acute renal failure in COVID-19].
|
NA
|
NA
|
|
How the COVID-19 pandemic is affecting paediatric orthopaedic practice in Turkey.
|
NA
|
NA
|
|
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation.
|
NA
|
NA
|
|
Microfluidic-based approaches for COVID-19 diagnosis.
|
NA
|
NA
|
|
[How to differentiate COVID-19 pneumonia from heart failure? A case report].
|
NA
|
NA
|
|
Respiratory distress in a patient with Klinefelter syndrome: a suspicion of COVID-19 hiding severe pulmonary embolism.
|
NA
|
NA
|
|
[The fight against COVID-19 in Cameroon needs a second breath].
|
NA
|
NA
|
|
Preparedness of health facilities providing HIV services during COVID-19 pandemic and assessment of their compliance to COVID-19 prevention measures: findings from the Tanzania Service Provision Assessment (SPA) survey.
|
NA
|
NA
|
|
IoMT-Based Automated Detection and Classification of Leukemia Using Deep Learning.
|
NA
|
NA
|
|
Innate lymphoid cell composition associates with COVID-19 disease severity.
|
NA
|
NA
|
|
Prone position ventilation and femoro-femoral veno-venous extracorporeal membrane oxygenation for COVID-19 treatment.
|
NA
|
NA
|
|
Full recovery of a stage IV cancer patient facing COVID-19 pandemic.
|
NA
|
NA
|
|
Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19.
|
NA
|
NA
|
|
Possible Prophylactic Approach for SARS-CoV-2 Infection by Combination of Melatonin, Vitamin C and Zinc in Animals.
|
NA
|
NA
|
|
Holistic care model of time-sharing management for severe and critical COVID-19 patients.
|
NA
|
NA
|
|
High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang.
|
NA
|
NA
|
|
No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19.
|
NA
|
NA
|
|
Intraoperative care of elderly patients with COVID-19 undergoing double lung transplantation: Two case reports.
|
NA
|
NA
|
|
Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy.
|
NA
|
NA
|
|
Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.
|
NA
|
NA
|
|
Interpersonal psychotherapy-based psychological intervention for patient suffering from COVID-19: A case report.
|
NA
|
NA
|
|
Fourty-nine years old woman co-infected with SARS-CoV-2 and Mycoplasma: A case report.
|
NA
|
NA
|
|
Symptomatic and optimal supportive care of critical COVID-19: A case report and literature review.
|
NA
|
NA
|
|
What Pediatric Dentists Need to Know about Coronavirus Disease (COVID-19).
|
NA
|
NA
|
|
Investigation on penetration of saffron components through lipid bilayer bound to spike protein of SARS-CoV-2 using steered molecular dynamics simulation.
|
NA
|
NA
|
|
Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy.
|
NA
|
NA
|
|
Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
|
NA
|
NA
|
|
Workload changes during the COVID-19 pandemic and effects on the flow of cancer patients in the Maxillofacial Surgery Department.
|
NA
|
NA
|
|
Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients.
|
NA
|
NA
|
|
Can drug repurposing strategies be the solution to the COVID-19 crisis?
|
NA
|
NA
|
|
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
|
NA
|
NA
|
|
Development and Prospective Validation of a Deep Learning Algorithm for Predicting Need for Mechanical Ventilation.
|
NA
|
NA
|
|
Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
|
NA
|
NA
|
|
Underlying heart diseases and acute COVID-19 outcomes.
|
NA
|
NA
|
|
Research on the individualized short-term training model of nurses in emergency isolation wards during the outbreak of COVID-19.
|
NA
|
NA
|
|
[The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
|
NA
|
NA
|
|
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules.
|
NA
|
NA
|
|
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia.
|
NA
|
NA
|
|
Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic.
|
NA
|
NA
|
|
[Proposals for the diagnosis and treatment of andrologic diseases during the novel coronavirus pneumonia epidemic].
|
NA
|
NA
|
|
[Management of androgenic diseases during the epidemic of COVID-19 pneumonia].
|
NA
|
NA
|
|
Thrombophilia in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Secondary to Coronavirus Disease 2019 Supported on Extracorporeal Membrane Oxygenation.
|
NA
|
NA
|
|
Patient Perspectives on the Effect of the SARS-CoV-2 Pandemic on Patients With Systemic Sclerosis: An International Patient Survey.
|
NA
|
NA
|
|
Implications of the COVID-19 Pandemic for the Development and Update of Clinical Practice Guidelines: Viewpoint.
|
NA
|
NA
|
|
A modular framework for multiscale, multicellular, spatiotemporal modeling of acute primary viral infection and immune response in epithelial tissues and its application to drug therapy timing and effectiveness.
|
NA
|
NA
|
|
Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia.
|
NA
|
NA
|
|
Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
|
NA
|
NA
|
|
Decontamination of SARS-CoV-2 contaminated N95 filtering facepiece respirators (FFRs) with moist heat generated by a multicooker.
|
NA
|
NA
|
|
Return to Work: Managing Employee Population Health During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Coronavirus Disease 2019 in Lung Transplant Recipients.
|
NA
|
NA
|
|
The role of NO in COVID-19 and potential therapeutic strategies.
|
NA
|
NA
|
|
Different mutations in SARS-CoV-2 associate with severe and mild outcome.
|
NA
|
NA
|
|
Colorado Palliative Care and Hospice Crisis Standards: Moving Beyond Critical Care Planning.
|
NA
|
NA
|
|
A pandemic response to home delivery for ambulatory ECG monitoring: Development and validation.
|
NA
|
NA
|
|
Reduction and partitioning of viral and bacterial indicators in a UASB reactor followed by high rate algal ponds treating domestic sewage.
|
NA
|
NA
|
|
Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study.
|
NA
|
NA
|
|
The emergency department care for hemodialysis patient during the COVID-19 pandemic.
|
NA
|
NA
|
|
D-Dimer as a potential biomarker for disease severity in COVID-19.
|
NA
|
NA
|
|
Interferon-inducer antivirals: Potential candidates to combat COVID-19.
|
NA
|
NA
|
|
Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic.
|
NA
|
NA
|
|
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies.
|
NA
|
NA
|
|
Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.
|
NA
|
NA
|
|
Stress and Anxiety Levels in Pregnant and Post-Partum Women during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications.
|
NA
|
NA
|
|
Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic.
|
NA
|
NA
|
|
Hydrogen Gas Therapy: From Preclinical Studies to Clinical Trials.
|
NA
|
NA
|
|
Perceived vulnerability to COVID-19 infection from event attendance: results from Louisiana, USA, two weeks preceding the national emergency declaration.
|
NA
|
NA
|
|
The German Corona Consensus Dataset (GECCO): a standardized dataset for COVID-19 research in university medicine and beyond.
|
NA
|
NA
|
|
Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus.
|
NA
|
NA
|
|
Impacts of lockdown during the SARS-CoV-2 pandemic on patients presenting with cervicofacial infection of odontogenic origin: a comparative study.
|
NA
|
NA
|
|
[Management of communication between inpatients isolated due to COVID-19 and their families].
|
NA
|
NA
|
|
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
|
NA
|
NA
|
|
Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report.
|
NA
|
NA
|
|
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension.
|
NA
|
NA
|
|
The SARS-CoV-2 RNA-protein interactome in infected human cells.
|
NA
|
NA
|
|
[Evaluation and management of insomnia in clinical practice and in the time of CoViD-19 in Italy: expert consensus and task-force recommendations from five scientific societies].
|
NA
|
NA
|
|
Framework for PESTEL dimensions of sustainable healthcare waste management: Learnings from COVID-19 outbreak.
|
NA
|
NA
|
|
Ethical considerations of the dynamics of clinical trials in an epidemic context: Studies on COVID-19.
|
NA
|
NA
|
|
Spiky nanostructures for virus inhibition and infection prevention.
|
NA
|
NA
|
|
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform.
|
NA
|
NA
|
|
The effect of angiotensin-converting enzyme levels on Covid-19 susceptibility and severity: a Mendelian randomization study.
|
NA
|
NA
|
|
Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis.
|
NA
|
NA
|
|
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy.
|
NA
|
NA
|
|
Ferritin as a Platform for Creating Antiviral Mosaic Nanocages: Prospects for Treating COVID-19.
|
NA
|
NA
|
|
Quarantine Facility for Patients with COVID-19 with Mild Symptoms in Korea: Experience from Eighteen Residential Treatment Centers.
|
NA
|
NA
|
|
Consensus Recommendations for Botulinum Toxin Injections in the Spasticity Management of Children with Cerebral Palsy During COVID-19 Outbreak.
|
NA
|
NA
|
|
Long-term effects of appendectomy in humans: is it the optimal management of appendicitis?
|
NA
|
NA
|
|
Pragmatic Recommendations for the Management of COVID-19 Patients with Shock in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
[Vitamin D supplementation and COVID-19: expert consensus and guidelines].
|
NA
|
NA
|
|
Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: A retrospective study.
|
NA
|
NA
|
|
Voice through the lens: Personal experience of those on methadone.
|
NA
|
NA
|
|
Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses.
|
NA
|
NA
|
|
Biochemical study on the protective effect of curcumin on acetaminophen and gamma-irradiation induced hepatic toxicity in rats.
|
NA
|
NA
|
|
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre study.
|
NA
|
NA
|
|
Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients.
|
NA
|
NA
|
|
Use of Telehealth in Fellowship-Affiliated Developmental Behavioral Pediatric Practices During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: a Multicenter Cohort Study From India.
|
NA
|
NA
|
|
Remdesivir Approved to Treat COVID-19 Amid Controversy.
|
NA
|
NA
|
|
Remdesivir in The Treatment of COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.
|
NA
|
NA
|
|
Diverse clinical processes of 16 COVID-19 cases who concentrated infection in the same workplace in Beijing, China: An observational study.
|
NA
|
NA
|
|
COVID-19: anxiety among hospital staff and associated factors.
|
NA
|
NA
|
|
The Impact of the Coronavirus Pandemic on Pediatric Palliative Care Team Structures, Services, and Care Delivery.
|
NA
|
NA
|
|
How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.
|
NA
|
NA
|
|
Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up.
|
NA
|
NA
|
|
A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies.
|
NA
|
NA
|
|
Healthcare cyber-attacks and the COVID-19 pandemic: an urgent threat to global health.
|
NA
|
NA
|
|
The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.
|
NA
|
NA
|
|
Determinants of mental health outcomes among people with and without diabetes during the COVID-19 outbreak in the Arab Gulf Region.
|
NA
|
NA
|
|
[Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry].
|
NA
|
NA
|
|
[Screening for gestational diabetes due to of the COVID-19 pandemic].
|
NA
|
NA
|
|
[The role of HLA genes: from autoimmune diseases to COVID-19].
|
NA
|
NA
|
|
[Androgens and Antiandrogens influence on COVID-19 disease in men].
|
NA
|
NA
|
|
Favorable outcome of SARS-CoV-2 infection in a patient with pituitary insufficiency.
|
NA
|
NA
|
|
Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality.
|
NA
|
NA
|
|
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.
|
NA
|
NA
|
|
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?
|
NA
|
NA
|
|
Century: In Respectful Memory of the Warriors All Over the World.
|
NA
|
NA
|
|
COVID-19 Treatment at a Glance.
|
NA
|
NA
|
|
COVID-19 Pneumonia and Idiopathic Pulmonary Fibrosis: A Novel Combination.
|
NA
|
NA
|
|
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics.
|
NA
|
NA
|
|
Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea.
|
NA
|
NA
|
|
Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.
|
NA
|
NA
|
|
COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
|
NA
|
NA
|
|
Iatrogenic Pneumothorax and Pneumomediastinum in a Patient with COVID-19.
|
NA
|
NA
|
|
Coronavirus disease (COVID 2019): protocol for a living overview of systematic reviews.
|
NA
|
NA
|
|
A case of bilateral unusual retinal hemorrhages in a COVID-19 patient.
|
NA
|
NA
|
|
The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic.
|
NA
|
NA
|
|
Effects of Tocilizumab in COVID-19 patients: a cohort study.
|
NA
|
NA
|
|
Prognostic value of bedside lung ultrasound score in patients with COVID-19.
|
NA
|
NA
|
|
Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials.
|
NA
|
NA
|
|
DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey.
|
NA
|
NA
|
|
Child maltreatment in the time of the COVID-19 pandemic: A proposed global framework on research, policy and practice.
|
NA
|
NA
|
|
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19.
|
NA
|
NA
|
|
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India.
|
NA
|
NA
|
|
Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York.
|
NA
|
NA
|
|
Utility of Hypertonic Saline and Diazepam in COVID-19-Related Hydroxychloroquine Toxicity.
|
NA
|
NA
|
|
The importance of rigour in the reporting of evidence for osteopathic care in Covid-19 papers.
|
NA
|
NA
|
|
Staff Emotional Support at Montefiore Medical Center During the COVID-19 Pandemic.
|
NA
|
NA
|
|
New statistical RI index allow to better track the dynamics of COVID-19 outbreak in Italy.
|
NA
|
NA
|
|
Patient’s Perspectives of Telepsychiatry: The Past, Present and Future.
|
NA
|
NA
|
|
Telepsychiatry and Outpatient Department Services.
|
NA
|
NA
|
|
Telepsychiatry and Addiction Treatment.
|
NA
|
NA
|
|
Telerehabilitation in Psychiatry.
|
NA
|
NA
|
|
Telepsychiatry and Telepsychotherapy: Critical Issues Faced by Indian Patients and Psychiatrists.
|
NA
|
NA
|
|
[Impact of confinement on the follow-up of oral immunotherapies: A multicentre study in the Île-de-France region].
|
NA
|
NA
|
|
COVID-19: challenges for dementia care and research.
|
NA
|
NA
|
|
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort.
|
NA
|
NA
|
|
The Role of Sex in Malaria-COVID19 Coinfection and Some Associated Factors in Rivers State, Nigeria.
|
NA
|
NA
|
|
Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.
|
NA
|
NA
|
|
USE OF REMDESIVIR IN PATIENTS WITH COVID-19 ON HEMODIALYSIS- A STUDY OF SAFETY AND TOLERANCE.
|
NA
|
NA
|
|
Host-Viral Interactions Revealed among Shared Transcriptomics Signatures of ARDS and Thrombosis: A Clue into COVID-19 Pathogenesis.
|
NA
|
NA
|
|
Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia.
|
NA
|
NA
|
|
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective.
|
NA
|
NA
|
|
Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting real-world data from a multicenter observational study targeting inflammatory and infectious dermatoses.
|
NA
|
NA
|
|
Group therapy via videoconferencing for individuals with early psychosis: A pilot study.
|
NA
|
NA
|
|
Recommendations on the management of multiple myeloma in 2020.
|
NA
|
NA
|
|
A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management.
|
NA
|
NA
|
|
Pericytes Within A Pulmonary Neurovascular Unit in Coronavirus Disease 2019 Elicited Pathological Changes.
|
NA
|
NA
|
|
The Gross National Happiness Framework and the Health System Response to the COVID-19 Pandemic in Bhutan.
|
NA
|
NA
|
|
Harmful consequences of COVID-19 fear in patients with cancer.
|
NA
|
NA
|
|
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.
|
NA
|
NA
|
|
COVID-19 in children treated with immunosuppressive medication for kidney diseases.
|
NA
|
NA
|
|
Effectiveness of early treatment of lopinavir-ritonavir in patients with severe COVID-19: a case series.
|
NA
|
NA
|
|
Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress.
|
NA
|
NA
|
|
The role of biomaterials and three dimensional (3D) in vitro tissue models in fighting against COVID-19.
|
NA
|
NA
|
|
Cardiac arrhythmias in patients with SARS-CoV‑2 infection and effects of the lockdown on invasive rhythmological therapy.
|
NA
|
NA
|
|
The paradox of the link between health literacy and health promotion: the case of COVID-19.
|
NA
|
NA
|
|
Application of Remote Follow-Up Via the WeChat Platform for Patients who Underwent Congenital Cardiac Surgery During the COVID-19 Epidemic.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation in COVID-19 Treatment: a Systematic Literature Review.
|
NA
|
NA
|
|
Association between oxygen saturation/fraction of inhaled oxygen and mortality in patients with COVID-19 associated pneumonia requiring oxygen therapy.
|
NA
|
NA
|
|
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
|
NA
|
NA
|
|
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.
|
NA
|
NA
|
|
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City.
|
NA
|
NA
|
|
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
|
NA
|
NA
|
|
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19.
|
NA
|
NA
|
|
DeepDILI: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation.
|
NA
|
NA
|
|
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
|
NA
|
NA
|
|
Clinical Manifestation of Patients Who Died Due to COVID-19; A Retrospective Study from Qom-Iran.
|
NA
|
NA
|
|
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany.
|
NA
|
NA
|
|
On the molecular structure of Remdesivir for the treatment of Covid-19.
|
NA
|
NA
|
|
Natural history of COVID-19 and therapeutic options.
|
NA
|
NA
|
|
Preliminary experiences in acute occupational therapy for in-patients with coronavirus-19 (COVID-19): leveraging assistive technology in three case studies of male veterans.
|
NA
|
NA
|
|
Different aspects of convalescent plasma therapy for COVID-19 treatment; a critical review.
|
NA
|
NA
|
|
Evolving management strategies for lymphomas during the COVID-19 pandemic.
|
NA
|
NA
|
|
Herbal medicine, a reliable support in COVID therapy.
|
NA
|
NA
|
|
Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19.
|
NA
|
NA
|
|
Heart failure and COVID-19: synergism of two inflammatory conditions?
|
NA
|
NA
|
|
A rapid response and treatment service for care homes: a case study.
|
NA
|
NA
|
|
Awake-Prone Positioning Strategy for Non-Intubated Hypoxic Patients with COVID-19: A Pilot Trial with Embedded Implementation Evaluation.
|
NA
|
NA
|
|
Comparison of Critical Care Occupancy and Outcomes of Critically ill Patients during the 2020 COVID-19 Winter Surge and 2009 H1N1 Influenza Pandemic in Australia.
|
NA
|
NA
|
|
Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
|
NA
|
NA
|
|
Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.
|
NA
|
NA
|
|
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
|
NA
|
NA
|
|
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.
|
NA
|
NA
|
|
[COVID-19-related respiratory distress in emergency departments: reality and perspectives.]
|
NA
|
NA
|
|
[Non-intensive care of COVID-19 patients: treatment plan and therapeutic orientations.]
|
NA
|
NA
|
|
[The role of thoracic CT scan, a triage tool for suspected COVID-19 cases].
|
NA
|
NA
|
|
[Management of flows and supply shortages of health products in hospitals during the COVID-19 crisis].
|
NA
|
NA
|
|
A systematic review of ECG findings in patients with COVID-19.
|
NA
|
NA
|
|
Cardiovascular complications and its impact on outcomes in COVID-19.
|
NA
|
NA
|
|
[COVID-19: risks of psychological trauma for patients in intensive care or for their families].
|
NA
|
NA
|
|
Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.
|
NA
|
NA
|
|
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
|
NA
|
NA
|
|
Comprehensive Landscape of Heparin Therapy for COVID-19.
|
NA
|
NA
|
|
[Impact of COVID-19 pandemic on breast and gynecologic cancers management. Experience of the Surgery Department in the Nice Anticancer Center].
|
NA
|
NA
|
|
Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre.
|
NA
|
NA
|
|
Impact of COVID-19 lockdown in children with neurological disorders in Italy.
|
NA
|
NA
|
|
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
|
NA
|
NA
|
|
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study.
|
NA
|
NA
|
|
Tocilizumab in the Management of COVID-19: A Preliminary Report.
|
NA
|
NA
|
|
Patient characterization and adverse health care-related events in SARS-CoV-2 infected patients who died in a tertiary hospital.
|
NA
|
NA
|
|
[Control of SARS-CoV-2 in prisons].
|
NA
|
NA
|
|
Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment.
|
NA
|
NA
|
|
Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease.
|
NA
|
NA
|
|
Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP).
|
NA
|
NA
|
|
Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review.
|
NA
|
NA
|
|
The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS.
|
NA
|
NA
|
|
Intraocular Pressure Telemetry for Managing Glaucoma during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Impact of Integrating Palliative Medicine Into COVID-19 Critical Care.
|
NA
|
NA
|
|
Palliative Care Consultation in Hospitalized Patients With COVID-19: A Retrospective Study of Characteristics, Outcomes, and Unmet Needs.
|
NA
|
NA
|
|
COVID-19 vaccines: The status and perspectives in delivery points of view.
|
NA
|
NA
|
|
The Impact of COVID-19 Surge on Clinical Palliative Care: A Descriptive Study From a New York Hospital System.
|
NA
|
NA
|
|
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).
|
NA
|
NA
|
|
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
|
NA
|
NA
|
|
Obesity - A Risk Factor for Psoriasis and COVID-19.
|
NA
|
NA
|
|
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies.
|
NA
|
NA
|
|
The Impact of the Novel Coronavirus Disease 2019 on Therapy Service Delivery for Children with Disabilities.
|
NA
|
NA
|
|
Treatment of a case of COVID-19 by intravenous immunoglobulin.
|
NA
|
NA
|
|
No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
|
NA
|
NA
|
|
A COMMENTARY ON IMPROVING CLOZAPINE ACCESSIBILITY AND REDUCING TREATMENT COST.
|
NA
|
NA
|
|
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
|
NA
|
NA
|
|
Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?
|
NA
|
NA
|
|
SARS-CoV-2 RNA monitoring in wastewater as a potential early warning system for COVID-19 transmission in the community: A temporal case study.
|
NA
|
NA
|
|
Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.
|
NA
|
NA
|
|
Importance of infection control and continence management plans in assisted living communities during the COVID-19 pandemic.
|
NA
|
NA
|
|
Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.
|
NA
|
NA
|
|
4-Aminoquinoline compounds from the Spanish flu to COVID-19.
|
NA
|
NA
|
|
Experience of South American MS and/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine.
|
NA
|
NA
|
|
Efficient detection of SARS-CoV-2 RNA in the solid fraction of wastewater.
|
NA
|
NA
|
|
Clinico-epidemiological characteristics of Kawasaki-like disease in paediatric patients with COVID-19: a protocol for rapid living systematic review.
|
NA
|
NA
|
|
Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial.
|
NA
|
NA
|
|
Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Improving Hospital Oxygen Systems for COVID-19 in Low-Resource Settings: Lessons From the Field.
|
NA
|
NA
|
|
Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.
|
NA
|
NA
|
|
Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19.
|
NA
|
NA
|
|
Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
|
NA
|
NA
|
|
Four Cases of Coronavirus Disease 2019 Transferred from a Cruise Ship.
|
NA
|
NA
|
|
Remdesivir for the treatment of COVID-19: a living systematic review.
|
NA
|
NA
|
|
Macrolides for the treatment of COVID-19: a living, systematic review.
|
NA
|
NA
|
|
Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19.
|
NA
|
NA
|
|
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.
|
NA
|
NA
|
|
Calcification of the thoracic aorta on low-dose chest CT predicts severe COVID-19.
|
NA
|
NA
|
|
Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective.
|
NA
|
NA
|
|
[Digital innovation in medicine: the COVID-19 pandemic as an accelerator of “digital health”].
|
NA
|
NA
|
|
The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre.
|
NA
|
NA
|
|
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review.
|
NA
|
NA
|
|
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
|
NA
|
NA
|
|
Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation.
|
NA
|
NA
|
|
Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients.
|
NA
|
NA
|
|
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
|
NA
|
NA
|
|
[COVID-19 and acute kidney injury in the intensive care unit].
|
NA
|
NA
|
|
Clinical features and radiological manifestations of COVID-19 disease.
|
NA
|
NA
|
|
Multimodality imaging in COVID-19 patients: A key role from diagnosis to prognosis.
|
NA
|
NA
|
|
Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities.
|
NA
|
NA
|
|
Euglycemic DKA (euDKA) as a presentation of COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound.
|
NA
|
NA
|
|
Thymosin alpha 1: A comprehensive review of the literature.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs.
|
NA
|
NA
|
|
Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections.
|
NA
|
NA
|
|
“Recovering With Nature”: A Review of Ecotherapy and Implications for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications.
|
NA
|
NA
|
|
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2.
|
NA
|
NA
|
|
Telemedicine in Heart Failure During COVID-19: A Step Into the Future.
|
NA
|
NA
|
|
Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19.
|
NA
|
NA
|
|
A critical review of emerging technologies for tackling COVID-19 pandemic.
|
NA
|
NA
|
|
The Assessment of Convalescent Plasma Efficacy against COVID-19.
|
NA
|
NA
|
|
Design and implementation of a temporary emergency department-intensive care unit patient care model during the COVID-19 pandemic surge.
|
NA
|
NA
|
|
COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment.
|
NA
|
NA
|
|
An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease.
|
NA
|
NA
|
|
COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms.
|
NA
|
NA
|
|
Management of Intractable Pain in Patients With Implanted Spinal Cord Stimulation Devices During the COVID-19 Pandemic Using a Remote and Wireless Programming System.
|
NA
|
NA
|
|
MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics.
|
NA
|
NA
|
|
L.): A Brief Review of the Advances and Challenges.
|
NA
|
NA
|
|
SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: A case report.
|
NA
|
NA
|
|
Home treatment of type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome) an alternative at this time of COVID-19 pandemic: A case in Peru.
|
NA
|
NA
|
|
Heatstroke-like symptoms in a patient with coronavirus disease pneumonia.
|
NA
|
NA
|
|
Hemophagocytic Lymphohistiocytosis as the Presenting Manifestation of Relapsed Classic Hodgkin’s Lymphoma in the Presence of Concurrent Human Immunodeficiency Virus, Genital Herpes, Epstein-Barr Virus and Mycobacterium Avium Complex Infection.
|
NA
|
NA
|
|
The Structure and the Outcome of Telephone-Based Cardiac Consultations During Lockdown: A Lesson From COVID-19.
|
NA
|
NA
|
|
Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
|
NA
|
NA
|
|
The Impact of the COVID-19 Epidemic on Orthodontic Patients in China: An Analysis of Posts on Weibo.
|
NA
|
NA
|
|
Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies.
|
NA
|
NA
|
|
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse.
|
NA
|
NA
|
|
Retrospective investigation of organization and examination results of the state examination in restorative dentistry, endodontology and periodontology under simulated conditions in times of Covid-19 compared to standard conditions when treating patients.
|
NA
|
NA
|
|
approach.
|
NA
|
NA
|
|
Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its application during the pandemic.
|
NA
|
NA
|
|
Argumentum ad Ignorantiam: Smartphone-Connected Listening Devices.
|
NA
|
NA
|
|
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database.
|
NA
|
NA
|
|
The Association between Chronic Use of Renin-Angiotensin-Aldosterone System Blockers and in-Hospital Adverse Events among COVID-19 Patients with Hypertension.
|
NA
|
NA
|
|
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
|
NA
|
NA
|
|
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs.
|
NA
|
NA
|
|
PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships.
|
NA
|
NA
|
|
Hydroxychloroquine in COVID-19 Patients: Pros and Cons.
|
NA
|
NA
|
|
Bibliotherapy: Reading OVID During COVID.
|
NA
|
NA
|
|
Thyroid Hormone Changes in Early Pregnancy Along With the COVID-19 Pandemic.
|
NA
|
NA
|
|
Current directions, conceptions and viewpoints on 2019-nCoV (Review).
|
NA
|
NA
|
|
Treatment of unusual hangman’s fracture in cluster region during coronavirus 2019 pandemic.
|
NA
|
NA
|
|
COVID-19: The First 30 Days at a UK Level 1 Trauma Centre and Lessons Learnt.
|
NA
|
NA
|
|
Icosapent Ethyl (Vascepa®) for the Treatment of Acute, Severe Pancreatitis.
|
NA
|
NA
|
|
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study.
|
NA
|
NA
|
|
Is COVID-19 Fatality Rate Associated with Malaria Endemicity?
|
NA
|
NA
|
|
Assessing the role of the universal addition of CT thorax to CT abdomen and pelvis in the COVID era. A retrospective multicentre cohort study.
|
NA
|
NA
|
|
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
|
NA
|
NA
|
|
Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
|
NA
|
NA
|
|
Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries.
|
NA
|
NA
|
|
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2.
|
NA
|
NA
|
|
Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
|
NA
|
NA
|
|
Hypercoagulopathy in Severe COVID-19: Implications for Acute Care.
|
NA
|
NA
|
|
Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
|
NA
|
NA
|
|
Editorial Perspective: Rethinking child and adolescent mental health care after COVID-19.
|
NA
|
NA
|
|
COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations.
|
NA
|
NA
|
|
Screening donors for COVID-19 convalescent plasma.
|
NA
|
NA
|
|
Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.
|
NA
|
NA
|
|
) as a potential treatment for acute and chronic fatigue.
|
NA
|
NA
|
|
Predicting outcomes and sudden gains from initial in-session interactions during remote cognitive-behavioural therapy for severe health anxiety.
|
NA
|
NA
|
|
Motivators of and barriers to becoming a COVID-19 convalescent plasma donor: A survey study.
|
NA
|
NA
|
|
Survival prediction algorithms for COVID-19 patients admitted to a UK district general hospital.
|
NA
|
NA
|
|
COVID-19 from the perspective of dentists: A case report and brief review of more than 170 cases.
|
NA
|
NA
|
|
Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.
|
NA
|
NA
|
|
Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
|
NA
|
NA
|
|
Might proton pump or sodium-hydrogen exchanger inhibitors be of value to ameliorate SARs-CoV-2 pathophysiology?
|
NA
|
NA
|
|
Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population.
|
NA
|
NA
|
|
[TREATMENT OF ONCOLOGY PATIENTS DURING THE CORONA VIRUS ERA].
|
NA
|
NA
|
|
[A DELICATE BALANCE OF ONCOLOGY PRACTICE DURING THE COVID-19 PANDEMIC].
|
NA
|
NA
|
|
[LEGAL ASPECTS OF TELEMEDICINE].
|
NA
|
NA
|
|
[Differential diagnosis of high altitude pulmonary edema and COVID-19 with computed tomography feature].
|
NA
|
NA
|
|
Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
|
NA
|
NA
|
|
[Characteristics and outcome of 70 ventilated COVID-19 patients : Summary after the first wave at a university center].
|
NA
|
NA
|
|
Venous Doppler ultrasound in critically Ill COVID-19 patients: game changer in anticoagulation therapy.
|
NA
|
NA
|
|
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
|
NA
|
NA
|
|
The effects of transition to technician-delivered telehealth ABA treatment during the COVID-19 crisis: A preliminary analysis.
|
NA
|
NA
|
|
The COVID-19 pandemic and dental residency training in Nigeria.
|
NA
|
NA
|
|
Treatment management of COVID-19 positive patients with renal colic secondary to distal ureteral stone.
|
NA
|
NA
|
|
Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy.
|
NA
|
NA
|
|
Development of a Low-Cost Cotton-Tipped Electrochemical Immunosensor for the Detection of SARS-CoV-2.
|
NA
|
NA
|
|
Does Hyperbaric Oxygen Improve Lower Extremity Ulcer Outcomes?
|
NA
|
NA
|
|
Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States.
|
NA
|
NA
|
|
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy.
|
NA
|
NA
|
|
Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis.
|
NA
|
NA
|
|
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives.
|
NA
|
NA
|
|
Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.
|
NA
|
NA
|
|
Rural disparities in early childhood well child visit attendance.
|
NA
|
NA
|
|
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.
|
NA
|
NA
|
|
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness.
|
NA
|
NA
|
|
COVID-19 Infodemic and Public Trust from the Perspective of Public and Global Mental Health.
|
NA
|
NA
|
|
Telepsychiatry in the Time of the COVID-19 and Earthquake in Zagreb as Odysseus between Scylla and Charybdis.
|
NA
|
NA
|
|
Peer Education Intervention on Adolescents’ Anxiety, Depression, and Sleep Disorder during the COVID-19 Pandemic.
|
NA
|
NA
|
|
SARSCoV-2 Psychosomatic Effects and Fear of Stigma on the Discharge Day of Infected Individuals: SAPFO Study.
|
NA
|
NA
|
|
Potential secondary transmission of SARS-CoV-2 via wastewater.
|
NA
|
NA
|
|
Efficacy and safety of mesenchymal stem cells for the treatment of patients infected with COVID-19: a systematic review and meta-analysis protocol.
|
NA
|
NA
|
|
Clinical characteristics and viral shedding kinetics of 38 asymptomatic patients with coronavirus disease 2019: A retrospective observational study.
|
NA
|
NA
|
|
Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia.
|
NA
|
NA
|
|
Internal treatment in traditional Chinese medicine for patients with COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
The effects of exercise therapy on the prognosis of patients with COVID-19: A protocol for systematic review.
|
NA
|
NA
|
|
A retrospective view of pediatric cases infected with SARS-CoV-2 of a middle-sized city in mainland China.
|
NA
|
NA
|
|
Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on “Internal and External Relieving -Truncated Torsion” strategy.
|
NA
|
NA
|
|
Nursing Interventions to Prevent Delirium in Critically Ill Patients in the Intensive Care Unit during the COVID19 Pandemic-Narrative Overview.
|
NA
|
NA
|
|
Understanding South Korea’s Response to the COVID-19 Outbreak: A Real-Time Analysis.
|
NA
|
NA
|
|
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics.
|
NA
|
NA
|
|
Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials.
|
NA
|
NA
|
|
Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results.
|
NA
|
NA
|
|
Adherence to intravenous biological treatment in inflammatory bowel disease patients during the COVID-19 pandemic.
|
NA
|
NA
|
|
The fight against human viruses: how NMR can help.
|
NA
|
NA
|
|
The potential mechanism of N-acetylcysteine in treating COVID-19.
|
NA
|
NA
|
|
Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19.
|
NA
|
NA
|
|
ACE2 as a potential target for management of novel coronavirus (nCoV- 2019).
|
NA
|
NA
|
|
An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
|
NA
|
NA
|
|
A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2.
|
NA
|
NA
|
|
Drug discovery of small molecules for the treatment of COVID-19: A review on clinical studies.
|
NA
|
NA
|
|
Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and how do They Behave?
|
NA
|
NA
|
|
Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study.
|
NA
|
NA
|
|
Statistical power in COVID-19 case-control host genomic study design.
|
NA
|
NA
|
|
The immune system view of the coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
After COVID-19: The Way We Die from Now On.
|
NA
|
NA
|
|
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.
|
NA
|
NA
|
|
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
|
NA
|
NA
|
|
Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study.
|
NA
|
NA
|
|
Risk factors of the severity of COVID-19: A meta-analysis.
|
NA
|
NA
|
|
Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.
|
NA
|
NA
|
|
A review on favipiravir: the properties, function, and usefulness to treat COVID-19.
|
NA
|
NA
|
|
analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection.
|
NA
|
NA
|
|
Platypnea-orthodeoxia in a patient with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.
|
NA
|
NA
|
|
perspective.
|
NA
|
NA
|
|
Deep Venous Thrombosis in COVID-19 Patients: A Cohort Analysis.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old.
|
NA
|
NA
|
|
[Evaluation of COVID-19 emergency and state of alarm impact on Neonatal Screening Programs in Madrid: endocrine and metabolic disorders program and hearing program review.]
|
NA
|
NA
|
|
Risk of a syndemic between COVID-19 and dengue fever in southern Mexico.
|
NA
|
NA
|
|
Tomographic behavior of pneumonia caused by SARS-CoV-2.
|
NA
|
NA
|
|
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction.
|
NA
|
NA
|
|
Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2.
|
NA
|
NA
|
|
Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice.
|
NA
|
NA
|
|
Time to Enhance Immunity via Functional Foods and Supplements: Hope for SARS-CoV-2 Outbreak.
|
NA
|
NA
|
|
The Potentially Recommended Pharmacotherapy for COVID-19.
|
NA
|
NA
|
|
Mucin signature as a potential tool to predict susceptibility to COVID-19.
|
NA
|
NA
|
|
Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia.
|
NA
|
NA
|
|
COVID-19 diagnostic laboratory strategies: modern technologies and development trends (review of literature).
|
NA
|
NA
|
|
Palliative Care as Essential to a Hospital System’s Pandemic Preparedness Planning: How to Get Ready for the Next Wave.
|
NA
|
NA
|
|
Documented Reasons of Cancellation and Rescheduling of Telehealth Appointments During the Pandemic.
|
NA
|
NA
|
|
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
|
NA
|
NA
|
|
Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.
|
NA
|
NA
|
|
COVID-19, ferrosenescence and neurodegeneration, a mini-review.
|
NA
|
NA
|
|
Conus venom fractions inhibit the adhesion of Plasmodium falciparum erythrocyte membrane protein 1 domains to the host vascular receptors.
|
NA
|
NA
|
|
Cancer treatment in the coronavirus disease pandemic.
|
NA
|
NA
|
|
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak.
|
NA
|
NA
|
|
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study.
|
NA
|
NA
|
|
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
|
NA
|
NA
|
|
Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.
|
NA
|
NA
|
|
Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study.
|
NA
|
NA
|
|
Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System.
|
NA
|
NA
|
|
Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology.
|
NA
|
NA
|
|
Disinfection Treatments of Disposable Respirators Influencing the Bactericidal/Bacteria Removal Efficiency, Filtration Performance, and Structural Integrity.
|
NA
|
NA
|
|
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
|
NA
|
NA
|
|
Effect of Sex on Clinical Outcomes in Patients with Coronavirus Disease: A Population-Based Study.
|
NA
|
NA
|
|
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
|
NA
|
NA
|
|
Current Status and Future Prospects of Perinatal Stem Cells.
|
NA
|
NA
|
|
Point of Care Diagnostics in the Age of COVID-19.
|
NA
|
NA
|
|
Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
|
NA
|
NA
|
|
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
|
NA
|
NA
|
|
Plant-Based Vaccines: The Way Ahead?
|
NA
|
NA
|
|
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
|
NA
|
NA
|
|
Development of Case Numbers during the COVID-19 Pandemic in a Center of Maximum-Care for Traumatology and Orthopedic Oncology.
|
NA
|
NA
|
|
Sterols and Triterpenes: Antiviral Potential Supported by In-Silico Analysis.
|
NA
|
NA
|
|
Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19.
|
NA
|
NA
|
|
The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19.
|
NA
|
NA
|
|
Dietary Supplements during COVID-19 Outbreak. Results of Google Trends Analysis Supported by PLifeCOVID-19 Online Studies.
|
NA
|
NA
|
|
Take-Home Messages from the COVID-19 Pandemic: Strengths and Pitfalls of the Italian National Health Service from a Medico-Legal Point of View.
|
NA
|
NA
|
|
Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
|
NA
|
NA
|
|
The Managerial Implications of the Key Performance Indicators in Healthcare Sector: A Cluster Analysis.
|
NA
|
NA
|
|
The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review.
|
NA
|
NA
|
|
Development of a Family-Friendly System for Japanese Parents Infected With COVID-19.
|
NA
|
NA
|
|
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.
|
NA
|
NA
|
|
Progress in understanding COVID-19: insights from the omics approach.
|
NA
|
NA
|
|
Impacts of the COVID-19 outbreak on visits and treatments for patients with ureteral stones in a general hospital emergency department.
|
NA
|
NA
|
|
Impacts of COVID-19 on residential treatment programs for substance use disorder.
|
NA
|
NA
|
|
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.
|
NA
|
NA
|
|
Cross-sectional analysis to explore the awareness, attitudes and actions of UK adults at high risk of severe illness from COVID-19.
|
NA
|
NA
|
|
The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries.
|
NA
|
NA
|
|
The Clinical Laboratory: A Key Player in Diagnosis and Management of COVID-19.
|
NA
|
NA
|
|
Improved COVID-19 Testing by Extraction-Free SARS-CoV-2 RT-PCR.
|
NA
|
NA
|
|
Clinical and computed tomography features in patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Necrotizing Soft Tissue Infection of the Breast during COVID-19 Pandemic.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics of 35 children with COVID-19 in Beijing, China.
|
NA
|
NA
|
|
Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children.
|
NA
|
NA
|
|
Progresses in clinical studies on antiviral therapies for COVID-19-Experience and lessons in design of clinical trials.
|
NA
|
NA
|
|
Type I interferon: From innate response to treatment for COVID-19.
|
NA
|
NA
|
|
Cell-mediated immunity to SARS-CoV-2.
|
NA
|
NA
|
|
Frequent neurocognitive deficits after recovery from mild COVID-19.
|
NA
|
NA
|
|
Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry.
|
NA
|
NA
|
|
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
|
NA
|
NA
|
|
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
|
NA
|
NA
|
|
Urgent dental care on a national level during the COVID-19 epidemic.
|
NA
|
NA
|
|
Omega 3 Fatty Acids and COVID-19: A Comprehensive Review.
|
NA
|
NA
|
|
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
|
NA
|
NA
|
|
Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain.
|
NA
|
NA
|
|
Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
Misleading Diagnosis of Radiological Imaging of COVID-19 Pneumonia During Pandemic Era: Risk on the Existence of CMV Infection.
|
NA
|
NA
|
|
The development of neutralizing antibodies against SARS-CoV-2 and their common features.
|
NA
|
NA
|
|
SARS-CoV-2 infection and the antiviral innate immune response.
|
NA
|
NA
|
|
Longitudinal Examination of COVID-19 Public Health Measures on Mental Health for Rural Patients With Serious Mental Illness.
|
NA
|
NA
|
|
Medication Safety in Older Adults: Learning From 2020 as We Launch into 2021.
|
NA
|
NA
|
|
Nervous system complications of COVID-19 with a focus on stroke.
|
NA
|
NA
|
|
Consideration of immunomodulatory actions of morphine in COVID-19 - Short report.
|
NA
|
NA
|
|
Predictors of mechanical ventilation for COVID-19: combined data from three designated hospitals.
|
NA
|
NA
|
|
Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
|
NA
|
NA
|
|
Long-term application of hydroxychloroquine could not prevent the infection of COVID-19.
|
NA
|
NA
|
|
COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?
|
NA
|
NA
|
|
A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.
|
NA
|
NA
|
|
Adherence towards COVID-19 mitigation measures and its associated factors among Gondar City residents: A community-based cross-sectional study in Northwest Ethiopia.
|
NA
|
NA
|
|
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
|
NA
|
NA
|
|
Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia.
|
NA
|
NA
|
|
Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort.
|
NA
|
NA
|
|
Therapeutic approaches against coronaviruses acute respiratory syndrome.
|
NA
|
NA
|
|
A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.
|
NA
|
NA
|
|
Severe Bleeding Complications Resulting in Death Following Anticoagulant Treatment in COVID-19 Surgical Patients.
|
NA
|
NA
|
|
Optimal control on COVID-19 eradication program in Indonesia under the effect of community awareness.
|
NA
|
NA
|
|
Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential.
|
NA
|
NA
|
|
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.
|
NA
|
NA
|
|
Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues.
|
NA
|
NA
|
|
Coagulopathy associated with COVID-19.
|
NA
|
NA
|
|
Ethical connotations of the treatment of COVID-19 disease.
|
NA
|
NA
|
|
Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: A Cohort Study and Analysis of Physiology.
|
NA
|
NA
|
|
ACE2: the molecular doorway to SARS-CoV-2.
|
NA
|
NA
|
|
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis.
|
NA
|
NA
|
|
Cognitive impact of COVID-19: looking beyond the short term.
|
NA
|
NA
|
|
Association between iron status and the risk of adverse outcomes in COVID-19.
|
NA
|
NA
|
|
Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19?
|
NA
|
NA
|
|
Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systematic review and meta-analysis in response to COVID-19.
|
NA
|
NA
|
|
Role of methemoglobin and carboxyhemoglobin levels in predicting COVID-19 prognosis: an observational study.
|
NA
|
NA
|
|
A narrative review of hydrogen-oxygen mixture for medical purpose and the inhaler thereof.
|
NA
|
NA
|
|
Active Video Games and Low-Cost Virtual Reality: An Ideal Therapeutic Modality for Children With Physical Disabilities During a Global Pandemic.
|
NA
|
NA
|
|
Plant Molecular Farming as a Strategy Against COVID-19 - The Italian Perspective.
|
NA
|
NA
|
|
Low-dose radiation therapy for coronavirus disease-2019 pneumonia: Is it time to look beyond apprehensions?
|
NA
|
NA
|
|
Impact of Covid-19 on the restless legs syndrome.
|
NA
|
NA
|
|
COVID-19 and dental sleep medicine: risks, precautions and patient guidance.
|
NA
|
NA
|
|
Effectiveness of a brief behavioral intervention for insomnia (BBII) during the COVID-19 pandemic: Mexican case report.
|
NA
|
NA
|
|
Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic.
|
NA
|
NA
|
|
Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China.
|
NA
|
NA
|
|
Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019.
|
NA
|
NA
|
|
Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes.
|
NA
|
NA
|
|
The urine foaming test in COVID-19 as a useful tool in diagnosis, prognosis and follow-up: Preliminary results.
|
NA
|
NA
|
|
Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019-Related Coagulopathy.
|
NA
|
NA
|
|
FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2.
|
NA
|
NA
|
|
Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.
|
NA
|
NA
|
|
The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Virtual repurposing of ursodeoxycholate and chenodeoxycholate as lead candidates against SARS-Cov2-Envelope protein: A molecular dynamics investigation.
|
NA
|
NA
|
|
Cell-based therapies for COVID-19: A living, systematic review.
|
NA
|
NA
|
|
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.
|
NA
|
NA
|
|
Award for Distinguished Professional Contributions to Independent Practice: Adam S. Weissman.
|
NA
|
NA
|
|
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
|
NA
|
NA
|
|
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.
|
NA
|
NA
|
|
The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
|
NA
|
NA
|
|
Antibody response to SARS-CoV-2 infection in humans: A systematic review.
|
NA
|
NA
|
|
The role of CPAP as a potential bridge to invasive ventilation and as a ceiling-of-care for patients hospitalized with Covid-19-An observational study.
|
NA
|
NA
|
|
Thrombotic thrombocytopenic Purpura as the initial Presentation of COVID-19.
|
NA
|
NA
|
|
Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings.
|
NA
|
NA
|
|
Molecular and cellular mechanisms of liver dysfunction in COVID-19.
|
NA
|
NA
|
|
A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.
|
NA
|
NA
|
|
False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
|
NA
|
NA
|
|
Discharge characteristics and care transitions of hospitalized patients with COVID-19.
|
NA
|
NA
|
|
The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the COVID-19 outbreak: a before and after study.
|
NA
|
NA
|
|
Ethnicity and the relationship between covid-19 and the herpes simplex viruses.
|
NA
|
NA
|
|
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.
|
NA
|
NA
|
|
Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.
|
NA
|
NA
|
|
Responding to the Under-Utilisation of Necessary Health Care in the Time of COVID-19: A Precision Public Health intervention.
|
NA
|
NA
|
|
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Superficial Cerebral Venous Thrombosis and Intracerebral Hematoma in a 48-Year-Old Man with SARS-CoV-2 Infection: A Case Report.
|
NA
|
NA
|
|
A model to rate strategies for managing disease due to COVID-19 infection.
|
NA
|
NA
|
|
Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
|
NA
|
NA
|
|
Position Statement of IACDE for managing dental patients during COVID-19.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus.
|
NA
|
NA
|
|
Immunomodulation and COVID-19: Is There a Winning Combination?
|
NA
|
NA
|
|
Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systematic Review of Clinical Trials.
|
NA
|
NA
|
|
Insomnia in the Italian Population During Covid-19 Outbreak: A Snapshot on One Major Risk Factor for Depression and Anxiety.
|
NA
|
NA
|
|
Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR.
|
NA
|
NA
|
|
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
|
NA
|
NA
|
|
Diabetic patients with COVID-19 need more attention and better glycemic control.
|
NA
|
NA
|
|
Additive manufacturing for COVID-19: Devices, materials, prospects, and challenges.
|
NA
|
NA
|
|
National preparedness survey of pediatric intensive care units with simulation centers during the coronavirus pandemic.
|
NA
|
NA
|
|
Conducting CBT for Anxiety in Children with Autism Spectrum Disorder During COVID-19 Pandemic.
|
NA
|
NA
|
|
Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19.
|
NA
|
NA
|
|
Bidirectional Association Between COVID-19 and the Environment: a Systematic Review.
|
NA
|
NA
|
|
Plasma renin activity has a complex prognostic role in patients with acute coronary syndromes.
|
NA
|
NA
|
|
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.
|
NA
|
NA
|
|
A review on the effect of COVID-19 in type 2 asthma and its management.
|
NA
|
NA
|
|
Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit.
|
NA
|
NA
|
|
The plausible mechanisms of tramadol for treatment of COVID-19.
|
NA
|
NA
|
|
Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced “cytokines storm”.
|
NA
|
NA
|
|
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada.
|
NA
|
NA
|
|
Providing pharmacy services in a basketball arena: Reflections on building a pharmacy in a COVID-19 surge facility.
|
NA
|
NA
|
|
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
|
NA
|
NA
|
|
The effect of the COVID-19 pandemic on community mental health: A psychometric and prevalence study in Turkey.
|
NA
|
NA
|
|
The periodontal senior case clinical challenge: Students’ opinions of a formative virtual assessment during the COVID-19 emergency.
|
NA
|
NA
|
|
Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
|
NA
|
NA
|
|
Pre-pandemic Ageism Toward Older Adults Predicts Behavioral Intentions During the COVID-19 Pandemic.
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients with primary central nervous system lymphoma.
|
NA
|
NA
|
|
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020.
|
NA
|
NA
|
|
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
|
NA
|
NA
|
|
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
|
NA
|
NA
|
|
QTc Prolongation in COVID-19 Patients Using Chloroquine.
|
NA
|
NA
|
|
COVID-19 and congenital heart disease: a case series of nine children.
|
NA
|
NA
|
|
Severe acute kidney injury in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Does volume or occupancy influence emergency access block? A multivariate time series analysis from a single emergency department in Sydney, Australia during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19-positive cancer patients undergoing active anticancer treatment: An analysis of clinical features and outcomes.
|
NA
|
NA
|
|
Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations.
|
NA
|
NA
|
|
Clinical Response to COVID-19 and Utilization of an Emergency Dental Clinic in an Academic Institution.
|
NA
|
NA
|
|
Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs.
|
NA
|
NA
|
|
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.
|
NA
|
NA
|
|
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).
|
NA
|
NA
|
|
Management of acute cardiovascular events in patients with COVID-19.
|
NA
|
NA
|
|
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection.
|
NA
|
NA
|
|
Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management.
|
NA
|
NA
|
|
Covid-19 In Man: A Very Dangerous Affair.
|
NA
|
NA
|
|
Validity and reliability of the Self-Care Activities Screening Scale (SASS-14) during COVID-19 lockdown.
|
NA
|
NA
|
|
Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.
|
NA
|
NA
|
|
Remdesivir: From Ebola to COVID-19.
|
NA
|
NA
|
|
Emergency Care EMTALA Alterations During the COVID-19 Pandemic in the United States.
|
NA
|
NA
|
|
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review.
|
NA
|
NA
|
|
Effects of mechanical ventilation and portable air cleaner on aerosol removal from dental treatment rooms.
|
NA
|
NA
|
|
Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19.
|
NA
|
NA
|
|
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
|
NA
|
NA
|
|
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
|
NA
|
NA
|
|
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy.
|
NA
|
NA
|
|
Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
|
NA
|
NA
|
|
Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of COVID-19 in Children and Adolescents.
|
NA
|
NA
|
|
Predicting outcome in acute severe colitis - controversies in clinical practice in 2021.
|
NA
|
NA
|
|
The impact and prevalence of SARS-CoV-2 in patients with head and neck cancer and acute upper airway infection in a tertiary otorhinolaryngology referral center in Denmark.
|
NA
|
NA
|
|
The evolution of the changes in the clinical course: a multicenter survey-related impression of the ophthalmologists at the peak of the COVID-19 pandemic in Turkey.
|
NA
|
NA
|
|
Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.
|
NA
|
NA
|
|
The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
|
NA
|
NA
|
|
A case of thrombotic thrombocytopenic purpura associated with COVID-19.
|
NA
|
NA
|
|
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19.
|
NA
|
NA
|
|
Ozone potential to fight against SAR-COV-2 pandemic: facts and research needs.
|
NA
|
NA
|
|
The relationship between COVID-19 and the dental damage stage determined by radiological examination.
|
NA
|
NA
|
|
High incidence of venous thrombosis in patients with moderate-to-severe COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 therapeutics: how far do we stand from a remedy?
|
NA
|
NA
|
|
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes.
|
NA
|
NA
|
|
Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial.
|
NA
|
NA
|
|
Facial Pressure Injuries from Prone Positioning in the COVID-19 Era.
|
NA
|
NA
|
|
Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.
|
NA
|
NA
|
|
Dermatologic comorbidities of the patients with severe COVID-19: A case-control study.
|
NA
|
NA
|
|
Does COVID-19 Affect Periodontal and Peri-Implant Diseases?
|
NA
|
NA
|
|
Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea.
|
NA
|
NA
|
|
Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus.
|
NA
|
NA
|
|
Alu retrotransposons and COVID-19 susceptibility and morbidity.
|
NA
|
NA
|
|
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy.
|
NA
|
NA
|
|
Latest updates on COVID-19 vaccines.
|
NA
|
NA
|
|
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
|
NA
|
NA
|
|
Increased secondary infection in COVID-19 patients treated with steroids in New York City.
|
NA
|
NA
|
|
Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid.
|
NA
|
NA
|
|
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic.
|
NA
|
NA
|
|
Recent Clinical Trials on Natural Products and Traditional Chinese Medicine Combating the COVID-19.
|
NA
|
NA
|
|
Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part I: Complexation with iodine in different solvents.
|
NA
|
NA
|
|
Excited-state electronic properties, structural studies, noncovalent interactions, and inhibition of the novel severe acute respiratory syndrome coronavirus 2 proteins in Ripretinib by first-principle simulations.
|
NA
|
NA
|
|
ResGNet-C: A graph convolutional neural network for detection of COVID-19.
|
NA
|
NA
|
|
Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review.
|
NA
|
NA
|
|
Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker.
|
NA
|
NA
|
|
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy.
|
NA
|
NA
|
|
Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period.
|
NA
|
NA
|
|
DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.
|
NA
|
NA
|
|
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations.
|
NA
|
NA
|
|
End-stage heart failure patients should be treated instantly despite a pandemic with all-time available technology to ensure best outcomes.
|
NA
|
NA
|
|
Patient with heart failure: importance to treat valvular diseases.
|
NA
|
NA
|
|
Patient with valvular disease: evolving care patterns.
|
NA
|
NA
|
|
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19.
|
NA
|
NA
|
|
Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2.
|
NA
|
NA
|
|
COVID-19 Disease and Vitamin D: A Mini-Review.
|
NA
|
NA
|
|
COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations.
|
NA
|
NA
|
|
A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters.
|
NA
|
NA
|
|
Necrotizing Skin Findings in Coronavirus Disease 2019: A Case Report.
|
NA
|
NA
|
|
SARS-CoV-2 paediatric inflammatory syndrome.
|
NA
|
NA
|
|
Immunopathogenesis and treatment of cytokine storm in COVID-19.
|
NA
|
NA
|
|
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
|
NA
|
NA
|
|
, and clinical trials.
|
NA
|
NA
|
|
Manganese nanodepot augments host immune response against coronavirus.
|
NA
|
NA
|
|
Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.
|
NA
|
NA
|
|
Fabry disease and COVID-19: international expert recommendations for management based on real-world experience.
|
NA
|
NA
|
|
Air Should Not be There: A Case of Pneumomediastinum and Pneumopericardium in COVID-19.
|
NA
|
NA
|
|
Burton’s Agammaglobulinemia and COVID-19.
|
NA
|
NA
|
|
Recovery From Acute Kidney Injury With Diabetic Ketoacidosis Following SARS-CoV-2 Infection: A Case Report and Literature Review.
|
NA
|
NA
|
|
Warfarin-Induced Calciphylaxis in a COVID-19 Patient.
|
NA
|
NA
|
|
Refuting Spurious COVID-19 Treatment Claims Reduces Demand and Misinformation Sharing.
|
NA
|
NA
|
|
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty?
|
NA
|
NA
|
|
COVID-19 Induced Acute Respiratory Distress Syndrome-A Multicenter Observational Study.
|
NA
|
NA
|
|
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be.
|
NA
|
NA
|
|
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic.
|
NA
|
NA
|
|
Type 2 diabetes is associated with increased risk of critical respiratory illness in patients COVID-19 in a community hospital.
|
NA
|
NA
|
|
Coronavirus (COVID-19) in Nigeria: Survival rate.
|
NA
|
NA
|
|
Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study.
|
NA
|
NA
|
|
Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study.
|
NA
|
NA
|
|
Community hospital experience in the emergency management of COVID-19: Preventing morbidity and preserving resources.
|
NA
|
NA
|
|
Initial assessment and management of respiratory infections in persons with spinal cord injuries and disorders in the COVID-19 era.
|
NA
|
NA
|
|
Intra-fractional patient setup error during fractionated intracranial stereotactic irradiation treatment of patients wearing medical masks: comparison with and without bite block during COVID-19 pandemic.
|
NA
|
NA
|
|
Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19.
|
NA
|
NA
|
|
The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice.
|
NA
|
NA
|
|
Hip fracture care during Covid-19: a regional trauma centre’s experience.
|
NA
|
NA
|
|
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
|
NA
|
NA
|
|
CRISPR-based strategies in infectious disease diagnosis and therapy.
|
NA
|
NA
|
|
Therapeutic targets and potential agents for the treatment of COVID-19.
|
NA
|
NA
|
|
Functional outcome after inpatient rehabilitation in post-intensive care unit COVID-19 patients: findings and clinical implications from a real-practice retrospective study.
|
NA
|
NA
|
|
Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
|
NA
|
NA
|
|
Safety of current immune checkpoint inhibitors in non-small cell lung cancer.
|
NA
|
NA
|
|
Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article.
|
NA
|
NA
|
|
Clinical outcome, viral response and safety profile of chloroquine in COVID-19 patients - initial experience.
|
NA
|
NA
|
|
SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report.
|
NA
|
NA
|
|
Can you hear me now?: Improving palliative care access through telehealth.
|
NA
|
NA
|
|
Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19.
|
NA
|
NA
|
|
Metaproteomics Analysis of SARS-CoV-2-Infected Patient Samples Reveals Presence of Potential Coinfecting Microorganisms.
|
NA
|
NA
|
|
Characteristics of U.S. Army Beneficiary Cases of COVID-19 in Europe, 12 March 2020-17 April 2020.
|
NA
|
NA
|
|
COVID-19: An Update on Pathogenesis and Treatment.
|
NA
|
NA
|
|
Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California.
|
NA
|
NA
|
|
[Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment].
|
NA
|
NA
|
|
Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version).
|
NA
|
NA
|
|
Role of Telemedicine in Follow-up Care of Children with Respiratory Illnesses at a Tertiary Care Hospital - An Ambispective Observational Study.
|
NA
|
NA
|
|
Percutaneous cholecystostomy instead of laparoscopy to treat acute cholecystitis during the COVID-19 pandemic period: single center experience.
|
NA
|
NA
|
|
Clinical approach to patients admitted to the emergency room due to acute cholecystitis during the COVID-19 pandemic and percutaneous cholecystostomy experience.
|
NA
|
NA
|
|
Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation and Extracorporeal Cardiopulmonary Resuscitation for a COVID-19 Paediatric Patient: A Successful Outcome.
|
NA
|
NA
|
|
COVID-19 myocarditis and long-term heart failure sequelae.
|
NA
|
NA
|
|
When should we use corticosteroids in severe community-acquired pneumonia?
|
NA
|
NA
|
|
Acute severe respiratory syndrome coronavirus-2 treatment overview for pediatrics.
|
NA
|
NA
|
|
Cancer Patients in the Era of Coronavirus: What to Fear Most?
|
NA
|
NA
|
|
An overview of cutaneous changes in COVID-19 patients.
|
NA
|
NA
|
|
Is it Safe to Be Transplanted From Living Donors Who Recovered From COVID-19? Experience of 31 Kidney Transplants in a Multicenter Cohort Study From India.
|
NA
|
NA
|
|
Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings.
|
NA
|
NA
|
|
Sodium bicarbonate therapy for acute respiratory acidosis.
|
NA
|
NA
|
|
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Telemedicine for cancer care: implementation across a multicenter community oncology practice.
|
NA
|
NA
|
|
Zinc against COVID-19? Symptom surveillance and deficiency risk groups.
|
NA
|
NA
|
|
Maintaining Mobility in a Patient Who Is Pregnant and Has COVID-19 Requiring Extracorporeal Membrane Oxygenation: A Case Report.
|
NA
|
NA
|
|
Brachial Plexus Neuropathies During the COVID-19 Pandemic: A Retrospective Case Series of 15 Patients in Critical Care.
|
NA
|
NA
|
|
Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID).
|
NA
|
NA
|
|
Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology.
|
NA
|
NA
|
|
COMPULSORY LICENSING IN CONTEXT OF THE COVID-19 PANDEMIC AS A TOOL FOR ENSURING THE BALANCE BETWEEN RIGHTS-HOLDERS’ AND SOCIETY’S INTERESTS.
|
NA
|
NA
|
|
Laboratory Management and Quality Control Practice of SARS-CoV-2 Nucleic Acid Detection.
|
NA
|
NA
|
|
A bleeding GIST in pandemic times, a cooperative approach to a delayed complication, a case report.
|
NA
|
NA
|
|
The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
|
NA
|
NA
|
|
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities.
|
NA
|
NA
|
|
The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications.
|
NA
|
NA
|
|
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
|
NA
|
NA
|
|
methods.
|
NA
|
NA
|
|
A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19.
|
NA
|
NA
|
|
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
|
NA
|
NA
|
|
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.
|
NA
|
NA
|
|
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19.
|
NA
|
NA
|
|
The influence of pre-existing hypertension on coronavirus disease 2019 patients.
|
NA
|
NA
|
|
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy.
|
NA
|
NA
|
|
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study.
|
NA
|
NA
|
|
A Southeast Asian Perspective on the COVID-19 Pandemic: Hemoglobin E (HbE)-Trait Confers Resistance Against COVID-19.
|
NA
|
NA
|
|
Prevalence and Predictors of Stress, anxiety, and Depression among Healthcare Workers Managing COVID-19 Pandemic in India: A Nationwide Observational Study.
|
NA
|
NA
|
|
A novel perspective approach to explore pros and cons of face mask in prevention the spread of SARS-CoV-2 and other pathogens.
|
NA
|
NA
|
|
Novel coronavirus disease (COVID-19) pandemic: A recent mini review.
|
NA
|
NA
|
|
Does COVID19 activates previous chronic pain? A case series.
|
NA
|
NA
|
|
Rapid and label-free detection of COVID-19 using coherent anti-Stokes Raman scattering microscopy.
|
NA
|
NA
|
|
Optimal surveillance mitigation of COVID’19 disease outbreak: Fractional order optimal control of compartment model.
|
NA
|
NA
|
|
Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
|
NA
|
NA
|
|
Teleneurology based management of infantile spasms during COVID-19 pandemic: A consensus report by the South Asia Allied West syndrome research group.
|
NA
|
NA
|
|
Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Withdrawing critical care from patients in a triage situation.
|
NA
|
NA
|
|
Hypokalemia in Patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs.
|
NA
|
NA
|
|
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm.
|
NA
|
NA
|
|
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
|
NA
|
NA
|
|
Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.
|
NA
|
NA
|
|
The interplay between emerging human coronavirus infections and autophagy.
|
NA
|
NA
|
|
The Effect of Ebola Virus Disease on Maternal and Child Health Services and Child Mortality in Sierra Leone, 2014-2015: Implications for COVID-19.
|
NA
|
NA
|
|
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
|
NA
|
NA
|
|
Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.
|
NA
|
NA
|
|
Pulmonary pathology of COVID-19: a review of autopsy studies.
|
NA
|
NA
|
|
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
|
NA
|
NA
|
|
[Ethical aspects of the COVID-19 pandemic in pediatrics].
|
NA
|
NA
|
|
[Expanding ICU facilities in a pandemic scenario].
|
NA
|
NA
|
|
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
|
NA
|
NA
|
|
Psychological distress and postponed fertility care during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19: inflammatory responses, structure-based drug design and potential therapeutics.
|
NA
|
NA
|
|
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.
|
NA
|
NA
|
|
Predictors of mortality of COVID-19 in the general population and nursing homes.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on neuroendocrine tumour services in England.
|
NA
|
NA
|
|
Effect of Covid-19 pandemic process on STEMI patients timeline.
|
NA
|
NA
|
|
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
|
NA
|
NA
|
|
COVID-19 Vaccine and Biologics: An Impending Dilemma.
|
NA
|
NA
|
|
Presentation and Management of Cutaneous Manifestations of COVID-19.
|
NA
|
NA
|
|
Mobile App-Based Remote Patient Monitoring in Acute Medical Conditions: Prospective Feasibility Study Exploring Digital Health Solutions on Clinical Workload During the COVID Crisis.
|
NA
|
NA
|
|
Blockchain-Based Digital Contact Tracing Apps for COVID-19 Pandemic Management: Issues, Challenges, Solutions, and Future Directions.
|
NA
|
NA
|
|
Knowledge About COVID-19 in Brazil: Cross-Sectional Web-Based Study.
|
NA
|
NA
|
|
The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Self-assembled mRNA vaccines.
|
NA
|
NA
|
|
Passive immunization and its rebirth in the era of the COVID-19 pandemic.
|
NA
|
NA
|
|
A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19.
|
NA
|
NA
|
|
COVID-19 and chronic fatigue syndrome: Is the worst yet to come?
|
NA
|
NA
|
|
Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-κB p50 as the regulator of cytokine storm.
|
NA
|
NA
|
|
A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2.
|
NA
|
NA
|
|
The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
|
NA
|
NA
|
|
Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis.
|
NA
|
NA
|
|
Haemostasis in coronavirus disease 2019 - lesson from viscoelastic methods: a systematic review.
|
NA
|
NA
|
|
Intensive care nurses’ experiences during the COVID-19 pandemic: A qualitative study.
|
NA
|
NA
|
|
The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community.
|
NA
|
NA
|
|
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review.
|
NA
|
NA
|
|
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase.
|
NA
|
NA
|
|
Acute dacryoadenitis in a patient with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19.
|
NA
|
NA
|
|
Complement Factors in COVID-19 Therapeutics and Vaccines.
|
NA
|
NA
|
|
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection.
|
NA
|
NA
|
|
Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19): a protocol for a living systematic review.
|
NA
|
NA
|
|
In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
|
NA
|
NA
|
|
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
|
NA
|
NA
|
|
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers.
|
NA
|
NA
|
|
Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
|
NA
|
NA
|
|
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study.
|
NA
|
NA
|
|
Virus containment box for retinopathy of prematurity screening and laser.
|
NA
|
NA
|
|
Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications.
|
NA
|
NA
|
|
Resumption of Elective Orthopaedic Surgery in the US Epicenter of COVID-19.
|
NA
|
NA
|
|
Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis.
|
NA
|
NA
|
|
Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China.
|
NA
|
NA
|
|
Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndrome.
|
NA
|
NA
|
|
Heart transplant recipient survivor from COVID-19: The first case of Turkey.
|
NA
|
NA
|
|
Pneumothorax in COVID-19 Acute Respiratory Distress Syndrome: Case Series.
|
NA
|
NA
|
|
COVID-19 and Its Psychological Impacts on Healthcare Staff - A Multi-Centric Comparative Cross-Sectional Study.
|
NA
|
NA
|
|
Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape.
|
NA
|
NA
|
|
Upper gastrointestinal stenting during the SARS-CoV-2 outbreak: impact of mitigation measures and risk of contamination for patients and staff.
|
NA
|
NA
|
|
Predicting severe COVID-19 in the Emergency Department.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19.
|
NA
|
NA
|
|
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.
|
NA
|
NA
|
|
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient.
|
NA
|
NA
|
|
Pharmacotherapeutics of SARS-CoV-2 Infections.
|
NA
|
NA
|
|
COVID-19: What Do Rheumatologists Need to Know?
|
NA
|
NA
|
|
Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation.
|
NA
|
NA
|
|
Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
|
NA
|
NA
|
|
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience.
|
NA
|
NA
|
|
Age discrimination in critical care triage in South Africa: The law and the allocation of scarce health resources in the COVID-19 pandemic.
|
NA
|
NA
|
|
Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory.
|
NA
|
NA
|
|
Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
|
NA
|
NA
|
|
Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic.
|
NA
|
NA
|
|
Do COVID-19 patients needing extended care in an intensive care unit fall under the ‘emergency medical treatment’ provisions of the South African Constitution?
|
NA
|
NA
|
|
Antihypertensives and their relation to mortality by SARS-CoV-2 infection.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
|
NA
|
NA
|
|
Prevalence and predictors of psychological response during immediate COVID-19 pandemic.
|
NA
|
NA
|
|
Lung ultrasound in the diagnosis and monitoring of 30 children with coronavirus disease 2019.
|
NA
|
NA
|
|
Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2.
|
NA
|
NA
|
|
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients.
|
NA
|
NA
|
|
Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19.
|
NA
|
NA
|
|
Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.
|
NA
|
NA
|
|
Screening supportive care needs, compliance with exercise program, quality of life, and anxiety level during the COVID-19 pandemic in individuals treated with hematopoietic stem cell transplantation.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic and the Importance of Telemedicine in Managing Acute ST Segment Elevation Myocardial Infarction Patients: Preliminary Experience and Literature Review.
|
NA
|
NA
|
|
Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic.
|
NA
|
NA
|
|
Religious Support as a Contribution to Face the Effects of Social Isolation in Mental Health During the Pandemic of COVID-19.
|
NA
|
NA
|
|
Is COVID-19 Gender-sensitive?
|
NA
|
NA
|
|
Telogen effluvium associated with COVID-19 infection.
|
NA
|
NA
|
|
Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic.
|
NA
|
NA
|
|
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
|
NA
|
NA
|
|
Severe Acute Respiratory Syndrome Coronavirus-2-Associated Acute Kidney Injury: A Narrative Review Focused Upon Pathophysiology.
|
NA
|
NA
|
|
Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots.
|
NA
|
NA
|
|
Willingness to Adopt mHealth Among Chinese Parents During the COVID-19 Outbreak: Cross-sectional Questionnaire Study.
|
NA
|
NA
|
|
Effect of early oxygen therapy and antiviral treatment on disease progression in patients with COVID-19: A retrospective study of medical charts in China.
|
NA
|
NA
|
|
Quantitative UV-C dose validation with photochromic indicators for informed N95 emergency decontamination.
|
NA
|
NA
|
|
Optimal periodic closure for minimizing risk in emerging disease outbreaks.
|
NA
|
NA
|
|
The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges.
|
NA
|
NA
|
|
A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors.
|
NA
|
NA
|
|
HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
|
NA
|
NA
|
|
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology.
|
NA
|
NA
|
|
Estimating the Effect of Social Distancing Interventions on COVID-19 in the United States.
|
NA
|
NA
|
|
COVID-19 in Pediatric Granulomatosis with Polyangiitis.
|
NA
|
NA
|
|
Automatic Evaluation of the Lung Condition of COVID-19 Patients Using X-ray Images and Convolutional Neural Networks.
|
NA
|
NA
|
|
Emerging Health and Education Issues Related to Internet Technologies and Addictive Problems.
|
NA
|
NA
|
|
Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network.
|
NA
|
NA
|
|
Psychological impact in the time of COVID-19: A cross-sectional population survey study during confinement.
|
NA
|
NA
|
|
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.
|
NA
|
NA
|
|
Rapid single cell evaluation of human disease and disorder targets using REVEAL: SingleCell™.
|
NA
|
NA
|
|
Anti-synthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities-a case report with literature review.
|
NA
|
NA
|
|
Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo.
|
NA
|
NA
|
|
Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study.
|
NA
|
NA
|
|
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization.
|
NA
|
NA
|
|
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN’ (REGAIN): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Friedreich ataxia in COVID-19 time: current impact and future possibilities.
|
NA
|
NA
|
|
Legionnaires’ disease in the time of COVID-19.
|
NA
|
NA
|
|
Otitis media in coronavirus disease 2019: a case series.
|
NA
|
NA
|
|
Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
|
NA
|
NA
|
|
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals.
|
NA
|
NA
|
|
Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19.
|
NA
|
NA
|
|
A child with Henoch-Schonlein purpura secondary to a COVID-19 infection.
|
NA
|
NA
|
|
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.
|
NA
|
NA
|
|
How can we build and maintain the resilience of our health care professionals during COVID-19? Recommendations based on a scoping review.
|
NA
|
NA
|
|
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.
|
NA
|
NA
|
|
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.
|
NA
|
NA
|
|
Major Stressors and Coping Strategies of Frontline Nursing Staff During the Outbreak of Coronavirus Disease 2020 (COVID-19) in Alabama.
|
NA
|
NA
|
|
Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project.
|
NA
|
NA
|
|
Obesity Increases the Severity and Mortality of Influenza and COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Hypertension and Electrolyte Disorders in Patients with COVID-19.
|
NA
|
NA
|
|
Challenges posed by COVID-19 and neurosurgical nursing strategies in developing countries.
|
NA
|
NA
|
|
The Role of Vitamin C as Adjuvant Therapy in COVID-19.
|
NA
|
NA
|
|
In-Hospital Mortality and Prediction in an Urban U.S. Population With COVID-19.
|
NA
|
NA
|
|
Treatment Experience With Inhaled Corticosteroids in Combination with Remdesivir and Dexamethasone Among COVID-19 Patients Admitted to a Rural Community Hospital: A Case Series.
|
NA
|
NA
|
|
Association Between Self-Reported Adherence to Preventive Practices and Probability of Turning COVID-19 Positive: A Cross-Sectional Analytical Study.
|
NA
|
NA
|
|
Complete pulmonary recovery after COVID-19 infection requiring extracorporeal membrane oxygenation: A case report.
|
NA
|
NA
|
|
Recent discovery and development on SARS-CoV-2: A review of current literature.
|
NA
|
NA
|
|
Evaluating the effect of nurse-led telephone follow-ups (tele-nursing) on the anxiety levels in people with coronavirus.
|
NA
|
NA
|
|
Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs).
|
NA
|
NA
|
|
COVID-19 handling report for pre-case, case (pre-hospital and hospital), and post-case phases in the elderly as vulnerable populations in 6 Asia Pacific countries.
|
NA
|
NA
|
|
Using flowchart for ophthalmic consultations in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and Telenutrition: Remote Consultation in Clinical Nutrition Practice.
|
NA
|
NA
|
|
Clinical and practical considerations in the design of appropriate compensation schedules following treatment interruptions.
|
NA
|
NA
|
|
Head lice were also affected by COVID-19: a decrease on Pediculosis infestation during lockdown in Buenos Aires.
|
NA
|
NA
|
|
Effects of the COVID-19 pandemic on reperfusion therapy for acute ischemic stroke patients in Huizhou City, China.
|
NA
|
NA
|
|
Active vitamin D supplementation and COVID-19 infections: review.
|
NA
|
NA
|
|
Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc.
|
NA
|
NA
|
|
Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics.
|
NA
|
NA
|
|
Living with respiratory viruses: The next saga in human/viral coexistence?
|
NA
|
NA
|
|
Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: Prone to complications?
|
NA
|
NA
|
|
Pragmatic Recommendations for Identification and Triage of Patients with COVID-19 Disease in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
COVID-19 and Corticosteroids: Unfamiliar but Potentially Fatal Infections That Can Arise following Short-Course Steroid Treatment.
|
NA
|
NA
|
|
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development.
|
NA
|
NA
|
|
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19.
|
NA
|
NA
|
|
Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.
|
NA
|
NA
|
|
Stroke management during the COVID-19 outbreak: challenges and results of a hub-center in Lombardy, Italy.
|
NA
|
NA
|
|
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.
|
NA
|
NA
|
|
COVID-19, rheumatic diseases and immune dysregulation-a perspective.
|
NA
|
NA
|
|
The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
|
NA
|
NA
|
|
A multi-mechanism approach reduces length of stay in the ICU for severe COVID-19 patients.
|
NA
|
NA
|
|
Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
|
NA
|
NA
|
|
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
|
NA
|
NA
|
|
Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 - An in silico study.
|
NA
|
NA
|
|
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency.
|
NA
|
NA
|
|
Psychological Impact of the Pandemic on Ambulatory Cardiometabolic Patients Without Evidence of SARS-CoV-2 Infection. The CorCOVID Latam Psy Study.
|
NA
|
NA
|
|
Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients.
|
NA
|
NA
|
|
Acute Kidney Injury and COVID-19: A Picture from an Intensive Care Unit.
|
NA
|
NA
|
|
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study.
|
NA
|
NA
|
|
Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2.
|
NA
|
NA
|
|
[Covid-19 and clinical-epidemiological research in Italy: proposal of a research agenda on priority topics by the Italian association of epidemiology].
|
NA
|
NA
|
|
Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
|
NA
|
NA
|
|
[Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy].
|
NA
|
NA
|
|
[Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
|
NA
|
NA
|
|
A screening and treatment programme to deal with perinatal anxiety and depression during the COVID-19 pandemic.
|
NA
|
NA
|
|
[Sex/gender differences in COVID-19 lethality: what the data say, and do not say].
|
NA
|
NA
|
|
Clinical management of patients with primary immunodeficiencies during the COVID-19 pandemic.
|
NA
|
NA
|
|
Home-based music therapy for children with developmental disorders during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical Course and Risk Factors of Disease Deterioration in Critically Ill Patients with COVID-19.
|
NA
|
NA
|
|
H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
|
NA
|
NA
|
|
Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2.
|
NA
|
NA
|
|
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
|
NA
|
NA
|
|
Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists.
|
NA
|
NA
|
|
Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review.
|
NA
|
NA
|
|
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.
|
NA
|
NA
|
|
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
|
NA
|
NA
|
|
The State of Melanoma: Emergent Challenges and Opportunities.
|
NA
|
NA
|
|
Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery.
|
NA
|
NA
|
|
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype.
|
NA
|
NA
|
|
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
|
NA
|
NA
|
|
Dental emergencies presenting to maxillofacial units during the COVID-19 pandemic: a five-centre UK hospital study.
|
NA
|
NA
|
|
Stress Management: COVID-19 - Psychological and Spiritual Context.
|
NA
|
NA
|
|
COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil.
|
NA
|
NA
|
|
Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review.
|
NA
|
NA
|
|
Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines.
|
NA
|
NA
|
|
SARS-CoV-2 and Asbestos Exposure: Can Our Experience With Mesothelioma Patients Help Us Understand the Psychological Consequences of COVID-19 and Develop Interventions?
|
NA
|
NA
|
|
Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems.
|
NA
|
NA
|
|
Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity.
|
NA
|
NA
|
|
Dealing with lung cancer in the COVID-19 scenario (A review).
|
NA
|
NA
|
|
Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.
|
NA
|
NA
|
|
The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective.
|
NA
|
NA
|
|
Optimizing Kidney Replacement Therapy During the COVID-19 Pandemic Across a Complex Healthcare System.
|
NA
|
NA
|
|
SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness.
|
NA
|
NA
|
|
Cascaded deep transfer learning on thoracic CT in COVID-19 patients treated with steroids.
|
NA
|
NA
|
|
Addressing the Needs of Migrant Workers in ICUs in Singapore.
|
NA
|
NA
|
|
Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey.
|
NA
|
NA
|
|
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era.
|
NA
|
NA
|
|
Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report.
|
NA
|
NA
|
|
Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction.
|
NA
|
NA
|
|
[Effect of moxibustion on clinical symptoms, peripheral inflammatory indexes and T lymphocyte subsets in COVID-19 patients].
|
NA
|
NA
|
|
The Rights to Life, Dignity and the Highest Attainable Standard of Health: Internationally Influential African Jurisprudence.
|
NA
|
NA
|
|
Clinical Research without Consent: Challenges for COVID-19 Research.
|
NA
|
NA
|
|
Safety of Biological Therapy in Children With Inflammatory Bowel Disease.
|
NA
|
NA
|
|
What Factors Influence Symptom Reporting and Access to Healthcare During an Emerging Infectious Disease Outbreak? A Rapid Review of the Evidence.
|
NA
|
NA
|
|
Evidence of Gender Differences in the Diagnosis and Management of Coronavirus Disease 2019 Patients: An Analysis of Electronic Health Records Using Natural Language Processing and Machine Learning.
|
NA
|
NA
|
|
An Ethical Analysis of Hospital Visitor Restrictions and Masking Requirements During the COVID-19 Pandemic
|
NA
|
NA
|
|
Surveying Tenants of Permanent Supportive Housing in Skid Row about COVID-19.
|
NA
|
NA
|
|
Medical Students’ Response to the COVID-19 Pandemic: Experience and Recommendations from Five Countries.
|
NA
|
NA
|
|
SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
|
NA
|
NA
|
|
Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system.
|
NA
|
NA
|
|
Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany.
|
NA
|
NA
|
|
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
|
NA
|
NA
|
|
Are all cytokine storms the same?
|
NA
|
NA
|
|
Rituximab for the treatment of multiple sclerosis: a review.
|
NA
|
NA
|
|
Learning from pathophysiological aspects of COVID-19 clinical, laboratory, and high-resolution CT features: a retrospective analysis of 128 cases by disease severity.
|
NA
|
NA
|
|
Remotely delivered information, training and support for informal caregivers of people with dementia.
|
NA
|
NA
|
|
Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study.
|
NA
|
NA
|
|
Ethical Implications of COVID-19: Palliative Care, Public Health, and Long-Term Care Facilities.
|
NA
|
NA
|
|
Early Returns on Small Molecule Therapeutics for SARS-CoV-2.
|
NA
|
NA
|
|
Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2).
|
NA
|
NA
|
|
Perceived Utilities of COVID-19 Related Chatbots in Saudi Arabia: a Cross-sectional Study.
|
NA
|
NA
|
|
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for COVID-19 Convalescent Plasma.
|
NA
|
NA
|
|
[COVID-19 in orthopedics].
|
NA
|
NA
|
|
[The Mexican Association of Spine Surgery Guideline for the decision making to perform a spine surgery during the COVID-19 pandemic].
|
NA
|
NA
|
|
Decontamination of common healthcare facility surfaces contaminated with SARS-CoV-2 using peracetic acid dry fogging.
|
NA
|
NA
|
|
iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.
|
NA
|
NA
|
|
Botulinum toxin as an ultrasensitive reporter for bacterial and SARS-CoV-2 nucleic acid diagnostics.
|
NA
|
NA
|
|
Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target.
|
NA
|
NA
|
|
BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19.
|
NA
|
NA
|
|
Spatial analysis of the impact of urban geometry and socio-demographic characteristics on COVID-19, a study in Hong Kong.
|
NA
|
NA
|
|
An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2.
|
NA
|
NA
|
|
[Clinical progression of the first wave of novel coronavirus infection in Ostrava].
|
NA
|
NA
|
|
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience.
|
NA
|
NA
|
|
Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID-19): Multicenter experience of referral hospitals in a large health care system.
|
NA
|
NA
|
|
Effects and safety of herbal medicines among community-dwelling residents during COVID-19 pandemic: A large prospective, randomized controlled trial (RCT).
|
NA
|
NA
|
|
Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab.
|
NA
|
NA
|
|
Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study.
|
NA
|
NA
|
|
Network graph representation of COVID-19 scientific publications to aid knowledge discovery.
|
NA
|
NA
|
|
Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on appendicitis treatment in Germany-a population-based analysis.
|
NA
|
NA
|
|
Chinese Medicine in Fighting against Covid-19: Role and Inspiration.
|
NA
|
NA
|
|
Coronavirus Disease 19 (COVID-19) complicated with post-viral arthritis.
|
NA
|
NA
|
|
Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
|
NA
|
NA
|
|
F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus.
|
NA
|
NA
|
|
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients.
|
NA
|
NA
|
|
Acute stroke care during the first phase of COVID-19 pandemic in Norway.
|
NA
|
NA
|
|
Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection.
|
NA
|
NA
|
|
Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.
|
NA
|
NA
|
|
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19.
|
NA
|
NA
|
|
Immune reactivity during COVID-19: Implications for treatment.
|
NA
|
NA
|
|
Thrombosis and Haemostasis challenges in COVID-19 - Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review.
|
NA
|
NA
|
|
Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?
|
NA
|
NA
|
|
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.
|
NA
|
NA
|
|
Supportive care in patients with cancer during the COVID-19 pandemic.
|
NA
|
NA
|
|
Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
|
NA
|
NA
|
|
Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020.
|
NA
|
NA
|
|
Sarcopenia: An underlying treatment target during the COVID-19 pandemic.
|
NA
|
NA
|
|
A longitudinal study on clinically relevant self-reported depression, anxiety and acute stress features among Italian community-dwelling adults during the COVID-19 related lockdown: Evidence of a predictive role for baseline dysfunctional personality dimensions.
|
NA
|
NA
|
|
Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study).
|
NA
|
NA
|
|
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
|
NA
|
NA
|
|
Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic.
|
NA
|
NA
|
|
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study.
|
NA
|
NA
|
|
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments.
|
NA
|
NA
|
|
Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre.
|
NA
|
NA
|
|
Maintaining Standards in Colorectal Cancer Surgery During the Global Pandemic: A Cohort Study.
|
NA
|
NA
|
|
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
|
NA
|
NA
|
|
Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?
|
NA
|
NA
|
|
A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
|
NA
|
NA
|
|
Trends in Dental Medication Prescribing in Australia during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The Implementation of an Emergency Medicine Telehealth System During a Pandemic.
|
NA
|
NA
|
|
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases.
|
NA
|
NA
|
|
[Characteristics and evolution of COVID-19 in an urban Health Center at the pandemic beginning’].
|
NA
|
NA
|
|
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
|
NA
|
NA
|
|
Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19.
|
NA
|
NA
|
|
Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.
|
NA
|
NA
|
|
Conservative Approach for Treatment of Isolated Mandibular Fractures, the Adaptations During COVID 19 Pandemic.
|
NA
|
NA
|
|
Effects of COVID-19 lockdown phases in India: an atmospheric perspective.
|
NA
|
NA
|
|
Drug Shortage and Critical Medication Inventory Management at a Children’s Hospital During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.
|
NA
|
NA
|
|
Assessment of Depression Severity During Coronavirus Disease 2019 Pandemic Among the Palestinian Population: A Growing Concern and an Immediate Consideration.
|
NA
|
NA
|
|
Reduction of Physical Activity Levels During the COVID-19 Pandemic Might Negatively Disturb Sleep Pattern.
|
NA
|
NA
|
|
The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19.
|
NA
|
NA
|
|
Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.
|
NA
|
NA
|
|
Network pharmacology-based analysis of Zukamu granules for the treatment of COVID-19.
|
NA
|
NA
|
|
Carbon-based nanomaterials for viral infection management.
|
NA
|
NA
|
|
Coronavirus infection and kidney disease: a review of current and emerging evidence.
|
NA
|
NA
|
|
A brief review of the latest pharmacological treatments of COVID-19.
|
NA
|
NA
|
|
Neurologic manifestations in patients with COVID-19: A case report.
|
NA
|
NA
|
|
SARS-CoV-2 infection and psychiatric manifestations in a previous healthy patient.
|
NA
|
NA
|
|
Complete heart block and itchy rash in a patient with COVID-19.
|
NA
|
NA
|
|
Plasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19.
|
NA
|
NA
|
|
Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2.
|
NA
|
NA
|
|
Surgical approach for kidney transplantation under spinal anesthesia.
|
NA
|
NA
|
|
COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review.
|
NA
|
NA
|
|
The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis.
|
NA
|
NA
|
|
) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study.
|
NA
|
NA
|
|
Risk Assessment and Crisis Intervention for Youth in a Time of Telehealth.
|
NA
|
NA
|
|
Successful Use of Veno-Venous Extracorporeal Membrane Oxygenation in a Patient With Severe COVID-19 Pneumonia.
|
NA
|
NA
|
|
A Case of Multisystem Inflammatory Syndrome Post-COVID-19 Infection in an Adult.
|
NA
|
NA
|
|
The Impact of the COVID-19 Pandemic on Plastic Surgery Consultations in the Emergency Department.
|
NA
|
NA
|
|
Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection.
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.
|
NA
|
NA
|
|
COVID-19 Unintended Effects on Breast Cancer in Italy After the Great Lockdown.
|
NA
|
NA
|
|
Treatment Therapy Strategies Can Save Lives With Mitigation and Suppression of SARS-CoV-2 Infection: An Evidence Review.
|
NA
|
NA
|
|
Some Questions to Our Chinese Colleagues Pioneering Research Into Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic.
|
NA
|
NA
|
|
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure.
|
NA
|
NA
|
|
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19.
|
NA
|
NA
|
|
Exploring the Potential of Carbon Dots to Combat COVID-19.
|
NA
|
NA
|
|
Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues.
|
NA
|
NA
|
|
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs.
|
NA
|
NA
|
|
Correlates of Psychological Distress in Patients with Parkinson’s Disease During the COVID-19 Outbreak.
|
NA
|
NA
|
|
Matched cohort study on the efficacy of tocilizumab in patients with COVID-19.
|
NA
|
NA
|
|
Friend or Foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment.
|
NA
|
NA
|
|
Newer post-COVID perspective: Teledental encryption by de-multiplexed perceptrons.
|
NA
|
NA
|
|
Deep-LSTM ensemble framework to forecast Covid-19: an insight to the global pandemic.
|
NA
|
NA
|
|
Biologics for atopic diseases: Indication, side effect management, and new developments.
|
NA
|
NA
|
|
An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics.
|
NA
|
NA
|
|
Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report.
|
NA
|
NA
|
|
Community-Level Prevention of Childhood Maltreatment: Next Steps in a World with COVID-19.
|
NA
|
NA
|
|
Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19.
|
NA
|
NA
|
|
ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.
|
NA
|
NA
|
|
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study.
|
NA
|
NA
|
|
High fitness levels, frequent sauna bathing and risk of pneumonia in a cohort study: Are there potential implications for COVID-19?
|
NA
|
NA
|
|
Interobserver Agreement of Lung Ultrasound Findings of COVID-19.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on the well-being of children with neurodevelopmental disabilities and their parents.
|
NA
|
NA
|
|
Non-pharmacological remedies for upper respiratory diseases in the pandemic COVID-19 era.
|
NA
|
NA
|
|
Application of Plastic Sheet Barrier and Video Intubating Stylet to Protect Tracheal Intubators During Coronavirus Disease 2019 Pandemic: A Taiwan Experience.
|
NA
|
NA
|
|
Superior vena cava syndrome during veno-venous extracorporeal membrane oxygenation for COVID-19.
|
NA
|
NA
|
|
Therapeutic options for COVID-19: a quick review.
|
NA
|
NA
|
|
Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study.
|
NA
|
NA
|
|
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.
|
NA
|
NA
|
|
Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections.
|
NA
|
NA
|
|
Spontaneous pregnancies among infertile couples during assisted reproduction lockdown for COVID-19 pandemic.
|
NA
|
NA
|
|
Olfactory and Gustatory Dysfunctions in COVID-19 Patients: From a Different Perspective.
|
NA
|
NA
|
|
[The disaster task force medical officer as a pivotal decision maker in the superordinate pandemic hospital capacity management : A field report covering the initial COVID-19 surge in a Bavarian district].
|
NA
|
NA
|
|
Reassessing IVIg therapy in chronic inflammatory demyelinating polyradiculoneuropathy during COVID-19: a chance to verify the need for chronic maintenance therapy.
|
NA
|
NA
|
|
Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.
|
NA
|
NA
|
|
Buprenorphine maintenance treatment in patients with opioid use disorder diagnosed with COVID-19.
|
NA
|
NA
|
|
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
|
NA
|
NA
|
|
Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
|
NA
|
NA
|
|
Is Europe facing an opioid epidemic: What does European monitoring data tell us?
|
NA
|
NA
|
|
COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Clinical Features of COVID-19 Infection in Patients Treated at a Large Veterans Affairs Medical Center.
|
NA
|
NA
|
|
Low Rate of SARS-CoV-2 Infection in Adults With Active Cancer Diagnosis in a Nonendemic Region in the United States.
|
NA
|
NA
|
|
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
|
NA
|
NA
|
|
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic.
|
NA
|
NA
|
|
CRISPR systems: Novel approaches for detection and combating COVID-19.
|
NA
|
NA
|
|
Nanocarrier Vaccines for SARS-CoV-2.
|
NA
|
NA
|
|
Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.
|
NA
|
NA
|
|
EMS responses and non-transports during the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review.
|
NA
|
NA
|
|
Xuan Fei Bai Du Fang for treating coronavirus disease 2019: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience.
|
NA
|
NA
|
|
Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis.
|
NA
|
NA
|
|
Therapy of diarrhea in COVID-19 with external treatment of traditional Chinese medicine: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Management of acute coronary syndrome in the context of coronavirus disease 2019.
|
NA
|
NA
|
|
Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Awareness and Knowledge of SARS-CoV-2 Infection among Dental Professionals According to the Turkish National Dental Guidelines.
|
NA
|
NA
|
|
Frontline Healthcare Workers’ Knowledge, Perception and Risk Prevention Practices Regarding COVID-19 in Afghanistan: A Cross-Sectional Study.
|
NA
|
NA
|
|
The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review.
|
NA
|
NA
|
|
COVID-19 Pandemic Stressors and Psychological Symptoms in Breast Cancer Patients.
|
NA
|
NA
|
|
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections.
|
NA
|
NA
|
|
Being a Gambler during the COVID-19 Pandemic: A Study with Italian Patients and the Effects of Reduced Exposition.
|
NA
|
NA
|
|
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.
|
NA
|
NA
|
|
Changing attitudes towards teletherapy in Austrian therapists during the COVID-19 pandemic.
|
NA
|
NA
|
|
Priority-setting dilemmas, moral distress and support experienced by nurses and physicians in the early phase of the COVID-19 pandemic in Norway.
|
NA
|
NA
|
|
Palliative Care for Older Adults with Multimorbidity in the Time of COVID 19.
|
NA
|
NA
|
|
COVID -19 infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment.
|
NA
|
NA
|
|
Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical based Evidence.
|
NA
|
NA
|
|
In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2.
|
NA
|
NA
|
|
“Can nature heal and be a possible remedy for the management of Covid- 19?”
|
NA
|
NA
|
|
JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data.
|
NA
|
NA
|
|
COVID-19-induced sarcopenia and physical deconditioning may require reassessment of surgical risk for patients with cancer.
|
NA
|
NA
|
|
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review.
|
NA
|
NA
|
|
Outcomes and Impact of a Universal COVID-19 Screening Protocol for Asymptomatic Oncology Patients.
|
NA
|
NA
|
|
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
|
NA
|
NA
|
|
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
|
NA
|
NA
|
|
Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis.
|
NA
|
NA
|
|
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.
|
NA
|
NA
|
|
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
|
NA
|
NA
|
|
Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective.
|
NA
|
NA
|
|
Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy.
|
NA
|
NA
|
|
2019-nCoV effects, transmission and preventive measures: an overview.
|
NA
|
NA
|
|
Persistent Complete Heart Block in a Patient with COVID-19 Infection: a Case Report.
|
NA
|
NA
|
|
Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.
|
NA
|
NA
|
|
Bioinformatics resources facilitate understanding and harnessing clinical research of SARS-CoV-2.
|
NA
|
NA
|
|
Challenges and the innovations in the care of advanced heart failure patients during COVID-19.
|
NA
|
NA
|
|
Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
|
NA
|
NA
|
|
Smart secretion management to protect nurses from COVID19 and other infectious diseases.
|
NA
|
NA
|
|
Pragmatic Recommendations for the Prevention and Treatment of Acute Kidney Injury in Patients with COVID-19 in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
Women, opioid use and addiction.
|
NA
|
NA
|
|
Novel 3D segmentation for reliable volumetric assessment of the nasal airway: a CBCT study.
|
NA
|
NA
|
|
Pandemic aspect of dexamethasone: Molecular mechanisms and clinical application.
|
NA
|
NA
|
|
Persistent Post-COVID-19 Inflammatory Interstitial Lung Disease: An Observational Study of Corticosteroid Treatment.
|
NA
|
NA
|
|
Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.
|
NA
|
NA
|
|
[Psychological stress during the COVID-19 pandemic: consequences for psychiatric patients and therapeutic implications].
|
NA
|
NA
|
|
Stroke and digital technology: a wake-up call from COVID-19 pandemic.
|
NA
|
NA
|
|
A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.
|
NA
|
NA
|
|
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany.
|
NA
|
NA
|
|
The Escalating Biomedical Waste Management To Control the Environmental Transmission of COVID-19 Pandemic: A Perspective from Two South Asian Countries.
|
NA
|
NA
|
|
Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil.
|
NA
|
NA
|
|
Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19.
|
NA
|
NA
|
|
Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic.
|
NA
|
NA
|
|
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
|
NA
|
NA
|
|
Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
|
NA
|
NA
|
|
Mental health of staff working in intensive care during COVID-19.
|
NA
|
NA
|
|
Probiotic Effects against Virus Infections: New Weapons for an Old War.
|
NA
|
NA
|
|
Hospital-Acquired SARS-Cov-2 Infections in Patients: Inevitable Conditions or Medical Malpractice?
|
NA
|
NA
|
|
Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.
|
NA
|
NA
|
|
Is There a Relationship between COVID-19 and Hyponatremia?
|
NA
|
NA
|
|
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections.
|
NA
|
NA
|
|
Magnesium in Infectious Diseases in Older People.
|
NA
|
NA
|
|
Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Obesity and COVID-19: 2 The ominous duet affecting the renin-angiotensin system.
|
NA
|
NA
|
|
Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.
|
NA
|
NA
|
|
Post-hospital discharge venous thromboembolism prophylaxis in medically ill patients.
|
NA
|
NA
|
|
Implementation of an integrated care programme to avoid fragility fractures of the hip in older adults in 18 Bavarian hospitals - study protocol for the cluster-randomised controlled fracture liaison service FLS-CARE.
|
NA
|
NA
|
|
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.
|
NA
|
NA
|
|
Depression, risk factors, and coping strategies in the context of social dislocations resulting from the second wave of COVID-19 in Japan.
|
NA
|
NA
|
|
Pre-hospital critical care management of severe hypoxemia in victims of Covid-19: a case series.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on individuals with eating disorders: the role of emotion regulation and exploration of online treatment experiences.
|
NA
|
NA
|
|
Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus.
|
NA
|
NA
|
|
Bacterial but no SARS-CoV-2 contamination after terminal disinfection of tertiary care intensive care units treating COVID-19 patients.
|
NA
|
NA
|
|
Pediatric behavioral telehealth in the age of COVID-19: Brief evidence review and practice considerations.
|
NA
|
NA
|
|
Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.
|
NA
|
NA
|
|
Myocarditis in SARS-CoV-2 negative patients with suspected preceding infection.
|
NA
|
NA
|
|
Work of a paediatric bioethics centre during the COVID-19 pandemic first phase.
|
NA
|
NA
|
|
Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV assay for simultaneous detection of SARS-CoV-2, Influenza A/B and Respiratory Syncytial Viruses in nasopharyngeal specimens.
|
NA
|
NA
|
|
Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19.
|
NA
|
NA
|
|
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
|
NA
|
NA
|
|
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir.
|
NA
|
NA
|
|
Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19?
|
NA
|
NA
|
|
Statins as inhibitors of voltage-gated potassium channels Kv1.3 in cancer cells.
|
NA
|
NA
|
|
Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study.
|
NA
|
NA
|
|
Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19.
|
NA
|
NA
|
|
Impact of COVID-19 on Pregnancy.
|
NA
|
NA
|
|
COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.
|
NA
|
NA
|
|
A disease progression prediction model and nervous system symptoms in coronavirus disease 2019 patients.
|
NA
|
NA
|
|
Effect of Ultraviolet C Disinfection Treatment on the Nanomechanical and Topographic Properties of N95 Respirator Filtration Microfibers.
|
NA
|
NA
|
|
Persistent Hallucinations in a 46-Year-Old Woman After COVID-19 Infection: A Case Report.
|
NA
|
NA
|
|
COVID-19 and Palliative Care Services: Comparative Patterns of Inpatient, Outpatient, and Consultation Services in a Tertiary Care Center in Riyadh.
|
NA
|
NA
|
|
Influenza Vaccination Quality Improvement as a Model for COVID-19 Prophylaxis.
|
NA
|
NA
|
|
The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort.
|
NA
|
NA
|
|
COVID-19 and information and communication technology in radiation oncology: A new paradigm.
|
NA
|
NA
|
|
Diagnosed with TB in the era of COVID-19: patient perspectives in Zambia.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic and Pattern of Patient Care in Otorhinolaryngology Practice in a Tertiary Referral Centre.
|
NA
|
NA
|
|
Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (COVID-19).
|
NA
|
NA
|
|
Suggested modifications in oncology/hematology inpatient service in Saudi Arabia during coronavirus disease-2019 (COVID-19) pandemic.
|
NA
|
NA
|
|
Pathogen Reduction Technology: A Novel Possibility for Inactivation of Blood Products Used in Oral and Periodontal Surgeries.
|
NA
|
NA
|
|
Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review.
|
NA
|
NA
|
|
COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities.
|
NA
|
NA
|
|
COVID-19 ventilator barotrauma management: less is more.
|
NA
|
NA
|
|
A predictive model for respiratory distress in patients with COVID-19: a retrospective study.
|
NA
|
NA
|
|
A narrative review of non-pharmacological management of SARS-CoV-2 respiratory failure: a call for an evidence based approach.
|
NA
|
NA
|
|
Case report of severe PCR-confirmed COVID-19 myocarditis in a European patient manifesting in mid January 2020.
|
NA
|
NA
|
|
A case report of a large intracardiac thrombus in a COVID-19 patient managed with percutaneous thrombectomy and right ventricular mechanical circulatory support.
|
NA
|
NA
|
|
A case report of arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Delayed manifestation of COVID-19 presenting as lower extremity multilevel arterial thrombosis: a case report.
|
NA
|
NA
|
|
Infective endocarditis complicating COVID-19 pneumonia: a case report.
|
NA
|
NA
|
|
Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.
|
NA
|
NA
|
|
Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.
|
NA
|
NA
|
|
A Systematic Review and Meta-Analysis of Clinical Characteristics and Outcomes in Patients With Lung Cancer with Coronavirus Disease 2019.
|
NA
|
NA
|
|
Operational experience of the Dutch helicopter emergency medical services (HEMS) during the initial phase of the COVID-19 pandemic: jeopardy on the prehospital care system?
|
NA
|
NA
|
|
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up.
|
NA
|
NA
|
|
Point-of-care lung ultrasound for the assessment of pneumonia: a narrative review in the COVID-19 era.
|
NA
|
NA
|
|
The swedish covid-19 intensive care cohort: Risk factors of ICU admission and ICU mortality.
|
NA
|
NA
|
|
A comprehensive review of COVID-19 in India: A frequent catch of the information.
|
NA
|
NA
|
|
Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era.
|
NA
|
NA
|
|
Psychopathological effects of the Coronavirus (Sars-CoV-2) imposed lockdown on vulnerable patients in treatment in a mental health outpatient department for migrants and individuals in poor socioeconomic conditions.
|
NA
|
NA
|
|
Regenerative Medicine Approaches in COVID -19 Pneumonia.
|
NA
|
NA
|
|
Using Dental Health Care Personnel During a Crisis : COVID-19 Pandemic in the Bronx, New York.
|
NA
|
NA
|
|
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience.
|
NA
|
NA
|
|
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy).
|
NA
|
NA
|
|
Emergency Remote Training in Psychoanalysis and Psychotherapy: An Initial Assessment from Columbia.
|
NA
|
NA
|
|
Early Outcomes of a National Cancer Center’s Strategy Against COVID-19 Executed Through a Disease Outbreak Response Taskforce.
|
NA
|
NA
|
|
Diet, Nutrition, Obesity, and Their Implications for COVID-19 Mortality: Development of a Marginalized Two-Part Model for Semicontinuous Data.
|
NA
|
NA
|
|
Impact of COVID-19 on hospital admission of acute stroke patients in Bangladesh.
|
NA
|
NA
|
|
Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area.
|
NA
|
NA
|
|
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
|
NA
|
NA
|
|
Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil.
|
NA
|
NA
|
|
Prone positioning as an emerging tool in the care provided to patients infected with COVID-19: a scoping review.
|
NA
|
NA
|
|
Critical analysis on the use of cholecalciferol as a COVID-19 intervention: a narrative review.
|
NA
|
NA
|
|
Socio-economic determinants of global COVID-19 mortalities: policy lessons for current and future pandemics.
|
NA
|
NA
|
|
Myopericarditis caused by severe acute respiratory syndrome coronavirus 2.
|
NA
|
NA
|
|
The Role of Rotational Thromboelastometry during the COVID-19 Pandemic: A Narrative Review.
|
NA
|
NA
|
|
Suggestions for lung function testing in the context of COVID-19.
|
NA
|
NA
|
|
An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.
|
NA
|
NA
|
|
Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets.
|
NA
|
NA
|
|
Is glucagon-like peptide 1 receptor analogues effective and safe in severe COVID-19 patients with type 2 diabetes?-a case report.
|
NA
|
NA
|
|
Liver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study.
|
NA
|
NA
|
|
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
|
NA
|
NA
|
|
Deep learning in the quest for compound nomination for fighting COVID-19.
|
NA
|
NA
|
|
Crosstalk Between Covid-19 And Associated Neurological Disorders: A Review.
|
NA
|
NA
|
|
COVID-19 Pandemic: Influence of Relationship Status on Stress, Anxiety, and Depression in Canada.
|
NA
|
NA
|
|
Fighting viruses with materials science: Prospects for antivirus surfaces, drug delivery systems and artificial intelligence.
|
NA
|
NA
|
|
How can we decide a fair allocation of healthcare resources during a pandemic?
|
NA
|
NA
|
|
Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
|
NA
|
NA
|
|
Protocol for a qualitative study to identify strategies to optimise hospital ePrescribing systems.
|
NA
|
NA
|
|
Rationale for azithromycin in COVID-19: an overview of existing evidence.
|
NA
|
NA
|
|
Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19.
|
NA
|
NA
|
|
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients.
|
NA
|
NA
|
|
Use of Facebook to Serve Information Needs of Persons with Diabetes in the Philippines amid the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19: What Should the General Practitioner Know?
|
NA
|
NA
|
|
Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature.
|
NA
|
NA
|
|
Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study.
|
NA
|
NA
|
|
Experimental Pharmacotherapy for COVID-19: The Latest Advances.
|
NA
|
NA
|
|
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic.
|
NA
|
NA
|
|
First Reported Case in Romania of a Successfully Treated Severe COVID-19 in a Kidney Transplant Recipient: A Focus on Acute Kidney Injury.
|
NA
|
NA
|
|
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
|
NA
|
NA
|
|
Myopericarditis and myositis in a patient with COVID-19: a case report.
|
NA
|
NA
|
|
Intra-cardiac microcomputer allows for innovative telemedicine in chronic heart failure during coronavirus disease-2019 pandemic: a case report.
|
NA
|
NA
|
|
Public interest in spa therapy during the COVID-19 pandemic: analysis of Google Trends data among Turkey.
|
NA
|
NA
|
|
Early experience of aortic surgery during the COVID-19 pandemic in the UK: A multicentre study.
|
NA
|
NA
|
|
Mechanical circulatory support-Challenges, strategies, and preparations.
|
NA
|
NA
|
|
International teleproctoring in neurointerventional surgery and its potential impact on clinical trials in the era of COVID-19: legal and technical considerations.
|
NA
|
NA
|
|
Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors’ Plasma and Other Blood Components.
|
NA
|
NA
|
|
Severe COVID-19: Immunosuppression or Hyperinflammation?
|
NA
|
NA
|
|
Medical Oncology Professionals’ Perceptions of Telehealth Video Visits.
|
NA
|
NA
|
|
Efficacy of synthetic glucocorticoids in COVID-19 endothelites.
|
NA
|
NA
|
|
Predictors of self-perceived health worsening over COVID-19 emergency in ALS.
|
NA
|
NA
|
|
[Delirium as the only symptom of COVID-19 pneumonia in the elderly].
|
NA
|
NA
|
|
[Psychiatry].
|
NA
|
NA
|
|
[HIV in the time of COVID-19 : the meeting between two pandemics].
|
NA
|
NA
|
|
COVID-19 Outbreak During Inpatient Rehabilitation: Impact on Settings and Clinical Course of Neuromusculoskeletal Rehabilitation Patients.
|
NA
|
NA
|
|
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection.
|
NA
|
NA
|
|
Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
|
NA
|
NA
|
|
Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study.
|
NA
|
NA
|
|
Understanding public preferences and trade-offs for government responses during a pandemic: a protocol for a discrete choice experiment in the UK.
|
NA
|
NA
|
|
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19.
|
NA
|
NA
|
|
Impact of altitude on COVID-19 infection and death in the United States: A modeling and observational study.
|
NA
|
NA
|
|
The Impact of the first COVID-19 shelter-in-place announcement on social distancing, difficulty in daily activities, and levels of concern in the San Francisco Bay Area: A cross-sectional social media survey.
|
NA
|
NA
|
|
Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study.
|
NA
|
NA
|
|
Immune response to COVID-19 infection: a double-edged sword.
|
NA
|
NA
|
|
Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on characteristics of retinal detachments: the Canadian experience.
|
NA
|
NA
|
|
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
|
NA
|
NA
|
|
COVID-19 patients may become predisposed to pulmonary arterial hypertension.
|
NA
|
NA
|
|
Teaching Sexual History Taking in Health Care Using Online Technology: A PLISSIT-Plus Zoom Approach During the Coronavirus Disease 2019 Shutdown.
|
NA
|
NA
|
|
COVID-19: Performance study of microplastic inhalation risk posed by wearing masks.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh.
|
NA
|
NA
|
|
Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.
|
NA
|
NA
|
|
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
|
NA
|
NA
|
|
Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study.
|
NA
|
NA
|
|
Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.
|
NA
|
NA
|
|
Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.
|
NA
|
NA
|
|
molecular docking models of the SARS-CoV-2.
|
NA
|
NA
|
|
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
|
NA
|
NA
|
|
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study.
|
NA
|
NA
|
|
International Impact of COVID-19 on the Diagnosis of Heart Disease.
|
NA
|
NA
|
|
Platelet-Rich Plasma for Vocal Fold Scar: A Preliminary Report of Concept.
|
NA
|
NA
|
|
Prone position pressure sores in the COVID-19 pandemic: The Madrid experience.
|
NA
|
NA
|
|
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages.
|
NA
|
NA
|
|
Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients’ behavior.
|
NA
|
NA
|
|
Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.
|
NA
|
NA
|
|
The Impact of COVID-19 Pandemic in Children With Cancer: A Report From Saudi Arabia.
|
NA
|
NA
|
|
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review.
|
NA
|
NA
|
|
Knowledge and Attitude Towards the Current Pandemic Corona Virus Disease and Associated Factors Among Pregnant Women Attending Antenatal Care in Debre Tabor General Hospital Northwest Ethiopia: An Institutional-Based Cross-Sectional Study.
|
NA
|
NA
|
|
Sleep Disordered Breathing Diagnosis and Treatment During the COVID-19 Pandemic: A Nationwide Survey in China.
|
NA
|
NA
|
|
Surgical Triage of Breast Disorders During the COVID-19 Pandemic: An Indian Perspective.
|
NA
|
NA
|
|
Canadian Immunization Guide: “Anaphylaxis and other acute reactions following vaccination” chapter update.
|
NA
|
NA
|
|
Cancer in corona times.
|
NA
|
NA
|
|
COVID-19 and Possible Pharmacological Preventive Options.
|
NA
|
NA
|
|
COVID-19 infection in known epileptic and non-epileptic children: what is the place of chloroquine sulfate? (a case report).
|
NA
|
NA
|
|
Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.
|
NA
|
NA
|
|
Narrative review of the novel coronavirus SARS-CoV-2: update on genomic characteristics, transmissions and animal model.
|
NA
|
NA
|
|
The Assessment of Knowledge, Behaviors, and Anxiety Levels of the Orthodontists about COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery.
|
NA
|
NA
|
|
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study.
|
NA
|
NA
|
|
Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago.
|
NA
|
NA
|
|
Management of 3 Cases of Pheochromocytoma During the COVID-19 Pandemic in New York City: Lessons Learned.
|
NA
|
NA
|
|
Cardiovascular medications and regulation of COVID-19 receptors expression.
|
NA
|
NA
|
|
To treat or not to treat: perceptions of the initial American Society for Reproductive Medicine COVID-19 recommendations among women’s health providers.
|
NA
|
NA
|
|
Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications.
|
NA
|
NA
|
|
COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
|
NA
|
NA
|
|
[Mechanism and intervention of mucosal immune regulation based on “lung and large intestine being interior-exteriorly related” theory of traditional Chinese medicine].
|
NA
|
NA
|
|
C-reactive protein and clinical outcomes in patients with COVID-19.
|
NA
|
NA
|
|
COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review).
|
NA
|
NA
|
|
Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID‑19 (Review).
|
NA
|
NA
|
|
Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trial.
|
NA
|
NA
|
|
Patients Left Behind: Ethical Challenges in Caring for Indirect Victims of the Covid-19 Pandemic.
|
NA
|
NA
|
|
Clinical efficacy of Methylprednisolone and the combined use of Lopinavir/Ritonavir with Arbidol in treatment of Coronavirus Disease 2019.
|
NA
|
NA
|
|
Therapeutic interventions in in-person and remote psychotherapy: Survey with psychotherapists and patients experiencing in-person and remote psychotherapy during COVID-19.
|
NA
|
NA
|
|
Spotlight on COVID-19: from biology to therapy and prevention.
|
NA
|
NA
|
|
D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Is there any effect of smoking status on severity and mortality of hospitalized patients with COVID-19 pneumonia?
|
NA
|
NA
|
|
[Post-COVID-19 pulmonary sequla: longterm follow up and management].
|
NA
|
NA
|
|
The role of mesenchymal stem cells in COVID-19 treatment.
|
NA
|
NA
|
|
Beneficial effects of multi-disciplinary rehabilitation in post-acute COVID-19 - an observational cohort study.
|
NA
|
NA
|
|
Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem.
|
NA
|
NA
|
|
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines.
|
NA
|
NA
|
|
Community pharmacist’s professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists.
|
NA
|
NA
|
|
Clinical outcomes of COVID-19 in hemodialysis patients in the city of Zonguldak, Turkey.
|
NA
|
NA
|
|
SARS-CoV-2 infection and thrombotic complications: a narrative review.
|
NA
|
NA
|
|
Chemotherapy in the Covid-19 era: the patient’s perception.
|
NA
|
NA
|
|
French survey on a cohort of emergency general surgery modifications induced by lockdown of the SARS-CoV-2 pandemic.
|
NA
|
NA
|
|
An investigation of risk factors of in-hospital death due to COVID-19: a case-control study in Rasht, Iran.
|
NA
|
NA
|
|
[Improving the diagnosis, treatment and secondary prevention of stroke using a unified online system: primary vascular department - regional vascular center - family doctor].
|
NA
|
NA
|
|
Tiered Model of Nurse Staffing for Critical Care and Emergency Departments in the Wake of a Pandemic.
|
NA
|
NA
|
|
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India.
|
NA
|
NA
|
|
Even if it looks like COVID-19, think again: the importance of differential diagnosis during a pandemic.
|
NA
|
NA
|
|
Driving Digital Transformation During a Pandemic: Case Study of Virtual Collaboration in a German Hospital.
|
NA
|
NA
|
|
Parents’ and Students’ Perceptions of Telepractice Services for Speech-Language Therapy During the COVID-19 Pandemic: Survey Study.
|
NA
|
NA
|
|
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
|
NA
|
NA
|
|
COVID-19, a tale of two pandemics: novel coronavirus and fake news messaging.
|
NA
|
NA
|
|
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
|
NA
|
NA
|
|
Myocardial injury in severe COVID-19: Identification and management.
|
NA
|
NA
|
|
Physical activity and exercise in the context of SARS-Cov-2: A perspective from geroscience field.
|
NA
|
NA
|
|
Social isolation and connection in adolescents with cancer and survivors of childhood cancer: A systematic review.
|
NA
|
NA
|
|
Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic.
|
NA
|
NA
|
|
Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
|
NA
|
NA
|
|
Different characteristics of critical COVID-19 and thinking of treatment strategies in non-elderly and elderly severe adult patients.
|
NA
|
NA
|
|
Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate.
|
NA
|
NA
|
|
Flexible care in breast cancer.
|
NA
|
NA
|
|
[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19].
|
NA
|
NA
|
|
Favipiravir in Therapy of Viral Infections.
|
NA
|
NA
|
|
Laboratory-Based Resources for COVID-19 Diagnostics: Traditional Tools and Novel Technologies. A Perspective of Personalized Medicine.
|
NA
|
NA
|
|
Development of Coronavirus Treatments Using Neutralizing Antibodies.
|
NA
|
NA
|
|
COVID-19 preventive behaviors and influencing factors in the Iranian population; a web-based survey.
|
NA
|
NA
|
|
Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
|
NA
|
NA
|
|
Kidney Transplantation and COVID-19: Two Case Reports.
|
NA
|
NA
|
|
Dysregulation of Cell Signaling by SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 in IBD: The experience of a single tertiary IBD center.
|
NA
|
NA
|
|
Systemic therapy and COVID19: Immunotherapy and chemotherapy.
|
NA
|
NA
|
|
Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort study.
|
NA
|
NA
|
|
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.
|
NA
|
NA
|
|
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report.
|
NA
|
NA
|
|
SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
|
NA
|
NA
|
|
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
|
NA
|
NA
|
|
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
|
NA
|
NA
|
|
Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology.
|
NA
|
NA
|
|
Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID-19 pandemic.
|
NA
|
NA
|
|
Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
|
NA
|
NA
|
|
Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
|
NA
|
NA
|
|
Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as “bridge treatment” during the COVID-19 pandemic in Italy.
|
NA
|
NA
|
|
Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer.
|
NA
|
NA
|
|
Estimation of the uncertainty of values assigned to calibration materials prepared in-house: An example for hydroxychloroquine calibrators in blood-hemolysate-based matrix.
|
NA
|
NA
|
|
The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
|
NA
|
NA
|
|
Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction.
|
NA
|
NA
|
|
COVID-19 after kidney transplantation: Early outcomes and renal function following antiviral treatment.
|
NA
|
NA
|
|
The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: Young people and caregiver survey.
|
NA
|
NA
|
|
The impact of COVID-19 on foot and ankle surgery in a major trauma centre.
|
NA
|
NA
|
|
The effect of the COVID-19 pandemic on ED referrals and care for stroke patients: A four-year comparative study.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
|
NA
|
NA
|
|
Clinically applicable approach for predicting mechanical ventilation in patients with COVID-19.
|
NA
|
NA
|
|
The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Physiopathology and Clinical Implications.
|
NA
|
NA
|
|
Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control study.
|
NA
|
NA
|
|
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs.
|
NA
|
NA
|
|
Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity.
|
NA
|
NA
|
|
Incineration of sewage sludge and recovery of residue ash as building material: A valuable option as a consequence of the COVID-19 pandemic.
|
NA
|
NA
|
|
Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.
|
NA
|
NA
|
|
Patient and Provider-Reported Satisfaction of Cancer Rehabilitation Telemedicine Visits During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Ensuring contact: calling rural Appalachian older adults during the COVID-19 epidemic.
|
NA
|
NA
|
|
Palliative Care and COVID-19 Pandemic: Retrospective Study of Factors Associated With Infection and Death at an Oncological Palliative Care Reference Center.
|
NA
|
NA
|
|
Graft Retrieval for Liver Transplant in a Donor With Giant Thoracoabdominal Aortic Aneurysm.
|
NA
|
NA
|
|
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
|
NA
|
NA
|
|
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial.
|
NA
|
NA
|
|
Levels of burn-out among healthcare workers during the COVID-19 pandemic and their associated factors: a cross-sectional study in a tertiary hospital of a highly burdened area of north-east Italy.
|
NA
|
NA
|
|
Life before COVID-19: how was the World actually performing?
|
NA
|
NA
|
|
COVID-19: Analysis of Drug Repositioning Practice.
|
NA
|
NA
|
|
COVID-19 discharge and follow-up recommendations.
|
NA
|
NA
|
|
Eat to Beat Stress.
|
NA
|
NA
|
|
Parameter Estimation and Prediction of COVID-19 Epidemic Turning Point and Ending Time of a Case Study on SIR/SQAIR Epidemic Models.
|
NA
|
NA
|
|
Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review).
|
NA
|
NA
|
|
Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.
|
NA
|
NA
|
|
Clinical presentations and management of COVID-19 infected children seen in a district health facility in Kambia, northern Sierra Leone.
|
NA
|
NA
|
|
Use of tocilizumab in a patient with severe COVID-19 in a Teaching Hospital in Ghana: a case report.
|
NA
|
NA
|
|
Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report.
|
NA
|
NA
|
|
Recent applications and strategies in nanotechnology for lung diseases.
|
NA
|
NA
|
|
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
|
NA
|
NA
|
|
Clinical Characteristics of 47 Death Cases With COVID-19: A Retrospective Study at a Tertiary Center in Lahore.
|
NA
|
NA
|
|
Recent biotechnological advances as potential intervention strategies against COVID-19.
|
NA
|
NA
|
|
Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis.
|
NA
|
NA
|
|
Exuberant bullous vasculitis associated with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Epidemiological and clinical characteristics analysis of 11 children with 2019 novel coronavirus infection in Chongqing: a single-center retrospective study.
|
NA
|
NA
|
|
A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.
|
NA
|
NA
|
|
Tracheostomy in the COVID19 Patients: Our Experience in 12 Cases.
|
NA
|
NA
|
|
Presentation of Severe Rheumatic Mitral Stenosis at the Peak of the COVID-19 Pandemic and the Presumptive Treatment as Severe Coronavirus Illness.
|
NA
|
NA
|
|
Treatment of Crimean-Congo Haemorrhagic Fever by Favipiravir in a Patient with Novel Coronavirus Co-Infection.
|
NA
|
NA
|
|
Critical Care COVID-19 Patient with a Picture of Thrombotic Thrombocytopenic Purpura.
|
NA
|
NA
|
|
The Oncology Family Forum: Collaborating With Families to Codesign Pediatric Oncology Services.
|
NA
|
NA
|
|
Searching for answers: Cancer care during the COVID pandemic.
|
NA
|
NA
|
|
A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) Pandemic.
|
NA
|
NA
|
|
Takotsubo Syndrome a Rare Entity in COVID-19: a Systemic Review-Focus on Biomarkers, Imaging, Treatment, and Outcome.
|
NA
|
NA
|
|
Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
|
NA
|
NA
|
|
The impact of SARS-CoV-2 on skeletal muscles.
|
NA
|
NA
|
|
Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review.
|
NA
|
NA
|
|
Review of pharmacologic and immunologic agents in the management of COVID-19.
|
NA
|
NA
|
|
“Principles” Guiding Our Medical ICU.
|
NA
|
NA
|
|
Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
|
NA
|
NA
|
|
Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
|
NA
|
NA
|
|
Covid-19 Convalescent Plasma Donor Characteristics, Product Disposition and Comparison With Standard Apheresis Donors.
|
NA
|
NA
|
|
[SARS-CoV-2 Detection in cerebrospinal fluid in a pediatric patient. Case report].
|
NA
|
NA
|
|
The economic and psychological impact of cancellations of elective spinal surgeries in the COVID-19 era.
|
NA
|
NA
|
|
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
|
NA
|
NA
|
|
Antibodies to watch in 2021.
|
NA
|
NA
|
|
Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study.
|
NA
|
NA
|
|
analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease.
|
NA
|
NA
|
|
Therapeutic agents against COVID-19 with clinical evidence.
|
NA
|
NA
|
|
Epidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis.
|
NA
|
NA
|
|
The musculoskeletal problems and psychosocial status of teachers giving online education during the COVID-19 pandemic and preventive telerehabilitation for musculoskeletal problems.
|
NA
|
NA
|
|
Can occupational therapy manpower be replaced with social robots in a singing group during COVID-19?
|
NA
|
NA
|
|
Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
|
NA
|
NA
|
|
Adverse effects, pharmacological interactions, and cardiovascular drugs in COVID-19 treatment.
|
NA
|
NA
|
|
[Telerehabilitation: from the virtual world to reality-Medicine in the twenty-first century : Video-assisted treatment in times of COVID-19].
|
NA
|
NA
|
|
Most notable 100 articles of COVID-19: an Altmetric study based on bibliometric analysis.
|
NA
|
NA
|
|
Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
Post Abortion Care and Management After Induced Abortion During the COVID-19 Pandemic: A Chinese Expert Consensus.
|
NA
|
NA
|
|
Differences between radiological findings of COVID-19 and non-COVID-19 infections in pediatric patients.
|
NA
|
NA
|
|
COVID-19-Related Knowledge and Practices Among Health Care Workers in Saudi Arabia: Cross-sectional Questionnaire Study.
|
NA
|
NA
|
|
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.
|
NA
|
NA
|
|
Optimal control of the SIR model in the presence of transmission and treatment uncertainty.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India.
|
NA
|
NA
|
|
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19.
|
NA
|
NA
|
|
Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.
|
NA
|
NA
|
|
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.
|
NA
|
NA
|
|
Patient preferences for telehealth services in a large multispecialty practice.
|
NA
|
NA
|
|
Factors associated with hospitalization, invasive mechanical ventilation treatment and death among all confirmed COVID-19 cases in Norway: Prospective cohort study.
|
NA
|
NA
|
|
Ambulatory chemotherapy: Past, present, and future.
|
NA
|
NA
|
|
Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
|
NA
|
NA
|
|
Higher comorbidities and early death in hospitalized African-American patients with Covid-19.
|
NA
|
NA
|
|
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
|
NA
|
NA
|
|
Impact of a pandemic on surgical neuro-oncology-maintaining functionality in the early phase of crisis.
|
NA
|
NA
|
|
Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study.
|
NA
|
NA
|
|
Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia.
|
NA
|
NA
|
|
Effects of previous exposure to psychotherapeutic strategies on depression and anxiety symptoms during the COVID-19 pandemic.
|
NA
|
NA
|
|
Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
|
NA
|
NA
|
|
Lung transplantation during the outbreak of Coronavirus Disease 2019 in China.
|
NA
|
NA
|
|
COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK.
|
NA
|
NA
|
|
Present cum future of SARS-CoV-2 virus and its associated control of virus-laden air pollutants leading to potential environmental threat - A global review.
|
NA
|
NA
|
|
Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives.
|
NA
|
NA
|
|
GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - A case report, systemic review and implication for vaccine development.
|
NA
|
NA
|
|
inhibitors.
|
NA
|
NA
|
|
Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study.
|
NA
|
NA
|
|
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome.
|
NA
|
NA
|
|
Outcomes of COVID-19 Positive Acute Coronary Syndrome Patients; a multisource Electronic Healthcare Records Study from England.
|
NA
|
NA
|
|
Case series of 20 pregnant women with 2019 novel coronavirus disease in Wuhan, China.
|
NA
|
NA
|
|
The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study.
|
NA
|
NA
|
|
The Psychological Burden of COVID-19 Stigma: Evaluation of the Mental Health of Isolated Mild Condition COVID-19 Patients.
|
NA
|
NA
|
|
Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
|
NA
|
NA
|
|
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
|
NA
|
NA
|
|
The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study.
|
NA
|
NA
|
|
[Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].
|
NA
|
NA
|
|
[Follow-up results of 117 discharged patients with coronavirus disease 2019 in Wuhan Mobile Cabin Hospital].
|
NA
|
NA
|
|
Mucor in a Viral Land: A Tale of Two Pathogens.
|
NA
|
NA
|
|
Practical Considerations for Converting Operating Rooms and Post-anaesthesia Care Units into Intensive Care Units in the COVID-19 Pandemic - Experience from a Large Singapore Tertiary Hospital.
|
NA
|
NA
|
|
Strategies for Management of Peritoneal Dialysis Patients in Singapore during COVID-19 Pandemic.
|
NA
|
NA
|
|
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
|
NA
|
NA
|
|
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic.
|
NA
|
NA
|
|
17β-estradiol reduces SARS-CoV-2 infection in vitro.
|
NA
|
NA
|
|
Minireview: The Introduction of COVID-19 and Microvascular Disease-Introduction of COVID-19 and the Relationship between Its Receptor and Diabetic Vascular Complications.
|
NA
|
NA
|
|
Reasoned therapeutic protocol in outpatients with covid 19.
|
NA
|
NA
|
|
Management of patients with severe acute respiratory failure due to SARSCoV-2 pneumonia with non-invasive ventilatory support outside Intensive Care Unit.
|
NA
|
NA
|
|
Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?
|
NA
|
NA
|
|
Clinicopathologic Features of COVID-19: A Case Report and Value of Forensic Autopsy in Studying SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
|
NA
|
NA
|
|
COVID-19 in spinal cord injury patients at a veterans administration hospital: A case series.
|
NA
|
NA
|
|
High frequency of smell and taste dysfunctions in allergy health care professionals suffering from COVID-19.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic on Disordered Eating Behavior: Qualitative Analysis of Social Media Posts.
|
NA
|
NA
|
|
The Use of Topical Oxygen Therapy to Treat a Calciphylaxis Wound During a Global Pandemic: A Case Report.
|
NA
|
NA
|
|
Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.
|
NA
|
NA
|
|
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.
|
NA
|
NA
|
|
Efficacy of canakinumab in mild or severe COVID-19 pneumonia.
|
NA
|
NA
|
|
Impact of high dose prophylactic anticoagulation in critically ill patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Estimating the minimum number of SARS-CoV-2 infected cases needed to detect viral RNA in wastewater: To what extent of the outbreak can surveillance of wastewater tell us?
|
NA
|
NA
|
|
COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.
|
NA
|
NA
|
|
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients.
|
NA
|
NA
|
|
Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications.
|
NA
|
NA
|
|
Tele-health and cancer care in the era of COVID-19: New opportunities in low and middle income countries (LMICs).
|
NA
|
NA
|
|
Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: A single-center, retrospective, observational study.
|
NA
|
NA
|
|
The effects of health-preserving sports on the treatment of COVID-19: A protocol for systematic review.
|
NA
|
NA
|
|
Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials.
|
NA
|
NA
|
|
Autism, Therapy and COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.
|
NA
|
NA
|
|
COVID-19-Awareness and Practice of Dentists in Saudi Arabia.
|
NA
|
NA
|
|
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The “ImpACT-COVID-19 for Patients” Multi-Centre Observational Study.
|
NA
|
NA
|
|
Implementation of a Savvy Mobile ECG Sensor for Heart Rhythm Disorder Screening at the Primary Healthcare Level: An Observational Prospective Study.
|
NA
|
NA
|
|
Postponed Dental Visits during the COVID-19 Pandemic and their Correlates. Evidence from the Nationally Representative COVID-19 Snapshot Monitoring in Germany (COSMO).
|
NA
|
NA
|
|
Significance of NETs Formation in COVID-19.
|
NA
|
NA
|
|
L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment.
|
NA
|
NA
|
|
SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations.
|
NA
|
NA
|
|
Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection.
|
NA
|
NA
|
|
May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia.
|
NA
|
NA
|
|
Knowledge of Emergency Management of Avulsed Teeth among Italian Dentists-Questionnaire Study and Next Future Perspectives.
|
NA
|
NA
|
|
A Global Review on Short Peptides: Frontiers and Perspectives.
|
NA
|
NA
|
|
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City.
|
NA
|
NA
|
|
The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals.
|
NA
|
NA
|
|
Palliative Care Professionals’ Inner Lives: Cross-Cultural Application of the Awareness Model of Self-Care.
|
NA
|
NA
|
|
Influence of the onset of the SARS-CoV-2 pandemic on the diagnosis and treatment of ulcerative colitis.
|
NA
|
NA
|
|
American Association for Emergency Psychiatry Recommendations to Address Psychiatric Staff Shortages in Emergency Settings.
|
NA
|
NA
|
|
Editorial for special issue on neglect rehabilitation.
|
NA
|
NA
|
|
Multienzymes activity of metals and metal oxide nanomaterials: applications from biotechnology to medicine and environmental engineering.
|
NA
|
NA
|
|
Evaluation of organizational and social commitments and related factors during the coronavirus pandemic of healthcare workers in northern Iran.
|
NA
|
NA
|
|
What was the impact of a global pandemic (COVID-19) lockdown period on experiences within an eating disorder service? A service evaluation of the views of patients, parents/carers and staff.
|
NA
|
NA
|
|
Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources.
|
NA
|
NA
|
|
MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
|
NA
|
NA
|
|
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2.
|
NA
|
NA
|
|
Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
|
NA
|
NA
|
|
Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
|
NA
|
NA
|
|
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes.
|
NA
|
NA
|
|
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.
|
NA
|
NA
|
|
.
|
NA
|
NA
|
|
Integrated photothermal decontamination device for N95 respirators.
|
NA
|
NA
|
|
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
|
NA
|
NA
|
|
Patients’ Responses to the Sudden Interruption of Chemotherapy During the Outbreak of the Novel Coronavirus: A Cross-Sectional Study.
|
NA
|
NA
|
|
Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal.
|
NA
|
NA
|
|
Diagnostic Performance of a Blood Urea Nitrogen to Creatinine Ratio-based Nomogram for Predicting In-hospital Mortality in COVID-19 Patients.
|
NA
|
NA
|
|
Accurate detection of Covid-19 patients based on Feature Correlated Naïve Bayes (FCNB) classification strategy.
|
NA
|
NA
|
|
Response of L V Prasad Eye Institute to COVID-19 outbreak in India: experience at its tertiary eye care centre and adoption to its Eye Health Pyramid.
|
NA
|
NA
|
|
Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
|
NA
|
NA
|
|
Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).
|
NA
|
NA
|
|
Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker’s yeast: SARS-CoV-2 as a case study.
|
NA
|
NA
|
|
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
An Evolving Clinical Need: Discordant Oxygenation Measurements of Intubated COVID-19 Patients.
|
NA
|
NA
|
|
Clinical Outcomes of Critically III Patients with COVID-19 by Race.
|
NA
|
NA
|
|
Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*.
|
NA
|
NA
|
|
Association between maternity harassment and depression during pregnancy amid the COVID-19 state of emergency.
|
NA
|
NA
|
|
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?
|
NA
|
NA
|
|
A severe COVID-19 case with schizophrenia as well as other chronic diseases.
|
NA
|
NA
|
|
Analysis of scientific production on the new coronavirus (COVID-19): a bibliometric analysis.
|
NA
|
NA
|
|
[2020 scientific breakthroughs in ambulatory general internal medicine].
|
NA
|
NA
|
|
COVID-19 and hepatic damage: what we know? A systematic review.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation for COVID-19 respiratory distress syndrome: an Italian Society for Cardiac Surgery Report.
|
NA
|
NA
|
|
COVID-19: should we consider it as a septic shock? (The treatment of COVID-19 patients in the ICU).
|
NA
|
NA
|
|
Delayed treatment of bacteremia during the COVID-19 pandemic.
|
NA
|
NA
|
|
A considerable asymptomatic proportion and thromboembolism risk of pregnant women with COVID-19 infection in Wuhan, China.
|
NA
|
NA
|
|
Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation.
|
NA
|
NA
|
|
New twist to an old problem: COVID-19 and idiopathic pulmonary fibrosis.
|
NA
|
NA
|
|
Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
A review of Ciclesonide in COVID-19. Still a long way to go.
|
NA
|
NA
|
|
Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic.
|
NA
|
NA
|
|
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
|
NA
|
NA
|
|
Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
|
NA
|
NA
|
|
Distance Management of Spinal Disorders During the COVID-19 Pandemic and Beyond: Evidence-Based Patient and Clinician Guides From the Global Spine Care Initiative.
|
NA
|
NA
|
|
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death.
|
NA
|
NA
|
|
Clinical characteristics of 14 COVID-19 deaths in Tianmen, China: a single-center retrospective study.
|
NA
|
NA
|
|
Clinical course and challenging management of early COVID-19 infection after heart transplantation: case report of two patients.
|
NA
|
NA
|
|
Survival of silver diamine fluoride among patients treated in community dental clinics: a naturalistic study.
|
NA
|
NA
|
|
Lockdowns and low- and middle-income countries: building a feasible, effective, and ethical COVID-19 response strategy.
|
NA
|
NA
|
|
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.
|
NA
|
NA
|
|
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
|
NA
|
NA
|
|
COVID-19, anorexia nervosa and obese patients with an eating disorder - some considerations for practitioners and researchers.
|
NA
|
NA
|
|
Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges.
|
NA
|
NA
|
|
Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China.
|
NA
|
NA
|
|
Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis.
|
NA
|
NA
|
|
The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
|
NA
|
NA
|
|
Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial.
|
NA
|
NA
|
|
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
|
NA
|
NA
|
|
Delivering safe and timely cancer care during COVID-19: lessons and successes from the transition period.
|
NA
|
NA
|
|
Australian specialist palliative care’s response to COVID-19: an anonymous online survey of service providers.
|
NA
|
NA
|
|
Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.
|
NA
|
NA
|
|
study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase.
|
NA
|
NA
|
|
Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study.
|
NA
|
NA
|
|
Shortages of Palliative Care Medications in Canada during the COVID-19 Pandemic: Gambling with Suffering.
|
NA
|
NA
|
|
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 Pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned.
|
NA
|
NA
|
|
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
|
NA
|
NA
|
|
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC.
|
NA
|
NA
|
|
Post-lockdown abatement of COVID-19 by fast periodic switching.
|
NA
|
NA
|
|
Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial.
|
NA
|
NA
|
|
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
|
NA
|
NA
|
|
[A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China].
|
NA
|
NA
|
|
Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model.
|
NA
|
NA
|
|
Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy.
|
NA
|
NA
|
|
Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19.
|
NA
|
NA
|
|
Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.
|
NA
|
NA
|
|
Prophylaxis for COVID-19: a systematic review.
|
NA
|
NA
|
|
Alteration of Auto-CPAP requirements in obstructive sleep apnea patients with COVID-19 history.
|
NA
|
NA
|
|
Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.
|
NA
|
NA
|
|
Rescue Therapy of Refractory Diffuse Large B-Cell Lymphomas BCL2 with Venetoclax: Case Report.
|
NA
|
NA
|
|
COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection.
|
NA
|
NA
|
|
A Case Series: Successfully Preventing COVID-19 Outbreak in a Residential Community Setting at a Drug and Alcohol Addiction Treatment Center.
|
NA
|
NA
|
|
Burnout Prevalence and Its Associated Factors among Malaysian Healthcare Workers during COVID-19 Pandemic: An Embedded Mixed-Method Study.
|
NA
|
NA
|
|
Telemedicine during the Coronavirus Disease (COVID-19) Pandemic: A Multiple Sclerosis (MS) Outpatients Service Perspective.
|
NA
|
NA
|
|
Perceptions of Romanian Physicians on Lockdowns for COVID-19 Prevention.
|
NA
|
NA
|
|
mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.
|
NA
|
NA
|
|
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics.
|
NA
|
NA
|
|
The Profile of the Obstetric Patients with SARS-CoV-2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature.
|
NA
|
NA
|
|
The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.
|
NA
|
NA
|
|
The Potential of Selected Agri-Food Loss and Waste to Contribute to a Circular Economy: Applications in the Food, Cosmetic and Pharmaceutical Industries.
|
NA
|
NA
|
|
SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on patient preferences and decision-making for symptomatic urolithiasis.
|
NA
|
NA
|
|
Mechanistic modeling of the SARS-CoV-2 disease map.
|
NA
|
NA
|
|
Catastrophic cognitions about coronavirus: the Oxford psychological investigation of coronavirus questionnaire [TOPIC-Q].
|
NA
|
NA
|
|
Cancer diagnosis in Brazil in the COVID-19 era.
|
NA
|
NA
|
|
Early prone positioning therapy for patients with mild COVID-19 disease.
|
NA
|
NA
|
|
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
|
NA
|
NA
|
|
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
|
NA
|
NA
|
|
Monitored anesthesia care during mechanical thrombectomy for stroke: need for data-driven and individualized decisions.
|
NA
|
NA
|
|
Association of Early-Phase In-Hospital Glycemic Fluctuation With Mortality in Adult Patients With Coronavirus Disease 2019.
|
NA
|
NA
|
|
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
|
NA
|
NA
|
|
Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
|
NA
|
NA
|
|
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
|
NA
|
NA
|
|
“Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?
|
NA
|
NA
|
|
Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.
|
NA
|
NA
|
|
Recommandations of the Tunisian Association of Surgery for the practice of visceral surgery during COVID-19 pandemic.
|
NA
|
NA
|
|
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
|
NA
|
NA
|
|
Challenges experienced by ICU nurses throughout the provision of care for COVID-19 patients: A qualitative study.
|
NA
|
NA
|
|
Care Process of Recanalization Therapy for Acute Stroke during the COVID-19 Outbreak in South Korea.
|
NA
|
NA
|
|
Cupric Oxide Coating That Rapidly Reduces Infection by SARS-CoV-2 via Solids.
|
NA
|
NA
|
|
Nanotechnology Enabled Solutions to Combat Covid-19: Prevention, Treatment and Diagnosis.
|
NA
|
NA
|
|
COVID-19 and Clinical Trials: Current Challenges and Future Directions.
|
NA
|
NA
|
|
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
|
NA
|
NA
|
|
Anxiety Due to COVID-19 in Different Palliative Care Settings in Germany.
|
NA
|
NA
|
|
Availability of Outpatient Telemental Health Services in the United States at the Outset of the COVID-19 Pandemic.
|
NA
|
NA
|
|
The J-IDEA Pandemic Planner: A Framework for Implementing Hospital Provision Interventions During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Complement activation and coagulopathy - an ominous duo in COVID19.
|
NA
|
NA
|
|
Convalescent Plasma: Education and Administration Implications.
|
NA
|
NA
|
|
Telehealth in Palliative Care: Communication Strategies From the COVID-19 Pandemic.
|
NA
|
NA
|
|
Care Delivery and Treatment Decision Making: Bioethical and Nursing Considerations During and After the COVID-19 Pandemic.
|
NA
|
NA
|
|
Ambulatory Oncology: Infrastructure Development in Response to the COVID-19 Pandemic.
|
NA
|
NA
|
|
Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study.
|
NA
|
NA
|
|
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana.
|
NA
|
NA
|
|
Focus on COVID-19: Antiviral polymers in drugs and vaccines.
|
NA
|
NA
|
|
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges.
|
NA
|
NA
|
|
[Preliminary results of a non-invasive ventilatory support unit in SARS-COVID-2].
|
NA
|
NA
|
|
[Convalescent plasma as a therapy for severe COVID-19 pneumonia].
|
NA
|
NA
|
|
Usefulness of blood cultures in COVID-19 pneumonia.
|
NA
|
NA
|
|
COVID-19 with and without pneumonia: clinical outcomes in the internal medicine ward.
|
NA
|
NA
|
|
[Effect of the COVID-19 pandemic and preventive social isolation measures on the number of outpatient visits, hospitalizations and treatment of cerebrovascular accident in a neurological center in Argentina].
|
NA
|
NA
|
|
Treatment of hypothyroidism in special situations.
|
NA
|
NA
|
|
[Acute myocardial infarction in patients recovering from COVID-19 pneumonia].
|
NA
|
NA
|
|
Use of Telehealth in Substance Use Disorder Services During and After COVID-19: Online Survey Study.
|
NA
|
NA
|
|
Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies.
|
NA
|
NA
|
|
COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders.
|
NA
|
NA
|
|
Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience.
|
NA
|
NA
|
|
The independent factors associated with oxygen therapy in COVID-19 patients under 65 years old.
|
NA
|
NA
|
|
Early mortality benefit with COVID-19 convalescent plasma: a matched control study.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
|
NA
|
NA
|
|
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.
|
NA
|
NA
|
|
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.
|
NA
|
NA
|
|
An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology.
|
NA
|
NA
|
|
Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.
|
NA
|
NA
|
|
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases.
|
NA
|
NA
|
|
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
|
NA
|
NA
|
|
Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy.
|
NA
|
NA
|
|
A Homeopathic View of the Influence of Chronic Diseases in the Manifestation of COVID-19.
|
NA
|
NA
|
|
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-analysis.
|
NA
|
NA
|
|
The use of electrical impedance tomography for individualized ventilation strategy in COVID-19: a case report.
|
NA
|
NA
|
|
A pilot trial of human amniotic fluid for the treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19 in Kidney Transplant Patients From a Large UK Transplant Center: Exploring Risk Factors for Disease Severity.
|
NA
|
NA
|
|
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
|
NA
|
NA
|
|
Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?
|
NA
|
NA
|
|
Palliative care in Creutzfeldt-Jakob disease: looking back, thinking ahead.
|
NA
|
NA
|
|
Does thinking make it so? Differential associations between adversity worries and experiences and mental health during the COVID-19 pandemic.
|
NA
|
NA
|
|
Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study.
|
NA
|
NA
|
|
Developing statewide remdesivir use criteria.
|
NA
|
NA
|
|
Advancing ambulatory pharmacy practice through a crisis: Objectives and strategies used in an ambulatory care action team’s response to the COVID-19 pandemic.
|
NA
|
NA
|
|
Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes.
|
NA
|
NA
|
|
A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
|
NA
|
NA
|
|
Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage.
|
NA
|
NA
|
|
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
|
NA
|
NA
|
|
An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19.
|
NA
|
NA
|
|
Now we are 30: 10 more years of MASCC.
|
NA
|
NA
|
|
Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown.
|
NA
|
NA
|
|
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort.
|
NA
|
NA
|
|
Myocarditis in COVID-19 patients: current problems.
|
NA
|
NA
|
|
Green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: history and phylogeny.
|
NA
|
NA
|
|
Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress.
|
NA
|
NA
|
|
Containment of procedure-associated aerosols by an extractor tent: effect on nebulized drug particle dispersal.
|
NA
|
NA
|
|
Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective.
|
NA
|
NA
|
|
Effect of antiplatelet treatments on patients with COVID-19 infection: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Environmental management strategy in response to COVID-19 in China: Based on text mining of government open information.
|
NA
|
NA
|
|
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
|
NA
|
NA
|
|
Development and protocol for a nurse-led telephonic palliative care program.
|
NA
|
NA
|
|
Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle.
|
NA
|
NA
|
|
Systemic diseases and the cornea.
|
NA
|
NA
|
|
rRT-PCR for SARS-CoV-2: Analytical considerations.
|
NA
|
NA
|
|
Mortality Risk Assessment in Covid-19 Veno-Venous Extracorporeal Membrane Oxygenation.
|
NA
|
NA
|
|
An assessment of outpatient clinic room ventilation systems and possible relationship to disease transmission.
|
NA
|
NA
|
|
Bioprosthetic Valve Thrombosis and Obstruction Secondary to COVID-19.
|
NA
|
NA
|
|
Dissecting the novel mechanism of Reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification.
|
NA
|
NA
|
|
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.
|
NA
|
NA
|
|
A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
|
NA
|
NA
|
|
Drugs acting on the renin-angiotensin system and SARS-CoV-2.
|
NA
|
NA
|
|
Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms?
|
NA
|
NA
|
|
Survey of rapid development of environmental surveillance methods for SARS-CoV-2 detection in wastewater.
|
NA
|
NA
|
|
The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.
|
NA
|
NA
|
|
Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic.
|
NA
|
NA
|
|
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview.
|
NA
|
NA
|
|
Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.
|
NA
|
NA
|
|
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) in critically ill pediatric patients admitted to the intensive care unit: A multicenter retrospective cohort study.
|
NA
|
NA
|
|
The Pediatric Neurology 2020 Research Workforce Survey: Optimism in a Time of Challenge.
|
NA
|
NA
|
|
Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial.
|
NA
|
NA
|
|
Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic.
|
NA
|
NA
|
|
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study.
|
NA
|
NA
|
|
Evaluation of ocular symptoms in COVID-19 subjects in inpatient and outpatient settings.
|
NA
|
NA
|
|
SARS-COV-2 infection and lung tumor microenvironment.
|
NA
|
NA
|
|
Extracorporeal membrane oxygenation versus mechanical ventilation alone in adults with severe acute respiratory distress syndrome: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
|
NA
|
NA
|
|
Prognostic Value of Antithrombin Levels in COVID-19 Patients and Impact of Fresh Frozen Plasma Treatment: A Retrospective Study
|
NA
|
NA
|
|
[Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)].
|
NA
|
NA
|
|
[Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19].
|
NA
|
NA
|
|
A practical approach to imaging characteristics and standardized reporting of COVID-19: a radiologic review.
|
NA
|
NA
|
|
COVID-19: can we treat the mother without harming her baby?
|
NA
|
NA
|
|
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
|
NA
|
NA
|
|
Prone positioning in patients with acute respiratory distress syndrome, translating research and implementing practice change from bench to bedside in the era of coronavirus disease 2019.
|
NA
|
NA
|
|
COVID-19 Treatment: Drug Safety Prior to Conception and During Pregnancy and Breastfeeding.
|
NA
|
NA
|
|
Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study.
|
NA
|
NA
|
|
Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.
|
NA
|
NA
|
|
The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.
|
NA
|
NA
|
|
Case Report: Postacute Rehabilitation of Guillain-Barré Syndrome and Cerebral Vasculitis-Like Pattern Accompanied by SARS-CoV-2 Infection.
|
NA
|
NA
|
|
The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
|
NA
|
NA
|
|
Practical Experience of Endoscope Reprocessing and Working-Platform Disinfection in COVID-19 Patients: A Report from Guangdong China during the Pandemic.
|
NA
|
NA
|
|
Engineered Aptamers for Enhanced COVID-19 Theranostics.
|
NA
|
NA
|
|
Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
|
NA
|
NA
|
|
Management of life-threatening acute respiratory syndrome and severe pneumonia secondary to COVID-19 in pregnancy: A case report and literature review.
|
NA
|
NA
|
|
Tocilizumab-induced cytomegalovirus colitis in a patient with COVID-19.
|
NA
|
NA
|
|
Clinical, electromyographical, histopathological characteristics of COVID-19 related rhabdomyolysis.
|
NA
|
NA
|
|
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection.
|
NA
|
NA
|
|
COVID 19 with neurological symptoms, rhabdomyolysis and brain death: a case report.
|
NA
|
NA
|
|
Lung Semiotics Ultrasound in COVID-19 Infection.
|
NA
|
NA
|
|
Lung Ultrasound in COVID-19 Critically Ill Patients with Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
COVID-19: High-JAKing of the Inflammatory “Flight” by Ruxolitinib to Avoid the Cytokine Storm.
|
NA
|
NA
|
|
Challenges of non-COVID-19 patients with chronic illness during the pandemic.
|
NA
|
NA
|
|
Room to Breathe: The Impact of Oxygen Rationing on Health Outcomes in SARS-CoV2.
|
NA
|
NA
|
|
Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses.
|
NA
|
NA
|
|
Chinese Expert Consensus on the Nucleic Acid Detection of SARS-CoV-2.
|
NA
|
NA
|
|
A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19.
|
NA
|
NA
|
|
Real-Time Telehealth Treatment Team Consultation for Self-Injury by Individuals with Autism Spectrum Disorder.
|
NA
|
NA
|
|
Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy.
|
NA
|
NA
|
|
Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
|
NA
|
NA
|
|
Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge.
|
NA
|
NA
|
|
What Are People Concerned About During the Pandemic? Detecting Evolving Topics about COVID-19 from Twitter.
|
NA
|
NA
|
|
Management and Prevention of Cerebrovascular Accidents in SARS-CoV-2-Positive Patients Recovering from COVID-19: a Case Report and Review of Literature.
|
NA
|
NA
|
|
Capsid integrity quantitative PCR to determine virus infectivity in environmental and food applications - A systematic review.
|
NA
|
NA
|
|
Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing.
|
NA
|
NA
|
|
A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity.
|
NA
|
NA
|
|
Turning tables: a war-like approach to neurosurgical emergencies in the Covid-19.
|
NA
|
NA
|
|
Study on Laboratory Indicators Related to Lung Injury of Corona Virus Disease 2019.
|
NA
|
NA
|
|
Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.
|
NA
|
NA
|
|
Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?
|
NA
|
NA
|
|
Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.
|
NA
|
NA
|
|
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review).
|
NA
|
NA
|
|
Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.
|
NA
|
NA
|
|
Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management.
|
NA
|
NA
|
|
Parkinson’s Disease and the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 and the Kidneys, Implications and Outcomes.
|
NA
|
NA
|
|
Early Physical Therapist Interventions for Patients With COVID-19 in the Acute Care Hospital: A Case Report Series.
|
NA
|
NA
|
|
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study.
|
NA
|
NA
|
|
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.
|
NA
|
NA
|
|
Exploring the Efficacy of Telehealth for Family Therapy Through Systematic, Meta-analytic, and Qualitative Evidence.
|
NA
|
NA
|
|
Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health.
|
NA
|
NA
|
|
Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.
|
NA
|
NA
|
|
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
|
NA
|
NA
|
|
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy.
|
NA
|
NA
|
|
Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID-19.
|
NA
|
NA
|
|
Available drugs and supplements for rapid deployment for treatment of COVID-19.
|
NA
|
NA
|
|
Policy Responses to the Addiction Crisis.
|
NA
|
NA
|
|
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study.
|
NA
|
NA
|
|
Surfactant for Treatment of ARDS in COVID-19 Patient.
|
NA
|
NA
|
|
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model.
|
NA
|
NA
|
|
Investigating the real impact of COVID-19 pandemic on the daily neurosurgical practice?
|
NA
|
NA
|
|
Bedside Tunneled Hemodialysis Catheter Placement in Patients with COVID-19.
|
NA
|
NA
|
|
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
|
NA
|
NA
|
|
Ergosterol peroxide exhibits antiviral and immunomodulatory abilities against porcine deltacoronavirus (PDCoV) via suppression of NF-κB and p38/MAPK signaling pathways in vitro.
|
NA
|
NA
|
|
The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions.
|
NA
|
NA
|
|
An extensive study on the COVID-19 pandemic, an emerging global crisis: Risks, transmission, impacts and mitigation.
|
NA
|
NA
|
|
Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk.
|
NA
|
NA
|
|
Tracheostomy and Improvement in Utilization of Hospital Resources During SARS-CoV-2 Pandemic Surge.
|
NA
|
NA
|
|
Prevalence and Factors Associated with Mental and Emotional Health Outcomes among Africans during the COVID-19 Lockdown Period-A Web-based Cross-Sectional Study.
|
NA
|
NA
|
|
COVID-19: Characteristics and Therapeutics.
|
NA
|
NA
|
|
Identification of risk factors for in-hospital death of COVID - 19 pneumonia – lessions from the early outbreak.
|
NA
|
NA
|
|
Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients.
|
NA
|
NA
|
|
Systemic lupus erythematosus manifestation following COVID-19: a case report.
|
NA
|
NA
|
|
COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report.
|
NA
|
NA
|
|
Can extraoral suction units minimize droplet spatter during a simulated dental procedure?
|
NA
|
NA
|
|
Streptokinase in a COVID-19-positive patient with STEMI in a PPCI centre: a local experience.
|
NA
|
NA
|
|
In the interest of public safety: rapid response to the COVID-19 epidemic in Vietnam.
|
NA
|
NA
|
|
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
|
NA
|
NA
|
|
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
|
NA
|
NA
|
|
Localized Plasmonic Photothermal Therapy as a Life-saving Treatment Paradigm for Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
Subacute mesenteric venous thrombosis secondary to COVID-19: A late thrombotic complication in a nonsevere patient.
|
NA
|
NA
|
|
A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets.
|
NA
|
NA
|
|
Emergence of Additive Manufacturing in global scale during the crisis of 2019-nCoV (novel corona virus).
|
NA
|
NA
|
|
Regional COVID-19 registry in Khuzestan, Iran: A study protocol and lessons learned from a pilot implementation.
|
NA
|
NA
|
|
Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
|
NA
|
NA
|
|
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.
|
NA
|
NA
|
|
The feasibility and safety of routine thoracic surgeries in the low risk areas during the COVID-19 pandemic.
|
NA
|
NA
|
|
Psychological impact of the SARS-CoV-2 outbreak on the staff of a French hospital.
|
NA
|
NA
|
|
Are colorectal cancer patients at risk for COVID-19 infection during the postoperative period? The Covid-GRECCAR study.
|
NA
|
NA
|
|
Acute necrotizing glomerulonephritis associated with COVID-19 infection: report of two pediatric cases.
|
NA
|
NA
|
|
Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD.
|
NA
|
NA
|
|
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options.
|
NA
|
NA
|
|
Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy.
|
NA
|
NA
|
|
[Potential therapies for COVID-19 cardiovascular complications using artemisinin and its derivatives intervene based on its cardiovascular protection].
|
NA
|
NA
|
|
COVID-19-Related Misinformation among Parents of Patients with Pediatric Cancer.
|
NA
|
NA
|
|
The important impact of COVID-19 pandemic on the reorganization of a Rehabilitation Unit in a National Healthcare System hospital in Italy: lessons from our experience.
|
NA
|
NA
|
|
The relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey.
|
NA
|
NA
|
|
Clinical Characterization of Patients With COVID-19 in Primary Care in Catalonia: Retrospective Observational Study.
|
NA
|
NA
|
|
Implementation of an Interactive Voice Response System for Cancer Awareness in Uganda: Mixed Methods Study.
|
NA
|
NA
|
|
Association Between Care Utilization and Anxiety Outcomes in an On-Demand Mental Health System: Retrospective Observational Study.
|
NA
|
NA
|
|
The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
|
NA
|
NA
|
|
[Assessment of the risk of infection from SARS-CoV-2 for healthcare workers-findings from practice].
|
NA
|
NA
|
|
Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study.
|
NA
|
NA
|
|
An overview of chitosan and its application in infectious diseases.
|
NA
|
NA
|
|
Dynamic assessment of interleukin-6 during hemodialysis and mortality in coronavirus disease-19.
|
NA
|
NA
|
|
Monoclonal Antibodies Receive EUA to Treat Mild to Moderate COVID-19.
|
NA
|
NA
|
|
Telerehabilitation Guidelines in Saudi Arabia.
|
NA
|
NA
|
|
Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease.
|
NA
|
NA
|
|
Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network.
|
NA
|
NA
|
|
Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Anxiety and its association with perceived stress and insomnia among nurses fighting against COVID-19 in Wuhan: a cross-sectional survey.
|
NA
|
NA
|
|
Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva.
|
NA
|
NA
|
|
Management of Chronic Pain in Nursing Homes: Navigating Challenges to Improve Person-Centered Care.
|
NA
|
NA
|
|
Antiviral activity of bioactive phytocompounds against coronavirus: An update.
|
NA
|
NA
|
|
Severe COVID-19 pneumonia in Piacenza, Italy - A cohort study of the first pandemic wave.
|
NA
|
NA
|
|
CRISPR-based detection of SARS-CoV-2: A review from sample to result.
|
NA
|
NA
|
|
The COVID-19 pandemic face mask waste: A blooming threat to the marine environment.
|
NA
|
NA
|
|
Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
|
NA
|
NA
|
|
[Experience and thinking on the normalization stage of prevention and control of COVID-19 in China].
|
NA
|
NA
|
|
Quantitative microbial risk assessment (QMRA) of occupational exposure to SARS-CoV-2 in wastewater treatment plants.
|
NA
|
NA
|
|
Analysis of the Different Approaches Adopted in the Italian Regions to Care for Patients Affected by COVID-19.
|
NA
|
NA
|
|
Case Report: Massive Spontaneous Pneumothorax-A Rare Form of Presentation for Severe COVID-19 Pneumonia.
|
NA
|
NA
|
|
Quit Experiences among Primary Care Patients Enrolled in a Smoking Cessation Pilot RCT Early in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis-Induced Neutropenia.
|
NA
|
NA
|
|
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants.
|
NA
|
NA
|
|
A Bibliometric Network Analysis of Coronavirus during the First Eight Months of COVID-19 in 2020.
|
NA
|
NA
|
|
Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.
|
NA
|
NA
|
|
Diabetic Foot Disease during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
|
NA
|
NA
|
|
Manual vs Mechanical Oral Hygiene Procedures: Has the Role of the Dental Hygienist in Phase 2 Post-lockdown Really Changed?
|
NA
|
NA
|
|
HIGHLIGHTS OF ADVANCES IN MEDICAL RETINA FROM THE VIRTUAL WORLD OPHTHALMOLOGY CONGRESS 2020.
|
NA
|
NA
|
|
Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
|
NA
|
NA
|
|
Unexpected sequelae of the COVID-19 pandemic: A strange case of myoclonus in the Tasmanian winter.
|
NA
|
NA
|
|
Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
The National Immunization Technical Advisory Group in Israel.
|
NA
|
NA
|
|
Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.
|
NA
|
NA
|
|
SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
|
NA
|
NA
|
|
Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
|
NA
|
NA
|
|
Evaluation of patient characteristics, management and outcomes for COVID-19 at district hospitals in the Western Cape, South Africa: descriptive observational study.
|
NA
|
NA
|
|
causing a pyogenic liver abscess: a rare complication of periodontal disease that occurred during the COVID-19 pandemic.
|
NA
|
NA
|
|
The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic.
|
NA
|
NA
|
|
Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit.
|
NA
|
NA
|
|
Probing CAS database as prospective antiviral agents against SARS-CoV-2 main protease.
|
NA
|
NA
|
|
Expressive Flamenco ©: An Emerging Expressive Arts-Based Practice.
|
NA
|
NA
|
|
RT-PCR Combined with CT Examination in the Diagnosis and Prognosis Evaluation of COVID-19 Patients in Fangcang Hospital: A Case Series.
|
NA
|
NA
|
|
The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020.
|
NA
|
NA
|
|
Telemedicine in the Cardiovascular World: Ready for the Future?
|
NA
|
NA
|
|
Digital Health: Opportunities and Challenges to Develop the Next-Generation Technology-Enabled Models of Cardiovascular Care.
|
NA
|
NA
|
|
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19).
|
NA
|
NA
|
|
Applying augmented reality to treat Fournier’s gangrene in COVID-19 positive patients whilst safeguarding the multi-disciplinary surgical team: A case series.
|
NA
|
NA
|
|
Predicting thromboembolic complications in COVID-19 ICU patients using machine learning.
|
NA
|
NA
|
|
[Structure of hospital care for COVID-19 patients up to July 2020 in Germany].
|
NA
|
NA
|
|
Breast cancer progression when definitive surgery is delayed.
|
NA
|
NA
|
|
Review of Anesthesia Versus Intensive Care Unit Ventilators and Ventilatory Strategies: COVID-19 Patient Management Implications.
|
NA
|
NA
|
|
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
|
NA
|
NA
|
|
Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
|
NA
|
NA
|
|
COVID-19 in Immunocompromised Hosts: What We Know So Far.
|
NA
|
NA
|
|
Physiologically-Based Pharmacokinetic Modeling of Remdesivir and its Metabolites to Support Dose Selection for the Treatment of Pediatric Patients with COVID-19.
|
NA
|
NA
|
|
Characteristics, management and survival of ICU patients with coronavirus disease-19 in Norway, March-June 2020. A prospective observational study.
|
NA
|
NA
|
|
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
|
NA
|
NA
|
|
Telepsychiatry in Low- and Middle-Income Countries During COVID-19: Pandemic, Barriers, and Road Model.
|
NA
|
NA
|
|
Development of a Model to Estimate the Association Between Delay in Cancer Treatment and Local Tumor Control and Risk of Metastases.
|
NA
|
NA
|
|
Association of Serum Mannose With Acute Respiratory Distress Syndrome Risk and Survival.
|
NA
|
NA
|
|
Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents.
|
NA
|
NA
|
|
COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases.
|
NA
|
NA
|
|
Viral infections and their relationship to neurological disorders.
|
NA
|
NA
|
|
Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.
|
NA
|
NA
|
|
Prophylactic anticoagulants for people hospitalised with COVID-19.
|
NA
|
NA
|
|
Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia.
|
NA
|
NA
|
|
Are clarithromycin, azithromycin and their analogues effective in the treatment of COVID19?
|
NA
|
NA
|
|
Clinical characteristics, maternal and neonatal outcomes of pregnant women with SARS-CoV-2 infection in Turkey.
|
NA
|
NA
|
|
Soluble ACE2 as a potential therapy for COVID-19.
|
NA
|
NA
|
|
Analyzing Digital Evidence From a Telemental Health Platform to Assess Complex Psychological Responses to the COVID-19 Pandemic: Content Analysis of Text Messages.
|
NA
|
NA
|
|
Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France.
|
NA
|
NA
|
|
Using prosocial behavior to safeguard mental health and foster emotional well-being during the COVID-19 pandemic: A registered report protocol for a randomized trial.
|
NA
|
NA
|
|
Adverse drug reactions in patients with COVID-19 in Brazil: analysis of spontaneous notifications of the Brazilian pharmacovigilance system.
|
NA
|
NA
|
|
Prescription Drug Priorities under the Biden Administration.
|
NA
|
NA
|
|
Multi-organ proteomic landscape of COVID-19 autopsies.
|
NA
|
NA
|
|
Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
|
NA
|
NA
|
|
Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients.
|
NA
|
NA
|
|
Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach.
|
NA
|
NA
|
|
Pain Management Recommendation for Indonesian COVID-19 Patients by Indonesian Society of Anesthesiology for Pain Management (ISAPM).
|
NA
|
NA
|
|
Intensive care digital health response to emerging infectious disease outbreaks such as COVID-19.
|
NA
|
NA
|
|
A Psoriatic Patient-Based Survey on the Understanding of the Use of Vaccines While on Biologics During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Pathogenesis of COVID-19, Disease outbreak: A Review.
|
NA
|
NA
|
|
An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.
|
NA
|
NA
|
|
Patents related to pathogenic human coronaviruses.
|
NA
|
NA
|
|
Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.
|
NA
|
NA
|
|
External validation of multimodal termination of resuscitation rules for out-of-hospital cardiac arrest patients in the COVID-19 era.
|
NA
|
NA
|
|
Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT.
|
NA
|
NA
|
|
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
|
NA
|
NA
|
|
Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit.
|
NA
|
NA
|
|
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients.
|
NA
|
NA
|
|
Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.
|
NA
|
NA
|
|
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
|
NA
|
NA
|
|
Identifying critically ill patients at risk of death from coronavirus disease.
|
NA
|
NA
|
|
Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2.
|
NA
|
NA
|
|
Managing children with brain tumors during the COVID-19 era: Don’t stop the care!
|
NA
|
NA
|
|
Laryngotracheal stenosis following intubation and tracheostomy for COVID-19 pneumonia: a case report.
|
NA
|
NA
|
|
COVID-19 and active primary tuberculosis in a low-resource setting: A case report.
|
NA
|
NA
|
|
Pneumothorax in Mechanically Ventilated Patients with COVID-19 Infection.
|
NA
|
NA
|
|
in a Patient with Multiple Myeloma.
|
NA
|
NA
|
|
COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm.
|
NA
|
NA
|
|
Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic.
|
NA
|
NA
|
|
Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
|
NA
|
NA
|
|
The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families.
|
NA
|
NA
|
|
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Acute Kidney Injury in Hospitalized Patients Infected with COVID-19 from Wuhan, China: A Retrospective Study.
|
NA
|
NA
|
|
Clinical Findings in Diabetes Mellitus Patients with COVID-19.
|
NA
|
NA
|
|
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients.
|
NA
|
NA
|
|
Human Challenge Studies With Wild-Type Severe Acute Respiratory Sydrome Coronavirus 2 Violate Longstanding Codes of Human Subjects Research.
|
NA
|
NA
|
|
Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020.
|
NA
|
NA
|
|
Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center.
|
NA
|
NA
|
|
Collaborative platform trials to fight COVID-19: methodological and regulatory considerations for a better societal outcome.
|
NA
|
NA
|
|
RAAS blockade and COVID-19: Mechanistic Modeling of mas and AT1 Receptor Occupancy as Indicators of Pro- and Anti-Inflammatory Balance.
|
NA
|
NA
|
|
siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?
|
NA
|
NA
|
|
Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
|
NA
|
NA
|
|
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience.
|
NA
|
NA
|
|
High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
|
NA
|
NA
|
|
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
|
NA
|
NA
|
|
Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis.
|
NA
|
NA
|
|
Quinacrine as a potential treatment for COVID-19 virus infection.
|
NA
|
NA
|
|
Nursing management at a Chinese fever clinic during the COVID-19 pandemic.
|
NA
|
NA
|
|
Case Management on the Front Lines of COVID-19: The Importance of the Individualized Care Plan Across Care Settings.
|
NA
|
NA
|
|
Telemedicine Management of Musculoskeletal Issues.
|
NA
|
NA
|
|
) in the age of COVID-19.
|
NA
|
NA
|
|
A review of pharmaceutical occurrence and pathways in the aquatic environment in the context of a changing climate and the COVID-19 pandemic.
|
NA
|
NA
|
|
Early Intervention for the Treatment of Acute Laryngeal Injury After Intubation.
|
NA
|
NA
|
|
Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America.
|
NA
|
NA
|
|
Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
|
NA
|
NA
|
|
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study.
|
NA
|
NA
|
|
Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint.
|
NA
|
NA
|
|
Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.
|
NA
|
NA
|
|
Acute abdomen in COVID-19 disease: the pediatric surgeon’s standpoint.
|
NA
|
NA
|
|
Immediate impact of the COVID-19 pandemic on pediatric surgery: analysis of a tertiary healthcare facility.
|
NA
|
NA
|
|
[Scientific literature on integrative medicine in 2020].
|
NA
|
NA
|
|
[Cardiology].
|
NA
|
NA
|
|
[Recent Advances in Neurology].
|
NA
|
NA
|
|
[Rheumatology update 2020: the focus was on Covid-19].
|
NA
|
NA
|
|
Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions.
|
NA
|
NA
|
|
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.
|
NA
|
NA
|
|
High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.
|
NA
|
NA
|
|
Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis.
|
NA
|
NA
|
|
Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
|
NA
|
NA
|
|
Glucocorticoids and the Brain after Critical Illness.
|
NA
|
NA
|
|
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
|
NA
|
NA
|
|
Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies.
|
NA
|
NA
|
|
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
|
NA
|
NA
|
|
SARS-CoV-2 infection in patients with autoimmune hepatitis.
|
NA
|
NA
|
|
Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19?
|
NA
|
NA
|
|
Factors associated with survival in older patients affected by COVID-19: A retrospective cohort study.
|
NA
|
NA
|
|
Utilization of telemedicine in rhinologic practice during COVID-19 pandemic.
|
NA
|
NA
|
|
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.
|
NA
|
NA
|
|
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
|
NA
|
NA
|
|
Acute Rehabilitation of a Patient With COVID-19 Myocarditis: A Case Report.
|
NA
|
NA
|
|
Pure SARS-CoV-2 related AVDS (Acute Vascular Distress Syndrome).
|
NA
|
NA
|
|
Anti-inflammatory potential of Quercetin in COVID-19 treatment.
|
NA
|
NA
|
|
Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders.
|
NA
|
NA
|
|
Emergency Management in a Dental Clinic During the Coronavirus Disease 2019 (COVID-19) Epidemic in Beijing.
|
NA
|
NA
|
|
[COVID-19: Coagulopathy and thrombosis].
|
NA
|
NA
|
|
The intersection between integrative medicine and neuropathic pain: A case report.
|
NA
|
NA
|
|
Caring for critically ill adults in paediatric intensive care units in England during the COVID-19 pandemic: planning, implementation and lessons for the future.
|
NA
|
NA
|
|
Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection.
|
NA
|
NA
|
|
Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
|
NA
|
NA
|
|
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
|
NA
|
NA
|
|
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.
|
NA
|
NA
|
|
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
|
NA
|
NA
|
|
Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
|
NA
|
NA
|
|
Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.
|
NA
|
NA
|
|
Triage of urology service to cope with COVID-19 pandemic: A single institution study.
|
NA
|
NA
|
|
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.
|
NA
|
NA
|
|
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
|
NA
|
NA
|
|
Compassion-Focused Group Therapy for Treatment-Resistant OCD: Initial Evaluation Using a Multiple Baseline Design.
|
NA
|
NA
|
|
SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters.
|
NA
|
NA
|
|
Intradialytic exercise in the treatment of social frailty: a single-center prospective study-preliminary results during the unexpected COVID-19 pandemic.
|
NA
|
NA
|
|
Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale.
|
NA
|
NA
|
|
A Case of Post-COVID-19 Subacute Thyroiditis.
|
NA
|
NA
|
|
Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients.
|
NA
|
NA
|
|
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh.
|
NA
|
NA
|
|
Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19.
|
NA
|
NA
|
|
COVID-19: An overview and a clinical update.
|
NA
|
NA
|
|
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2.
|
NA
|
NA
|
|
SARS-CoV-2 and Systemic Lupus Erythematosus.
|
NA
|
NA
|
|
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.
|
NA
|
NA
|
|
Olecranon fractures in the elderly during the COVID-19 pandemic: Is non-operative treatment reasonable? Review of the current evidence.
|
NA
|
NA
|
|
COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.
|
NA
|
NA
|
|
Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review.
|
NA
|
NA
|
|
COVID-19-induced toxic epidermal necrolysis.
|
NA
|
NA
|
|
Tocilizumab in COVID-19 interstitial pneumonia.
|
NA
|
NA
|
|
Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19.
|
NA
|
NA
|
|
Things You Should Know in the Performing Echocardiographic Examination in Patients with COVID-19.
|
NA
|
NA
|
|
NEUROLOGICAL RISKS AND BENEFITS OF CYTOKINE-BASED TREATMENTS IN COVID-19: FROM PRECLINICAL TO CLINICAL EVIDENCE.
|
NA
|
NA
|
|
Editorial: Evidence, policy and practice - gold standard, good enough or doing it differently?
|
NA
|
NA
|
|
Efficacy of a Six-Week-Long Therapist-Guided Online Therapy Versus Self-help Internet-Based Therapy for COVID-19-Induced Anxiety and Depression: Open-label, Pragmatic, Randomized Controlled Trial.
|
NA
|
NA
|
|
[Imagine a new relationship of trust in medicine.]
|
NA
|
NA
|
|
Apoptosis induced by SARS-CoV-2: can we target it?
|
NA
|
NA
|
|
Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity.
|
NA
|
NA
|
|
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
|
NA
|
NA
|
|
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis.
|
NA
|
NA
|
|
The value of ECG changes in risk stratification of COVID-19 patients.
|
NA
|
NA
|
|
Digital Technology for AMD Management in the Post-COVID-19 New Normal.
|
NA
|
NA
|
|
Did COVID-19 Affect Time to Presentation in the Setting of Pediatric Testicular Torsion?
|
NA
|
NA
|
|
A Community Orthopaedic Residency Approach to Education and Training During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort.
|
NA
|
NA
|
|
Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19.
|
NA
|
NA
|
|
High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration.
|
NA
|
NA
|
|
Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India.
|
NA
|
NA
|
|
Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands.
|
NA
|
NA
|
|
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
|
NA
|
NA
|
|
Cardiovascular protective properties of oxytocin against COVID-19.
|
NA
|
NA
|
|
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
|
NA
|
NA
|
|
The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki, Finland.
|
NA
|
NA
|
|
Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review.
|
NA
|
NA
|
|
[Steroids in infection medicine].
|
NA
|
NA
|
|
Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions.
|
NA
|
NA
|
|
A basic investigation into the optimization of cylindrical tubes used as acoustic stethoscopes for auscultation in COVID-19 diagnosis.
|
NA
|
NA
|
|
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein.
|
NA
|
NA
|
|
Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis.
|
NA
|
NA
|
|
Infection control strategy and primary care assistance in Campania region during the national lockdown due to COVID-19 outbreak: the experience of two tertiary emergency centers.
|
NA
|
NA
|
|
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues.
|
NA
|
NA
|
|
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
|
NA
|
NA
|
|
Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
|
NA
|
NA
|
|
More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years.
|
NA
|
NA
|
|
National health system cuts and triage decisions during the COVID-19 pandemic in Italy and Spain: ethical implications.
|
NA
|
NA
|
|
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies.
|
NA
|
NA
|
|
What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
|
NA
|
NA
|
|
The incidence of arm, forearm, and hip osteoporotic fractures during early stage of COVID-19 pandemic.
|
NA
|
NA
|
|
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
|
NA
|
NA
|
|
Selective cranial multineuritis in severe COVID-19 pneumonia: two cases and literature review.
|
NA
|
NA
|
|
Patient Volume and Dispositions in a VA Psychiatric Emergency Room During COVID-19.
|
NA
|
NA
|
|
Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies.
|
NA
|
NA
|
|
Management of diabetes and hyperglycaemia in the hospital.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease.
|
NA
|
NA
|
|
The effect of heat-treatment on SARS-CoV-2 viability and detection.
|
NA
|
NA
|
|
Machine learning predictive model for severe COVID-19.
|
NA
|
NA
|
|
Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection.
|
NA
|
NA
|
|
A combination of phototherapy modalities for extensive lip lesions in a patient with SARS-CoV-2 infection.
|
NA
|
NA
|
|
Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study.
|
NA
|
NA
|
|
Clinical trial preparations for the next pandemic.
|
NA
|
NA
|
|
Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
|
NA
|
NA
|
|
R-type disinfection by-product formation during wastewater treatment.
|
NA
|
NA
|
|
Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking.
|
NA
|
NA
|
|
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
|
NA
|
NA
|
|
Takotsubo’s syndrome presenting as cardiogenic shock in patients with COVID-19: A case-series and review of current literature.
|
NA
|
NA
|
|
Role of Famotidine and Other Acid Reflux Medications for SARS-CoV-2: A Pilot Study.
|
NA
|
NA
|
|
Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm.
|
NA
|
NA
|
|
Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with IBD?
|
NA
|
NA
|
|
[Contribution of a hospital pharmacy team to critical care of patients infected with SARS-CoV-2].
|
NA
|
NA
|
|
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
|
NA
|
NA
|
|
Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2.
|
NA
|
NA
|
|
A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic.
|
NA
|
NA
|
|
Coronavirus disease 2019 vaccines in pregnancy.
|
NA
|
NA
|
|
Metaplastic squamous cell breast cancer: A case report and treatment strategy during covid-19 pandemic.
|
NA
|
NA
|
|
High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis.
|
NA
|
NA
|
|
Lessons Learnt during the COVID-19 Pandemic: For Patients with End-Stage Renal Disease, We Should Prioritize Home-Based Treatment and Telemedicine.
|
NA
|
NA
|
|
Acute Lower-Extremity Ischemia in a Patient with COVID-19.
|
NA
|
NA
|
|
Repurposing approved drugs for cancer therapy.
|
NA
|
NA
|
|
Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study).
|
NA
|
NA
|
|
How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography.
|
NA
|
NA
|
|
Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology.
|
NA
|
NA
|
|
Management challenges in patients with comorbid COVID-19 associated delirium and serious mental illness - A case series.
|
NA
|
NA
|
|
Mental health impact of the Covid-19 pandemic on parents in high-risk, low income communities.
|
NA
|
NA
|
|
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review.
|
NA
|
NA
|
|
Managing cancer in context of pandemic: a qualitative study to explore the emotional and behavioural responses of patients with cancer and their caregivers to COVID-19.
|
NA
|
NA
|
|
The relationship between obesity, hemoglobin A1c and the severity of COVID-19 at an urban tertiary care center in New York City: a retrospective cohort study.
|
NA
|
NA
|
|
Inactivation of SARS-CoV-2 by Catechins from Green Tea.
|
NA
|
NA
|
|
Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19.
|
NA
|
NA
|
|
Computed optical spectra of SARS-CoV-2 proteins.
|
NA
|
NA
|
|
Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.
|
NA
|
NA
|
|
Electrochemical sensing: A prognostic tool in the fight against COVID-19.
|
NA
|
NA
|
|
The potential of electrochemistry for the detection of coronavirus-induced infections.
|
NA
|
NA
|
|
Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part II: Complexation with several π-acceptors (PA, CLA, CHL).
|
NA
|
NA
|
|
Single-use surgical face masks, as a potential source of microplastics: Do they act as pollutant carriers?
|
NA
|
NA
|
|
Psychological impact of covid-19 crises on students through the lens of Stimulus-Organism-Response (SOR) model.
|
NA
|
NA
|
|
[Medical applications of social networks. Specific aspects of the COVID-19 pandemic].
|
NA
|
NA
|
|
[Nutrition and the COVID-19 pandemic].
|
NA
|
NA
|
|
The clinical practice of Pediatric Dentistry post-COVID-19: the current evidences.
|
NA
|
NA
|
|
Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
|
NA
|
NA
|
|
Comparison of deep learning approaches to predict COVID-19 infection.
|
NA
|
NA
|
|
Mathematical modeling of the spread of COVID-19 among different age groups in Morocco: Optimal control approach for intervention strategies.
|
NA
|
NA
|
|
Global stability analysis of the role of multi-therapies and non-pharmaceutical treatment protocols for COVID-19 pandemic.
|
NA
|
NA
|
|
What is the difference between the first and the second/third wave of Covid-19? - German perspective.
|
NA
|
NA
|
|
Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding.
|
NA
|
NA
|
|
An Open Clinical Evaluation Of Selected Siddha Regimen In Expediting The Management Of Covid-19 -A Randomized Controlled Study.
|
NA
|
NA
|
|
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects.
|
NA
|
NA
|
|
Fibrinolysis Therapy Combined with Deferred PCI versus Primary Angioplasty for STEMI Patients During the COVID-19 Pandemic: Preliminary Results from a Single Center.
|
NA
|
NA
|
|
A Rare Giant Midesophageal Diverticulum: Fever is the Only Symptom.
|
NA
|
NA
|
|
Analysis of the Public Health Functions of the Chinese Government in the Prevention and Control of COVID-19.
|
NA
|
NA
|
|
Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey.
|
NA
|
NA
|
|
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.
|
NA
|
NA
|
|
Potential impacts of COVID-19 on reproductive health: Scientific findings and social dimension.
|
NA
|
NA
|
|
Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic?
|
NA
|
NA
|
|
The impact of COVID-19 on industry-related characteristics and risk contagion.
|
NA
|
NA
|
|
Self- Care for Health Professionals During Coronavirus Disease 2019 Crisis.
|
NA
|
NA
|
|
Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia.
|
NA
|
NA
|
|
COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments.
|
NA
|
NA
|
|
Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19.
|
NA
|
NA
|
|
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target.
|
NA
|
NA
|
|
3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.
|
NA
|
NA
|
|
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
|
NA
|
NA
|
|
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress.
|
NA
|
NA
|
|
Polish Experiences of Safety Measures Involving Forensic Psychiatric Inpatients Implemented During the SARS-CoV-2 Pandemic.
|
NA
|
NA
|
|
Efforts and Challenges to Ensure Continuity of Mental Healthcare Service Delivery in a Low Resource Settings During COVID-19 Pandemic-A Case of a Kenyan Referral Hospital.
|
NA
|
NA
|
|
Patients Living With Breast Cancer During the Coronavirus Pandemic: The Role of Family Resilience, Coping Flexibility, and Locus of Control on Affective Responses.
|
NA
|
NA
|
|
Remote W.A.R.A. Compared With Face-to-Face W.A.R.A.: A Pilot Study.
|
NA
|
NA
|
|
Continuity of Care During COVID-19 Lockdown: A Survey on Stakeholders’ Experience With Telerehabilitation.
|
NA
|
NA
|
|
Cognitive Telerehabilitation for Older Adults With Neurodegenerative Diseases in the COVID-19 Era: A Perspective Study.
|
NA
|
NA
|
|
Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
|
NA
|
NA
|
|
Case Report: Late-Onset Congenital Adrenal Hyperplasia and Acute Covid-19 Infection in a Pregnant Woman: Multidisciplinary Management.
|
NA
|
NA
|
|
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
|
NA
|
NA
|
|
Coping strategies in obsessive-compulsive patients during Covid-19 lockdown.
|
NA
|
NA
|
|
Nanotechnology for virus treatment.
|
NA
|
NA
|
|
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections.
|
NA
|
NA
|
|
[Histological pulmonary features due to the Sars-CoV-2].
|
NA
|
NA
|
|
Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.
|
NA
|
NA
|
|
Acute right ventricular failure in COVID-19 infection: A case series.
|
NA
|
NA
|
|
Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites.
|
NA
|
NA
|
|
Telehealth for the Provision of Occupational Therapy: Reflections on Experiences During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Telepractice as a Reaction to the COVID-19 Crisis: Insights from Croatian SLP Settings.
|
NA
|
NA
|
|
Telehealth and Home Health Occupational Therapy: Clients’ Perceived Satisfaction with and Perception of Occupational Performance.
|
NA
|
NA
|
|
Acute pericarditis revealing COVID-19 infection: Case report.
|
NA
|
NA
|
|
Emergency high ligation in a suspected COVID-19 pediatric patient with incarcerated inguinal hernia: A case report.
|
NA
|
NA
|
|
Chloroquine and COVID-19: role as a bitter taste receptor agonist?
|
NA
|
NA
|
|
A Retrospective Analysis of Thromboembolic Phenomena in Mechanically Ventilated Patients with COVID-19.
|
NA
|
NA
|
|
The Scientific Foundation of Chinese Herbal Medicine against COVID-19.
|
NA
|
NA
|
|
A Rare Presentation of Cerebrovascular Accident in a COVID-19 Patient: A Case Report.
|
NA
|
NA
|
|
High Dose Steroid Therapy to Prevent Severe Hypoxia in COVID-19 Patients: A Potential Solution for Low Resource Clinical Setting.
|
NA
|
NA
|
|
COVID-19 Infection and Acute Pulmonary Embolism in an Adolescent Female With Sickle Cell Disease.
|
NA
|
NA
|
|
Isolated Radial Vein Thrombosis: Upper Extremity Deep Vein Thrombosis in a Patient With COVID-19 Infection.
|
NA
|
NA
|
|
Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach.
|
NA
|
NA
|
|
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective.
|
NA
|
NA
|
|
Modeling and analysis of the dynamics of novel coronavirus (COVID-19) with Caputo fractional derivative.
|
NA
|
NA
|
|
Identification of dominant risk factor involved in spread of COVID-19 using hesitant fuzzy MCDM methodology.
|
NA
|
NA
|
|
In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex.
|
NA
|
NA
|
|
COVID-19: Environment concern and impact of Indian medicinal system.
|
NA
|
NA
|
|
Continuing cancer care in a religious facility: A feasible alternative in the COVID-19 Pandemic Era?
|
NA
|
NA
|
|
COVID-19 presenting as intussusception in infants: A case report with literature review.
|
NA
|
NA
|
|
Improving early detection of infection in nursing home residents in South Africa.
|
NA
|
NA
|
|
Awake craniotomy in a Covid-19 positive patient: The challenges and outcome.
|
NA
|
NA
|
|
Cerebral venous sinus thrombosis in patients with COVID-19 infection.
|
NA
|
NA
|
|
Convolutional neural network use chest radiography images for identification of COVID-19.
|
NA
|
NA
|
|
approach.
|
NA
|
NA
|
|
COVID-19: Considerations for Children and Families During the Pandemic.
|
NA
|
NA
|
|
Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown.
|
NA
|
NA
|
|
Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate.
|
NA
|
NA
|
|
Perinatal Cells: A Promising COVID-19 Therapy?
|
NA
|
NA
|
|
An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants.
|
NA
|
NA
|
|
Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications.
|
NA
|
NA
|
|
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
|
NA
|
NA
|
|
Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
|
NA
|
NA
|
|
Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.
|
NA
|
NA
|
|
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.
|
NA
|
NA
|
|
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors.
|
NA
|
NA
|
|
Pneumococcal superinfection in COVID-19 patients: A series of 5 cases.
|
NA
|
NA
|
|
Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.
|
NA
|
NA
|
|
Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19.
|
NA
|
NA
|
|
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients.
|
NA
|
NA
|
|
A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19.
|
NA
|
NA
|
|
COVID-19: What you need to know.
|
NA
|
NA
|
|
Genetic variations among SARS-CoV-2 strains isolated in China.
|
NA
|
NA
|
|
Re-use of health masks after autoclaving.
|
NA
|
NA
|
|
The Novel Use of a Commercially Available Video-Conference Platform to Facilitate Multidisciplinary Target Volume Review and Delineation for Skull-Base Radiation Therapy During the Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19-Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center.
|
NA
|
NA
|
|
COVID-19 intervention models: An initial aggressive treatment strategy for controlling the infection.
|
NA
|
NA
|
|
Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report.
|
NA
|
NA
|
|
A Systematic Review of Systematic Reviews on the COVID-19 Pandemic.
|
NA
|
NA
|
|
Bibliometric analysis of global scientific research on COVID-19.
|
NA
|
NA
|
|
Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections.
|
NA
|
NA
|
|
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
|
NA
|
NA
|
|
AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate.
|
NA
|
NA
|
|
Risk factors of developing critical conditions in Iranian patients with COVID-19.
|
NA
|
NA
|
|
Aortic thrombosis in COVID-19.
|
NA
|
NA
|
|
Critical Ethics: How to Balance Patient Autonomy With Fairness When Patients Refuse Coronavirus Disease 2019 Testing.
|
NA
|
NA
|
|
Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
|
NA
|
NA
|
|
Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.
|
NA
|
NA
|
|
Human eggs, zygotes, and embryos express the receptor ACE2 and protease TMPRSS2 protein necessary for SARS-CoV-2 infection.
|
NA
|
NA
|
|
The current situation of COVID-19 in India.
|
NA
|
NA
|
|
Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature.
|
NA
|
NA
|
|
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency.
|
NA
|
NA
|
|
A skeleton in the closet: The implications of COVID-19 on XDR strain of typhoid in Pakistan.
|
NA
|
NA
|
|
Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries.
|
NA
|
NA
|
|
Power of universal health coverage in the era of COVID-19: A nationwide observational study.
|
NA
|
NA
|
|
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients.
|
NA
|
NA
|
|
Patients’ Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation.
|
NA
|
NA
|
|
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
|
NA
|
NA
|
|
Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder.
|
NA
|
NA
|
|
Tele-practice for children and young people with communication disabilities: Employing the COM-B model to review the intervention literature and inform guidance for practitioners.
|
NA
|
NA
|
|
[Design and Feasibility Study of Tracheal Intubation Device Based on Magnetic Navigation Technology].
|
NA
|
NA
|
|
[Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients].
|
NA
|
NA
|
|
Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19.
|
NA
|
NA
|
|
COVID-19 management in heart transplanted recipients: registry of Almazov National Medical Research Centre.
|
NA
|
NA
|
|
Severe hypocalcaemia in a COVID-19 female patient.
|
NA
|
NA
|
|
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
|
NA
|
NA
|
|
Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
|
NA
|
NA
|
|
COVID-19: how has a global pandemic changed manual therapy technique education in chiropractic programs around the world?
|
NA
|
NA
|
|
Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease.
|
NA
|
NA
|
|
Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials.
|
NA
|
NA
|
|
A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.
|
NA
|
NA
|
|
High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
|
NA
|
NA
|
|
Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead.
|
NA
|
NA
|
|
COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
|
NA
|
NA
|
|
Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19?
|
NA
|
NA
|
|
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
|
NA
|
NA
|
|
Clinical activity changes in the neurology department of Wenzhou during the COVID-19 pandemic: an observational analysis.
|
NA
|
NA
|
|
[Pharmachologic treatment of acute postoperative pain: A clinical practice guideline of The Turkish Society of Algology].
|
NA
|
NA
|
|
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
|
NA
|
NA
|
|
Synthesis and Biopharmaceutical Applications of Sugar-Based Polymers: New Advances and Future Prospects.
|
NA
|
NA
|
|
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models.
|
NA
|
NA
|
|
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.
|
NA
|
NA
|
|
Antiviral drug discovery: preparing for the next pandemic.
|
NA
|
NA
|
|
Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells.
|
NA
|
NA
|
|
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
|
NA
|
NA
|
|
Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.
|
NA
|
NA
|
|
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study.
|
NA
|
NA
|
|
A German AWMF’s S2e/realist synthesis and meta-narrative snapshot of craniomaxillofacial manifestations in COVID-19 patients: Rapid living update on 1 January 2021.
|
NA
|
NA
|
|
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review.
|
NA
|
NA
|
|
COVID-19 convalescent plasma composition and immunological effects in severe patients.
|
NA
|
NA
|
|
What do we know about the antibody responses to SARS-CoV-2?
|
NA
|
NA
|
|
Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?
|
NA
|
NA
|
|
Facing the Threat of COVID-19 in Pakistan: A Nation’s Dilemma.
|
NA
|
NA
|
|
Effect of the COVID-19 Pandemic in German Trauma Centres and Geriatric Trauma Centres DGU.
|
NA
|
NA
|
|
NA
|
NA
|
NA
|
|
Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies.
|
NA
|
NA
|
|
Modeling and analysis of COVID-19 based on a time delay dynamic model.
|
NA
|
NA
|
|
Pandemic COVID-19: the residents’ resilience.
|
NA
|
NA
|
|
The characteristics of cancerous patients infected with COVID-19 in hospital setting.
|
NA
|
NA
|
|
Evidence of significant difference in key COVID-19 biomarkers during the Italian lockdown strategy. A retrospective study on patients admitted to a hospital emergency department in Northern Italy.
|
NA
|
NA
|
|
Taking care of healthcare workers during COVID-19 pandemic: does plastic surgery have a role?
|
NA
|
NA
|
|
Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study.
|
NA
|
NA
|
|
Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial.
|
NA
|
NA
|
|
Antithrombotic prophylaxis in children and adolescents’ patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians.
|
NA
|
NA
|
|
Clinical features and short-term outcomes of COVID-19 in Tehran, Iran: An analysis of mortality and hospital stay.
|
NA
|
NA
|
|
Clinical Outcome of Eosinophilia in Patients with COVID-19: A Controlled Study.
|
NA
|
NA
|
|
Proposed Scoring System for Evaluating Clinico-radiological Severity of COVID- 19 using Plain Chest X- ray (CXR) changes (CO X-RADS): Preliminary results.
|
NA
|
NA
|
|
Rehabilitative treatment of patients with COVID-19 infection: the P.A.R.M.A. evidence based clinical practice protocol.
|
NA
|
NA
|
|
Current Perspectives of convalescent plasma therapy in COVID-19.
|
NA
|
NA
|
|
Obstructive sleep apnea, cpap and COVID-19: a brief review.
|
NA
|
NA
|
|
COVID-19 and its impact on cardiology service.
|
NA
|
NA
|
|
Hepcidin is a friend rather than a foe in COVID19-induced complications.
|
NA
|
NA
|
|
The role of angiotensin-converting enzyme 2 in COVID-19 induced lung injury.
|
NA
|
NA
|
|
Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report.
|
NA
|
NA
|
|
Treatment of COVID-19 in Pregnancy with Hydroxychloroquine and Azithromycin: a case report.
|
NA
|
NA
|
|
Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
|
NA
|
NA
|
|
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies.
|
NA
|
NA
|
|
Lithium and Therapeutic Targeting of GSK-3.
|
NA
|
NA
|
|
Management of inflammatory bowel disease in the COVID-19 era.
|
NA
|
NA
|
|
Obstacles, Challenges, and Benefits of Online Group Psychotherapy.
|
NA
|
NA
|
|
Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis.
|
NA
|
NA
|
|
Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
|
NA
|
NA
|
|
Respiratory viral infections during pregnancy: effects of SARS-CoV-2 and other related viruses over the offspring.
|
NA
|
NA
|
|
A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre.
|
NA
|
NA
|
|
The interplay between neutrophils, complement, and microthrombi in COVID-19.
|
NA
|
NA
|
|
The protective effect of rheumatic disease agents in COVID-19.
|
NA
|
NA
|
|
Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01.
|
NA
|
NA
|
|
Kinetic characterization and inhibitor screening for the proteases leading to identification of drugs against SARS-CoV-2.
|
NA
|
NA
|
|
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
|
NA
|
NA
|
|
KNOWLEDGE, ATTITUDES AND PERCEPTION AMONG PATIENTS TOWARDS CROSS-INFECTION CONTROL MEASURES IN DENTAL CLINICS IN GEORGIA BEFORE THE COVID-19 PANDEMIC.
|
NA
|
NA
|
|
The impact of COVID-19 on systemic anticancer treatment delivery in Scotland.
|
NA
|
NA
|
|
[Between care for others and self-care: intensive care nursing in times of the COVID-19 pandemic].
|
NA
|
NA
|
|
A fuzzy rule-based efficient hospital bed management approach for coronavirus disease-19 infected patients.
|
NA
|
NA
|
|
gene expression analysis.
|
NA
|
NA
|
|
COVINet: a convolutional neural network approach for predicting COVID-19 from chest X-ray images.
|
NA
|
NA
|
|
Persistent Hypokalemia post SARS-coV-2 infection, is it a life-long complication? Case report.
|
NA
|
NA
|
|
A Three-Step, Single Session Therapy Intervention for COVID-Related Anxiety in a Pediatric Emergency Department.
|
NA
|
NA
|
|
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit.
|
NA
|
NA
|
|
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD.
|
NA
|
NA
|
|
Severe outcomes of COVID-19 among patients with COPD and asthma.
|
NA
|
NA
|
|
Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection.
|
NA
|
NA
|
|
Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein.
|
NA
|
NA
|
|
Care for Older People with Dementia During COVID-19 Pandemic.
|
NA
|
NA
|
|
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report.
|
NA
|
NA
|
|
COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications.
|
NA
|
NA
|
|
Factors associated with psychological distress among patients with breast cancer during the COVID-19 pandemic: a cross-sectional study in Wuhan, China.
|
NA
|
NA
|
|
mTOR inhibition: a double-edged sword in patients with COVID-19?
|
NA
|
NA
|
|
Raloxifene as a treatment option for viral infections.
|
NA
|
NA
|
|
Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection.
|
NA
|
NA
|
|
SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma.
|
NA
|
NA
|
|
When cardiomyopathy, cancer, and COVID-19 collide: A case report.
|
NA
|
NA
|
|
Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics.
|
NA
|
NA
|
|
Autoimmune and Chronic Inflammatory Disease Patients with COVID-19.
|
NA
|
NA
|
|
Predictive value of the preliminary findings in the severity of COVID-19 disease and the effect on therapeutic approaches.
|
NA
|
NA
|
|
Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients.
|
NA
|
NA
|
|
Limited Benefit of Facility Isolation and the Rationale for Home Care in Children with Mild COVID-19.
|
NA
|
NA
|
|
Quantitative Assessment of Chest CT Patterns in COVID-19 and Bacterial Pneumonia Patients: a Deep Learning Perspective.
|
NA
|
NA
|
|
Itolizumab Treatment for Cytokine Release Syndrome in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: Clinical Outcomes, A Retrospective Study.
|
NA
|
NA
|
|
Transmission routes, preventive measures and control strategies of SARS-CoV-2 in the food factory.
|
NA
|
NA
|
|
Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis.
|
NA
|
NA
|
|
Developing a new flexible tool for handover.
|
NA
|
NA
|
|
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.
|
NA
|
NA
|
|
Ophthalmology and Therapy: Reflecting on 2020 and Embracing the Challenges of 2021.
|
NA
|
NA
|
|
Retrospective study in clinical governance and financing system impacts of the COVID-19 pandemic in the hand surgery and microsurgery HUB center.
|
NA
|
NA
|
|
Clinical features of neurological patients with coronavirus 2019: an observational study of one centre.
|
NA
|
NA
|
|
Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study.
|
NA
|
NA
|
|
Inhaled corticosteroids may have a protective effect against coronavirus infection.
|
NA
|
NA
|
|
Managing food allergy immunotherapy in children during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of the COVID-19 Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution.
|
NA
|
NA
|
|
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.
|
NA
|
NA
|
|
Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2.
|
NA
|
NA
|
|
Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation.
|
NA
|
NA
|
|
Transformation and operation of a uniform psychiatric ward dedicated to COVID-19 patients during the pandemic.
|
NA
|
NA
|
|
Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region.
|
NA
|
NA
|
|
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.
|
NA
|
NA
|
|
Hematological manifestations and complications of COVID-19.
|
NA
|
NA
|
|
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.
|
NA
|
NA
|
|
Swallowing and Voice Outcomes in Patients Hospitalized With COVID-19: An Observational Cohort Study.
|
NA
|
NA
|
|
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves.
|
NA
|
NA
|
|
Efficacy and Safety Assessment of Severe COVID-19 Patients with Chinese Medicine: a Retrospective Case Series Study at Early Stage of the COVID-19 Epidemic in Wuhan, China.
|
NA
|
NA
|
|
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
|
NA
|
NA
|
|
Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity.
|
NA
|
NA
|
|
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review.
|
NA
|
NA
|
|
Genetic Variation, Diet, Inflammation, and the Risk for COVID-19.
|
NA
|
NA
|
|
Diabetes Care During COVID-19 Pandemic in Singapore Using a Telehealth Strategy.
|
NA
|
NA
|
|
Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19.
|
NA
|
NA
|
|
Simultaneous cardio-cerebral infarction in the coronavirus disease pandemic era: A case series.
|
NA
|
NA
|
|
Co-infection in patients with hypoxemic pneumonia due to COVID-19 in Reunion Island.
|
NA
|
NA
|
|
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
|
NA
|
NA
|
|
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets.
|
NA
|
NA
|
|
Review of Medical Therapies for the Management of Pulmonary Embolism.
|
NA
|
NA
|
|
COVID-19 and Pediatric Asthma: Clinical and Management Challenges.
|
NA
|
NA
|
|
An ethics framework for consolidating and prioritizing COVID-19 clinical trials.
|
NA
|
NA
|
|
Comparison of clinical and serological features of RT-PCR positive and negative COVID-19 patients.
|
NA
|
NA
|
|
Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients From Bedside to Outside the Patient Room.
|
NA
|
NA
|
|
Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2.
|
NA
|
NA
|
|
Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: a conceptual investigation.
|
NA
|
NA
|
|
Clinical Practice Guideline: Recommendations on Inpatient Treatment of Patients with COVID-19.
|
NA
|
NA
|
|
Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
|
NA
|
NA
|
|
Telerehabilitation in Subjects With Respiratory Disease: A Scoping Review.
|
NA
|
NA
|
|
A 75-Year-Old Woman with COVID-19 Pneumonia and Wellens Syndrome Diagnosed by Electrocardiography.
|
NA
|
NA
|
|
Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
|
NA
|
NA
|
|
More light on cancer and COVID-19 reciprocal interaction.
|
NA
|
NA
|
|
Paediatric dental care during and post-COVID-19 era: changes and challenges ahead.
|
NA
|
NA
|
|
Application of Nanotechnology in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.
|
NA
|
NA
|
|
Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020-July 2020.
|
NA
|
NA
|
|
Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review.
|
NA
|
NA
|
|
[COVID-19 and renal transplantation].
|
NA
|
NA
|
|
The impact of COVID-19 on surgical practice in Jordan during the second outbreak: A survey.
|
NA
|
NA
|
|
Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations.
|
NA
|
NA
|
|
Navigated Recovery of Fractured Dental Injection Needles: Case Report and Suggestions for Management during Pandemic Crises.
|
NA
|
NA
|
|
COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region.
|
NA
|
NA
|
|
Age in the Time of COVID-19: An Ethical Analysis.
|
NA
|
NA
|
|
Low level of Vitamin C and dysregulation of Vitamin C transporter might be involved in the severity of COVID-19 Infection.
|
NA
|
NA
|
|
Neurological Manifestations of COVID-19: Causality or Coincidence?
|
NA
|
NA
|
|
Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19.
|
NA
|
NA
|
|
A Comprehensive Summary of the Knowledge on COVID-19 Treatment.
|
NA
|
NA
|
|
Successful Treatment of Elderly Male With COVID-19 Infection With Severe Acute Respiratory Distress Syndrome Using Multimodal Therapy, Including Immune Modulation Therapy.
|
NA
|
NA
|
|
The History of Methylprednisolone, Ascorbic Acid, Thiamine, and Heparin Protocol and I-MASK+ Ivermectin Protocol for COVID-19.
|
NA
|
NA
|
|
Spatial statistical analysis of pre-existing mortalities of 20 diseases with COVID-19 mortalities in the continental United States.
|
NA
|
NA
|
|
Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology.
|
NA
|
NA
|
|
COVID-19 reinfection: Linked Possibilities and future outlook.
|
NA
|
NA
|
|
The knowledge about coronavirus (COVID-19) among populations in two different Arab countries.
|
NA
|
NA
|
|
Initial experiences regarding COVID19 mortality in Punjab-A mixed method analysis.
|
NA
|
NA
|
|
Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study.
|
NA
|
NA
|
|
Accurate Representations of the Microphysical Processes Occurring during the Transport of Exhaled Aerosols and Droplets.
|
NA
|
NA
|
|
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development.
|
NA
|
NA
|
|
A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives.
|
NA
|
NA
|
|
Elderly’s food security and its associated socioeconomic determinants in Tehran: A cross-sectional study.
|
NA
|
NA
|
|
Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.
|
NA
|
NA
|
|
Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department.
|
NA
|
NA
|
|
Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells.
|
NA
|
NA
|
|
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives.
|
NA
|
NA
|
|
Long non-coding RNAs: Promising new targets in pulmonary fibrosis.
|
NA
|
NA
|
|
Graphene Sheets with Defined Dual Functionalities for the Strong SARS-CoV-2 Interactions.
|
NA
|
NA
|
|
Obesity and Critical Illness in COVID-19: Respiratory Pathophysiology.
|
NA
|
NA
|
|
[The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis].
|
NA
|
NA
|
|
Removal and Inactivation of an Enveloped Virus Surrogate by Iron Conventional Coagulation and Electrocoagulation.
|
NA
|
NA
|
|
Control and prevention of infectious diseases from a One Health perspective.
|
NA
|
NA
|
|
Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.
|
NA
|
NA
|
|
Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group.
|
NA
|
NA
|
|
Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians.
|
NA
|
NA
|
|
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
|
NA
|
NA
|
|
Use of convalescent plasma for COVID-19 in India: A review & practical guidelines.
|
NA
|
NA
|
|
Anesthetic challenges while performing emergency laparotomy in a patient having COVID-19 infection.
|
NA
|
NA
|
|
Restructuring service at a mastology outpatient clinic during the COVID-19 pandemic.
|
NA
|
NA
|
|
Impact of COVID-19 on management of urogynaecology patients: a rapid review of the literature.
|
NA
|
NA
|
|
Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case-Control Study.
|
NA
|
NA
|
|
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
|
NA
|
NA
|
|
Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide.
|
NA
|
NA
|
|
Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
|
NA
|
NA
|
|
Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a).
|
NA
|
NA
|
|
National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.
|
NA
|
NA
|
|
A Case of Atypical Skull Base Osteomyelitis Secondary to Otitis Media Due to Delayed Diagnosis.
|
NA
|
NA
|
|
Paediatric allergy practice in the era of coronavirus disease 2019.
|
NA
|
NA
|
|
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but ….
|
NA
|
NA
|
|
Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer.
|
NA
|
NA
|
|
Development and Validation of a Machine Learning Approach for Automated Severity Assessment of COVID-19 Based on Clinical and Imaging Data: Retrospective Study.
|
NA
|
NA
|
|
Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study.
|
NA
|
NA
|
|
Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
Pragmatic Recommendations for the Management of Acute Respiratory Failure and Mechanical Ventilation in Patients with COVID-19 in Low- and Middle-Income Countries.
|
NA
|
NA
|
|
Exploratory study on the psychological impact of COVID-19 on the general Brazilian population.
|
NA
|
NA
|
|
Innate and Adaptive Immune Responses to SARS-CoV-2 in Humans: Relevance to Acquired Immunity and Vaccine Responses.
|
NA
|
NA
|
|
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection.
|
NA
|
NA
|
|
On Ambiguity Reduction and the Role of Decision Analysis during the Pandemic.
|
NA
|
NA
|
|
A case of Guillain-Barré syndrome related to COVID-19 infection.
|
NA
|
NA
|
|
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.
|
NA
|
NA
|
|
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
|
NA
|
NA
|
|
Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design.
|
NA
|
NA
|
|
Neuroimaging Findings in Conjunction with Severe COVID-19.
|
NA
|
NA
|
|
Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic.
|
NA
|
NA
|
|
Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.
|
NA
|
NA
|
|
‘Online therapy’ to reduce caregiver’s distress and to stimulate post-severe acquired brain injury motor and cognitive recovery: A Sicilian hospital experience in the COVID era.
|
NA
|
NA
|
|
Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19.
|
NA
|
NA
|
|
Molecular Elucidation and Therapeutic Targeting for combating COVID19: Current Scenario and Future Prospective.
|
NA
|
NA
|
|
Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.
|
NA
|
NA
|
|
Overview of Tertiary Addictions Services response to Opioid dependence during the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 in a patient with severe asthma using mepolizumab.
|
NA
|
NA
|
|
COVID-19 pandemic management and the rheumatology patient.
|
NA
|
NA
|
|
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
|
NA
|
NA
|
|
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
|
NA
|
NA
|
|
Risk of aerosol formation by high flow nasal cannula treatment in critically-ill patients.
|
NA
|
NA
|
|
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.
|
NA
|
NA
|
|
Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?
|
NA
|
NA
|
|
Which Factors, Smoking, Drinking Alcohol, Betel Quid Chewing, or Underlying Diseases, Are More Likely to Influence the Severity of COVID-19?
|
NA
|
NA
|
|
Acute Stroke Care in the With-COVID-19 Era: Experience at a Comprehensive Stroke Center in Japan.
|
NA
|
NA
|
|
Unmet Needs of People With Parkinson’s Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis.
|
NA
|
NA
|
|
Delayed Diagnosis of a Testicular Mass During COVID-19 Pandemic in Lombardy: A Case Report.
|
NA
|
NA
|
|
An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2.
|
NA
|
NA
|
|
Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019.
|
NA
|
NA
|
|
Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention.
|
NA
|
NA
|
|
A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy.
|
NA
|
NA
|
|
COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States.
|
NA
|
NA
|
|
Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis.
|
NA
|
NA
|
|
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality.
|
NA
|
NA
|
|
Biomedical applications of methionine-based systems.
|
NA
|
NA
|
|
SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study.
|
NA
|
NA
|
|
The Early Impact of COVID-19 on Chronic Pain: A Cross-Sectional Investigation of a Large Online Sample of Individuals with Chronic Pain in the United States, April to May, 2020.
|
NA
|
NA
|
|
Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
|
NA
|
NA
|
|
Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review).
|
NA
|
NA
|
|
Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?
|
NA
|
NA
|
|
Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection.
|
NA
|
NA
|
|
[The effects of covid-19 on psychiatry training in the Netherlands].
|
NA
|
NA
|
|
COVID-19 experience in mainland China: Nursing lessons for the United States of America.
|
NA
|
NA
|
|
The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients.
|
NA
|
NA
|
|
SARS-CoV-2 and self-medication in Cameroon: a mathematical model.
|
NA
|
NA
|
|
Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
|
NA
|
NA
|
|
Increasing Short- and Long-Term Buprenorphine Treatment Capacity: Providing Waiver Training for Medical Students.
|
NA
|
NA
|
|
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
|
NA
|
NA
|
|
COVID-19 and Alcohol Misuse: A Case Report.
|
NA
|
NA
|
|
Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin’s lymphoma history from north of Iran.
|
NA
|
NA
|
|
Being in touch: narrative assessment of patients receiving online integrative oncology treatments during COVID-19.
|
NA
|
NA
|
|
Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.
|
NA
|
NA
|
|
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection.
|
NA
|
NA
|
|
Public perceptions and preventive behaviours during the early phase of the COVID-19 pandemic: a comparative study between Hong Kong and the United Kingdom.
|
NA
|
NA
|
|
Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020.
|
NA
|
NA
|
|
Experiences, distress and burden among neurologists in Norway during the COVID-19 pandemic.
|
NA
|
NA
|
|
Aerosol generation and control in the dental operatory: An in vitro spectrometric study of typical clinical setups.
|
NA
|
NA
|
|
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic.
|
NA
|
NA
|
|
Minimal invasive surgery for left colectomy adapted to the COVID-19 pandemic: laparoscopic intracorporeal resection and anastomosis, a ‘don’t touch the bowel’ technique.
|
NA
|
NA
|
|
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
|
NA
|
NA
|
|
Balancing Risks: Making Decisions for Maternal Treatment without Data on Fetal Safety.
|
NA
|
NA
|
|
Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.
|
NA
|
NA
|
|
Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment.
|
NA
|
NA
|
|
ABO phenotype and SARS-CoV-2 infection: Is there any correlation?
|
NA
|
NA
|
|
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
|
NA
|
NA
|
|
Fluorescence polarization system for rapid COVID-19 diagnosis.
|
NA
|
NA
|
|
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status.
|
NA
|
NA
|
|
Managing the Journey of Patients under Chemotherapy in a Pandemic Era: A Nursing Perspective.
|
NA
|
NA
|
|
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
|
NA
|
NA
|
|
) and Its Use as a Virucidal Cream for Topical Application.
|
NA
|
NA
|
|
Comprehensive rehabilitation treatment for sub acute COVID-19 patients: an observational study.
|
NA
|
NA
|
|
The consequences of COVID-19 outbreak on outpatient rehabilitation services: a single-centre experience in Slovenia.
|
NA
|
NA
|
|
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network.
|
NA
|
NA
|
|
[Attach importance to the training of critical care physicians in China].
|
NA
|
NA
|
|
[Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
|
NA
|
NA
|
|
[Clinical and laboratory characteristics of 215 cases of coronavirus disease 2019 with different prognosis].
|
NA
|
NA
|
|
Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis.
|
NA
|
NA
|
|
Hypereosinophilic syndrome with multiorgan involvement: an interdisciplinary work-up.
|
NA
|
NA
|
|
Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy.
|
NA
|
NA
|
|
Steroid harms if given early in COVID-19 viraemia.
|
NA
|
NA
|
|
A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
|
NA
|
NA
|
|
Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides.
|
NA
|
NA
|
|
Risk of major cardiovascular events according to educational level before and after the initial COVID-19 public lockdown: a nationwide study.
|
NA
|
NA
|
|
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
|
NA
|
NA
|
|
Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic.
|
NA
|
NA
|
|
Intermittent High-Frequency Percussive Ventilation Therapy in 3 Patients with Severe COVID-19 Pneumonia.
|
NA
|
NA
|
|
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.
|
NA
|
NA
|
|
Clinical progression and outcomes of 260 patients with severe COVID-19: an observational study.
|
NA
|
NA
|
|
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency.
|
NA
|
NA
|
|
Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.
|
NA
|
NA
|
|
Identifying the Stroke Mimics.
|
NA
|
NA
|
|
Teleconsultation and Teletreatment Protocol to Diagnose and Manage Patients with Benign Paroxysmal Positional Vertigo (BPPV) during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The impact of COVID-19 outbreak on otolaryngology practice, jordanian experience: A qualitative study.
|
NA
|
NA
|
|
Low-Level Laser Therapy in Prevention of the Development of Endothelial Dysfunction and Clinical Experience of Treatment and Rehabilitation of COVID-19 Patients.
|
NA
|
NA
|
|
COVID-19 and Diabetic Ketoacidosis: A Single Center Experience.
|
NA
|
NA
|
|
Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19.
|
NA
|
NA
|
|
An Urgent Webinar for Therapists Working in Local Facilities by Physiatrists and Therapists in a Regional Core Hospital during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Recovery from respiratory failure after 49-day extracorporeal membrane oxygenation support in a critically ill patient with COVID-19: case report.
|
NA
|
NA
|
|
Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases.
|
NA
|
NA
|
|
[A cross-sectional survey of attention and knowledge level among dental students in Jiangxi province during the epidemic period of COVID-19].
|
NA
|
NA
|
|
The efficacy of a protective protocol for oral and maxillofacial surgery procedures in a COVID-19 pandemic area-results from 1471 patients.
|
NA
|
NA
|
|
Immune checkpoint inhibition in COVID-19: risks and benefits.
|
NA
|
NA
|
|
Cyberbullying perpetration in the COVID-19 era: An application of general strain theory.
|
NA
|
NA
|
|
PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
A single-center observational study on clinical features and outcomes of 21 SARS-CoV-2-infected neonates from India.
|
NA
|
NA
|
|
Renal resistive index is associated with acute kidney injury in COVID-19 patients treated in the intensive care unit.
|
NA
|
NA
|
|
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.
|
NA
|
NA
|
|
Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
|
NA
|
NA
|
|
COVID-19 Pandemic and Infertility: Gynecological Dilemma from an Indian Perspective.
|
NA
|
NA
|
|
Epithelial response to IFN-γ promotes SARS-CoV-2 infection.
|
NA
|
NA
|
|
Updated overview on the interplay between obesity and COVID-19.
|
NA
|
NA
|
|
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis.
|
NA
|
NA
|
|
Preventive aspect of ayurveda and yoga towards newly emerging disease COVID-19.
|
NA
|
NA
|
|
COVID-19 pathway signage for operating theatres.
|
NA
|
NA
|
|
Lexicon Development for COVID-19-related Concepts Using Open-source Word Embedding Sources: An Intrinsic and Extrinsic Evaluation.
|
NA
|
NA
|
|
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
|
NA
|
NA
|
|
COVID-19 associated anxiety enhances tinnitus.
|
NA
|
NA
|
|
Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment.
|
NA
|
NA
|
|
Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
|
NA
|
NA
|
|
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
|
NA
|
NA
|
|
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes.
|
NA
|
NA
|
|
Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
|
NA
|
NA
|
|
The effects of COVID-19 lockdown on lifestyle and emotional state in women undergoing assisted reproductive technology: Results of an Italian survey.
|
NA
|
NA
|
|
Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study.
|
NA
|
NA
|
|
SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
|
NA
|
NA
|
|
SARS-CoV-2 evolution during treatment of chronic infection.
|
NA
|
NA
|
|
The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.
|
NA
|
NA
|
|
The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
Efficacy and safety of Reyanning mixture combined with conventional Western medicine for treating COVID-19: A protocol for systematic review and meta-analysis.
|
NA
|
NA
|
|
COVID-19 Patient with Severe Comorbidity in Multimodal Acute Care Setting with Non-Invasive Medical Ventilation: A Clinical Outcome Report.
|
NA
|
NA
|
|
Shedding Light on the Main Characteristics and Perspectives of Romanian Medicinal Oxygen Market.
|
NA
|
NA
|
|
Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon.
|
NA
|
NA
|
|
Assessment of the Impact of a Daily Rehabilitation Program on Anxiety and Depression Symptoms and the Quality of Life of People with Mental Disorders during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Chest CT Severity Score as an Auxiliary Grading Tool to COVID-19 Pneumonia Imaging Classification: A Tertiary Care Experience in Pakistan.
|
NA
|
NA
|
|
Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19.
|
NA
|
NA
|
|
High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.
|
NA
|
NA
|
|
An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital.
|
NA
|
NA
|
|
Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea.
|
NA
|
NA
|
|
Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health.
|
NA
|
NA
|
|
Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis.
|
NA
|
NA
|
|
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Transitional care from skilled nursing facilities to home: study protocol for a stepped wedge cluster randomized trial.
|
NA
|
NA
|
|
Managing head and neck cancer patients during the COVID-19 pandemic: the experience of a tertiary referral center in southern Italy.
|
NA
|
NA
|
|
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma.
|
NA
|
NA
|
|
Child maltreatment in the time of COVID-19: Changes in the Florida foster care system surrounding the COVID-19 safer-at-home order.
|
NA
|
NA
|
|
COVID-19 in patients with cancer: Risks and precautions.
|
NA
|
NA
|
|
Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic.
|
NA
|
NA
|
|
Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid.
|
NA
|
NA
|
|
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19.
|
NA
|
NA
|
|
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
|
NA
|
NA
|
|
Immune cartography of macrophage activation syndrome in the COVID-19 era.
|
NA
|
NA
|
|
COVID-19 Pandemic: Changes in Care for a Community Academic Breast Center and Patient Perception of Those Changes.
|
NA
|
NA
|
|
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data.
|
NA
|
NA
|
|
Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients.
|
NA
|
NA
|
|
Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure.
|
NA
|
NA
|
|
Pandemic nightmares: Effects on dream activity of the COVID-19 lockdown in Italy.
|
NA
|
NA
|
|
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations.
|
NA
|
NA
|
|
Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.
|
NA
|
NA
|
|
Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force.
|
NA
|
NA
|
|
Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis.
|
NA
|
NA
|
|
Basic sanitation: a new indicator for the spread of COVID-19?
|
NA
|
NA
|
|
Implications of liver injury in risk-stratification and management of patients with COVID-19.
|
NA
|
NA
|
|
SARS-CoV-2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in COVID-19 endemic areas: prospective cross-sectional study in Japan.
|
NA
|
NA
|
|
COVID-19 vaccination for people with severe mental illness: why, what, and how?
|
NA
|
NA
|
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
|
NA
|
NA
|
|
How glycobiology can help us treat and beat the COVID-19 pandemic.
|
NA
|
NA
|
|
AEROSOLS GENERATED DURING ENDODONTIC TREATMENTS: A SPECIAL CONCERN DURING COVID-19 PANDEMIC.
|
NA
|
NA
|
|
The three frontlines against COVID-19: Brain, Behavior, and Immunity.
|
NA
|
NA
|
|
The immediate psychological response of the general population in Saudi Arabia during COVID-19 pandemic: A cross-sectional study.
|
NA
|
NA
|
|
Prognostic bioindicators in severe COVID-19 patients.
|
NA
|
NA
|
|
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum.
|
NA
|
NA
|
|
COVID-19 and Its Implications for Thrombosis and Anticoagulation.
|
NA
|
NA
|
|
The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis.
|
NA
|
NA
|
|
Arterial Thrombotic Events in Adult Inpatients With COVID-19.
|
NA
|
NA
|
|
COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine.
|
NA
|
NA
|
|
Herbal Medication to Enhance or Modulate Viral Infections.
|
NA
|
NA
|
|
Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid 19.
|
NA
|
NA
|
|
A rapid review of the impacts of “Big Events” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.
|
NA
|
NA
|
|
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
|
NA
|
NA
|
|
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
|
NA
|
NA
|
|
Evaluation of SARS-COV-2 transmission through indoor air in hospitals and prevention methods: A systematic review.
|
NA
|
NA
|
|
A role for pathogen risk factors and autoimmunity in encephalitis lethargica?
|
NA
|
NA
|
|
The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19.
|
NA
|
NA
|
|
Palliative Care in Toronto During the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 Impact on Vascular Surgery Practice: Experience From an Italian University Regional Hub Center for Vascular Pathology.
|
NA
|
NA
|
|
Mental health interventions for healthcare workers during the first wave of COVID-19 pandemic in Spain.
|
NA
|
NA
|
|
Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding.
|
NA
|
NA
|
|
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review.
|
NA
|
NA
|
|
Targets and strategies for vaccine development against SARS-CoV-2.
|
NA
|
NA
|
|
SARS-CoV-2: From the pathogenesis to potential anti-viral treatments.
|
NA
|
NA
|
|
Surviving traumatic cardiac arrest: Identification of factors associated with survival.
|
NA
|
NA
|
|
Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis.
|
NA
|
NA
|
|
Structural insights into SARS-CoV-2 infection and therapeutics development.
|
NA
|
NA
|
|
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
|
NA
|
NA
|
|
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
|
NA
|
NA
|
|
Experiences of telehealth e-mentoring within postgraduate musculoskeletal physical therapy education in the UK and Canada: a protocol for parallel mixed-methods studies and cross-cultural comparison.
|
NA
|
NA
|
|
Impact of the COVID‒19 pandemic on ophthalmic outpatient care at the Ophthalmology Department of the New St. John’s Hospital, Budapest
|
NA
|
NA
|
|
[Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
|
NA
|
NA
|
|
Appendicitis during the COVID-19 lockdown: results of a multicenter analysis in Germany.
|
NA
|
NA
|
|
Beyond Individual Triage: Regional Allocation of Life-Saving Resources such as Ventilators in Public Health Emergencies.
|
NA
|
NA
|
|
Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review.
|
NA
|
NA
|
|
Therapeutic efficacy, mechanical ventilation, length of hospital stay, and mortality rate in severe COVID-19 patients treated with tocilizumab.
|
NA
|
NA
|
|
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.
|
NA
|
NA
|
|
[Course of Revision of the Diagnosis and Treatment Protocol for COVID-19 and the Forensic Contribution].
|
NA
|
NA
|
|
Anticoagulation prior to hospitalization is a potential protective factor for COVID-19: insight from a French multicenter cohort study.
|
NA
|
NA
|
|
Emerging therapeutic approaches to COVID-19.
|
NA
|
NA
|
|
The computational intervention of macrolide antibiotics in the treatment of COVID-19.
|
NA
|
NA
|
|
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
|
NA
|
NA
|
|
Obesity and clinical severity in patients with COVID-19: a scoping review protocol.
|
NA
|
NA
|
|
A telephone assessment and advice service within an ED physiotherapy clinic: a single-site quality improvement cohort study.
|
NA
|
NA
|
|
Psychological Adjustment in Spain during the COVID-19 Pandemic: Positive and Negative Mental Health Outcomes in the General Population.
|
NA
|
NA
|
|
The impact and lessons learnt from the COVID-19 pandemic on a UK Burns Centre.
|
NA
|
NA
|
|
Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity.
|
NA
|
NA
|
|
COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study.
|
NA
|
NA
|
|
Sudomotor dysfunction in patients recovered from COVID-19.
|
NA
|
NA
|
|
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.
|
NA
|
NA
|
|
[Successful steroid pulse therapy for COVID-19 associated respiratory failure initially mimicking bortezomib-induced lung injury].
|
NA
|
NA
|
|
[Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
|
NA
|
NA
|
|
Another silver lining?: Anthropological perspectives on the promise and practice of relaxed restrictions for telemedicine and medication-assisted treatment in the context of COVID-19.
|
NA
|
NA
|
|
COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
|
NA
|
NA
|
|
Managing the COVID-19 emergency: A coordination framework to enhance response practices and actions.
|
NA
|
NA
|
|
Community perspectives on the COVID-19 response, Zimbabwe.
|
NA
|
NA
|
|
Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study.
|
NA
|
NA
|
|
Optimal control of a fractional order model for the COVID - 19 pandemic.
|
NA
|
NA
|
|
Awareness and knowledge of undergraduate dental students about the signs and symptoms of Corona viral infection (COVID-19), and the required infection control measures to prevent its spread.
|
NA
|
NA
|
|
Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach.
|
NA
|
NA
|
|
Critical roles of TLRs on the polarization of mesenchymal stem cells for cell therapy of viral infections: a notice for COVID-19 treatment.
|
NA
|
NA
|
|
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
|
NA
|
NA
|
|
Theoretical Mapping of Suicidal Risk Factors During the COVID-19 Pandemic: A Mini-Review.
|
NA
|
NA
|
|
Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple Thromboembolism.
|
NA
|
NA
|
|
On an SE(Is)(Ih)AR epidemic model with combined vaccination and antiviral controls for COVID-19 pandemic.
|
NA
|
NA
|
|
Deep Learning-Based Potential Ligand Prediction Framework for COVID-19 with Drug-Target Interaction Model.
|
NA
|
NA
|
|
The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.
|
NA
|
NA
|
|
Pulmonary emphysema, bullae, and pneumothorax in COVID-19 pneumonia.
|
NA
|
NA
|
|
Anaesthesiologist-intensivist phycisians at the core of the management of critically ill COVID-19 patients in Africa: persistent challenges, some resolved dilemma and future perspective.
|
NA
|
NA
|
|
[SARS-CoV-2 infection in pregnant women: Tunisian series of 11 cases].
|
NA
|
NA
|
|
ALLERGY AND CORONAVIRUS DISEASE (COVID-19) INTERNATIONAL SURVEY: REAL-LIFE DATA FROM THE ALLERGY COMMUNITY DURING THE PANDEMIC.
|
NA
|
NA
|
|
Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19.
|
NA
|
NA
|
|
Prompt and unavoidable requalification of ordinary hospital wards into a centralized department characterized by high-intensity treatment due to COVID-19 epidemic: the experience of Romano di Lombardia Hospital.
|
NA
|
NA
|
|
A case report on a severely ill COVID-19 patient with rapid clearing of chest infiltrates 43 hours after treatment with multiple modalities.
|
NA
|
NA
|
|
Remdesivir in a pregnant patient with COVID-19 pneumonia.
|
NA
|
NA
|
|
Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques.
|
NA
|
NA
|
|
Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2.
|
NA
|
NA
|
|
COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India.
|
NA
|
NA
|
|
An Atypical Case of COVID-19 Induced Pancytopenia, Rhabdomyolysis and Myocarditis.
|
NA
|
NA
|
|
Recent Advancement in SARS-CoV-2 Diagnosis, Treatment, and Vaccine Formulation: a New Paradigm of Nanotechnology in Strategic Combating of COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
|
NA
|
NA
|
|
Organizing pneumonia and COVID-19: A report of two cases.
|
NA
|
NA
|
|
Fuzzy Cloud Based COVID-19 Diagnosis Assistant for identifying affected cases globally using MCDM.
|
NA
|
NA
|
|
Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context.
|
NA
|
NA
|
|
Emperor’s syndrome in the COVID-19 era: Time for patient-centered nephrology?
|
NA
|
NA
|
|
Influence of Empathy Disposition and Risk Perception on the Psychological Impact of Lockdown During the Coronavirus Disease Pandemic Outbreak.
|
NA
|
NA
|
|
Computational Characterizations of the Interactions Between the Pontacyl Violet 6R and Exoribonuclease as a Potential Drug Target Against SARS-CoV-2.
|
NA
|
NA
|
|
Can GPR4 Be a Potential Therapeutic Target for COVID-19?
|
NA
|
NA
|
|
Deep Learning-Based Haptic Guidance for Surgical Skills Transfer.
|
NA
|
NA
|
|
Effect of liver injury on prognosis and treatment of hospitalized patients with COVID-19 pneumonia.
|
NA
|
NA
|
|
Clinical findings in a group of COVID-19 patients: a single-center retrospective study.
|
NA
|
NA
|
|
The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus.
|
NA
|
NA
|
|
Guillain-Barré Syndrome in a COVID-19 Patient: A Case Report and Review of Management Strategies.
|
NA
|
NA
|
|
Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
|
NA
|
NA
|
|
An Ophthalmic Insight into Novel Coronavirus 2019 Disease: A Comprehensive Review of the Ocular Manifestations and Clinical Hazards.
|
NA
|
NA
|
|
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients.
|
NA
|
NA
|
|
A short review on nanotechnology interventions against COVID-19.
|
NA
|
NA
|
|
Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker.
|
NA
|
NA
|
|
Applicability of COVID-19 Pandemic Recommendations for Urology Practice: Data from Three Major Italian Hot Spots (BreBeMi).
|
NA
|
NA
|
|
Epidemiological and Clinical Characteristics of COVID-19 in Adolescents and Young Adults.
|
NA
|
NA
|
|
Fear of novel coronavirus disease (COVID-19) among pregnant and infertile women in Japan.
|
NA
|
NA
|
|
COVID 19 infection: Pediatric perspectives.
|
NA
|
NA
|
|
Hybrid Surgical Hot Clinic (HSHC): Evaluation of Surgical Hot Clinic Services during COVID-19 Lockdown.
|
NA
|
NA
|
|
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
|
NA
|
NA
|
|
Impact of COVID-19 on wound care in Germany.
|
NA
|
NA
|
|
Lower respiratory tract samples are reliable for severe acute respiratory syndrome coronavirus 2 nucleic acid diagnosis and animal model study.
|
NA
|
NA
|
|
Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.
|
NA
|
NA
|
|
The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
|
NA
|
NA
|
|
The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Worldwide Survey of COVID-19 Associated Arrhythmias.
|
NA
|
NA
|
|
Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic.
|
NA
|
NA
|
|
Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19.
|
NA
|
NA
|
|
The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.
|
NA
|
NA
|
|
Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives.
|
NA
|
NA
|
|
COVID-19: the new challenge for rheumatologists. One year later.
|
NA
|
NA
|
|
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
|
NA
|
NA
|
|
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart.
|
NA
|
NA
|
|
Long-term sero-positivity for IgG, sequelae of respiratory symptoms, and abundance of malformed sperms in a patient recovered from severe COVID-19.
|
NA
|
NA
|
|
Clinical characteristics of COVID-19 infection in a dialysis center during a nosocomial outbreak.
|
NA
|
NA
|
|
Paraneoplastic cerebellar degeneration as a presenting manifestation of non-Hodgkin’s lymphoma.
|
NA
|
NA
|
|
Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics.
|
NA
|
NA
|
|
The effects of coronavirus disease 2019 (COVID-19) pandemic on people with epilepsy (PwE): an online survey-based study.
|
NA
|
NA
|
|
Front-Line Innovation: Rapid Implementation of a Nurse-Driven Protocol for Care of Outpatients with COVID-19.
|
NA
|
NA
|
|
Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry.
|
NA
|
NA
|
|
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
|
NA
|
NA
|
|
Comparison of Associations between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Telehealth for Dysphagia Across the Life Span: Using Contemporary Evidence and Expertise to Guide Clinical Practice During and After COVID-19.
|
NA
|
NA
|
|
A Vital Layer of Support: One Safety Net Hospital’s Palliative Care Response to the Pandemic.
|
NA
|
NA
|
|
Telemedicine in Pediatrics: Systematic Review of Randomized Controlled Trials.
|
NA
|
NA
|
|
Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study.
|
NA
|
NA
|
|
COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience.
|
NA
|
NA
|
|
Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020.
|
NA
|
NA
|
|
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
|
NA
|
NA
|
|
SARS-CoV-2 and indoor/outdoor air samples: a methodological approach to have consistent and comparable results.
|
NA
|
NA
|
|
Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia.
|
NA
|
NA
|
|
The challenges of caring for people dying from COVID-19: a multinational, observational study (CovPall).
|
NA
|
NA
|
|
The fate of SARS-COV-2 in WWTPS points out the sludge line as a suitable spot for detection of COVID-19.
|
NA
|
NA
|
|
Wireless and battery-free platforms for collection of biosignals.
|
NA
|
NA
|
|
Characteristics and outcomes of COVID-19 inpatients who underwent psychiatric consultations.
|
NA
|
NA
|
|
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
|
NA
|
NA
|
|
Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.
|
NA
|
NA
|
|
In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19.
|
NA
|
NA
|
|
Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases.
|
NA
|
NA
|
|
COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis.
|
NA
|
NA
|
|
Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
|
NA
|
NA
|
|
New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.
|
NA
|
NA
|
|
Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment.
|
NA
|
NA
|
|
SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges.
|
NA
|
NA
|
|
Transition to Multidisciplinary Pediatric Telerehabilitation during the COVID-19 Pandemic: Strategy Development and Implementation.
|
NA
|
NA
|
|
Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.
|
NA
|
NA
|
|
Interim Analysis of Attrition Rates in Palliative Care Study on Dignity Therapy.
|
NA
|
NA
|
|
COVID-19 lung CT image segmentation using deep learning methods: U-Net versus SegNet.
|
NA
|
NA
|
|
Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis.
|
NA
|
NA
|
|
Impacts of the Covid-19 lockdown and relevant vulnerabilities on capability well-being, mental health and social support: an Austrian survey study.
|
NA
|
NA
|
|
Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning.
|
NA
|
NA
|
|
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics.
|
NA
|
NA
|
|
Dysentery as the only presentation of COVID-19 in a child: a case report.
|
NA
|
NA
|
|
Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome - a retrospective cohort study.
|
NA
|
NA
|
|
Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report.
|
NA
|
NA
|
|
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy.
|
NA
|
NA
|
|
Assessing patient risk from cancer and COVID-19: Managing patient distress.
|
NA
|
NA
|
|
“How will I get my next week’s script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
|
NA
|
NA
|
|
Suspension of fertility treatment during the COVID-19 pandemic: views, emotional reactions and psychological distress among women undergoing fertility treatment.
|
NA
|
NA
|
|
Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence.
|
NA
|
NA
|
|
Plitidepsin: a repurposed drug for the treatment of COVID-19.
|
NA
|
NA
|
|
and a promising oral antiviral for treatment of COVID-19.
|
NA
|
NA
|
|
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody.
|
NA
|
NA
|
|
Impact of COVID-19 pandemic on eye cancer care in United Kingdom.
|
NA
|
NA
|
|
Early cancer diagnosis: reaching targets across whole populations amidst setbacks.
|
NA
|
NA
|
|
The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic.
|
NA
|
NA
|
|
Urological cancer patients receiving treatment during COVID-19: a single-centre perspective.
|
NA
|
NA
|
|
Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2.
|
NA
|
NA
|
|
Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients.
|
NA
|
NA
|
|
Relationship between physical activity, healthy lifestyle and COVID-19 disease severity; a cross-sectional study.
|
NA
|
NA
|
|
Analysis of COVID-19 epidemic and clinical risk factors of patients under epidemiological Markov model.
|
NA
|
NA
|
|
Cost-effectiveness of surgical mask, N-95 respirator, hand-hygiene and surgical mask with hand hygiene in the prevention of COVID-19: Cost effectiveness analysis from Indian context.
|
NA
|
NA
|
|
Decreasing Incidence of AKI in Patients with COVID-19 critical illness in New York City.
|
NA
|
NA
|
|
COVID-19: patient characteristics in the first phase of post-intensive care rehabilitation.
|
NA
|
NA
|
|
COVID-19 May Affect Male Fertility but is Not Sexually Transmitted: A Systematic Review.
|
NA
|
NA
|
|
[Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].
|
NA
|
NA
|
|
How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
|
NA
|
NA
|
|
Evaluating the feasibility of performing elective gastrointestinal cancer surgery during the COVID-19 pandemic: An observational study with 60 days follow-up results of a tertiary referral pandemic hospital.
|
NA
|
NA
|
|
What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021.
|
NA
|
NA
|
|
St Andrew’s COVID-19 surgery safety study: hand trauma.
|
NA
|
NA
|
|
The effect of the COVID-19 pandemic on mental health associated trauma, admissions and fractures at a London major trauma centre.
|
NA
|
NA
|
|
Precaution Measures for the Safety of the Personnel in the Surgical Wards during the COVID-19 Pandemic.
|
NA
|
NA
|
|
The burden of proximal femur fractures and other skeletal injuries during the Covid-19 pandemic lockdown: a retrospective comparative study.
|
NA
|
NA
|
|
[Mortality in sepsis and septic shock in Germany. Results of a systematic review and meta-analysis].
|
NA
|
NA
|
|
[Urologic cancer care during the first wave of the COVID-19 pandemic : Role of federal cancer registration in Germany].
|
NA
|
NA
|
|
The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding.
|
NA
|
NA
|
|
“COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment”.
|
NA
|
NA
|
|
[Cough in times of coronavirus].
|
NA
|
NA
|
|
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6.
|
NA
|
NA
|
|
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19.
|
NA
|
NA
|
|
The cytokine storm and thyroid hormone changes in COVID-19.
|
NA
|
NA
|
|
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019.
|
NA
|
NA
|
|
Renin-angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis of observational studies.
|
NA
|
NA
|
|
The Value of Triage during Periods of Intense COVID-19 Demand: Simulation Modeling Study.
|
NA
|
NA
|
|
The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19.
|
NA
|
NA
|
|
COVID-19 and the kidney: A South African state healthcare experience.
|
NA
|
NA
|
|
Pharmacological treatment during CoViD-19 and mental health issues.
|
NA
|
NA
|
|
Dual-mode gradient HPLC and TLC densitometry methods for the simultaneous determination of paracetamol and methionine in the presence of paracetamol impurities.
|
NA
|
NA
|
|
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.
|
NA
|
NA
|
|
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.
|
NA
|
NA
|
|
Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19.
|
NA
|
NA
|
|
Management of Allergic Diseases During COVID-19 Outbreak.
|
NA
|
NA
|
|
Eating disorders during COVID-19 pandemic: the experience of Italian healthcare providers.
|
NA
|
NA
|
|
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19.
|
NA
|
NA
|
|
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
|
NA
|
NA
|
|
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients.
|
NA
|
NA
|
|
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System’s Initiative to Expand Treatment Access during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Reduction in Oregon’s Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication.
|
NA
|
NA
|
|
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis.
|
NA
|
NA
|
|
Cutaneous manifestations of COVID-19.
|
NA
|
NA
|
|
Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
|
NA
|
NA
|
|
antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor.
|
NA
|
NA
|
|
Where There’s Smoke, There’s Fire: A Case Report of Turbulent Blood Flow in Lower Extremity Point-of-care Ultrasound in COVID-19.
|
NA
|
NA
|
|
The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical diseases: Why should we worry?
|
NA
|
NA
|
|
Effectiveness of telerehabilitation in physical therapy: A rapid overview.
|
NA
|
NA
|
|
Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.
|
NA
|
NA
|
|
Lessons learned from a cross-sectional survey among patients and staff in an acute psychiatric unit during an ongoing pandemic outbreak.
|
NA
|
NA
|
|
The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology.
|
NA
|
NA
|
|
Discovering symptom patterns of COVID-19 patients using association rule mining.
|
NA
|
NA
|
|
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
|
NA
|
NA
|
|
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis.
|
NA
|
NA
|
|
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders.
|
NA
|
NA
|
|
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation.
|
NA
|
NA
|
|
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.
|
NA
|
NA
|
|
for Public Palliative Care Education during the COVID-19 Pandemic.
|
NA
|
NA
|
|
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment.
|
NA
|
NA
|
|
Nucleoside Inhibitors of Coronaviruses.
|
NA
|
NA
|
|
Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
|
NA
|
NA
|
|
Impact of the coronavirus disease 2019 pandemic on orthodontic patients and their attitude to orthodontic treatment.
|
NA
|
NA
|
|
A Medication Therapy Management Residency Rotation Adjusts to Coronavirus Disease 2019 Constraints.
|
NA
|
NA
|
|
The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.
|
NA
|
NA
|
|
Challenges in diabetic foot treatment during pandemic of COVID-19.
|
NA
|
NA
|
|
Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19.
|
NA
|
NA
|
|
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
|
NA
|
NA
|
|
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19.
|
NA
|
NA
|
|
Structural modeling and analysis of the SARS-CoV-2 cell entry inhibitor camostat bound to the trypsin-like protease TMPRSS2.
|
NA
|
NA
|
|
Treating Social Anxiety in an Era of Social Distancing: Adapting Exposure Therapy for Youth During COVID-19.
|
NA
|
NA
|
|
A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19).
|
NA
|
NA
|
|
Coagulopathy is associated with multiple organ damage and prognosis of COVID-19.
|
NA
|
NA
|
|
The value of artificial intelligence and imaging diagnosis in the fight against COVID-19.
|
NA
|
NA
|
|
COVID-19 pandemic and breast cancer management: A retrospective observational clinical study from Pakistan.
|
NA
|
NA
|
|
Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study.
|
NA
|
NA
|
|
Safety and Efficacy of Low-Dose Corticosteroids in Patients With Non-severe Coronavirus Disease 2019: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Budd-Chiari Syndrome: A Case Report of a Rare Presentation of COVID-19.
|
NA
|
NA
|
|
A peptide-based assay discriminates individual antibody response to SARS-CoV-2.
|
NA
|
NA
|
|
Future-proof Radiation therapist (RTT) practice in a pandemic - Lessons learnt from COVID-19.
|
NA
|
NA
|
|
Biases in evaluating the safety and effectiveness of drugs for covid-19: designing real-world evidence studies.
|
NA
|
NA
|
|
There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia.
|
NA
|
NA
|
|
Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
|
NA
|
NA
|
|
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there?
|
NA
|
NA
|
|
Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection.
|
NA
|
NA
|
|
Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID-19.
|
NA
|
NA
|
|
[Intenational breakthroughs in critical care medicine 2020].
|
NA
|
NA
|
|
The challenge of avidity determination in SARS-CoV-2 serology.
|
NA
|
NA
|
|
Neuro-axial steroid injection in pain management and COVID-19 vaccine.
|
NA
|
NA
|
|
Aortic stenosis in the time of COVID-19: Development and outcomes of a rapid turnaround TAVI service.
|
NA
|
NA
|
|
Factors Contributing to Parents’ Psychological and Medical Help Seeking During the COVID-19 Global Pandemic.
|
NA
|
NA
|
|
Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-α Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy.
|
NA
|
NA
|
|
Black and Latino Persons Living with HIV Evidence Risk and Resilience in the Context of COVID-19: A Mixed-Methods Study of the Early Phase of the Pandemic.
|
NA
|
NA
|
|
Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR.
|
NA
|
NA
|
|
A case of COVID-19 with papulovesicular rash that progressed to retiform purpura, accompanied by cherry angiomas.
|
NA
|
NA
|
|
Chlorine dioxide and chlorine derivatives for the prevention or treatment of COVID-19: a systematic review.
|
NA
|
NA
|
|
COVID-19 in cancer patients: a systematic review.
|
NA
|
NA
|
|
Clinical and epidemiological characteristics of children with COVID-19 in a pediatric hospital in Peru.
|
NA
|
NA
|
|
[Transfusion of convalescent plasma from patients with COVID -19].
|
NA
|
NA
|
|
Interventions related to cardiovascular complications in people hospitalized by covid-19: a scoping review.
|
NA
|
NA
|
|
Continuing cancer surgery through the first six months of the COVID-19 pandemic at an academic university hospital in India: A lower-middle-income country experience.
|
NA
|
NA
|
|
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
|
NA
|
NA
|
|
Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids.
|
NA
|
NA
|
|
Clinical Characteristics and Remedy Profiles of Patients with COVID-19: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment?
|
NA
|
NA
|
|
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
|
NA
|
NA
|
|
Could Physical Therapy Interventions Be Adopted in the Management of Critically Ill Patients with COVID-19? A Scoping Review.
|
NA
|
NA
|
|
A recommended management plan for coronavirus disease 2019-positive geriatric patients based in South African old age homes.
|
NA
|
NA
|
|
Ibrutinib-induced acute kidney injury via interstitial nephritis.
|
NA
|
NA
|
|
Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.
|
NA
|
NA
|
|
Risk Factors for Potential Mental Illness Among Brazilians in Quarantine Due To COVID-19.
|
NA
|
NA
|
|
Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19).
|
NA
|
NA
|
|
Impact of COVID-19 on Pakistani dentists: a nationwide cross sectional study.
|
NA
|
NA
|
|
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients.
|
NA
|
NA
|
|
Pneumonia scoring systems for severe COVID-19: which one is better.
|
NA
|
NA
|
|
Treatment of eating disorders in adolescents during the COVID-19 pandemic: a case series.
|
NA
|
NA
|
|
Universal health coverage and COVID-19: recent developments and implications.
|
NA
|
NA
|
|
Virtual health care & telehealth: Current therapy practice patterns.
|
NA
|
NA
|
|
Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission (POCUSCO): a study protocol of an international study.
|
NA
|
NA
|
|
Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area.
|
NA
|
NA
|
|
Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
|
NA
|
NA
|
|
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
|
NA
|
NA
|
|
Stress and Anxiety Management During the COVID-19 Pandemic (Lessons Learnt from a Cohort of Orthopaedic Registrars Redeployed to ITU).
|
NA
|
NA
|
|
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.
|
NA
|
NA
|
|
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19.
|
NA
|
NA
|
|
Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures.
|
NA
|
NA
|
|
Optimal control of the COVID-19 pandemic: controlled sanitary deconfinement in Portugal.
|
NA
|
NA
|
|
Short-Term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits.
|
NA
|
NA
|
|
Adherence with COVID-19 Preventive Measures and Associated Factors Among Residents of Dirashe District, Southern Ethiopia.
|
NA
|
NA
|
|
The Impact of the SARS-CoV-2 Pandemic on the Emergency Department and Management of the Pediatric Asthmatic Patient.
|
NA
|
NA
|
|
Guidelines and Safety Considerations in the Laboratory Diagnosis of SARS-CoV-2 Infection: A Prerequisite Study for Health Professionals.
|
NA
|
NA
|
|
An extended fuzzy decision-making framework using hesitant fuzzy sets for the drug selection to treat the mild symptoms of Coronavirus Disease 2019 (COVID-19).
|
NA
|
NA
|
|
Current treatment in COVID-19 disease: a rapid review.
|
NA
|
NA
|
|
Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials.
|
NA
|
NA
|
|
Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic.
|
NA
|
NA
|
|
Diagnosis and treatment of 471 patients with 2019 novel coronavirus disease (COVID-19).
|
NA
|
NA
|
|
COVID-19 related thrombi in ascending and descending thoracic aorta with peripheral embolization: a case report.
|
NA
|
NA
|
|
Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress.
|
NA
|
NA
|
|
COVID-19 and immunity: quo vadis?
|
NA
|
NA
|
|
Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS).
|
NA
|
NA
|
|
Translational Sleep Science in Behavioral Medicine: Introduction to this Special Issue.
|
NA
|
NA
|
|
CRISPR/Cas technology as a promising weapon to combat viral infections.
|
NA
|
NA
|
|
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.
|
NA
|
NA
|
|
[Preterm delivery by cesarean section in a woman with severe COVID-19 pneumonia].
|
NA
|
NA
|
|
Integrated care for older adults during the COVID-19 pandemic in Belgium: Lessons learned the hard way.
|
NA
|
NA
|
|
A cross-sectional study of pain status and psychological distress among individuals living with chronic pain: the Chronic Pain & COVID-19 Pan-Canadian Study.
|
NA
|
NA
|
|
Nutritional perspectives for the prevention and mitigation of COVID-19.
|
NA
|
NA
|
|
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
|
NA
|
NA
|
|
The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia.
|
NA
|
NA
|
|
Evaluation of COVID-19 Phobia and the Feeling of Loneliness in the Geriatric Age Group.
|
NA
|
NA
|
|
Preventing Clinician Suicide: A Call to Action During the COVID-19 Pandemic and Beyond.
|
NA
|
NA
|
|
COVID-19 and Orthopaedic International Humanitarianism.
|
NA
|
NA
|
|
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
|
NA
|
NA
|
|
Risk Factors of Coronavirus Disease 2019-Related Mortality and Optimal Treatment Regimens: A Retrospective Study.
|
NA
|
NA
|
|
Prediction and control of COVID-19 spreading based on a hybrid intelligent model.
|
NA
|
NA
|
|
Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration.
|
NA
|
NA
|
|
COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-A systematic review and meta-analysis.
|
NA
|
NA
|
|
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
|
NA
|
NA
|
|
Dissecting lipid metabolism alterations in SARS-CoV-2.
|
NA
|
NA
|
|
Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population.
|
NA
|
NA
|
|
Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review.
|
NA
|
NA
|
|
Impact of COVID-19 on the lives and psychosocial well-being of persons with epilepsy during the third trimester of the pandemic: Results from an international, online survey.
|
NA
|
NA
|
|
COVID-19 pandemic gestational diabetes screening guidelines: A retrospective study in Australian women.
|
NA
|
NA
|
|
‘It’s not hands-on therapy, so it’s very limited’: Telehealth use and views among allied health clinicians during the coronavirus pandemic.
|
NA
|
NA
|
|
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
|
NA
|
NA
|
|
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Fluoxetine Can Inhibit SARS-CoV-2 In Vitro.
|
NA
|
NA
|
|
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics.
|
NA
|
NA
|
|
No Evidence for Classic Thrombotic Microangiopathy in COVID-19.
|
NA
|
NA
|
|
Impact of Corticosteroid Administration within 7 Days of the Hospitalization for Influenza Pneumonia with Respiratory Failure: A Propensity Score Analysis Using a Nationwide Administrative Database.
|
NA
|
NA
|
|
Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.
|
NA
|
NA
|
|
More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation.
|
NA
|
NA
|
|
How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report.
|
NA
|
NA
|
|
The Impact of SARS-CoV-2 Outbreak on the Polish Dental Community’s Standards of Care-A Six-Month Retrospective Survey-Based Study.
|
NA
|
NA
|
|
The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany.
|
NA
|
NA
|
|
Phytonutrient and Nutraceutical Action against COVID-19: Current Review of Characteristics and Benefits.
|
NA
|
NA
|
|
Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization.
|
NA
|
NA
|
|
COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds.
|
NA
|
NA
|
|
Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection.
|
NA
|
NA
|
|
Elective orthopaedic cancellations due to the COVID-19 pandemic: where are we now, and where are we heading?
|
NA
|
NA
|
|
Trampolines injuries are bouncing back.
|
NA
|
NA
|
|
The impact of COVID-19 on primary retinopexy in preventing retinal detachment in a tertiary eye hospital emergency department.
|
NA
|
NA
|
|
Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: Preliminary results.
|
NA
|
NA
|
|
The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic.
|
NA
|
NA
|
|
Role of community pharmacists in medication management during COVID-19 lockdown.
|
NA
|
NA
|
|
Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
|
NA
|
NA
|
|
Pandemics in New South Wales prisons: the more things change….
|
NA
|
NA
|
|
The effect of online multimedia psychoeducational interventions on the resilience and perceived stress of hospitalized patients with COVID-19: a pilot cluster randomized parallel-controlled trial.
|
NA
|
NA
|
|
High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure.
|
NA
|
NA
|
|
Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
|
NA
|
NA
|
|
A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
|
NA
|
NA
|
|
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
|
NA
|
NA
|
|
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center.
|
NA
|
NA
|
|
Management of Viral Complications of Pregnancy: Pharmacotherapy to Reduce Vertical Transmission.
|
NA
|
NA
|
|
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19.
|
NA
|
NA
|
|
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies.
|
NA
|
NA
|
|
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.
|
NA
|
NA
|
|
Point-of-care lung ultrasound assessment for risk stratification and therapy guiding in COVID-19 patients. A prospective non-interventional study.
|
NA
|
NA
|
|
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study.
|
NA
|
NA
|
|
Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial.
|
NA
|
NA
|
|
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody.
|
NA
|
NA
|
|
Convalescent Plasma for the Treatment of Severe COVID-19.
|
NA
|
NA
|
|
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19.
|
NA
|
NA
|
|
Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis.
|
NA
|
NA
|
|
Potential of Immune-Related Therapy in COVID-19.
|
NA
|
NA
|
|
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature.
|
NA
|
NA
|
|
COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases.
|
NA
|
NA
|
|
Interventional cytopathology and cancer in Peru: how to act during COVID-19?
|
NA
|
NA
|
|
Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population.
|
NA
|
NA
|
|
Rhabdomyolysis in COVID-19 Patients: A Retrospective Observational Study.
|
NA
|
NA
|
|
Clinical Presentation and Successful Management of an Infant With Down Syndrome and COVID-19 in Riyadh, Saudi Arabia.
|
NA
|
NA
|
|
Pneumoperitoneum in a COVID-19 Patient Due to the Macklin Effect.
|
NA
|
NA
|
|
A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19.
|
NA
|
NA
|
|
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.
|
NA
|
NA
|
|
Malnutrition Prolongs the Hospitalization of Patients with COVID-19 Infection: A Clinical Epidemiological Analysis.
|
NA
|
NA
|
|
A sprayable Acid-Oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: a new potential solution for upper respiratory tract hygiene.
|
NA
|
NA
|
|
[The global impact of the COVID-19 pandemic on the care provision for people with mental health problems].
|
NA
|
NA
|
|
[Systemic consequences and clinical aspects of SARS-CoV-2 infection].
|
NA
|
NA
|
|
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.
|
NA
|
NA
|
|
Halting SARS-CoV-2: lung organoids step up to the plate.
|
NA
|
NA
|
|
Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection. A longitudinal prospective study nested to a population cohort.
|
NA
|
NA
|
|
Available apps for stroke telerehabilitation during corona virus disease 2019 confinement in Spain.
|
NA
|
NA
|
|
Characteristics, Treatment, and Outcomes of Patients With Severe or Life-threatening COVID-19 at a Military Treatment Facility-A Descriptive Cohort Study.
|
NA
|
NA
|
|
Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).
|
NA
|
NA
|
|
The “Maskne” microbiome - pathophysiology and therapeutics.
|
NA
|
NA
|
|
Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France.
|
NA
|
NA
|
|
Effects of anxiety sensitivity, disgust, and intolerance of uncertainty on the COVID stress syndrome: a longitudinal assessment of transdiagnostic constructs and the behavioural immune system.
|
NA
|
NA
|
|
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
|
NA
|
NA
|
|
The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuria.
|
NA
|
NA
|
|
Experiences of people affected by cancer during the outbreak of the COVID-19 pandemic: an exploratory qualitative analysis of public online forums.
|
NA
|
NA
|
|
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
|
NA
|
NA
|
|
Healthcare workers’ knowledge and attitudes towards COVID-19 in Saudi Arabia.
|
NA
|
NA
|
|
Effect of glucocorticoid therapy on the prognosis of patients with severe and critical COVID-19: a single-center retrospective cohort study.
|
NA
|
NA
|
|
Effects of non-drug interventions on depression, anxiety and sleep in COVID-19 patients: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Relationship between COVID-19 and the male reproductive system.
|
NA
|
NA
|
|
Pathogenesis of dysgeusia in COVID-19 patients: a scoping review.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.
|
NA
|
NA
|
|
Montelukast in Hospitalized Patients Diagnosed with COVID-19.
|
NA
|
NA
|
|
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review.
|
NA
|
NA
|
|
DIABETES MELLITUS IN COVID-19 PATIENTS: VERDICT OR NOT?
|
NA
|
NA
|
|
Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy.
|
NA
|
NA
|
|
Integration of genetically regulated gene expression and pharmacological library provides therapeutic drug candidates.
|
NA
|
NA
|
|
Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and the Acute Respiratory Distress Syndrome.
|
NA
|
NA
|
|
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
|
NA
|
NA
|
|
Potential drug targets of SARS-CoV-2: From genomics to therapeutics.
|
NA
|
NA
|
|
Decontamination of skin from SARS-CoV-2 with disinfectants active during and after application.
|
NA
|
NA
|
|
The Effect of Probiotics on Respiratory Tract Infection with Special Emphasis on COVID-19: A Periodic Review during 2010-2020.
|
NA
|
NA
|
|
Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
|
NA
|
NA
|
|
COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review.
|
NA
|
NA
|
|
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence.
|
NA
|
NA
|
|
Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
|
NA
|
NA
|
|
An On-Line Cross-Sectional Questionnaire to Assess Knowledge of COVID-19 Pandemic among Citizens Tested for the SARS-CoV-2 Virus in Quito and Ibarra, Ecuador.
|
NA
|
NA
|
|
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors.
|
NA
|
NA
|
|
Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea.
|
NA
|
NA
|
|
Challenges and advances in clinical applications of mesenchymal stromal cells.
|
NA
|
NA
|
|
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic.
|
NA
|
NA
|
|
Secondary care interface: optimising communication between teams within secondary care to improve the rehabilitation journey for older people.
|
NA
|
NA
|
|
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19.
|
NA
|
NA
|
|
Healthcare risk management during the SARS-CoV-2 virus pandemic in the European Union: The guaranteed access to medicines.
|
NA
|
NA
|
|
Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure.
|
NA
|
NA
|
|
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.
|
NA
|
NA
|
|
COVID-19 patients with hypertension are at potential risk of worsened organ injury.
|
NA
|
NA
|
|
Black Nurses Collaborative Approach to Addressing COVID-19 in Black Communities.
|
NA
|
NA
|
|
Optimal Investment in Prevention and Recovery for Mitigating Epidemic Risks.
|
NA
|
NA
|
|
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
|
NA
|
NA
|
|
Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm.
|
NA
|
NA
|
|
Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management.
|
NA
|
NA
|
|
A new horizon for the old antibacterial drug clofoctol.
|
NA
|
NA
|
|
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change.
|
NA
|
NA
|
|
Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
|
NA
|
NA
|
|
Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy.
|
NA
|
NA
|
|
Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients.
|
NA
|
NA
|
|
Pathogenesis of COVID-19 and the quality control of nucleic acid detection.
|
NA
|
NA
|
|
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
|
NA
|
NA
|
|
Assisted mobilisation in critical patients with COVID-19.
|
NA
|
NA
|
|
Surveillance of common respiratory infections during COVID-19 pandemic demonstrates preventive effectiveness of non-pharmaceutical interventions.
|
NA
|
NA
|
|
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.
|
NA
|
NA
|
|
Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays.
|
NA
|
NA
|
|
Neurological involvement in the respiratory manifestations of COVID-19 patients.
|
NA
|
NA
|
|
Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
|
NA
|
NA
|
|
Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.
|
NA
|
NA
|
|
Corticosteroids Treatment of Patients with Coronavirus Disease 2019: A Propensity Score Matching Study.
|
NA
|
NA
|
|
Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
|
NA
|
NA
|
|
Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: protocol and statistical analysis plan.
|
NA
|
NA
|
|
Paracentral acute middle maculopathy in the setting of central retinal artery occlusion following COVID-19 diagnosis.
|
NA
|
NA
|
|
Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study.
|
NA
|
NA
|
|
identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.
|
NA
|
NA
|
|
Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review.
|
NA
|
NA
|
|
Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
|
NA
|
NA
|
|
Institutional policies and readiness in management of critical illness among patients with viral hemorrhagic fever.
|
NA
|
NA
|
|
Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2.
|
NA
|
NA
|
|
Nasal Foreign Body, an Unanticipated Complication of COVID-19 Care: A Case Report.
|
NA
|
NA
|
|
Successful use of mild therapeutic hypothermia as compassionate treatment for severe refractory hypoxemia in COVID-19.
|
NA
|
NA
|
|
Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study.
|
NA
|
NA
|
|
Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient.
|
NA
|
NA
|
|
Cardiac Manifestations, Treatment Characteristics, and Outcomes of Paediatric Inflammatory Multisystem Syndrome Temporally Associated with Severe Acute Respiratory Syndrome Coronavirus-2: systematic review of case reports and case series.
|
NA
|
NA
|
|
2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.
|
NA
|
NA
|
|
Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections.
|
NA
|
NA
|
|
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice.
|
NA
|
NA
|
|
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
|
NA
|
NA
|
|
Case Report: Posterior Reversible Leukoencephalopathy Syndrome (PRES) as a Biologically Predictable Neurological Association in Severe COVID-19. First Reported Case From Australia and Review of Internationally Published Cases.
|
NA
|
NA
|
|
COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
|
NA
|
NA
|
|
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.
|
NA
|
NA
|
|
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
|
NA
|
NA
|
|
Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
|
NA
|
NA
|
|
What the COVID-19 Pandemic Reveals about Racial Differences in Child Welfare and Child Well-Being: An Introduction to the Special Issue.
|
NA
|
NA
|
|
Early estimation of the epidemiological parameters of novel coronavirus disease (COVID-2019) outbreak in Iran: 19 Feb-15 March, 2020.
|
NA
|
NA
|
|
“Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience”, a retrospective study-original article.
|
NA
|
NA
|
|
Emerging therapeutics in the management of COVID-19.
|
NA
|
NA
|
|
Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients.
|
NA
|
NA
|
|
Living under lockdown in the shadow of the COVID-19 pandemic in South Africa: anxious voices from the unplanned shift to online therapy.
|
NA
|
NA
|
|
Characteristics of effective online interventions: implications for adolescents with personality disorder during a global pandemic.
|
NA
|
NA
|
|
My story in response to the stories of my patients’ experience of the impact of the COVID-19 pandemic: a relational psychoanalytic approach.
|
NA
|
NA
|
|
Online Supportive Group as social intervention to face COVID lockdown. A qualitative study on psychotherapists, psychology trainees and students, and community people.
|
NA
|
NA
|
|
COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature.
|
NA
|
NA
|
|
Levels as Indicators of Possible Mechanical Ventilation-Induced Hyperventilation in COVID-19 Patients: A Retrospective Analysis.
|
NA
|
NA
|
|
Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.
|
NA
|
NA
|
|
Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis.
|
NA
|
NA
|
|
Case Report: Sublingual Microcirculatory Alterations in a Covid-19 Patient With Subcutaneous Emphysema, Venous Thrombosis, and Pneumomediastinum.
|
NA
|
NA
|
|
Indoor versus outdoor transmission of SARS-COV-2: environmental factors in virus spread and underestimated sources of risk.
|
NA
|
NA
|
|
Alternative to traditional noninvasive ventilation using a modified snorkel mask in a patient with SARS-COV2: A case report.
|
NA
|
NA
|
|
Effectiveness of glucocorticoids in patients hospitalized for severe SARS-CoV-2 pneumonia.
|
NA
|
NA
|
|
be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019.
|
NA
|
NA
|
|
Effects of neuromuscular electrical stimulation therapy on physical function in patients with COVID-19 associated pneumonia: Study protocol of a randomized controlled trial.
|
NA
|
NA
|
|
Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil Impact of COVID-19 on Brazilian Radiotherapy.
|
NA
|
NA
|
|
Reinfection or Reactivation of Coronavirus-19 in Patients with Hematologic Malignancies: Case Report Series.
|
NA
|
NA
|
|
Mucosal immune responses in COVID19 - a living review.
|
NA
|
NA
|
|
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in COVID-19 patients with Regular Intravenous Immunoglobulin Therapy.
|
NA
|
NA
|
|
Virtual fracture liaison clinics in the COVID era: an initiative to maintain fracture prevention services during the pandemic associated with positive patient experience.
|
NA
|
NA
|
|
Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China.
|
NA
|
NA
|
|
COVID-19 convalescent plasma: interim recommendations from the AABB.
|
NA
|
NA
|
|
COVID-19: immunopathology, pathophysiological mechanisms, and treatment options.
|
NA
|
NA
|
|
Mesenchymal stromal cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
|
NA
|
NA
|
|
Reply to Prophylactic Anticoagulation: Comment on the ACR Guidance for Management of Multisystem Inflammatory Syndrome in Children.
|
NA
|
NA
|
|
COVID-19 is viewed as severe as tumor and HIV; perceptions towards COVID-19.
|
NA
|
NA
|
|
The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
|
NA
|
NA
|
|
Therapeutic opportunities of edible antiviral plants for COVID-19.
|
NA
|
NA
|
|
Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.
|
NA
|
NA
|
|
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV.
|
NA
|
NA
|
|
Discovery and structural optimization of 3-O-β-chacotriosyl oleanane-type triterpenoids as potent entry inhibitors of SARS-CoV-2 virus infections.
|
NA
|
NA
|
|
Factors associated with delayed viral shedding in COVID-19 infected patients: A retrospective small-scale study.
|
NA
|
NA
|
|
EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro.
|
NA
|
NA
|
|
Biological responses to COVID-19: Insights from physiological and blood biomarker profiles.
|
NA
|
NA
|
|
[Psychological Distress during the Corona Shutdown: Associations between Behavioral Adaption and Psychological Distress in Individuals with Preexisting Psychiatric Conditions and Healthy Controls].
|
NA
|
NA
|
|
Could nutritional supplements act as therapeutic adjuvants in COVID-19?
|
NA
|
NA
|
|
The effects of disease-related knowledge on illness perception and psychological status of patients with COVID-19 in Hunan, China.
|
NA
|
NA
|
|
Psychosis, Telehealth, and COVID-19: Successes and Lessons Learned from the First Wave of the Pandemic.
|
NA
|
NA
|
|
Knowledge, attitude, and practices (KAPs) of Community pharmacists regarding COVID-19: A cross-sectional survey in two provinces of Pakistan.
|
NA
|
NA
|
|
Safety and Efficacy of Tocilizumab in the Treatment of Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia: A Retrospective Cohort Study.
|
NA
|
NA
|
|
Can Quantitative RT-PCR for SARS-CoV-2 Help in Better Management of Patients and Control of Coronavirus Disease 2019 Pandemic.
|
NA
|
NA
|
|
Comparison of Two Real-time Polymerase Chain Reaction Assays for the Detection of Severe Acute Respiratory Syndrome-CoV-2 from Combined Nasopharyngeal-Throat Swabs.
|
NA
|
NA
|
|
[Safe surgery and COVID-19: A narrative review].
|
NA
|
NA
|
|
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider.
|
NA
|
NA
|
|
Diagnostic imaging in COVID-19 pneumonia: a literature review.
|
NA
|
NA
|
|
Extracorporeal Life Support in COVID-19-related Acute Respiratory Distress Syndrome - a EuroELSO international survey.
|
NA
|
NA
|
|
The Double-Edged Sword of Systemic Corticosteroid Therapy in Viral Pneumonia:A Case Report and Comparative Review of Influenza Associated Mucormycosis Versus COVID-19 Associated Mucormycosis.
|
NA
|
NA
|
|
COVID-19 and the generation of novel scientific knowledge: Research questions and study designs.
|
NA
|
NA
|
|
Challenges facing users of hearing aids during the COVID-19 pandemic.
|
NA
|
NA
|
|
Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol 2020; 92:915-918.
|
NA
|
NA
|
|
Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.
|
NA
|
NA
|
|
Medicinal plants: Treasure for antiviral drug discovery.
|
NA
|
NA
|
|
Genetic and epigenetic factors associated with increased severity of Covid-19.
|
NA
|
NA
|
|
Digital Health Technology and Telemedicine-Based Hospital and Home Programs in Pulmonary Medicine During the COVID-19 Pandemic.
|
NA
|
NA
|
|
“Remdesivir-Associated Pancreatitis”.
|
NA
|
NA
|
|
von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
|
NA
|
NA
|
|
Impact of COVID-19 on Heart Failure Self-Care: A Qualitative Study.
|
NA
|
NA
|
|
[The role of supplying population with vitamin D in conditions of COVID-19 pandemic: foreign publications review].
|
NA
|
NA
|
|
Generation and validation of in-hospital mortality prediction score in COVID-19 patients: Alba-score.
|
NA
|
NA
|
|
Minimizing the impact of the COVID-19 epidemic on oncology clinical trials: a retrospective study of Beijing Cancer Hospital.
|
NA
|
NA
|
|
Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.
|
NA
|
NA
|
|
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.
|
NA
|
NA
|
|
An unusual case of gardening ocular injury during Covid-19 lockdown.
|
NA
|
NA
|
|
Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study.
|
NA
|
NA
|
|
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
|
NA
|
NA
|
|
The Role of Sialylation in Respiratory Viral Infection and Treatment.
|
NA
|
NA
|
|
Cross talk between COVID-19 and breast cancer.
|
NA
|
NA
|
|
Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.
|
NA
|
NA
|
|
Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19.
|
NA
|
NA
|
|
Toxicity as prime selection criterion among SARS-active herbal medications.
|
NA
|
NA
|
|
Point-of-care ultrasonography in the initial characterization of patients with COVID-19.
|
NA
|
NA
|
|
Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis.
|
NA
|
NA
|
|
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection.
|
NA
|
NA
|
|
Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension.
|
NA
|
NA
|
|
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
|
NA
|
NA
|
|
Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19.
|
NA
|
NA
|
|
The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: an Unknown Role of Bacterial Coinfections in COVID-19 Patients?
|
NA
|
NA
|
|
Optimal age- and sex-based management of the queue to ventilators during the Covid-19 crisis.
|
NA
|
NA
|
|
Acute pulmonary embolism and systemic thrombolysis in the era of COVID-19 global pandemic 2020: a case series of seven patients admitted to a regional hospital in the French epidemic cluster.
|
NA
|
NA
|
|
Nonstructural protein 7 and 8 complexes of SARS-CoV-2.
|
NA
|
NA
|
|
Evidence that Ginkgo Biloba could use in the influenza and coronavirus COVID-19 infections.
|
NA
|
NA
|
|
Low diaphragm muscle mass predicts adverse outcome in patients hospitalized for Covid-19 pneumonia: an exploratory pilot study.
|
NA
|
NA
|
|
Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19.
|
NA
|
NA
|
|
Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
|
NA
|
NA
|
|
Risk Factors for Mortality in COVID-19 Patients in a Community Teaching Hospital.
|
NA
|
NA
|
|
COVID-19 Crisis Effect: Experience at Two Orthopedic Trauma Units.
|
NA
|
NA
|
|
The Effect of COVID-19 on Israeli Ophthalmology Departments: Directors’ Perspectives.
|
NA
|
NA
|
|
Impact of teleophthalmology during COVID-19 lockdown in a tertiary care center in South India.
|
NA
|
NA
|
|
Aerosol containment box for laser treatment of retinopathy of prematurity in COVID-19 pandemic.
|
NA
|
NA
|
|
COVID-19-associated papilledema secondary to cerebral venous thrombosis in a young patient.
|
NA
|
NA
|
|
Resuming elective paediatric surgical procedures in the era of COVID-19.
|
NA
|
NA
|
|
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
|
NA
|
NA
|
|
Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center.
|
NA
|
NA
|
|
Delphi Project on the trends in Implant Dentistry in the COVID-19 era: Perspectives from Latin America.
|
NA
|
NA
|
|
Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends.
|
NA
|
NA
|
|
Recommendation to Use Wearable-based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients during the COVID-19 Pandemic.
|
NA
|
NA
|
|
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
|
NA
|
NA
|
|
The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
|
NA
|
NA
|
|
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.
|
NA
|
NA
|
|
Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.
|
NA
|
NA
|
|
Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
|
NA
|
NA
|
|
In the Zoom Where It Happened: Telepractice and the Voice Clinic in 2020.
|
NA
|
NA
|